data_2nbh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2nbh _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 39' ' ' TYR . 92.9 t . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 108.375 -0.972 . . . . 1.18 108.375 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.68 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 97.2 m-85 -130.63 139.68 50.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.478 0.656 . . . . 1.17 111.601 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 91' ' ' ALA . 36.9 t -107.9 98.64 8.19 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.166 -0.925 . . . . 0.82 109.346 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.588 ' HB2' ' NE2' ' A' ' 92' ' ' GLN . 33.9 m -104.24 141.71 35.8 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.393 -0.595 . . . . 0.25 109.393 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -59.63 -30.43 68.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.673 -0.694 . . . . 2.35 110.769 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.17 123.46 0.98 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.644 -0.872 . . . . 3.06 108.644 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.625 ' N ' HE22 ' A' ' 92' ' ' GLN . 1.5 p -86.65 127.99 34.97 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.814 -0.754 . . . . 1.06 110.433 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 72' ' ' VAL . 8.8 tp10 -103.45 138.07 40.68 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.973 -1.012 . . . . 1.14 109.649 -172.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.448 ' O ' HD13 ' A' ' 50' ' ' LEU . 6.3 m-20 -65.01 107.44 1.51 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.235 -0.439 . . . . 1.77 111.015 -174.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 92.9 p -65.48 -6.38 10.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.88 -0.6 . . . . 1.28 112.032 -174.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 3.6 mppt? -77.09 -38.63 51.94 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.434 0.635 . . . . 3.21 109.639 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -142.61 67.93 1.31 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.936 -1.029 . . . . 2.83 110.988 -176.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.474 ' CD2' ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -61.91 160.34 12.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.476 0.655 . . . . 1.8 111.469 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -67.65 155.6 38.81 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.341 -0.985 . . . . 1.81 108.341 171.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.402 ' HD2' ' C ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -62.61 -28.93 70.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.418 0.553 . . . . 3.71 110.233 178.061 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.581 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -67.62 -38.18 89.98 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.801 -0.714 . . . . 0.41 111.495 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.562 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 37.0 m -79.0 -41.36 29.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.995 0.426 . . . . 1.05 110.119 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.2 m -54.71 -35.16 63.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.52 -0.764 . . . . 1.06 109.851 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.19 -53.67 55.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.26 -0.882 . . . . 1.06 111.537 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.581 HD21 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -58.42 -45.46 88.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.416 0.626 . . . . 1.1 110.238 -178.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.5 mt -58.56 -43.31 89.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.954 -1.021 . . . . 1.07 110.175 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.18 -36.91 93.1 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.77 -0.728 . . . . 0.26 112.196 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.5 mt -60.6 -44.79 95.88 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.506 0.67 . . . . 1.15 110.248 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.578 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.2 mt -87.64 1.06 54.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.945 -1.025 . . . . 1.1 111.543 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 71.29 26.65 3.31 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.825 -0.625 . . . . 2.46 111.392 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.4 mt -78.44 140.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.938 -0.574 . . . . 1.07 110.281 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.537 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 11.5 mptt -91.26 118.0 30.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.709 -0.678 . . . . 2.65 109.815 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.01 -36.95 52.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.83 -0.623 . . . . 1.07 110.195 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.31 -19.23 79.6 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.735 -0.745 . . . . 0.57 112.283 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -85.25 -16.77 39.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.048 0.452 . . . . 0.86 110.331 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 94.1 mt -64.01 154.07 35.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.883 -0.598 . . . . 1.18 111.393 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -109.38 -80.37 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.647 -0.706 . . . . 2.47 112.503 -171.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -98.69 -90.67 0.29 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 112.537 0.569 . . . . 1.09 112.537 -170.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.0 OUTLIER -120.77 166.23 14.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.891 -0.595 . . . . 1.03 110.989 178.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.9 OUTLIER -118.03 171.37 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 106.665 -1.605 . . . . 1.03 106.665 167.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.77 120.6 1.76 Allowed Glycine 0 C--N 1.31 -0.911 0 C-N-CA 119.668 -1.254 . . . . 0.37 112.132 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -91.54 140.02 30.14 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 120.089 -0.644 . . . . 1.12 110.148 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.412 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 3.0 t-20 50.9 49.86 20.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.921 -1.036 . . . . 1.85 110.559 176.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 7.9 t -92.1 150.44 20.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.733 -1.121 . . . . 1.12 110.805 -174.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 t -109.41 121.12 43.43 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.794 -0.639 . . . . 1.6 110.022 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.69 124.24 10.92 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.514 2.142 . . . . 0.7 112.527 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.416 HD13 ' HB2' ' A' ' 40' ' ' CYS . 23.9 mt . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 115.966 -0.561 . . . . 1.49 109.715 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.569 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 110.013 -0.366 . . . . 1.08 110.013 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.625 HE22 ' N ' ' A' ' 44' ' ' THR . 1.2 tt0 -84.0 136.3 34.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.678 -0.49 . . . . 0.99 109.678 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.21 121.36 45.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.341 0.591 . . . . 1.11 111.217 -174.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.502 HG11 ' HA ' ' A' ' 111' ' ' PRO . 1.9 m -133.07 164.18 35.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.515 -0.766 . . . . 1.06 110.877 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.4 t -108.24 109.08 20.36 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.347 -0.842 . . . . 0.71 109.159 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 28.8 m -106.76 153.73 22.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.202 -0.454 . . . . 0.61 110.135 -175.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 t -86.64 -28.03 23.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.113 -0.494 . . . . 1.06 110.655 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.604 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 24.1 m120 -151.74 168.08 26.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.693 -0.484 . . . . 0.93 109.693 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.8 t -139.66 144.34 37.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.181 0.301 . . . . 1.18 110.783 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.493 ' HB2' HG22 ' A' ' 105' ' ' VAL . 50.8 m-85 -134.07 153.12 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.094 -0.336 . . . . 1.2 110.094 175.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.642 ' NE2' HD13 ' A' ' 104' ' ' LEU . 9.6 mm100 62.6 30.41 17.01 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.303 0.483 . . . . 1.11 112.303 172.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 67.05 -0.89 1.57 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.868 0.467 . . . . 2.63 111.827 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 76' ' ' CYS . . . 140.61 -13.73 2.94 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.805 -0.712 . . . . 0.29 112.514 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.642 HD13 ' NE2' ' A' ' 101' ' ' GLN . 48.2 mt -52.1 -36.13 50.07 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.991 0.424 . . . . 1.14 111.0 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.578 HG21 ' CD1' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -137.52 139.04 44.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.504 -0.771 . . . . 1.51 109.786 174.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.571 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.5 t30 -136.37 157.93 45.63 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.711 -0.848 . . . . 1.24 108.711 -174.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.604 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 10.7 m -135.64 150.87 29.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.983 0.734 . . . . 1.09 112.983 -175.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.69 50.31 67.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 114.74 -1.118 . . . . 0.24 112.086 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 81.0 m -96.87 125.92 41.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.767 0.318 . . . . 0.43 110.576 -175.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.9 p -119.39 138.95 27.02 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.901 -0.591 . . . . 1.16 109.78 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.502 ' HA ' HG11 ' A' ' 94' ' ' VAL . 36.7 Cg_exo -64.92 108.63 1.13 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.889 2.393 . . . . 0.42 112.006 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.1 tt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.585 -0.734 . . . . 1.21 111.007 -175.481 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.47 HG11 ' N ' ' A' ' 39' ' ' TYR . 19.2 t . . . . . 0 N--CA 1.461 0.084 0 N-CA-C 110.29 -0.263 . . . . 1.18 110.29 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.47 ' N ' HG11 ' A' ' 38' ' ' VAL . 63.8 m-85 -132.91 140.1 47.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.978 0.418 . . . . 1.17 110.577 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.672 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 52.4 t -117.79 103.21 9.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.017 -0.538 . . . . 0.82 110.778 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.8 m -100.17 129.58 46.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.703 -0.851 . . . . 0.25 108.703 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.493 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 94.6 m-20 -59.78 -24.24 63.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.55 0.69 . . . . 2.35 109.585 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 5.3 mmmm -161.78 134.64 6.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.088 -1.414 . . . . 3.06 107.724 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.495 HG22 HG11 ' A' ' 94' ' ' VAL . 22.9 p -88.39 157.73 18.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.441 -0.903 . . . . 1.06 110.49 169.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.454 ' CB ' HG23 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -119.12 142.53 47.83 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.366 -0.834 . . . . 1.14 110.179 -176.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.555 ' O ' HD11 ' A' ' 50' ' ' LEU . 11.9 t70 -71.88 101.51 2.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.523 -0.762 . . . . 1.77 110.349 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.498 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 57.1 p -67.72 -6.67 22.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.631 0.604 . . . . 1.28 112.631 -172.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.55 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -77.73 -40.9 39.59 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.777 0.799 . . . . 3.21 109.179 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -147.12 68.86 1.15 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.692 -1.14 . . . . 2.83 109.874 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.555 HD11 ' O ' ' A' ' 46' ' ' ASP . 3.1 mm? -53.08 153.18 3.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.562 0.696 . . . . 1.8 112.418 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.9 146.54 31.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.711 -1.132 . . . . 1.81 108.703 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -59.6 -27.62 66.45 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.705 -0.398 . . . . 3.71 110.857 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.602 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -69.77 -37.07 75.73 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.547 -0.835 . . . . 0.41 111.624 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.549 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 23.5 m -80.03 -43.95 21.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.831 0.348 . . . . 1.05 110.228 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.7 m -51.93 -36.2 48.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 1.06 109.813 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.558 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.36 -53.7 55.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.511 -0.768 . . . . 1.06 111.78 176.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.602 HD22 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -58.49 -46.59 86.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.462 0.649 . . . . 1.1 110.313 -178.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 54' ' ' THR . 52.9 mt -58.43 -44.8 89.27 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.854 -1.066 . . . . 1.07 110.135 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.44 -32.91 79.13 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.968 -0.634 . . . . 0.26 112.945 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.8 mt -64.01 -43.47 95.55 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.826 0.822 . . . . 1.15 110.123 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.437 ' CD1' HG21 ' A' ' 105' ' ' VAL . 3.4 mt -86.68 -1.33 57.62 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.535 -1.212 . . . . 1.1 110.961 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.2 m120 65.61 36.03 6.71 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.215 -0.902 . . . . 2.46 111.072 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.1 mt -82.96 145.09 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.599 -0.728 . . . . 1.07 109.502 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.58 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -99.32 117.96 34.93 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.331 0.586 . . . . 2.65 109.762 -178.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.29 -28.12 34.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.277 -0.874 . . . . 1.07 110.877 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.13 -15.44 78.65 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.168 -0.539 . . . . 0.57 112.6 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.437 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 17.2 t70 -86.21 -29.39 23.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.925 0.393 . . . . 0.86 110.332 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 86.0 mt -52.5 139.39 25.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.099 -0.955 . . . . 1.18 111.951 -174.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -96.67 -81.98 0.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.992 -1.004 . . . . 2.47 112.197 -171.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -94.77 -92.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.05 0.389 . . . . 1.09 112.05 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.3 mm? -117.39 171.32 8.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.319 0.58 . . . . 1.03 110.917 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.6 OUTLIER -121.08 172.88 7.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.565 -1.643 . . . . 1.03 106.565 165.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 105' ' ' VAL . . . -139.39 129.16 4.26 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 119.89 -1.147 . . . . 0.37 112.106 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.639 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -99.21 135.96 39.85 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.442 -0.503 . . . . 1.12 109.895 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.2 m120 46.56 51.16 12.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.199 -0.91 . . . . 1.85 110.531 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -87.41 147.98 25.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.064 -0.971 . . . . 1.12 109.575 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.7 m -109.59 108.97 59.94 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 116.048 -0.524 . . . . 1.6 110.356 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.59 120.02 7.15 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.12 1.88 . . . . 0.7 111.371 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.4 mt . . . . . 0 C--N 1.317 -0.809 0 CA-C-N 115.601 -0.727 . . . . 1.49 109.26 -177.754 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.672 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--O 1.234 0.262 0 N-CA-C 110.064 -0.346 . . . . 1.08 110.064 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.73 115.96 21.88 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.852 0.834 . . . . 0.99 109.694 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 117.13 33.24 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.169 -0.923 . . . . 1.11 110.832 -169.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 111' ' ' PRO . 9.5 m -129.93 171.53 17.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.547 -0.751 . . . . 1.06 111.854 -176.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 37.7 t -115.0 108.32 16.55 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.812 -1.085 . . . . 0.71 108.93 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 27.6 m -106.03 145.43 31.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.313 -0.403 . . . . 0.61 110.076 -176.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -76.04 -28.87 57.85 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.258 -0.428 . . . . 1.06 110.348 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.427 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 12.1 m120 -151.34 164.18 37.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 0.93 109.843 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 t -137.63 133.55 34.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.05 -0.523 . . . . 1.18 109.944 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.46 ' HB2' HG22 ' A' ' 105' ' ' VAL . 66.2 m-85 -119.37 157.25 28.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.963 -0.562 . . . . 1.2 109.827 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.664 ' NE2' HD13 ' A' ' 104' ' ' LEU . 8.8 mm100 60.35 30.51 19.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.441 . . . . 1.11 111.586 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 63.68 9.82 4.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 2.63 111.875 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.83 -24.29 3.02 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.73 -0.747 . . . . 0.29 112.507 175.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.664 HD13 ' NE2' ' A' ' 101' ' ' GLN . 18.6 mt -49.86 -36.13 25.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.825 0.305 . . . . 1.14 111.825 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 100' ' ' TYR . 0.3 OUTLIER -141.38 118.82 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.392 0.615 . . . . 1.51 110.992 173.148 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.571 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 7.5 m-20 -111.03 162.64 14.66 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.5 -0.773 . . . . 1.24 109.488 176.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.4 m -132.85 154.32 39.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.336 0.495 . . . . 1.09 112.336 -176.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 59.8 52.29 53.87 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.278 -0.874 . . . . 0.24 111.88 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 73.3 m -96.81 123.6 40.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.878 0.37 . . . . 0.43 111.116 -174.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.4 p -119.72 125.94 27.18 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.919 -0.582 . . . . 1.16 110.131 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.505 ' HA ' HG13 ' A' ' 94' ' ' VAL . 81.5 Cg_exo -48.38 109.87 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.752 2.301 . . . . 0.42 111.665 175.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.3 tt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 1.21 111.747 -169.477 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.9 t . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 110.144 -0.317 . . . . 1.18 110.144 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.29 136.44 48.16 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.855 -0.424 . . . . 1.17 109.855 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 48.0 t -102.99 114.82 29.42 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.806 0.336 . . . . 0.82 110.589 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.1 m -115.25 125.18 53.02 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.928 -0.767 . . . . 0.25 108.928 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.448 ' HA ' ' HB2' ' A' ' 91' ' ' ALA . 24.7 t-20 -50.64 -34.36 25.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.614 -0.721 . . . . 2.35 110.231 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -154.58 127.48 8.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.652 -1.158 . . . . 3.06 108.725 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.501 HG22 HG13 ' A' ' 94' ' ' VAL . 18.0 p -84.37 156.94 21.62 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.53 -0.868 . . . . 1.06 110.514 168.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -120.58 139.23 53.25 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.617 -0.72 . . . . 1.14 109.451 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.417 ' O ' HD13 ' A' ' 50' ' ' LEU . 24.1 t70 -65.65 110.81 2.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.029 -0.532 . . . . 1.77 110.376 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.536 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 58.5 p -69.41 -2.45 11.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.262 -0.426 . . . . 1.28 112.073 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -90.12 -27.99 19.26 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.115 0.483 . . . . 3.21 109.759 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -141.62 64.28 1.41 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.57 . . . . 2.83 110.592 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.505 HD12 ' CG1' ' A' ' 72' ' ' VAL . 2.8 mm? -60.74 150.21 33.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.291 0.567 . . . . 1.8 111.559 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.93 144.13 57.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.831 -1.077 . . . . 1.81 108.438 169.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -62.8 -21.07 65.62 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.213 -0.195 . . . . 3.71 110.902 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.531 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -71.31 -36.57 63.36 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.583 -0.818 . . . . 0.41 111.202 174.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.523 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 37.9 m -82.05 -43.98 17.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.817 0.342 . . . . 1.05 110.198 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.1 m -52.5 -35.37 52.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.698 -0.683 . . . . 1.06 110.04 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.629 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -55.82 -53.69 53.62 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.377 -0.829 . . . . 1.06 111.288 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.531 HD21 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -59.6 -44.9 93.23 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.221 0.534 . . . . 1.1 109.995 -178.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 54' ' ' THR . 54.1 mt -58.12 -46.08 86.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.094 -0.957 . . . . 1.07 109.992 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.24 -29.66 75.15 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.003 -0.617 . . . . 0.26 112.574 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.1 mt -65.73 -47.53 75.01 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.639 0.733 . . . . 1.15 110.161 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.461 ' CD1' HG22 ' A' ' 105' ' ' VAL . 3.7 mt -83.09 -2.41 55.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.764 -1.107 . . . . 1.1 110.996 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.2 t30 68.17 38.38 2.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.222 -0.899 . . . . 2.46 110.978 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 58' ' ' LEU . 51.3 mt -84.32 137.74 20.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.778 -0.646 . . . . 1.07 110.099 175.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 64' ' ' LYS . 1.9 mppt? -84.11 118.0 23.81 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.645 -0.707 . . . . 2.65 110.304 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.91 -31.69 51.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.763 -0.653 . . . . 1.07 109.902 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.92 -9.53 86.61 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.774 -0.648 . . . . 0.57 112.604 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -95.6 -8.78 33.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.399 0.618 . . . . 0.86 110.283 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.6 mt -69.22 144.08 53.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.721 -0.672 . . . . 1.18 111.223 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -101.17 -68.73 0.8 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.843 -1.071 . . . . 2.47 112.557 -168.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -114.51 -91.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.853 0.359 . . . . 1.09 111.825 -172.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 46' ' ' ASP . 1.3 mm? -116.25 169.34 9.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.056 0.455 . . . . 1.03 110.393 174.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.505 ' CG1' HD12 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -124.89 166.88 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.596 -1.631 . . . . 1.03 106.596 166.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.463 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -134.1 148.24 19.38 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 119.807 -1.187 . . . . 0.37 111.364 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -112.1 134.4 53.67 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.151 -0.62 . . . . 1.12 110.549 177.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.51 45.14 25.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.824 -1.08 . . . . 1.85 111.163 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.463 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 63.3 m -77.61 146.91 35.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.334 0.588 . . . . 1.12 111.275 -176.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t -98.03 113.28 63.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.168 -0.924 . . . . 1.6 109.523 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.06 124.39 12.56 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.379 2.053 . . . . 0.7 111.954 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.8 mt . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 115.932 -0.576 . . . . 1.49 109.729 -178.789 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.761 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 110.362 -0.236 . . . . 1.08 110.362 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.0 124.03 31.23 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.404 0.621 . . . . 0.99 110.069 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.33 115.73 30.89 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.826 -0.625 . . . . 1.11 110.991 -173.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 111' ' ' PRO . 9.5 m -126.42 165.08 25.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.936 -0.574 . . . . 1.06 111.316 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.6 121.96 45.03 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.079 -1.082 . . . . 0.71 108.079 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 27.1 m -120.57 152.35 38.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 0.61 111.664 -167.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.404 HG22 ' HA3' ' A' ' 108' ' ' GLY . 10.9 t -81.2 -30.08 34.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.072 -0.967 . . . . 1.06 110.637 -170.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.466 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 17.8 m120 -154.56 167.82 28.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.39 -0.596 . . . . 0.93 109.39 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 t -147.37 135.99 21.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.118 0.485 . . . . 1.18 110.622 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.427 ' HB2' HG23 ' A' ' 105' ' ' VAL . 67.1 m-85 -129.55 154.31 47.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.361 -0.607 . . . . 1.2 109.361 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.646 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 10.7 mm100 59.88 38.1 21.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.545 -0.298 . . . . 1.11 111.48 176.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.7 p80 58.88 2.18 0.23 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.152 0.981 . . . . 2.63 113.201 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.69 -18.19 3.01 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.691 -0.766 . . . . 0.29 112.242 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 20.7 mt -49.8 -44.02 48.88 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.871 0.336 . . . . 1.14 110.767 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.461 HG22 ' CD1' ' A' ' 61' ' ' LEU . 1.4 m -128.9 119.65 50.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.698 0.761 . . . . 1.51 110.344 172.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.448 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 32.5 t30 -119.12 146.31 45.23 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.075 -1.083 . . . . 1.24 108.075 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.526 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 11.3 m -132.45 156.21 42.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.537 0.94 . . . . 1.09 113.537 -173.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.689 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 65.45 49.36 61.12 Favored Glycine 0 CA--C 1.503 -0.66 0 CA-C-N 114.952 -1.022 . . . . 0.24 111.716 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 98.7 m -98.15 126.59 43.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.964 0.411 . . . . 0.43 111.533 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -120.86 126.14 26.78 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.505 -0.771 . . . . 1.16 109.852 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.505 ' HA ' HG12 ' A' ' 94' ' ' VAL . 71.7 Cg_exo -50.15 112.34 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.049 2.499 . . . . 0.42 112.117 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.0 tt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.894 -0.594 . . . . 1.21 111.096 -173.343 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 107.85 -1.167 . . . . 1.18 107.85 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -118.3 137.01 53.36 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.872 0.844 . . . . 1.17 111.817 -176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.683 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 53.1 t -109.05 115.71 30.57 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.842 -1.072 . . . . 0.82 110.152 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.7 m -113.57 126.69 55.57 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.201 -0.666 . . . . 0.25 109.201 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -57.63 -23.21 49.92 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.473 -0.785 . . . . 2.35 109.769 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -166.24 132.46 2.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.55 -1.204 . . . . 3.06 108.028 172.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.507 HG22 HG12 ' A' ' 94' ' ' VAL . 25.1 p -89.6 159.47 17.15 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.456 -0.898 . . . . 1.06 110.494 172.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.401 ' CB ' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -120.58 144.89 47.85 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.208 -0.905 . . . . 1.14 109.305 -176.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 48' ' ' LYS . 33.4 t70 -78.52 105.49 9.83 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.973 -0.558 . . . . 1.77 110.313 -174.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.488 ' HA ' HD21 ' A' ' 50' ' ' LEU . 80.1 p -63.21 -7.07 5.17 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.125 0.787 . . . . 1.28 113.125 -172.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 2.9 mptp? -81.4 -43.49 18.88 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.335 0.588 . . . . 3.21 110.301 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -135.78 63.94 1.58 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.222 -0.899 . . . . 2.83 111.211 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.8 mm? -60.06 155.97 15.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.265 0.555 . . . . 1.8 111.453 176.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.26 152.29 41.4 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.638 -0.875 . . . . 1.81 108.638 168.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -63.24 -28.96 70.39 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.415 -0.514 . . . . 3.71 110.638 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.533 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -67.54 -38.14 90.29 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.796 -0.716 . . . . 0.41 111.879 177.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.554 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 41.7 m -78.93 -41.79 28.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.961 0.41 . . . . 1.05 109.931 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -52.41 -36.11 53.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.448 -0.796 . . . . 1.06 109.805 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.15 -53.99 52.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.046 -0.979 . . . . 1.06 111.626 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -57.37 -46.31 83.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.492 0.663 . . . . 1.1 110.016 -179.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.0 mt -58.69 -45.22 89.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.719 -1.128 . . . . 1.07 109.827 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.34 -36.39 90.85 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.762 -0.654 . . . . 0.26 112.657 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 25.5 mt -59.41 -40.29 86.19 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.613 0.72 . . . . 1.15 110.439 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.68 -3.65 57.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.923 -1.035 . . . . 1.1 110.836 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 72.03 30.69 2.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.353 -0.84 . . . . 2.46 111.305 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.59 141.95 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.984 -0.553 . . . . 1.07 109.819 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.477 ' CG ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -97.46 117.69 32.28 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.355 0.598 . . . . 2.65 110.084 -177.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.7 -39.15 59.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.199 -0.909 . . . . 1.07 110.791 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.9 -11.42 60.67 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.949 -0.643 . . . . 0.57 112.952 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.477 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 36.6 t70 -111.94 3.63 17.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.253 0.549 . . . . 0.86 110.793 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.4 mt -70.85 164.72 24.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.304 -0.407 . . . . 1.18 110.636 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -106.52 -91.93 0.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.586 0.587 . . . . 2.47 112.586 -174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.445 ' O ' HD12 ' A' ' 71' ' ' LEU . 5.6 m-20 -91.81 -84.43 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.622 0.601 . . . . 1.09 112.622 -171.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -123.55 166.88 14.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.358 0.599 . . . . 1.03 111.032 176.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 106' ' ' ASN . 0.8 OUTLIER -117.48 172.92 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.526 -1.657 . . . . 1.03 106.526 166.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.529 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -143.26 149.12 21.07 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.145 -1.026 . . . . 0.37 111.532 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -112.52 132.73 54.95 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.137 0.494 . . . . 1.12 109.96 175.117 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.4 m120 55.59 47.51 20.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.867 -1.06 . . . . 1.85 110.91 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.529 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 63.6 m -82.58 138.93 34.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.871 -0.604 . . . . 1.12 110.952 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.5 m -103.02 127.52 29.68 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.576 -0.738 . . . . 1.6 110.482 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.04 126.35 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.491 2.127 . . . . 0.7 112.365 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.449 -0.796 . . . . 1.49 109.563 -179.521 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.683 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 108.46 -0.941 . . . . 1.08 108.46 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.33 116.41 20.39 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.669 0.747 . . . . 0.99 109.336 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.19 123.52 44.53 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.558 -0.746 . . . . 1.11 110.445 -171.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.507 HG12 HG22 ' A' ' 44' ' ' THR . 7.6 m -134.41 163.16 37.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.508 -0.769 . . . . 1.06 111.423 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 47.3 t -107.99 114.88 29.11 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.301 -1.0 . . . . 0.71 108.301 176.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 28.0 m -114.88 148.2 38.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.166 -0.47 . . . . 0.61 110.142 -173.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -78.97 -32.9 45.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.958 -0.565 . . . . 1.06 110.651 -174.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -153.02 163.4 39.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.93 110.313 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -136.03 143.23 44.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.13 -0.486 . . . . 1.18 110.119 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.498 ' HB2' HG21 ' A' ' 105' ' ' VAL . 60.0 m-85 -129.67 153.42 48.15 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.332 -0.618 . . . . 1.2 109.332 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.626 ' NE2' HD11 ' A' ' 104' ' ' LEU . 10.1 mm100 62.9 30.59 16.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 1.11 111.075 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 65.53 2.41 2.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.808 -0.633 . . . . 2.63 112.378 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.37 -16.62 3.37 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.32 -0.943 . . . . 0.29 112.868 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.626 HD11 ' NE2' ' A' ' 101' ' ' GLN . 20.5 mt -50.11 -38.05 36.95 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.026 0.413 . . . . 1.14 110.689 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.498 HG21 ' HB2' ' A' ' 100' ' ' TYR . 5.6 m -130.0 149.14 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.755 -0.657 . . . . 1.51 109.312 171.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 7.8 t30 -144.31 149.99 37.13 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.778 -0.823 . . . . 1.24 108.778 -174.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.0 m -130.88 151.59 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 113.006 0.743 . . . . 1.09 113.006 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.19 50.42 67.32 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 114.838 -1.074 . . . . 0.24 112.104 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 74.7 m -97.75 126.47 43.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.608 0.242 . . . . 0.43 111.304 -175.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 21.4 p -118.88 138.05 25.64 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.464 -0.334 . . . . 1.16 110.465 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.506 ' HA ' HG11 ' A' ' 94' ' ' VAL . 24.2 Cg_exo -67.53 110.85 2.17 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.294 2.663 . . . . 0.42 112.889 -175.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.8 tt . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.942 -0.572 . . . . 1.21 111.123 -178.78 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 107.953 -1.129 . . . . 1.18 107.953 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.458 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 94.6 m-85 -120.89 138.49 54.06 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.827 -0.749 . . . . 1.17 111.594 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.74 ' SG ' ' HB2' ' A' ' 91' ' ' ALA . 42.2 t -111.75 100.29 8.83 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.043 -0.98 . . . . 0.82 110.031 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.9 m -101.95 128.19 48.47 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.085 -0.709 . . . . 0.25 109.085 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -57.12 -24.6 55.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.817 -0.629 . . . . 2.35 110.261 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.8 120.09 0.88 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.308 -0.86 . . . . 3.06 108.703 177.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.508 HG21 HG12 ' A' ' 94' ' ' VAL . 18.4 p -78.81 147.35 33.29 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.121 -1.032 . . . . 1.06 110.505 172.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -114.07 142.32 46.35 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.479 -0.782 . . . . 1.14 109.421 -175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.45 ' O ' HD13 ' A' ' 50' ' ' LEU . 28.2 m-20 -70.45 103.97 2.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.949 -0.569 . . . . 1.77 111.129 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.477 ' HA ' HD23 ' A' ' 50' ' ' LEU . 7.1 m -58.71 -14.59 8.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.309 0.485 . . . . 1.28 112.309 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -77.16 -35.64 55.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.834 0.349 . . . . 3.21 110.218 -178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -146.74 65.35 1.18 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.07 -0.514 . . . . 2.83 111.073 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 47' ' ' SER . 2.7 mm? -57.0 151.3 15.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.481 . . . . 1.8 111.242 175.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.77 156.49 39.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.203 -0.666 . . . . 1.81 109.203 172.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -59.99 -33.35 71.85 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.806 -0.358 . . . . 3.71 111.014 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.554 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -61.83 -34.2 87.93 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.843 -0.694 . . . . 0.41 111.812 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.522 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 24.1 m -85.04 -43.08 14.25 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.456 -0.202 . . . . 1.05 110.456 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.5 m -52.84 -35.22 57.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.256 0.551 . . . . 1.06 109.763 173.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.608 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.5 -55.45 33.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.277 -0.874 . . . . 1.06 111.494 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.554 HD21 ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -58.9 -44.76 91.29 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.34 0.59 . . . . 1.1 110.103 -177.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.4 mt -59.99 -43.44 95.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.138 -0.937 . . . . 1.07 110.114 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.14 -38.01 94.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.718 -0.754 . . . . 0.26 112.162 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.3 mt -62.23 -40.99 97.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.798 0.809 . . . . 1.15 110.187 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.7 mt -91.27 4.95 51.03 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.566 -1.197 . . . . 1.1 111.274 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 64.85 33.62 9.94 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.717 -0.674 . . . . 2.46 111.403 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.9 mt -89.91 144.13 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.875 -0.602 . . . . 1.07 110.324 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 11.3 mptt -94.31 118.43 31.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.825 -0.625 . . . . 2.65 109.963 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 65' ' ' ILE . 1.8 mp -68.48 -35.67 71.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.499 -0.773 . . . . 1.07 110.386 -177.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.87 -14.15 82.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.904 -0.665 . . . . 0.57 112.39 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -88.01 -19.71 26.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.006 0.431 . . . . 0.86 110.549 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.419 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 93.0 mt -55.5 141.93 35.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.699 0.762 . . . . 1.18 111.771 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.487 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -87.86 -66.62 0.89 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.725 -1.125 . . . . 2.47 112.457 -170.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 0.3 OUTLIER -123.73 -84.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.786 -0.366 . . . . 1.09 111.157 -177.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.45 167.12 11.33 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.291 0.567 . . . . 1.03 111.983 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.415 ' CG1' HD12 ' A' ' 50' ' ' LEU . 1.9 m -119.78 165.13 15.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.18 -1.415 . . . . 1.03 107.18 168.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.42 133.85 6.67 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.655 -1.26 . . . . 0.37 112.404 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.652 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.23 135.77 36.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.901 -0.407 . . . . 1.12 109.901 176.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.7 m120 46.79 52.92 10.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.466 -0.788 . . . . 1.85 110.634 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 9.3 t -92.85 137.38 32.42 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.118 -0.946 . . . . 1.12 109.883 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.3 t -100.55 125.71 38.17 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.92 -0.582 . . . . 1.6 110.893 -173.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.27 122.13 6.45 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.758 2.305 . . . . 0.7 112.568 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.627 -0.715 . . . . 1.49 109.845 -179.838 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.74 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.909 -0.404 . . . . 1.08 109.909 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.7 115.06 25.96 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.603 0.716 . . . . 0.99 110.697 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.64 124.08 37.4 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.422 -0.808 . . . . 1.11 111.154 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 111' ' ' PRO . 12.0 m -135.47 166.34 27.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.418 -0.81 . . . . 1.06 111.086 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.9 t -112.47 118.63 35.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.795 -0.817 . . . . 0.71 108.795 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 13.6 m -120.26 153.37 36.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.903 0.382 . . . . 0.61 111.117 -170.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 t -82.39 -29.46 30.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.799 -0.637 . . . . 1.06 111.082 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.411 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 13.3 m120 -156.17 159.16 38.74 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.125 -0.489 . . . . 0.93 109.965 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.8 t -135.3 142.44 45.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.127 -0.488 . . . . 1.18 110.036 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -130.28 159.74 35.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.646 -0.707 . . . . 1.2 109.635 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.655 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 9.7 mm100 59.32 31.32 21.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.16 -0.473 . . . . 1.11 111.61 177.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 67.98 -0.27 2.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.709 -0.678 . . . . 2.63 111.814 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 142.76 -19.63 2.37 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.78 -0.724 . . . . 0.29 112.162 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 34.5 mt -50.3 -43.4 53.57 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.316 0.579 . . . . 1.14 110.593 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 t -121.66 123.62 69.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.915 -1.039 . . . . 1.51 109.707 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.441 ' ND2' ' SG ' ' A' ' 96' ' ' CYS . 37.3 t30 -128.17 144.58 51.13 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.142 -1.058 . . . . 1.24 108.142 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.465 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 14.5 m -131.9 153.54 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 113.631 0.974 . . . . 1.09 113.631 -172.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.647 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 62.94 50.24 65.4 Favored Glycine 0 CA--C 1.505 -0.563 0 CA-C-N 114.729 -1.123 . . . . 0.24 111.725 176.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 70' ' ' ASP . 92.5 m -97.28 130.46 44.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.928 0.394 . . . . 0.43 111.436 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.8 p -124.22 125.43 25.72 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.659 -0.7 . . . . 1.16 109.962 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.515 ' HA ' HG11 ' A' ' 94' ' ' VAL . 78.5 Cg_exo -49.23 122.12 8.02 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.164 2.576 . . . . 0.42 113.002 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.9 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.751 -0.658 . . . . 1.21 110.84 -179.736 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 39' ' ' TYR . 91.4 t . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 107.515 -1.291 . . . . 1.18 107.515 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.572 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 95.2 m-85 -129.98 135.45 48.31 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.643 0.735 . . . . 1.17 112.23 -177.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.1 t -111.15 98.03 7.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.876 -1.056 . . . . 0.82 110.031 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.2 m -99.59 134.2 42.82 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.541 -0.541 . . . . 0.25 109.541 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.435 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 5.0 m-20 -51.47 -30.6 20.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.485 -0.78 . . . . 2.35 110.342 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -170.51 131.81 0.94 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.456 -1.247 . . . . 3.06 108.365 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.502 HG22 HG13 ' A' ' 94' ' ' VAL . 17.9 p -87.82 152.43 22.11 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.337 -0.945 . . . . 1.06 111.08 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.455 ' HB3' HG21 ' A' ' 72' ' ' VAL . 10.8 tp10 -119.6 141.25 49.46 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.99 -1.004 . . . . 1.14 109.665 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.446 ' O ' HD12 ' A' ' 50' ' ' LEU . 6.1 m-20 -68.88 110.59 4.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.477 -0.329 . . . . 1.77 110.981 -176.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.539 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 89.3 p -65.93 -8.69 23.87 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.099 0.476 . . . . 1.28 111.335 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.486 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 3.7 mppt? -74.31 -36.39 63.71 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.512 0.673 . . . . 3.21 110.123 175.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -143.83 65.2 1.31 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.09 -0.959 . . . . 2.83 111.107 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 47' ' ' SER . 2.3 mm? -59.68 157.27 12.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.595 0.712 . . . . 1.8 111.609 174.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.32 161.09 30.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.637 -1.165 . . . . 1.81 109.08 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.603 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -64.08 -32.01 73.41 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.959 -0.696 . . . . 3.71 110.551 177.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.542 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -66.0 -37.1 92.86 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.624 -0.798 . . . . 0.41 111.293 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.546 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 11.7 m -78.89 -42.59 26.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.121 0.486 . . . . 1.05 110.275 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.2 m -53.18 -35.25 59.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.335 -0.848 . . . . 1.06 109.797 172.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.498 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.88 -54.8 42.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.433 -0.803 . . . . 1.06 111.616 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.542 HD21 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -58.75 -45.72 89.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.467 0.651 . . . . 1.1 110.319 -178.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.5 mt -61.35 -42.1 98.15 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.964 -1.016 . . . . 1.07 109.941 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -34.14 84.25 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.791 -0.641 . . . . 0.26 112.583 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 26.0 mt -61.64 -50.2 73.5 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.637 0.732 . . . . 1.15 109.814 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 mt -83.99 8.25 15.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.569 -1.196 . . . . 1.1 110.669 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.1 p30 50.97 38.19 19.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.495 1.118 . . . . 2.46 111.737 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.4 mt -79.44 140.89 16.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.795 -1.093 . . . . 1.07 110.055 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 11.8 mptt -82.6 117.14 22.35 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.887 -0.597 . . . . 2.65 110.001 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.78 -31.32 50.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.342 0.591 . . . . 1.07 110.138 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.92 -22.24 72.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.031 -0.604 . . . . 0.57 112.638 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.58 -13.19 57.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.242 0.544 . . . . 0.86 110.253 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 92.3 mt -64.32 151.55 43.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.498 -0.774 . . . . 1.18 111.804 -177.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -101.66 -71.12 0.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.811 -1.086 . . . . 2.47 113.017 -169.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -120.49 -83.6 0.66 Allowed 'General case' 0 C--O 1.237 0.41 0 N-CA-C 112.54 0.57 . . . . 1.09 112.54 -171.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.2 mm? -119.41 168.41 10.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.296 0.57 . . . . 1.03 110.606 175.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.557 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -122.95 168.24 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 106.517 -1.66 . . . . 1.03 106.517 167.294 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.14 129.02 4.24 Favored Glycine 0 C--N 1.312 -0.773 0 C-N-CA 119.62 -1.276 . . . . 0.37 112.041 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.77 135.88 36.91 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.551 -0.46 . . . . 1.12 110.544 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m120 49.51 49.03 20.58 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.024 -0.989 . . . . 1.85 110.731 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 9.0 t -85.98 144.1 27.79 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.159 -0.928 . . . . 1.12 110.592 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.6 m -102.12 113.44 65.86 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.855 -0.611 . . . . 1.6 110.855 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.89 130.79 26.98 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.847 2.365 . . . . 0.7 112.816 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 mt . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.675 -0.693 . . . . 1.49 109.213 177.657 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.824 -0.436 . . . . 1.08 109.824 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.74 127.04 31.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.098 0.475 . . . . 0.99 110.139 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.91 120.32 39.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.274 0.559 . . . . 1.11 110.836 -174.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.502 HG13 HG22 ' A' ' 44' ' ' THR . 10.6 m -131.94 164.75 33.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.624 -0.716 . . . . 1.06 111.271 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 34.2 t -109.81 112.12 23.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.178 -0.919 . . . . 0.71 109.156 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 35.4 m -107.88 149.19 28.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.883 0.373 . . . . 0.61 110.725 -174.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.3 t -80.49 -27.21 37.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.914 -0.584 . . . . 1.06 110.455 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.509 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.6 m120 -153.83 163.85 39.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.449 -0.796 . . . . 0.93 109.064 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.5 t -136.22 134.21 37.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.165 0.507 . . . . 1.18 110.184 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.421 ' HB2' HG21 ' A' ' 105' ' ' VAL . 89.3 m-85 -117.64 149.5 40.59 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.668 -0.696 . . . . 1.2 109.94 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.617 ' NE2' HD12 ' A' ' 104' ' ' LEU . 9.7 mm100 62.57 26.92 15.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.759 -0.655 . . . . 1.11 111.265 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 64.01 9.07 4.35 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.251 -0.886 . . . . 2.63 112.177 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.27 -25.47 1.87 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.342 -0.932 . . . . 0.29 113.113 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 16.1 mt -49.16 -41.34 36.21 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.904 0.352 . . . . 1.14 111.54 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.421 HG21 ' HB2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -139.78 118.87 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.422 0.63 . . . . 1.51 111.047 173.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.557 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 8.7 m-20 -108.16 162.66 13.86 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.579 -0.737 . . . . 1.24 109.475 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.509 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 14.3 m -135.28 155.43 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.299 0.481 . . . . 1.09 112.299 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 58.62 51.82 56.64 Favored Glycine 0 CA--C 1.505 -0.578 0 CA-C-N 115.396 -0.82 . . . . 0.24 111.872 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 84.1 m -97.99 129.02 44.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.703 0.287 . . . . 0.43 110.721 -175.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.9 p -125.26 128.19 24.81 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.912 -0.585 . . . . 1.16 110.054 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.486 ' HA ' HG12 ' A' ' 94' ' ' VAL . 73.1 Cg_exo -51.3 109.28 0.3 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.785 2.323 . . . . 0.42 112.061 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.6 tt . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.637 -0.711 . . . . 1.21 110.735 -176.195 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.2 t . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 108.443 -0.947 . . . . 1.18 108.443 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.6 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 90.5 m-85 -122.28 136.88 54.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.496 0.665 . . . . 1.17 111.396 -177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 34.7 t -109.25 98.32 7.77 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.233 -0.894 . . . . 0.82 109.604 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.5 m -99.16 137.59 37.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.111 -0.699 . . . . 0.25 109.111 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.459 ' HA ' ' HB2' ' A' ' 91' ' ' ALA . 39.8 m-80 -59.03 -24.69 63.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.855 -0.611 . . . . 2.35 109.965 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -171.75 131.06 0.68 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.409 -1.269 . . . . 3.06 108.085 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.494 HG22 HG11 ' A' ' 94' ' ' VAL . 18.1 p -86.55 157.47 19.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.169 -1.012 . . . . 1.06 110.253 171.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HB3' HG23 ' A' ' 72' ' ' VAL . 7.1 tp10 -121.77 138.2 54.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.836 -0.62 . . . . 1.14 109.509 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.409 ' HA ' HD11 ' A' ' 71' ' ' LEU . 12.9 m-20 -67.6 109.5 3.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.194 -0.457 . . . . 1.77 110.159 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.1 p -57.09 -24.34 53.28 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.498 0.499 . . . . 1.28 111.208 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -90.78 -12.13 37.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.903 0.383 . . . . 3.21 111.284 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -126.37 25.2 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.979 0.418 . . . . 2.83 110.85 -176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.59 156.39 16.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.629 0.728 . . . . 1.8 111.91 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.95 168.48 9.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.894 -1.048 . . . . 1.81 109.767 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 11.8 mptt -62.01 -33.58 74.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.8 0.333 . . . . 3.71 110.502 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.438 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -61.75 -36.21 92.4 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.152 -0.547 . . . . 0.41 112.72 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.529 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 25.6 m -82.73 -43.36 16.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.819 0.31 . . . . 1.05 110.434 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.5 m -54.67 -33.21 60.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.896 -0.593 . . . . 1.06 110.053 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.558 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.23 -54.32 46.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.478 -0.783 . . . . 1.06 111.508 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.513 HD21 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.42 -47.29 84.42 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.268 0.556 . . . . 1.1 109.96 -178.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 54' ' ' THR . 25.1 mt -59.63 -41.99 91.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.98 -1.009 . . . . 1.07 110.188 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.53 -36.88 93.25 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.752 -0.658 . . . . 0.26 112.23 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 19.8 mt -61.3 -39.34 90.12 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.714 0.768 . . . . 1.15 110.092 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.526 HD23 ' HG2' ' A' ' 101' ' ' GLN . 4.5 mt -90.81 0.58 57.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.468 -1.242 . . . . 1.1 111.113 -176.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 69.03 34.53 3.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.481 -0.781 . . . . 2.46 111.349 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 58' ' ' LEU . 41.6 mt -88.71 147.12 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.001 -0.545 . . . . 1.07 110.042 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.538 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -100.62 118.96 37.84 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.383 0.611 . . . . 2.65 110.061 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.437 ' N ' HD13 ' A' ' 65' ' ' ILE . 1.8 mp -71.64 -31.48 42.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.15 -0.932 . . . . 1.07 110.972 -174.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.16 -15.34 74.49 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.966 -0.635 . . . . 0.57 112.752 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.4 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 23.8 t70 -95.32 -14.15 24.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.86 110.532 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.0 mt -57.87 140.32 52.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.268 0.556 . . . . 1.18 110.909 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -94.94 -77.64 0.46 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.231 -0.895 . . . . 2.47 112.532 -170.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.03 -98.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.975 0.361 . . . . 1.09 111.975 -173.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.6 mm? -109.04 168.92 9.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.558 0.694 . . . . 1.03 111.271 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.8 OUTLIER -117.18 167.9 9.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 106.754 -1.573 . . . . 1.03 106.754 166.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.34 121.59 2.22 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 119.765 -1.207 . . . . 0.37 111.893 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.682 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -94.06 136.02 34.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.742 -0.783 . . . . 1.12 109.705 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 53.14 61.33 3.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.041 0.924 . . . . 1.85 109.792 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.6 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 7.9 t -103.66 146.1 29.08 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.607 -1.179 . . . . 1.12 110.777 -171.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.1 m -102.26 109.97 61.56 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.823 -0.626 . . . . 1.6 110.216 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.9 120.32 7.24 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.777 2.318 . . . . 0.7 112.299 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 1.49 109.555 -179.716 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.459 ' HB2' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 110.017 -0.364 . . . . 1.08 110.017 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.05 124.23 28.55 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.354 0.597 . . . . 0.99 110.097 -176.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.52 116.0 31.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.744 -0.662 . . . . 1.11 110.875 -171.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 111' ' ' PRO . 11.2 m -128.29 164.63 29.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.663 -0.699 . . . . 1.06 111.457 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.1 t -108.34 110.98 22.68 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.623 -0.88 . . . . 0.71 108.623 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.8 m -112.92 146.41 39.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.934 0.397 . . . . 0.61 110.713 -172.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.7 t -81.11 -23.11 38.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 1.06 111.289 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -159.5 168.1 27.01 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.511 -0.551 . . . . 0.93 109.511 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.9 t -140.26 142.47 35.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.538 -0.301 . . . . 1.18 110.633 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.507 ' HB2' HG22 ' A' ' 105' ' ' VAL . 83.9 m-85 -134.12 158.32 43.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.909 -0.316 . . . . 1.2 110.686 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.561 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 6.5 mm100 59.43 40.25 21.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.138 -0.483 . . . . 1.11 111.549 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 p80 58.04 2.07 0.17 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.117 0.967 . . . . 2.63 112.393 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 101' ' ' GLN . . . 139.98 -15.9 3.04 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.966 -0.635 . . . . 0.29 112.658 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 24.6 mt -56.1 -37.29 69.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.076 0.438 . . . . 1.14 111.594 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 100' ' ' TYR . 3.6 m -130.39 149.82 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.333 0.587 . . . . 1.51 110.314 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.469 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.5 t30 -142.98 153.35 42.91 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.6 -0.889 . . . . 1.24 108.6 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.5 m -131.62 150.41 34.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.783 0.66 . . . . 1.09 112.783 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.11 52.32 53.52 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.939 -1.028 . . . . 0.24 111.824 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 83.1 m -97.31 127.05 42.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.741 0.305 . . . . 0.43 111.225 -176.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 p -120.79 126.47 26.67 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.93 -0.577 . . . . 1.16 110.574 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.499 ' HA ' HG13 ' A' ' 94' ' ' VAL . 50.5 Cg_exo -53.8 110.68 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.917 2.411 . . . . 0.42 112.112 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.4 tt . . . . . 0 C--N 1.324 -0.539 0 CA-C-O 121.273 0.559 . . . . 1.21 110.882 -177.191 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.455 HG11 ' N ' ' A' ' 39' ' ' TYR . 97.6 t . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 107.761 -1.2 . . . . 1.18 107.761 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.455 ' N ' HG11 ' A' ' 38' ' ' VAL . 91.9 m-85 -124.21 135.48 53.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.885 0.85 . . . . 1.17 111.605 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 91' ' ' ALA . 44.0 t -107.98 111.09 22.99 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.833 -1.076 . . . . 0.82 109.964 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 65.4 m -110.37 129.62 55.72 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.32 -0.622 . . . . 0.25 109.32 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -62.88 -17.49 61.69 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.538 -0.756 . . . . 2.35 109.832 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -169.28 133.83 1.44 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.765 -1.107 . . . . 3.06 108.622 172.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.49 HG22 HG11 ' A' ' 94' ' ' VAL . 29.2 p -94.53 151.84 19.02 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.442 -0.903 . . . . 1.06 110.679 168.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.7 tp10 -119.78 142.73 48.32 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.194 -0.912 . . . . 1.14 109.527 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.491 ' O ' HD11 ' A' ' 50' ' ' LEU . 44.8 m-20 -67.28 108.39 2.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.523 -0.308 . . . . 1.77 110.52 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 70.0 p -68.67 -1.16 6.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.955 -0.566 . . . . 1.28 112.513 -172.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -79.17 -43.82 23.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.928 0.394 . . . . 3.21 110.145 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -144.77 70.95 1.29 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.569 -0.53 . . . . 2.83 109.569 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 46' ' ' ASP . 3.1 mm? -55.32 153.49 7.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.338 -0.846 . . . . 1.8 112.406 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.95 153.34 21.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.672 -1.149 . . . . 1.81 109.406 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -55.96 -41.45 74.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.249 0.477 . . . . 3.71 110.601 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.517 ' O ' HD23 ' A' ' 57' ' ' LEU . . . -61.41 -36.85 93.15 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.839 -0.619 . . . . 0.41 112.32 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.524 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 29.2 m -82.29 -41.43 20.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.836 0.351 . . . . 1.05 110.274 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.0 m -53.77 -34.99 60.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.781 -0.645 . . . . 1.06 109.861 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.517 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.46 -52.74 63.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.367 -0.833 . . . . 1.06 111.92 175.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -61.17 -44.43 97.31 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.556 0.693 . . . . 1.1 110.037 -178.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 54' ' ' THR . 46.1 mt -60.05 -44.41 94.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.822 -1.081 . . . . 1.07 109.903 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.82 -32.42 79.31 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.631 -0.713 . . . . 0.26 113.043 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 33.9 mt -59.83 -41.96 92.49 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.833 0.825 . . . . 1.15 110.323 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.437 ' CD1' HG21 ' A' ' 105' ' ' VAL . 3.8 mt -91.18 -5.61 54.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.406 -1.27 . . . . 1.1 110.855 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.9 t30 69.62 36.9 2.03 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.047 -0.979 . . . . 2.46 110.661 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 58' ' ' LEU . 64.2 mt -77.77 146.19 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.797 -0.638 . . . . 1.07 110.029 175.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.596 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -93.99 117.72 30.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.74 -0.664 . . . . 2.65 110.279 -178.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.91 -40.6 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.609 -0.723 . . . . 1.07 111.279 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.93 -7.48 62.22 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.75 -0.738 . . . . 0.57 112.845 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.461 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 28.7 t70 -104.5 -12.44 16.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.08 0.467 . . . . 0.86 110.529 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.1 mt -62.33 149.84 41.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.845 -0.616 . . . . 1.18 110.974 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -95.86 -78.59 0.46 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.458 0.91 . . . . 2.47 113.458 -169.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 0.2 OUTLIER -105.95 -85.19 0.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.8 -0.36 . . . . 1.09 111.741 -172.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 0.9 OUTLIER -120.97 168.17 11.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.169 0.509 . . . . 1.03 110.871 177.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -122.25 168.5 14.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 106.821 -1.548 . . . . 1.03 106.821 165.192 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.503 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -136.53 144.09 15.67 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.83 -1.176 . . . . 0.37 111.698 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -104.96 128.14 53.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.128 0.49 . . . . 1.12 110.116 176.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.4 m120 57.77 53.48 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.974 -1.012 . . . . 1.85 110.999 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.503 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 58.9 m -87.67 141.57 28.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.399 -0.819 . . . . 1.12 111.067 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.2 m -101.21 124.69 40.48 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.679 -0.692 . . . . 1.6 110.399 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.08 129.07 15.65 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.524 2.149 . . . . 0.7 112.57 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 mt . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.285 -0.87 . . . . 1.49 109.307 178.844 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.697 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--O 1.235 0.29 0 N-CA-C 109.515 -0.55 . . . . 1.08 109.515 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.76 121.54 25.48 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.549 0.69 . . . . 0.99 110.033 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.77 121.38 41.57 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.774 -0.648 . . . . 1.11 111.356 -171.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.494 HG13 ' HA ' ' A' ' 111' ' ' PRO . 9.0 m -133.78 165.87 30.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.598 -0.728 . . . . 1.06 110.847 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 18.0 m -114.06 125.09 53.6 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.75 -0.659 . . . . 0.71 109.233 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 22.8 m -121.23 149.97 42.04 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.074 -0.512 . . . . 0.61 110.465 -171.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.3 t -80.85 -28.37 36.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.73 -0.668 . . . . 1.06 110.789 -171.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.55 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 21.9 m120 -152.73 159.68 43.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.93 109.764 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.4 t -136.12 147.39 47.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.472 -0.331 . . . . 1.18 110.114 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.481 ' HB2' HG22 ' A' ' 105' ' ' VAL . 65.7 m-85 -137.17 158.24 44.89 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.83 -0.433 . . . . 1.2 109.83 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.423 ' HG2' HD23 ' A' ' 61' ' ' LEU . 7.8 mm100 62.51 26.6 15.82 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.566 -0.288 . . . . 1.11 111.54 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 65.52 0.19 1.36 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.87 -0.604 . . . . 2.63 112.534 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.8 -21.99 1.29 Allowed Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.91 -1.138 . . . . 0.29 113.621 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.8 mt -51.07 -37.31 44.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.583 0.692 . . . . 1.14 111.198 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 100' ' ' TYR . 5.6 m -131.7 144.43 37.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.813 -0.631 . . . . 1.51 109.768 174.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 15.4 t30 -142.86 141.41 31.56 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.974 -1.121 . . . . 1.24 107.974 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.55 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.2 m -125.68 152.27 32.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 113.291 0.849 . . . . 1.09 113.291 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 64.53 51.71 49.74 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.799 -1.091 . . . . 0.24 111.665 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 74.6 m -97.98 128.45 44.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.856 0.36 . . . . 0.43 111.494 -174.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.0 p -124.03 126.36 25.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.757 -0.656 . . . . 1.16 109.418 173.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.494 ' HA ' HG13 ' A' ' 94' ' ' VAL . 79.6 Cg_exo -50.69 109.15 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.058 2.505 . . . . 0.42 112.336 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.2 tt . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 115.679 -0.691 . . . . 1.21 111.144 -177.08 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.435 HG11 ' N ' ' A' ' 39' ' ' TYR . 92.1 t . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.547 -0.538 . . . . 1.18 109.547 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.435 ' N ' HG11 ' A' ' 38' ' ' VAL . 52.8 m-85 -129.69 134.99 47.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.869 0.366 . . . . 1.17 110.54 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.596 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 38.6 t -108.06 112.06 24.43 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.302 -0.408 . . . . 0.82 109.95 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 72.9 m -103.31 134.15 47.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.143 0.496 . . . . 0.25 110.422 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.44 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 88.4 m-20 -59.65 -19.58 50.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.226 -0.897 . . . . 2.35 110.361 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.511 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -173.13 124.66 0.42 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.71 -1.132 . . . . 3.06 107.986 176.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.534 HG23 HG11 ' A' ' 94' ' ' VAL . 8.0 p -78.2 148.0 34.22 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.243 -0.983 . . . . 1.06 110.838 170.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.428 ' OE2' ' HA ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -109.96 138.81 45.81 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.009 -0.996 . . . . 1.14 109.017 -176.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.405 ' O ' HD11 ' A' ' 50' ' ' LEU . 9.7 m-20 -73.67 104.9 4.76 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.741 -0.663 . . . . 1.77 110.337 -174.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.502 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 50.1 m -58.93 -16.64 18.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.473 0.546 . . . . 1.28 112.473 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -86.57 -20.23 28.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.744 0.307 . . . . 3.21 110.659 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -148.76 57.21 1.04 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.456 -0.338 . . . . 2.83 111.601 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.504 HD13 ' CG1' ' A' ' 72' ' ' VAL . 2.4 mm? -59.59 145.75 43.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.39 0.614 . . . . 1.8 111.665 176.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -71.03 156.76 39.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.146 -0.934 . . . . 1.81 109.714 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -59.56 -41.65 90.62 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.909 -0.317 . . . . 3.71 110.948 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.553 ' O ' HD23 ' A' ' 57' ' ' LEU . . . -57.03 -38.29 84.59 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.116 -0.564 . . . . 0.41 112.34 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.544 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 26.2 m -79.92 -43.72 21.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.881 0.372 . . . . 1.05 110.559 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -53.89 -34.8 60.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.673 -0.694 . . . . 1.06 109.823 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.601 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.14 -52.23 66.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.85 -1.068 . . . . 1.06 111.549 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -60.48 -45.75 92.62 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.424 0.63 . . . . 1.1 109.958 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 54' ' ' THR . 50.6 mt -57.96 -45.86 86.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.848 -1.069 . . . . 1.07 109.917 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.03 -36.87 91.7 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.621 -0.718 . . . . 0.26 112.573 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 25.5 mt -59.61 -47.37 85.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.597 0.713 . . . . 1.15 110.238 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.474 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.7 mt -84.48 -4.76 59.11 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.683 -1.144 . . . . 1.1 111.556 -176.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 70.63 35.54 1.84 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.741 0.781 . . . . 2.46 110.524 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.446 HD11 ' HA ' ' A' ' 58' ' ' LEU . 60.6 mt -79.6 146.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.162 -0.681 . . . . 1.07 109.162 174.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.525 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.33 117.44 32.75 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.536 0.684 . . . . 2.65 110.127 -177.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.44 -31.4 42.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.054 -0.975 . . . . 1.07 110.628 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.06 -14.83 78.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.941 -0.647 . . . . 0.57 113.404 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -101.58 -12.57 18.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.07 0.435 . . . . 0.86 110.91 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.5 mt -51.75 127.09 19.72 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.661 0.743 . . . . 1.18 111.447 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -76.16 -54.38 6.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.424 -1.262 . . . . 2.47 113.263 -166.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.17 -84.41 0.37 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.963 -0.295 . . . . 1.09 111.614 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -115.11 168.04 10.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.426 0.631 . . . . 1.03 110.798 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.504 ' CG1' HD13 ' A' ' 50' ' ' LEU . 1.6 m -121.67 172.26 9.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.362 -1.718 . . . . 1.03 106.362 168.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.419 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -138.96 150.12 21.03 Favored Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.119 -1.038 . . . . 0.37 111.486 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -116.36 133.72 55.7 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.989 0.423 . . . . 1.12 109.876 174.55 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.5 m120 53.09 52.92 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.965 -1.016 . . . . 1.85 111.027 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.419 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 35.7 m -86.46 152.4 22.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.479 -0.782 . . . . 1.12 110.473 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.5 m -107.37 115.55 59.42 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.773 -0.648 . . . . 1.6 109.932 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.37 121.77 9.11 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.546 2.164 . . . . 0.7 111.769 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.483 HD12 ' HB2' ' A' ' 40' ' ' CYS . 27.1 mt . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 115.747 -0.661 . . . . 1.49 110.027 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.596 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.532 0.206 . . . . 1.08 110.841 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.41 122.87 32.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.271 0.557 . . . . 0.99 110.745 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.97 123.16 39.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.229 0.538 . . . . 1.11 111.147 -174.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.534 HG11 HG23 ' A' ' 44' ' ' THR . 6.5 m -133.85 167.54 26.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.588 -0.733 . . . . 1.06 111.49 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 41.8 t -111.35 121.74 46.04 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.473 -0.936 . . . . 0.71 108.473 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 22.9 m -122.35 148.63 44.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.023 0.439 . . . . 0.61 110.969 -171.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.9 t -79.2 -28.15 42.6 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.423 -0.808 . . . . 1.06 110.837 -169.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.484 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 19.6 m120 -156.0 161.64 40.44 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.053 -0.721 . . . . 0.93 109.053 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.7 t -142.22 144.67 33.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.799 0.333 . . . . 1.18 110.516 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.477 ' HB2' HG22 ' A' ' 105' ' ' VAL . 70.3 m-85 -133.65 160.77 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.756 -0.461 . . . . 1.2 109.756 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.628 ' NE2' HD12 ' A' ' 104' ' ' LEU . 11.4 mm100 60.97 23.7 13.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 1.11 111.566 175.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 63.01 13.39 6.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.582 -0.735 . . . . 2.63 112.442 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.88 -24.34 3.01 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.211 -0.995 . . . . 0.29 113.133 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.628 HD12 ' NE2' ' A' ' 101' ' ' GLN . 14.9 mt -49.63 -38.01 30.37 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.852 0.326 . . . . 1.14 111.018 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' A' ' 100' ' ' TYR . 4.2 m -131.87 141.53 45.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.892 -0.595 . . . . 1.51 109.559 172.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.438 ' ND2' ' SG ' ' A' ' 96' ' ' CYS . 21.5 t30 -140.63 144.63 35.85 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.201 -1.037 . . . . 1.24 108.201 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.484 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.4 m -129.46 151.02 35.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 113.396 0.887 . . . . 1.09 113.396 -172.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 64.07 51.85 49.6 Favored Glycine 0 CA--C 1.506 -0.505 0 CA-C-N 114.91 -1.041 . . . . 0.24 111.807 177.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 90.9 m -97.12 127.91 43.53 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.014 0.435 . . . . 0.43 111.884 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.7 p -122.26 126.47 26.23 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.528 -0.76 . . . . 1.16 109.701 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.503 ' HA ' HG13 ' A' ' 94' ' ' VAL . 71.4 Cg_exo -50.46 110.49 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.003 2.469 . . . . 0.42 112.586 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.688 -0.687 . . . . 1.21 110.664 -179.439 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 39' ' ' TYR . 94.5 t . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 108.143 -1.058 . . . . 1.18 108.143 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.43 ' N ' HG13 ' A' ' 38' ' ' VAL . 45.7 m-85 -124.2 130.82 53.19 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.875 -0.73 . . . . 1.17 111.362 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 91' ' ' ALA . 36.2 t -105.14 106.12 16.47 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.442 -0.799 . . . . 0.82 109.426 176.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -97.8 133.3 42.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.801 -0.636 . . . . 0.25 110.44 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.416 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 3.1 m-20 -58.53 -24.85 61.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.772 . . . . 2.35 109.716 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.523 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -162.79 135.61 5.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.176 -1.375 . . . . 3.06 107.446 177.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 94' ' ' VAL . 23.7 p -92.63 159.67 15.36 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.356 -0.938 . . . . 1.06 110.062 165.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HB3' HG22 ' A' ' 72' ' ' VAL . 8.0 tp10 -126.28 140.32 52.62 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.608 -0.724 . . . . 1.14 109.712 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' HD12 ' A' ' 50' ' ' LEU . 3.2 m-20 -72.31 109.15 5.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.073 -0.512 . . . . 1.77 110.438 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.48 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 88.0 p -64.12 -4.92 3.97 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.48 0.548 . . . . 1.28 112.48 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.4 mptp? -73.84 -42.11 61.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.342 0.592 . . . . 3.21 110.243 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -142.51 66.67 1.33 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.19 -0.913 . . . . 2.83 110.735 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.48 ' CD2' ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -56.97 148.76 20.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.176 0.512 . . . . 1.8 111.522 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.26 166.16 19.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.589 -0.732 . . . . 1.81 109.78 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -58.98 -47.68 84.28 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.539 -0.464 . . . . 3.71 110.698 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.581 ' O ' HD23 ' A' ' 57' ' ' LEU . . . -55.65 -39.27 75.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.066 -0.587 . . . . 0.41 112.517 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.602 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 13.4 m -77.86 -43.17 31.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.753 0.311 . . . . 1.05 110.559 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.9 m -56.05 -33.71 65.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.3 0.572 . . . . 1.06 109.795 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.29 -54.51 46.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.17 -0.923 . . . . 1.06 111.304 176.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -58.12 -46.75 85.05 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.485 0.66 . . . . 1.1 110.039 -179.244 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.5 mt -58.69 -44.83 90.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.972 -1.013 . . . . 1.07 110.195 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.82 -37.18 92.11 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.955 -0.64 . . . . 0.26 112.686 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.5 mt -60.12 -45.58 92.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.041 0.924 . . . . 1.15 110.312 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.453 ' CD1' HG21 ' A' ' 105' ' ' VAL . 6.8 mt -86.31 -0.02 54.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.391 -1.277 . . . . 1.1 111.371 -176.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 68.79 31.25 4.51 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.544 -0.753 . . . . 2.46 111.093 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' A' ' 58' ' ' LEU . 53.6 mt -79.95 145.08 9.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.827 -0.624 . . . . 1.07 109.806 177.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.512 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -98.35 118.2 34.47 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.761 -0.654 . . . . 2.65 109.93 -178.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.14 -38.02 54.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.345 -0.843 . . . . 1.07 110.963 -174.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.75 -1.98 63.43 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.846 -0.693 . . . . 0.57 113.007 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.476 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 33.9 t70 -113.97 2.13 14.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.628 0.728 . . . . 0.86 109.968 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.7 mt -74.19 152.47 39.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.593 -0.73 . . . . 1.18 111.074 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -95.84 -97.64 0.18 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 2.47 112.401 -173.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.79 -93.27 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.13 0.419 . . . . 1.09 112.13 -173.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.1 mm? -111.61 170.02 8.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.41 0.624 . . . . 1.03 111.279 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.9 OUTLIER -121.39 165.5 16.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 106.189 -1.782 . . . . 1.03 106.189 165.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.47 134.08 6.8 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 119.748 -1.215 . . . . 0.37 112.124 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.638 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -100.89 136.45 40.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.459 . . . . 1.12 110.581 178.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.6 m120 51.49 52.2 15.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.855 -1.066 . . . . 1.85 111.095 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.1 m -88.51 138.75 31.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.001 -0.545 . . . . 1.12 110.89 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 m -86.68 119.6 71.39 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.75 -0.659 . . . . 1.6 110.139 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.27 121.16 7.53 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.467 2.111 . . . . 0.7 112.133 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 mt . . . . . 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 1.49 109.196 179.91 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.586 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.809 0.338 . . . . 1.08 111.279 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.56 117.83 30.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.33 0.586 . . . . 0.99 110.753 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.71 121.92 32.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.323 0.583 . . . . 1.11 111.566 -174.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.526 HG13 HG21 ' A' ' 44' ' ' THR . 6.7 m -133.26 164.27 35.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.552 -0.749 . . . . 1.06 110.939 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.9 t -113.38 112.29 23.41 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.54 -0.754 . . . . 0.71 109.317 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 21.9 m -106.28 145.0 32.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.363 -0.381 . . . . 0.61 110.311 -174.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.3 t -77.3 -25.53 51.39 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.069 -0.514 . . . . 1.06 110.797 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.628 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 19.8 m120 -148.67 155.75 41.45 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.786 -0.82 . . . . 0.93 108.786 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.4 t -123.12 144.54 49.26 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.915 0.388 . . . . 1.18 110.181 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.459 ' CB ' HG22 ' A' ' 105' ' ' VAL . 26.0 m-85 -130.19 143.27 50.68 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.016 -0.538 . . . . 1.2 110.731 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.651 ' NE2' HD12 ' A' ' 104' ' ' LEU . 7.9 mm100 60.93 32.85 19.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 1.11 111.817 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 66.06 0.33 1.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.197 0.599 . . . . 2.63 112.431 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.97 -19.78 1.96 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.372 -0.918 . . . . 0.29 112.817 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.651 HD12 ' NE2' ' A' ' 101' ' ' GLN . 20.0 mt -51.89 -39.51 59.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.742 0.271 . . . . 1.14 111.258 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.459 HG22 ' CB ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -136.4 145.41 30.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.385 -0.371 . . . . 1.51 110.531 175.15 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.591 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 41.4 m-80 -140.28 161.95 36.46 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.298 -0.63 . . . . 1.24 109.298 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.628 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 8.3 m -133.71 150.05 31.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.009 0.374 . . . . 1.09 112.009 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 58.7 54.89 34.15 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.328 -0.851 . . . . 0.24 111.583 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 75.5 m -96.3 124.48 40.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.997 0.427 . . . . 0.43 110.669 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 p -121.18 125.49 26.93 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.629 -0.714 . . . . 1.16 110.524 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.522 ' HA ' HG12 ' A' ' 94' ' ' VAL . 78.6 Cg_exo -47.62 114.01 0.93 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.29 2.66 . . . . 0.42 112.776 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.2 tt . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.503 -0.771 . . . . 1.21 110.799 -176.951 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 39' ' ' TYR . 47.3 t . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 107.99 -1.115 . . . . 1.18 107.99 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.533 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 75.4 m-85 -128.71 120.62 26.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.954 0.883 . . . . 1.17 112.034 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.509 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 33.1 t -91.13 99.13 12.2 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.344 -1.298 . . . . 0.82 110.305 177.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.8 m -101.89 129.65 48.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.674 -0.861 . . . . 0.25 108.674 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -53.57 -29.52 37.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.356 -0.838 . . . . 2.35 110.439 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -170.5 125.13 0.72 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.001 -1.111 . . . . 3.06 108.001 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.498 HG23 HG11 ' A' ' 94' ' ' VAL . 20.5 p -85.59 142.15 29.32 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.286 -0.966 . . . . 1.06 111.462 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.6 tp10 -114.21 142.21 46.55 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.891 -1.05 . . . . 1.14 109.591 -174.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.446 ' O ' HD12 ' A' ' 50' ' ' LEU . 10.3 m-20 -62.0 110.79 1.68 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.372 -0.377 . . . . 1.77 110.443 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 77.5 p -65.88 -8.32 21.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.198 0.523 . . . . 1.28 111.173 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -91.23 -24.68 19.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.993 -0.549 . . . . 3.21 110.067 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -141.06 59.71 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.029 -0.532 . . . . 2.83 111.132 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.489 HD11 ' CG1' ' A' ' 72' ' ' VAL . 2.7 mm? -64.21 152.61 40.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 1.8 111.768 176.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.82 152.86 43.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.551 -0.907 . . . . 1.81 108.551 171.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.477 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -57.81 -29.4 64.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.121 -0.632 . . . . 3.71 110.146 176.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.524 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -66.17 -40.47 94.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.119 -0.562 . . . . 0.41 111.736 176.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.526 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 20.0 m -78.06 -42.34 32.58 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.025 -0.27 . . . . 1.05 110.647 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.0 m -53.61 -35.62 61.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.962 -0.563 . . . . 1.06 109.685 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.75 -54.32 47.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.211 -0.904 . . . . 1.06 111.772 176.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.524 HD22 ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -59.56 -45.46 91.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.48 0.657 . . . . 1.1 109.919 -178.289 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 54' ' ' THR . 48.6 mt -60.01 -44.38 94.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.886 -1.052 . . . . 1.07 109.767 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.79 -38.71 92.64 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.707 -0.679 . . . . 0.26 112.44 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 24.8 mt -56.89 -49.17 76.35 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.657 0.741 . . . . 1.15 110.176 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.401 ' CD1' HG22 ' A' ' 105' ' ' VAL . 5.7 mt -84.16 -0.78 53.4 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.589 -1.187 . . . . 1.1 111.13 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 66.91 35.82 4.65 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.269 -0.878 . . . . 2.46 111.252 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.5 mt -84.08 142.22 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 115.626 -0.716 . . . . 1.07 109.702 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.67 118.2 31.92 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.345 0.593 . . . . 2.65 110.12 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.58 -30.26 44.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.114 -0.948 . . . . 1.07 110.573 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.61 -8.59 84.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.862 -0.685 . . . . 0.57 112.968 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -110.04 3.26 20.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.376 0.607 . . . . 0.86 110.638 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.2 mt -72.81 156.49 38.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.272 0.558 . . . . 1.18 111.05 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -92.76 -82.47 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.543 -0.753 . . . . 2.47 112.854 -170.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.42 -88.36 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 1.09 111.857 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.1 mm? -114.0 169.23 9.16 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.13 0.49 . . . . 1.03 110.892 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.611 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -121.57 168.26 14.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.037 -1.468 . . . . 1.03 107.037 167.491 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.49 127.27 3.72 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.687 -1.244 . . . . 0.37 112.414 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -90.86 136.08 33.31 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.259 -0.576 . . . . 1.12 110.179 178.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.8 m120 49.67 49.69 19.59 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.15 -0.932 . . . . 1.85 110.848 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 6.0 t -87.62 142.13 28.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.448 -0.796 . . . . 1.12 110.523 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.7 m -113.57 116.27 46.05 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.627 -0.715 . . . . 1.6 111.07 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.95 129.8 24.18 Favored 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 122.623 2.216 . . . . 0.7 112.078 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.486 HD21 ' HB2' ' A' ' 40' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 N-CA-C 109.688 -0.486 . . . . 1.49 109.688 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.509 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--O 1.235 0.324 0 N-CA-C 110.08 -0.341 . . . . 1.08 110.08 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.83 134.13 35.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.718 -0.475 . . . . 0.99 109.718 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.69 117.85 34.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.284 0.564 . . . . 1.11 111.216 -172.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 111' ' ' PRO . 6.7 m -131.78 165.48 31.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.616 -0.72 . . . . 1.06 110.942 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 37.6 t -110.58 120.75 43.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.419 -0.956 . . . . 0.71 108.419 176.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 30.9 m -117.85 151.42 37.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.036 0.446 . . . . 0.61 110.844 -170.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.6 t -78.92 -28.39 43.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.631 -0.713 . . . . 1.06 110.448 -172.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.41 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 13.5 m120 -153.57 163.45 39.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.921 -0.581 . . . . 0.93 109.977 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.0 t -127.99 130.5 48.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.108 0.48 . . . . 1.18 110.375 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 105' ' ' VAL . 44.2 m-85 -119.48 142.21 48.48 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.749 -0.659 . . . . 1.2 110.79 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.441 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 6.6 mm100 61.56 33.27 18.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.071 -0.513 . . . . 1.11 111.824 175.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 63.21 6.58 2.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.044 0.538 . . . . 2.63 112.181 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.28 -22.11 2.92 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.893 -1.146 . . . . 0.29 113.425 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 13.7 mt -50.12 -40.85 47.39 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.475 0.638 . . . . 1.14 110.547 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -130.14 119.09 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.494 0.664 . . . . 1.51 110.298 174.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.611 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 2.7 t30 -113.51 151.87 30.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.321 -0.992 . . . . 1.24 108.321 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 10.5 m -135.55 152.16 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.048 0.758 . . . . 1.09 113.048 -175.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 65.75 49.1 61.4 Favored Glycine 0 CA--C 1.506 -0.511 0 CA-C-N 115.154 -0.93 . . . . 0.24 111.755 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 72.5 m -97.89 126.36 43.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.894 0.378 . . . . 0.43 111.454 -172.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -120.23 126.05 26.99 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.703 -0.681 . . . . 1.16 110.009 175.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.517 ' HA ' HG13 ' A' ' 94' ' ' VAL . 73.6 Cg_exo -49.61 109.87 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.12 2.546 . . . . 0.42 112.345 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 tt . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.665 -0.698 . . . . 1.21 110.789 -175.233 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.48 HG11 ' N ' ' A' ' 39' ' ' TYR . 97.5 t . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 107.616 -1.253 . . . . 1.18 107.616 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.48 ' N ' HG11 ' A' ' 38' ' ' VAL . 77.1 m-85 -127.06 139.05 53.28 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.892 0.769 . . . . 1.17 111.779 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 42.7 t -116.14 103.77 10.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.323 -0.853 . . . . 0.82 110.292 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.6 m -106.01 135.95 46.54 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.253 -0.647 . . . . 0.25 109.253 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.456 ' HA ' ' HB2' ' A' ' 91' ' ' ALA . 59.0 m-80 -59.32 -23.66 62.66 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.696 -0.684 . . . . 2.35 110.622 177.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HD3' ' O ' ' A' ' 44' ' ' THR . 12.4 tmtt? -176.15 125.33 0.2 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.739 -1.208 . . . . 3.06 107.739 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.578 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 34.1 p -89.64 152.55 21.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.43 -0.908 . . . . 1.06 111.538 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HB3' HG21 ' A' ' 72' ' ' VAL . 14.8 tp10 -115.14 138.33 51.02 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.256 -0.883 . . . . 1.14 109.15 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.434 ' HA ' HD13 ' A' ' 71' ' ' LEU . 17.6 m-20 -74.59 109.23 7.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.357 -0.383 . . . . 1.77 110.495 -175.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.3 m -50.76 -25.31 4.23 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.971 0.794 . . . . 1.28 112.454 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.4 mptp? -64.83 -45.5 85.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.238 0.542 . . . . 3.21 111.012 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -133.45 58.07 1.78 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.548 -0.751 . . . . 2.83 110.522 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.5 mt -57.17 158.36 5.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.311 -0.859 . . . . 1.8 112.812 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.66 154.97 39.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.505 -1.225 . . . . 1.81 109.243 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -67.54 -32.99 74.15 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.066 -0.346 . . . . 3.71 110.066 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.525 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -67.01 -33.74 84.75 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.478 -0.649 . . . . 0.41 111.478 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.499 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 28.3 m -79.33 -44.29 21.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 1.05 110.056 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.4 m -52.79 -35.37 56.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.485 -0.78 . . . . 1.06 109.819 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.76 -51.59 68.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.306 -0.861 . . . . 1.06 112.013 176.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.525 HD22 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -61.84 -43.66 98.39 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.518 0.675 . . . . 1.1 109.961 -178.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.2 mt -60.24 -44.25 95.4 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.933 -1.03 . . . . 1.07 110.105 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.29 -38.08 89.15 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.775 -0.648 . . . . 0.26 112.281 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 32.7 mt -57.11 -50.44 72.77 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.746 0.784 . . . . 1.15 110.124 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.42 HD23 ' HG2' ' A' ' 101' ' ' GLN . 5.0 mt -84.02 -2.85 57.43 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.581 -1.19 . . . . 1.1 111.501 -174.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 68.17 35.01 3.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.725 0.774 . . . . 2.46 110.488 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 55.8 mt -81.77 146.61 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.468 -0.787 . . . . 1.07 110.008 176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -95.98 117.92 31.59 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.265 0.555 . . . . 2.65 110.198 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 65' ' ' ILE . 1.8 mp -71.72 -29.98 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.297 -0.865 . . . . 1.07 110.332 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.22 -16.64 78.63 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.949 -0.569 . . . . 0.57 112.679 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -91.67 -16.41 27.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.179 0.514 . . . . 0.86 110.2 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.37 137.86 57.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.64 -0.709 . . . . 1.18 111.025 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 2.4 mptp? -94.07 -88.72 0.23 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.168 -0.923 . . . . 2.47 111.808 -170.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.13 -96.2 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.888 0.329 . . . . 1.09 111.888 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 44' ' ' THR . 1.8 mm? -111.24 170.83 7.85 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.475 0.655 . . . . 1.03 111.363 178.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -125.14 169.9 15.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 107.065 -1.457 . . . . 1.03 107.065 166.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.69 131.43 5.33 Favored Glycine 0 C--N 1.311 -0.822 0 C-N-CA 119.653 -1.261 . . . . 0.37 112.159 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.31 136.21 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.354 -0.538 . . . . 1.12 109.787 178.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.97 49.3 19.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.133 -0.94 . . . . 1.85 110.662 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 11.6 t -90.68 144.52 25.66 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.521 -1.218 . . . . 1.12 109.588 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 40' ' ' CYS . 13.5 p -106.29 118.63 54.3 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.507 -0.315 . . . . 1.6 111.252 -177.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.15 119.6 6.41 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.457 2.105 . . . . 0.7 111.783 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.661 -0.699 . . . . 1.49 109.313 -179.29 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 110.151 -0.314 . . . . 1.08 110.151 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.409 HE21 ' HB2' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -82.46 124.59 30.21 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.444 0.64 . . . . 0.99 110.366 -176.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.49 126.4 45.42 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.52 0.676 . . . . 1.11 111.359 -170.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.519 HG11 ' HA ' ' A' ' 111' ' ' PRO . 5.0 m -134.0 165.85 30.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.228 -0.896 . . . . 1.06 110.69 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 46.0 t -112.87 120.95 43.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.541 -0.911 . . . . 0.71 108.541 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 13.8 m -124.07 153.55 41.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.864 0.364 . . . . 0.61 110.954 -169.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.2 t -83.5 -19.24 36.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.905 -0.589 . . . . 1.06 111.671 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -166.93 169.02 13.47 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 122.554 0.342 . . . . 0.93 110.424 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.3 t -145.9 143.53 29.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.869 -0.605 . . . . 1.18 110.429 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.505 ' HB2' HG21 ' A' ' 105' ' ' VAL . 35.8 m-85 -135.04 160.21 39.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.074 -0.512 . . . . 1.2 109.885 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.42 ' HG2' HD23 ' A' ' 61' ' ' LEU . 8.5 mm100 61.14 25.18 15.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.347 -0.388 . . . . 1.11 111.842 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 60.17 13.94 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 2.63 112.306 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.68 -30.84 1.67 Allowed Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.146 -1.026 . . . . 0.29 113.414 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 14.6 mt -49.23 -40.51 34.12 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.969 0.385 . . . . 1.14 111.843 -175.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.505 HG21 ' HB2' ' A' ' 100' ' ' TYR . 3.7 m -131.07 136.23 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.546 0.689 . . . . 1.51 110.664 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.484 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 32.0 t30 -132.76 141.98 48.79 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.271 -1.381 . . . . 1.24 107.271 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 17.1 m -125.07 150.23 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 113.623 0.972 . . . . 1.09 113.623 -170.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 63.54 51.7 52.13 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.726 -1.125 . . . . 0.24 111.755 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 90.4 m -97.02 131.04 44.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.992 0.425 . . . . 0.43 111.66 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 p -123.37 126.56 25.84 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.529 -0.76 . . . . 1.16 110.0 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.519 ' HA ' HG11 ' A' ' 94' ' ' VAL . 52.6 Cg_exo -52.31 116.59 2.93 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.8 2.333 . . . . 0.42 112.462 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.2 tt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.855 -0.612 . . . . 1.21 110.549 -178.65 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 39' ' ' TYR . 84.2 t . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 107.801 -1.185 . . . . 1.18 107.801 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.481 ' N ' HG12 ' A' ' 38' ' ' VAL . 87.4 m-85 -127.99 132.25 49.18 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 118.68 0.673 . . . . 1.17 111.211 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.817 ' SG ' ' HB2' ' A' ' 77' ' ' SER . 27.1 p -107.09 107.66 18.76 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.555 -0.748 . . . . 0.82 110.025 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.6 m -98.66 137.38 37.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.445 -0.798 . . . . 0.25 110.626 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -55.03 -27.67 46.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.781 0.801 . . . . 2.35 109.356 172.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -169.56 137.4 1.78 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.306 -1.316 . . . . 3.06 108.247 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.511 HG21 HG13 ' A' ' 94' ' ' VAL . 14.3 p -92.85 149.28 21.37 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.461 -0.896 . . . . 1.06 110.306 168.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 72' ' ' VAL . 6.7 tp10 -112.35 134.32 53.96 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.528 -0.76 . . . . 1.14 109.287 -176.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.459 ' HA ' HD11 ' A' ' 71' ' ' LEU . 4.7 m-20 -67.14 114.1 5.62 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.729 -0.669 . . . . 1.77 111.051 -174.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.53 ' HA ' HD22 ' A' ' 50' ' ' LEU . 68.5 m -60.14 -13.03 10.03 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.392 0.433 . . . . 1.28 111.88 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.548 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -79.29 -36.22 40.04 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.522 0.677 . . . . 3.21 109.95 177.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -140.4 66.08 1.39 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.039 -0.982 . . . . 2.83 111.517 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.53 HD22 ' HA ' ' A' ' 47' ' ' SER . 2.7 mm? -64.91 147.43 53.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.096 0.474 . . . . 1.8 110.962 171.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.59 171.06 13.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.638 -0.71 . . . . 1.81 110.221 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -61.24 -47.96 83.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.62 0.248 . . . . 3.71 111.088 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.488 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -55.64 -35.32 62.0 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.41 112.708 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.537 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 11.2 m -81.8 -41.61 20.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.243 -0.28 . . . . 1.05 110.243 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.2 m -53.81 -34.77 60.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.409 0.623 . . . . 1.06 109.928 174.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.96 -53.76 54.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.063 -0.971 . . . . 1.06 111.908 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.5 HD21 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -61.12 -46.19 91.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.547 0.689 . . . . 1.1 109.973 -178.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 54' ' ' THR . 46.1 mt -58.64 -41.93 87.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.685 -1.143 . . . . 1.07 109.848 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.92 -32.45 84.01 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.748 -0.66 . . . . 0.26 112.704 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.1 mt -62.96 -50.55 70.34 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.666 0.746 . . . . 1.15 109.811 177.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.435 ' CD1' HG23 ' A' ' 105' ' ' VAL . 3.6 mt -81.43 -0.75 42.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.517 -1.219 . . . . 1.1 111.216 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 t30 68.61 38.18 2.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.324 -0.853 . . . . 2.46 110.559 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.4 HD11 ' HA ' ' A' ' 58' ' ' LEU . 49.3 mt -87.07 141.59 14.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.584 -0.735 . . . . 1.07 109.746 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.65 118.6 31.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.532 0.682 . . . . 2.65 110.179 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.65 -36.99 77.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.818 -1.083 . . . . 1.07 110.93 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.58 -14.91 70.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.97 -0.633 . . . . 0.57 113.177 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.12 3.62 33.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.238 0.542 . . . . 0.86 110.725 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 94.2 mt -71.47 144.27 49.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.052 0.453 . . . . 1.18 110.853 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -94.85 -96.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.581 -0.736 . . . . 2.47 112.542 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.59 -85.98 0.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 1.09 111.897 -172.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.3 mm? -120.13 165.14 15.15 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.529 0.681 . . . . 1.03 111.063 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.443 ' CG1' HD13 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -119.9 167.56 13.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 106.017 -1.846 . . . . 1.03 106.017 167.262 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.556 ' O ' ' HA ' ' A' ' 105' ' ' VAL . . . -135.01 137.59 9.36 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.671 -1.252 . . . . 0.37 111.583 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.638 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -109.85 129.49 55.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.49 0.645 . . . . 1.12 110.765 178.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.504 ' ND2' HD22 ' A' ' 104' ' ' LEU . 0.4 OUTLIER 54.3 52.9 11.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.6 -1.182 . . . . 1.85 111.487 176.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.6 m -92.0 154.06 19.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.252 -0.885 . . . . 1.12 109.983 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.817 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 57.6 m -102.75 129.64 25.43 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.38 -0.373 . . . . 1.6 110.089 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 6.6 Cg_exo -74.09 119.64 5.93 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.601 2.201 . . . . 0.7 112.276 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.696 HD22 ' SG ' ' A' ' 40' ' ' CYS . 9.8 mt . . . . . 0 C--N 1.32 -0.71 0 CA-C-N 115.527 -0.76 . . . . 1.49 108.952 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 110.201 -0.296 . . . . 1.08 110.201 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.55 117.24 29.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.316 0.579 . . . . 0.99 109.536 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.85 122.49 33.61 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.817 -0.629 . . . . 1.11 111.078 -173.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.511 HG13 HG21 ' A' ' 44' ' ' THR . 12.3 m -135.29 162.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.629 -0.714 . . . . 1.06 111.191 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 49.6 t -108.49 109.68 21.0 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.793 -0.817 . . . . 0.71 108.793 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 39.5 m -102.01 148.19 25.66 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.242 -0.281 . . . . 0.61 110.242 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.0 t -81.46 -27.27 34.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.055 0.455 . . . . 1.06 110.501 -173.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.508 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 14.8 m120 -149.05 165.89 30.35 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.769 -0.65 . . . . 0.93 109.374 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.2 t -136.73 139.87 42.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.118 -0.492 . . . . 1.18 110.223 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.47 ' HB2' HG21 ' A' ' 105' ' ' VAL . 57.7 m-85 -128.07 147.88 50.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.922 -0.581 . . . . 1.2 109.732 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.436 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER 63.58 22.91 13.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 1.11 111.208 178.143 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 67.49 9.99 7.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.921 -0.581 . . . . 2.63 112.079 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.11 -22.12 2.1 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.333 -0.936 . . . . 0.29 113.269 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.8 mt -54.0 -35.78 62.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.877 0.338 . . . . 1.14 111.574 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -144.14 119.6 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.253 0.549 . . . . 1.51 111.042 174.516 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -114.62 161.82 17.59 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.728 -0.669 . . . . 1.24 109.785 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.9 m -130.73 156.89 42.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 111.896 0.332 . . . . 1.09 111.896 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 57.37 52.64 50.42 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.554 -0.748 . . . . 0.24 111.929 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 68.4 m -96.79 128.42 43.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.763 0.316 . . . . 0.43 110.739 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.1 p -123.02 127.36 25.72 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.93 -0.577 . . . . 1.16 110.355 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.493 ' HA ' HG12 ' A' ' 94' ' ' VAL . 51.8 Cg_exo -53.58 115.33 2.25 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.129 2.552 . . . . 0.42 112.934 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.739 -0.664 . . . . 1.21 110.064 178.04 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 39' ' ' TYR . 49.1 t . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 120.791 0.329 . . . . 1.18 110.228 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.421 ' N ' HG13 ' A' ' 38' ' ' VAL . 70.2 m-85 -135.77 141.48 44.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.089 0.471 . . . . 1.17 109.91 177.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.579 ' HB3' ' OG ' ' A' ' 77' ' ' SER . 16.4 t -107.0 107.86 19.08 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.166 -0.47 . . . . 0.82 109.966 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.0 m -108.08 134.18 51.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.925 0.393 . . . . 0.25 110.426 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.465 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 4.8 m-20 -60.11 -20.23 57.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 2.35 110.293 176.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.92 129.91 0.31 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.1 -1.074 . . . . 3.06 108.1 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.516 HG23 HG13 ' A' ' 94' ' ' VAL . 18.4 p -87.42 152.86 21.9 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.174 -1.011 . . . . 1.06 111.09 172.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.408 ' OE2' ' HA ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -115.16 142.43 46.67 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.238 -0.892 . . . . 1.14 109.29 -174.595 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.453 ' HA ' HD12 ' A' ' 71' ' ' LEU . 10.2 m-20 -78.31 108.4 11.62 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.105 -0.498 . . . . 1.77 110.86 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.508 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 46.7 m -58.92 -12.49 4.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.064 0.765 . . . . 1.28 113.064 -176.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -81.18 -32.84 33.38 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.967 -0.293 . . . . 3.21 110.343 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -147.29 67.11 1.14 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.328 -0.396 . . . . 2.83 110.75 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.508 ' CD2' ' HA ' ' A' ' 47' ' ' SER . 2.9 mm? -59.42 153.63 18.75 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.462 0.648 . . . . 1.8 111.495 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.86 150.67 48.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.916 -1.038 . . . . 1.81 109.388 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.637 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -55.58 -36.4 66.84 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.01 0.194 . . . . 3.71 111.12 176.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.519 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -63.58 -40.66 98.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.793 -0.718 . . . . 0.41 111.778 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.514 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 24.5 m -78.53 -42.84 28.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.853 0.359 . . . . 1.05 110.229 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.5 m -52.04 -36.59 50.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.571 -0.741 . . . . 1.06 109.957 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.494 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.06 -54.41 47.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.264 -0.88 . . . . 1.06 111.817 176.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.519 HD21 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -59.18 -45.02 92.14 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.385 0.612 . . . . 1.1 110.216 -177.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 54' ' ' THR . 48.5 mt -58.54 -42.33 87.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.905 -1.043 . . . . 1.07 110.132 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.37 -37.05 93.98 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.712 -0.756 . . . . 0.26 112.068 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 15.1 mt -63.03 -40.32 97.39 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.651 0.739 . . . . 1.15 110.194 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.4 ' CD1' HG21 ' A' ' 105' ' ' VAL . 5.6 mt -90.5 4.19 51.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.86 -1.064 . . . . 1.1 111.417 -176.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.9 m120 70.41 26.68 4.12 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.461 -0.79 . . . . 2.46 111.264 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.419 HD11 ' HA ' ' A' ' 58' ' ' LEU . 52.8 mt -81.48 145.86 8.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.02 -0.536 . . . . 1.07 110.485 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.579 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -97.01 117.7 31.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.599 -0.728 . . . . 2.65 109.987 -178.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -75.69 -42.8 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.645 -0.707 . . . . 1.07 111.449 -174.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.34 -8.63 71.14 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 121.017 -0.611 . . . . 0.57 112.838 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.471 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 29.5 t70 -104.02 -9.31 18.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.974 0.416 . . . . 0.86 110.497 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.507 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 94.8 mt -60.92 140.1 57.83 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.03 -0.532 . . . . 1.18 110.657 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -88.89 -62.02 1.58 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.325 -0.852 . . . . 2.47 113.085 -169.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.77 -95.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.379 0.511 . . . . 1.09 112.379 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.1 mm? -117.77 165.78 13.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.544 0.688 . . . . 1.03 111.391 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.476 ' CG1' HD11 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -119.86 173.4 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.776 -1.565 . . . . 1.03 106.776 169.169 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.541 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -141.41 148.66 20.35 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.844 -1.17 . . . . 0.37 111.533 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -110.76 133.52 53.27 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.879 -0.415 . . . . 1.12 109.879 174.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.8 m120 53.34 50.47 17.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.992 -1.004 . . . . 1.85 111.188 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.541 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 60.6 m -86.93 143.01 27.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.07 -0.513 . . . . 1.12 110.705 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.579 ' OG ' ' HB3' ' A' ' 40' ' ' CYS . 7.0 p -97.15 114.61 64.99 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.104 -0.498 . . . . 1.6 109.789 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.26 120.53 8.14 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.44 2.093 . . . . 0.7 112.357 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.419 HD11 ' HB2' ' A' ' 40' ' ' CYS . 35.0 mt . . . . . 0 C--N 1.322 -0.623 0 N-CA-C 108.964 -0.754 . . . . 1.49 108.964 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 110.408 -0.219 . . . . 1.08 110.408 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.57 130.09 38.92 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.235 0.54 . . . . 0.99 109.769 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.79 119.11 38.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.319 0.581 . . . . 1.11 111.448 -171.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.516 HG13 HG23 ' A' ' 44' ' ' THR . 5.2 m -130.99 163.86 35.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.577 -0.738 . . . . 1.06 110.573 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.5 t -109.6 120.34 42.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.575 -0.898 . . . . 0.71 108.575 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.69 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 17.9 m -121.57 148.51 44.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.053 0.454 . . . . 0.61 110.98 -169.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.4 t -78.29 -29.53 47.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.632 -0.713 . . . . 1.06 110.891 -172.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.4 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 17.0 m120 -157.0 158.74 37.11 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.91 -0.404 . . . . 0.93 109.91 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 t -132.61 149.2 52.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.388 -0.597 . . . . 1.18 109.388 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.51 ' HB2' HG22 ' A' ' 105' ' ' VAL . 81.6 m-85 -131.29 154.0 48.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.287 -0.634 . . . . 1.2 109.287 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.645 ' NE2' HD12 ' A' ' 104' ' ' LEU . 8.7 mm100 63.63 27.11 14.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 1.11 110.878 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 65.48 6.53 3.79 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.594 -0.73 . . . . 2.63 112.465 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 140.64 -19.64 2.77 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.207 -0.997 . . . . 0.29 113.211 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.645 HD12 ' NE2' ' A' ' 101' ' ' GLN . 20.7 mt -47.91 -39.6 19.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.006 0.403 . . . . 1.14 110.919 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 100' ' ' TYR . 4.5 m -130.38 149.93 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.209 -0.663 . . . . 1.51 109.209 171.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.467 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 31.5 t30 -144.05 147.82 34.34 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.154 -1.054 . . . . 1.24 108.154 -173.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.434 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 9.2 m -131.59 153.52 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.415 0.895 . . . . 1.09 113.415 -174.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.69 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 62.02 51.72 54.99 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.784 -1.098 . . . . 0.24 111.985 176.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 83.9 m -97.82 127.76 43.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.978 0.418 . . . . 0.43 111.919 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 p -119.78 127.83 26.19 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.806 -0.634 . . . . 1.16 110.226 173.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.516 ' HA ' HG12 ' A' ' 94' ' ' VAL . 54.0 Cg_exo -51.29 113.23 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.049 2.5 . . . . 0.42 112.563 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 tt . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.44 -0.8 . . . . 1.21 110.414 -176.204 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 39' ' ' TYR . 86.7 t . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 107.397 -1.334 . . . . 1.18 107.397 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.453 ' CD2' ' HB2' ' A' ' 96' ' ' CYS . 90.3 m-85 -129.09 134.41 48.07 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.518 -0.873 . . . . 1.17 111.952 -177.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 31.9 t -105.46 103.47 13.0 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.857 -1.065 . . . . 0.82 109.905 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.0 m -100.62 132.39 46.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.316 0.579 . . . . 0.25 110.48 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.457 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 5.8 m-20 -57.6 -24.56 57.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.997 -1.001 . . . . 2.35 110.508 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.86 119.33 0.35 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.266 -1.013 . . . . 3.06 108.266 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.537 HG21 HG12 ' A' ' 94' ' ' VAL . 15.2 p -80.27 150.81 29.87 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 118.765 -1.174 . . . . 1.06 110.832 174.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.462 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.2 tp10 -119.87 138.32 53.47 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.44 -0.8 . . . . 1.14 109.322 -176.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.52 ' HA ' HD11 ' A' ' 71' ' ' LEU . 26.5 m-20 -69.75 114.34 7.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.039 -0.528 . . . . 1.77 110.987 -173.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.529 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 49.5 m -61.03 -9.43 4.38 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.115 -0.493 . . . . 1.28 111.831 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -90.19 -16.28 29.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.563 -0.29 . . . . 3.21 110.642 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -154.15 57.85 0.72 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.513 -0.312 . . . . 2.83 111.542 -176.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.529 ' CD2' ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -60.79 149.33 36.14 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.456 0.646 . . . . 1.8 112.064 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.53 145.52 52.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.011 -0.995 . . . . 1.81 108.401 172.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -20.33 66.23 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.779 -0.368 . . . . 3.71 110.742 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.497 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -73.24 -33.56 58.95 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.079 -0.808 . . . . 0.41 111.079 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.53 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 43.3 m -79.97 -41.56 25.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.725 0.298 . . . . 1.05 110.377 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.6 m -53.05 -35.2 59.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.338 0.59 . . . . 1.06 109.777 172.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -55.59 -54.66 41.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.259 -0.882 . . . . 1.06 111.611 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -60.22 -44.02 95.53 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.373 0.606 . . . . 1.1 110.214 -178.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 54' ' ' THR . 53.3 mt -58.6 -45.06 89.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.988 -1.006 . . . . 1.07 109.82 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.27 -36.59 91.26 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.833 -0.622 . . . . 0.26 112.744 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 18.6 mt -59.71 -47.81 84.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.712 0.768 . . . . 1.15 110.283 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.499 ' CD1' HG23 ' A' ' 105' ' ' VAL . 4.1 mt -86.12 -1.34 57.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.72 -1.127 . . . . 1.1 111.115 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 66.17 36.54 5.51 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.256 -0.884 . . . . 2.46 111.056 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.408 HD11 ' HA ' ' A' ' 58' ' ' LEU . 54.8 mt -80.15 143.28 12.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.661 -0.699 . . . . 1.07 109.474 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.558 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -94.18 117.87 30.73 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.462 0.649 . . . . 2.65 110.002 -177.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.39 -34.08 56.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.957 -1.019 . . . . 1.07 110.679 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.73 -16.88 72.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.017 -0.611 . . . . 0.57 112.741 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.433 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 29.8 t70 -94.5 -15.76 23.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.76 0.314 . . . . 0.86 110.659 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 94.1 mt -55.12 129.59 38.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.394 0.616 . . . . 1.18 110.984 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 3.3 mptp? -88.07 -86.82 0.16 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.987 -1.006 . . . . 2.47 112.262 -170.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -90.74 -94.92 0.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 1.09 111.466 -171.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.52 HD11 ' HA ' ' A' ' 46' ' ' ASP . 1.2 mm? -113.6 167.62 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.088 -0.505 . . . . 1.03 110.134 172.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.616 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -118.32 166.66 12.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 106.378 -1.712 . . . . 1.03 106.378 167.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.39 138.07 9.43 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 119.524 -1.322 . . . . 0.37 112.247 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -102.66 132.44 48.78 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.011 -0.676 . . . . 1.12 109.64 173.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 59.0 57.96 3.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.804 -1.089 . . . . 1.85 110.813 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 40' ' ' CYS . 29.4 m -94.72 139.23 31.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.531 -0.759 . . . . 1.12 111.002 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.0 t -94.27 120.82 64.9 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.87 -0.604 . . . . 1.6 109.825 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.86 120.4 7.04 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.816 2.344 . . . . 0.7 112.632 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.5 mt . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 115.51 -0.768 . . . . 1.49 109.336 179.621 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 110.001 -0.37 . . . . 1.08 110.001 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.48 122.94 28.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.097 0.475 . . . . 0.99 110.289 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.24 122.72 35.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.321 0.581 . . . . 1.11 111.034 -175.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.537 HG12 HG21 ' A' ' 44' ' ' THR . 9.0 m -132.02 161.85 40.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.444 -0.798 . . . . 1.06 110.968 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 37.1 t -108.19 109.63 21.07 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.92 -0.77 . . . . 0.71 108.92 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 14.3 m -110.14 153.56 24.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.229 -0.442 . . . . 0.61 110.416 -173.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.7 t -80.7 -26.9 37.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.938 -0.574 . . . . 1.06 110.495 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.428 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 3.6 m120 -155.15 166.21 34.3 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.93 109.565 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.431 ' HB ' ' CE1' ' A' ' 39' ' ' TYR . 15.3 t -129.97 143.45 50.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.075 0.464 . . . . 1.18 110.026 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.462 ' CB ' HG21 ' A' ' 105' ' ' VAL . 42.0 m-85 -126.12 141.65 51.85 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.79 -0.641 . . . . 1.2 110.05 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.419 HE21 ' HB3' ' A' ' 101' ' ' GLN . 6.4 mm100 62.06 25.36 15.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.872 0.368 . . . . 1.11 110.939 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 62.09 11.56 4.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.424 -0.807 . . . . 2.63 112.318 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 149.33 -29.07 1.21 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.891 -1.147 . . . . 0.29 113.73 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 15.5 mt -54.92 -35.3 64.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.391 0.596 . . . . 1.14 111.394 -175.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.499 HG23 ' CD1' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -132.69 143.89 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.809 -0.632 . . . . 1.51 109.774 173.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.616 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.0 OUTLIER -139.39 157.75 45.32 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.41 -0.589 . . . . 1.24 109.41 -174.314 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.428 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.9 m -136.61 144.61 32.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.879 0.696 . . . . 1.09 112.879 -174.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.07 51.63 57.26 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 114.949 -1.023 . . . . 0.24 112.05 176.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.436 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 73.0 m -97.5 131.12 44.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.611 0.243 . . . . 0.43 111.381 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.24 130.65 24.08 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.325 -0.398 . . . . 1.16 110.305 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.519 ' HA ' HG11 ' A' ' 94' ' ' VAL . 54.2 Cg_exo -52.6 109.5 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.79 2.327 . . . . 0.42 111.78 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.1 tt . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.796 -0.638 . . . . 1.21 111.365 -174.089 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.512 HG11 ' N ' ' A' ' 39' ' ' TYR . 98.5 t . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 107.833 -1.173 . . . . 1.18 107.833 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.512 ' N ' HG11 ' A' ' 38' ' ' VAL . 62.8 m-85 -131.05 136.1 48.16 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.424 -0.798 . . . . 1.17 111.459 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 26.8 t -111.62 109.96 20.12 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.417 -0.81 . . . . 0.82 109.67 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.4 m -107.98 133.73 51.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.219 -0.446 . . . . 0.25 110.293 -176.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.421 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 53.8 m-80 -55.94 -28.4 56.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.395 -0.821 . . . . 2.35 110.057 175.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -164.24 133.46 3.79 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.01 -0.995 . . . . 3.06 108.87 176.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.524 HG22 HG11 ' A' ' 94' ' ' VAL . 24.2 p -93.04 142.84 26.85 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.156 -1.018 . . . . 1.06 110.902 168.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HB3' HG21 ' A' ' 72' ' ' VAL . 6.1 tp10 -112.53 138.0 49.93 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.115 -0.948 . . . . 1.14 109.59 -175.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.446 ' HA ' HD13 ' A' ' 71' ' ' LEU . 5.3 m-20 -74.46 107.96 6.93 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.336 -0.393 . . . . 1.77 110.666 -175.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.8 p -54.69 -23.02 15.67 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.898 -0.592 . . . . 1.28 112.473 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -73.78 -33.31 64.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.046 -0.262 . . . . 3.21 110.951 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -134.45 58.14 1.78 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.813 0.815 . . . . 2.83 111.409 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.05 157.73 27.61 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.782 -1.099 . . . . 1.8 111.517 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.66 154.68 36.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.947 -1.024 . . . . 1.81 108.675 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -65.71 -26.58 67.82 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.587 -0.445 . . . . 3.71 109.971 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.514 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -65.07 -38.17 95.05 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.47 -0.652 . . . . 0.41 111.47 174.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.507 ' HA ' HD21 ' A' ' 57' ' ' LEU . 27.9 m -76.72 -43.76 36.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.38 . . . . 1.05 110.653 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.3 m -53.01 -34.43 56.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.651 -0.704 . . . . 1.06 109.937 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.81 -54.11 50.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.839 -1.073 . . . . 1.06 111.794 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.514 HD21 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -59.33 -44.14 92.64 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.434 0.635 . . . . 1.1 110.136 -177.247 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 54' ' ' THR . 36.1 mt -60.14 -42.83 95.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.898 -1.046 . . . . 1.07 110.116 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.16 -33.41 84.12 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.742 -0.663 . . . . 0.26 112.508 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.9 mt -64.12 -29.51 70.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.748 0.785 . . . . 1.15 110.497 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.449 ' CD1' HG22 ' A' ' 105' ' ' VAL . 6.0 mt -102.98 -0.78 30.4 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.68 -1.146 . . . . 1.1 110.668 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 68.26 31.64 5.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.993 -1.003 . . . . 2.46 111.071 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 58' ' ' LEU . 54.8 mt -80.08 148.68 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.811 -0.632 . . . . 1.07 110.551 177.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -97.21 118.64 34.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.293 0.568 . . . . 2.65 110.177 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.51 -38.57 52.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 1.07 111.2 -174.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.85 -22.5 70.29 Favored Glycine 0 CA--C 1.516 0.151 0 C-N-CA 120.989 -0.624 . . . . 0.57 112.683 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.29 -4.94 55.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.189 0.519 . . . . 0.86 110.709 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.13 138.59 55.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.293 0.568 . . . . 1.18 110.733 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -89.52 -86.07 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.044 -0.98 . . . . 2.47 112.289 -171.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.63 -102.35 0.15 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.293 0.479 . . . . 1.09 112.293 -173.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 46' ' ' ASP . 1.9 mm? -105.82 170.1 8.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.577 0.703 . . . . 1.03 111.15 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -122.89 170.53 13.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 106.724 -1.584 . . . . 1.03 106.724 167.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.49 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -136.78 142.75 13.93 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 119.838 -1.172 . . . . 0.37 111.567 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -106.42 129.28 54.43 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.14 -0.624 . . . . 1.12 110.02 174.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.22 55.39 6.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.0 -1.0 . . . . 1.85 111.198 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.49 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 58.7 m -88.62 144.0 26.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.628 -0.715 . . . . 1.12 111.071 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m -100.52 118.82 60.27 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.733 -0.667 . . . . 1.6 109.969 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.24 124.64 12.38 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.547 2.165 . . . . 0.7 111.85 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.2 mt . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 115.938 -0.573 . . . . 1.49 109.865 -178.882 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.421 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.73 -0.47 . . . . 1.08 109.73 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.15 126.06 30.34 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.028 0.442 . . . . 0.99 110.359 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.19 123.1 44.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.265 0.555 . . . . 1.11 111.299 -171.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.524 HG11 HG22 ' A' ' 44' ' ' THR . 1.5 m -136.44 173.32 13.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.653 -0.703 . . . . 1.06 111.426 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 53.8 t -124.37 118.47 26.79 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.566 -0.743 . . . . 0.71 109.964 177.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 1.2 m -103.41 168.49 9.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.598 . . . . 0.61 111.921 -175.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.499 HG21 ' O ' ' A' ' 107' ' ' VAL . 9.0 t -87.04 -29.83 21.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.378 -0.828 . . . . 1.06 109.738 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.42 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.2 m120 -151.84 162.76 40.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.68 -0.691 . . . . 0.93 109.913 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 t -127.64 129.02 46.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.329 0.585 . . . . 1.18 109.87 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.424 ' CB ' HG23 ' A' ' 105' ' ' VAL . 30.0 m-85 -120.51 144.87 47.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.681 -0.69 . . . . 1.2 111.414 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.627 ' NE2' HD11 ' A' ' 104' ' ' LEU . 7.1 mm100 60.84 34.49 19.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.802 -0.635 . . . . 1.11 111.159 176.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 65.4 -0.86 1.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.756 -0.656 . . . . 2.63 112.415 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.46 -20.25 2.05 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.512 -0.851 . . . . 0.29 112.454 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.627 HD11 ' NE2' ' A' ' 101' ' ' GLN . 28.5 mt -49.77 -40.89 42.84 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.725 0.298 . . . . 1.14 111.085 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -130.15 119.3 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.547 0.689 . . . . 1.51 110.489 174.077 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.469 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 2.8 t30 -111.21 144.18 40.78 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.348 -0.982 . . . . 1.24 108.348 177.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.499 ' O ' HG21 ' A' ' 97' ' ' THR . 5.9 m -127.13 137.75 56.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 113.113 0.782 . . . . 1.09 113.113 -174.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 70.9 51.44 19.16 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.999 -1.001 . . . . 0.24 111.975 176.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 1.5 m -97.06 131.83 43.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.346 0.593 . . . . 0.43 111.502 -177.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.8 p -116.65 141.42 28.08 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.058 -0.974 . . . . 1.16 109.594 174.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.522 ' HA ' HG13 ' A' ' 94' ' ' VAL . 24.5 Cg_exo -67.42 108.38 1.58 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.717 2.278 . . . . 0.42 111.803 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 1.21 110.466 -178.865 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.43 HG11 ' N ' ' A' ' 39' ' ' TYR . 92.1 t . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 110.306 -0.257 . . . . 1.18 110.306 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.43 ' N ' HG11 ' A' ' 38' ' ' VAL . 29.3 m-85 -127.96 135.69 50.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.135 0.493 . . . . 1.17 110.701 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.424 ' HB2' HD13 ' A' ' 79' ' ' LEU . 17.7 t -103.43 107.53 18.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.942 -0.572 . . . . 0.82 109.721 177.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -102.46 130.79 49.37 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.804 -0.443 . . . . 0.25 109.804 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.524 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 18.3 m120 -57.54 -29.72 64.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.583 -0.735 . . . . 2.35 109.749 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 8.3 mmmm -162.86 132.23 4.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.443 -1.253 . . . . 3.06 108.013 175.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.501 HG21 HG13 ' A' ' 94' ' ' VAL . 28.1 p -88.86 167.21 13.43 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.36 -0.936 . . . . 1.06 110.101 169.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -126.49 139.07 53.51 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.504 -0.771 . . . . 1.14 109.424 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' HD12 ' A' ' 50' ' ' LEU . 11.1 m-20 -71.26 111.66 6.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.057 -0.52 . . . . 1.77 110.519 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.521 ' HB3' ' CB ' ' A' ' 68' ' ' LEU . 6.1 m -60.15 -10.45 4.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.803 -0.635 . . . . 1.28 112.603 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -90.02 -17.56 27.61 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.669 -0.412 . . . . 3.21 110.338 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -149.53 57.92 1.0 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.328 -0.397 . . . . 2.83 111.136 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.482 HD11 ' CG1' ' A' ' 72' ' ' VAL . 2.0 mm? -60.26 150.7 29.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.267 0.556 . . . . 1.8 111.679 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.91 146.35 54.82 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.079 -1.082 . . . . 1.81 108.079 170.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -60.4 -28.13 68.0 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.499 -0.481 . . . . 3.71 110.463 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.524 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -66.7 -35.95 90.56 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.866 -0.683 . . . . 0.41 111.417 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.579 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 22.7 m -79.06 -42.94 25.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 1.05 110.411 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.2 m -53.94 -33.69 57.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.325 0.583 . . . . 1.06 110.126 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.559 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.31 -53.81 53.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.167 -0.924 . . . . 1.06 111.285 175.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.524 HD22 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -60.69 -44.25 96.76 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.441 0.639 . . . . 1.1 110.013 -179.129 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 54' ' ' THR . 53.0 mt -59.35 -43.22 92.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.001 -0.999 . . . . 1.07 110.145 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.62 -36.97 92.67 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.906 -0.664 . . . . 0.26 112.439 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.2 mt -60.24 -46.78 88.62 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.878 0.847 . . . . 1.15 109.903 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 mt -85.71 2.75 44.13 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.364 -1.289 . . . . 1.1 111.405 -175.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 65.5 35.35 7.32 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.486 -0.779 . . . . 2.46 111.534 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.2 mt -88.0 147.25 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.551 -0.75 . . . . 1.07 110.043 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -100.41 117.67 35.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.319 0.581 . . . . 2.65 110.369 -178.427 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.73 -41.99 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.313 -0.858 . . . . 1.07 111.449 -174.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.58 -7.15 68.19 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.857 -0.687 . . . . 0.57 112.991 -176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.478 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 21.0 t70 -103.81 -16.76 15.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.86 110.712 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.521 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 95.4 mt -55.5 147.81 16.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.881 -0.6 . . . . 1.18 111.626 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -95.32 -85.89 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.159 -0.928 . . . . 2.47 112.026 -172.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.27 -101.56 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.873 0.324 . . . . 1.09 111.873 -174.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.5 mm? -110.52 169.3 8.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.403 0.621 . . . . 1.03 111.216 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.482 ' CG1' HD11 ' A' ' 50' ' ' LEU . 1.5 m -121.07 163.72 18.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 106.058 -1.83 . . . . 1.03 106.058 166.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.57 142.18 13.65 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 119.818 -1.182 . . . . 0.37 111.38 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.586 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -115.4 135.17 54.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.049 -0.661 . . . . 1.12 110.4 178.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.431 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 1.4 t-20 54.79 47.54 22.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.522 -1.217 . . . . 1.85 110.904 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 24.5 m -85.41 150.06 24.99 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.177 -0.92 . . . . 1.12 110.554 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.0 m -100.42 117.18 63.44 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.623 -0.717 . . . . 1.6 109.75 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -64.78 130.68 26.85 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.646 2.23 . . . . 0.7 112.293 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' A' ' 40' ' ' CYS . 33.8 mt . . . . . 0 C--N 1.317 -0.808 0 CA-C-N 115.509 -0.769 . . . . 1.49 109.371 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.59 0.233 . . . . 1.08 110.408 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.98 112.88 18.79 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.772 0.796 . . . . 0.99 110.03 -177.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.86 121.11 32.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.215 -0.902 . . . . 1.11 110.447 -174.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.501 HG13 HG21 ' A' ' 44' ' ' THR . 13.6 m -133.15 162.81 39.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.458 0.646 . . . . 1.06 112.129 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 37.6 t -112.24 114.02 26.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.92 -1.036 . . . . 0.71 109.156 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.3 m -108.48 146.67 32.81 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.442 -0.344 . . . . 0.61 110.318 -174.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.9 t -76.45 -26.77 55.77 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.279 -0.419 . . . . 1.06 110.668 -173.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.593 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.2 m120 -147.03 155.05 41.92 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.131 -0.692 . . . . 0.93 109.131 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.2 t -132.58 132.82 42.94 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.122 0.487 . . . . 1.18 110.42 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -130.7 156.72 44.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.832 -0.622 . . . . 1.2 110.48 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.637 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 12.8 mm100 60.34 28.96 18.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.79 -0.641 . . . . 1.11 111.992 174.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 66.37 -1.02 1.33 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.217 0.607 . . . . 2.63 112.535 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 142.64 -14.97 2.45 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.441 -0.885 . . . . 0.29 112.161 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 40.8 mt -54.19 -36.89 63.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.994 0.426 . . . . 1.14 110.562 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 t -139.3 121.54 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.359 -0.837 . . . . 1.51 110.549 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.429 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 95.0 m-20 -124.08 160.4 27.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.641 -0.708 . . . . 1.24 109.227 174.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.593 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 5.5 m -134.97 151.51 31.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 111.833 0.309 . . . . 1.09 111.833 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.48 54.66 35.31 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.597 -0.729 . . . . 0.24 111.439 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 76.4 m -97.2 125.88 42.02 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.72 0.295 . . . . 0.43 111.29 -175.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 p -118.28 125.65 27.74 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.169 -0.469 . . . . 1.16 110.395 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.492 ' HA ' HG12 ' A' ' 94' ' ' VAL . 68.3 Cg_exo -51.59 109.96 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.255 2.637 . . . . 0.42 112.953 178.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 tt . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.632 -0.713 . . . . 1.21 110.271 -179.843 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 108.256 -1.016 . . . . 1.18 108.256 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.91 131.21 47.55 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.384 0.611 . . . . 1.17 110.823 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.406 ' HB2' HD11 ' A' ' 79' ' ' LEU . 14.4 t -99.43 107.17 19.32 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.382 -0.826 . . . . 0.82 109.692 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.4 m -104.34 129.64 52.22 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.012 -0.54 . . . . 0.25 109.819 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.469 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 18.4 m120 -55.46 -25.59 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.473 -0.785 . . . . 2.35 110.42 176.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 1.8 mmmm -168.85 124.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.243 -1.344 . . . . 3.06 108.223 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.525 HG21 HG12 ' A' ' 94' ' ' VAL . 16.8 p -79.61 157.51 27.29 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.493 -0.883 . . . . 1.06 110.713 171.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.473 ' CB ' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.34 146.21 42.62 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.268 -0.878 . . . . 1.14 108.957 -176.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.06 108.74 14.99 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.227 -0.442 . . . . 1.77 111.115 -173.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.515 ' HA ' HD22 ' A' ' 50' ' ' LEU . 27.5 m -57.68 -12.3 2.81 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.084 0.772 . . . . 1.28 113.084 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -90.32 -25.56 20.43 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.882 -0.327 . . . . 3.21 110.644 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -145.92 60.54 1.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.503 -0.317 . . . . 2.83 111.299 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.515 HD22 ' HA ' ' A' ' 47' ' ' SER . 2.9 mm? -60.7 147.26 42.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.763 0.792 . . . . 1.8 111.784 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -68.02 153.11 44.42 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.235 -1.348 . . . . 1.81 109.814 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.572 ' HD3' ' N ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -62.86 -26.6 68.85 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.056 -0.258 . . . . 3.71 111.18 178.538 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.572 ' N ' ' HD3' ' A' ' 52' ' ' LYS . . . -69.51 -37.41 78.41 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.489 -0.863 . . . . 0.41 111.332 177.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.53 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 26.1 m -80.98 -43.3 19.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.919 -0.4 . . . . 1.05 109.919 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.9 m -52.88 -34.8 56.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.539 -0.755 . . . . 1.06 110.233 173.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.539 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.34 -51.99 66.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.435 -0.802 . . . . 1.06 111.34 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -61.55 -44.77 96.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.407 0.623 . . . . 1.1 109.893 -179.62 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 54' ' ' THR . 58.5 mt -58.0 -45.12 87.36 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.867 -1.061 . . . . 1.07 110.162 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.06 -37.06 92.2 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.793 -0.64 . . . . 0.26 112.471 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.6 mt -60.19 -47.38 86.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.502 0.668 . . . . 1.15 110.303 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.408 ' CD1' HG22 ' A' ' 105' ' ' VAL . 2.9 mt -84.56 -2.33 57.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.857 -1.065 . . . . 1.1 111.343 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 69.76 37.75 1.79 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.939 0.876 . . . . 2.46 110.664 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 58' ' ' LEU . 56.1 mt -85.25 145.82 7.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.713 -0.676 . . . . 1.07 110.173 175.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.59 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -96.34 117.89 31.76 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.68 -0.691 . . . . 2.65 109.937 -178.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.403 HG23 HD23 ' A' ' 50' ' ' LEU . 1.8 mp -73.34 -40.18 56.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.509 -0.769 . . . . 1.07 111.049 -174.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.83 -9.87 63.42 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.976 -0.63 . . . . 0.57 113.055 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -109.15 4.61 23.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 0.86 110.903 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 98.3 mt -74.53 142.89 44.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.336 -0.393 . . . . 1.18 110.437 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -96.42 -94.64 0.2 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.683 0.623 . . . . 2.47 112.683 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.75 -99.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.17 0.433 . . . . 1.09 112.17 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.26 164.26 14.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.468 0.652 . . . . 1.03 110.928 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.574 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -115.4 172.16 4.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 106.162 -1.792 . . . . 1.03 106.162 168.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.82 138.8 9.16 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.933 -1.127 . . . . 0.37 111.113 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -111.41 132.22 54.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.532 -0.867 . . . . 1.12 110.499 176.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.42 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 2.1 t-20 58.23 46.57 15.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.49 -1.232 . . . . 1.85 110.747 175.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 35.4 m -83.72 142.11 30.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.524 -0.762 . . . . 1.12 111.096 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -88.27 116.38 66.06 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.568 -0.742 . . . . 1.6 109.375 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.15 122.2 9.25 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.792 2.328 . . . . 0.7 112.876 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.406 HD11 ' HB2' ' A' ' 40' ' ' CYS . 11.9 mt . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 115.434 -0.803 . . . . 1.49 109.21 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.45 0.167 . . . . 1.08 110.802 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.79 120.22 23.76 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.289 0.566 . . . . 0.99 110.428 -176.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.37 117.21 29.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.9 -0.591 . . . . 1.11 110.892 -175.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.525 HG12 HG21 ' A' ' 44' ' ' THR . 2.9 m -129.29 164.35 32.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.736 -0.666 . . . . 1.06 111.583 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 49.3 t -118.32 110.95 18.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.376 -0.829 . . . . 0.71 109.461 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 106' ' ' ASN . 1.3 m -92.34 166.16 12.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.309 0.576 . . . . 0.61 111.483 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.9 t -90.95 -24.23 20.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.346 -0.843 . . . . 1.06 109.406 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -156.68 166.86 32.18 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.346 -0.843 . . . . 0.93 109.183 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.6 t -138.99 143.19 38.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.991 0.424 . . . . 1.18 110.403 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.403 ' HB2' HG23 ' A' ' 105' ' ' VAL . 83.8 m-85 -126.78 149.48 49.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.048 -0.524 . . . . 1.2 109.609 176.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 101' ' ' GLN . 8.1 mm100 64.67 24.62 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 1.11 111.361 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 64.4 6.04 2.89 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.602 -0.726 . . . . 2.63 112.357 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.15 -20.14 1.39 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.905 -1.14 . . . . 0.29 113.552 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.1 mt -56.45 -37.3 70.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.619 0.71 . . . . 1.14 111.419 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.408 HG22 ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -142.79 118.87 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.58 0.705 . . . . 1.51 110.938 175.489 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.702 ' HB3' ' SG ' ' A' ' 96' ' ' CYS . 7.4 m-20 -115.37 162.33 17.28 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.234 -0.894 . . . . 1.24 109.528 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.0 m -133.64 142.46 41.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.549 0.574 . . . . 1.09 112.549 -175.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 66.78 53.09 29.35 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.094 -0.957 . . . . 0.24 112.254 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 1.3 m -96.65 129.83 43.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.394 0.616 . . . . 0.43 111.568 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.0 p -118.45 124.99 28.12 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.774 -1.103 . . . . 1.16 109.743 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.491 ' HA ' HG11 ' A' ' 94' ' ' VAL . 84.9 Cg_exo -47.91 112.28 0.55 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.405 2.737 . . . . 0.42 113.012 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.2 tt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.54 -0.755 . . . . 1.21 110.519 179.338 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.426 HG11 ' N ' ' A' ' 39' ' ' TYR . 38.8 t . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.858 0.361 . . . . 1.18 110.236 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.583 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 94.9 m-85 -137.35 135.89 37.44 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.933 0.396 . . . . 1.17 110.259 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.796 ' SG ' ' HB2' ' A' ' 77' ' ' SER . 22.1 p -104.04 102.55 12.31 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.869 0.842 . . . . 0.82 110.411 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.8 m -100.21 128.98 46.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.104 -0.953 . . . . 0.25 109.037 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 49.3 m-80 -57.6 -23.44 50.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.566 0.698 . . . . 2.35 110.47 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.566 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -161.61 128.96 4.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.31 -1.314 . . . . 3.06 107.902 176.339 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.502 HG23 HG11 ' A' ' 94' ' ' VAL . 23.0 p -87.46 155.24 20.1 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.151 -1.02 . . . . 1.06 109.769 167.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.2 tp10 -120.09 133.84 55.41 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.503 -0.771 . . . . 1.14 109.545 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.47 ' HA ' HD12 ' A' ' 71' ' ' LEU . 15.4 m-20 -69.83 112.62 6.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.507 -0.769 . . . . 1.77 109.788 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.5 p -52.67 -27.9 19.31 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.781 0.676 . . . . 1.28 112.183 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HZ1' ' HB3' ' A' ' 48' ' ' LYS . 1.3 mmmp? -89.45 -10.59 45.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.69 0.281 . . . . 3.21 111.519 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 46' ' ' ASP . 58.9 m-70 -127.79 34.29 4.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.739 0.304 . . . . 2.83 111.088 -177.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.405 HD21 ' HG3' ' A' ' 45' ' ' GLU . 96.0 mt -67.46 145.48 54.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.153 0.501 . . . . 1.8 111.668 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -86.79 169.55 12.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.382 -0.826 . . . . 1.81 109.71 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.71 -41.94 99.4 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.9 -0.32 . . . . 3.71 110.72 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.54 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -55.85 -42.28 85.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.308 -0.472 . . . . 0.41 112.969 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.527 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 86.9 m -82.6 -42.05 18.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.733 0.267 . . . . 1.05 111.121 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.3 m -54.5 -33.39 59.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.211 0.529 . . . . 1.06 110.074 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.573 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.57 -54.94 41.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.13 -0.941 . . . . 1.06 111.703 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.54 HD21 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -56.39 -47.16 79.52 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.494 0.664 . . . . 1.1 110.057 -178.164 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 54' ' ' THR . 34.2 mt -57.95 -43.69 86.54 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.738 -1.119 . . . . 1.07 110.169 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.19 -36.62 93.25 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.835 -0.698 . . . . 0.26 112.395 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 19.8 mt -62.68 -44.71 95.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.875 0.845 . . . . 1.15 109.939 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.414 ' CD1' HG21 ' A' ' 105' ' ' VAL . 6.1 mt -87.16 1.48 52.92 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.459 -1.246 . . . . 1.1 111.411 -175.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 69.24 27.5 5.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.702 -0.681 . . . . 2.46 111.628 174.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 58' ' ' LEU . 56.8 mt -78.69 142.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.953 -0.567 . . . . 1.07 110.291 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -90.07 117.84 29.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.846 -0.615 . . . . 2.65 110.058 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.27 -36.94 50.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.89 -0.596 . . . . 1.07 109.809 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.2 -10.48 84.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.57 112.511 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -101.83 -9.65 20.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.036 0.446 . . . . 0.86 110.733 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 64' ' ' LYS . 89.1 mt -55.71 134.99 51.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.261 0.553 . . . . 1.18 110.538 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 3.4 mptp? -82.35 -51.15 8.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.093 -0.958 . . . . 2.47 112.25 -169.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.491 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 1.1 t70 -139.37 -82.45 0.28 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.608 -0.437 . . . . 1.09 110.843 -178.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.4 mm? -114.44 173.95 6.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.383 0.611 . . . . 1.03 110.722 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 45' ' ' GLU . 1.2 m -121.92 166.1 16.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 106.62 -1.622 . . . . 1.03 106.62 164.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.1 126.16 3.6 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.806 -1.188 . . . . 0.37 112.055 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -99.58 139.59 35.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.11 -0.636 . . . . 1.12 110.018 -178.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 50.17 55.42 9.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.113 0.959 . . . . 1.85 109.889 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 20.9 t -105.4 146.77 29.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.043 -1.435 . . . . 1.12 110.198 -171.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.796 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 19.8 m -103.6 139.56 20.23 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 120.528 -0.469 . . . . 1.6 110.265 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 6.1 Cg_exo -80.45 119.84 3.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.614 2.209 . . . . 0.7 112.472 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.643 HD11 ' SG ' ' A' ' 40' ' ' CYS . 5.6 mp . . . . . 0 C--N 1.319 -0.727 0 N-CA-C 109.224 -0.658 . . . . 1.49 109.224 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.851 -0.425 . . . . 1.08 109.851 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.35 130.57 41.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.096 0.474 . . . . 0.99 110.872 -174.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.2 120.18 37.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.47 0.652 . . . . 1.11 112.562 -172.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.519 HG13 ' HA ' ' A' ' 111' ' ' PRO . 5.5 m -134.65 168.3 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.024 -0.989 . . . . 1.06 110.043 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.8 t -116.97 117.89 30.91 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.122 -0.696 . . . . 0.71 109.122 177.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.0 m -111.19 151.26 28.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.925 0.393 . . . . 0.61 110.887 -172.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 t -81.09 -28.81 35.08 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.963 -0.562 . . . . 1.06 110.664 -173.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -155.06 156.98 36.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.588 -0.733 . . . . 0.93 109.11 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.9 t -136.18 144.62 45.06 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.048 -0.353 . . . . 1.18 110.048 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.487 ' HB2' HG22 ' A' ' 105' ' ' VAL . 67.3 m-85 -138.33 161.93 35.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.674 0.273 . . . . 1.2 110.915 -177.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.578 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 7.5 mm100 62.63 33.27 15.84 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.03 -0.532 . . . . 1.11 112.255 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 65.43 -0.31 1.21 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.843 0.457 . . . . 2.63 112.067 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.55 -13.41 3.71 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.483 -0.865 . . . . 0.29 112.883 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 22.5 mt -55.25 -36.51 66.14 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 117.358 0.579 . . . . 1.14 110.862 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 100' ' ' TYR . 12.2 m -129.97 147.32 33.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.303 0.573 . . . . 1.51 110.529 174.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 4.2 t-20 -143.04 143.06 31.73 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.873 -1.158 . . . . 1.24 107.873 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.0 m -123.79 149.9 27.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 113.062 0.764 . . . . 1.09 113.062 -173.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 59.85 54.45 37.45 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 114.913 -1.04 . . . . 0.24 111.536 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 70' ' ' ASP . 74.8 m -97.92 123.5 41.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.757 0.313 . . . . 0.43 110.54 -173.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.3 p -118.95 126.82 26.87 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.817 -0.629 . . . . 1.16 110.91 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.519 ' HA ' HG13 ' A' ' 94' ' ' VAL . 54.2 Cg_exo -51.22 113.26 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.036 2.491 . . . . 0.42 112.141 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.8 tt . . . . . 0 N--CA 1.449 -0.515 0 CA-C-N 115.906 -0.588 . . . . 1.21 111.512 -175.982 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 39' ' ' TYR . 96.7 t . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 108.744 -0.835 . . . . 1.18 108.744 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.431 ' N ' HG12 ' A' ' 38' ' ' VAL . 97.0 m-85 -123.98 141.05 52.38 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.483 0.659 . . . . 1.17 111.362 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 91' ' ' ALA . 49.5 t -113.16 111.24 21.76 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.272 -0.876 . . . . 0.82 109.993 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.2 m -107.69 133.11 52.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.095 0.474 . . . . 0.25 110.001 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -53.99 -26.48 26.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.173 -0.921 . . . . 2.35 110.559 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.463 ' HE2' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -173.32 123.26 0.38 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.896 -1.15 . . . . 3.06 107.896 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.521 HG22 HG13 ' A' ' 94' ' ' VAL . 12.5 p -78.66 154.98 29.72 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.466 -0.893 . . . . 1.06 110.727 172.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.424 ' HG3' HD22 ' A' ' 50' ' ' LEU . 7.8 tp10 -120.88 137.94 54.33 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.979 -0.749 . . . . 1.14 108.979 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.467 ' HA ' HD13 ' A' ' 71' ' ' LEU . 11.6 m-20 -75.32 107.98 7.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.942 -0.572 . . . . 1.77 109.91 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 m -47.18 -31.17 3.39 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.849 0.718 . . . . 1.28 111.987 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 11.4 mptt -68.17 -40.95 82.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.5 0.667 . . . . 3.21 110.638 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -124.36 51.89 1.55 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.14 -0.936 . . . . 2.83 110.934 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.424 HD22 ' HG3' ' A' ' 45' ' ' GLU . 82.0 mt -62.96 159.92 15.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.573 0.701 . . . . 1.8 112.215 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.8 146.85 23.33 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.722 -1.126 . . . . 1.81 109.059 175.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -59.37 -25.06 63.93 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.239 0.337 . . . . 3.71 110.949 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.536 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -68.62 -41.45 83.95 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.759 -0.734 . . . . 0.41 111.844 176.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.51 ' HA ' HD22 ' A' ' 57' ' ' LEU . 98.3 m -81.15 -42.98 20.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.761 0.315 . . . . 1.05 110.559 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.7 m -54.84 -32.51 60.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.912 -0.586 . . . . 1.06 110.188 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.472 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.58 -54.43 46.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.562 -0.744 . . . . 1.06 111.406 175.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.536 HD22 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -58.44 -44.59 89.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.401 0.62 . . . . 1.1 110.147 -177.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.6 mt -58.9 -43.92 91.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.066 -0.97 . . . . 1.07 110.172 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.92 -35.79 91.04 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.928 -0.653 . . . . 0.26 112.537 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 16.9 mt -61.66 -39.81 92.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.751 0.786 . . . . 1.15 110.022 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.8 mt -91.61 2.06 56.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.7 -1.136 . . . . 1.1 111.085 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 68.28 30.12 5.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.85 0.833 . . . . 2.46 110.691 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 58' ' ' LEU . 54.1 mt -80.93 141.62 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.78 -0.646 . . . . 1.07 110.262 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.75 118.96 31.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.818 -0.628 . . . . 2.65 110.062 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.05 -29.35 28.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.454 -0.794 . . . . 1.07 110.856 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.42 -18.02 78.08 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.72 -0.752 . . . . 0.57 112.46 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -88.03 -19.18 27.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.071 0.462 . . . . 0.86 110.393 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.33 126.36 27.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.488 -0.778 . . . . 1.18 110.986 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -91.27 -76.32 0.45 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.053 -0.976 . . . . 2.47 112.202 -172.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -90.11 -112.11 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.457 -0.338 . . . . 1.09 111.268 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 46' ' ' ASP . 1.6 mm? -105.7 170.81 7.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.206 0.527 . . . . 1.03 111.182 176.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 106' ' ' ASN . 1.6 m -122.99 167.56 16.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 106.999 -1.482 . . . . 1.03 106.999 167.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.513 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -138.01 144.56 15.87 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.725 -1.226 . . . . 0.37 111.847 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -102.76 127.59 49.85 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.373 -0.531 . . . . 1.12 110.279 175.051 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.534 ' N ' HD21 ' A' ' 75' ' ' ASN . 0.8 OUTLIER 57.75 54.99 5.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.742 -1.117 . . . . 1.85 111.15 177.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.513 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 47.0 m -87.56 142.27 27.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.356 -0.838 . . . . 1.12 110.913 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 t -98.25 123.41 50.84 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.758 -0.656 . . . . 1.6 109.804 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.45 120.45 7.14 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.573 2.182 . . . . 0.7 112.123 175.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.767 -0.651 . . . . 1.49 109.728 -179.56 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--O 1.235 0.321 0 CA-C-O 120.564 0.221 . . . . 1.08 111.051 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.77 130.65 37.98 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.64 -0.504 . . . . 0.99 109.64 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.65 123.42 47.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.331 0.586 . . . . 1.11 110.952 -173.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 44' ' ' THR . 6.1 m -134.61 166.41 28.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.634 -0.712 . . . . 1.06 111.647 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.5 t -110.73 116.48 31.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.317 -0.856 . . . . 0.71 108.965 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.642 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 16.1 m -118.63 150.15 40.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.835 0.35 . . . . 0.61 110.642 -171.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.4 t -78.13 -32.2 50.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.81 -0.632 . . . . 1.06 110.827 -173.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.433 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.6 m120 -155.72 163.48 39.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.862 -0.608 . . . . 0.93 109.715 -176.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -139.63 148.68 42.8 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.62 -0.511 . . . . 1.18 109.62 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.511 ' HB2' HG21 ' A' ' 105' ' ' VAL . 60.6 m-85 -134.56 154.39 51.49 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.469 -0.567 . . . . 1.2 109.469 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.538 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 8.4 mm100 64.91 29.46 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.335 0.397 . . . . 1.11 111.489 176.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.7 m170 63.96 11.5 6.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.951 -0.568 . . . . 2.63 111.991 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 132.23 -17.77 4.78 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.136 -1.031 . . . . 0.29 113.333 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.598 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 14.7 mt -50.55 -40.25 51.49 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.556 0.678 . . . . 1.14 110.742 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' ' 100' ' ' TYR . 4.3 m -127.05 142.63 42.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.656 -0.702 . . . . 1.51 109.698 171.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.448 ' ND2' ' SG ' ' A' ' 96' ' ' CYS . 24.1 t30 -138.61 143.57 39.38 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.15 -1.056 . . . . 1.24 108.15 -175.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.2 m -126.19 152.24 33.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 113.393 0.886 . . . . 1.09 113.393 -172.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.06 52.73 51.05 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.703 -1.135 . . . . 0.24 112.057 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 93.7 m -96.65 126.72 42.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.951 0.405 . . . . 0.43 112.005 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -119.46 126.02 27.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.74 -0.664 . . . . 1.16 110.313 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.506 ' HA ' HG12 ' A' ' 94' ' ' VAL . 70.8 Cg_exo -51.33 110.08 0.38 Allowed 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.997 2.465 . . . . 0.42 112.417 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.9 tt . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 1.21 110.098 -179.639 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.4 tttm . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 120.907 0.384 . . . . 30.52 110.389 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 59.88 48.75 8.57 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.819 -0.628 . . . . 28.11 112.377 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.3 ptp -147.94 -32.16 0.27 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.112 0.482 . . . . 28.72 110.167 174.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.56 18.5 3.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.349 -0.611 . . . . 26.8 109.349 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.53 163.14 19.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.409 -0.814 . . . . 25.36 110.035 -175.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.4 pt -134.06 24.36 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.334 0.588 . . . . 25.15 109.886 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.36 -32.74 4.15 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.617 -0.719 . . . . 23.13 111.998 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.9 t -70.34 -27.85 64.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.881 0.372 . . . . 22.94 110.452 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.4 p -106.06 154.94 19.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.315 -0.402 . . . . 22.43 111.15 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.26 68.85 0.93 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.256 0.551 . . . . 21.22 110.188 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.29 76.56 68.36 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.636 -0.711 . . . . 19.19 111.399 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.17 -17.33 15.09 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.306 2.004 . . . . 18.61 112.66 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -89.19 -20.31 24.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.025 0.44 . . . . 18.57 110.305 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -81.51 123.91 29.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.863 -0.608 . . . . 14.82 109.789 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 m -119.86 146.98 23.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.792 0.329 . . . . 13.37 110.876 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -77.77 100.74 6.39 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.446 -0.575 . . . . 12.77 109.446 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.06 50.65 1.44 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.26 -0.736 . . . . 10.27 111.26 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.36 92.99 0.6 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.204 -0.522 . . . . 8.25 112.631 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.431 HG22 ' HD2' ' A' ' 30' ' ' PRO . 3.3 m -60.78 134.19 92.2 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.919 -0.4 . . . . 7.56 109.919 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.459 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 80.9 Cg_exo -41.1 -50.35 4.29 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.396 2.731 . . . . 6.56 114.911 -175.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 29' ' ' PRO . 2.2 Cg_endo -79.77 111.97 2.83 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.036 1.824 . . . . 5.71 111.448 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -68.17 141.1 56.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.277 -0.42 . . . . 4.21 111.102 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 p -149.37 174.83 12.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.941 -0.572 . . . . 2.12 110.21 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.2 m -98.81 135.87 39.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.93 0.395 . . . . 1.77 111.004 -175.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.6 t -80.57 -11.84 59.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.196 0.522 . . . . 2.81 109.723 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 p -76.86 -8.85 58.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.818 -0.628 . . . . 2.8 110.955 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.29 170.02 15.19 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.618 -0.593 . . . . 1.82 111.618 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -46.63 151.31 2.02 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.692 2.928 . . . . 1.43 113.76 176.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 39' ' ' TYR . 92.9 t -83.52 164.76 2.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.883 -1.053 . . . . 1.18 108.375 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.68 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 97.2 m-85 -130.63 139.68 50.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.478 0.656 . . . . 1.17 111.601 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 91' ' ' ALA . 36.9 t -107.9 98.64 8.19 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.166 -0.925 . . . . 0.82 109.346 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.588 ' HB2' ' NE2' ' A' ' 92' ' ' GLN . 33.9 m -104.24 141.71 35.8 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.393 -0.595 . . . . 0.25 109.393 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -59.63 -30.43 68.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.673 -0.694 . . . . 2.35 110.769 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.17 123.46 0.98 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.644 -0.872 . . . . 3.06 108.644 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.625 ' N ' HE22 ' A' ' 92' ' ' GLN . 1.5 p -86.65 127.99 34.97 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.814 -0.754 . . . . 1.06 110.433 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 72' ' ' VAL . 8.8 tp10 -103.45 138.07 40.68 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.973 -1.012 . . . . 1.14 109.649 -172.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.448 ' O ' HD13 ' A' ' 50' ' ' LEU . 6.3 m-20 -65.01 107.44 1.51 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.235 -0.439 . . . . 1.77 111.015 -174.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.539 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 92.9 p -65.48 -6.38 10.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.88 -0.6 . . . . 1.28 112.032 -174.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.522 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 3.6 mppt? -77.09 -38.63 51.94 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.434 0.635 . . . . 3.21 109.639 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -142.61 67.93 1.31 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.936 -1.029 . . . . 2.83 110.988 -176.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.474 ' CD2' ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -61.91 160.34 12.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.476 0.655 . . . . 1.8 111.469 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -67.65 155.6 38.81 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.341 -0.985 . . . . 1.81 108.341 171.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.402 ' HD2' ' C ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -62.61 -28.93 70.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.418 0.553 . . . . 3.71 110.233 178.061 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.581 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -67.62 -38.18 89.98 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.801 -0.714 . . . . 0.41 111.495 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.562 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 37.0 m -79.0 -41.36 29.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.995 0.426 . . . . 1.05 110.119 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.2 m -54.71 -35.16 63.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.52 -0.764 . . . . 1.06 109.851 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.555 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.19 -53.67 55.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.26 -0.882 . . . . 1.06 111.537 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.581 HD21 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -58.42 -45.46 88.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.416 0.626 . . . . 1.1 110.238 -178.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.5 mt -58.56 -43.31 89.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.954 -1.021 . . . . 1.07 110.175 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.18 -36.91 93.1 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.77 -0.728 . . . . 0.26 112.196 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.5 mt -60.6 -44.79 95.88 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.506 0.67 . . . . 1.15 110.248 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.578 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.2 mt -87.64 1.06 54.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.945 -1.025 . . . . 1.1 111.543 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 71.29 26.65 3.31 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.825 -0.625 . . . . 2.46 111.392 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.4 mt -78.44 140.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.938 -0.574 . . . . 1.07 110.281 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.537 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 11.5 mptt -91.26 118.0 30.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.709 -0.678 . . . . 2.65 109.815 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.01 -36.95 52.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.83 -0.623 . . . . 1.07 110.195 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.31 -19.23 79.6 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.735 -0.745 . . . . 0.57 112.283 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -85.25 -16.77 39.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.048 0.452 . . . . 0.86 110.331 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.539 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 94.1 mt -64.01 154.07 35.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.883 -0.598 . . . . 1.18 111.393 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -109.38 -80.37 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.647 -0.706 . . . . 2.47 112.503 -171.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -98.69 -90.67 0.29 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 112.537 0.569 . . . . 1.09 112.537 -170.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.0 OUTLIER -120.77 166.23 14.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.891 -0.595 . . . . 1.03 110.989 178.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.9 OUTLIER -118.03 171.37 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 106.665 -1.605 . . . . 1.03 106.665 167.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.77 120.6 1.76 Allowed Glycine 0 C--N 1.31 -0.911 0 C-N-CA 119.668 -1.254 . . . . 0.37 112.132 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -91.54 140.02 30.14 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 120.089 -0.644 . . . . 1.12 110.148 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.412 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 3.0 t-20 50.9 49.86 20.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.921 -1.036 . . . . 1.85 110.559 176.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.68 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 7.9 t -92.1 150.44 20.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.733 -1.121 . . . . 1.12 110.805 -174.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 17.9 t -109.41 121.12 43.43 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.794 -0.639 . . . . 1.6 110.022 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.69 124.24 10.92 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.514 2.142 . . . . 0.7 112.527 178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.416 HD13 ' HB2' ' A' ' 40' ' ' CYS . 23.9 mt -103.09 87.63 2.95 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.966 -0.561 . . . . 1.49 109.715 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.535 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 27.5 p -100.24 -41.64 7.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.951 0.405 . . . . 1.79 110.506 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 m -95.44 103.23 14.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.397 0.618 . . . . 2.13 111.042 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 48.8 mm -68.45 139.45 20.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.786 -0.643 . . . . 2.17 110.625 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.13 -127.41 7.9 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.369 -1.092 . . . . 3.18 110.369 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 m -67.83 114.63 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.331 0.586 . . . . 5.02 110.207 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.85 -71.08 0.2 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.566 -0.613 . . . . 4.93 111.566 -176.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.44 -44.81 82.87 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 121.063 -0.589 . . . . 3.64 112.648 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -95.03 23.64 5.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.761 0.791 . . . . 6.1 109.4 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.4 m -110.64 22.53 15.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.371 -0.831 . . . . 4.78 109.678 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.7 t -73.06 114.58 11.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.404 -0.816 . . . . 1.99 110.411 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.2 t -101.24 -9.62 21.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.184 0.516 . . . . 2.07 109.99 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.569 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -93.25 -158.31 0.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.855 -0.611 . . . . 1.08 110.013 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.625 HE22 ' N ' ' A' ' 44' ' ' THR . 1.2 tt0 -84.0 136.3 34.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.678 -0.49 . . . . 0.99 109.678 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.21 121.36 45.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.341 0.591 . . . . 1.11 111.217 -174.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.502 HG11 ' HA ' ' A' ' 111' ' ' PRO . 1.9 m -133.07 164.18 35.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.515 -0.766 . . . . 1.06 110.877 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.4 t -108.24 109.08 20.36 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.347 -0.842 . . . . 0.71 109.159 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 28.8 m -106.76 153.73 22.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.202 -0.454 . . . . 0.61 110.135 -175.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 t -86.64 -28.03 23.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.113 -0.494 . . . . 1.06 110.655 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.604 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 24.1 m120 -151.74 168.08 26.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.693 -0.484 . . . . 0.93 109.693 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.8 t -139.66 144.34 37.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.181 0.301 . . . . 1.18 110.783 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.493 ' HB2' HG22 ' A' ' 105' ' ' VAL . 50.8 m-85 -134.07 153.12 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.094 -0.336 . . . . 1.2 110.094 175.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.642 ' NE2' HD13 ' A' ' 104' ' ' LEU . 9.6 mm100 62.6 30.41 17.01 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.303 0.483 . . . . 1.11 112.303 172.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 67.05 -0.89 1.57 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.868 0.467 . . . . 2.63 111.827 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 76' ' ' CYS . . . 140.61 -13.73 2.94 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.805 -0.712 . . . . 0.29 112.514 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.642 HD13 ' NE2' ' A' ' 101' ' ' GLN . 48.2 mt -52.1 -36.13 50.07 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.991 0.424 . . . . 1.14 111.0 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.578 HG21 ' CD1' ' A' ' 61' ' ' LEU . 0.3 OUTLIER -137.52 139.04 44.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.504 -0.771 . . . . 1.51 109.786 174.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.571 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.5 t30 -136.37 157.93 45.63 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.711 -0.848 . . . . 1.24 108.711 -174.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.604 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 10.7 m -135.64 150.87 29.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.983 0.734 . . . . 1.09 112.983 -175.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.558 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.69 50.31 67.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 114.74 -1.118 . . . . 0.24 112.086 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 81.0 m -96.87 125.92 41.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.767 0.318 . . . . 0.43 110.576 -175.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.9 p -119.39 138.95 27.02 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.901 -0.591 . . . . 1.16 109.78 175.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.502 ' HA ' HG11 ' A' ' 94' ' ' VAL . 36.7 Cg_exo -64.92 108.63 1.13 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.889 2.393 . . . . 0.42 112.006 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.1 tt -94.58 132.37 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.585 -0.734 . . . . 1.21 111.007 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -93.42 100.26 12.6 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.844 -0.798 . . . . 3.02 108.844 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.484 HD13 ' N ' ' A' ' 115' ' ' GLY . 1.2 pp -66.75 -21.07 27.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.328 -0.396 . . . . 2.28 111.933 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.484 ' N ' HD13 ' A' ' 114' ' ' ILE . . . 100.06 -22.77 38.7 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.615 -0.802 . . . . 2.61 113.666 173.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.43 HD22 ' H ' ' A' ' 116' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.199 -0.905 . . . . 4.15 111.037 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.034 -0.358 . . . . 30.52 110.034 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.78 73.76 0.44 Allowed 'General case' 0 C--O 1.233 0.201 0 O-C-N 123.604 0.565 . . . . 28.11 110.735 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -84.55 46.73 1.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.239 -0.437 . . . . 28.72 111.696 -175.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.5 35.58 25.4 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.788 -0.642 . . . . 26.8 112.445 174.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -94.1 147.73 22.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.534 -0.543 . . . . 25.36 109.534 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.4 mm -120.48 103.44 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.77 0.319 . . . . 25.15 110.963 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.25 -25.74 12.13 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.332 -0.707 . . . . 23.13 111.332 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.8 m -125.46 117.39 23.55 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.68 -0.489 . . . . 22.94 109.68 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.2 m -58.73 -38.0 77.39 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.671 -0.695 . . . . 22.43 111.602 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -149.29 -58.12 0.21 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.23 0.538 . . . . 21.22 110.439 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 m -126.68 125.92 24.44 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.856 -0.611 . . . . 19.19 110.321 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.59 -30.96 77.09 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.165 2.577 . . . . 18.61 112.749 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -122.58 135.75 54.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.823 -0.436 . . . . 18.57 109.823 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -83.36 54.86 2.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.38 0.609 . . . . 14.82 111.103 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.29 117.47 55.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.489 -0.778 . . . . 13.37 109.396 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -82.7 42.66 0.79 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.972 0.415 . . . . 12.77 110.917 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.01 138.19 26.47 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.898 -0.592 . . . . 10.27 111.826 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.89 173.87 13.53 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.749 -0.739 . . . . 8.25 111.449 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.481 HG23 ' HD2' ' A' ' 30' ' ' PRO . 6.9 m -148.35 123.13 4.98 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-O 120.937 0.398 . . . . 7.56 110.133 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 21.7 Cg_exo -56.51 -54.4 3.91 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.101 2.534 . . . . 6.56 112.765 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 28' ' ' THR . 91.9 Cg_endo -79.53 45.58 1.98 Allowed 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 121.492 1.461 . . . . 5.71 112.459 173.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -65.91 125.56 25.76 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.906 -0.776 . . . . 4.21 108.906 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 p -153.34 -165.85 2.27 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.786 -0.365 . . . . 2.12 111.6 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.6 m -77.07 176.88 8.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.134 0.492 . . . . 1.77 111.328 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 m -89.92 -28.26 19.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 2.81 110.495 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.8 p -98.64 10.93 39.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 2.8 111.274 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.42 -176.16 37.96 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.324 -0.941 . . . . 1.82 112.516 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.467 ' HG2' ' HA ' ' A' ' 80' ' ' SER . 8.4 Cg_exo -73.72 -158.76 0.07 OUTLIER 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.718 2.945 . . . . 1.43 112.738 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.47 HG11 ' N ' ' A' ' 39' ' ' TYR . 19.2 t -84.44 166.35 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 110.29 -0.263 . . . . 1.18 110.29 -176.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.47 ' N ' HG11 ' A' ' 38' ' ' VAL . 63.8 m-85 -132.91 140.1 47.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.978 0.418 . . . . 1.17 110.577 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.672 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 52.4 t -117.79 103.21 9.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.017 -0.538 . . . . 0.82 110.778 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.8 m -100.17 129.58 46.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.703 -0.851 . . . . 0.25 108.703 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.493 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 94.6 m-20 -59.78 -24.24 63.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.55 0.69 . . . . 2.35 109.585 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 5.3 mmmm -161.78 134.64 6.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.088 -1.414 . . . . 3.06 107.724 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.495 HG22 HG11 ' A' ' 94' ' ' VAL . 22.9 p -88.39 157.73 18.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.441 -0.903 . . . . 1.06 110.49 169.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.454 ' CB ' HG23 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -119.12 142.53 47.83 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.366 -0.834 . . . . 1.14 110.179 -176.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.555 ' O ' HD11 ' A' ' 50' ' ' LEU . 11.9 t70 -71.88 101.51 2.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.523 -0.762 . . . . 1.77 110.349 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.498 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 57.1 p -67.72 -6.67 22.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.631 0.604 . . . . 1.28 112.631 -172.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.55 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -77.73 -40.9 39.59 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.777 0.799 . . . . 3.21 109.179 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -147.12 68.86 1.15 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.692 -1.14 . . . . 2.83 109.874 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.555 HD11 ' O ' ' A' ' 46' ' ' ASP . 3.1 mm? -53.08 153.18 3.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.562 0.696 . . . . 1.8 112.418 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.9 146.54 31.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.711 -1.132 . . . . 1.81 108.703 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -59.6 -27.62 66.45 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.705 -0.398 . . . . 3.71 110.857 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.602 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -69.77 -37.07 75.73 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.547 -0.835 . . . . 0.41 111.624 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.549 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 23.5 m -80.03 -43.95 21.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.831 0.348 . . . . 1.05 110.228 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.7 m -51.93 -36.2 48.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 1.06 109.813 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.558 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.36 -53.7 55.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.511 -0.768 . . . . 1.06 111.78 176.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.602 HD22 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -58.49 -46.59 86.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.462 0.649 . . . . 1.1 110.313 -178.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 54' ' ' THR . 52.9 mt -58.43 -44.8 89.27 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.854 -1.066 . . . . 1.07 110.135 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.44 -32.91 79.13 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.968 -0.634 . . . . 0.26 112.945 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.8 mt -64.01 -43.47 95.55 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.826 0.822 . . . . 1.15 110.123 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.437 ' CD1' HG21 ' A' ' 105' ' ' VAL . 3.4 mt -86.68 -1.33 57.62 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.535 -1.212 . . . . 1.1 110.961 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.2 m120 65.61 36.03 6.71 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.215 -0.902 . . . . 2.46 111.072 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.1 mt -82.96 145.09 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.599 -0.728 . . . . 1.07 109.502 175.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.58 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -99.32 117.96 34.93 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.331 0.586 . . . . 2.65 109.762 -178.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.29 -28.12 34.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.277 -0.874 . . . . 1.07 110.877 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.13 -15.44 78.65 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.168 -0.539 . . . . 0.57 112.6 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.437 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 17.2 t70 -86.21 -29.39 23.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.925 0.393 . . . . 0.86 110.332 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 86.0 mt -52.5 139.39 25.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.099 -0.955 . . . . 1.18 111.951 -174.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -96.67 -81.98 0.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.992 -1.004 . . . . 2.47 112.197 -171.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -94.77 -92.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.05 0.389 . . . . 1.09 112.05 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.442 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.3 mm? -117.39 171.32 8.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.319 0.58 . . . . 1.03 110.917 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.6 OUTLIER -121.08 172.88 7.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.565 -1.643 . . . . 1.03 106.565 165.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 105' ' ' VAL . . . -139.39 129.16 4.26 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 119.89 -1.147 . . . . 0.37 112.106 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.639 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -99.21 135.96 39.85 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.442 -0.503 . . . . 1.12 109.895 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.2 m120 46.56 51.16 12.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.199 -0.91 . . . . 1.85 110.531 -175.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -87.41 147.98 25.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.064 -0.971 . . . . 1.12 109.575 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.7 m -109.59 108.97 59.94 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 116.048 -0.524 . . . . 1.6 110.356 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.59 120.02 7.15 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.12 1.88 . . . . 0.7 111.371 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 37' ' ' PRO . 35.4 mt -90.1 87.03 6.72 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.601 -0.727 . . . . 1.49 109.26 -177.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.467 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 10.4 m -80.01 -48.09 13.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.774 -0.648 . . . . 1.79 110.654 -175.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.8 m -104.05 113.98 42.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.3 0.571 . . . . 2.13 111.026 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.8 mt -122.09 126.78 74.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.922 -0.581 . . . . 2.17 110.95 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -180.0 -31.87 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.848 -0.691 . . . . 3.18 111.689 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.9 102.01 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.748 -0.464 . . . . 5.02 109.748 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.68 -66.0 3.38 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.946 -0.645 . . . . 4.93 112.329 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 124.94 12.18 4.08 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.909 -0.662 . . . . 3.64 112.445 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -120.27 -79.45 0.6 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.507 -0.553 . . . . 6.1 109.507 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.0 m 50.58 39.65 21.82 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.519 0.676 . . . . 4.78 110.94 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.43 -56.69 0.44 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.432 -0.804 . . . . 1.99 110.691 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t 64.37 12.29 7.16 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.982 0.513 . . . . 2.07 112.07 174.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.672 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -134.33 -158.72 0.9 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.064 -0.346 . . . . 1.08 110.064 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.73 115.96 21.88 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.852 0.834 . . . . 0.99 109.694 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 117.13 33.24 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.169 -0.923 . . . . 1.11 110.832 -169.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' A' ' 111' ' ' PRO . 9.5 m -129.93 171.53 17.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.547 -0.751 . . . . 1.06 111.854 -176.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 37.7 t -115.0 108.32 16.55 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.812 -1.085 . . . . 0.71 108.93 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 27.6 m -106.03 145.43 31.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.313 -0.403 . . . . 0.61 110.076 -176.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -76.04 -28.87 57.85 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.258 -0.428 . . . . 1.06 110.348 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.427 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 12.1 m120 -151.34 164.18 37.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 0.93 109.843 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 t -137.63 133.55 34.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.05 -0.523 . . . . 1.18 109.944 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.46 ' HB2' HG22 ' A' ' 105' ' ' VAL . 66.2 m-85 -119.37 157.25 28.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.963 -0.562 . . . . 1.2 109.827 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.664 ' NE2' HD13 ' A' ' 104' ' ' LEU . 8.8 mm100 60.35 30.51 19.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.441 . . . . 1.11 111.586 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 63.68 9.82 4.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 2.63 111.875 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.83 -24.29 3.02 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.73 -0.747 . . . . 0.29 112.507 175.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.664 HD13 ' NE2' ' A' ' 101' ' ' GLN . 18.6 mt -49.86 -36.13 25.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.825 0.305 . . . . 1.14 111.825 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 100' ' ' TYR . 0.3 OUTLIER -141.38 118.82 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.392 0.615 . . . . 1.51 110.992 173.148 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.571 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 7.5 m-20 -111.03 162.64 14.66 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.5 -0.773 . . . . 1.24 109.488 176.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.4 m -132.85 154.32 39.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.336 0.495 . . . . 1.09 112.336 -176.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 59.8 52.29 53.87 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.278 -0.874 . . . . 0.24 111.88 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 73.3 m -96.81 123.6 40.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.878 0.37 . . . . 0.43 111.116 -174.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.4 p -119.72 125.94 27.18 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.919 -0.582 . . . . 1.16 110.131 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.505 ' HA ' HG13 ' A' ' 94' ' ' VAL . 81.5 Cg_exo -48.38 109.87 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.752 2.301 . . . . 0.42 111.665 175.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.3 tt -92.64 144.21 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 1.21 111.747 -169.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -107.05 101.39 10.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.549 -0.751 . . . . 3.02 110.366 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.465 HD12 ' N ' ' A' ' 115' ' ' GLY . 1.4 pp -94.8 -19.39 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.059 -0.518 . . . . 2.28 111.374 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.465 ' N ' HD12 ' A' ' 114' ' ' ILE . . . 81.21 -8.56 57.61 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 121.149 -0.548 . . . . 2.61 113.621 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.539 -0.743 . . . . 4.15 109.811 -179.584 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.821 0.343 . . . . 30.52 110.846 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.29 134.64 36.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.771 0.319 . . . . 28.11 110.385 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.5 mtp -98.25 125.86 43.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.145 -0.479 . . . . 28.72 110.895 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.33 81.26 2.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.212 0.529 . . . . 26.8 109.618 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -77.98 134.39 37.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.637 -0.711 . . . . 25.36 110.514 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.428 HD11 ' H ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -133.65 20.19 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.986 -0.552 . . . . 25.15 110.728 -177.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.04 52.36 4.61 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.034 -0.603 . . . . 23.13 112.383 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.5 m -85.8 65.99 9.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.274 0.559 . . . . 22.94 110.038 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -77.75 64.9 3.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.407 -0.815 . . . . 22.43 111.195 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.91 48.23 0.94 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.939 -0.573 . . . . 21.22 110.791 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 20' ' ' VAL . 7.5 p -147.63 71.33 11.62 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 121.772 0.796 . . . . 19.19 110.677 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.25 -45.27 23.7 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.475 2.117 . . . . 18.61 110.816 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -147.29 123.93 11.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.498 -0.774 . . . . 18.57 109.949 175.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -108.03 -42.33 4.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.007 -0.542 . . . . 14.82 110.162 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.8 m -108.82 155.41 9.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.69 -0.687 . . . . 13.37 110.746 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -113.46 118.21 33.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.187 -0.461 . . . . 12.77 110.01 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -139.01 -165.24 10.17 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.844 -0.693 . . . . 10.27 112.335 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.83 -69.49 0.2 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.539 -0.624 . . . . 8.25 111.539 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.477 HG22 ' HD2' ' A' ' 30' ' ' PRO . 61.1 m -152.7 113.11 2.76 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 110.323 -0.251 . . . . 7.56 110.323 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 28' ' ' THR . 4.3 Cg_exo -43.5 -51.17 6.26 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.888 3.059 . . . . 6.56 114.713 -171.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.477 ' HD2' HG22 ' A' ' 28' ' ' THR . 70.0 Cg_exo -48.58 112.48 0.63 Allowed 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 122.435 2.09 . . . . 5.71 112.88 174.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -102.41 -34.07 9.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.172 -0.467 . . . . 4.21 110.392 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.3 t -78.16 178.63 7.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.796 -0.638 . . . . 2.12 109.588 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 73.8 m -101.95 147.45 26.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.99 0.424 . . . . 1.77 110.325 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 p -89.05 -10.84 45.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.091 -0.504 . . . . 2.81 110.932 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.2 t -94.62 9.13 39.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 2.8 110.181 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . 149.33 151.26 5.44 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.879 -0.889 . . . . 1.82 110.879 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -69.71 -159.6 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.492 2.128 . . . . 1.43 112.495 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.9 t -87.29 156.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.144 -0.317 . . . . 1.18 110.144 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.29 136.44 48.16 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.855 -0.424 . . . . 1.17 109.855 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.761 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 48.0 t -102.99 114.82 29.42 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.806 0.336 . . . . 0.82 110.589 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.1 m -115.25 125.18 53.02 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.928 -0.767 . . . . 0.25 108.928 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.448 ' HA ' ' HB2' ' A' ' 91' ' ' ALA . 24.7 t-20 -50.64 -34.36 25.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.614 -0.721 . . . . 2.35 110.231 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -154.58 127.48 8.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.652 -1.158 . . . . 3.06 108.725 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.501 HG22 HG13 ' A' ' 94' ' ' VAL . 18.0 p -84.37 156.94 21.62 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.53 -0.868 . . . . 1.06 110.514 168.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -120.58 139.23 53.25 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.617 -0.72 . . . . 1.14 109.451 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' O ' HD13 ' A' ' 50' ' ' LEU . 24.1 t70 -65.65 110.81 2.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.029 -0.532 . . . . 1.77 110.376 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.536 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 58.5 p -69.41 -2.45 11.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.262 -0.426 . . . . 1.28 112.073 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -90.12 -27.99 19.26 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.115 0.483 . . . . 3.21 109.759 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -141.62 64.28 1.41 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.57 . . . . 2.83 110.592 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.505 HD12 ' CG1' ' A' ' 72' ' ' VAL . 2.8 mm? -60.74 150.21 33.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.291 0.567 . . . . 1.8 111.559 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.93 144.13 57.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.831 -1.077 . . . . 1.81 108.438 169.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -62.8 -21.07 65.62 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.213 -0.195 . . . . 3.71 110.902 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.531 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -71.31 -36.57 63.36 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.583 -0.818 . . . . 0.41 111.202 174.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.523 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 37.9 m -82.05 -43.98 17.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.817 0.342 . . . . 1.05 110.198 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.1 m -52.5 -35.37 52.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.698 -0.683 . . . . 1.06 110.04 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.629 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -55.82 -53.69 53.62 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.377 -0.829 . . . . 1.06 111.288 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.531 HD21 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -59.6 -44.9 93.23 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.221 0.534 . . . . 1.1 109.995 -178.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 54' ' ' THR . 54.1 mt -58.12 -46.08 86.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.094 -0.957 . . . . 1.07 109.992 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.24 -29.66 75.15 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.003 -0.617 . . . . 0.26 112.574 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.1 mt -65.73 -47.53 75.01 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.639 0.733 . . . . 1.15 110.161 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.461 ' CD1' HG22 ' A' ' 105' ' ' VAL . 3.7 mt -83.09 -2.41 55.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.764 -1.107 . . . . 1.1 110.996 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.2 t30 68.17 38.38 2.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.222 -0.899 . . . . 2.46 110.978 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.41 HD12 ' HA ' ' A' ' 58' ' ' LEU . 51.3 mt -84.32 137.74 20.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.778 -0.646 . . . . 1.07 110.099 175.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 64' ' ' LYS . 1.9 mppt? -84.11 118.0 23.81 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.645 -0.707 . . . . 2.65 110.304 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.91 -31.69 51.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.763 -0.653 . . . . 1.07 109.902 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.92 -9.53 86.61 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.774 -0.648 . . . . 0.57 112.604 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -95.6 -8.78 33.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.399 0.618 . . . . 0.86 110.283 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.6 mt -69.22 144.08 53.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.721 -0.672 . . . . 1.18 111.223 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -101.17 -68.73 0.8 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.843 -1.071 . . . . 2.47 112.557 -168.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -114.51 -91.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.853 0.359 . . . . 1.09 111.825 -172.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 46' ' ' ASP . 1.3 mm? -116.25 169.34 9.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.056 0.455 . . . . 1.03 110.393 174.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.505 ' CG1' HD12 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -124.89 166.88 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.596 -1.631 . . . . 1.03 106.596 166.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.463 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -134.1 148.24 19.38 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 119.807 -1.187 . . . . 0.37 111.364 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -112.1 134.4 53.67 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.151 -0.62 . . . . 1.12 110.549 177.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.51 45.14 25.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.824 -1.08 . . . . 1.85 111.163 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.463 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 63.3 m -77.61 146.91 35.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.334 0.588 . . . . 1.12 111.275 -176.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t -98.03 113.28 63.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.168 -0.924 . . . . 1.6 109.523 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.06 124.39 12.56 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.379 2.053 . . . . 0.7 111.954 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.8 mt -103.45 88.46 3.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.932 -0.576 . . . . 1.49 109.729 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.4 m -76.8 -32.62 57.78 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.878 -0.601 . . . . 1.79 110.727 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 m -112.7 102.95 14.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.664 0.745 . . . . 2.13 111.566 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.5 mm -68.09 -47.69 77.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.264 -0.88 . . . . 2.17 112.164 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.7 -29.53 69.43 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.522 -0.847 . . . . 3.18 112.46 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.46 -46.1 32.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 122.863 -0.198 . . . . 5.02 110.918 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.14 59.97 0.27 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.201 -0.999 . . . . 4.93 112.859 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.7 -24.67 6.91 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.779 -0.724 . . . . 3.64 112.054 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -83.25 129.81 35.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.38 -0.23 . . . . 6.1 110.38 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 p 48.71 91.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.888 0.743 . . . . 4.78 111.591 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.549 ' SG ' HG22 ' A' ' 93' ' ' THR . 32.0 p -94.56 17.34 13.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.54 -0.755 . . . . 1.99 111.237 -173.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.6 t 68.45 6.62 5.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.796 -0.638 . . . . 2.07 110.636 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.761 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -154.44 -162.11 1.34 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.983 -0.553 . . . . 1.08 110.362 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.0 124.03 31.23 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.404 0.621 . . . . 0.99 110.069 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.549 HG22 ' SG ' ' A' ' 89' ' ' CYS . 0.2 OUTLIER -104.33 115.73 30.89 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.826 -0.625 . . . . 1.11 110.991 -173.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 111' ' ' PRO . 9.5 m -126.42 165.08 25.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.936 -0.574 . . . . 1.06 111.316 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.6 121.96 45.03 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.079 -1.082 . . . . 0.71 108.079 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 27.1 m -120.57 152.35 38.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 0.61 111.664 -167.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.404 HG22 ' HA3' ' A' ' 108' ' ' GLY . 10.9 t -81.2 -30.08 34.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.072 -0.967 . . . . 1.06 110.637 -170.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.466 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 17.8 m120 -154.56 167.82 28.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.39 -0.596 . . . . 0.93 109.39 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 t -147.37 135.99 21.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.118 0.485 . . . . 1.18 110.622 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.427 ' HB2' HG23 ' A' ' 105' ' ' VAL . 67.1 m-85 -129.55 154.31 47.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.361 -0.607 . . . . 1.2 109.361 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.646 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 10.7 mm100 59.88 38.1 21.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.545 -0.298 . . . . 1.11 111.48 176.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.7 p80 58.88 2.18 0.23 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.152 0.981 . . . . 2.63 113.201 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.69 -18.19 3.01 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.691 -0.766 . . . . 0.29 112.242 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 20.7 mt -49.8 -44.02 48.88 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.871 0.336 . . . . 1.14 110.767 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.461 HG22 ' CD1' ' A' ' 61' ' ' LEU . 1.4 m -128.9 119.65 50.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.698 0.761 . . . . 1.51 110.344 172.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.448 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 32.5 t30 -119.12 146.31 45.23 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.075 -1.083 . . . . 1.24 108.075 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.526 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 11.3 m -132.45 156.21 42.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.537 0.94 . . . . 1.09 113.537 -173.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.689 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 65.45 49.36 61.12 Favored Glycine 0 CA--C 1.503 -0.66 0 CA-C-N 114.952 -1.022 . . . . 0.24 111.716 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 98.7 m -98.15 126.59 43.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.964 0.411 . . . . 0.43 111.533 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -120.86 126.14 26.78 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.505 -0.771 . . . . 1.16 109.852 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.505 ' HA ' HG12 ' A' ' 94' ' ' VAL . 71.7 Cg_exo -50.15 112.34 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.049 2.499 . . . . 0.42 112.117 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.0 tt -99.57 148.56 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.894 -0.594 . . . . 1.21 111.096 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -124.17 109.61 13.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.502 -0.772 . . . . 3.02 109.451 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.457 HD12 ' H ' ' A' ' 115' ' ' GLY . 1.2 pp -76.59 -24.7 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.852 -0.339 . . . . 2.28 111.794 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.457 ' H ' HD12 ' A' ' 114' ' ' ILE . . . 88.53 7.78 71.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.586 -0.816 . . . . 2.61 113.555 173.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.483 -0.77 . . . . 4.15 109.956 176.513 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 120.934 0.397 . . . . 30.52 111.114 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.52 86.93 2.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.946 0.403 . . . . 28.11 110.128 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.9 mmt -77.62 66.36 3.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 28.72 110.902 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.83 132.4 54.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.065 -0.516 . . . . 26.8 110.258 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.08 94.73 2.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.004 0.431 . . . . 25.36 110.105 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.2 pt -113.54 158.02 14.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.055 -0.521 . . . . 25.15 111.113 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.44 56.86 0.55 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.415 -0.674 . . . . 23.13 111.415 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -87.5 -4.88 58.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.812 0.339 . . . . 22.94 110.9 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -70.12 142.46 52.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.92 0.39 . . . . 22.43 109.951 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.93 145.36 27.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.364 -0.38 . . . . 21.22 111.149 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 t 59.27 85.53 0.18 Allowed Pre-proline 0 CA--C 1.532 0.27 0 O-C-N 123.859 0.724 . . . . 19.19 111.53 176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.79 -20.38 45.95 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.501 2.134 . . . . 18.61 112.227 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -106.43 84.31 2.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.438 -0.347 . . . . 18.57 110.78 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.91 -19.35 58.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.339 -0.615 . . . . 14.82 109.339 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.57 137.48 18.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.207 -0.906 . . . . 13.37 109.317 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -82.65 79.27 9.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.205 0.526 . . . . 12.77 110.35 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.95 106.96 2.53 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.598 -0.728 . . . . 10.27 112.131 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.92 25.44 2.8 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.936 -0.649 . . . . 8.25 111.581 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.458 HG22 ' HD2' ' A' ' 30' ' ' PRO . 7.1 m -77.25 119.44 77.48 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 121.195 0.521 . . . . 7.56 110.66 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -56.62 -54.73 3.44 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.605 2.87 . . . . 6.56 113.835 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.458 ' HD2' HG22 ' A' ' 28' ' ' THR . 58.5 Cg_endo -70.18 152.43 67.15 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.243 1.295 . . . . 5.71 112.104 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.439 ' HB2' HG13 ' A' ' 112' ' ' ILE . 68.3 mttm -88.33 43.35 1.12 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.99 -0.55 . . . . 4.21 110.964 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.1 t -72.87 161.67 30.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.371 0.605 . . . . 2.12 110.457 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 57.1 m -89.47 124.82 34.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.365 -0.834 . . . . 1.77 110.432 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.9 t -66.54 -17.71 64.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.035 0.445 . . . . 2.81 110.312 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 t -71.19 -16.32 62.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.951 -0.568 . . . . 2.8 110.602 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.1 -123.79 3.55 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.812 -0.709 . . . . 1.82 112.166 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.54 153.76 33.75 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.142 2.562 . . . . 1.43 113.747 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t -89.06 161.47 2.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.453 -1.249 . . . . 1.18 107.85 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -118.3 137.01 53.36 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.872 0.844 . . . . 1.17 111.817 -176.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.683 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 53.1 t -109.05 115.71 30.57 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.842 -1.072 . . . . 0.82 110.152 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.7 m -113.57 126.69 55.57 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.201 -0.666 . . . . 0.25 109.201 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -57.63 -23.21 49.92 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.473 -0.785 . . . . 2.35 109.769 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -166.24 132.46 2.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.55 -1.204 . . . . 3.06 108.028 172.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.507 HG22 HG12 ' A' ' 94' ' ' VAL . 25.1 p -89.6 159.47 17.15 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.456 -0.898 . . . . 1.06 110.494 172.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.401 ' CB ' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -120.58 144.89 47.85 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.208 -0.905 . . . . 1.14 109.305 -176.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 48' ' ' LYS . 33.4 t70 -78.52 105.49 9.83 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.973 -0.558 . . . . 1.77 110.313 -174.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.488 ' HA ' HD21 ' A' ' 50' ' ' LEU . 80.1 p -63.21 -7.07 5.17 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.125 0.787 . . . . 1.28 113.125 -172.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 2.9 mptp? -81.4 -43.49 18.88 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.335 0.588 . . . . 3.21 110.301 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -135.78 63.94 1.58 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.222 -0.899 . . . . 2.83 111.211 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.488 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.8 mm? -60.06 155.97 15.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.265 0.555 . . . . 1.8 111.453 176.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.26 152.29 41.4 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.638 -0.875 . . . . 1.81 108.638 168.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -63.24 -28.96 70.39 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.415 -0.514 . . . . 3.71 110.638 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.533 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -67.54 -38.14 90.29 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.796 -0.716 . . . . 0.41 111.879 177.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.554 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 41.7 m -78.93 -41.79 28.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.961 0.41 . . . . 1.05 109.931 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -52.41 -36.11 53.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.448 -0.796 . . . . 1.06 109.805 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.15 -53.99 52.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.046 -0.979 . . . . 1.06 111.626 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -57.37 -46.31 83.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.492 0.663 . . . . 1.1 110.016 -179.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.0 mt -58.69 -45.22 89.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.719 -1.128 . . . . 1.07 109.827 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.34 -36.39 90.85 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.762 -0.654 . . . . 0.26 112.657 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 25.5 mt -59.41 -40.29 86.19 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.613 0.72 . . . . 1.15 110.439 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.68 -3.65 57.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.923 -1.035 . . . . 1.1 110.836 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 72.03 30.69 2.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.353 -0.84 . . . . 2.46 111.305 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 60.1 mt -77.59 141.95 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.984 -0.553 . . . . 1.07 109.819 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.477 ' CG ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -97.46 117.69 32.28 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.355 0.598 . . . . 2.65 110.084 -177.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.7 -39.15 59.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.199 -0.909 . . . . 1.07 110.791 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.9 -11.42 60.67 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.949 -0.643 . . . . 0.57 112.952 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.477 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 36.6 t70 -111.94 3.63 17.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.253 0.549 . . . . 0.86 110.793 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.4 mt -70.85 164.72 24.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.304 -0.407 . . . . 1.18 110.636 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -106.52 -91.93 0.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.586 0.587 . . . . 2.47 112.586 -174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.445 ' O ' HD12 ' A' ' 71' ' ' LEU . 5.6 m-20 -91.81 -84.43 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.622 0.601 . . . . 1.09 112.622 -171.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -123.55 166.88 14.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.358 0.599 . . . . 1.03 111.032 176.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 106' ' ' ASN . 0.8 OUTLIER -117.48 172.92 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.526 -1.657 . . . . 1.03 106.526 166.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.529 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -143.26 149.12 21.07 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.145 -1.026 . . . . 0.37 111.532 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -112.52 132.73 54.95 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.137 0.494 . . . . 1.12 109.96 175.117 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.4 m120 55.59 47.51 20.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.867 -1.06 . . . . 1.85 110.91 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.529 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 63.6 m -82.58 138.93 34.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.871 -0.604 . . . . 1.12 110.952 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.5 m -103.02 127.52 29.68 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.576 -0.738 . . . . 1.6 110.482 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.04 126.35 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.491 2.127 . . . . 0.7 112.365 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.37 88.88 4.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.449 -0.796 . . . . 1.49 109.563 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.0 m -75.51 -26.09 57.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.28 -0.418 . . . . 1.79 111.138 -177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.8 m -117.73 105.54 18.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.463 0.649 . . . . 2.13 112.003 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.5 mt -117.61 127.47 74.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.503 -0.772 . . . . 2.17 110.562 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.59 -38.44 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.72 -0.952 . . . . 3.18 110.72 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.25 -41.96 43.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.242 -0.651 . . . . 5.02 109.242 172.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.65 -142.99 10.26 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.307 -0.86 . . . . 4.93 111.291 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.24 25.46 25.66 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.514 -0.85 . . . . 3.64 112.074 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -68.53 -24.95 64.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 6.1 111.294 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.9 p -75.73 -13.2 60.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.45 0.643 . . . . 4.78 110.204 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 12.5 t -104.69 -74.97 0.63 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.499 -0.773 . . . . 1.99 110.681 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.4 t 61.51 29.86 18.54 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.618 0.723 . . . . 2.07 110.623 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.683 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -145.62 -158.42 0.89 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.46 -0.941 . . . . 1.08 108.46 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.33 116.41 20.39 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.669 0.747 . . . . 0.99 109.336 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.19 123.52 44.53 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.558 -0.746 . . . . 1.11 110.445 -171.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.507 HG12 HG22 ' A' ' 44' ' ' THR . 7.6 m -134.41 163.16 37.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.508 -0.769 . . . . 1.06 111.423 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 47.3 t -107.99 114.88 29.11 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.301 -1.0 . . . . 0.71 108.301 176.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 28.0 m -114.88 148.2 38.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.166 -0.47 . . . . 0.61 110.142 -173.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -78.97 -32.9 45.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.958 -0.565 . . . . 1.06 110.651 -174.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -153.02 163.4 39.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.93 110.313 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -136.03 143.23 44.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.13 -0.486 . . . . 1.18 110.119 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.498 ' HB2' HG21 ' A' ' 105' ' ' VAL . 60.0 m-85 -129.67 153.42 48.15 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.332 -0.618 . . . . 1.2 109.332 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.626 ' NE2' HD11 ' A' ' 104' ' ' LEU . 10.1 mm100 62.9 30.59 16.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 1.11 111.075 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 65.53 2.41 2.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.808 -0.633 . . . . 2.63 112.378 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.37 -16.62 3.37 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.32 -0.943 . . . . 0.29 112.868 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.626 HD11 ' NE2' ' A' ' 101' ' ' GLN . 20.5 mt -50.11 -38.05 36.95 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.026 0.413 . . . . 1.14 110.689 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.498 HG21 ' HB2' ' A' ' 100' ' ' TYR . 5.6 m -130.0 149.14 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.755 -0.657 . . . . 1.51 109.312 171.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 7.8 t30 -144.31 149.99 37.13 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.778 -0.823 . . . . 1.24 108.778 -174.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.0 m -130.88 151.59 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 113.006 0.743 . . . . 1.09 113.006 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.19 50.42 67.32 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 114.838 -1.074 . . . . 0.24 112.104 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 74.7 m -97.75 126.47 43.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.608 0.242 . . . . 0.43 111.304 -175.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 21.4 p -118.88 138.05 25.64 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.464 -0.334 . . . . 1.16 110.465 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.506 ' HA ' HG11 ' A' ' 94' ' ' VAL . 24.2 Cg_exo -67.53 110.85 2.17 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.294 2.663 . . . . 0.42 112.889 -175.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.439 HG13 ' HB2' ' A' ' 31' ' ' LYS . 5.8 tt -95.85 127.4 47.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.942 -0.572 . . . . 1.21 111.123 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -109.49 102.07 10.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.895 -0.593 . . . . 3.02 110.806 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.52 2.99 9.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.195 0.521 . . . . 2.28 110.971 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.84 -10.2 7.1 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.158 -0.777 . . . . 2.61 111.158 -173.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.621 -0.704 . . . . 4.15 110.289 176.023 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 110.011 -0.366 . . . . 30.52 110.011 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.86 57.21 0.73 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.106 0.479 . . . . 28.11 110.302 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.4 ttm -95.37 71.57 3.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.37 0.605 . . . . 28.72 110.454 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.16 -8.06 58.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.726 -0.67 . . . . 26.8 109.569 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -69.94 127.07 31.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.098 -0.956 . . . . 25.36 110.595 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.506 HD13 ' H ' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -121.81 11.09 5.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.509 0.671 . . . . 25.15 109.694 177.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.46 -158.27 10.13 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.176 -0.92 . . . . 23.13 111.246 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.2 t -118.41 -57.12 2.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.83 0.348 . . . . 22.94 110.701 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.4 p -85.48 -42.41 14.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.446 -0.343 . . . . 22.43 111.848 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.38 135.0 35.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.778 0.323 . . . . 21.22 111.198 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.99 141.25 22.12 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.219 -0.446 . . . . 19.19 110.434 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.27 -22.34 46.49 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.859 2.373 . . . . 18.61 112.166 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -146.69 106.64 3.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.755 -0.657 . . . . 18.57 109.511 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -88.81 -70.33 0.65 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.191 -0.67 . . . . 14.82 109.191 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.5 t -129.32 -58.18 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.55 -0.907 . . . . 13.37 108.55 171.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.7 m120 49.16 66.66 1.04 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.232 -0.895 . . . . 12.77 111.146 173.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.67 -107.3 0.32 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.933 -0.651 . . . . 10.27 112.021 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.93 10.97 71.13 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.866 -0.683 . . . . 8.25 111.546 -177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.471 HG23 ' HD2' ' A' ' 30' ' ' PRO . 7.1 m -73.92 135.44 77.32 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.202 -0.296 . . . . 7.56 110.202 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 53.3 Cg_exo -36.52 -46.49 1.22 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 124.351 3.367 . . . . 6.56 115.927 -176.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 29' ' ' PRO . 7.1 Cg_exo -72.06 69.05 3.17 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 121.781 1.654 . . . . 5.71 111.483 177.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -81.62 48.84 1.23 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.378 -0.828 . . . . 4.21 110.68 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.2 t -87.07 174.41 8.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.134 -0.485 . . . . 2.12 110.802 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 40.9 m -96.81 151.73 19.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.707 -0.678 . . . . 1.77 110.032 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.7 m -84.58 -2.34 57.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.254 -0.43 . . . . 2.81 110.488 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.0 p -73.44 -24.66 60.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.797 -0.638 . . . . 2.8 111.08 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.79 -156.4 26.99 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.634 -0.793 . . . . 1.82 111.978 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -52.42 153.86 12.72 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.168 2.579 . . . . 1.43 113.723 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.43 158.6 3.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.953 -1.129 . . . . 1.18 107.953 171.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.458 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 94.6 m-85 -120.89 138.49 54.06 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.827 -0.749 . . . . 1.17 111.594 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.74 ' SG ' ' HB2' ' A' ' 91' ' ' ALA . 42.2 t -111.75 100.29 8.83 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.043 -0.98 . . . . 0.82 110.031 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.9 m -101.95 128.19 48.47 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.085 -0.709 . . . . 0.25 109.085 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -57.12 -24.6 55.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.817 -0.629 . . . . 2.35 110.261 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.8 120.09 0.88 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.308 -0.86 . . . . 3.06 108.703 177.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.508 HG21 HG12 ' A' ' 94' ' ' VAL . 18.4 p -78.81 147.35 33.29 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.121 -1.032 . . . . 1.06 110.505 172.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -114.07 142.32 46.35 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.479 -0.782 . . . . 1.14 109.421 -175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.45 ' O ' HD13 ' A' ' 50' ' ' LEU . 28.2 m-20 -70.45 103.97 2.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.949 -0.569 . . . . 1.77 111.129 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.477 ' HA ' HD23 ' A' ' 50' ' ' LEU . 7.1 m -58.71 -14.59 8.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.309 0.485 . . . . 1.28 112.309 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -77.16 -35.64 55.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.834 0.349 . . . . 3.21 110.218 -178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -146.74 65.35 1.18 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.07 -0.514 . . . . 2.83 111.073 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 47' ' ' SER . 2.7 mm? -57.0 151.3 15.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.481 . . . . 1.8 111.242 175.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.77 156.49 39.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.203 -0.666 . . . . 1.81 109.203 172.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -59.99 -33.35 71.85 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.806 -0.358 . . . . 3.71 111.014 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.554 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -61.83 -34.2 87.93 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.843 -0.694 . . . . 0.41 111.812 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.522 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 24.1 m -85.04 -43.08 14.25 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.456 -0.202 . . . . 1.05 110.456 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.5 m -52.84 -35.22 57.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.256 0.551 . . . . 1.06 109.763 173.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.608 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.5 -55.45 33.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.277 -0.874 . . . . 1.06 111.494 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.554 HD21 ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -58.9 -44.76 91.29 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.34 0.59 . . . . 1.1 110.103 -177.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.4 mt -59.99 -43.44 95.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.138 -0.937 . . . . 1.07 110.114 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.14 -38.01 94.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.718 -0.754 . . . . 0.26 112.162 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.3 mt -62.23 -40.99 97.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.798 0.809 . . . . 1.15 110.187 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.7 mt -91.27 4.95 51.03 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.566 -1.197 . . . . 1.1 111.274 -176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 64.85 33.62 9.94 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.717 -0.674 . . . . 2.46 111.403 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.9 mt -89.91 144.13 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.875 -0.602 . . . . 1.07 110.324 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 11.3 mptt -94.31 118.43 31.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.825 -0.625 . . . . 2.65 109.963 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.412 HD12 ' N ' ' A' ' 65' ' ' ILE . 1.8 mp -68.48 -35.67 71.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.499 -0.773 . . . . 1.07 110.386 -177.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.87 -14.15 82.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.904 -0.665 . . . . 0.57 112.39 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -88.01 -19.71 26.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.006 0.431 . . . . 0.86 110.549 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.419 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 93.0 mt -55.5 141.93 35.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.699 0.762 . . . . 1.18 111.771 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.487 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -87.86 -66.62 0.89 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.725 -1.125 . . . . 2.47 112.457 -170.376 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.467 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 0.3 OUTLIER -123.73 -84.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.786 -0.366 . . . . 1.09 111.157 -177.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -116.45 167.12 11.33 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.291 0.567 . . . . 1.03 111.983 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.415 ' CG1' HD12 ' A' ' 50' ' ' LEU . 1.9 m -119.78 165.13 15.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.18 -1.415 . . . . 1.03 107.18 168.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.42 133.85 6.67 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.655 -1.26 . . . . 0.37 112.404 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.652 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.23 135.77 36.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.901 -0.407 . . . . 1.12 109.901 176.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.7 m120 46.79 52.92 10.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.466 -0.788 . . . . 1.85 110.634 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 9.3 t -92.85 137.38 32.42 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.118 -0.946 . . . . 1.12 109.883 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.3 t -100.55 125.71 38.17 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.92 -0.582 . . . . 1.6 110.893 -173.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -76.27 122.13 6.45 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.758 2.305 . . . . 0.7 112.568 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.9 mt -100.4 89.24 3.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.627 -0.715 . . . . 1.49 109.845 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.2 m -73.87 -34.55 64.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.419 -0.355 . . . . 1.79 110.825 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.38 123.59 70.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.401 0.619 . . . . 2.13 111.367 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 48.9 mm -85.51 127.59 39.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.581 -0.736 . . . . 2.17 109.904 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 134.05 -65.05 0.59 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.801 -0.714 . . . . 3.18 111.858 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 p -95.62 105.55 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.319 0.581 . . . . 5.02 110.141 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.43 -51.77 4.25 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.726 -0.749 . . . . 4.93 112.168 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 82' ' ' ILE . . . -78.26 76.42 1.81 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 121.246 -0.502 . . . . 3.64 112.476 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -129.55 -88.75 0.51 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.742 -0.836 . . . . 6.1 108.742 172.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.2 t -97.54 -18.17 19.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.439 -0.948 . . . . 4.78 108.439 171.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.424 ' C ' ' H ' ' A' ' 91' ' ' ALA . 0.5 OUTLIER 69.54 6.14 5.55 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.503 -1.226 . . . . 1.99 112.654 172.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.0 m 69.21 -43.4 0.52 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.184 0.594 . . . . 2.07 111.831 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.74 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -88.58 -159.29 0.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.909 -0.404 . . . . 1.08 109.909 178.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.7 115.06 25.96 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.603 0.716 . . . . 0.99 110.697 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.407 HG22 ' SG ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -93.64 124.08 37.4 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.422 -0.808 . . . . 1.11 111.154 -176.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.515 HG11 ' HA ' ' A' ' 111' ' ' PRO . 12.0 m -135.47 166.34 27.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.418 -0.81 . . . . 1.06 111.086 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.9 t -112.47 118.63 35.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.795 -0.817 . . . . 0.71 108.795 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 13.6 m -120.26 153.37 36.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.903 0.382 . . . . 0.61 111.117 -170.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 t -82.39 -29.46 30.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.799 -0.637 . . . . 1.06 111.082 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.411 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 13.3 m120 -156.17 159.16 38.74 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.125 -0.489 . . . . 0.93 109.965 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.8 t -135.3 142.44 45.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.127 -0.488 . . . . 1.18 110.036 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -130.28 159.74 35.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.646 -0.707 . . . . 1.2 109.635 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.655 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 9.7 mm100 59.32 31.32 21.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.16 -0.473 . . . . 1.11 111.61 177.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 67.98 -0.27 2.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.709 -0.678 . . . . 2.63 111.814 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 142.76 -19.63 2.37 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.78 -0.724 . . . . 0.29 112.162 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 34.5 mt -50.3 -43.4 53.57 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.316 0.579 . . . . 1.14 110.593 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 t -121.66 123.62 69.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.915 -1.039 . . . . 1.51 109.707 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.441 ' ND2' ' SG ' ' A' ' 96' ' ' CYS . 37.3 t30 -128.17 144.58 51.13 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.142 -1.058 . . . . 1.24 108.142 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.465 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 14.5 m -131.9 153.54 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 113.631 0.974 . . . . 1.09 113.631 -172.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.647 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 62.94 50.24 65.4 Favored Glycine 0 CA--C 1.505 -0.563 0 CA-C-N 114.729 -1.123 . . . . 0.24 111.725 176.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 70' ' ' ASP . 92.5 m -97.28 130.46 44.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.928 0.394 . . . . 0.43 111.436 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.8 p -124.22 125.43 25.72 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.659 -0.7 . . . . 1.16 109.962 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.515 ' HA ' HG11 ' A' ' 94' ' ' VAL . 78.5 Cg_exo -49.23 122.12 8.02 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.164 2.576 . . . . 0.42 113.002 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.9 tt -117.48 137.07 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.751 -0.658 . . . . 1.21 110.84 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -122.91 118.97 29.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.712 -0.477 . . . . 3.02 109.712 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.501 HD11 ' N ' ' A' ' 115' ' ' GLY . 1.2 pp -92.11 -17.48 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.329 -0.396 . . . . 2.28 111.927 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.501 ' N ' HD11 ' A' ' 114' ' ' ILE . . . 73.2 -24.15 0.89 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.039 -0.6 . . . . 2.61 113.963 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.473 HD12 ' OXT' ' A' ' 116' ' ' LEU . 3.7 pp . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.489 -0.767 . . . . 4.15 110.872 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.058 -0.349 . . . . 30.52 110.058 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.3 75.68 1.48 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.929 0.395 . . . . 28.11 110.886 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.7 ptp -143.0 -29.56 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 28.72 111.009 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.65 113.17 23.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.429 -0.35 . . . . 26.8 110.623 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.3 t70 56.42 70.19 0.67 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.994 -0.548 . . . . 25.36 110.951 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.9 pt -117.08 33.21 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.053 0.454 . . . . 25.15 111.258 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.03 43.3 3.1 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.963 -0.637 . . . . 23.13 111.993 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.9 t -76.91 -55.1 5.76 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.991 -0.374 . . . . 22.94 109.991 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.5 m -80.78 66.4 6.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.495 0.665 . . . . 22.43 110.29 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -140.22 173.5 11.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.759 -0.655 . . . . 21.22 110.241 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.7 t -118.88 93.51 46.63 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.453 -0.34 . . . . 19.19 110.223 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.38 178.47 1.2 Allowed 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.764 2.31 . . . . 18.61 112.402 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.84 47.35 6.15 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.093 -0.503 . . . . 18.57 110.162 -174.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -76.92 -71.56 0.39 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.02 -0.536 . . . . 14.82 110.649 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.0 m 32.96 58.58 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 124.321 1.013 . . . . 13.37 112.897 -177.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -61.22 117.06 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 12.77 110.375 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.08 -7.51 69.66 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.726 -0.749 . . . . 10.27 112.065 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.2 -78.34 1.59 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.259 -0.496 . . . . 8.25 112.016 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.425 HG22 ' HD2' ' A' ' 30' ' ' PRO . 2.9 m -93.15 134.95 26.31 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.61 -0.515 . . . . 7.56 109.61 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.466 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 93.3 Cg_exo -39.56 -49.33 3.28 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.499 2.8 . . . . 6.56 115.269 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 29' ' ' PRO . 3.1 Cg_exo -74.48 101.35 1.42 Allowed 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.967 1.778 . . . . 5.71 111.725 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -86.06 31.93 0.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.258 -0.428 . . . . 4.21 111.15 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 m -78.05 -169.58 1.63 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.13 -0.486 . . . . 2.12 111.879 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 84.1 m -77.09 148.03 36.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.303 0.573 . . . . 1.77 112.0 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.1 p -87.27 -14.7 40.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.556 -0.747 . . . . 2.81 109.804 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.1 p -81.19 -8.05 59.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.146 -0.934 . . . . 2.8 110.844 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.46 -132.25 8.69 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.234 -0.746 . . . . 1.82 111.234 -177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.8 154.62 9.35 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.215 2.61 . . . . 1.43 113.801 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.477 HG13 ' N ' ' A' ' 39' ' ' TYR . 91.4 t -88.86 168.16 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 107.515 -1.291 . . . . 1.18 107.515 172.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.572 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 95.2 m-85 -129.98 135.45 48.31 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.643 0.735 . . . . 1.17 112.23 -177.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.1 t -111.15 98.03 7.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.876 -1.056 . . . . 0.82 110.031 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.2 m -99.59 134.2 42.82 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.541 -0.541 . . . . 0.25 109.541 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.435 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 5.0 m-20 -51.47 -30.6 20.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.485 -0.78 . . . . 2.35 110.342 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -170.51 131.81 0.94 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.456 -1.247 . . . . 3.06 108.365 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.502 HG22 HG13 ' A' ' 94' ' ' VAL . 17.9 p -87.82 152.43 22.11 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.337 -0.945 . . . . 1.06 111.08 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.455 ' HB3' HG21 ' A' ' 72' ' ' VAL . 10.8 tp10 -119.6 141.25 49.46 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.99 -1.004 . . . . 1.14 109.665 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.446 ' O ' HD12 ' A' ' 50' ' ' LEU . 6.1 m-20 -68.88 110.59 4.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.477 -0.329 . . . . 1.77 110.981 -176.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.539 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 89.3 p -65.93 -8.69 23.87 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.099 0.476 . . . . 1.28 111.335 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.486 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 3.7 mppt? -74.31 -36.39 63.71 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.512 0.673 . . . . 3.21 110.123 175.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -143.83 65.2 1.31 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.09 -0.959 . . . . 2.83 111.107 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.539 ' CD2' ' HA ' ' A' ' 47' ' ' SER . 2.3 mm? -59.68 157.27 12.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.595 0.712 . . . . 1.8 111.609 174.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.32 161.09 30.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.637 -1.165 . . . . 1.81 109.08 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.603 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -64.08 -32.01 73.41 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.959 -0.696 . . . . 3.71 110.551 177.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.542 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -66.0 -37.1 92.86 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.624 -0.798 . . . . 0.41 111.293 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.546 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 11.7 m -78.89 -42.59 26.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.121 0.486 . . . . 1.05 110.275 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.2 m -53.18 -35.25 59.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.335 -0.848 . . . . 1.06 109.797 172.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.498 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.88 -54.8 42.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.433 -0.803 . . . . 1.06 111.616 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.542 HD21 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -58.75 -45.72 89.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.467 0.651 . . . . 1.1 110.319 -178.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.5 mt -61.35 -42.1 98.15 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.964 -1.016 . . . . 1.07 109.941 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -34.14 84.25 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.791 -0.641 . . . . 0.26 112.583 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 26.0 mt -61.64 -50.2 73.5 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.637 0.732 . . . . 1.15 109.814 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.2 mt -83.99 8.25 15.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.569 -1.196 . . . . 1.1 110.669 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.1 p30 50.97 38.19 19.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.495 1.118 . . . . 2.46 111.737 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.4 mt -79.44 140.89 16.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.795 -1.093 . . . . 1.07 110.055 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 11.8 mptt -82.6 117.14 22.35 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.887 -0.597 . . . . 2.65 110.001 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.78 -31.32 50.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.342 0.591 . . . . 1.07 110.138 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.92 -22.24 72.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.031 -0.604 . . . . 0.57 112.638 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.58 -13.19 57.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.242 0.544 . . . . 0.86 110.253 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 92.3 mt -64.32 151.55 43.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.498 -0.774 . . . . 1.18 111.804 -177.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -101.66 -71.12 0.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.811 -1.086 . . . . 2.47 113.017 -169.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -120.49 -83.6 0.66 Allowed 'General case' 0 C--O 1.237 0.41 0 N-CA-C 112.54 0.57 . . . . 1.09 112.54 -171.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.2 mm? -119.41 168.41 10.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.296 0.57 . . . . 1.03 110.606 175.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.557 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -122.95 168.24 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 106.517 -1.66 . . . . 1.03 106.517 167.294 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.14 129.02 4.24 Favored Glycine 0 C--N 1.312 -0.773 0 C-N-CA 119.62 -1.276 . . . . 0.37 112.041 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.77 135.88 36.91 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.551 -0.46 . . . . 1.12 110.544 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m120 49.51 49.03 20.58 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.024 -0.989 . . . . 1.85 110.731 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 9.0 t -85.98 144.1 27.79 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.159 -0.928 . . . . 1.12 110.592 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.6 m -102.12 113.44 65.86 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.855 -0.611 . . . . 1.6 110.855 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.89 130.79 26.98 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.847 2.365 . . . . 0.7 112.816 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 mt -108.4 89.27 2.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.675 -0.693 . . . . 1.49 109.213 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.2 p -78.58 -39.15 38.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.287 -0.415 . . . . 1.79 111.422 -174.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.6 m -100.48 100.42 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.925 0.869 . . . . 2.13 112.258 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.7 mt -132.47 115.49 25.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.916 -1.038 . . . . 2.17 110.341 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.23 -47.71 0.42 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.317 -0.713 . . . . 3.18 111.317 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.1 t -99.31 48.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.203 -1.036 . . . . 5.02 108.203 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.2 126.34 4.1 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 114.913 -1.039 . . . . 4.93 111.123 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.23 17.99 16.33 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.837 -0.697 . . . . 3.64 112.102 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -90.38 83.39 5.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.121 0.486 . . . . 6.1 110.08 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.1 m -148.43 23.41 1.03 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.953 -0.567 . . . . 4.78 110.656 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.0 t -142.05 123.11 14.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.97 -0.559 . . . . 1.99 110.831 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.3 m -114.56 18.79 16.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.024 0.44 . . . . 2.07 110.68 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 42' ' ' ASN . . . -134.67 -158.73 0.9 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.874 -0.603 . . . . 1.08 109.824 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.74 127.04 31.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.098 0.475 . . . . 0.99 110.139 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.91 120.32 39.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.274 0.559 . . . . 1.11 110.836 -174.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.502 HG13 HG22 ' A' ' 44' ' ' THR . 10.6 m -131.94 164.75 33.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.624 -0.716 . . . . 1.06 111.271 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 34.2 t -109.81 112.12 23.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.178 -0.919 . . . . 0.71 109.156 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 35.4 m -107.88 149.19 28.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.883 0.373 . . . . 0.61 110.725 -174.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.3 t -80.49 -27.21 37.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.914 -0.584 . . . . 1.06 110.455 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.509 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.6 m120 -153.83 163.85 39.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.449 -0.796 . . . . 0.93 109.064 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.5 t -136.22 134.21 37.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.165 0.507 . . . . 1.18 110.184 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.421 ' HB2' HG21 ' A' ' 105' ' ' VAL . 89.3 m-85 -117.64 149.5 40.59 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.668 -0.696 . . . . 1.2 109.94 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.617 ' NE2' HD12 ' A' ' 104' ' ' LEU . 9.7 mm100 62.57 26.92 15.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.759 -0.655 . . . . 1.11 111.265 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 64.01 9.07 4.35 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.251 -0.886 . . . . 2.63 112.177 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.27 -25.47 1.87 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.342 -0.932 . . . . 0.29 113.113 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 16.1 mt -49.16 -41.34 36.21 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.904 0.352 . . . . 1.14 111.54 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.421 HG21 ' HB2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -139.78 118.87 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.422 0.63 . . . . 1.51 111.047 173.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.557 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 8.7 m-20 -108.16 162.66 13.86 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.579 -0.737 . . . . 1.24 109.475 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.509 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 14.3 m -135.28 155.43 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.299 0.481 . . . . 1.09 112.299 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 58.62 51.82 56.64 Favored Glycine 0 CA--C 1.505 -0.578 0 CA-C-N 115.396 -0.82 . . . . 0.24 111.872 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 84.1 m -97.99 129.02 44.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.703 0.287 . . . . 0.43 110.721 -175.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.9 p -125.26 128.19 24.81 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.912 -0.585 . . . . 1.16 110.054 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.486 ' HA ' HG12 ' A' ' 94' ' ' VAL . 73.1 Cg_exo -51.3 109.28 0.3 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.785 2.323 . . . . 0.42 112.061 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.6 tt -88.52 134.13 29.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.637 -0.711 . . . . 1.21 110.735 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -116.09 101.14 8.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.895 -0.593 . . . . 3.02 110.042 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.47 HD13 ' HG ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER -73.51 -19.4 18.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.856 -0.611 . . . . 2.28 111.766 -178.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.57 3.46 86.66 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 121.177 -0.535 . . . . 2.61 113.419 175.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.47 ' HG ' HD13 ' A' ' 114' ' ' ILE . 4.0 pp . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.309 -0.853 . . . . 4.15 110.03 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.713 0.292 . . . . 30.52 110.478 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.01 30.6 6.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.016 0.436 . . . . 28.11 110.838 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.1 ttt -77.63 -51.09 11.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.018 -0.537 . . . . 28.72 110.148 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.05 67.61 7.04 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.758 -0.655 . . . . 26.8 109.904 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.9 -27.97 64.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.647 -0.706 . . . . 25.36 110.635 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.4 mm -83.34 -4.96 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.869 0.842 . . . . 25.15 109.45 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.562 ' O ' ' HB ' ' A' ' 20' ' ' VAL . . . -95.72 49.59 1.81 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.54 -0.754 . . . . 23.13 111.398 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.2 t -75.33 -58.43 3.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.121 0.486 . . . . 22.94 109.92 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.8 p -97.32 -42.7 7.65 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.083 -0.508 . . . . 22.43 109.778 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.8 61.29 5.09 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.513 -0.767 . . . . 21.22 110.366 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.562 ' HB ' ' O ' ' A' ' 16' ' ' GLY . 7.3 p -112.26 129.84 23.92 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.413 -0.812 . . . . 19.19 110.015 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.93 113.5 1.75 Allowed 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.591 2.194 . . . . 18.61 112.033 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 20' ' ' VAL . 60.3 mtt180 -108.35 31.86 5.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.173 -0.467 . . . . 18.57 110.468 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.2 138.22 58.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.842 -0.617 . . . . 14.82 111.147 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t 60.78 92.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 115.523 -0.762 . . . . 13.37 111.283 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -82.62 -43.93 16.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.934 -0.576 . . . . 12.77 110.239 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.36 -106.22 0.5 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.844 -0.616 . . . . 10.27 111.794 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.67 -132.64 44.14 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.293 -0.479 . . . . 8.25 112.373 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.473 HG23 ' HD2' ' A' ' 30' ' ' PRO . 3.9 m 67.96 116.79 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 121.51 0.671 . . . . 7.56 110.878 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 34.5 Cg_exo -50.89 -50.8 12.7 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.523 2.815 . . . . 6.56 112.684 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.596 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 71.4 Cg_endo -76.25 106.01 2.18 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.474 1.449 . . . . 5.71 111.537 169.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -66.46 132.59 48.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.885 -0.598 . . . . 4.21 110.824 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.5 m -153.17 154.6 35.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.405 . . . . 2.12 110.122 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 59.8 m -76.22 136.7 39.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.272 -0.422 . . . . 1.77 110.646 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.0 m -90.03 -2.1 58.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.237 0.541 . . . . 2.81 110.381 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.5 p -74.41 -27.8 60.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.804 -0.634 . . . . 2.8 110.367 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 168.08 173.95 36.51 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-O 119.458 -0.634 . . . . 1.82 111.641 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' A' ' 80' ' ' SER . 52.0 Cg_exo -41.78 151.37 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.688 2.925 . . . . 1.43 114.166 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.81 158.75 2.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.63 -1.168 . . . . 1.18 108.443 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.6 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 90.5 m-85 -122.28 136.88 54.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.496 0.665 . . . . 1.17 111.396 -177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 34.7 t -109.25 98.32 7.77 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.233 -0.894 . . . . 0.82 109.604 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.5 m -99.16 137.59 37.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.111 -0.699 . . . . 0.25 109.111 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.459 ' HA ' ' HB2' ' A' ' 91' ' ' ALA . 39.8 m-80 -59.03 -24.69 63.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.855 -0.611 . . . . 2.35 109.965 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -171.75 131.06 0.68 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.409 -1.269 . . . . 3.06 108.085 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.494 HG22 HG11 ' A' ' 94' ' ' VAL . 18.1 p -86.55 157.47 19.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.169 -1.012 . . . . 1.06 110.253 171.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.443 ' HB3' HG23 ' A' ' 72' ' ' VAL . 7.1 tp10 -121.77 138.2 54.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.836 -0.62 . . . . 1.14 109.509 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.409 ' HA ' HD11 ' A' ' 71' ' ' LEU . 12.9 m-20 -67.6 109.5 3.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.194 -0.457 . . . . 1.77 110.159 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.1 p -57.09 -24.34 53.28 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.498 0.499 . . . . 1.28 111.208 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -90.78 -12.13 37.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.903 0.383 . . . . 3.21 111.284 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -126.37 25.2 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.979 0.418 . . . . 2.83 110.85 -176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.59 156.39 16.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.629 0.728 . . . . 1.8 111.91 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.95 168.48 9.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.894 -1.048 . . . . 1.81 109.767 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 52' ' ' LYS . 11.8 mptt -62.01 -33.58 74.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.8 0.333 . . . . 3.71 110.502 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.438 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -61.75 -36.21 92.4 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.152 -0.547 . . . . 0.41 112.72 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.529 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 25.6 m -82.73 -43.36 16.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.819 0.31 . . . . 1.05 110.434 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.5 m -54.67 -33.21 60.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.896 -0.593 . . . . 1.06 110.053 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.558 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.23 -54.32 46.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.478 -0.783 . . . . 1.06 111.508 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.513 HD21 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.42 -47.29 84.42 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.268 0.556 . . . . 1.1 109.96 -178.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 54' ' ' THR . 25.1 mt -59.63 -41.99 91.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.98 -1.009 . . . . 1.07 110.188 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.53 -36.88 93.25 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.752 -0.658 . . . . 0.26 112.23 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 19.8 mt -61.3 -39.34 90.12 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.714 0.768 . . . . 1.15 110.092 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.526 HD23 ' HG2' ' A' ' 101' ' ' GLN . 4.5 mt -90.81 0.58 57.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.468 -1.242 . . . . 1.1 111.113 -176.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 69.03 34.53 3.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.481 -0.781 . . . . 2.46 111.349 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 58' ' ' LEU . 41.6 mt -88.71 147.12 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.001 -0.545 . . . . 1.07 110.042 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.538 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -100.62 118.96 37.84 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.383 0.611 . . . . 2.65 110.061 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.437 ' N ' HD13 ' A' ' 65' ' ' ILE . 1.8 mp -71.64 -31.48 42.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.15 -0.932 . . . . 1.07 110.972 -174.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.16 -15.34 74.49 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.966 -0.635 . . . . 0.57 112.752 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.4 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 23.8 t70 -95.32 -14.15 24.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.86 110.532 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.0 mt -57.87 140.32 52.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.268 0.556 . . . . 1.18 110.909 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -94.94 -77.64 0.46 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.231 -0.895 . . . . 2.47 112.532 -170.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.03 -98.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.975 0.361 . . . . 1.09 111.975 -173.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.6 mm? -109.04 168.92 9.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.558 0.694 . . . . 1.03 111.271 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.8 OUTLIER -117.18 167.9 9.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 106.754 -1.573 . . . . 1.03 106.754 166.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.34 121.59 2.22 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 119.765 -1.207 . . . . 0.37 111.893 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.682 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -94.06 136.02 34.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.742 -0.783 . . . . 1.12 109.705 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 53.14 61.33 3.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.041 0.924 . . . . 1.85 109.792 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.6 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 7.9 t -103.66 146.1 29.08 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.607 -1.179 . . . . 1.12 110.777 -171.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.1 m -102.26 109.97 61.56 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.823 -0.626 . . . . 1.6 110.216 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.9 120.32 7.24 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.777 2.318 . . . . 0.7 112.299 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.5 mt -96.01 87.5 4.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 1.49 109.555 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.424 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 5.4 p -79.12 -52.27 8.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.9 -0.591 . . . . 1.79 109.816 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.7 m -81.06 105.48 11.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.376 -0.829 . . . . 2.13 110.286 176.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.9 mt -116.14 132.43 65.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.848 -0.614 . . . . 2.17 111.702 -176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -129.98 -105.3 1.12 Allowed Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.472 -0.785 . . . . 3.18 111.248 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 m -76.47 75.53 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.484 0.659 . . . . 5.02 111.486 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.75 49.35 29.98 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.778 -0.646 . . . . 4.93 111.89 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.11 -141.92 15.54 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.315 -0.714 . . . . 3.64 111.315 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -160.51 -61.02 0.06 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.009 0.433 . . . . 6.1 109.955 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.8 m -124.27 66.35 1.06 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.003 -0.544 . . . . 4.78 110.913 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 17.6 t -121.54 122.43 39.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.026 0.441 . . . . 1.99 110.815 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -127.89 26.62 5.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.508 0.67 . . . . 2.07 109.708 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.459 ' HB2' ' HA ' ' A' ' 42' ' ' ASN . . . -141.59 -158.44 0.86 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.353 -0.839 . . . . 1.08 110.017 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.05 124.23 28.55 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.354 0.597 . . . . 0.99 110.097 -176.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.52 116.0 31.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.744 -0.662 . . . . 1.11 110.875 -171.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' A' ' 111' ' ' PRO . 11.2 m -128.29 164.63 29.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.663 -0.699 . . . . 1.06 111.457 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.1 t -108.34 110.98 22.68 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.623 -0.88 . . . . 0.71 108.623 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.8 m -112.92 146.41 39.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.934 0.397 . . . . 0.61 110.713 -172.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.7 t -81.11 -23.11 38.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 1.06 111.289 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -159.5 168.1 27.01 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.511 -0.551 . . . . 0.93 109.511 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.9 t -140.26 142.47 35.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.538 -0.301 . . . . 1.18 110.633 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.507 ' HB2' HG22 ' A' ' 105' ' ' VAL . 83.9 m-85 -134.12 158.32 43.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.909 -0.316 . . . . 1.2 110.686 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.561 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 6.5 mm100 59.43 40.25 21.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.138 -0.483 . . . . 1.11 111.549 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 p80 58.04 2.07 0.17 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.117 0.967 . . . . 2.63 112.393 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 101' ' ' GLN . . . 139.98 -15.9 3.04 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.966 -0.635 . . . . 0.29 112.658 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.682 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 24.6 mt -56.1 -37.29 69.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.076 0.438 . . . . 1.14 111.594 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 100' ' ' TYR . 3.6 m -130.39 149.82 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.333 0.587 . . . . 1.51 110.314 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.469 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.5 t30 -142.98 153.35 42.91 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.6 -0.889 . . . . 1.24 108.6 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.5 m -131.62 150.41 34.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.783 0.66 . . . . 1.09 112.783 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.11 52.32 53.52 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.939 -1.028 . . . . 0.24 111.824 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 83.1 m -97.31 127.05 42.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.741 0.305 . . . . 0.43 111.225 -176.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 p -120.79 126.47 26.67 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.93 -0.577 . . . . 1.16 110.574 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.499 ' HA ' HG13 ' A' ' 94' ' ' VAL . 50.5 Cg_exo -53.8 110.68 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.917 2.411 . . . . 0.42 112.112 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.4 tt -100.54 134.51 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.273 0.559 . . . . 1.21 110.882 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -92.29 99.96 12.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.702 -0.681 . . . . 3.02 109.193 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 30' ' ' PRO . 1.2 pp -67.53 -10.76 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.715 0.635 . . . . 2.28 112.715 -177.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.91 -21.32 34.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.44 -0.886 . . . . 2.61 112.797 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.592 -0.718 . . . . 4.15 109.743 179.168 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 111.547 0.203 . . . . 30.52 111.547 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.94 -171.53 2.96 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.27 -0.27 . . . . 28.11 110.27 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.4 ptp -58.01 120.58 8.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.028 0.442 . . . . 28.72 110.293 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.26 14.36 14.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.156 -0.475 . . . . 26.8 111.123 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 66.12 94.13 0.06 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.416 -0.811 . . . . 25.36 111.294 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.9 mt 65.37 90.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.533 -0.758 . . . . 25.15 111.266 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.81 42.22 2.33 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.67 -0.776 . . . . 23.13 112.961 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.1 m -66.15 108.83 2.39 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.408 -0.219 . . . . 22.94 110.408 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.2 m 72.56 -54.42 0.69 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.888 -0.596 . . . . 22.43 111.509 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -115.61 127.03 54.92 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.185 -0.302 . . . . 21.22 110.185 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.15 120.35 69.84 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 121.133 0.492 . . . . 19.19 110.191 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.28 -23.21 9.03 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.523 2.148 . . . . 18.61 113.009 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -147.17 77.65 1.46 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.089 0.471 . . . . 18.57 110.564 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.6 120.02 24.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.089 -0.505 . . . . 14.82 110.557 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.6 169.52 20.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.41 . . . . 13.37 110.72 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -65.05 116.83 6.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.072 -0.513 . . . . 12.77 110.144 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.81 -9.36 27.7 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.706 -0.759 . . . . 10.27 111.485 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.61 -111.56 4.15 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.024 -0.607 . . . . 8.25 112.381 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.479 HG22 ' HD2' ' A' ' 30' ' ' PRO . 2.2 m -84.47 126.96 67.77 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 110.349 -0.241 . . . . 7.56 110.349 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.415 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 87.6 Cg_exo -40.59 -45.92 4.59 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 123.988 3.125 . . . . 6.56 115.996 -173.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.479 ' HD2' HG22 ' A' ' 28' ' ' THR . 21.7 Cg_exo -62.47 105.11 0.39 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 121.915 1.743 . . . . 5.71 111.898 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -84.04 55.08 3.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.844 -0.616 . . . . 4.21 111.308 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.1 t -70.62 149.99 46.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.653 0.74 . . . . 2.12 111.151 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.25 150.78 35.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.74 -1.118 . . . . 1.77 110.984 -177.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 m -71.05 0.56 7.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.854 -0.612 . . . . 2.81 111.986 -174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -78.51 -6.08 54.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.061 0.458 . . . . 2.8 110.893 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.06 -118.23 6.07 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.196 -0.762 . . . . 1.82 111.196 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.43 150.82 57.18 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.635 2.223 . . . . 1.43 112.979 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.455 HG11 ' N ' ' A' ' 39' ' ' TYR . 97.6 t -94.85 166.47 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 107.761 -1.2 . . . . 1.18 107.761 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.455 ' N ' HG11 ' A' ' 38' ' ' VAL . 91.9 m-85 -124.21 135.48 53.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.885 0.85 . . . . 1.17 111.605 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 91' ' ' ALA . 44.0 t -107.98 111.09 22.99 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.833 -1.076 . . . . 0.82 109.964 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 65.4 m -110.37 129.62 55.72 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.32 -0.622 . . . . 0.25 109.32 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -62.88 -17.49 61.69 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.538 -0.756 . . . . 2.35 109.832 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -169.28 133.83 1.44 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.765 -1.107 . . . . 3.06 108.622 172.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.49 HG22 HG11 ' A' ' 94' ' ' VAL . 29.2 p -94.53 151.84 19.02 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.442 -0.903 . . . . 1.06 110.679 168.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.401 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.7 tp10 -119.78 142.73 48.32 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.194 -0.912 . . . . 1.14 109.527 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.491 ' O ' HD11 ' A' ' 50' ' ' LEU . 44.8 m-20 -67.28 108.39 2.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.523 -0.308 . . . . 1.77 110.52 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 70.0 p -68.67 -1.16 6.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.955 -0.566 . . . . 1.28 112.513 -172.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -79.17 -43.82 23.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.928 0.394 . . . . 3.21 110.145 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -144.77 70.95 1.29 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.569 -0.53 . . . . 2.83 109.569 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 46' ' ' ASP . 3.1 mm? -55.32 153.49 7.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.338 -0.846 . . . . 1.8 112.406 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.95 153.34 21.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.672 -1.149 . . . . 1.81 109.406 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -55.96 -41.45 74.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.249 0.477 . . . . 3.71 110.601 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.517 ' O ' HD23 ' A' ' 57' ' ' LEU . . . -61.41 -36.85 93.15 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.839 -0.619 . . . . 0.41 112.32 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.524 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 29.2 m -82.29 -41.43 20.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.836 0.351 . . . . 1.05 110.274 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.0 m -53.77 -34.99 60.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.781 -0.645 . . . . 1.06 109.861 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.46 -52.74 63.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.367 -0.833 . . . . 1.06 111.92 175.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -61.17 -44.43 97.31 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.556 0.693 . . . . 1.1 110.037 -178.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 54' ' ' THR . 46.1 mt -60.05 -44.41 94.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.822 -1.081 . . . . 1.07 109.903 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.82 -32.42 79.31 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.631 -0.713 . . . . 0.26 113.043 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 33.9 mt -59.83 -41.96 92.49 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.833 0.825 . . . . 1.15 110.323 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.437 ' CD1' HG21 ' A' ' 105' ' ' VAL . 3.8 mt -91.18 -5.61 54.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.406 -1.27 . . . . 1.1 110.855 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.9 t30 69.62 36.9 2.03 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.047 -0.979 . . . . 2.46 110.661 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 58' ' ' LEU . 64.2 mt -77.77 146.19 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.797 -0.638 . . . . 1.07 110.029 175.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.596 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -93.99 117.72 30.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.74 -0.664 . . . . 2.65 110.279 -178.132 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.91 -40.6 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.609 -0.723 . . . . 1.07 111.279 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.93 -7.48 62.22 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.75 -0.738 . . . . 0.57 112.845 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.461 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 28.7 t70 -104.5 -12.44 16.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.08 0.467 . . . . 0.86 110.529 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.1 mt -62.33 149.84 41.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.845 -0.616 . . . . 1.18 110.974 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -95.86 -78.59 0.46 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.458 0.91 . . . . 2.47 113.458 -169.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 0.2 OUTLIER -105.95 -85.19 0.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.8 -0.36 . . . . 1.09 111.741 -172.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 0.9 OUTLIER -120.97 168.17 11.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.169 0.509 . . . . 1.03 110.871 177.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -122.25 168.5 14.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 106.821 -1.548 . . . . 1.03 106.821 165.192 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.503 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -136.53 144.09 15.67 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.83 -1.176 . . . . 0.37 111.698 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.562 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -104.96 128.14 53.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.128 0.49 . . . . 1.12 110.116 176.375 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.4 m120 57.77 53.48 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.974 -1.012 . . . . 1.85 110.999 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.503 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 58.9 m -87.67 141.57 28.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.399 -0.819 . . . . 1.12 111.067 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.2 m -101.21 124.69 40.48 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.679 -0.692 . . . . 1.6 110.399 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.08 129.07 15.65 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.524 2.149 . . . . 0.7 112.57 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 mt -109.39 89.89 3.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.285 -0.87 . . . . 1.49 109.307 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.0 p -82.32 -39.95 22.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.332 -0.394 . . . . 1.79 111.919 -173.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.74 108.39 24.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.668 0.747 . . . . 2.13 112.44 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.7 mt -121.62 149.95 24.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.445 -0.798 . . . . 2.17 109.166 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 131.49 -14.64 5.3 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.555 -0.831 . . . . 3.18 111.734 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.11 29.57 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.445 0.64 . . . . 5.02 109.861 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.57 164.89 12.61 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.41 -0.813 . . . . 4.93 111.31 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.58 8.16 56.38 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.835 -0.698 . . . . 3.64 111.929 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -74.75 79.3 2.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.398 0.618 . . . . 6.1 110.461 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 89' ' ' CYS . 50.6 m -159.39 160.5 35.0 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.084 -0.71 . . . . 4.78 109.084 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 88' ' ' SER . 8.3 t 73.43 -73.41 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 123.529 0.518 . . . . 1.99 111.944 176.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.5 m 61.34 26.22 16.06 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.953 0.406 . . . . 2.07 111.575 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.697 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -148.08 -158.29 0.9 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.515 -0.55 . . . . 1.08 109.515 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.76 121.54 25.48 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.549 0.69 . . . . 0.99 110.033 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.77 121.38 41.57 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.774 -0.648 . . . . 1.11 111.356 -171.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.494 HG13 ' HA ' ' A' ' 111' ' ' PRO . 9.0 m -133.78 165.87 30.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.598 -0.728 . . . . 1.06 110.847 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 18.0 m -114.06 125.09 53.6 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.75 -0.659 . . . . 0.71 109.233 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.639 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 22.8 m -121.23 149.97 42.04 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.074 -0.512 . . . . 0.61 110.465 -171.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.3 t -80.85 -28.37 36.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.73 -0.668 . . . . 1.06 110.789 -171.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.55 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 21.9 m120 -152.73 159.68 43.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.93 109.764 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.4 t -136.12 147.39 47.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.472 -0.331 . . . . 1.18 110.114 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.481 ' HB2' HG22 ' A' ' 105' ' ' VAL . 65.7 m-85 -137.17 158.24 44.89 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.83 -0.433 . . . . 1.2 109.83 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.423 ' HG2' HD23 ' A' ' 61' ' ' LEU . 7.8 mm100 62.51 26.6 15.82 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.566 -0.288 . . . . 1.11 111.54 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 65.52 0.19 1.36 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.87 -0.604 . . . . 2.63 112.534 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.8 -21.99 1.29 Allowed Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.91 -1.138 . . . . 0.29 113.621 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.562 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.8 mt -51.07 -37.31 44.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.583 0.692 . . . . 1.14 111.198 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 100' ' ' TYR . 5.6 m -131.7 144.43 37.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.813 -0.631 . . . . 1.51 109.768 174.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 15.4 t30 -142.86 141.41 31.56 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.974 -1.121 . . . . 1.24 107.974 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.55 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.2 m -125.68 152.27 32.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 113.291 0.849 . . . . 1.09 113.291 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.639 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 64.53 51.71 49.74 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.799 -1.091 . . . . 0.24 111.665 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 74.6 m -97.98 128.45 44.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.856 0.36 . . . . 0.43 111.494 -174.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.0 p -124.03 126.36 25.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.757 -0.656 . . . . 1.16 109.418 173.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.494 ' HA ' HG13 ' A' ' 94' ' ' VAL . 79.6 Cg_exo -50.69 109.15 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.058 2.505 . . . . 0.42 112.336 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.2 tt -88.02 133.8 29.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.679 -0.691 . . . . 1.21 111.144 -177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -91.79 99.01 11.96 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.044 -1.095 . . . . 3.02 108.044 171.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.501 HD13 ' N ' ' A' ' 115' ' ' GLY . 1.4 pp -68.99 -25.17 29.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.737 0.643 . . . . 2.28 112.737 -171.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.501 ' N ' HD13 ' A' ' 114' ' ' ILE . . . 93.3 -10.77 72.86 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.496 -0.859 . . . . 2.61 113.814 174.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 116' ' ' LEU . 1.2 pt? . . . . . 0 C--O 1.246 0.875 0 CA-C-N 117.342 0.571 . . . . 4.15 110.4 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.523 0.202 . . . . 30.52 111.358 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.43 88.58 5.55 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.058 0.456 . . . . 28.11 112.159 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 86.8 mtp -88.11 -31.8 19.02 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.712 -0.847 . . . . 28.72 108.712 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.89 157.28 43.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.952 -1.022 . . . . 26.8 108.553 172.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -82.2 70.16 9.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.476 0.655 . . . . 25.36 110.634 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pp -139.53 166.12 21.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.136 -0.938 . . . . 25.15 109.771 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.96 142.01 3.54 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.431 -0.89 . . . . 23.13 111.986 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 m -81.52 111.77 18.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.885 0.374 . . . . 22.94 110.661 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.2 t -87.22 5.96 35.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.073 0.463 . . . . 22.43 110.188 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.14 -168.81 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.537 -0.756 . . . . 21.22 110.421 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.424 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 27.9 t -63.57 -51.67 64.86 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 121.065 -0.254 . . . . 19.19 111.213 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 20' ' ' VAL . 57.1 Cg_endo -71.06 85.43 0.81 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.032 1.821 . . . . 18.61 112.66 175.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -96.07 110.43 22.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.364 -0.38 . . . . 18.57 110.225 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.55 ' O ' HG21 ' A' ' 24' ' ' VAL . 1.9 m-20 68.91 87.0 0.13 Allowed 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.938 0.774 . . . . 14.82 111.558 -177.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.55 HG21 ' O ' ' A' ' 23' ' ' ASP . 3.6 m 64.78 -28.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.967 1.707 . . . . 13.37 114.688 172.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -151.78 167.85 26.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.622 0.646 . . . . 12.77 111.131 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.82 116.16 0.78 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.392 -0.683 . . . . 10.27 111.392 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -160.84 -162.01 12.15 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.85 -0.691 . . . . 8.25 111.895 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.533 HG23 ' HD2' ' A' ' 30' ' ' PRO . 1.9 m -125.45 120.69 24.8 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-O 121.269 0.557 . . . . 7.56 109.872 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -45.78 -44.88 17.61 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 124.633 3.555 . . . . 6.56 115.818 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.533 ' HD2' HG23 ' A' ' 28' ' ' THR . 2.7 Cg_exo -73.71 109.09 2.79 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 121.855 1.703 . . . . 5.71 111.702 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -82.19 58.62 4.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.074 -0.512 . . . . 4.21 110.469 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.0 p -75.24 171.66 13.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.896 -0.593 . . . . 2.12 111.239 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.0 m -76.99 152.18 35.33 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.837 -0.62 . . . . 1.77 111.132 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.9 m -90.14 0.24 57.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.006 -0.543 . . . . 2.81 110.354 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.7 p -120.06 19.62 12.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 2.8 110.78 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.25 -175.97 27.29 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.445 -0.662 . . . . 1.82 111.445 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.638 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 72.4 Cg_endo -75.04 -160.0 0.1 OUTLIER 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.291 1.994 . . . . 1.43 112.659 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.435 HG11 ' N ' ' A' ' 39' ' ' TYR . 92.1 t -93.42 161.04 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.547 -0.538 . . . . 1.18 109.547 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.435 ' N ' HG11 ' A' ' 38' ' ' VAL . 52.8 m-85 -129.69 134.99 47.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.869 0.366 . . . . 1.17 110.54 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.596 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 38.6 t -108.06 112.06 24.43 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.302 -0.408 . . . . 0.82 109.95 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 72.9 m -103.31 134.15 47.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.143 0.496 . . . . 0.25 110.422 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.44 ' HA ' ' HB3' ' A' ' 91' ' ' ALA . 88.4 m-20 -59.65 -19.58 50.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.226 -0.897 . . . . 2.35 110.361 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.511 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -173.13 124.66 0.42 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.71 -1.132 . . . . 3.06 107.986 176.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.534 HG23 HG11 ' A' ' 94' ' ' VAL . 8.0 p -78.2 148.0 34.22 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.243 -0.983 . . . . 1.06 110.838 170.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.428 ' OE2' ' HA ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -109.96 138.81 45.81 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.009 -0.996 . . . . 1.14 109.017 -176.171 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.405 ' O ' HD11 ' A' ' 50' ' ' LEU . 9.7 m-20 -73.67 104.9 4.76 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.741 -0.663 . . . . 1.77 110.337 -174.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.502 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 50.1 m -58.93 -16.64 18.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.473 0.546 . . . . 1.28 112.473 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -86.57 -20.23 28.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.744 0.307 . . . . 3.21 110.659 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -148.76 57.21 1.04 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.456 -0.338 . . . . 2.83 111.601 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.504 HD13 ' CG1' ' A' ' 72' ' ' VAL . 2.4 mm? -59.59 145.75 43.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.39 0.614 . . . . 1.8 111.665 176.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -71.03 156.76 39.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.146 -0.934 . . . . 1.81 109.714 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -59.56 -41.65 90.62 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.909 -0.317 . . . . 3.71 110.948 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.553 ' O ' HD23 ' A' ' 57' ' ' LEU . . . -57.03 -38.29 84.59 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.116 -0.564 . . . . 0.41 112.34 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.544 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 26.2 m -79.92 -43.72 21.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.881 0.372 . . . . 1.05 110.559 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -53.89 -34.8 60.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.673 -0.694 . . . . 1.06 109.823 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.601 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.14 -52.23 66.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.85 -1.068 . . . . 1.06 111.549 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -60.48 -45.75 92.62 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.424 0.63 . . . . 1.1 109.958 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 54' ' ' THR . 50.6 mt -57.96 -45.86 86.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.848 -1.069 . . . . 1.07 109.917 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.03 -36.87 91.7 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.621 -0.718 . . . . 0.26 112.573 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 25.5 mt -59.61 -47.37 85.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.597 0.713 . . . . 1.15 110.238 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.474 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.7 mt -84.48 -4.76 59.11 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.683 -1.144 . . . . 1.1 111.556 -176.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 70.63 35.54 1.84 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.741 0.781 . . . . 2.46 110.524 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.446 HD11 ' HA ' ' A' ' 58' ' ' LEU . 60.6 mt -79.6 146.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.162 -0.681 . . . . 1.07 109.162 174.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.525 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.33 117.44 32.75 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.536 0.684 . . . . 2.65 110.127 -177.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.44 -31.4 42.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.054 -0.975 . . . . 1.07 110.628 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.06 -14.83 78.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.941 -0.647 . . . . 0.57 113.404 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -101.58 -12.57 18.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.07 0.435 . . . . 0.86 110.91 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.5 mt -51.75 127.09 19.72 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.661 0.743 . . . . 1.18 111.447 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -76.16 -54.38 6.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.424 -1.262 . . . . 2.47 113.263 -166.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.17 -84.41 0.37 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.963 -0.295 . . . . 1.09 111.614 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -115.11 168.04 10.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.426 0.631 . . . . 1.03 110.798 173.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.504 ' CG1' HD13 ' A' ' 50' ' ' LEU . 1.6 m -121.67 172.26 9.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.362 -1.718 . . . . 1.03 106.362 168.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.419 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -138.96 150.12 21.03 Favored Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.119 -1.038 . . . . 0.37 111.486 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -116.36 133.72 55.7 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.989 0.423 . . . . 1.12 109.876 174.55 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.5 m120 53.09 52.92 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.965 -1.016 . . . . 1.85 111.027 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.419 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 35.7 m -86.46 152.4 22.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.479 -0.782 . . . . 1.12 110.473 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.5 m -107.37 115.55 59.42 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.773 -0.648 . . . . 1.6 109.932 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.37 121.77 9.11 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.546 2.164 . . . . 0.7 111.769 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.638 ' O ' ' HB2' ' A' ' 37' ' ' PRO . 27.1 mt -100.5 87.99 3.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.747 -0.661 . . . . 1.49 110.027 -177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.0 m -71.52 -29.72 65.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.777 0.323 . . . . 1.79 110.659 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.8 m -133.8 123.75 45.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.191 0.52 . . . . 2.13 110.854 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.55 HG23 ' N ' ' A' ' 83' ' ' GLY . 6.9 mt -112.94 148.53 15.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.825 -0.625 . . . . 2.17 110.859 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.55 ' N ' HG23 ' A' ' 82' ' ' ILE . . . -83.78 50.66 4.44 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.865 -0.607 . . . . 3.18 112.267 175.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 66.4 t 70.21 -61.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.312 0.645 . . . . 5.02 111.682 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.83 88.39 0.65 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.08 -0.581 . . . . 4.93 112.394 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.97 46.66 2.98 Favored Glycine 0 CA--C 1.517 0.179 0 C-N-CA 121.468 -0.396 . . . . 3.64 113.257 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -127.28 -8.61 5.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.57 0.7 . . . . 6.1 109.433 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.1 m -104.34 87.19 2.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.674 -0.694 . . . . 4.78 110.341 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.512 ' SG ' HG23 ' A' ' 93' ' ' THR . 31.0 p -137.69 18.07 2.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.239 -0.437 . . . . 1.99 110.006 178.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.0 m 73.33 -33.07 0.25 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.126 -0.943 . . . . 2.07 111.631 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.596 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -119.27 -158.94 0.75 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.506 -0.315 . . . . 1.08 110.841 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.41 122.87 32.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.271 0.557 . . . . 0.99 110.745 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.512 HG23 ' SG ' ' A' ' 89' ' ' CYS . 0.2 OUTLIER -95.97 123.16 39.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.229 0.538 . . . . 1.11 111.147 -174.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.534 HG11 HG23 ' A' ' 44' ' ' THR . 6.5 m -133.85 167.54 26.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.588 -0.733 . . . . 1.06 111.49 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 41.8 t -111.35 121.74 46.04 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.473 -0.936 . . . . 0.71 108.473 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 22.9 m -122.35 148.63 44.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.023 0.439 . . . . 0.61 110.969 -171.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.9 t -79.2 -28.15 42.6 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.423 -0.808 . . . . 1.06 110.837 -169.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.484 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 19.6 m120 -156.0 161.64 40.44 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.053 -0.721 . . . . 0.93 109.053 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.7 t -142.22 144.67 33.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.799 0.333 . . . . 1.18 110.516 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.477 ' HB2' HG22 ' A' ' 105' ' ' VAL . 70.3 m-85 -133.65 160.77 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.756 -0.461 . . . . 1.2 109.756 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.628 ' NE2' HD12 ' A' ' 104' ' ' LEU . 11.4 mm100 60.97 23.7 13.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 1.11 111.566 175.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 63.01 13.39 6.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.582 -0.735 . . . . 2.63 112.442 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.88 -24.34 3.01 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.211 -0.995 . . . . 0.29 113.133 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.628 HD12 ' NE2' ' A' ' 101' ' ' GLN . 14.9 mt -49.63 -38.01 30.37 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.852 0.326 . . . . 1.14 111.018 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.477 HG22 ' HB2' ' A' ' 100' ' ' TYR . 4.2 m -131.87 141.53 45.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.892 -0.595 . . . . 1.51 109.559 172.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.438 ' ND2' ' SG ' ' A' ' 96' ' ' CYS . 21.5 t30 -140.63 144.63 35.85 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.201 -1.037 . . . . 1.24 108.201 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.484 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.4 m -129.46 151.02 35.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 113.396 0.887 . . . . 1.09 113.396 -172.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.625 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 64.07 51.85 49.6 Favored Glycine 0 CA--C 1.506 -0.505 0 CA-C-N 114.91 -1.041 . . . . 0.24 111.807 177.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 90.9 m -97.12 127.91 43.53 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.014 0.435 . . . . 0.43 111.884 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.7 p -122.26 126.47 26.23 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.528 -0.76 . . . . 1.16 109.701 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.503 ' HA ' HG13 ' A' ' 94' ' ' VAL . 71.4 Cg_exo -50.46 110.49 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.003 2.469 . . . . 0.42 112.586 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 tt -81.66 118.99 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.688 -0.687 . . . . 1.21 110.664 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -108.29 114.62 28.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.293 0.568 . . . . 3.02 110.04 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.2 pp -92.21 -10.81 9.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.101 -0.5 . . . . 2.28 111.688 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.16 1.65 80.89 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.108 -0.568 . . . . 2.61 113.092 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.542 -0.742 . . . . 4.15 109.873 -176.934 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.898 0.38 . . . . 30.52 110.255 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.78 34.4 5.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.479 0.656 . . . . 28.11 109.654 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.0 mmt -91.17 -55.82 3.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.282 -0.872 . . . . 28.72 110.291 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 67.92 117.84 0.03 OUTLIER 'General case' 0 C--O 1.235 0.291 0 O-C-N 124.048 0.842 . . . . 26.8 111.608 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.2 t70 73.19 -60.06 0.55 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.358 -0.837 . . . . 25.36 111.679 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.1 pt -105.23 -179.97 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 110.233 -0.284 . . . . 25.15 110.233 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.0 44.61 9.71 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.73 -0.748 . . . . 23.13 112.798 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 t 64.42 68.94 0.53 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.214 0.531 . . . . 22.94 110.859 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.0 p -102.15 -69.43 0.79 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.117 -0.492 . . . . 22.43 111.261 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.75 60.88 4.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.088 0.47 . . . . 21.22 111.245 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.7 t -113.36 97.99 45.0 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.082 -0.508 . . . . 19.19 110.025 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.17 110.82 2.92 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.379 2.053 . . . . 18.61 112.196 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -86.87 -35.04 19.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.999 -0.546 . . . . 18.57 110.086 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -88.27 97.65 11.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.803 -0.635 . . . . 14.82 109.747 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.5 m -92.43 27.1 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.995 -0.548 . . . . 13.37 112.073 -173.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.1 t30 59.04 57.79 3.4 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.466 0.65 . . . . 12.77 111.187 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.49 -63.65 0.49 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.908 -0.663 . . . . 10.27 112.051 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.41 -168.31 17.55 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.787 -0.72 . . . . 8.25 111.808 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.524 HG22 ' HD2' ' A' ' 30' ' ' PRO . 5.1 m -69.16 126.55 92.82 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 110.103 -0.332 . . . . 7.56 110.103 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' HB2' ' CD ' ' A' ' 30' ' ' PRO . 81.3 Cg_exo -42.73 -54.34 3.33 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.717 2.945 . . . . 6.56 114.953 -173.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.524 ' HD2' HG22 ' A' ' 28' ' ' THR . 37.8 Cg_endo -64.55 117.1 4.19 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.735 1.623 . . . . 5.71 112.214 176.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -75.97 142.38 41.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.449 -0.341 . . . . 4.21 110.275 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 p -150.53 176.28 11.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.278 -0.419 . . . . 2.12 110.413 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 71.6 m -83.5 129.96 35.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.429 -0.351 . . . . 1.77 110.667 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.7 p -76.0 -18.35 59.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.151 0.5 . . . . 2.81 109.999 176.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.5 t -74.85 -20.02 59.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.421 -0.809 . . . . 2.8 110.47 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . 140.03 -137.83 8.69 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.971 -0.633 . . . . 1.82 112.132 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.01 154.22 13.81 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.023 2.482 . . . . 1.43 113.418 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.43 HG13 ' N ' ' A' ' 39' ' ' TYR . 94.5 t -92.54 163.27 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.143 -1.058 . . . . 1.18 108.143 174.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.43 ' N ' HG13 ' A' ' 38' ' ' VAL . 45.7 m-85 -124.2 130.82 53.19 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.875 -0.73 . . . . 1.17 111.362 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 91' ' ' ALA . 36.2 t -105.14 106.12 16.47 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.442 -0.799 . . . . 0.82 109.426 176.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -97.8 133.3 42.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.801 -0.636 . . . . 0.25 110.44 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.416 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 3.1 m-20 -58.53 -24.85 61.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.772 . . . . 2.35 109.716 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.523 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -162.79 135.61 5.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.176 -1.375 . . . . 3.06 107.446 177.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.526 HG21 HG13 ' A' ' 94' ' ' VAL . 23.7 p -92.63 159.67 15.36 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.356 -0.938 . . . . 1.06 110.062 165.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.423 ' HB3' HG22 ' A' ' 72' ' ' VAL . 8.0 tp10 -126.28 140.32 52.62 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.608 -0.724 . . . . 1.14 109.712 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' HD12 ' A' ' 50' ' ' LEU . 3.2 m-20 -72.31 109.15 5.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.073 -0.512 . . . . 1.77 110.438 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.48 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 88.0 p -64.12 -4.92 3.97 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.48 0.548 . . . . 1.28 112.48 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.4 mptp? -73.84 -42.11 61.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.342 0.592 . . . . 3.21 110.243 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -142.51 66.67 1.33 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.19 -0.913 . . . . 2.83 110.735 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.48 ' CD2' ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -56.97 148.76 20.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.176 0.512 . . . . 1.8 111.522 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.26 166.16 19.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.589 -0.732 . . . . 1.81 109.78 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -58.98 -47.68 84.28 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.539 -0.464 . . . . 3.71 110.698 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.581 ' O ' HD23 ' A' ' 57' ' ' LEU . . . -55.65 -39.27 75.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.066 -0.587 . . . . 0.41 112.517 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.602 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 13.4 m -77.86 -43.17 31.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.753 0.311 . . . . 1.05 110.559 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.9 m -56.05 -33.71 65.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.3 0.572 . . . . 1.06 109.795 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.576 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.29 -54.51 46.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.17 -0.923 . . . . 1.06 111.304 176.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -58.12 -46.75 85.05 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.485 0.66 . . . . 1.1 110.039 -179.244 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.5 mt -58.69 -44.83 90.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.972 -1.013 . . . . 1.07 110.195 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.82 -37.18 92.11 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.955 -0.64 . . . . 0.26 112.686 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.5 mt -60.12 -45.58 92.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.041 0.924 . . . . 1.15 110.312 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.453 ' CD1' HG21 ' A' ' 105' ' ' VAL . 6.8 mt -86.31 -0.02 54.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.391 -1.277 . . . . 1.1 111.371 -176.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 68.79 31.25 4.51 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.544 -0.753 . . . . 2.46 111.093 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.471 HD11 ' HA ' ' A' ' 58' ' ' LEU . 53.6 mt -79.95 145.08 9.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.827 -0.624 . . . . 1.07 109.806 177.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.512 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -98.35 118.2 34.47 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.761 -0.654 . . . . 2.65 109.93 -178.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.14 -38.02 54.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.345 -0.843 . . . . 1.07 110.963 -174.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.75 -1.98 63.43 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.846 -0.693 . . . . 0.57 113.007 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.476 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 33.9 t70 -113.97 2.13 14.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.628 0.728 . . . . 0.86 109.968 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.7 mt -74.19 152.47 39.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.593 -0.73 . . . . 1.18 111.074 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -95.84 -97.64 0.18 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 2.47 112.401 -173.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.79 -93.27 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.13 0.419 . . . . 1.09 112.13 -173.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.1 mm? -111.61 170.02 8.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.41 0.624 . . . . 1.03 111.279 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.9 OUTLIER -121.39 165.5 16.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 106.189 -1.782 . . . . 1.03 106.189 165.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.47 134.08 6.8 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 119.748 -1.215 . . . . 0.37 112.124 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.638 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -100.89 136.45 40.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.459 . . . . 1.12 110.581 178.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.6 m120 51.49 52.2 15.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.855 -1.066 . . . . 1.85 111.095 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.1 m -88.51 138.75 31.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.001 -0.545 . . . . 1.12 110.89 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 m -86.68 119.6 71.39 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.75 -0.659 . . . . 1.6 110.139 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.27 121.16 7.53 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.467 2.111 . . . . 0.7 112.133 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 mt -99.68 88.24 3.77 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 1.49 109.196 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.8 m -70.39 -38.09 74.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.825 -0.625 . . . . 1.79 110.193 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.24 123.63 70.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.549 0.69 . . . . 2.13 110.442 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.9 mm -72.76 -45.8 55.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.234 -0.894 . . . . 2.17 111.483 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.12 137.74 30.11 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.66 -0.781 . . . . 3.18 111.579 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t 65.82 95.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 121.231 0.539 . . . . 5.02 110.596 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.74 6.5 46.45 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.823 -0.703 . . . . 4.93 112.156 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.96 -43.18 9.0 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.776 -0.726 . . . . 3.64 111.663 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -76.57 123.71 26.5 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.154 -0.313 . . . . 6.1 110.154 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 90' ' ' SER . 33.4 t 59.94 79.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.811 0.694 . . . . 4.78 110.608 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.539 ' SG ' HG23 ' A' ' 93' ' ' THR . 28.4 p -79.88 20.19 0.63 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.362 -0.381 . . . . 1.99 110.863 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 88' ' ' SER . 30.5 t 72.76 -11.41 0.85 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.82 0.848 . . . . 2.07 111.565 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.586 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -147.13 -159.06 0.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.809 0.338 . . . . 1.08 111.279 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.56 117.83 30.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.33 0.586 . . . . 0.99 110.753 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.539 HG23 ' SG ' ' A' ' 89' ' ' CYS . 0.1 OUTLIER -89.71 121.92 32.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.323 0.583 . . . . 1.11 111.566 -174.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.526 HG13 HG21 ' A' ' 44' ' ' THR . 6.7 m -133.26 164.27 35.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.552 -0.749 . . . . 1.06 110.939 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.9 t -113.38 112.29 23.41 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.54 -0.754 . . . . 0.71 109.317 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 21.9 m -106.28 145.0 32.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.363 -0.381 . . . . 0.61 110.311 -174.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.3 t -77.3 -25.53 51.39 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.069 -0.514 . . . . 1.06 110.797 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.628 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 19.8 m120 -148.67 155.75 41.45 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.786 -0.82 . . . . 0.93 108.786 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.4 t -123.12 144.54 49.26 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.915 0.388 . . . . 1.18 110.181 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.459 ' CB ' HG22 ' A' ' 105' ' ' VAL . 26.0 m-85 -130.19 143.27 50.68 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.016 -0.538 . . . . 1.2 110.731 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.651 ' NE2' HD12 ' A' ' 104' ' ' LEU . 7.9 mm100 60.93 32.85 19.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 1.11 111.817 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 66.06 0.33 1.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.197 0.599 . . . . 2.63 112.431 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.97 -19.78 1.96 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.372 -0.918 . . . . 0.29 112.817 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.651 HD12 ' NE2' ' A' ' 101' ' ' GLN . 20.0 mt -51.89 -39.51 59.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.742 0.271 . . . . 1.14 111.258 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.459 HG22 ' CB ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -136.4 145.41 30.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.385 -0.371 . . . . 1.51 110.531 175.15 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.591 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 41.4 m-80 -140.28 161.95 36.46 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.298 -0.63 . . . . 1.24 109.298 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.628 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 8.3 m -133.71 150.05 31.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.009 0.374 . . . . 1.09 112.009 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 58.7 54.89 34.15 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.328 -0.851 . . . . 0.24 111.583 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 75.5 m -96.3 124.48 40.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.997 0.427 . . . . 0.43 110.669 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 p -121.18 125.49 26.93 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.629 -0.714 . . . . 1.16 110.524 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.522 ' HA ' HG12 ' A' ' 94' ' ' VAL . 78.6 Cg_exo -47.62 114.01 0.93 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.29 2.66 . . . . 0.42 112.776 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.2 tt -117.02 138.06 48.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.503 -0.771 . . . . 1.21 110.799 -176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -111.87 120.01 40.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.554 -0.535 . . . . 3.02 109.554 173.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.413 ' CD1' ' H ' ' A' ' 116' ' ' LEU . 1.2 pp -72.14 -11.4 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.127 -0.488 . . . . 2.28 112.299 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.02 -8.58 59.41 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.497 -0.859 . . . . 2.61 113.231 174.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.413 ' H ' ' CD1' ' A' ' 114' ' ' ILE . 5.2 mp . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.429 -0.796 . . . . 4.15 110.161 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.516 ' HB3' ' HZ2' ' A' ' 10' ' ' LYS . 8.9 mtpm? . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.497 0.189 . . . . 30.52 111.104 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.19 115.91 19.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.819 0.342 . . . . 28.11 111.248 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.3 ttt -130.25 41.89 3.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.664 0.745 . . . . 28.72 109.317 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.51 -20.5 25.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.389 -0.823 . . . . 26.8 110.747 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -77.51 121.59 24.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.891 -0.595 . . . . 25.36 110.525 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.486 ' H ' HD12 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -115.86 140.17 38.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.042 -0.526 . . . . 25.15 110.476 -179.005 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.09 -6.17 89.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.942 -0.646 . . . . 23.13 112.985 -175.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -67.88 -30.72 70.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.008 0.433 . . . . 22.94 110.765 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 p -97.04 2.76 51.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.988 -0.551 . . . . 22.43 111.256 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.53 96.26 1.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.468 -0.333 . . . . 21.22 110.681 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 m 38.71 69.83 1.48 Allowed Pre-proline 0 N--CA 1.471 0.618 0 O-C-N 124.364 1.04 . . . . 19.19 113.134 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.64 -8.23 20.25 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.61 2.207 . . . . 18.61 112.151 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -103.58 136.52 43.15 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.572 -0.529 . . . . 18.57 109.572 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -100.7 -4.63 27.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.022 0.439 . . . . 14.82 110.594 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.24 157.14 38.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.964 -0.562 . . . . 13.37 110.251 175.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.7 m120 59.51 43.6 15.89 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.246 0.546 . . . . 12.77 110.962 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.12 43.78 0.92 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.632 -0.713 . . . . 10.27 111.319 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.38 -127.34 8.91 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.891 -0.671 . . . . 8.25 111.444 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.43 HG23 ' HD2' ' A' ' 30' ' ' PRO . 3.5 m -123.65 133.28 24.49 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 110.115 -0.328 . . . . 7.56 110.115 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 90.5 Cg_exo -40.06 -48.67 3.83 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.657 2.905 . . . . 6.56 115.47 -175.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 28' ' ' THR . 5.8 Cg_exo -76.31 104.9 1.98 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.095 1.863 . . . . 5.71 111.61 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' O ' HG21 ' A' ' 114' ' ' ILE . 39.8 ttmt -58.53 142.95 47.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.023 -0.535 . . . . 4.21 110.79 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.2 t -153.22 175.72 12.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.252 -0.431 . . . . 2.12 110.401 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.6 m -76.7 131.0 38.54 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.519 -0.549 . . . . 1.77 109.519 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t -73.68 -12.13 60.63 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.796 0.332 . . . . 2.81 110.675 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -91.58 -12.08 35.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.13 -0.486 . . . . 2.8 111.436 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.29 -156.53 26.73 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.471 -0.871 . . . . 1.82 112.73 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.03 155.67 4.19 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.663 2.909 . . . . 1.43 114.375 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.465 HG11 ' N ' ' A' ' 39' ' ' TYR . 47.3 t -85.62 173.76 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.99 -1.115 . . . . 1.18 107.99 172.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.533 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 75.4 m-85 -128.71 120.62 26.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.954 0.883 . . . . 1.17 112.034 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.509 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 33.1 t -91.13 99.13 12.2 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.344 -1.298 . . . . 0.82 110.305 177.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.8 m -101.89 129.65 48.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.674 -0.861 . . . . 0.25 108.674 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -53.57 -29.52 37.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.356 -0.838 . . . . 2.35 110.439 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -170.5 125.13 0.72 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.001 -1.111 . . . . 3.06 108.001 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.498 HG23 HG11 ' A' ' 94' ' ' VAL . 20.5 p -85.59 142.15 29.32 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.286 -0.966 . . . . 1.06 111.462 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.6 tp10 -114.21 142.21 46.55 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.891 -1.05 . . . . 1.14 109.591 -174.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.446 ' O ' HD12 ' A' ' 50' ' ' LEU . 10.3 m-20 -62.0 110.79 1.68 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.372 -0.377 . . . . 1.77 110.443 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 77.5 p -65.88 -8.32 21.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.198 0.523 . . . . 1.28 111.173 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -91.23 -24.68 19.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.993 -0.549 . . . . 3.21 110.067 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -141.06 59.71 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.029 -0.532 . . . . 2.83 111.132 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.489 HD11 ' CG1' ' A' ' 72' ' ' VAL . 2.7 mm? -64.21 152.61 40.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 1.8 111.768 176.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.82 152.86 43.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.551 -0.907 . . . . 1.81 108.551 171.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.477 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -57.81 -29.4 64.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.121 -0.632 . . . . 3.71 110.146 176.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.524 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -66.17 -40.47 94.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.119 -0.562 . . . . 0.41 111.736 176.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.526 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 20.0 m -78.06 -42.34 32.58 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.025 -0.27 . . . . 1.05 110.647 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.0 m -53.61 -35.62 61.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.962 -0.563 . . . . 1.06 109.685 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.75 -54.32 47.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.211 -0.904 . . . . 1.06 111.772 176.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.524 HD22 ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -59.56 -45.46 91.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.48 0.657 . . . . 1.1 109.919 -178.289 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 54' ' ' THR . 48.6 mt -60.01 -44.38 94.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.886 -1.052 . . . . 1.07 109.767 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.79 -38.71 92.64 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.707 -0.679 . . . . 0.26 112.44 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 24.8 mt -56.89 -49.17 76.35 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.657 0.741 . . . . 1.15 110.176 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.401 ' CD1' HG22 ' A' ' 105' ' ' VAL . 5.7 mt -84.16 -0.78 53.4 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.589 -1.187 . . . . 1.1 111.13 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 66.91 35.82 4.65 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.269 -0.878 . . . . 2.46 111.252 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 52.5 mt -84.08 142.22 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 115.626 -0.716 . . . . 1.07 109.702 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.67 118.2 31.92 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.345 0.593 . . . . 2.65 110.12 -178.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.58 -30.26 44.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.114 -0.948 . . . . 1.07 110.573 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.61 -8.59 84.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.862 -0.685 . . . . 0.57 112.968 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -110.04 3.26 20.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.376 0.607 . . . . 0.86 110.638 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.2 mt -72.81 156.49 38.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.272 0.558 . . . . 1.18 111.05 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -92.76 -82.47 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.543 -0.753 . . . . 2.47 112.854 -170.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.42 -88.36 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 1.09 111.857 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.1 mm? -114.0 169.23 9.16 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.13 0.49 . . . . 1.03 110.892 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.611 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -121.57 168.26 14.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.037 -1.468 . . . . 1.03 107.037 167.491 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.49 127.27 3.72 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.687 -1.244 . . . . 0.37 112.414 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -90.86 136.08 33.31 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.259 -0.576 . . . . 1.12 110.179 178.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.8 m120 49.67 49.69 19.59 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.15 -0.932 . . . . 1.85 110.848 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 6.0 t -87.62 142.13 28.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.448 -0.796 . . . . 1.12 110.523 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.7 m -113.57 116.27 46.05 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.627 -0.715 . . . . 1.6 111.07 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.95 129.8 24.18 Favored 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 122.623 2.216 . . . . 0.7 112.078 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.486 HD21 ' HB2' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -100.72 90.28 4.18 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.688 -0.486 . . . . 1.49 109.688 177.783 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 t -87.01 -3.01 59.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.443 0.639 . . . . 1.79 109.889 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.25 19.29 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 122.219 1.009 . . . . 2.13 110.892 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.7 mm -67.54 132.91 32.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.786 -1.097 . . . . 2.17 110.543 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.14 -74.48 0.21 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.042 -0.823 . . . . 3.18 111.042 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.0 t -84.61 61.34 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.556 0.693 . . . . 5.02 109.208 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.47 171.59 30.66 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.391 -0.822 . . . . 4.93 111.847 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.62 11.28 21.27 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.69 -0.766 . . . . 3.64 112.237 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -79.85 58.28 2.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.575 0.702 . . . . 6.1 110.483 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -108.45 2.11 22.11 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.868 0.842 . . . . 4.78 108.893 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 40' ' ' CYS . 1.9 t -137.39 141.33 41.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.041 -0.982 . . . . 1.99 110.395 -177.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.9 m -112.96 -18.23 12.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.062 0.458 . . . . 2.07 110.69 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.509 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -86.1 -157.9 0.37 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.03 -0.532 . . . . 1.08 110.08 176.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.83 134.13 35.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.718 -0.475 . . . . 0.99 109.718 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.69 117.85 34.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.284 0.564 . . . . 1.11 111.216 -172.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 111' ' ' PRO . 6.7 m -131.78 165.48 31.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.616 -0.72 . . . . 1.06 110.942 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 37.6 t -110.58 120.75 43.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.419 -0.956 . . . . 0.71 108.419 176.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 30.9 m -117.85 151.42 37.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.036 0.446 . . . . 0.61 110.844 -170.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.6 t -78.92 -28.39 43.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.631 -0.713 . . . . 1.06 110.448 -172.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.41 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 13.5 m120 -153.57 163.45 39.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.921 -0.581 . . . . 0.93 109.977 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.0 t -127.99 130.5 48.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.108 0.48 . . . . 1.18 110.375 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 105' ' ' VAL . 44.2 m-85 -119.48 142.21 48.48 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.749 -0.659 . . . . 1.2 110.79 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.441 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 6.6 mm100 61.56 33.27 18.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.071 -0.513 . . . . 1.11 111.824 175.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 63.21 6.58 2.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.044 0.538 . . . . 2.63 112.181 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.28 -22.11 2.92 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.893 -1.146 . . . . 0.29 113.425 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 13.7 mt -50.12 -40.85 47.39 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.475 0.638 . . . . 1.14 110.547 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -130.14 119.09 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.494 0.664 . . . . 1.51 110.298 174.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.611 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 2.7 t30 -113.51 151.87 30.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.321 -0.992 . . . . 1.24 108.321 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 10.5 m -135.55 152.16 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.048 0.758 . . . . 1.09 113.048 -175.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 65.75 49.1 61.4 Favored Glycine 0 CA--C 1.506 -0.511 0 CA-C-N 115.154 -0.93 . . . . 0.24 111.755 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 72.5 m -97.89 126.36 43.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.894 0.378 . . . . 0.43 111.454 -172.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -120.23 126.05 26.99 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.703 -0.681 . . . . 1.16 110.009 175.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.517 ' HA ' HG13 ' A' ' 94' ' ' VAL . 73.6 Cg_exo -49.61 109.87 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.12 2.546 . . . . 0.42 112.345 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 tt -101.81 136.82 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.665 -0.698 . . . . 1.21 110.789 -175.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -93.83 98.4 11.05 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.614 0.721 . . . . 3.02 109.743 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.445 ' C ' HD12 ' A' ' 114' ' ' ILE . 2.9 pp -82.46 9.42 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.31 -0.859 . . . . 2.28 111.254 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 119.91 -16.48 10.19 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.854 -0.898 . . . . 2.61 110.854 -173.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.583 ' O ' HD12 ' A' ' 116' ' ' LEU . 2.9 pp . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.567 -0.73 . . . . 4.15 110.827 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.557 0.218 . . . . 30.52 111.188 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.25 40.93 0.85 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.873 0.323 . . . . 28.11 111.873 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.1 mpp? 55.71 39.38 30.82 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.188 -0.46 . . . . 28.72 111.936 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.71 -22.63 9.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.13 0.491 . . . . 26.8 110.557 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.74 -39.31 16.09 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.239 -0.652 . . . . 25.36 109.239 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.2 pt -125.53 173.58 11.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.292 -0.867 . . . . 25.15 110.362 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.25 -175.77 22.67 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.375 -0.69 . . . . 23.13 111.375 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.6 m 57.03 52.71 8.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.238 0.542 . . . . 22.94 110.88 178.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.7 m -78.06 114.53 17.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.787 -0.642 . . . . 22.43 110.754 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.92 -24.07 16.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.96 -0.564 . . . . 21.22 110.832 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.0 m -88.83 115.92 64.86 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.165 0.507 . . . . 19.19 111.395 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.98 -20.33 11.7 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.545 2.163 . . . . 18.61 112.481 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -88.64 135.54 33.45 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.612 -0.514 . . . . 18.57 109.612 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -74.89 153.43 38.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.014 0.435 . . . . 14.82 110.892 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.6 t -102.93 21.8 2.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.872 0.844 . . . . 13.37 109.731 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.406 ' HB3' ' HB ' ' A' ' 28' ' ' THR . 54.0 m-80 -92.78 -55.16 3.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.605 -0.725 . . . . 12.77 109.984 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.35 60.84 7.29 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.858 -0.687 . . . . 10.27 112.379 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.47 52.8 3.26 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.765 -0.731 . . . . 8.25 113.124 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.694 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 8.9 t -80.41 145.84 60.39 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.677 -0.49 . . . . 7.56 109.677 176.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 28' ' ' THR . 69.2 Cg_endo -99.12 81.68 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.707 2.938 . . . . 6.56 113.402 173.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.694 ' HD3' ' O ' ' A' ' 28' ' ' THR . 5.3 Cg_exo -74.18 80.49 2.18 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.76 2.307 . . . . 5.71 112.041 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -146.96 174.31 11.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.7 . . . . 4.21 110.621 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.476 ' HA ' ' CD1' ' A' ' 112' ' ' ILE . 45.7 m 70.29 -178.15 0.22 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.75 0.656 . . . . 2.12 111.248 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.7 m -76.96 131.65 38.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.298 -0.41 . . . . 1.77 110.737 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 p -78.71 -8.38 58.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.118 0.485 . . . . 2.81 111.043 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -98.13 4.61 49.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.146 -0.479 . . . . 2.8 111.028 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 127.05 -131.57 7.29 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.334 -0.936 . . . . 1.82 113.332 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.48 153.61 17.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.643 2.896 . . . . 1.43 114.299 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.48 HG11 ' N ' ' A' ' 39' ' ' TYR . 97.5 t -96.0 169.13 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.275 -1.329 . . . . 1.18 107.616 172.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.48 ' N ' HG11 ' A' ' 38' ' ' VAL . 77.1 m-85 -127.06 139.05 53.28 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.892 0.769 . . . . 1.17 111.779 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 42.7 t -116.14 103.77 10.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.323 -0.853 . . . . 0.82 110.292 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.6 m -106.01 135.95 46.54 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.253 -0.647 . . . . 0.25 109.253 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.456 ' HA ' ' HB2' ' A' ' 91' ' ' ALA . 59.0 m-80 -59.32 -23.66 62.66 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.696 -0.684 . . . . 2.35 110.622 177.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HD3' ' O ' ' A' ' 44' ' ' THR . 12.4 tmtt? -176.15 125.33 0.2 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.739 -1.208 . . . . 3.06 107.739 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.578 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 34.1 p -89.64 152.55 21.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.43 -0.908 . . . . 1.06 111.538 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HB3' HG21 ' A' ' 72' ' ' VAL . 14.8 tp10 -115.14 138.33 51.02 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.256 -0.883 . . . . 1.14 109.15 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.434 ' HA ' HD13 ' A' ' 71' ' ' LEU . 17.6 m-20 -74.59 109.23 7.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.357 -0.383 . . . . 1.77 110.495 -175.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.3 m -50.76 -25.31 4.23 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.971 0.794 . . . . 1.28 112.454 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.4 mptp? -64.83 -45.5 85.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.238 0.542 . . . . 3.21 111.012 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -133.45 58.07 1.78 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.548 -0.751 . . . . 2.83 110.522 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.5 mt -57.17 158.36 5.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.311 -0.859 . . . . 1.8 112.812 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.66 154.97 39.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.505 -1.225 . . . . 1.81 109.243 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -67.54 -32.99 74.15 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.066 -0.346 . . . . 3.71 110.066 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.525 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -67.01 -33.74 84.75 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.478 -0.649 . . . . 0.41 111.478 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.499 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 28.3 m -79.33 -44.29 21.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 1.05 110.056 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.4 m -52.79 -35.37 56.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.485 -0.78 . . . . 1.06 109.819 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.76 -51.59 68.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.306 -0.861 . . . . 1.06 112.013 176.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.525 HD22 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -61.84 -43.66 98.39 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.518 0.675 . . . . 1.1 109.961 -178.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.2 mt -60.24 -44.25 95.4 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.933 -1.03 . . . . 1.07 110.105 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.29 -38.08 89.15 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.775 -0.648 . . . . 0.26 112.281 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 32.7 mt -57.11 -50.44 72.77 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.746 0.784 . . . . 1.15 110.124 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.42 HD23 ' HG2' ' A' ' 101' ' ' GLN . 5.0 mt -84.02 -2.85 57.43 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.581 -1.19 . . . . 1.1 111.501 -174.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 68.17 35.01 3.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.725 0.774 . . . . 2.46 110.488 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 55.8 mt -81.77 146.61 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.468 -0.787 . . . . 1.07 110.008 176.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -95.98 117.92 31.59 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.265 0.555 . . . . 2.65 110.198 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 65' ' ' ILE . 1.8 mp -71.72 -29.98 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.297 -0.865 . . . . 1.07 110.332 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.22 -16.64 78.63 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.949 -0.569 . . . . 0.57 112.679 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -91.67 -16.41 27.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.179 0.514 . . . . 0.86 110.2 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.37 137.86 57.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.64 -0.709 . . . . 1.18 111.025 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 2.4 mptp? -94.07 -88.72 0.23 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.168 -0.923 . . . . 2.47 111.808 -170.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.13 -96.2 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.888 0.329 . . . . 1.09 111.888 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.445 ' HB3' ' HB ' ' A' ' 44' ' ' THR . 1.8 mm? -111.24 170.83 7.85 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.475 0.655 . . . . 1.03 111.363 178.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -125.14 169.9 15.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 107.065 -1.457 . . . . 1.03 107.065 166.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -138.69 131.43 5.33 Favored Glycine 0 C--N 1.311 -0.822 0 C-N-CA 119.653 -1.261 . . . . 0.37 112.159 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.577 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.31 136.21 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.354 -0.538 . . . . 1.12 109.787 178.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.97 49.3 19.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.133 -0.94 . . . . 1.85 110.662 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 11.6 t -90.68 144.52 25.66 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.521 -1.218 . . . . 1.12 109.588 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 40' ' ' CYS . 13.5 p -106.29 118.63 54.3 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.507 -0.315 . . . . 1.6 111.252 -177.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.15 119.6 6.41 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.457 2.105 . . . . 0.7 111.783 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.6 mt -90.16 87.56 6.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.661 -0.699 . . . . 1.49 109.313 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.1 p -78.11 -43.52 28.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.934 -0.576 . . . . 1.79 111.123 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 m -93.16 96.78 6.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.985 0.898 . . . . 2.13 110.784 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 29.5 mm -86.94 -65.18 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.896 -1.047 . . . . 2.17 111.268 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.18 -136.5 13.3 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 110.952 -0.859 . . . . 3.18 110.952 -172.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.12 -30.65 4.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.265 0.555 . . . . 5.02 109.877 174.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.48 -59.57 0.24 Allowed Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.764 -0.653 . . . . 4.93 111.988 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.78 -97.27 0.18 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.652 -0.785 . . . . 3.64 112.525 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.6 t30 56.55 68.04 0.91 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.492 0.663 . . . . 6.1 110.473 -178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.6 t -151.88 15.49 0.65 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.515 -0.766 . . . . 4.78 109.638 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.3 t -137.0 121.41 18.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.829 -0.623 . . . . 1.99 111.24 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.9 m -107.88 22.33 16.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.899 -0.591 . . . . 2.07 110.589 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 42' ' ' ASN . . . -140.33 -158.24 0.84 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.054 -0.521 . . . . 1.08 110.151 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.409 HE21 ' HB2' ' A' ' 92' ' ' GLN . 0.0 OUTLIER -82.46 124.59 30.21 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.444 0.64 . . . . 0.99 110.366 -176.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.49 126.4 45.42 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.52 0.676 . . . . 1.11 111.359 -170.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.519 HG11 ' HA ' ' A' ' 111' ' ' PRO . 5.0 m -134.0 165.85 30.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.228 -0.896 . . . . 1.06 110.69 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 46.0 t -112.87 120.95 43.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.541 -0.911 . . . . 0.71 108.541 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.637 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 13.8 m -124.07 153.55 41.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.864 0.364 . . . . 0.61 110.954 -169.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.2 t -83.5 -19.24 36.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.905 -0.589 . . . . 1.06 111.671 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -166.93 169.02 13.47 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 122.554 0.342 . . . . 0.93 110.424 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.3 t -145.9 143.53 29.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.869 -0.605 . . . . 1.18 110.429 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.505 ' HB2' HG21 ' A' ' 105' ' ' VAL . 35.8 m-85 -135.04 160.21 39.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.074 -0.512 . . . . 1.2 109.885 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.42 ' HG2' HD23 ' A' ' 61' ' ' LEU . 8.5 mm100 61.14 25.18 15.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.347 -0.388 . . . . 1.11 111.842 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 60.17 13.94 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 2.63 112.306 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.68 -30.84 1.67 Allowed Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.146 -1.026 . . . . 0.29 113.414 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 14.6 mt -49.23 -40.51 34.12 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.969 0.385 . . . . 1.14 111.843 -175.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.505 HG21 ' HB2' ' A' ' 100' ' ' TYR . 3.7 m -131.07 136.23 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.546 0.689 . . . . 1.51 110.664 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.484 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 32.0 t30 -132.76 141.98 48.79 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.271 -1.381 . . . . 1.24 107.271 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 17.1 m -125.07 150.23 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 113.623 0.972 . . . . 1.09 113.623 -170.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.637 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 63.54 51.7 52.13 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.726 -1.125 . . . . 0.24 111.755 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 90.4 m -97.02 131.04 44.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.992 0.425 . . . . 0.43 111.66 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 p -123.37 126.56 25.84 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.529 -0.76 . . . . 1.16 110.0 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.519 ' HA ' HG11 ' A' ' 94' ' ' VAL . 52.6 Cg_exo -52.31 116.59 2.93 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.8 2.333 . . . . 0.42 112.462 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 32' ' ' SER . 7.2 tt -104.98 124.57 59.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.855 -0.612 . . . . 1.21 110.549 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -96.23 98.55 10.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.14 -0.482 . . . . 3.02 110.061 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 115' ' ' GLY . 1.3 pp -95.62 -14.43 7.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.896 -0.593 . . . . 2.28 110.94 178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.402 ' N ' HD13 ' A' ' 114' ' ' ILE . . . 73.99 12.12 81.3 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.812 -0.631 . . . . 2.61 113.648 173.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.531 -0.747 . . . . 4.15 109.65 178.597 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.084 -0.339 . . . . 30.52 110.084 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 59.07 32.14 21.94 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.605 0.566 . . . . 28.11 111.547 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 89.5 mtp -113.93 -7.66 13.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.364 0.602 . . . . 28.72 109.74 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.56 170.26 16.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.247 -0.888 . . . . 26.8 109.489 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 59.29 34.21 22.87 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.303 0.377 . . . . 25.36 110.957 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.5 mt -92.97 -30.62 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.143 0.497 . . . . 25.15 109.861 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.82 24.25 10.07 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.805 -0.712 . . . . 23.13 112.325 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 t -79.13 -19.78 50.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.216 0.532 . . . . 22.94 110.435 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.8 m -123.99 -55.5 1.69 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.946 -0.57 . . . . 22.43 110.612 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -140.93 162.21 36.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.354 -0.384 . . . . 21.22 110.814 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.6 p -172.43 131.1 0.66 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.988 -0.551 . . . . 19.19 110.023 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.39 20.02 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.884 2.389 . . . . 18.61 113.102 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -139.41 86.78 2.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.966 -0.383 . . . . 18.57 109.966 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.91 161.63 20.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.092 -0.503 . . . . 14.82 111.173 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -116.92 126.16 74.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.771 -0.649 . . . . 13.37 109.625 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -73.74 -28.72 61.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.1 0.476 . . . . 12.77 110.616 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.17 31.65 5.24 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.677 -0.773 . . . . 10.27 111.981 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.77 54.07 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.006 -0.616 . . . . 8.25 111.648 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.568 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 85.0 m -153.89 133.2 7.23 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.919 0.39 . . . . 7.56 111.287 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -101.39 76.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.528 3.485 . . . . 6.56 112.445 169.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 28' ' ' THR . 26.0 Cg_exo -61.87 83.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.829 2.353 . . . . 5.71 113.06 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -105.97 -14.58 15.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.218 0.533 . . . . 4.21 109.924 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 p -80.87 -168.78 1.91 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.514 -0.766 . . . . 2.12 111.244 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.6 m -75.42 131.05 39.91 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.653 -0.499 . . . . 1.77 109.653 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.6 m -74.01 -17.9 60.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.016 0.436 . . . . 2.81 110.692 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -83.96 -16.9 42.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.932 -0.576 . . . . 2.8 111.413 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.91 -138.21 6.78 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.305 -0.95 . . . . 1.82 113.39 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -55.02 154.38 22.27 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.704 2.936 . . . . 1.43 114.375 -176.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 39' ' ' TYR . 84.2 t -98.84 168.67 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.33 -1.305 . . . . 1.18 107.801 172.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.481 ' N ' HG12 ' A' ' 38' ' ' VAL . 87.4 m-85 -127.99 132.25 49.18 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 118.68 0.673 . . . . 1.17 111.211 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.817 ' SG ' ' HB2' ' A' ' 77' ' ' SER . 27.1 p -107.09 107.66 18.76 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.555 -0.748 . . . . 0.82 110.025 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.6 m -98.66 137.38 37.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.445 -0.798 . . . . 0.25 110.626 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -55.03 -27.67 46.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.781 0.801 . . . . 2.35 109.356 172.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -169.56 137.4 1.78 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.306 -1.316 . . . . 3.06 108.247 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.511 HG21 HG13 ' A' ' 94' ' ' VAL . 14.3 p -92.85 149.28 21.37 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.461 -0.896 . . . . 1.06 110.306 168.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.435 ' HB3' HG23 ' A' ' 72' ' ' VAL . 6.7 tp10 -112.35 134.32 53.96 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.528 -0.76 . . . . 1.14 109.287 -176.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.459 ' HA ' HD11 ' A' ' 71' ' ' LEU . 4.7 m-20 -67.14 114.1 5.62 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.729 -0.669 . . . . 1.77 111.051 -174.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.53 ' HA ' HD22 ' A' ' 50' ' ' LEU . 68.5 m -60.14 -13.03 10.03 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.392 0.433 . . . . 1.28 111.88 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.548 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -79.29 -36.22 40.04 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.522 0.677 . . . . 3.21 109.95 177.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -140.4 66.08 1.39 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.039 -0.982 . . . . 2.83 111.517 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.53 HD22 ' HA ' ' A' ' 47' ' ' SER . 2.7 mm? -64.91 147.43 53.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.096 0.474 . . . . 1.8 110.962 171.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.59 171.06 13.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.638 -0.71 . . . . 1.81 110.221 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -61.24 -47.96 83.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.62 0.248 . . . . 3.71 111.088 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.488 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -55.64 -35.32 62.0 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.41 112.708 -177.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.537 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 11.2 m -81.8 -41.61 20.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.243 -0.28 . . . . 1.05 110.243 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.2 m -53.81 -34.77 60.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.409 0.623 . . . . 1.06 109.928 174.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.96 -53.76 54.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.063 -0.971 . . . . 1.06 111.908 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.5 HD21 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -61.12 -46.19 91.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.547 0.689 . . . . 1.1 109.973 -178.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 54' ' ' THR . 46.1 mt -58.64 -41.93 87.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.685 -1.143 . . . . 1.07 109.848 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.92 -32.45 84.01 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.748 -0.66 . . . . 0.26 112.704 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.1 mt -62.96 -50.55 70.34 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.666 0.746 . . . . 1.15 109.811 177.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.435 ' CD1' HG23 ' A' ' 105' ' ' VAL . 3.6 mt -81.43 -0.75 42.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.517 -1.219 . . . . 1.1 111.216 -175.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 t30 68.61 38.18 2.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.324 -0.853 . . . . 2.46 110.559 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.4 HD11 ' HA ' ' A' ' 58' ' ' LEU . 49.3 mt -87.07 141.59 14.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.584 -0.735 . . . . 1.07 109.746 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.65 118.6 31.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.532 0.682 . . . . 2.65 110.179 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -67.65 -36.99 77.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.818 -1.083 . . . . 1.07 110.93 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.58 -14.91 70.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.97 -0.633 . . . . 0.57 113.177 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.12 3.62 33.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.238 0.542 . . . . 0.86 110.725 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 94.2 mt -71.47 144.27 49.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.052 0.453 . . . . 1.18 110.853 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -94.85 -96.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.581 -0.736 . . . . 2.47 112.542 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.59 -85.98 0.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 1.09 111.897 -172.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.3 mm? -120.13 165.14 15.15 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.529 0.681 . . . . 1.03 111.063 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.443 ' CG1' HD13 ' A' ' 50' ' ' LEU . 0.8 OUTLIER -119.9 167.56 13.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 106.017 -1.846 . . . . 1.03 106.017 167.262 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.556 ' O ' ' HA ' ' A' ' 105' ' ' VAL . . . -135.01 137.59 9.36 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.671 -1.252 . . . . 0.37 111.583 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.638 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -109.85 129.49 55.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.49 0.645 . . . . 1.12 110.765 178.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.504 ' ND2' HD22 ' A' ' 104' ' ' LEU . 0.4 OUTLIER 54.3 52.9 11.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.6 -1.182 . . . . 1.85 111.487 176.646 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.6 m -92.0 154.06 19.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.252 -0.885 . . . . 1.12 109.983 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.817 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 57.6 m -102.75 129.64 25.43 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.38 -0.373 . . . . 1.6 110.089 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 6.6 Cg_exo -74.09 119.64 5.93 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.601 2.201 . . . . 0.7 112.276 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.696 HD22 ' SG ' ' A' ' 40' ' ' CYS . 9.8 mt -94.97 89.58 5.65 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.527 -0.76 . . . . 1.49 108.952 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.6 p -80.58 -44.63 18.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.086 -0.506 . . . . 1.79 111.775 -173.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 m -92.79 99.27 9.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.83 0.824 . . . . 2.13 111.632 -176.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.0 mm -80.89 119.92 31.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.293 -0.867 . . . . 2.17 110.539 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 139.33 -48.22 0.87 Allowed Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.26 -1.136 . . . . 3.18 110.26 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.4 t -96.15 -46.63 13.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.184 -1.043 . . . . 5.02 108.184 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.55 169.61 28.95 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.083 -0.962 . . . . 4.93 110.725 172.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.04 -28.67 7.06 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.633 -0.794 . . . . 3.64 111.682 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -62.92 -47.21 84.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.281 0.562 . . . . 6.1 110.275 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.9 t -163.6 145.19 9.33 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.374 -0.83 . . . . 4.78 109.345 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.4 t -131.1 14.52 5.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.15 0.5 . . . . 1.99 110.142 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.5 m 59.09 16.57 4.86 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.577 -0.738 . . . . 2.07 110.554 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.33 -168.19 2.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.568 -0.742 . . . . 1.08 110.201 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.55 117.24 29.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.316 0.579 . . . . 0.99 109.536 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.85 122.49 33.61 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.817 -0.629 . . . . 1.11 111.078 -173.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.511 HG13 HG21 ' A' ' 44' ' ' THR . 12.3 m -135.29 162.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.629 -0.714 . . . . 1.06 111.191 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 49.6 t -108.49 109.68 21.0 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.793 -0.817 . . . . 0.71 108.793 176.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 39.5 m -102.01 148.19 25.66 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.242 -0.281 . . . . 0.61 110.242 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.0 t -81.46 -27.27 34.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.055 0.455 . . . . 1.06 110.501 -173.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.508 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 14.8 m120 -149.05 165.89 30.35 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.769 -0.65 . . . . 0.93 109.374 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.2 t -136.73 139.87 42.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.118 -0.492 . . . . 1.18 110.223 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.47 ' HB2' HG21 ' A' ' 105' ' ' VAL . 57.7 m-85 -128.07 147.88 50.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.922 -0.581 . . . . 1.2 109.732 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.436 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER 63.58 22.91 13.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 1.11 111.208 178.143 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 67.49 9.99 7.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.921 -0.581 . . . . 2.63 112.079 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.11 -22.12 2.1 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.333 -0.936 . . . . 0.29 113.269 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.8 mt -54.0 -35.78 62.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.877 0.338 . . . . 1.14 111.574 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -144.14 119.6 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.253 0.549 . . . . 1.51 111.042 174.516 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -114.62 161.82 17.59 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.728 -0.669 . . . . 1.24 109.785 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.508 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.9 m -130.73 156.89 42.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 111.896 0.332 . . . . 1.09 111.896 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 57.37 52.64 50.42 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.554 -0.748 . . . . 0.24 111.929 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 68.4 m -96.79 128.42 43.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.763 0.316 . . . . 0.43 110.739 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.1 p -123.02 127.36 25.72 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.93 -0.577 . . . . 1.16 110.355 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.493 ' HA ' HG12 ' A' ' 94' ' ' VAL . 51.8 Cg_exo -53.58 115.33 2.25 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.129 2.552 . . . . 0.42 112.934 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 tt -98.27 133.32 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.739 -0.664 . . . . 1.21 110.064 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -108.16 113.69 27.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.195 0.521 . . . . 3.02 110.865 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.44 HD13 ' N ' ' A' ' 115' ' ' GLY . 1.1 pp -82.92 -22.82 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.155 -0.475 . . . . 2.28 111.152 176.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.44 ' N ' HD13 ' A' ' 114' ' ' ILE . . . 70.02 6.59 57.14 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.936 -0.574 . . . . 2.61 113.762 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.432 ' HG ' HD12 ' A' ' 114' ' ' ILE . 3.4 pp . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.452 -0.785 . . . . 4.15 109.94 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.595 ' HE2' ' SD ' ' A' ' 12' ' ' MET . 4.1 ttpm? . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.9 -0.407 . . . . 30.52 109.9 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.21 103.02 1.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 28.11 111.194 -177.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.595 ' SD ' ' HE2' ' A' ' 10' ' ' LYS . 24.1 ptm -147.56 -42.19 0.17 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.999 -0.546 . . . . 28.72 110.472 175.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.06 18.98 16.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.811 0.815 . . . . 26.8 109.015 174.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -145.76 25.89 1.29 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.219 -1.355 . . . . 25.36 109.553 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.51 121.57 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.539 -0.755 . . . . 25.15 110.717 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.0 -44.3 1.92 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.877 -0.678 . . . . 23.13 111.528 -177.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.6 m 56.97 86.76 0.07 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.922 0.489 . . . . 22.94 110.58 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 m -62.54 92.75 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.749 -0.66 . . . . 22.43 111.449 -175.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -157.94 57.44 0.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 21.22 110.091 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.3 t -77.83 114.95 46.15 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.637 -0.711 . . . . 19.19 110.817 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.16 164.4 35.89 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.465 2.11 . . . . 18.61 112.028 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -144.69 156.05 43.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.559 -0.291 . . . . 18.57 110.575 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 65.84 20.24 11.39 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.713 0.633 . . . . 14.82 111.121 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 p -114.33 110.89 33.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.745 -0.661 . . . . 13.37 109.865 176.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -115.36 121.35 42.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.906 -0.588 . . . . 12.77 110.386 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.44 96.48 0.56 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.922 -0.656 . . . . 10.27 111.891 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.94 37.7 0.6 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.886 -0.673 . . . . 8.25 112.459 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.497 HG21 ' HD2' ' A' ' 30' ' ' PRO . 19.7 m -76.54 134.03 70.11 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.388 -0.597 . . . . 7.56 109.388 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 95.8 Cg_exo -41.47 -50.52 4.61 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.829 3.019 . . . . 6.56 115.751 -174.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.497 ' HD2' HG21 ' A' ' 28' ' ' THR . 2.8 Cg_endo -79.32 -10.17 14.91 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 121.793 1.662 . . . . 5.71 111.357 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.5 mttp 63.98 -78.99 0.03 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.725 -1.125 . . . . 4.21 111.502 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.508 ' OG ' ' HA ' ' A' ' 37' ' ' PRO . 32.7 t -71.14 159.69 34.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.269 0.557 . . . . 2.12 111.282 -175.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 27.9 m -85.63 155.49 21.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.284 -0.871 . . . . 1.77 109.527 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.6 t -80.14 -39.17 29.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.414 -0.357 . . . . 2.81 111.659 -174.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -71.72 -31.53 66.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.124 0.487 . . . . 2.8 110.449 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . -154.95 144.45 11.09 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.91 -0.876 . . . . 1.82 110.91 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.508 ' HA ' ' OG ' ' A' ' 32' ' ' SER . 13.3 Cg_exo -71.1 -161.77 0.1 OUTLIER 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.414 2.076 . . . . 1.43 112.554 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 39' ' ' TYR . 49.1 t -88.86 161.0 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.791 0.329 . . . . 1.18 110.228 -175.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.421 ' N ' HG13 ' A' ' 38' ' ' VAL . 70.2 m-85 -135.77 141.48 44.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.089 0.471 . . . . 1.17 109.91 177.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.579 ' HB3' ' OG ' ' A' ' 77' ' ' SER . 16.4 t -107.0 107.86 19.08 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.166 -0.47 . . . . 0.82 109.966 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.0 m -108.08 134.18 51.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.925 0.393 . . . . 0.25 110.426 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.465 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 4.8 m-20 -60.11 -20.23 57.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 2.35 110.293 176.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.92 129.91 0.31 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.1 -1.074 . . . . 3.06 108.1 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.516 HG23 HG13 ' A' ' 94' ' ' VAL . 18.4 p -87.42 152.86 21.9 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.174 -1.011 . . . . 1.06 111.09 172.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.408 ' OE2' ' HA ' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -115.16 142.43 46.67 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.238 -0.892 . . . . 1.14 109.29 -174.595 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.453 ' HA ' HD12 ' A' ' 71' ' ' LEU . 10.2 m-20 -78.31 108.4 11.62 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.105 -0.498 . . . . 1.77 110.86 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.508 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 46.7 m -58.92 -12.49 4.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.064 0.765 . . . . 1.28 113.064 -176.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -81.18 -32.84 33.38 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.967 -0.293 . . . . 3.21 110.343 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -147.29 67.11 1.14 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.328 -0.396 . . . . 2.83 110.75 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.508 ' CD2' ' HA ' ' A' ' 47' ' ' SER . 2.9 mm? -59.42 153.63 18.75 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.462 0.648 . . . . 1.8 111.495 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.86 150.67 48.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.916 -1.038 . . . . 1.81 109.388 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.637 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -55.58 -36.4 66.84 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.01 0.194 . . . . 3.71 111.12 176.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.519 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -63.58 -40.66 98.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.793 -0.718 . . . . 0.41 111.778 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.514 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 24.5 m -78.53 -42.84 28.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.853 0.359 . . . . 1.05 110.229 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.5 m -52.04 -36.59 50.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.571 -0.741 . . . . 1.06 109.957 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.494 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.06 -54.41 47.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.264 -0.88 . . . . 1.06 111.817 176.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.519 HD21 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -59.18 -45.02 92.14 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.385 0.612 . . . . 1.1 110.216 -177.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 54' ' ' THR . 48.5 mt -58.54 -42.33 87.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.905 -1.043 . . . . 1.07 110.132 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.37 -37.05 93.98 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.712 -0.756 . . . . 0.26 112.068 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 15.1 mt -63.03 -40.32 97.39 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.651 0.739 . . . . 1.15 110.194 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.4 ' CD1' HG21 ' A' ' 105' ' ' VAL . 5.6 mt -90.5 4.19 51.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.86 -1.064 . . . . 1.1 111.417 -176.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.9 m120 70.41 26.68 4.12 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.461 -0.79 . . . . 2.46 111.264 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.419 HD11 ' HA ' ' A' ' 58' ' ' LEU . 52.8 mt -81.48 145.86 8.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.02 -0.536 . . . . 1.07 110.485 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.579 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -97.01 117.7 31.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.599 -0.728 . . . . 2.65 109.987 -178.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -75.69 -42.8 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.645 -0.707 . . . . 1.07 111.449 -174.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.34 -8.63 71.14 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 121.017 -0.611 . . . . 0.57 112.838 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.471 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 29.5 t70 -104.02 -9.31 18.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.974 0.416 . . . . 0.86 110.497 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.507 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 94.8 mt -60.92 140.1 57.83 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.03 -0.532 . . . . 1.18 110.657 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -88.89 -62.02 1.58 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.325 -0.852 . . . . 2.47 113.085 -169.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.77 -95.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.379 0.511 . . . . 1.09 112.379 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.1 mm? -117.77 165.78 13.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.544 0.688 . . . . 1.03 111.391 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.476 ' CG1' HD11 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -119.86 173.4 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.776 -1.565 . . . . 1.03 106.776 169.169 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.541 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -141.41 148.66 20.35 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.844 -1.17 . . . . 0.37 111.533 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -110.76 133.52 53.27 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.879 -0.415 . . . . 1.12 109.879 174.732 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.8 m120 53.34 50.47 17.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.992 -1.004 . . . . 1.85 111.188 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.541 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 60.6 m -86.93 143.01 27.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.07 -0.513 . . . . 1.12 110.705 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.579 ' OG ' ' HB3' ' A' ' 40' ' ' CYS . 7.0 p -97.15 114.61 64.99 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.104 -0.498 . . . . 1.6 109.789 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.26 120.53 8.14 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.44 2.093 . . . . 0.7 112.357 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.419 HD11 ' HB2' ' A' ' 40' ' ' CYS . 35.0 mt -99.29 87.31 3.61 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.964 -0.754 . . . . 1.49 108.964 177.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.0 m -78.47 -18.51 54.76 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.885 -0.598 . . . . 1.79 110.944 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.493 ' O ' ' HA2' ' A' ' 86' ' ' GLY . 4.0 m -129.27 113.36 27.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.914 -0.585 . . . . 2.13 111.389 -175.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.7 mm -109.15 128.23 65.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.984 -0.553 . . . . 2.17 111.069 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 143.06 -136.69 7.2 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.679 -0.772 . . . . 3.18 112.058 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.6 t -71.91 -34.16 50.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.143 0.497 . . . . 5.02 110.397 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -105.89 49.52 0.88 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.757 -0.735 . . . . 4.93 112.287 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.493 ' HA2' ' O ' ' A' ' 81' ' ' VAL . . . -76.1 147.72 35.16 Favored Glycine 0 C--N 1.329 0.19 0 C-N-CA 121.069 -0.586 . . . . 3.64 112.249 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -91.38 35.3 0.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.057 0.392 . . . . 6.1 112.057 -175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.6 p 61.79 122.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.507 1.299 . . . . 4.78 114.507 170.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.3 t -130.99 125.41 33.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.014 -0.994 . . . . 1.99 109.523 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.4 p -121.01 10.78 10.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.899 0.38 . . . . 2.07 111.204 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -126.19 -159.2 0.9 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.108 -0.496 . . . . 1.08 110.408 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.57 130.09 38.92 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.235 0.54 . . . . 0.99 109.769 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.79 119.11 38.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.319 0.581 . . . . 1.11 111.448 -171.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.516 HG13 HG23 ' A' ' 44' ' ' THR . 5.2 m -130.99 163.86 35.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.577 -0.738 . . . . 1.06 110.573 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.5 t -109.6 120.34 42.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.575 -0.898 . . . . 0.71 108.575 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.69 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 17.9 m -121.57 148.51 44.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.053 0.454 . . . . 0.61 110.98 -169.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.4 t -78.29 -29.53 47.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.632 -0.713 . . . . 1.06 110.891 -172.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.4 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 17.0 m120 -157.0 158.74 37.11 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.91 -0.404 . . . . 0.93 109.91 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 t -132.61 149.2 52.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.388 -0.597 . . . . 1.18 109.388 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.51 ' HB2' HG22 ' A' ' 105' ' ' VAL . 81.6 m-85 -131.29 154.0 48.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.287 -0.634 . . . . 1.2 109.287 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.645 ' NE2' HD12 ' A' ' 104' ' ' LEU . 8.7 mm100 63.63 27.11 14.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 1.11 110.878 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 65.48 6.53 3.79 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.594 -0.73 . . . . 2.63 112.465 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 140.64 -19.64 2.77 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.207 -0.997 . . . . 0.29 113.211 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.645 HD12 ' NE2' ' A' ' 101' ' ' GLN . 20.7 mt -47.91 -39.6 19.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.006 0.403 . . . . 1.14 110.919 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 100' ' ' TYR . 4.5 m -130.38 149.93 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.209 -0.663 . . . . 1.51 109.209 171.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.467 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 31.5 t30 -144.05 147.82 34.34 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.154 -1.054 . . . . 1.24 108.154 -173.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.434 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 9.2 m -131.59 153.52 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.415 0.895 . . . . 1.09 113.415 -174.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.69 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 62.02 51.72 54.99 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.784 -1.098 . . . . 0.24 111.985 176.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 83.9 m -97.82 127.76 43.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.978 0.418 . . . . 0.43 111.919 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 p -119.78 127.83 26.19 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.806 -0.634 . . . . 1.16 110.226 173.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.516 ' HA ' HG12 ' A' ' 94' ' ' VAL . 54.0 Cg_exo -51.29 113.23 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.049 2.5 . . . . 0.42 112.563 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 tt -110.26 144.43 18.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.44 -0.8 . . . . 1.21 110.414 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -110.02 99.23 8.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.173 0.511 . . . . 3.02 109.693 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 pp -95.55 -18.3 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.625 -0.716 . . . . 2.28 112.524 -174.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.49 8.43 83.21 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.672 -0.775 . . . . 2.61 113.44 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 C--O 1.245 0.858 0 CA-C-O 118.166 -0.921 . . . . 4.15 109.416 176.058 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.3 pttp . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.467 0.175 . . . . 30.52 111.323 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.75 -51.65 11.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.337 . . . . 28.11 110.611 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 67.0 mtt -136.63 102.4 4.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.206 -0.452 . . . . 28.72 110.068 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.17 82.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.969 0.414 . . . . 26.8 110.594 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -159.35 151.85 21.39 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.564 -0.532 . . . . 25.36 109.564 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.6 pt -102.77 11.58 7.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.329 0.585 . . . . 25.15 110.403 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.25 103.72 0.5 Allowed Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.407 -0.815 . . . . 23.13 111.616 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.1 m -81.09 63.98 5.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.496 0.665 . . . . 22.94 110.252 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 t -90.73 -21.19 21.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.285 -0.87 . . . . 22.43 111.089 -177.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.28 -47.06 2.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.412 -0.358 . . . . 21.22 111.106 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.5 m -72.46 127.06 90.6 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.912 0.387 . . . . 19.19 111.109 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.7 79.12 2.84 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.795 2.33 . . . . 18.61 111.608 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? 60.54 78.69 0.27 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.722 -0.672 . . . . 18.57 110.578 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -75.31 -21.67 58.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 14.82 110.241 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -81.1 87.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.888 0.851 . . . . 13.37 109.717 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -95.67 -55.85 2.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.435 -0.802 . . . . 12.77 110.357 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.93 -33.21 83.23 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.73 -0.747 . . . . 10.27 112.317 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.36 -67.43 2.83 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.958 -0.639 . . . . 8.25 111.586 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.543 HG22 ' HD2' ' A' ' 30' ' ' PRO . 17.4 m -98.94 115.84 65.58 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.701 -0.481 . . . . 7.56 109.701 176.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -42.27 -55.01 2.74 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.434 2.756 . . . . 6.56 113.797 -173.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.543 ' HD2' HG22 ' A' ' 28' ' ' THR . 92.9 Cg_endo -82.57 133.41 7.12 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.801 1.667 . . . . 5.71 111.51 172.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 13.0 mptt -88.56 -169.45 2.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.291 -0.413 . . . . 4.21 111.023 -177.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 p 68.66 166.17 0.26 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.255 1.022 . . . . 2.12 111.161 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.0 m -84.43 130.9 34.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.056 -0.52 . . . . 1.77 111.17 -175.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.9 m -87.53 -6.44 58.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.413 0.625 . . . . 2.81 109.647 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.5 p -81.57 -8.92 59.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.373 -0.831 . . . . 2.8 110.742 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 134.81 -143.96 15.79 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 111.13 -0.788 . . . . 1.82 111.13 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.79 155.26 23.01 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.973 2.448 . . . . 1.43 113.556 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.446 HG13 ' N ' ' A' ' 39' ' ' TYR . 86.7 t -88.46 164.96 2.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.397 -1.334 . . . . 1.18 107.397 171.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.453 ' CD2' ' HB2' ' A' ' 96' ' ' CYS . 90.3 m-85 -129.09 134.41 48.07 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.518 -0.873 . . . . 1.17 111.952 -177.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 31.9 t -105.46 103.47 13.0 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.857 -1.065 . . . . 0.82 109.905 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.0 m -100.62 132.39 46.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.316 0.579 . . . . 0.25 110.48 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.457 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 5.8 m-20 -57.6 -24.56 57.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.997 -1.001 . . . . 2.35 110.508 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.86 119.33 0.35 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.266 -1.013 . . . . 3.06 108.266 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.537 HG21 HG12 ' A' ' 94' ' ' VAL . 15.2 p -80.27 150.81 29.87 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 118.765 -1.174 . . . . 1.06 110.832 174.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.462 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.2 tp10 -119.87 138.32 53.47 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.44 -0.8 . . . . 1.14 109.322 -176.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.52 ' HA ' HD11 ' A' ' 71' ' ' LEU . 26.5 m-20 -69.75 114.34 7.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.039 -0.528 . . . . 1.77 110.987 -173.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.529 ' HA ' ' CD2' ' A' ' 50' ' ' LEU . 49.5 m -61.03 -9.43 4.38 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.115 -0.493 . . . . 1.28 111.831 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -90.19 -16.28 29.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.563 -0.29 . . . . 3.21 110.642 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -154.15 57.85 0.72 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.513 -0.312 . . . . 2.83 111.542 -176.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.529 ' CD2' ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -60.79 149.33 36.14 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.456 0.646 . . . . 1.8 112.064 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.53 145.52 52.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.011 -0.995 . . . . 1.81 108.401 172.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -20.33 66.23 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.779 -0.368 . . . . 3.71 110.742 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.497 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -73.24 -33.56 58.95 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.079 -0.808 . . . . 0.41 111.079 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.53 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 43.3 m -79.97 -41.56 25.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.725 0.298 . . . . 1.05 110.377 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.6 m -53.05 -35.2 59.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.338 0.59 . . . . 1.06 109.777 172.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -55.59 -54.66 41.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.259 -0.882 . . . . 1.06 111.611 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -60.22 -44.02 95.53 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.373 0.606 . . . . 1.1 110.214 -178.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 54' ' ' THR . 53.3 mt -58.6 -45.06 89.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.988 -1.006 . . . . 1.07 109.82 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.27 -36.59 91.26 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.833 -0.622 . . . . 0.26 112.744 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 18.6 mt -59.71 -47.81 84.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.712 0.768 . . . . 1.15 110.283 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.499 ' CD1' HG23 ' A' ' 105' ' ' VAL . 4.1 mt -86.12 -1.34 57.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.72 -1.127 . . . . 1.1 111.115 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 66.17 36.54 5.51 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.256 -0.884 . . . . 2.46 111.056 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.408 HD11 ' HA ' ' A' ' 58' ' ' LEU . 54.8 mt -80.15 143.28 12.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.661 -0.699 . . . . 1.07 109.474 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.558 ' H ' ' HD2' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -94.18 117.87 30.73 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.462 0.649 . . . . 2.65 110.002 -177.378 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.39 -34.08 56.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.957 -1.019 . . . . 1.07 110.679 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.73 -16.88 72.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.017 -0.611 . . . . 0.57 112.741 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 29.8 t70 -94.5 -15.76 23.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.76 0.314 . . . . 0.86 110.659 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 94.1 mt -55.12 129.59 38.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.394 0.616 . . . . 1.18 110.984 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 3.3 mptp? -88.07 -86.82 0.16 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.987 -1.006 . . . . 2.47 112.262 -170.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -90.74 -94.92 0.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 1.09 111.466 -171.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.52 HD11 ' HA ' ' A' ' 46' ' ' ASP . 1.2 mm? -113.6 167.62 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.088 -0.505 . . . . 1.03 110.134 172.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.616 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -118.32 166.66 12.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 106.378 -1.712 . . . . 1.03 106.378 167.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.39 138.07 9.43 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 119.524 -1.322 . . . . 0.37 112.247 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.557 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -102.66 132.44 48.78 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.011 -0.676 . . . . 1.12 109.64 173.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 59.0 57.96 3.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.804 -1.089 . . . . 1.85 110.813 175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 40' ' ' CYS . 29.4 m -94.72 139.23 31.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.531 -0.759 . . . . 1.12 111.002 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 32.0 t -94.27 120.82 64.9 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.87 -0.604 . . . . 1.6 109.825 177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.86 120.4 7.04 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.816 2.344 . . . . 0.7 112.632 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.5 mt -105.09 89.08 3.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.51 -0.768 . . . . 1.49 109.336 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.3 t -80.8 -29.35 36.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.023 0.439 . . . . 1.79 110.651 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 m -106.65 102.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.48 0.657 . . . . 2.13 111.221 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.7 mm -99.23 143.24 13.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.565 -0.743 . . . . 2.17 110.911 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.4 -66.15 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.78 -0.724 . . . . 3.18 112.052 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 m -92.43 46.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.366 0.603 . . . . 5.02 110.708 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.34 -125.77 7.3 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.635 -0.712 . . . . 4.93 112.04 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.22 65.06 4.09 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.943 -0.646 . . . . 3.64 112.254 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -77.08 148.51 36.06 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.105 -0.331 . . . . 6.1 110.105 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.2 m 60.83 29.46 19.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.328 0.585 . . . . 4.78 110.116 -173.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 11.6 t -140.15 101.88 4.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.577 -0.738 . . . . 1.99 110.795 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.8 m -102.64 8.58 39.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.573 0.701 . . . . 2.07 110.01 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.457 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -116.17 -158.97 0.7 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.24 -0.891 . . . . 1.08 110.001 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.48 122.94 28.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.097 0.475 . . . . 0.99 110.289 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.24 122.72 35.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.321 0.581 . . . . 1.11 111.034 -175.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.537 HG12 HG21 ' A' ' 44' ' ' THR . 9.0 m -132.02 161.85 40.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.444 -0.798 . . . . 1.06 110.968 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 37.1 t -108.19 109.63 21.07 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.92 -0.77 . . . . 0.71 108.92 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 14.3 m -110.14 153.56 24.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.229 -0.442 . . . . 0.61 110.416 -173.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.7 t -80.7 -26.9 37.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.938 -0.574 . . . . 1.06 110.495 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.428 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 3.6 m120 -155.15 166.21 34.3 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.93 109.565 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.431 ' HB ' ' CE1' ' A' ' 39' ' ' TYR . 15.3 t -129.97 143.45 50.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.075 0.464 . . . . 1.18 110.026 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.462 ' CB ' HG21 ' A' ' 105' ' ' VAL . 42.0 m-85 -126.12 141.65 51.85 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.79 -0.641 . . . . 1.2 110.05 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.419 HE21 ' HB3' ' A' ' 101' ' ' GLN . 6.4 mm100 62.06 25.36 15.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.872 0.368 . . . . 1.11 110.939 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 62.09 11.56 4.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.424 -0.807 . . . . 2.63 112.318 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 149.33 -29.07 1.21 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.891 -1.147 . . . . 0.29 113.73 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 15.5 mt -54.92 -35.3 64.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.391 0.596 . . . . 1.14 111.394 -175.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.499 HG23 ' CD1' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -132.69 143.89 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.809 -0.632 . . . . 1.51 109.774 173.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.616 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.0 OUTLIER -139.39 157.75 45.32 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.41 -0.589 . . . . 1.24 109.41 -174.314 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.428 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.9 m -136.61 144.61 32.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.879 0.696 . . . . 1.09 112.879 -174.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.605 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.07 51.63 57.26 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 114.949 -1.023 . . . . 0.24 112.05 176.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.436 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 73.0 m -97.5 131.12 44.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.611 0.243 . . . . 0.43 111.381 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.24 130.65 24.08 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.325 -0.398 . . . . 1.16 110.305 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.519 ' HA ' HG11 ' A' ' 94' ' ' VAL . 54.2 Cg_exo -52.6 109.5 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.79 2.327 . . . . 0.42 111.78 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.1 tt -88.08 119.2 35.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.796 -0.638 . . . . 1.21 111.365 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -108.89 116.65 32.4 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.286 -0.87 . . . . 3.02 109.625 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.43 HD12 ' N ' ' A' ' 115' ' ' GLY . 1.1 pp -64.59 -21.48 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.045 0.387 . . . . 2.28 112.045 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.43 ' N ' HD12 ' A' ' 114' ' ' ILE . . . 66.78 16.84 66.48 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.288 -0.415 . . . . 2.61 113.642 174.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.433 ' O ' HD11 ' A' ' 116' ' ' LEU . 2.7 pp . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.88 -0.581 . . . . 4.15 110.574 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.498 -0.556 . . . . 30.52 109.498 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -18.74 65.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.411 0.523 . . . . 28.11 112.411 -173.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.6 mtt -73.85 -12.17 60.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.849 0.357 . . . . 28.72 111.057 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.94 97.47 3.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.455 . . . . 26.8 109.863 177.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.0 t70 70.39 112.78 0.05 Allowed 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.828 0.705 . . . . 25.36 110.416 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.2 mm -66.0 102.96 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.905 -0.589 . . . . 25.15 110.394 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.76 -7.26 88.64 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.998 -0.62 . . . . 23.13 112.102 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.6 t 65.69 37.33 5.86 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.284 0.564 . . . . 22.94 110.551 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.8 p -77.04 -20.3 56.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.864 -0.607 . . . . 22.43 111.125 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 72.9 -49.49 0.7 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.724 0.81 . . . . 21.22 111.857 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.18 149.21 56.84 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.576 -0.284 . . . . 19.19 110.528 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -84.9 38.13 0.65 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.89 2.393 . . . . 18.61 111.966 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -134.62 109.53 8.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.841 -0.618 . . . . 18.57 110.047 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -96.01 86.29 4.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.085 -0.507 . . . . 14.82 110.086 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.8 m -92.42 133.22 34.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.021 -0.536 . . . . 13.37 110.196 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -154.43 112.62 3.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.349 -0.387 . . . . 12.77 110.479 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.48 135.8 44.6 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.053 -0.521 . . . . 10.27 112.484 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.28 -62.96 4.04 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.723 -0.751 . . . . 8.25 111.614 -176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.468 HG23 ' HD2' ' A' ' 30' ' ' PRO . 7.0 m 68.22 120.52 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 121.692 0.758 . . . . 7.56 111.374 178.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 27.4 Cg_exo -54.72 -53.27 6.35 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.925 3.084 . . . . 6.56 114.077 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.468 ' HD2' HG23 ' A' ' 28' ' ' THR . 61.8 Cg_endo -72.61 88.35 0.9 Allowed 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 121.657 1.571 . . . . 5.71 112.248 176.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -90.69 84.02 5.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.968 -0.56 . . . . 4.21 110.305 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 p -169.84 177.76 4.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.848 -0.615 . . . . 2.12 110.524 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.5 m -85.15 149.87 25.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.013 0.435 . . . . 1.77 110.928 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.1 t -67.54 -25.87 66.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.915 -0.584 . . . . 2.81 110.458 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 m -81.19 -5.81 58.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.414 . . . . 2.8 110.783 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.24 -95.48 0.83 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.977 -0.63 . . . . 1.82 112.587 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.83 151.66 15.01 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.246 2.63 . . . . 1.43 114.063 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.512 HG11 ' N ' ' A' ' 39' ' ' TYR . 98.5 t -94.53 174.63 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.401 -1.272 . . . . 1.18 107.833 174.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.512 ' N ' HG11 ' A' ' 38' ' ' VAL . 62.8 m-85 -131.05 136.1 48.16 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.424 -0.798 . . . . 1.17 111.459 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 26.8 t -111.62 109.96 20.12 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.417 -0.81 . . . . 0.82 109.67 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.4 m -107.98 133.73 51.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.219 -0.446 . . . . 0.25 110.293 -176.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.421 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 53.8 m-80 -55.94 -28.4 56.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.395 -0.821 . . . . 2.35 110.057 175.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -164.24 133.46 3.79 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.01 -0.995 . . . . 3.06 108.87 176.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.524 HG22 HG11 ' A' ' 94' ' ' VAL . 24.2 p -93.04 142.84 26.85 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.156 -1.018 . . . . 1.06 110.902 168.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' HB3' HG21 ' A' ' 72' ' ' VAL . 6.1 tp10 -112.53 138.0 49.93 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.115 -0.948 . . . . 1.14 109.59 -175.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.446 ' HA ' HD13 ' A' ' 71' ' ' LEU . 5.3 m-20 -74.46 107.96 6.93 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.336 -0.393 . . . . 1.77 110.666 -175.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.8 p -54.69 -23.02 15.67 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.898 -0.592 . . . . 1.28 112.473 -175.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -73.78 -33.31 64.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.046 -0.262 . . . . 3.21 110.951 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -134.45 58.14 1.78 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.813 0.815 . . . . 2.83 111.409 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.4 mt -65.05 157.73 27.61 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.782 -1.099 . . . . 1.8 111.517 177.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.66 154.68 36.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.947 -1.024 . . . . 1.81 108.675 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -65.71 -26.58 67.82 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.587 -0.445 . . . . 3.71 109.971 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.514 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -65.07 -38.17 95.05 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.47 -0.652 . . . . 0.41 111.47 174.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.507 ' HA ' HD21 ' A' ' 57' ' ' LEU . 27.9 m -76.72 -43.76 36.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.38 . . . . 1.05 110.653 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.3 m -53.01 -34.43 56.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.651 -0.704 . . . . 1.06 109.937 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.81 -54.11 50.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.839 -1.073 . . . . 1.06 111.794 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.514 HD21 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -59.33 -44.14 92.64 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.434 0.635 . . . . 1.1 110.136 -177.247 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 54' ' ' THR . 36.1 mt -60.14 -42.83 95.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.898 -1.046 . . . . 1.07 110.116 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.16 -33.41 84.12 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.742 -0.663 . . . . 0.26 112.508 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.9 mt -64.12 -29.51 70.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.748 0.785 . . . . 1.15 110.497 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.449 ' CD1' HG22 ' A' ' 105' ' ' VAL . 6.0 mt -102.98 -0.78 30.4 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.68 -1.146 . . . . 1.1 110.668 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 68.26 31.64 5.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.993 -1.003 . . . . 2.46 111.071 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 58' ' ' LEU . 54.8 mt -80.08 148.68 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.811 -0.632 . . . . 1.07 110.551 177.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -97.21 118.64 34.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.293 0.568 . . . . 2.65 110.177 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.51 -38.57 52.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 1.07 111.2 -174.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.85 -22.5 70.29 Favored Glycine 0 CA--C 1.516 0.151 0 C-N-CA 120.989 -0.624 . . . . 0.57 112.683 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.29 -4.94 55.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.189 0.519 . . . . 0.86 110.709 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.13 138.59 55.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.293 0.568 . . . . 1.18 110.733 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -89.52 -86.07 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.044 -0.98 . . . . 2.47 112.289 -171.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.63 -102.35 0.15 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.293 0.479 . . . . 1.09 112.293 -173.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 46' ' ' ASP . 1.9 mm? -105.82 170.1 8.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.577 0.703 . . . . 1.03 111.15 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -122.89 170.53 13.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 106.724 -1.584 . . . . 1.03 106.724 167.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.49 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -136.78 142.75 13.93 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 119.838 -1.172 . . . . 0.37 111.567 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.527 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -106.42 129.28 54.43 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.14 -0.624 . . . . 1.12 110.02 174.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.22 55.39 6.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.0 -1.0 . . . . 1.85 111.198 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.49 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 58.7 m -88.62 144.0 26.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.628 -0.715 . . . . 1.12 111.071 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m -100.52 118.82 60.27 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.733 -0.667 . . . . 1.6 109.969 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.24 124.64 12.38 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.547 2.165 . . . . 0.7 111.85 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.2 mt -99.42 88.29 3.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.938 -0.573 . . . . 1.49 109.865 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.1 m -75.17 -40.04 59.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.876 -0.602 . . . . 1.79 110.225 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.6 m -93.98 117.0 36.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.364 -0.835 . . . . 2.13 110.676 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 42.4 mm -92.9 142.73 12.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.928 -0.578 . . . . 2.17 110.938 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.48 112.0 0.27 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.439 -0.664 . . . . 3.18 111.439 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t 56.54 49.69 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.797 0.808 . . . . 5.02 109.317 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.19 -61.71 4.43 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.356 -0.838 . . . . 4.93 111.793 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.19 101.72 0.16 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.001 -0.619 . . . . 3.64 112.063 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -64.15 -27.68 69.24 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.968 0.413 . . . . 6.1 110.803 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.6 p -81.25 6.12 15.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.911 -0.586 . . . . 4.78 111.264 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 41.2 t -112.44 129.7 56.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.389 -0.369 . . . . 1.99 110.427 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.8 t -134.54 28.29 3.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.032 -0.729 . . . . 2.07 109.032 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.421 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -149.25 -157.71 0.84 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.941 -1.027 . . . . 1.08 109.73 -177.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.15 126.06 30.34 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.028 0.442 . . . . 0.99 110.359 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.19 123.1 44.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.265 0.555 . . . . 1.11 111.299 -171.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.524 HG11 HG22 ' A' ' 44' ' ' THR . 1.5 m -136.44 173.32 13.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.653 -0.703 . . . . 1.06 111.426 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 53.8 t -124.37 118.47 26.79 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.566 -0.743 . . . . 0.71 109.964 177.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 1.2 m -103.41 168.49 9.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.598 . . . . 0.61 111.921 -175.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.499 HG21 ' O ' ' A' ' 107' ' ' VAL . 9.0 t -87.04 -29.83 21.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.378 -0.828 . . . . 1.06 109.738 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.42 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.2 m120 -151.84 162.76 40.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.68 -0.691 . . . . 0.93 109.913 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 t -127.64 129.02 46.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.329 0.585 . . . . 1.18 109.87 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.424 ' CB ' HG23 ' A' ' 105' ' ' VAL . 30.0 m-85 -120.51 144.87 47.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.681 -0.69 . . . . 1.2 111.414 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.627 ' NE2' HD11 ' A' ' 104' ' ' LEU . 7.1 mm100 60.84 34.49 19.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.802 -0.635 . . . . 1.11 111.159 176.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 65.4 -0.86 1.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.756 -0.656 . . . . 2.63 112.415 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.46 -20.25 2.05 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.512 -0.851 . . . . 0.29 112.454 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.627 HD11 ' NE2' ' A' ' 101' ' ' GLN . 28.5 mt -49.77 -40.89 42.84 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.725 0.298 . . . . 1.14 111.085 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -130.15 119.3 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.547 0.689 . . . . 1.51 110.489 174.077 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.469 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 2.8 t30 -111.21 144.18 40.78 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.348 -0.982 . . . . 1.24 108.348 177.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.499 ' O ' HG21 ' A' ' 97' ' ' THR . 5.9 m -127.13 137.75 56.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 113.113 0.782 . . . . 1.09 113.113 -174.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 70.9 51.44 19.16 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.999 -1.001 . . . . 0.24 111.975 176.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 1.5 m -97.06 131.83 43.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.346 0.593 . . . . 0.43 111.502 -177.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.8 p -116.65 141.42 28.08 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.058 -0.974 . . . . 1.16 109.594 174.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.522 ' HA ' HG13 ' A' ' 94' ' ' VAL . 24.5 Cg_exo -67.42 108.38 1.58 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.717 2.278 . . . . 0.42 111.803 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.4 tt -85.1 100.34 8.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 1.21 110.466 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -95.65 99.87 11.67 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.553 -0.749 . . . . 3.02 110.494 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.29 -10.75 13.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.61 -0.723 . . . . 2.28 111.81 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.69 17.0 80.0 Favored Glycine 0 C--O 1.228 -0.248 0 C-N-CA 121.217 -0.516 . . . . 2.61 112.141 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.3 tp . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.827 -0.606 . . . . 4.15 109.742 -176.999 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.4 tptp . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.78 0.324 . . . . 30.52 110.327 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.5 81.05 6.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.907 0.384 . . . . 28.11 110.397 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.38 125.78 27.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.025 -0.534 . . . . 28.72 110.235 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.21 136.2 41.59 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.786 -0.643 . . . . 26.8 109.983 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -85.55 66.0 9.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.181 0.515 . . . . 25.36 110.563 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.0 mt -95.23 103.89 15.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.73 -0.668 . . . . 25.15 109.472 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.63 23.21 4.26 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.463 -0.875 . . . . 23.13 112.497 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.1 m -57.05 132.36 52.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.762 0.315 . . . . 22.94 111.037 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.6 m -78.86 84.06 4.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.191 0.519 . . . . 22.43 109.91 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.81 62.29 7.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.821 -0.627 . . . . 21.22 111.193 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.56 126.96 3.67 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.877 -0.601 . . . . 19.19 110.432 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.91 55.48 4.44 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.816 2.344 . . . . 18.61 112.072 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -80.54 -18.14 49.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.744 -0.662 . . . . 18.57 110.395 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -127.06 86.58 2.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.603 -0.726 . . . . 14.82 109.185 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.85 138.56 31.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.992 -0.549 . . . . 13.37 110.586 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -121.69 75.09 1.17 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.074 -0.512 . . . . 12.77 110.032 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.13 -59.02 4.93 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.737 -0.744 . . . . 10.27 111.661 -177.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.3 151.99 17.93 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.594 -0.602 . . . . 8.25 111.594 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.452 HG22 ' HD2' ' A' ' 30' ' ' PRO . 2.5 m -66.42 131.38 94.22 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 119.668 -0.206 . . . . 7.56 110.57 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.448 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 82.2 Cg_exo -42.19 -51.89 4.53 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.318 2.679 . . . . 6.56 114.475 -176.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 28' ' ' THR . 6.2 Cg_endo -88.33 16.3 1.9 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.726 2.284 . . . . 5.71 111.545 -176.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp 71.33 -59.92 0.53 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.185 -0.916 . . . . 4.21 110.363 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.8 p -77.46 165.28 24.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.196 -0.456 . . . . 2.12 110.394 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 17.1 m -79.19 156.8 28.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.029 -0.532 . . . . 1.77 110.951 -174.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -89.8 -11.72 41.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.299 0.571 . . . . 2.81 110.465 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.1 p -104.45 5.0 33.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.797 -0.638 . . . . 2.8 110.79 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . 159.61 175.29 30.41 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.173 -0.771 . . . . 1.82 111.173 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' CB ' ' HA ' ' A' ' 80' ' ' SER . 13.4 Cg_exo -72.35 -165.12 0.2 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.381 2.054 . . . . 1.43 112.296 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.43 HG11 ' N ' ' A' ' 39' ' ' TYR . 92.1 t -86.77 161.45 2.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.306 -0.257 . . . . 1.18 110.306 -174.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.43 ' N ' HG11 ' A' ' 38' ' ' VAL . 29.3 m-85 -127.96 135.69 50.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.135 0.493 . . . . 1.17 110.701 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.424 ' HB2' HD13 ' A' ' 79' ' ' LEU . 17.7 t -103.43 107.53 18.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.942 -0.572 . . . . 0.82 109.721 177.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -102.46 130.79 49.37 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.804 -0.443 . . . . 0.25 109.804 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.524 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 18.3 m120 -57.54 -29.72 64.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.583 -0.735 . . . . 2.35 109.749 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 8.3 mmmm -162.86 132.23 4.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.443 -1.253 . . . . 3.06 108.013 175.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.501 HG21 HG13 ' A' ' 94' ' ' VAL . 28.1 p -88.86 167.21 13.43 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.36 -0.936 . . . . 1.06 110.101 169.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -126.49 139.07 53.51 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.504 -0.771 . . . . 1.14 109.424 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' HD12 ' A' ' 50' ' ' LEU . 11.1 m-20 -71.26 111.66 6.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.057 -0.52 . . . . 1.77 110.519 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.521 ' HB3' ' CB ' ' A' ' 68' ' ' LEU . 6.1 m -60.15 -10.45 4.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.803 -0.635 . . . . 1.28 112.603 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -90.02 -17.56 27.61 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.669 -0.412 . . . . 3.21 110.338 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -149.53 57.92 1.0 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.328 -0.397 . . . . 2.83 111.136 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.482 HD11 ' CG1' ' A' ' 72' ' ' VAL . 2.0 mm? -60.26 150.7 29.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.267 0.556 . . . . 1.8 111.679 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.91 146.35 54.82 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.079 -1.082 . . . . 1.81 108.079 170.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -60.4 -28.13 68.0 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.499 -0.481 . . . . 3.71 110.463 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.524 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -66.7 -35.95 90.56 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.866 -0.683 . . . . 0.41 111.417 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.579 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 22.7 m -79.06 -42.94 25.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 1.05 110.411 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.2 m -53.94 -33.69 57.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.325 0.583 . . . . 1.06 110.126 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.559 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.31 -53.81 53.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.167 -0.924 . . . . 1.06 111.285 175.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.524 HD22 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -60.69 -44.25 96.76 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.441 0.639 . . . . 1.1 110.013 -179.129 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 54' ' ' THR . 53.0 mt -59.35 -43.22 92.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.001 -0.999 . . . . 1.07 110.145 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.62 -36.97 92.67 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.906 -0.664 . . . . 0.26 112.439 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.2 mt -60.24 -46.78 88.62 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.878 0.847 . . . . 1.15 109.903 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 mt -85.71 2.75 44.13 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.364 -1.289 . . . . 1.1 111.405 -175.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 65.5 35.35 7.32 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.486 -0.779 . . . . 2.46 111.534 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.2 mt -88.0 147.25 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.551 -0.75 . . . . 1.07 110.043 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.494 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -100.41 117.67 35.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.319 0.581 . . . . 2.65 110.369 -178.427 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.73 -41.99 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.313 -0.858 . . . . 1.07 111.449 -174.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.58 -7.15 68.19 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.857 -0.687 . . . . 0.57 112.991 -176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.478 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 21.0 t70 -103.81 -16.76 15.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.86 110.712 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.521 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 95.4 mt -55.5 147.81 16.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.881 -0.6 . . . . 1.18 111.626 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -95.32 -85.89 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.159 -0.928 . . . . 2.47 112.026 -172.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.27 -101.56 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.873 0.324 . . . . 1.09 111.873 -174.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.5 mm? -110.52 169.3 8.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.403 0.621 . . . . 1.03 111.216 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.482 ' CG1' HD11 ' A' ' 50' ' ' LEU . 1.5 m -121.07 163.72 18.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 106.058 -1.83 . . . . 1.03 106.058 166.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.57 142.18 13.65 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 119.818 -1.182 . . . . 0.37 111.38 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.586 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -115.4 135.17 54.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.049 -0.661 . . . . 1.12 110.4 178.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.431 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 1.4 t-20 54.79 47.54 22.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.522 -1.217 . . . . 1.85 110.904 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 24.5 m -85.41 150.06 24.99 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.177 -0.92 . . . . 1.12 110.554 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.0 m -100.42 117.18 63.44 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.623 -0.717 . . . . 1.6 109.75 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -64.78 130.68 26.85 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.646 2.23 . . . . 0.7 112.293 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.424 HD13 ' HB2' ' A' ' 40' ' ' CYS . 33.8 mt -106.86 87.82 2.6 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.509 -0.769 . . . . 1.49 109.371 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.401 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 11.9 p -79.8 -24.1 41.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.02 -0.536 . . . . 1.79 111.45 -173.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.3 m -114.89 106.92 21.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.598 0.713 . . . . 2.13 111.3 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.73 141.7 14.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.595 -0.73 . . . . 2.17 110.545 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.26 -119.38 5.51 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.773 -0.727 . . . . 3.18 111.698 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.0 m -59.57 -38.3 74.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.831 0.348 . . . . 5.02 111.399 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -80.43 -9.35 86.6 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.767 -0.73 . . . . 4.93 112.451 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.27 -15.05 81.91 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.886 -0.674 . . . . 3.64 112.115 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -70.48 -8.76 53.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.939 0.4 . . . . 6.1 110.929 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.7 p -68.49 -22.84 64.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 4.78 110.553 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 29.1 t -77.1 122.79 25.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 1.99 110.082 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.3 t -127.06 24.52 6.37 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.001 -0.74 . . . . 2.07 109.001 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.456 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -132.85 -158.3 0.88 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.339 -0.846 . . . . 1.08 110.408 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.98 112.88 18.79 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.772 0.796 . . . . 0.99 110.03 -177.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.86 121.11 32.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.215 -0.902 . . . . 1.11 110.447 -174.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.501 HG13 HG21 ' A' ' 44' ' ' THR . 13.6 m -133.15 162.81 39.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.458 0.646 . . . . 1.06 112.129 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 37.6 t -112.24 114.02 26.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.92 -1.036 . . . . 0.71 109.156 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.3 m -108.48 146.67 32.81 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.442 -0.344 . . . . 0.61 110.318 -174.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.9 t -76.45 -26.77 55.77 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.279 -0.419 . . . . 1.06 110.668 -173.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.593 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.2 m120 -147.03 155.05 41.92 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.131 -0.692 . . . . 0.93 109.131 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.2 t -132.58 132.82 42.94 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.122 0.487 . . . . 1.18 110.42 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -130.7 156.72 44.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.832 -0.622 . . . . 1.2 110.48 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.637 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 12.8 mm100 60.34 28.96 18.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.79 -0.641 . . . . 1.11 111.992 174.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 66.37 -1.02 1.33 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.217 0.607 . . . . 2.63 112.535 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 142.64 -14.97 2.45 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.441 -0.885 . . . . 0.29 112.161 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 40.8 mt -54.19 -36.89 63.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.994 0.426 . . . . 1.14 110.562 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 t -139.3 121.54 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.359 -0.837 . . . . 1.51 110.549 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.429 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 95.0 m-20 -124.08 160.4 27.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.641 -0.708 . . . . 1.24 109.227 174.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.593 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 5.5 m -134.97 151.51 31.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 111.833 0.309 . . . . 1.09 111.833 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.585 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.48 54.66 35.31 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.597 -0.729 . . . . 0.24 111.439 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 76.4 m -97.2 125.88 42.02 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.72 0.295 . . . . 0.43 111.29 -175.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 p -118.28 125.65 27.74 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.169 -0.469 . . . . 1.16 110.395 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.492 ' HA ' HG12 ' A' ' 94' ' ' VAL . 68.3 Cg_exo -51.59 109.96 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.255 2.637 . . . . 0.42 112.953 178.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 tt -103.25 139.84 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.632 -0.713 . . . . 1.21 110.271 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -103.2 110.6 22.62 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.923 -0.399 . . . . 3.02 109.923 175.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.2 pp -77.12 -13.16 14.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.984 -0.553 . . . . 2.28 112.385 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.65 19.72 79.29 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.894 -0.669 . . . . 2.61 113.165 175.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 21.8 mt . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.894 -0.574 . . . . 4.15 109.709 176.546 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.2 mttp . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.643 0.259 . . . . 30.52 110.324 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.2 34.47 5.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.072 0.463 . . . . 28.11 110.305 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.2 ttt -75.35 -47.28 28.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.005 -0.543 . . . . 28.72 110.103 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.43 21.04 0.99 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.077 -0.51 . . . . 26.8 110.899 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.06 -34.8 78.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.762 -0.654 . . . . 25.36 111.328 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.415 HD11 ' N ' ' A' ' 15' ' ' ILE . 3.0 mp -70.53 -29.32 38.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.778 -0.646 . . . . 25.15 110.603 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.91 -66.87 0.66 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.958 -0.857 . . . . 23.13 110.958 -175.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -92.88 46.01 1.21 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.046 -0.353 . . . . 22.94 110.046 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.5 m -64.54 111.85 2.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 22.43 110.824 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -158.35 163.66 37.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.807 -0.633 . . . . 21.22 109.647 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.0 m -119.73 76.98 20.91 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 121.095 0.474 . . . . 19.19 110.979 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.69 107.23 2.42 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.702 2.268 . . . . 18.61 111.758 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -83.12 69.59 9.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.394 0.616 . . . . 18.57 109.537 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -154.37 137.78 15.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.472 -0.786 . . . . 14.82 109.796 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.78 126.38 59.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.44 -0.345 . . . . 13.37 110.251 -178.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -82.31 -31.52 29.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.219 -0.446 . . . . 12.77 110.069 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 160.36 -138.08 5.35 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.697 -0.763 . . . . 10.27 112.526 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.3 42.89 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.459 -0.657 . . . . 8.25 111.459 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.568 ' C ' ' HD3' ' A' ' 30' ' ' PRO . 86.6 m -157.18 140.72 11.31 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 110.041 -0.355 . . . . 7.56 110.041 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -102.5 73.3 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.845 3.03 . . . . 6.56 113.71 171.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.568 ' HD3' ' C ' ' A' ' 28' ' ' THR . 17.3 Cg_exo -67.38 -18.31 49.71 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.228 1.952 . . . . 5.71 112.148 175.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -138.65 130.95 28.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.927 -0.578 . . . . 4.21 110.533 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 p -165.51 178.0 7.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.224 -0.444 . . . . 2.12 110.163 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 59.1 m -106.04 119.62 39.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.087 0.47 . . . . 1.77 111.42 -174.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 t -71.98 -26.15 62.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.245 0.545 . . . . 2.81 109.962 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.9 p -72.56 -13.9 61.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.549 -0.75 . . . . 2.8 111.691 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . 165.81 158.32 10.72 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.685 -0.769 . . . . 1.82 112.478 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.525 ' HB3' ' HA ' ' A' ' 80' ' ' SER . 1.1 Cg_endo -47.41 153.77 1.82 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.836 3.024 . . . . 1.43 113.235 175.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.9 t -85.5 157.19 3.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.256 -1.016 . . . . 1.18 108.256 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.91 131.21 47.55 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.384 0.611 . . . . 1.17 110.823 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.406 ' HB2' HD11 ' A' ' 79' ' ' LEU . 14.4 t -99.43 107.17 19.32 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.382 -0.826 . . . . 0.82 109.692 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.4 m -104.34 129.64 52.22 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.012 -0.54 . . . . 0.25 109.819 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.469 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 18.4 m120 -55.46 -25.59 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.473 -0.785 . . . . 2.35 110.42 176.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 1.8 mmmm -168.85 124.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.243 -1.344 . . . . 3.06 108.223 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.525 HG21 HG12 ' A' ' 94' ' ' VAL . 16.8 p -79.61 157.51 27.29 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.493 -0.883 . . . . 1.06 110.713 171.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.473 ' CB ' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.34 146.21 42.62 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.268 -0.878 . . . . 1.14 108.957 -176.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.06 108.74 14.99 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.227 -0.442 . . . . 1.77 111.115 -173.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.515 ' HA ' HD22 ' A' ' 50' ' ' LEU . 27.5 m -57.68 -12.3 2.81 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.084 0.772 . . . . 1.28 113.084 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -90.32 -25.56 20.43 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.882 -0.327 . . . . 3.21 110.644 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -145.92 60.54 1.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.503 -0.317 . . . . 2.83 111.299 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.515 HD22 ' HA ' ' A' ' 47' ' ' SER . 2.9 mm? -60.7 147.26 42.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.763 0.792 . . . . 1.8 111.784 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -68.02 153.11 44.42 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.235 -1.348 . . . . 1.81 109.814 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.572 ' HD3' ' N ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -62.86 -26.6 68.85 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.056 -0.258 . . . . 3.71 111.18 178.538 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.572 ' N ' ' HD3' ' A' ' 52' ' ' LYS . . . -69.51 -37.41 78.41 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.489 -0.863 . . . . 0.41 111.332 177.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.53 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 26.1 m -80.98 -43.3 19.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.919 -0.4 . . . . 1.05 109.919 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.9 m -52.88 -34.8 56.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.539 -0.755 . . . . 1.06 110.233 173.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.539 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.34 -51.99 66.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.435 -0.802 . . . . 1.06 111.34 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.503 HD23 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -61.55 -44.77 96.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.407 0.623 . . . . 1.1 109.893 -179.62 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 54' ' ' THR . 58.5 mt -58.0 -45.12 87.36 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.867 -1.061 . . . . 1.07 110.162 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.06 -37.06 92.2 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.793 -0.64 . . . . 0.26 112.471 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.6 mt -60.19 -47.38 86.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.502 0.668 . . . . 1.15 110.303 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.408 ' CD1' HG22 ' A' ' 105' ' ' VAL . 2.9 mt -84.56 -2.33 57.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.857 -1.065 . . . . 1.1 111.343 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 69.76 37.75 1.79 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.939 0.876 . . . . 2.46 110.664 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.435 HD13 ' HA ' ' A' ' 58' ' ' LEU . 56.1 mt -85.25 145.82 7.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.713 -0.676 . . . . 1.07 110.173 175.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.59 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -96.34 117.89 31.76 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.68 -0.691 . . . . 2.65 109.937 -178.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.403 HG23 HD23 ' A' ' 50' ' ' LEU . 1.8 mp -73.34 -40.18 56.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.509 -0.769 . . . . 1.07 111.049 -174.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.83 -9.87 63.42 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.976 -0.63 . . . . 0.57 113.055 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -109.15 4.61 23.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 0.86 110.903 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 98.3 mt -74.53 142.89 44.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.336 -0.393 . . . . 1.18 110.437 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -96.42 -94.64 0.2 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.683 0.623 . . . . 2.47 112.683 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.75 -99.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.17 0.433 . . . . 1.09 112.17 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.26 164.26 14.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.468 0.652 . . . . 1.03 110.928 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.574 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -115.4 172.16 4.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 106.162 -1.792 . . . . 1.03 106.162 168.512 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.82 138.8 9.16 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.933 -1.127 . . . . 0.37 111.113 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -111.41 132.22 54.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.532 -0.867 . . . . 1.12 110.499 176.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.42 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 2.1 t-20 58.23 46.57 15.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.49 -1.232 . . . . 1.85 110.747 175.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 35.4 m -83.72 142.11 30.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.524 -0.762 . . . . 1.12 111.096 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -88.27 116.38 66.06 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.568 -0.742 . . . . 1.6 109.375 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.15 122.2 9.25 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.792 2.328 . . . . 0.7 112.876 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.406 HD11 ' HB2' ' A' ' 40' ' ' CYS . 11.9 mt -107.59 88.52 2.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.434 -0.803 . . . . 1.49 109.21 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.525 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 58.0 p -98.37 -50.54 4.28 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.606 -0.27 . . . . 1.79 110.745 -177.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 m -95.27 101.39 12.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.523 0.678 . . . . 2.13 110.515 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.2 mt -116.76 139.81 41.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.859 -0.609 . . . . 2.17 111.047 -176.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -164.49 -115.71 0.34 Allowed Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 111.179 -0.768 . . . . 3.18 111.179 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.5 t -72.89 -30.92 34.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.358 0.599 . . . . 5.02 109.416 175.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -106.72 -93.94 2.33 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.279 -0.873 . . . . 4.93 111.309 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.82 56.49 2.6 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.757 -0.735 . . . . 3.64 112.156 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.8 m120 64.67 -170.63 0.19 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.898 0.38 . . . . 6.1 110.595 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.0 m -121.52 74.51 1.12 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.4 -0.363 . . . . 4.78 110.363 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.545 ' SG ' HG22 ' A' ' 93' ' ' THR . 22.2 t -77.91 93.54 4.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.229 0.538 . . . . 1.99 110.445 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 m -103.57 23.99 11.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.897 -0.592 . . . . 2.07 109.897 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -134.97 -159.12 0.93 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.668 -0.696 . . . . 1.08 110.802 -177.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.79 120.22 23.76 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.289 0.566 . . . . 0.99 110.428 -176.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.545 HG22 ' SG ' ' A' ' 89' ' ' CYS . 0.2 OUTLIER -94.37 117.21 29.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.9 -0.591 . . . . 1.11 110.892 -175.043 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.525 HG12 HG21 ' A' ' 44' ' ' THR . 2.9 m -129.29 164.35 32.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.736 -0.666 . . . . 1.06 111.583 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 49.3 t -118.32 110.95 18.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.376 -0.829 . . . . 0.71 109.461 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 106' ' ' ASN . 1.3 m -92.34 166.16 12.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.309 0.576 . . . . 0.61 111.483 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.9 t -90.95 -24.23 20.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.346 -0.843 . . . . 1.06 109.406 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -156.68 166.86 32.18 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.346 -0.843 . . . . 0.93 109.183 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.6 t -138.99 143.19 38.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.991 0.424 . . . . 1.18 110.403 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.403 ' HB2' HG23 ' A' ' 105' ' ' VAL . 83.8 m-85 -126.78 149.48 49.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.048 -0.524 . . . . 1.2 109.609 176.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.418 HE21 ' HB3' ' A' ' 101' ' ' GLN . 8.1 mm100 64.67 24.62 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 1.11 111.361 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 64.4 6.04 2.89 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.602 -0.726 . . . . 2.63 112.357 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.15 -20.14 1.39 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.905 -1.14 . . . . 0.29 113.552 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.1 mt -56.45 -37.3 70.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.619 0.71 . . . . 1.14 111.419 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.408 HG22 ' CD1' ' A' ' 61' ' ' LEU . 0.2 OUTLIER -142.79 118.87 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.58 0.705 . . . . 1.51 110.938 175.489 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.702 ' HB3' ' SG ' ' A' ' 96' ' ' CYS . 7.4 m-20 -115.37 162.33 17.28 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.234 -0.894 . . . . 1.24 109.528 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.0 m -133.64 142.46 41.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.549 0.574 . . . . 1.09 112.549 -175.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 66.78 53.09 29.35 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.094 -0.957 . . . . 0.24 112.254 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 1.3 m -96.65 129.83 43.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.394 0.616 . . . . 0.43 111.568 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.0 p -118.45 124.99 28.12 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.774 -1.103 . . . . 1.16 109.743 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.491 ' HA ' HG11 ' A' ' 94' ' ' VAL . 84.9 Cg_exo -47.91 112.28 0.55 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.405 2.737 . . . . 0.42 113.012 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.2 tt -115.69 134.69 58.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.54 -0.755 . . . . 1.21 110.519 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -97.35 99.62 11.06 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.171 -0.677 . . . . 3.02 109.171 171.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.446 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 2.7 pp -72.46 -3.02 3.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.479 0.657 . . . . 2.28 110.903 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 143.12 -25.75 2.2 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 109.067 -1.613 . . . . 2.61 109.067 -173.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 C--O 1.248 0.976 0 CA-C-N 114.771 -0.715 . . . . 4.15 109.595 176.189 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.7 0.286 . . . . 30.52 110.272 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 57.83 40.98 25.56 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.758 -0.656 . . . . 28.11 111.878 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 93.8 mmm 61.29 61.62 1.51 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.914 -0.585 . . . . 28.72 110.93 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.94 -29.17 58.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.888 -0.596 . . . . 26.8 110.414 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.52 147.68 39.05 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.356 -0.609 . . . . 25.36 109.356 175.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 15' ' ' ILE . 4.1 mp -119.15 63.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.758 0.79 . . . . 25.15 109.42 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.63 37.79 2.17 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.503 -0.771 . . . . 23.13 112.745 175.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 21' ' ' PRO . 49.0 m -96.37 103.56 15.47 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.886 0.375 . . . . 22.94 110.619 178.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.5 p -74.67 118.66 17.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.063 -0.517 . . . . 22.43 110.772 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 71.43 -67.39 0.26 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.587 -0.733 . . . . 21.22 111.548 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.0 m -130.44 140.63 39.23 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 120.804 0.335 . . . . 19.19 110.978 -177.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.412 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 85.2 Cg_endo -83.28 48.39 2.67 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.911 2.408 . . . . 18.61 112.312 177.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.518 ' HA ' ' OD1' ' A' ' 113' ' ' ASN . 43.4 ttp180 -89.19 96.48 10.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.3 -0.409 . . . . 18.57 110.864 -177.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 59.88 30.2 19.74 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.632 -0.713 . . . . 14.82 112.263 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.1 t -71.17 -41.25 75.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.014 -0.736 . . . . 13.37 109.014 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -124.43 11.04 8.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.159 -0.928 . . . . 12.77 109.65 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.01 -106.23 0.4 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.465 -0.789 . . . . 10.27 112.138 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.5 116.38 2.7 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.769 -0.729 . . . . 8.25 112.274 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.52 HG21 ' HD2' ' A' ' 30' ' ' PRO . 2.2 m 70.25 120.44 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 123.352 0.661 . . . . 7.56 111.136 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.415 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 88.5 Cg_exo -43.42 -45.03 10.45 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.906 3.737 . . . . 6.56 116.225 -174.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.52 ' HD2' HG21 ' A' ' 28' ' ' THR . 13.9 Cg_exo -67.63 102.06 0.7 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.696 1.598 . . . . 5.71 111.683 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 32.7 mmtp -102.14 4.15 39.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.997 -0.547 . . . . 4.21 110.416 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.1 t -71.48 170.35 13.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.964 -0.562 . . . . 2.12 110.796 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 59.4 m -106.1 150.1 26.11 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.558 -0.746 . . . . 1.77 109.987 -177.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.1 p -85.36 -12.03 53.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.047 0.451 . . . . 2.81 110.578 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 t -95.29 21.06 8.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.494 0.664 . . . . 2.8 109.981 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . 135.42 150.1 5.94 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.229 -0.749 . . . . 1.82 111.229 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.583 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 74.0 Cg_endo -71.01 -159.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.519 2.146 . . . . 1.43 112.98 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.426 HG11 ' N ' ' A' ' 39' ' ' TYR . 38.8 t -80.29 162.56 3.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.009 -0.541 . . . . 1.18 110.236 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.583 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 94.9 m-85 -137.35 135.89 37.44 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.933 0.396 . . . . 1.17 110.259 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.796 ' SG ' ' HB2' ' A' ' 77' ' ' SER . 22.1 p -104.04 102.55 12.31 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.869 0.842 . . . . 0.82 110.411 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.8 m -100.21 128.98 46.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.104 -0.953 . . . . 0.25 109.037 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 49.3 m-80 -57.6 -23.44 50.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.566 0.698 . . . . 2.35 110.47 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.566 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -161.61 128.96 4.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.31 -1.314 . . . . 3.06 107.902 176.339 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.502 HG23 HG11 ' A' ' 94' ' ' VAL . 23.0 p -87.46 155.24 20.1 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.151 -1.02 . . . . 1.06 109.769 167.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.457 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.2 tp10 -120.09 133.84 55.41 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.503 -0.771 . . . . 1.14 109.545 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.47 ' HA ' HD12 ' A' ' 71' ' ' LEU . 15.4 m-20 -69.83 112.62 6.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.507 -0.769 . . . . 1.77 109.788 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.5 p -52.67 -27.9 19.31 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.781 0.676 . . . . 1.28 112.183 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.461 ' HZ1' ' HB3' ' A' ' 48' ' ' LYS . 1.3 mmmp? -89.45 -10.59 45.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.69 0.281 . . . . 3.21 111.519 -178.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 46' ' ' ASP . 58.9 m-70 -127.79 34.29 4.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.739 0.304 . . . . 2.83 111.088 -177.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.405 HD21 ' HG3' ' A' ' 45' ' ' GLU . 96.0 mt -67.46 145.48 54.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.153 0.501 . . . . 1.8 111.668 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -86.79 169.55 12.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.382 -0.826 . . . . 1.81 109.71 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.71 -41.94 99.4 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.9 -0.32 . . . . 3.71 110.72 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.54 ' O ' HD21 ' A' ' 57' ' ' LEU . . . -55.85 -42.28 85.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.308 -0.472 . . . . 0.41 112.969 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.527 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 86.9 m -82.6 -42.05 18.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.733 0.267 . . . . 1.05 111.121 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.3 m -54.5 -33.39 59.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.211 0.529 . . . . 1.06 110.074 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.573 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.57 -54.94 41.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.13 -0.941 . . . . 1.06 111.703 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.54 HD21 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -56.39 -47.16 79.52 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.494 0.664 . . . . 1.1 110.057 -178.164 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 54' ' ' THR . 34.2 mt -57.95 -43.69 86.54 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.738 -1.119 . . . . 1.07 110.169 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.19 -36.62 93.25 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.835 -0.698 . . . . 0.26 112.395 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 19.8 mt -62.68 -44.71 95.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.875 0.845 . . . . 1.15 109.939 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.414 ' CD1' HG21 ' A' ' 105' ' ' VAL . 6.1 mt -87.16 1.48 52.92 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.459 -1.246 . . . . 1.1 111.411 -175.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 69.24 27.5 5.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.702 -0.681 . . . . 2.46 111.628 174.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 58' ' ' LEU . 56.8 mt -78.69 142.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.953 -0.567 . . . . 1.07 110.291 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -90.07 117.84 29.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.846 -0.615 . . . . 2.65 110.058 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.27 -36.94 50.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.89 -0.596 . . . . 1.07 109.809 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.2 -10.48 84.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.57 112.511 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -101.83 -9.65 20.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.036 0.446 . . . . 0.86 110.733 178.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 64' ' ' LYS . 89.1 mt -55.71 134.99 51.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.261 0.553 . . . . 1.18 110.538 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 3.4 mptp? -82.35 -51.15 8.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.093 -0.958 . . . . 2.47 112.25 -169.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 1.1 t70 -139.37 -82.45 0.28 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.608 -0.437 . . . . 1.09 110.843 -178.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.4 mm? -114.44 173.95 6.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.383 0.611 . . . . 1.03 110.722 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 45' ' ' GLU . 1.2 m -121.92 166.1 16.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 106.62 -1.622 . . . . 1.03 106.62 164.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.1 126.16 3.6 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.806 -1.188 . . . . 0.37 112.055 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -99.58 139.59 35.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.11 -0.636 . . . . 1.12 110.018 -178.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 50.17 55.42 9.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.113 0.959 . . . . 1.85 109.889 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.583 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 20.9 t -105.4 146.77 29.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.043 -1.435 . . . . 1.12 110.198 -171.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.796 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 19.8 m -103.6 139.56 20.23 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 120.528 -0.469 . . . . 1.6 110.265 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.425 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 6.1 Cg_exo -80.45 119.84 3.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.614 2.209 . . . . 0.7 112.472 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.643 HD11 ' SG ' ' A' ' 40' ' ' CYS . 5.6 mp -97.13 87.02 4.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.224 -0.658 . . . . 1.49 109.224 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.416 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 23.8 p -77.81 -34.04 52.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.085 -0.507 . . . . 1.79 111.035 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.6 m -103.31 125.75 57.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.205 0.526 . . . . 2.13 110.481 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.5 mm -83.34 137.87 20.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.008 -0.542 . . . . 2.17 110.17 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.77 -102.26 1.29 Allowed Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.984 -0.846 . . . . 3.18 110.984 -176.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 m -62.91 103.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.253 0.549 . . . . 5.02 111.008 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.58 19.71 79.01 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.816 -0.707 . . . . 4.93 111.714 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.89 -42.22 1.13 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.901 -0.666 . . . . 3.64 112.03 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -91.47 -21.08 21.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.118 0.485 . . . . 6.1 110.414 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 p -140.0 113.5 8.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.561 -0.745 . . . . 4.78 109.333 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.454 ' SG ' HD11 ' A' ' 79' ' ' LEU . 24.9 t -123.54 19.86 9.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.331 -0.395 . . . . 1.99 110.72 -175.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.5 m 65.63 0.69 1.52 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.872 -0.604 . . . . 2.07 111.545 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -140.25 172.58 12.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.179 -0.464 . . . . 1.08 109.851 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.35 130.57 41.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.096 0.474 . . . . 0.99 110.872 -174.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.2 120.18 37.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.47 0.652 . . . . 1.11 112.562 -172.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.519 HG13 ' HA ' ' A' ' 111' ' ' PRO . 5.5 m -134.65 168.3 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.024 -0.989 . . . . 1.06 110.043 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.8 t -116.97 117.89 30.91 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.122 -0.696 . . . . 0.71 109.122 177.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.0 m -111.19 151.26 28.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.925 0.393 . . . . 0.61 110.887 -172.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 t -81.09 -28.81 35.08 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.963 -0.562 . . . . 1.06 110.664 -173.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -155.06 156.98 36.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.588 -0.733 . . . . 0.93 109.11 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.9 t -136.18 144.62 45.06 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.048 -0.353 . . . . 1.18 110.048 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.487 ' HB2' HG22 ' A' ' 105' ' ' VAL . 67.3 m-85 -138.33 161.93 35.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.674 0.273 . . . . 1.2 110.915 -177.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.578 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 7.5 mm100 62.63 33.27 15.84 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.03 -0.532 . . . . 1.11 112.255 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 65.43 -0.31 1.21 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.843 0.457 . . . . 2.63 112.067 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.55 -13.41 3.71 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.483 -0.865 . . . . 0.29 112.883 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.622 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 22.5 mt -55.25 -36.51 66.14 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 117.358 0.579 . . . . 1.14 110.862 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.487 HG22 ' HB2' ' A' ' 100' ' ' TYR . 12.2 m -129.97 147.32 33.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.303 0.573 . . . . 1.51 110.529 174.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 4.2 t-20 -143.04 143.06 31.73 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.873 -1.158 . . . . 1.24 107.873 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 18.0 m -123.79 149.9 27.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 113.062 0.764 . . . . 1.09 113.062 -173.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 59.85 54.45 37.45 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 114.913 -1.04 . . . . 0.24 111.536 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 70' ' ' ASP . 74.8 m -97.92 123.5 41.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.757 0.313 . . . . 0.43 110.54 -173.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.3 p -118.95 126.82 26.87 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.817 -0.629 . . . . 1.16 110.91 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.519 ' HA ' HG13 ' A' ' 94' ' ' VAL . 54.2 Cg_exo -51.22 113.26 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.036 2.491 . . . . 0.42 112.141 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.8 tt -98.05 121.25 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.906 -0.588 . . . . 1.21 111.512 -175.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.518 ' OD1' ' HA ' ' A' ' 22' ' ' ARG . 26.3 t-20 -98.22 106.22 18.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.79 -0.641 . . . . 3.02 109.88 175.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.538 HD11 ' N ' ' A' ' 115' ' ' GLY . 1.4 pp -90.04 -19.75 7.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.362 -0.381 . . . . 2.28 111.002 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.538 ' N ' HD11 ' A' ' 114' ' ' ILE . . . 89.74 -19.34 41.77 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.781 -0.724 . . . . 2.61 114.357 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 116' ' ' LEU . 1.4 pt? . . . . . 0 C--O 1.244 0.771 0 CA-C-N 117.759 0.779 . . . . 4.15 110.88 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 110.061 -0.348 . . . . 30.52 110.061 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 71.19 -63.35 0.42 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.021 0.825 . . . . 28.11 112.105 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.436 ' HG2' ' H ' ' A' ' 14' ' ' ASP . 49.5 ttm -131.52 118.9 20.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.672 0.272 . . . . 28.72 110.306 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.05 24.05 9.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.752 0.311 . . . . 26.8 110.924 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.436 ' H ' ' HG2' ' A' ' 12' ' ' MET . 11.8 m-20 67.52 -80.72 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.37 -0.832 . . . . 25.36 111.569 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.0 pt -98.88 174.1 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.042 -0.527 . . . . 25.15 111.217 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.31 -166.45 14.19 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.321 -0.711 . . . . 23.13 111.321 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.5 t -117.02 25.19 10.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.507 0.67 . . . . 22.94 110.115 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 p -112.73 122.91 49.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.708 -0.678 . . . . 22.43 110.864 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 68.76 162.67 0.21 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.332 0.653 . . . . 21.22 111.417 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.97 111.26 65.24 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.857 -0.61 . . . . 19.19 110.532 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.68 114.18 3.02 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.832 2.355 . . . . 18.61 111.548 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -84.48 80.06 9.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.371 -0.377 . . . . 18.57 110.796 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.0 t70 69.32 -65.24 0.31 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.765 0.826 . . . . 14.82 110.717 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 p -136.93 125.15 33.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.228 -0.656 . . . . 13.37 109.228 175.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.457 HD21 ' H ' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -127.45 45.02 2.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.603 0.716 . . . . 12.77 111.057 -175.713 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -139.11 174.53 22.11 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.433 -0.803 . . . . 10.27 111.921 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.47 -176.86 14.59 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.308 -0.717 . . . . 8.25 111.308 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.432 ' OG1' ' HB ' ' A' ' 114' ' ' ILE . 5.1 m -82.28 125.3 77.06 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 117.019 0.41 . . . . 7.56 110.079 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -41.27 -51.07 4.18 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 124.188 3.258 . . . . 6.56 116.312 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.42 ' HD2' HG21 ' A' ' 28' ' ' THR . 2.0 Cg_endo -80.66 3.85 7.39 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.072 1.848 . . . . 5.71 113.165 -171.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -131.41 115.31 16.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.73 0.3 . . . . 4.21 110.728 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.5 t -175.11 -178.45 1.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 2.12 110.365 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.3 m -122.14 142.64 50.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.062 -0.517 . . . . 1.77 109.808 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -74.39 -6.68 49.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.955 0.407 . . . . 2.81 111.055 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.9 t -72.93 -25.53 61.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.115 -0.493 . . . . 2.8 110.604 177.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.03 -174.98 28.49 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.515 -0.85 . . . . 1.82 112.458 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HB3' ' HA ' ' A' ' 80' ' ' SER . 12.9 Cg_exo -41.46 149.75 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.282 3.321 . . . . 1.43 114.295 176.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 39' ' ' TYR . 96.7 t -78.83 161.04 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.914 -1.039 . . . . 1.18 108.744 174.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.431 ' N ' HG12 ' A' ' 38' ' ' VAL . 97.0 m-85 -123.98 141.05 52.38 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.483 0.659 . . . . 1.17 111.362 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 91' ' ' ALA . 49.5 t -113.16 111.24 21.76 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.272 -0.876 . . . . 0.82 109.993 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.2 m -107.69 133.11 52.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.095 0.474 . . . . 0.25 110.001 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -53.99 -26.48 26.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.173 -0.921 . . . . 2.35 110.559 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.463 ' HE2' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -173.32 123.26 0.38 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.896 -1.15 . . . . 3.06 107.896 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.521 HG22 HG13 ' A' ' 94' ' ' VAL . 12.5 p -78.66 154.98 29.72 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.466 -0.893 . . . . 1.06 110.727 172.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.424 ' HG3' HD22 ' A' ' 50' ' ' LEU . 7.8 tp10 -120.88 137.94 54.33 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.979 -0.749 . . . . 1.14 108.979 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.467 ' HA ' HD13 ' A' ' 71' ' ' LEU . 11.6 m-20 -75.32 107.98 7.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.942 -0.572 . . . . 1.77 109.91 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 m -47.18 -31.17 3.39 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.849 0.718 . . . . 1.28 111.987 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 11.4 mptt -68.17 -40.95 82.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.5 0.667 . . . . 3.21 110.638 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -124.36 51.89 1.55 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.14 -0.936 . . . . 2.83 110.934 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.424 HD22 ' HG3' ' A' ' 45' ' ' GLU . 82.0 mt -62.96 159.92 15.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.573 0.701 . . . . 1.8 112.215 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.8 146.85 23.33 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.722 -1.126 . . . . 1.81 109.059 175.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -59.37 -25.06 63.93 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.239 0.337 . . . . 3.71 110.949 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.536 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -68.62 -41.45 83.95 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.759 -0.734 . . . . 0.41 111.844 176.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.51 ' HA ' HD22 ' A' ' 57' ' ' LEU . 98.3 m -81.15 -42.98 20.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.761 0.315 . . . . 1.05 110.559 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.7 m -54.84 -32.51 60.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.912 -0.586 . . . . 1.06 110.188 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.472 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.58 -54.43 46.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.562 -0.744 . . . . 1.06 111.406 175.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.536 HD22 ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -58.44 -44.59 89.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.401 0.62 . . . . 1.1 110.147 -177.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.6 mt -58.9 -43.92 91.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.066 -0.97 . . . . 1.07 110.172 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.92 -35.79 91.04 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.928 -0.653 . . . . 0.26 112.537 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 16.9 mt -61.66 -39.81 92.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.751 0.786 . . . . 1.15 110.022 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.8 mt -91.61 2.06 56.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.7 -1.136 . . . . 1.1 111.085 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 68.28 30.12 5.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.85 0.833 . . . . 2.46 110.691 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.414 HD12 ' HA ' ' A' ' 58' ' ' LEU . 54.1 mt -80.93 141.62 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.78 -0.646 . . . . 1.07 110.262 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.75 118.96 31.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.818 -0.628 . . . . 2.65 110.062 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.05 -29.35 28.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.454 -0.794 . . . . 1.07 110.856 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.42 -18.02 78.08 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.72 -0.752 . . . . 0.57 112.46 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -88.03 -19.18 27.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.071 0.462 . . . . 0.86 110.393 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.33 126.36 27.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.488 -0.778 . . . . 1.18 110.986 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -91.27 -76.32 0.45 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.053 -0.976 . . . . 2.47 112.202 -172.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -90.11 -112.11 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.457 -0.338 . . . . 1.09 111.268 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.467 HD13 ' HA ' ' A' ' 46' ' ' ASP . 1.6 mm? -105.7 170.81 7.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.206 0.527 . . . . 1.03 111.182 176.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 106' ' ' ASN . 1.6 m -122.99 167.56 16.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 106.999 -1.482 . . . . 1.03 106.999 167.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.513 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -138.01 144.56 15.87 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.725 -1.226 . . . . 0.37 111.847 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.598 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -102.76 127.59 49.85 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.373 -0.531 . . . . 1.12 110.279 175.051 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.534 ' N ' HD21 ' A' ' 75' ' ' ASN . 0.8 OUTLIER 57.75 54.99 5.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.742 -1.117 . . . . 1.85 111.15 177.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.513 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 47.0 m -87.56 142.27 27.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.356 -0.838 . . . . 1.12 110.913 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 t -98.25 123.41 50.84 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.758 -0.656 . . . . 1.6 109.804 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.45 120.45 7.14 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.573 2.182 . . . . 0.7 112.123 175.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.3 mt -95.52 88.85 5.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.767 -0.651 . . . . 1.49 109.728 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.406 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 8.4 p -92.75 -46.32 7.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.853 -0.612 . . . . 1.79 111.724 -174.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.7 m -81.7 102.28 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.962 0.887 . . . . 2.13 111.303 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.7 mm -91.3 137.74 21.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.255 -0.884 . . . . 2.17 110.799 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.18 -43.07 3.18 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.706 -0.759 . . . . 3.18 111.718 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.8 t -79.14 79.85 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.887 -0.412 . . . . 5.02 109.887 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.99 62.05 4.23 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.692 -0.766 . . . . 4.93 111.624 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.7 -116.24 2.24 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.646 -0.787 . . . . 3.64 112.607 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 64.86 -86.7 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.291 0.636 . . . . 6.1 111.294 -176.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.0 p -108.23 166.03 11.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.772 0.32 . . . . 4.78 110.526 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 p -125.43 162.92 23.75 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.138 -0.69 . . . . 1.99 109.138 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.4 m -71.48 1.29 6.64 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.422 0.527 . . . . 2.07 112.422 -170.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -151.98 -157.14 0.77 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.564 0.221 . . . . 1.08 111.051 -176.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.77 130.65 37.98 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.64 -0.504 . . . . 0.99 109.64 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.65 123.42 47.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.331 0.586 . . . . 1.11 110.952 -173.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 44' ' ' THR . 6.1 m -134.61 166.41 28.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.634 -0.712 . . . . 1.06 111.647 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.5 t -110.73 116.48 31.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.317 -0.856 . . . . 0.71 108.965 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.642 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 16.1 m -118.63 150.15 40.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.835 0.35 . . . . 0.61 110.642 -171.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.4 t -78.13 -32.2 50.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.81 -0.632 . . . . 1.06 110.827 -173.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.433 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.6 m120 -155.72 163.48 39.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.862 -0.608 . . . . 0.93 109.715 -176.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -139.63 148.68 42.8 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.62 -0.511 . . . . 1.18 109.62 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.511 ' HB2' HG21 ' A' ' 105' ' ' VAL . 60.6 m-85 -134.56 154.39 51.49 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.469 -0.567 . . . . 1.2 109.469 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.538 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 8.4 mm100 64.91 29.46 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.335 0.397 . . . . 1.11 111.489 176.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.7 m170 63.96 11.5 6.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.951 -0.568 . . . . 2.63 111.991 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 132.23 -17.77 4.78 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.136 -1.031 . . . . 0.29 113.333 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.598 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 14.7 mt -50.55 -40.25 51.49 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.556 0.678 . . . . 1.14 110.742 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' ' 100' ' ' TYR . 4.3 m -127.05 142.63 42.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.656 -0.702 . . . . 1.51 109.698 171.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.448 ' ND2' ' SG ' ' A' ' 96' ' ' CYS . 24.1 t30 -138.61 143.57 39.38 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.15 -1.056 . . . . 1.24 108.15 -175.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.2 m -126.19 152.24 33.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 113.393 0.886 . . . . 1.09 113.393 -172.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.06 52.73 51.05 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.703 -1.135 . . . . 0.24 112.057 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' CYS . . . . . . . . . . . . . 93.7 m -96.65 126.72 42.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.951 0.405 . . . . 0.43 112.005 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -119.46 126.02 27.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.74 -0.664 . . . . 1.16 110.313 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.506 ' HA ' HG12 ' A' ' 94' ' ' VAL . 70.8 Cg_exo -51.33 110.08 0.38 Allowed 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.997 2.465 . . . . 0.42 112.417 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.9 tt -89.8 127.57 42.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 1.21 110.098 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -84.58 99.12 10.55 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.962 -0.755 . . . . 3.02 108.962 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.539 HD13 ' N ' ' A' ' 115' ' ' GLY . 1.4 pp -67.07 -23.86 31.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.025 -0.534 . . . . 2.28 112.41 -175.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.539 ' N ' HD13 ' A' ' 114' ' ' ILE . . . 51.33 29.91 24.01 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.244 -0.889 . . . . 2.61 114.009 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.48 -0.771 . . . . 4.15 110.248 -178.242 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 39' ' ' TYR . 92.9 t . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 108.375 -0.972 . . . . 0.58999999999999997 108.375 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.7 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 97.2 m-85 -130.63 139.68 50.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.478 0.656 . . . . 0.78000000000000003 111.601 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 36.9 t -107.9 98.64 8.19 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.166 -0.925 . . . . 0.81999999999999995 109.346 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.461 ' HB2' ' OE1' ' A' ' 92' ' ' GLN . 33.9 m -104.24 141.71 35.8 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.393 -0.595 . . . . 0.23999999999999999 109.393 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -59.63 -30.43 68.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.673 -0.694 . . . . 2.0800000000000001 110.769 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.17 123.46 0.98 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.644 -0.872 . . . . 2.5800000000000001 108.644 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.897 ' H ' HE22 ' A' ' 92' ' ' GLN . 1.5 p -86.65 127.99 34.97 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.814 -0.754 . . . . 0.37 110.433 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.67 ' HB3' HG22 ' A' ' 72' ' ' VAL . 8.8 tp10 -103.45 138.07 40.68 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.973 -1.012 . . . . 1.1200000000000001 109.649 -172.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.46 ' HA ' HD12 ' A' ' 71' ' ' LEU . 6.3 m-20 -65.01 107.44 1.51 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.235 -0.439 . . . . 1.77 111.015 -174.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.593 ' HA ' HD21 ' A' ' 50' ' ' LEU . 92.9 p -65.48 -6.38 10.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.88 -0.6 . . . . 0.92000000000000004 112.032 -174.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.497 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 3.6 mppt? -77.09 -38.63 51.94 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.434 0.635 . . . . 2.77 109.639 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -142.61 67.93 1.31 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.936 -1.029 . . . . 2.3300000000000001 110.988 -176.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.593 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -61.91 160.34 12.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.476 0.655 . . . . 1.1599999999999999 111.469 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -67.65 155.6 38.81 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.341 -0.985 . . . . 1.8100000000000001 108.341 171.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -28.93 70.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.418 0.553 . . . . 3.23 110.233 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -67.62 -38.18 89.98 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.801 -0.714 . . . . 0.34000000000000002 111.495 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.684 ' HA ' HD22 ' A' ' 57' ' ' LEU . 37.0 m -79.0 -41.36 29.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.995 0.426 . . . . 0.35999999999999999 110.119 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.2 m -54.71 -35.16 63.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.52 -0.764 . . . . 0.29999999999999999 109.851 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.19 -53.67 55.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.26 -0.882 . . . . 0.23000000000000001 111.537 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.684 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.42 -45.46 88.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.416 0.626 . . . . 0.23999999999999999 110.238 -178.539 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.5 mt -58.56 -43.31 89.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.954 -1.021 . . . . 0.17999999999999999 110.175 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.18 -36.91 93.1 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.77 -0.728 . . . . 0.26000000000000001 112.196 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.5 mt -60.6 -44.79 95.88 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.506 0.67 . . . . 0.34000000000000002 110.248 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.581 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.2 mt -87.64 1.06 54.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.945 -1.025 . . . . 0.35999999999999999 111.543 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 71.29 26.65 3.31 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.825 -0.625 . . . . 1.8899999999999999 111.392 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 58' ' ' LEU . 60.4 mt -78.44 140.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.938 -0.574 . . . . 0.26000000000000001 110.281 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.54 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 11.5 mptt -91.26 118.0 30.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.709 -0.678 . . . . 2.2200000000000002 109.815 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -73.01 -36.95 52.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.83 -0.623 . . . . 0.28999999999999998 110.195 -175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.31 -19.23 79.6 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.735 -0.745 . . . . 0.56999999999999995 112.283 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -85.25 -16.77 39.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.048 0.452 . . . . 0.85999999999999999 110.331 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 94.1 mt -64.01 154.07 35.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.883 -0.598 . . . . 0.46000000000000002 111.393 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 12.5 mptt -109.38 -80.37 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.647 -0.706 . . . . 2.0099999999999998 112.503 -171.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -98.69 -90.67 0.29 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 112.537 0.569 . . . . 1.0900000000000001 112.537 -170.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.0 OUTLIER -120.77 166.23 14.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.891 -0.595 . . . . 0.14999999999999999 110.989 178.445 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.67 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.9 OUTLIER -118.03 171.37 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 106.665 -1.605 . . . . 0.25 106.665 167.023 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.77 120.6 1.76 Allowed Glycine 0 C--N 1.31 -0.911 0 C-N-CA 119.668 -1.254 . . . . 0.37 112.132 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.61 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -91.54 140.02 30.14 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 120.089 -0.644 . . . . 0.28999999999999998 110.148 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.502 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 3.0 t-20 50.9 49.86 20.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.921 -1.036 . . . . 1.8500000000000001 110.559 176.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.7 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 7.9 t -92.1 150.44 20.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.733 -1.121 . . . . 1.1200000000000001 110.805 -174.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 17.9 t -109.41 121.12 43.43 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.794 -0.639 . . . . 1.26 110.022 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 12.7 Cg_exo -69.69 124.24 10.92 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.514 2.142 . . . . 0.60999999999999999 112.527 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 40' ' ' CYS . 23.9 mt . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 115.966 -0.561 . . . . 0.85999999999999999 109.715 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.585 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 110.013 -0.366 . . . . 0.54000000000000004 110.013 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.897 HE22 ' H ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -84.0 136.3 34.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.678 -0.49 . . . . 0.78000000000000003 109.678 -178.561 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.21 121.36 45.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.341 0.591 . . . . 0.39000000000000001 111.217 -174.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.595 HG12 ' HA ' ' A' ' 111' ' ' PRO . 1.9 m -133.07 164.18 35.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.515 -0.766 . . . . 0.22 110.877 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.4 t -108.24 109.08 20.36 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.347 -0.842 . . . . 0.70999999999999996 109.159 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 28.8 m -106.76 153.73 22.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.202 -0.454 . . . . 0.60999999999999999 110.135 -175.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 t -86.64 -28.03 23.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.38 110.655 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.617 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 24.1 m120 -151.74 168.08 26.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.693 -0.484 . . . . 0.78000000000000003 109.693 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.8 t -139.66 144.34 37.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.181 0.301 . . . . 0.41999999999999998 110.783 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.606 ' HB2' HG23 ' A' ' 105' ' ' VAL . 50.8 m-85 -134.07 153.12 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.094 -0.336 . . . . 0.77000000000000002 110.094 175.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.535 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 13.2 mm-40 62.6 30.41 17.01 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.303 0.483 . . . . 0.80000000000000004 112.303 172.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 67.05 -0.89 1.57 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.868 0.467 . . . . 2.1200000000000001 111.827 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 76' ' ' CYS . . . 140.61 -13.73 2.94 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.805 -0.712 . . . . 0.28000000000000003 112.514 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 48.2 mt -52.1 -36.13 50.07 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.991 0.424 . . . . 0.35999999999999999 111.0 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.606 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.3 OUTLIER -137.52 139.04 44.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.504 -0.771 . . . . 0.85999999999999999 109.786 174.389 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.575 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.5 t30 -136.37 157.93 45.63 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.711 -0.848 . . . . 0.91000000000000003 108.711 -174.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.617 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 10.7 m -135.64 150.87 29.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.983 0.734 . . . . 0.29999999999999999 112.983 -175.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.69 50.31 67.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 114.74 -1.118 . . . . 0.20000000000000001 112.086 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 81.0 m -96.87 125.92 41.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.767 0.318 . . . . 0.42999999999999999 110.576 -175.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 18.9 p -119.39 138.95 27.02 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.901 -0.591 . . . . 0.29999999999999999 109.78 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.595 ' HA ' HG12 ' A' ' 94' ' ' VAL . 36.7 Cg_exo -64.92 108.63 1.13 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.889 2.393 . . . . 0.34000000000000002 112.006 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.1 tt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.585 -0.734 . . . . 0.58999999999999997 111.007 -175.481 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 39' ' ' TYR . 19.2 t . . . . . 0 N--CA 1.461 0.084 0 N-CA-C 110.29 -0.263 . . . . 0.58999999999999997 110.29 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.493 ' N ' HG12 ' A' ' 38' ' ' VAL . 63.8 m-85 -132.91 140.1 47.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.978 0.418 . . . . 0.78000000000000003 110.577 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 52.4 t -117.79 103.21 9.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.017 -0.538 . . . . 0.81999999999999995 110.778 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.8 m -100.17 129.58 46.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.703 -0.851 . . . . 0.23999999999999999 108.703 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.489 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 94.6 m-20 -59.78 -24.24 63.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.55 0.69 . . . . 2.0800000000000001 109.585 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 5.3 mmmm -161.78 134.64 6.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.088 -1.414 . . . . 2.5800000000000001 107.724 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.514 HG21 HG11 ' A' ' 94' ' ' VAL . 22.9 p -88.39 157.73 18.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.441 -0.903 . . . . 0.37 110.49 169.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.509 ' CB ' HG22 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -119.12 142.53 47.83 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.366 -0.834 . . . . 1.1200000000000001 110.179 -176.337 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.523 ' O ' HD13 ' A' ' 50' ' ' LEU . 11.9 t70 -71.88 101.51 2.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.523 -0.762 . . . . 1.77 110.349 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.575 ' HA ' HD21 ' A' ' 50' ' ' LEU . 57.1 p -67.72 -6.67 22.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.631 0.604 . . . . 0.92000000000000004 112.631 -172.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.553 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -77.73 -40.9 39.59 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.777 0.799 . . . . 2.77 109.179 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -147.12 68.86 1.15 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.692 -1.14 . . . . 2.3300000000000001 109.874 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.575 HD21 ' HA ' ' A' ' 47' ' ' SER . 3.1 mm? -53.08 153.18 3.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.562 0.696 . . . . 1.1599999999999999 112.418 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.9 146.54 31.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.711 -1.132 . . . . 1.8100000000000001 108.703 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -59.6 -27.62 66.45 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.705 -0.398 . . . . 3.23 110.857 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.458 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -69.77 -37.07 75.73 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.547 -0.835 . . . . 0.34000000000000002 111.624 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.692 ' HA ' HD22 ' A' ' 57' ' ' LEU . 23.5 m -80.03 -43.95 21.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.831 0.348 . . . . 0.35999999999999999 110.228 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.7 m -51.93 -36.2 48.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 0.29999999999999999 109.813 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.36 -53.7 55.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.511 -0.768 . . . . 0.23000000000000001 111.78 176.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.692 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.49 -46.59 86.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.462 0.649 . . . . 0.23999999999999999 110.313 -178.586 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 54' ' ' THR . 52.9 mt -58.43 -44.8 89.27 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.854 -1.066 . . . . 0.17999999999999999 110.135 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.44 -32.91 79.13 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.968 -0.634 . . . . 0.26000000000000001 112.945 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.8 mt -64.01 -43.47 95.55 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.826 0.822 . . . . 0.34000000000000002 110.123 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.475 HD21 ' HG2' ' A' ' 101' ' ' GLN . 3.4 mt -86.68 -1.33 57.62 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.535 -1.212 . . . . 0.35999999999999999 110.961 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.2 m120 65.61 36.03 6.71 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.215 -0.902 . . . . 1.8899999999999999 111.072 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 58' ' ' LEU . 50.1 mt -82.96 145.09 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.599 -0.728 . . . . 0.26000000000000001 109.502 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.656 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -99.32 117.96 34.93 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.331 0.586 . . . . 2.2200000000000002 109.762 -178.157 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.29 -28.12 34.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.277 -0.874 . . . . 0.28999999999999998 110.877 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.13 -15.44 78.65 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.168 -0.539 . . . . 0.56999999999999995 112.6 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.492 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 17.2 t70 -86.21 -29.39 23.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.925 0.393 . . . . 0.85999999999999999 110.332 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 86.0 mt -52.5 139.39 25.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.099 -0.955 . . . . 0.46000000000000002 111.951 -174.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -96.67 -81.98 0.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.992 -1.004 . . . . 2.0099999999999998 112.197 -171.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -94.77 -92.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.05 0.389 . . . . 1.0900000000000001 112.05 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.3 mm? -117.39 171.32 8.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.319 0.58 . . . . 0.14999999999999999 110.917 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.6 OUTLIER -121.08 172.88 7.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.565 -1.643 . . . . 0.25 106.565 165.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.483 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -139.39 129.16 4.26 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 119.89 -1.147 . . . . 0.37 112.106 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.659 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -99.21 135.96 39.85 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.442 -0.503 . . . . 0.28999999999999998 109.895 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.41 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 24.2 m120 46.56 51.16 12.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.199 -0.91 . . . . 1.8500000000000001 110.531 -175.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -87.41 147.98 25.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.064 -0.971 . . . . 1.1200000000000001 109.575 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.7 m -109.59 108.97 59.94 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 116.048 -0.524 . . . . 1.26 110.356 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.59 120.02 7.15 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.12 1.88 . . . . 0.60999999999999999 111.371 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.4 mt . . . . . 0 C--N 1.317 -0.809 0 CA-C-N 115.601 -0.727 . . . . 0.85999999999999999 109.26 -177.754 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.698 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--O 1.234 0.262 0 N-CA-C 110.064 -0.346 . . . . 0.54000000000000004 110.064 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.73 115.96 21.88 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.852 0.834 . . . . 0.78000000000000003 109.694 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 117.13 33.24 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.169 -0.923 . . . . 0.39000000000000001 110.832 -169.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.514 HG11 HG21 ' A' ' 44' ' ' THR . 9.5 m -129.93 171.53 17.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.547 -0.751 . . . . 0.22 111.854 -176.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 37.7 t -115.0 108.32 16.55 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.812 -1.085 . . . . 0.70999999999999996 108.93 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 27.6 m -106.03 145.43 31.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.313 -0.403 . . . . 0.60999999999999999 110.076 -176.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -76.04 -28.87 57.85 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.38 110.348 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.445 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 12.1 m120 -151.34 164.18 37.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 0.78000000000000003 109.843 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 t -137.63 133.55 34.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.05 -0.523 . . . . 0.41999999999999998 109.944 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.555 ' HB2' HG23 ' A' ' 105' ' ' VAL . 66.2 m-85 -119.37 157.25 28.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.963 -0.562 . . . . 0.77000000000000002 109.827 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.623 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 12.5 mm-40 60.35 30.51 19.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.441 . . . . 0.80000000000000004 111.586 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 63.68 9.82 4.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 2.1200000000000001 111.875 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.83 -24.29 3.02 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.73 -0.747 . . . . 0.28000000000000003 112.507 175.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 18.6 mt -49.86 -36.13 25.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.825 0.305 . . . . 0.35999999999999999 111.825 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.555 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.3 OUTLIER -141.38 118.82 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.392 0.615 . . . . 0.85999999999999999 110.992 173.148 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.588 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 7.5 m-20 -111.03 162.64 14.66 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.5 -0.773 . . . . 0.91000000000000003 109.488 176.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.445 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.4 m -132.85 154.32 39.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.336 0.495 . . . . 0.29999999999999999 112.336 -176.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 59.8 52.29 53.87 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.278 -0.874 . . . . 0.20000000000000001 111.88 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 73.3 m -96.81 123.6 40.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.878 0.37 . . . . 0.42999999999999999 111.116 -174.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.4 p -119.72 125.94 27.18 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.919 -0.582 . . . . 0.29999999999999999 110.131 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.48 ' HA ' HG12 ' A' ' 94' ' ' VAL . 81.5 Cg_exo -48.38 109.87 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.752 2.301 . . . . 0.34000000000000002 111.665 175.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.3 tt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 0.58999999999999997 111.747 -169.477 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.9 t . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 110.144 -0.317 . . . . 0.58999999999999997 110.144 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.29 136.44 48.16 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.855 -0.424 . . . . 0.78000000000000003 109.855 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 48.0 t -102.99 114.82 29.42 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.806 0.336 . . . . 0.81999999999999995 110.589 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.1 m -115.25 125.18 53.02 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.928 -0.767 . . . . 0.23999999999999999 108.928 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.512 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 24.7 t-20 -50.64 -34.36 25.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.614 -0.721 . . . . 2.0800000000000001 110.231 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -154.58 127.48 8.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.652 -1.158 . . . . 2.5800000000000001 108.725 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.515 HG21 HG11 ' A' ' 94' ' ' VAL . 18.0 p -84.37 156.94 21.62 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.53 -0.868 . . . . 0.37 110.514 168.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.8 tp10 -120.58 139.23 53.25 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.617 -0.72 . . . . 1.1200000000000001 109.451 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.442 ' HA ' HD12 ' A' ' 71' ' ' LEU . 24.1 t70 -65.65 110.81 2.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.029 -0.532 . . . . 1.77 110.376 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 58.5 p -69.41 -2.45 11.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.262 -0.426 . . . . 0.92000000000000004 112.073 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -90.12 -27.99 19.26 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.115 0.483 . . . . 2.77 109.759 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -141.62 64.28 1.41 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.57 . . . . 2.3300000000000001 110.592 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.547 HD11 HG13 ' A' ' 72' ' ' VAL . 2.8 mm? -60.74 150.21 33.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.291 0.567 . . . . 1.1599999999999999 111.559 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.93 144.13 57.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.831 -1.077 . . . . 1.8100000000000001 108.438 169.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -62.8 -21.07 65.62 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.213 -0.195 . . . . 3.23 110.902 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.31 -36.57 63.36 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.583 -0.818 . . . . 0.34000000000000002 111.202 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.643 ' HA ' HD22 ' A' ' 57' ' ' LEU . 37.9 m -82.05 -43.98 17.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.817 0.342 . . . . 0.35999999999999999 110.198 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.1 m -52.5 -35.37 52.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.698 -0.683 . . . . 0.29999999999999999 110.04 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.637 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -55.82 -53.69 53.62 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.377 -0.829 . . . . 0.23000000000000001 111.288 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.643 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -59.6 -44.9 93.23 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.221 0.534 . . . . 0.23999999999999999 109.995 -178.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 54' ' ' THR . 54.1 mt -58.12 -46.08 86.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.094 -0.957 . . . . 0.17999999999999999 109.992 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.24 -29.66 75.15 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.003 -0.617 . . . . 0.26000000000000001 112.574 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.1 mt -65.73 -47.53 75.01 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.639 0.733 . . . . 0.34000000000000002 110.161 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' CD1' HG21 ' A' ' 105' ' ' VAL . 3.7 mt -83.09 -2.41 55.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.764 -1.107 . . . . 0.35999999999999999 110.996 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.2 t30 68.17 38.38 2.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.222 -0.899 . . . . 1.8899999999999999 110.978 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 58' ' ' LEU . 51.3 mt -84.32 137.74 20.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.778 -0.646 . . . . 0.26000000000000001 110.099 175.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -84.11 118.0 23.81 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.645 -0.707 . . . . 2.2200000000000002 110.304 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.91 -31.69 51.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.763 -0.653 . . . . 0.28999999999999998 109.902 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.92 -9.53 86.61 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.774 -0.648 . . . . 0.56999999999999995 112.604 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -95.6 -8.78 33.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.399 0.618 . . . . 0.85999999999999999 110.283 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.6 mt -69.22 144.08 53.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.721 -0.672 . . . . 0.46000000000000002 111.223 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -101.17 -68.73 0.8 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.843 -1.071 . . . . 2.0099999999999998 112.557 -168.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -114.51 -91.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.853 0.359 . . . . 1.0900000000000001 111.825 -172.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.3 mm? -116.25 169.34 9.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.056 0.455 . . . . 0.14999999999999999 110.393 174.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.547 HG13 HD11 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -124.89 166.88 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.596 -1.631 . . . . 0.25 106.596 166.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.464 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -134.1 148.24 19.38 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 119.807 -1.187 . . . . 0.37 111.364 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -112.1 134.4 53.67 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.151 -0.62 . . . . 0.28999999999999998 110.549 177.128 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 55.51 45.14 25.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.824 -1.08 . . . . 1.8500000000000001 111.163 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.464 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 63.3 m -77.61 146.91 35.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.334 0.588 . . . . 1.1200000000000001 111.275 -176.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t -98.03 113.28 63.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.168 -0.924 . . . . 1.26 109.523 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.06 124.39 12.56 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.379 2.053 . . . . 0.60999999999999999 111.954 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.8 mt . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 115.932 -0.576 . . . . 0.85999999999999999 109.729 -178.789 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.786 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 110.362 -0.236 . . . . 0.54000000000000004 110.362 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.0 124.03 31.23 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.404 0.621 . . . . 0.78000000000000003 110.069 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.33 115.73 30.89 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.826 -0.625 . . . . 0.39000000000000001 110.991 -173.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 111' ' ' PRO . 9.5 m -126.42 165.08 25.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.936 -0.574 . . . . 0.22 111.316 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.6 121.96 45.03 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.079 -1.082 . . . . 0.70999999999999996 108.079 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.709 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 27.1 m -120.57 152.35 38.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 0.60999999999999999 111.664 -167.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.525 HG22 ' HA3' ' A' ' 108' ' ' GLY . 10.9 t -81.2 -30.08 34.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.072 -0.967 . . . . 0.38 110.637 -170.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.487 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 17.8 m120 -154.56 167.82 28.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.39 -0.596 . . . . 0.78000000000000003 109.39 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 t -147.37 135.99 21.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.118 0.485 . . . . 0.41999999999999998 110.622 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.531 ' HB2' HG23 ' A' ' 105' ' ' VAL . 67.1 m-85 -129.55 154.31 47.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.361 -0.607 . . . . 0.77000000000000002 109.361 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.663 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 14.4 mm-40 59.88 38.1 21.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.545 -0.298 . . . . 0.80000000000000004 111.48 176.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.7 p80 58.88 2.18 0.23 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.152 0.981 . . . . 2.1200000000000001 113.201 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.69 -18.19 3.01 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.691 -0.766 . . . . 0.28000000000000003 112.242 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 20.7 mt -49.8 -44.02 48.88 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.871 0.336 . . . . 0.35999999999999999 110.767 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 100' ' ' TYR . 1.4 m -128.9 119.65 50.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.698 0.761 . . . . 0.85999999999999999 110.344 172.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.462 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 32.5 t30 -119.12 146.31 45.23 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.075 -1.083 . . . . 0.91000000000000003 108.075 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.537 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 11.3 m -132.45 156.21 42.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.537 0.94 . . . . 0.29999999999999999 113.537 -173.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 65.45 49.36 61.12 Favored Glycine 0 CA--C 1.503 -0.66 0 CA-C-N 114.952 -1.022 . . . . 0.20000000000000001 111.716 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 98.7 m -98.15 126.59 43.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.964 0.411 . . . . 0.42999999999999999 111.533 -172.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -120.86 126.14 26.78 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.505 -0.771 . . . . 0.29999999999999999 109.852 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 94' ' ' VAL . 71.7 Cg_exo -50.15 112.34 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.049 2.499 . . . . 0.34000000000000002 112.117 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.0 tt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.894 -0.594 . . . . 0.58999999999999997 111.096 -173.343 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 107.85 -1.167 . . . . 0.58999999999999997 107.85 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -118.3 137.01 53.36 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.872 0.844 . . . . 0.78000000000000003 111.817 -176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 53.1 t -109.05 115.71 30.57 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.842 -1.072 . . . . 0.81999999999999995 110.152 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.7 m -113.57 126.69 55.57 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.201 -0.666 . . . . 0.23999999999999999 109.201 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -57.63 -23.21 49.92 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.473 -0.785 . . . . 2.0800000000000001 109.769 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -166.24 132.46 2.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.55 -1.204 . . . . 2.5800000000000001 108.028 172.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.494 HG21 HG11 ' A' ' 94' ' ' VAL . 25.1 p -89.6 159.47 17.15 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.456 -0.898 . . . . 0.37 110.494 172.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.449 ' CB ' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -120.58 144.89 47.85 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.208 -0.905 . . . . 1.1200000000000001 109.305 -176.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.469 ' OD2' ' HB2' ' A' ' 48' ' ' LYS . 33.4 t70 -78.52 105.49 9.83 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.973 -0.558 . . . . 1.77 110.313 -174.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.711 ' HA ' HD21 ' A' ' 50' ' ' LEU . 80.1 p -63.21 -7.07 5.17 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.125 0.787 . . . . 0.92000000000000004 113.125 -172.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 2.9 mptp? -81.4 -43.49 18.88 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.335 0.588 . . . . 2.77 110.301 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -135.78 63.94 1.58 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.222 -0.899 . . . . 2.3300000000000001 111.211 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.711 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.8 mm? -60.06 155.97 15.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.265 0.555 . . . . 1.1599999999999999 111.453 176.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.26 152.29 41.4 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.638 -0.875 . . . . 1.8100000000000001 108.638 168.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -63.24 -28.96 70.39 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.415 -0.514 . . . . 3.23 110.638 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -67.54 -38.14 90.29 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.796 -0.716 . . . . 0.34000000000000002 111.879 177.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.686 ' HA ' HD22 ' A' ' 57' ' ' LEU . 41.7 m -78.93 -41.79 28.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.961 0.41 . . . . 0.35999999999999999 109.931 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -52.41 -36.11 53.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.448 -0.796 . . . . 0.29999999999999999 109.805 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.57 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.15 -53.99 52.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.046 -0.979 . . . . 0.23000000000000001 111.626 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.686 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -57.37 -46.31 83.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.492 0.663 . . . . 0.23999999999999999 110.016 -179.048 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.0 mt -58.69 -45.22 89.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.719 -1.128 . . . . 0.17999999999999999 109.827 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.34 -36.39 90.85 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.762 -0.654 . . . . 0.26000000000000001 112.657 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 25.5 mt -59.41 -40.29 86.19 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.613 0.72 . . . . 0.34000000000000002 110.439 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.475 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.3 mt -90.68 -3.65 57.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.923 -1.035 . . . . 0.35999999999999999 110.836 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 72.03 30.69 2.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.353 -0.84 . . . . 1.8899999999999999 111.305 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 58' ' ' LEU . 60.1 mt -77.59 141.95 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.984 -0.553 . . . . 0.26000000000000001 109.819 176.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.495 ' CG ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -97.46 117.69 32.28 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.355 0.598 . . . . 2.2200000000000002 110.084 -177.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.7 -39.15 59.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.199 -0.909 . . . . 0.28999999999999998 110.791 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.9 -11.42 60.67 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.949 -0.643 . . . . 0.56999999999999995 112.952 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.495 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 36.6 t70 -111.94 3.63 17.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.253 0.549 . . . . 0.85999999999999999 110.793 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.41 ' CB ' ' HB2' ' A' ' 47' ' ' SER . 94.4 mt -70.85 164.72 24.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.304 -0.407 . . . . 0.46000000000000002 110.636 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -106.52 -91.93 0.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.586 0.587 . . . . 2.0099999999999998 112.586 -174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.451 ' O ' HD13 ' A' ' 71' ' ' LEU . 5.6 m-20 -91.81 -84.43 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.622 0.601 . . . . 1.0900000000000001 112.622 -171.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.0 OUTLIER -123.55 166.88 14.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.358 0.599 . . . . 0.14999999999999999 111.032 176.759 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.511 HG23 ' N ' ' A' ' 73' ' ' GLY . 0.8 OUTLIER -117.48 172.92 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.526 -1.657 . . . . 0.25 106.526 166.129 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.533 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -143.26 149.12 21.07 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.145 -1.026 . . . . 0.37 111.532 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.606 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -112.52 132.73 54.95 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.137 0.494 . . . . 0.28999999999999998 109.96 175.117 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 55.59 47.51 20.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.867 -1.06 . . . . 1.8500000000000001 110.91 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.533 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 63.6 m -82.58 138.93 34.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.871 -0.604 . . . . 1.1200000000000001 110.952 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 19.5 m -103.02 127.52 29.68 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.576 -0.738 . . . . 1.26 110.482 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 3.5 Cg_exo -76.04 126.35 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.491 2.127 . . . . 0.60999999999999999 112.365 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.449 -0.796 . . . . 0.85999999999999999 109.563 -179.521 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.697 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 108.46 -0.941 . . . . 0.54000000000000004 108.46 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.33 116.41 20.39 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.669 0.747 . . . . 0.78000000000000003 109.336 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.19 123.52 44.53 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.558 -0.746 . . . . 0.39000000000000001 110.445 -171.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 111' ' ' PRO . 7.6 m -134.41 163.16 37.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.508 -0.769 . . . . 0.22 111.423 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 47.3 t -107.99 114.88 29.11 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.301 -1.0 . . . . 0.70999999999999996 108.301 176.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 28.0 m -114.88 148.2 38.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.166 -0.47 . . . . 0.60999999999999999 110.142 -173.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -78.97 -32.9 45.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.958 -0.565 . . . . 0.38 110.651 -174.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.401 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 19.9 m120 -153.02 163.4 39.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.78000000000000003 110.313 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -136.03 143.23 44.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.13 -0.486 . . . . 0.41999999999999998 110.119 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.612 ' HB2' HG23 ' A' ' 105' ' ' VAL . 60.0 m-85 -129.67 153.42 48.15 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.332 -0.618 . . . . 0.77000000000000002 109.332 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.637 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 16.6 mm-40 62.9 30.59 16.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 0.80000000000000004 111.075 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 65.53 2.41 2.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.808 -0.633 . . . . 2.1200000000000001 112.378 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.37 -16.62 3.37 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.32 -0.943 . . . . 0.28000000000000003 112.868 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 20.5 mt -50.11 -38.05 36.95 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.026 0.413 . . . . 0.35999999999999999 110.689 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.612 HG23 ' HB2' ' A' ' 100' ' ' TYR . 5.6 m -130.0 149.14 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.755 -0.657 . . . . 0.85999999999999999 109.312 171.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 7.8 t30 -144.31 149.99 37.13 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.778 -0.823 . . . . 0.91000000000000003 108.778 -174.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.401 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 11.0 m -130.88 151.59 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 113.006 0.743 . . . . 0.29999999999999999 113.006 -174.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.19 50.42 67.32 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 114.838 -1.074 . . . . 0.20000000000000001 112.104 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 74.7 m -97.75 126.47 43.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.608 0.242 . . . . 0.42999999999999999 111.304 -175.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 21.4 p -118.88 138.05 25.64 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.464 -0.334 . . . . 0.29999999999999999 110.465 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.553 ' HA ' HG12 ' A' ' 94' ' ' VAL . 24.2 Cg_exo -67.53 110.85 2.17 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.294 2.663 . . . . 0.34000000000000002 112.889 -175.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.8 tt . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.942 -0.572 . . . . 0.58999999999999997 111.123 -178.78 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 107.953 -1.129 . . . . 0.58999999999999997 107.953 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.476 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 94.6 m-85 -120.89 138.49 54.06 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.827 -0.749 . . . . 0.78000000000000003 111.594 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 42.2 t -111.75 100.29 8.83 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.043 -0.98 . . . . 0.81999999999999995 110.031 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.9 m -101.95 128.19 48.47 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.085 -0.709 . . . . 0.23999999999999999 109.085 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -57.12 -24.6 55.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.817 -0.629 . . . . 2.0800000000000001 110.261 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.8 120.09 0.88 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.308 -0.86 . . . . 2.5800000000000001 108.703 177.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.553 HG21 HG11 ' A' ' 94' ' ' VAL . 18.4 p -78.81 147.35 33.29 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.121 -1.032 . . . . 0.37 110.505 172.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.472 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.2 tp10 -114.07 142.32 46.35 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.479 -0.782 . . . . 1.1200000000000001 109.421 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.436 ' O ' HD13 ' A' ' 50' ' ' LEU . 28.2 m-20 -70.45 103.97 2.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.949 -0.569 . . . . 1.77 111.129 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.681 ' HA ' HD21 ' A' ' 50' ' ' LEU . 7.1 m -58.71 -14.59 8.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.309 0.485 . . . . 0.92000000000000004 112.309 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -77.16 -35.64 55.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.834 0.349 . . . . 2.77 110.218 -178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -146.74 65.35 1.18 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.07 -0.514 . . . . 2.3300000000000001 111.073 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.681 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.7 mm? -57.0 151.3 15.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.481 . . . . 1.1599999999999999 111.242 175.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.77 156.49 39.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.203 -0.666 . . . . 1.8100000000000001 109.203 172.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -59.99 -33.35 71.85 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.806 -0.358 . . . . 3.23 111.014 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.408 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -61.83 -34.2 87.93 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.843 -0.694 . . . . 0.34000000000000002 111.812 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.658 ' HA ' HD22 ' A' ' 57' ' ' LEU . 24.1 m -85.04 -43.08 14.25 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.456 -0.202 . . . . 0.35999999999999999 110.456 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.5 m -52.84 -35.22 57.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.256 0.551 . . . . 0.29999999999999999 109.763 173.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.619 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.5 -55.45 33.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.277 -0.874 . . . . 0.23000000000000001 111.494 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.658 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -58.9 -44.76 91.29 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.34 0.59 . . . . 0.23999999999999999 110.103 -177.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.4 mt -59.99 -43.44 95.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.138 -0.937 . . . . 0.17999999999999999 110.114 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.14 -38.01 94.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.718 -0.754 . . . . 0.26000000000000001 112.162 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.3 mt -62.23 -40.99 97.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.798 0.809 . . . . 0.34000000000000002 110.187 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.425 HD21 ' HG2' ' A' ' 101' ' ' GLN . 10.7 mt -91.27 4.95 51.03 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.566 -1.197 . . . . 0.35999999999999999 111.274 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 64.85 33.62 9.94 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.717 -0.674 . . . . 1.8899999999999999 111.403 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.9 mt -89.91 144.13 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.875 -0.602 . . . . 0.26000000000000001 110.324 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.546 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 11.3 mptt -94.31 118.43 31.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.825 -0.625 . . . . 2.2200000000000002 109.963 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -68.48 -35.67 71.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.499 -0.773 . . . . 0.28999999999999998 110.386 -177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.87 -14.15 82.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.904 -0.665 . . . . 0.56999999999999995 112.39 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 32.0 t70 -88.01 -19.71 26.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.006 0.431 . . . . 0.85999999999999999 110.549 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.433 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 93.0 mt -55.5 141.93 35.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.699 0.762 . . . . 0.46000000000000002 111.771 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -87.86 -66.62 0.89 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.725 -1.125 . . . . 2.0099999999999998 112.457 -170.376 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.489 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 0.3 OUTLIER -123.73 -84.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.786 -0.366 . . . . 1.0900000000000001 111.157 -177.61 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.5 mm? -116.45 167.12 11.33 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.291 0.567 . . . . 0.14999999999999999 111.983 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 45' ' ' GLU . 1.9 m -119.78 165.13 15.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.18 -1.415 . . . . 0.25 107.18 168.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.403 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -137.42 133.85 6.67 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.655 -1.26 . . . . 0.37 112.404 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.23 135.77 36.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.901 -0.407 . . . . 0.28999999999999998 109.901 176.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.419 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 19.7 m120 46.79 52.92 10.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.466 -0.788 . . . . 1.8500000000000001 110.634 -177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 9.3 t -92.85 137.38 32.42 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.118 -0.946 . . . . 1.1200000000000001 109.883 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 13.3 t -100.55 125.71 38.17 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.92 -0.582 . . . . 1.26 110.893 -173.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 3.5 Cg_exo -76.27 122.13 6.45 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.758 2.305 . . . . 0.60999999999999999 112.568 177.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.627 -0.715 . . . . 0.85999999999999999 109.845 -179.838 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.753 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.909 -0.404 . . . . 0.54000000000000004 109.909 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.7 115.06 25.96 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.603 0.716 . . . . 0.78000000000000003 110.697 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.64 124.08 37.4 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.422 -0.808 . . . . 0.39000000000000001 111.154 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 111' ' ' PRO . 12.0 m -135.47 166.34 27.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.418 -0.81 . . . . 0.22 111.086 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.9 t -112.47 118.63 35.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.795 -0.817 . . . . 0.70999999999999996 108.795 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 13.6 m -120.26 153.37 36.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.903 0.382 . . . . 0.60999999999999999 111.117 -170.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 t -82.39 -29.46 30.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.799 -0.637 . . . . 0.38 111.082 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.43 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 13.3 m120 -156.17 159.16 38.74 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.125 -0.489 . . . . 0.78000000000000003 109.965 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.8 t -135.3 142.44 45.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.127 -0.488 . . . . 0.41999999999999998 110.036 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -130.28 159.74 35.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.646 -0.707 . . . . 0.77000000000000002 109.635 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.667 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 11.5 mm-40 59.32 31.32 21.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.16 -0.473 . . . . 0.80000000000000004 111.61 177.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 67.98 -0.27 2.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.709 -0.678 . . . . 2.1200000000000001 111.814 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 142.76 -19.63 2.37 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.78 -0.724 . . . . 0.28000000000000003 112.162 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 34.5 mt -50.3 -43.4 53.57 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.316 0.579 . . . . 0.35999999999999999 110.593 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 t -121.66 123.62 69.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.915 -1.039 . . . . 0.85999999999999999 109.707 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.441 ' ND2' ' SG ' ' A' ' 96' ' ' CYS . 37.3 t30 -128.17 144.58 51.13 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.142 -1.058 . . . . 0.91000000000000003 108.142 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 14.5 m -131.9 153.54 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 113.631 0.974 . . . . 0.29999999999999999 113.631 -172.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 62.94 50.24 65.4 Favored Glycine 0 CA--C 1.505 -0.563 0 CA-C-N 114.729 -1.123 . . . . 0.20000000000000001 111.725 176.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 70' ' ' ASP . 92.5 m -97.28 130.46 44.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.928 0.394 . . . . 0.42999999999999999 111.436 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.8 p -124.22 125.43 25.72 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.659 -0.7 . . . . 0.29999999999999999 109.962 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.587 ' HA ' HG12 ' A' ' 94' ' ' VAL . 78.5 Cg_exo -49.23 122.12 8.02 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.164 2.576 . . . . 0.34000000000000002 113.002 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.9 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.751 -0.658 . . . . 0.58999999999999997 110.84 -179.736 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 39' ' ' TYR . 91.4 t . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 107.515 -1.291 . . . . 0.58999999999999997 107.515 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.593 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 95.2 m-85 -129.98 135.45 48.31 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.643 0.735 . . . . 0.78000000000000003 112.23 -177.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.1 t -111.15 98.03 7.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.876 -1.056 . . . . 0.81999999999999995 110.031 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.2 m -99.59 134.2 42.82 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.541 -0.541 . . . . 0.23999999999999999 109.541 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.442 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 5.0 m-20 -51.47 -30.6 20.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.485 -0.78 . . . . 2.0800000000000001 110.342 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -170.51 131.81 0.94 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.456 -1.247 . . . . 2.5800000000000001 108.365 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.605 HG21 HG11 ' A' ' 94' ' ' VAL . 17.9 p -87.82 152.43 22.11 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.337 -0.945 . . . . 0.37 111.08 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.586 ' HB3' HG22 ' A' ' 72' ' ' VAL . 10.8 tp10 -119.6 141.25 49.46 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.99 -1.004 . . . . 1.1200000000000001 109.665 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.473 ' HA ' HD12 ' A' ' 71' ' ' LEU . 6.1 m-20 -68.88 110.59 4.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.477 -0.329 . . . . 1.77 110.981 -176.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.618 ' HA ' HD21 ' A' ' 50' ' ' LEU . 89.3 p -65.93 -8.69 23.87 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.099 0.476 . . . . 0.92000000000000004 111.335 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 3.7 mppt? -74.31 -36.39 63.71 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.512 0.673 . . . . 2.77 110.123 175.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -143.83 65.2 1.31 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.09 -0.959 . . . . 2.3300000000000001 111.107 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.618 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.3 mm? -59.68 157.27 12.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.595 0.712 . . . . 1.1599999999999999 111.609 174.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.32 161.09 30.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.637 -1.165 . . . . 1.8100000000000001 109.08 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.675 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -64.08 -32.01 73.41 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.959 -0.696 . . . . 3.23 110.551 177.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -66.0 -37.1 92.86 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.624 -0.798 . . . . 0.34000000000000002 111.293 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.667 ' HA ' HD22 ' A' ' 57' ' ' LEU . 11.7 m -78.89 -42.59 26.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.121 0.486 . . . . 0.35999999999999999 110.275 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.2 m -53.18 -35.25 59.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.335 -0.848 . . . . 0.29999999999999999 109.797 172.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.88 -54.8 42.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.433 -0.803 . . . . 0.23000000000000001 111.616 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.75 -45.72 89.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.467 0.651 . . . . 0.23999999999999999 110.319 -178.282 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.5 mt -61.35 -42.1 98.15 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.964 -1.016 . . . . 0.17999999999999999 109.941 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -34.14 84.25 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.791 -0.641 . . . . 0.26000000000000001 112.583 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 26.0 mt -61.64 -50.2 73.5 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.637 0.732 . . . . 0.34000000000000002 109.814 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.468 HD21 ' HG2' ' A' ' 101' ' ' GLN . 3.2 mt -83.99 8.25 15.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.569 -1.196 . . . . 0.35999999999999999 110.669 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.1 p30 50.97 38.19 19.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.495 1.118 . . . . 1.8899999999999999 111.737 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 58' ' ' LEU . 48.4 mt -79.44 140.89 16.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.795 -1.093 . . . . 0.26000000000000001 110.055 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 11.8 mptt -82.6 117.14 22.35 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.887 -0.597 . . . . 2.2200000000000002 110.001 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.78 -31.32 50.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.342 0.591 . . . . 0.28999999999999998 110.138 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.92 -22.24 72.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.031 -0.604 . . . . 0.56999999999999995 112.638 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.58 -13.19 57.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.242 0.544 . . . . 0.85999999999999999 110.253 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 92.3 mt -64.32 151.55 43.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.498 -0.774 . . . . 0.46000000000000002 111.804 -177.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -101.66 -71.12 0.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.811 -1.086 . . . . 2.0099999999999998 113.017 -169.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -120.49 -83.6 0.66 Allowed 'General case' 0 C--O 1.237 0.41 0 N-CA-C 112.54 0.57 . . . . 1.0900000000000001 112.54 -171.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.2 mm? -119.41 168.41 10.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.296 0.57 . . . . 0.14999999999999999 110.606 175.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.586 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -122.95 168.24 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 106.517 -1.66 . . . . 0.25 106.517 167.294 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.14 129.02 4.24 Favored Glycine 0 C--N 1.312 -0.773 0 C-N-CA 119.62 -1.276 . . . . 0.37 112.041 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.64 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.77 135.88 36.91 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.551 -0.46 . . . . 0.28999999999999998 110.544 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 49.51 49.03 20.58 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.024 -0.989 . . . . 1.8500000000000001 110.731 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 9.0 t -85.98 144.1 27.79 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.159 -0.928 . . . . 1.1200000000000001 110.592 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.6 m -102.12 113.44 65.86 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.855 -0.611 . . . . 1.26 110.855 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.89 130.79 26.98 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.847 2.365 . . . . 0.60999999999999999 112.816 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 mt . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.675 -0.693 . . . . 0.85999999999999999 109.213 177.657 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.824 -0.436 . . . . 0.54000000000000004 109.824 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.74 127.04 31.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.098 0.475 . . . . 0.78000000000000003 110.139 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.91 120.32 39.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.274 0.559 . . . . 0.39000000000000001 110.836 -174.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.605 HG11 HG21 ' A' ' 44' ' ' THR . 10.6 m -131.94 164.75 33.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.624 -0.716 . . . . 0.22 111.271 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 34.2 t -109.81 112.12 23.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.178 -0.919 . . . . 0.70999999999999996 109.156 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 35.4 m -107.88 149.19 28.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.883 0.373 . . . . 0.60999999999999999 110.725 -174.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.405 HG22 ' HA3' ' A' ' 108' ' ' GLY . 13.3 t -80.49 -27.21 37.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.914 -0.584 . . . . 0.38 110.455 -174.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.528 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.6 m120 -153.83 163.85 39.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.449 -0.796 . . . . 0.78000000000000003 109.064 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.5 t -136.22 134.21 37.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.165 0.507 . . . . 0.41999999999999998 110.184 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.51 ' HB2' HG23 ' A' ' 105' ' ' VAL . 89.3 m-85 -117.64 149.5 40.59 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.668 -0.696 . . . . 0.77000000000000002 109.94 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.486 ' OE1' HD12 ' A' ' 104' ' ' LEU . 13.6 mm-40 62.57 26.92 15.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.759 -0.655 . . . . 0.80000000000000004 111.265 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 64.01 9.07 4.35 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.251 -0.886 . . . . 2.1200000000000001 112.177 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.27 -25.47 1.87 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.342 -0.932 . . . . 0.28000000000000003 113.113 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 16.1 mt -49.16 -41.34 36.21 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.904 0.352 . . . . 0.35999999999999999 111.54 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.51 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -139.78 118.87 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.422 0.63 . . . . 0.85999999999999999 111.047 173.52 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.566 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 8.7 m-20 -108.16 162.66 13.86 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.579 -0.737 . . . . 0.91000000000000003 109.475 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 14.3 m -135.28 155.43 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.299 0.481 . . . . 0.29999999999999999 112.299 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 58.62 51.82 56.64 Favored Glycine 0 CA--C 1.505 -0.578 0 CA-C-N 115.396 -0.82 . . . . 0.20000000000000001 111.872 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 84.1 m -97.99 129.02 44.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.703 0.287 . . . . 0.42999999999999999 110.721 -175.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.9 p -125.26 128.19 24.81 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.912 -0.585 . . . . 0.29999999999999999 110.054 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.459 ' HA ' HG12 ' A' ' 94' ' ' VAL . 73.1 Cg_exo -51.3 109.28 0.3 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.785 2.323 . . . . 0.34000000000000002 112.061 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.6 tt . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.637 -0.711 . . . . 0.58999999999999997 110.735 -176.195 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.2 t . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 108.443 -0.947 . . . . 0.58999999999999997 108.443 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.618 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 90.5 m-85 -122.28 136.88 54.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.496 0.665 . . . . 0.78000000000000003 111.396 -177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 34.7 t -109.25 98.32 7.77 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.233 -0.894 . . . . 0.81999999999999995 109.604 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.5 m -99.16 137.59 37.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.111 -0.699 . . . . 0.23999999999999999 109.111 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.446 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 39.8 m-80 -59.03 -24.69 63.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.855 -0.611 . . . . 2.0800000000000001 109.965 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -171.75 131.06 0.68 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.409 -1.269 . . . . 2.5800000000000001 108.085 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.556 HG21 HG11 ' A' ' 94' ' ' VAL . 18.1 p -86.55 157.47 19.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.169 -1.012 . . . . 0.37 110.253 171.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HB3' HG22 ' A' ' 72' ' ' VAL . 7.1 tp10 -121.77 138.2 54.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.836 -0.62 . . . . 1.1200000000000001 109.509 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HA ' HD12 ' A' ' 71' ' ' LEU . 12.9 m-20 -67.6 109.5 3.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.194 -0.457 . . . . 1.77 110.159 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.1 p -57.09 -24.34 53.28 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.498 0.499 . . . . 0.92000000000000004 111.208 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -90.78 -12.13 37.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.903 0.383 . . . . 2.77 111.284 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -126.37 25.2 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.979 0.418 . . . . 2.3300000000000001 110.85 -176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.59 156.39 16.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.629 0.728 . . . . 1.1599999999999999 111.91 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.95 168.48 9.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.894 -1.048 . . . . 1.8100000000000001 109.767 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 11.8 mptt -62.01 -33.58 74.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.8 0.333 . . . . 3.23 110.502 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.75 -36.21 92.4 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.152 -0.547 . . . . 0.34000000000000002 112.72 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.585 ' HA ' HD22 ' A' ' 57' ' ' LEU . 25.6 m -82.73 -43.36 16.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.819 0.31 . . . . 0.35999999999999999 110.434 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.5 m -54.67 -33.21 60.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.896 -0.593 . . . . 0.29999999999999999 110.053 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.23 -54.32 46.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.478 -0.783 . . . . 0.23000000000000001 111.508 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.585 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.42 -47.29 84.42 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.268 0.556 . . . . 0.23999999999999999 109.96 -178.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 54' ' ' THR . 25.1 mt -59.63 -41.99 91.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.98 -1.009 . . . . 0.17999999999999999 110.188 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.53 -36.88 93.25 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.752 -0.658 . . . . 0.26000000000000001 112.23 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 19.8 mt -61.3 -39.34 90.12 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.714 0.768 . . . . 0.34000000000000002 110.092 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.644 HD21 ' HG2' ' A' ' 101' ' ' GLN . 4.5 mt -90.81 0.58 57.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.468 -1.242 . . . . 0.35999999999999999 111.113 -176.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 69.03 34.53 3.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.481 -0.781 . . . . 1.8899999999999999 111.349 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 58' ' ' LEU . 41.6 mt -88.71 147.12 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.001 -0.545 . . . . 0.26000000000000001 110.042 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.614 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -100.62 118.96 37.84 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.383 0.611 . . . . 2.2200000000000002 110.061 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -71.64 -31.48 42.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.15 -0.932 . . . . 0.28999999999999998 110.972 -174.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.16 -15.34 74.49 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.966 -0.635 . . . . 0.56999999999999995 112.752 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.451 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 23.8 t70 -95.32 -14.15 24.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.85999999999999999 110.532 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.0 mt -57.87 140.32 52.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.268 0.556 . . . . 0.46000000000000002 110.909 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -94.94 -77.64 0.46 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.231 -0.895 . . . . 2.0099999999999998 112.532 -170.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.03 -98.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.975 0.361 . . . . 1.0900000000000001 111.975 -173.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.6 mm? -109.04 168.92 9.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.558 0.694 . . . . 0.14999999999999999 111.271 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -117.18 167.9 9.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 106.754 -1.573 . . . . 0.25 106.754 166.518 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -138.34 121.59 2.22 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 119.765 -1.207 . . . . 0.37 111.893 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.711 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -94.06 136.02 34.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.742 -0.783 . . . . 0.28999999999999998 109.705 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 53.14 61.33 3.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.041 0.924 . . . . 1.8500000000000001 109.792 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 7.9 t -103.66 146.1 29.08 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.607 -1.179 . . . . 1.1200000000000001 110.777 -171.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.1 m -102.26 109.97 61.56 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.823 -0.626 . . . . 1.26 110.216 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.9 120.32 7.24 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.777 2.318 . . . . 0.60999999999999999 112.299 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 0.85999999999999999 109.555 -179.716 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 110.017 -0.364 . . . . 0.54000000000000004 110.017 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.05 124.23 28.55 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.354 0.597 . . . . 0.78000000000000003 110.097 -176.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.52 116.0 31.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.744 -0.662 . . . . 0.39000000000000001 110.875 -171.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 44' ' ' THR . 11.2 m -128.29 164.63 29.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.663 -0.699 . . . . 0.22 111.457 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.1 t -108.34 110.98 22.68 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.623 -0.88 . . . . 0.70999999999999996 108.623 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.8 m -112.92 146.41 39.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.934 0.397 . . . . 0.60999999999999999 110.713 -172.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.7 t -81.11 -23.11 38.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 0.38 111.289 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.0 m-20 -159.5 168.1 27.01 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.511 -0.551 . . . . 0.78000000000000003 109.511 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.9 t -140.26 142.47 35.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.538 -0.301 . . . . 0.41999999999999998 110.633 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.637 ' HB2' HG23 ' A' ' 105' ' ' VAL . 83.9 m-85 -134.12 158.32 43.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.909 -0.316 . . . . 0.77000000000000002 110.686 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.644 ' HG2' HD21 ' A' ' 61' ' ' LEU . 41.9 mm-40 59.43 40.25 21.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.80000000000000004 111.549 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 p80 58.04 2.07 0.17 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.117 0.967 . . . . 2.1200000000000001 112.393 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.98 -15.9 3.04 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.966 -0.635 . . . . 0.28000000000000003 112.658 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.711 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 24.6 mt -56.1 -37.29 69.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.076 0.438 . . . . 0.35999999999999999 111.594 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.637 HG23 ' HB2' ' A' ' 100' ' ' TYR . 3.6 m -130.39 149.82 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.333 0.587 . . . . 0.85999999999999999 110.314 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.488 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.5 t30 -142.98 153.35 42.91 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.6 -0.889 . . . . 0.91000000000000003 108.6 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.5 m -131.62 150.41 34.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.783 0.66 . . . . 0.29999999999999999 112.783 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.11 52.32 53.52 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.939 -1.028 . . . . 0.20000000000000001 111.824 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 83.1 m -97.31 127.05 42.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.741 0.305 . . . . 0.42999999999999999 111.225 -176.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 p -120.79 126.47 26.67 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.93 -0.577 . . . . 0.29999999999999999 110.574 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.513 ' HA ' HG12 ' A' ' 94' ' ' VAL . 50.5 Cg_exo -53.8 110.68 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.917 2.411 . . . . 0.34000000000000002 112.112 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.4 tt . . . . . 0 C--N 1.324 -0.539 0 CA-C-O 121.273 0.559 . . . . 0.58999999999999997 110.882 -177.191 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 39' ' ' TYR . 97.6 t . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 107.761 -1.2 . . . . 0.58999999999999997 107.761 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.452 ' N ' HG12 ' A' ' 38' ' ' VAL . 91.9 m-85 -124.21 135.48 53.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.885 0.85 . . . . 0.78000000000000003 111.605 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.709 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 44.0 t -107.98 111.09 22.99 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.833 -1.076 . . . . 0.81999999999999995 109.964 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 65.4 m -110.37 129.62 55.72 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.32 -0.622 . . . . 0.23999999999999999 109.32 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -62.88 -17.49 61.69 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.538 -0.756 . . . . 2.0800000000000001 109.832 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -169.28 133.83 1.44 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.765 -1.107 . . . . 2.5800000000000001 108.622 172.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.495 HG21 HG11 ' A' ' 94' ' ' VAL . 29.2 p -94.53 151.84 19.02 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.442 -0.903 . . . . 0.37 110.679 168.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.538 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.7 tp10 -119.78 142.73 48.32 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.194 -0.912 . . . . 1.1200000000000001 109.527 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.465 ' O ' HD13 ' A' ' 50' ' ' LEU . 44.8 m-20 -67.28 108.39 2.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.523 -0.308 . . . . 1.77 110.52 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.561 ' HA ' HD21 ' A' ' 50' ' ' LEU . 70.0 p -68.67 -1.16 6.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.955 -0.566 . . . . 0.92000000000000004 112.513 -172.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -79.17 -43.82 23.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.928 0.394 . . . . 2.77 110.145 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -144.77 70.95 1.29 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.569 -0.53 . . . . 2.3300000000000001 109.569 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 47' ' ' SER . 3.1 mm? -55.32 153.49 7.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.338 -0.846 . . . . 1.1599999999999999 112.406 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.95 153.34 21.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.672 -1.149 . . . . 1.8100000000000001 109.406 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -55.96 -41.45 74.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.249 0.477 . . . . 3.23 110.601 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -61.41 -36.85 93.15 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.839 -0.619 . . . . 0.34000000000000002 112.32 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.656 ' HA ' HD22 ' A' ' 57' ' ' LEU . 29.2 m -82.29 -41.43 20.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.836 0.351 . . . . 0.35999999999999999 110.274 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.0 m -53.77 -34.99 60.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.781 -0.645 . . . . 0.29999999999999999 109.861 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.523 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.46 -52.74 63.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.367 -0.833 . . . . 0.23000000000000001 111.92 175.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.656 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -61.17 -44.43 97.31 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.556 0.693 . . . . 0.23999999999999999 110.037 -178.456 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 54' ' ' THR . 46.1 mt -60.05 -44.41 94.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.822 -1.081 . . . . 0.17999999999999999 109.903 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.82 -32.42 79.31 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.631 -0.713 . . . . 0.26000000000000001 113.043 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 33.9 mt -59.83 -41.96 92.49 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.833 0.825 . . . . 0.34000000000000002 110.323 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.479 HD21 ' HG2' ' A' ' 101' ' ' GLN . 3.8 mt -91.18 -5.61 54.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.406 -1.27 . . . . 0.35999999999999999 110.855 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.9 t30 69.62 36.9 2.03 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.047 -0.979 . . . . 1.8899999999999999 110.661 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 58' ' ' LEU . 64.2 mt -77.77 146.19 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.797 -0.638 . . . . 0.26000000000000001 110.029 175.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.665 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -93.99 117.72 30.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.74 -0.664 . . . . 2.2200000000000002 110.279 -178.132 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.91 -40.6 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.609 -0.723 . . . . 0.28999999999999998 111.279 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.93 -7.48 62.22 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.75 -0.738 . . . . 0.56999999999999995 112.845 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.477 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 28.7 t70 -104.5 -12.44 16.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.08 0.467 . . . . 0.85999999999999999 110.529 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.1 mt -62.33 149.84 41.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.845 -0.616 . . . . 0.46000000000000002 110.974 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -95.86 -78.59 0.46 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.458 0.91 . . . . 2.0099999999999998 113.458 -169.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 0.2 OUTLIER -105.95 -85.19 0.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.8 -0.36 . . . . 1.0900000000000001 111.741 -172.244 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 0.9 OUTLIER -120.97 168.17 11.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.169 0.509 . . . . 0.14999999999999999 110.871 177.762 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -122.25 168.5 14.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 106.821 -1.548 . . . . 0.25 106.821 165.192 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.508 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -136.53 144.09 15.67 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.83 -1.176 . . . . 0.37 111.698 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -104.96 128.14 53.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.128 0.49 . . . . 0.28999999999999998 110.116 176.375 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.4 m120 57.77 53.48 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.974 -1.012 . . . . 1.8500000000000001 110.999 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.508 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 58.9 m -87.67 141.57 28.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.399 -0.819 . . . . 1.1200000000000001 111.067 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.2 m -101.21 124.69 40.48 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.679 -0.692 . . . . 1.26 110.399 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.08 129.07 15.65 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.524 2.149 . . . . 0.60999999999999999 112.57 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 mt . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.285 -0.87 . . . . 0.85999999999999999 109.307 178.844 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.709 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--O 1.235 0.29 0 N-CA-C 109.515 -0.55 . . . . 0.54000000000000004 109.515 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.76 121.54 25.48 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.549 0.69 . . . . 0.78000000000000003 110.033 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.77 121.38 41.57 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.774 -0.648 . . . . 0.39000000000000001 111.356 -171.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 111' ' ' PRO . 9.0 m -133.78 165.87 30.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.598 -0.728 . . . . 0.22 110.847 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 18.0 m -114.06 125.09 53.6 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.75 -0.659 . . . . 0.70999999999999996 109.233 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 22.8 m -121.23 149.97 42.04 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.074 -0.512 . . . . 0.60999999999999999 110.465 -171.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.3 t -80.85 -28.37 36.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.73 -0.668 . . . . 0.38 110.789 -171.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.563 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 21.9 m120 -152.73 159.68 43.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.78000000000000003 109.764 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.4 t -136.12 147.39 47.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.472 -0.331 . . . . 0.41999999999999998 110.114 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.579 ' HB2' HG23 ' A' ' 105' ' ' VAL . 65.7 m-85 -137.17 158.24 44.89 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.83 -0.433 . . . . 0.77000000000000002 109.83 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.479 ' HG2' HD21 ' A' ' 61' ' ' LEU . 57.6 mm-40 62.51 26.6 15.82 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.566 -0.288 . . . . 0.80000000000000004 111.54 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 65.52 0.19 1.36 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.87 -0.604 . . . . 2.1200000000000001 112.534 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.8 -21.99 1.29 Allowed Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.91 -1.138 . . . . 0.28000000000000003 113.621 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.8 mt -51.07 -37.31 44.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.583 0.692 . . . . 0.35999999999999999 111.198 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.579 HG23 ' HB2' ' A' ' 100' ' ' TYR . 5.6 m -131.7 144.43 37.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.813 -0.631 . . . . 0.85999999999999999 109.768 174.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 15.4 t30 -142.86 141.41 31.56 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.974 -1.121 . . . . 0.91000000000000003 107.974 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.563 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.2 m -125.68 152.27 32.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 113.291 0.849 . . . . 0.29999999999999999 113.291 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 64.53 51.71 49.74 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.799 -1.091 . . . . 0.20000000000000001 111.665 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 74.6 m -97.98 128.45 44.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.856 0.36 . . . . 0.42999999999999999 111.494 -174.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.0 p -124.03 126.36 25.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.757 -0.656 . . . . 0.29999999999999999 109.418 173.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.539 ' HA ' HG12 ' A' ' 94' ' ' VAL . 79.6 Cg_exo -50.69 109.15 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.058 2.505 . . . . 0.34000000000000002 112.336 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.41 HD12 ' SG ' ' A' ' 95' ' ' CYS . 4.2 tt . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 115.679 -0.691 . . . . 0.58999999999999997 111.144 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 39' ' ' TYR . 92.1 t . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.547 -0.538 . . . . 0.58999999999999997 109.547 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.423 ' N ' HG12 ' A' ' 38' ' ' VAL . 52.8 m-85 -129.69 134.99 47.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.869 0.366 . . . . 0.78000000000000003 110.54 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 38.6 t -108.06 112.06 24.43 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.302 -0.408 . . . . 0.81999999999999995 109.95 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 72.9 m -103.31 134.15 47.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.143 0.496 . . . . 0.23999999999999999 110.422 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.464 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 88.4 m-20 -59.65 -19.58 50.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.226 -0.897 . . . . 2.0800000000000001 110.361 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -173.13 124.66 0.42 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.71 -1.132 . . . . 2.5800000000000001 107.986 176.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.581 HG21 HG11 ' A' ' 94' ' ' VAL . 8.0 p -78.2 148.0 34.22 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.243 -0.983 . . . . 0.37 110.838 170.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -109.96 138.81 45.81 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.009 -0.996 . . . . 1.1200000000000001 109.017 -176.171 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.67 104.9 4.76 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.741 -0.663 . . . . 1.77 110.337 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.704 ' HA ' HD21 ' A' ' 50' ' ' LEU . 50.1 m -58.93 -16.64 18.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.473 0.546 . . . . 0.92000000000000004 112.473 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -86.57 -20.23 28.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.744 0.307 . . . . 2.77 110.659 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -148.76 57.21 1.04 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.456 -0.338 . . . . 2.3300000000000001 111.601 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -59.59 145.75 43.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.39 0.614 . . . . 1.1599999999999999 111.665 176.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -71.03 156.76 39.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.146 -0.934 . . . . 1.8100000000000001 109.714 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -59.56 -41.65 90.62 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.909 -0.317 . . . . 3.23 110.948 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.03 -38.29 84.59 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.116 -0.564 . . . . 0.34000000000000002 112.34 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.668 ' HA ' HD22 ' A' ' 57' ' ' LEU . 26.2 m -79.92 -43.72 21.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.881 0.372 . . . . 0.35999999999999999 110.559 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -53.89 -34.8 60.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.673 -0.694 . . . . 0.29999999999999999 109.823 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.607 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.14 -52.23 66.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.85 -1.068 . . . . 0.23000000000000001 111.549 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.668 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -60.48 -45.75 92.62 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.424 0.63 . . . . 0.23999999999999999 109.958 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 54' ' ' THR . 50.6 mt -57.96 -45.86 86.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.848 -1.069 . . . . 0.17999999999999999 109.917 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.03 -36.87 91.7 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.621 -0.718 . . . . 0.26000000000000001 112.573 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 25.5 mt -59.61 -47.37 85.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.597 0.713 . . . . 0.34000000000000002 110.238 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.538 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.7 mt -84.48 -4.76 59.11 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.683 -1.144 . . . . 0.35999999999999999 111.556 -176.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.1 t30 70.63 35.54 1.84 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.741 0.781 . . . . 1.8899999999999999 110.524 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 58' ' ' LEU . 60.6 mt -79.6 146.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.162 -0.681 . . . . 0.26000000000000001 109.162 174.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.601 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.33 117.44 32.75 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.536 0.684 . . . . 2.2200000000000002 110.127 -177.442 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.44 -31.4 42.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.054 -0.975 . . . . 0.28999999999999998 110.628 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.06 -14.83 78.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.941 -0.647 . . . . 0.56999999999999995 113.404 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -101.58 -12.57 18.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.07 0.435 . . . . 0.85999999999999999 110.91 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.5 mt -51.75 127.09 19.72 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.661 0.743 . . . . 0.46000000000000002 111.447 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -76.16 -54.38 6.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.424 -1.262 . . . . 2.0099999999999998 113.263 -166.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.17 -84.41 0.37 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.963 -0.295 . . . . 1.0900000000000001 111.614 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.4 mm? -115.11 168.04 10.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.426 0.631 . . . . 0.14999999999999999 110.798 173.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 50' ' ' LEU . 1.6 m -121.67 172.26 9.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.362 -1.718 . . . . 0.25 106.362 168.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -138.96 150.12 21.03 Favored Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.119 -1.038 . . . . 0.37 111.486 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -116.36 133.72 55.7 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.989 0.423 . . . . 0.28999999999999998 109.876 174.55 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 53.09 52.92 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.965 -1.016 . . . . 1.8500000000000001 111.027 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.422 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 35.7 m -86.46 152.4 22.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.479 -0.782 . . . . 1.1200000000000001 110.473 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.5 m -107.37 115.55 59.42 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.773 -0.648 . . . . 1.26 109.932 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.37 121.77 9.11 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.546 2.164 . . . . 0.60999999999999999 111.769 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.518 HD11 ' HB2' ' A' ' 40' ' ' CYS . 27.1 mt . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 115.747 -0.661 . . . . 0.85999999999999999 110.027 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.605 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.532 0.206 . . . . 0.54000000000000004 110.841 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.41 122.87 32.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.271 0.557 . . . . 0.78000000000000003 110.745 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.97 123.16 39.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.229 0.538 . . . . 0.39000000000000001 111.147 -174.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.581 HG11 HG21 ' A' ' 44' ' ' THR . 6.5 m -133.85 167.54 26.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.588 -0.733 . . . . 0.22 111.49 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 41.8 t -111.35 121.74 46.04 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.473 -0.936 . . . . 0.70999999999999996 108.473 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 22.9 m -122.35 148.63 44.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.023 0.439 . . . . 0.60999999999999999 110.969 -171.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.9 t -79.2 -28.15 42.6 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.423 -0.808 . . . . 0.38 110.837 -169.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.499 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 19.6 m120 -156.0 161.64 40.44 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.053 -0.721 . . . . 0.78000000000000003 109.053 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.7 t -142.22 144.67 33.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.799 0.333 . . . . 0.41999999999999998 110.516 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.589 ' HB2' HG23 ' A' ' 105' ' ' VAL . 70.3 m-85 -133.65 160.77 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.756 -0.461 . . . . 0.77000000000000002 109.756 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.539 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 15.9 mm-40 60.97 23.7 13.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 0.80000000000000004 111.566 175.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 63.01 13.39 6.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.582 -0.735 . . . . 2.1200000000000001 112.442 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.88 -24.34 3.01 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.211 -0.995 . . . . 0.28000000000000003 113.133 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 14.9 mt -49.63 -38.01 30.37 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.852 0.326 . . . . 0.35999999999999999 111.018 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.589 HG23 ' HB2' ' A' ' 100' ' ' TYR . 4.2 m -131.87 141.53 45.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.892 -0.595 . . . . 0.85999999999999999 109.559 172.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.438 ' ND2' ' SG ' ' A' ' 96' ' ' CYS . 21.5 t30 -140.63 144.63 35.85 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.201 -1.037 . . . . 0.91000000000000003 108.201 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.499 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.4 m -129.46 151.02 35.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 113.396 0.887 . . . . 0.29999999999999999 113.396 -172.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 64.07 51.85 49.6 Favored Glycine 0 CA--C 1.506 -0.505 0 CA-C-N 114.91 -1.041 . . . . 0.20000000000000001 111.807 177.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 90.9 m -97.12 127.91 43.53 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.014 0.435 . . . . 0.42999999999999999 111.884 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.7 p -122.26 126.47 26.23 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.528 -0.76 . . . . 0.29999999999999999 109.701 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.522 ' HA ' HG12 ' A' ' 94' ' ' VAL . 71.4 Cg_exo -50.46 110.49 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.003 2.469 . . . . 0.34000000000000002 112.586 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.688 -0.687 . . . . 0.58999999999999997 110.664 -179.439 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 39' ' ' TYR . 94.5 t . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 108.143 -1.058 . . . . 0.58999999999999997 108.143 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.434 ' N ' HG12 ' A' ' 38' ' ' VAL . 45.7 m-85 -124.2 130.82 53.19 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.875 -0.73 . . . . 0.78000000000000003 111.362 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 36.2 t -105.14 106.12 16.47 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.442 -0.799 . . . . 0.81999999999999995 109.426 176.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -97.8 133.3 42.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.801 -0.636 . . . . 0.23999999999999999 110.44 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.435 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 3.1 m-20 -58.53 -24.85 61.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.772 . . . . 2.0800000000000001 109.716 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.547 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -162.79 135.61 5.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.176 -1.375 . . . . 2.5800000000000001 107.446 177.323 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.603 HG21 HG11 ' A' ' 94' ' ' VAL . 23.7 p -92.63 159.67 15.36 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.356 -0.938 . . . . 0.37 110.062 165.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.554 ' HB3' HG22 ' A' ' 72' ' ' VAL . 8.0 tp10 -126.28 140.32 52.62 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.608 -0.724 . . . . 1.1200000000000001 109.712 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.426 ' HA ' HD12 ' A' ' 71' ' ' LEU . 3.2 m-20 -72.31 109.15 5.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.073 -0.512 . . . . 1.77 110.438 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.603 ' HA ' HD21 ' A' ' 50' ' ' LEU . 88.0 p -64.12 -4.92 3.97 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.48 0.548 . . . . 0.92000000000000004 112.48 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.4 mptp? -73.84 -42.11 61.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.342 0.592 . . . . 2.77 110.243 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -142.51 66.67 1.33 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.19 -0.913 . . . . 2.3300000000000001 110.735 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.603 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -56.97 148.76 20.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.176 0.512 . . . . 1.1599999999999999 111.522 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.26 166.16 19.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.589 -0.732 . . . . 1.8100000000000001 109.78 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 11.3 mptt -58.98 -47.68 84.28 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.539 -0.464 . . . . 3.23 110.698 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.65 -39.27 75.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.066 -0.587 . . . . 0.34000000000000002 112.517 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.674 ' HA ' HD22 ' A' ' 57' ' ' LEU . 13.4 m -77.86 -43.17 31.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.753 0.311 . . . . 0.35999999999999999 110.559 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.9 m -56.05 -33.71 65.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.3 0.572 . . . . 0.29999999999999999 109.795 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.586 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.29 -54.51 46.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.17 -0.923 . . . . 0.23000000000000001 111.304 176.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.674 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -58.12 -46.75 85.05 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.485 0.66 . . . . 0.23999999999999999 110.039 -179.244 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.5 mt -58.69 -44.83 90.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.972 -1.013 . . . . 0.17999999999999999 110.195 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.82 -37.18 92.11 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.955 -0.64 . . . . 0.26000000000000001 112.686 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.5 mt -60.12 -45.58 92.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.041 0.924 . . . . 0.34000000000000002 110.312 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.432 ' CD1' HG21 ' A' ' 105' ' ' VAL . 6.8 mt -86.31 -0.02 54.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.391 -1.277 . . . . 0.35999999999999999 111.371 -176.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 68.79 31.25 4.51 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.544 -0.753 . . . . 1.8899999999999999 111.093 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 58' ' ' LEU . 53.6 mt -79.95 145.08 9.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.827 -0.624 . . . . 0.26000000000000001 109.806 177.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.56 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -98.35 118.2 34.47 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.761 -0.654 . . . . 2.2200000000000002 109.93 -178.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.14 -38.02 54.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.345 -0.843 . . . . 0.28999999999999998 110.963 -174.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.75 -1.98 63.43 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.846 -0.693 . . . . 0.56999999999999995 113.007 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.492 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 33.9 t70 -113.97 2.13 14.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.628 0.728 . . . . 0.85999999999999999 109.968 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.7 mt -74.19 152.47 39.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.593 -0.73 . . . . 0.46000000000000002 111.074 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -95.84 -97.64 0.18 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 2.0099999999999998 112.401 -173.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.79 -93.27 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.13 0.419 . . . . 1.0900000000000001 112.13 -173.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.1 mm? -111.61 170.02 8.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.41 0.624 . . . . 0.14999999999999999 111.279 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.606 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.9 OUTLIER -121.39 165.5 16.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 106.189 -1.782 . . . . 0.25 106.189 165.478 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.47 134.08 6.8 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 119.748 -1.215 . . . . 0.37 112.124 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.659 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -100.89 136.45 40.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.459 . . . . 0.28999999999999998 110.581 178.537 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 51.49 52.2 15.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.855 -1.066 . . . . 1.8500000000000001 111.095 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.1 m -88.51 138.75 31.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.001 -0.545 . . . . 1.1200000000000001 110.89 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 m -86.68 119.6 71.39 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.75 -0.659 . . . . 1.26 110.139 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.27 121.16 7.53 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.467 2.111 . . . . 0.60999999999999999 112.133 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 mt . . . . . 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 0.85999999999999999 109.196 179.91 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.598 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.809 0.338 . . . . 0.54000000000000004 111.279 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.56 117.83 30.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.33 0.586 . . . . 0.78000000000000003 110.753 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.71 121.92 32.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.323 0.583 . . . . 0.39000000000000001 111.566 -174.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.603 HG11 HG21 ' A' ' 44' ' ' THR . 6.7 m -133.26 164.27 35.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.552 -0.749 . . . . 0.22 110.939 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.9 t -113.38 112.29 23.41 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.54 -0.754 . . . . 0.70999999999999996 109.317 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 21.9 m -106.28 145.0 32.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.363 -0.381 . . . . 0.60999999999999999 110.311 -174.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.3 t -77.3 -25.53 51.39 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.069 -0.514 . . . . 0.38 110.797 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.64 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 19.8 m120 -148.67 155.75 41.45 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.786 -0.82 . . . . 0.78000000000000003 108.786 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.4 t -123.12 144.54 49.26 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.915 0.388 . . . . 0.41999999999999998 110.181 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.532 ' CB ' HG23 ' A' ' 105' ' ' VAL . 26.0 m-85 -130.19 143.27 50.68 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.016 -0.538 . . . . 0.77000000000000002 110.731 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.552 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 11.2 mm-40 60.93 32.85 19.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.80000000000000004 111.817 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 66.06 0.33 1.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.197 0.599 . . . . 2.1200000000000001 112.431 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.97 -19.78 1.96 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.372 -0.918 . . . . 0.28000000000000003 112.817 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 20.0 mt -51.89 -39.51 59.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.742 0.271 . . . . 0.35999999999999999 111.258 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.532 HG23 ' CB ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -136.4 145.41 30.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.385 -0.371 . . . . 0.85999999999999999 110.531 175.15 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.606 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 41.4 m-80 -140.28 161.95 36.46 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.298 -0.63 . . . . 0.91000000000000003 109.298 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.64 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 8.3 m -133.71 150.05 31.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.009 0.374 . . . . 0.29999999999999999 112.009 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 58.7 54.89 34.15 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.328 -0.851 . . . . 0.20000000000000001 111.583 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 75.5 m -96.3 124.48 40.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.997 0.427 . . . . 0.42999999999999999 110.669 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 p -121.18 125.49 26.93 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.629 -0.714 . . . . 0.29999999999999999 110.524 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HA ' HG12 ' A' ' 94' ' ' VAL . 78.6 Cg_exo -47.62 114.01 0.93 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.29 2.66 . . . . 0.34000000000000002 112.776 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.2 tt . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.503 -0.771 . . . . 0.58999999999999997 110.799 -176.951 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.53 HG12 ' N ' ' A' ' 39' ' ' TYR . 47.3 t . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 107.99 -1.115 . . . . 0.58999999999999997 107.99 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.557 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 75.4 m-85 -128.71 120.62 26.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.954 0.883 . . . . 0.78000000000000003 112.034 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.622 ' HB2' HD21 ' A' ' 79' ' ' LEU . 33.1 t -91.13 99.13 12.2 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.344 -1.298 . . . . 0.81999999999999995 110.305 177.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.8 m -101.89 129.65 48.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.674 -0.861 . . . . 0.23999999999999999 108.674 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -53.57 -29.52 37.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.356 -0.838 . . . . 2.0800000000000001 110.439 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -170.5 125.13 0.72 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.001 -1.111 . . . . 2.5800000000000001 108.001 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.567 HG21 HG11 ' A' ' 94' ' ' VAL . 20.5 p -85.59 142.15 29.32 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.286 -0.966 . . . . 0.37 111.462 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.58 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.6 tp10 -114.21 142.21 46.55 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.891 -1.05 . . . . 1.1200000000000001 109.591 -174.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.414 ' O ' HD13 ' A' ' 50' ' ' LEU . 10.3 m-20 -62.0 110.79 1.68 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.372 -0.377 . . . . 1.77 110.443 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.587 ' HA ' HD21 ' A' ' 50' ' ' LEU . 77.5 p -65.88 -8.32 21.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.198 0.523 . . . . 0.92000000000000004 111.173 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -91.23 -24.68 19.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.993 -0.549 . . . . 2.77 110.067 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -141.06 59.71 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.029 -0.532 . . . . 2.3300000000000001 111.132 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.7 mm? -64.21 152.61 40.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 1.1599999999999999 111.768 176.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.82 152.86 43.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.551 -0.907 . . . . 1.8100000000000001 108.551 171.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.545 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -57.81 -29.4 64.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.121 -0.632 . . . . 3.23 110.146 176.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -66.17 -40.47 94.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.119 -0.562 . . . . 0.34000000000000002 111.736 176.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.651 ' HA ' HD22 ' A' ' 57' ' ' LEU . 20.0 m -78.06 -42.34 32.58 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.025 -0.27 . . . . 0.35999999999999999 110.647 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.0 m -53.61 -35.62 61.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.962 -0.563 . . . . 0.29999999999999999 109.685 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.527 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.75 -54.32 47.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.211 -0.904 . . . . 0.23000000000000001 111.772 176.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.651 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -59.56 -45.46 91.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.48 0.657 . . . . 0.23999999999999999 109.919 -178.289 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 54' ' ' THR . 48.6 mt -60.01 -44.38 94.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.886 -1.052 . . . . 0.17999999999999999 109.767 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.79 -38.71 92.64 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.707 -0.679 . . . . 0.26000000000000001 112.44 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 24.8 mt -56.89 -49.17 76.35 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.657 0.741 . . . . 0.34000000000000002 110.176 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.7 mt -84.16 -0.78 53.4 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.589 -1.187 . . . . 0.35999999999999999 111.13 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 66.91 35.82 4.65 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.269 -0.878 . . . . 1.8899999999999999 111.252 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 58' ' ' LEU . 52.5 mt -84.08 142.22 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 115.626 -0.716 . . . . 0.26000000000000001 109.702 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.401 ' H ' ' HD3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -95.67 118.2 31.92 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.345 0.593 . . . . 2.2200000000000002 110.12 -178.065 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.58 -30.26 44.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.114 -0.948 . . . . 0.28999999999999998 110.573 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.61 -8.59 84.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.862 -0.685 . . . . 0.56999999999999995 112.968 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -110.04 3.26 20.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.376 0.607 . . . . 0.85999999999999999 110.638 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.2 mt -72.81 156.49 38.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.272 0.558 . . . . 0.46000000000000002 111.05 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -92.76 -82.47 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.543 -0.753 . . . . 2.0099999999999998 112.854 -170.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.42 -88.36 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 1.0900000000000001 111.857 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.1 mm? -114.0 169.23 9.16 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.13 0.49 . . . . 0.14999999999999999 110.892 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.618 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -121.57 168.26 14.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.037 -1.468 . . . . 0.25 107.037 167.491 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.401 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -138.49 127.27 3.72 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.687 -1.244 . . . . 0.37 112.414 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -90.86 136.08 33.31 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.259 -0.576 . . . . 0.28999999999999998 110.179 178.416 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 49.67 49.69 19.59 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.15 -0.932 . . . . 1.8500000000000001 110.848 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 6.0 t -87.62 142.13 28.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.448 -0.796 . . . . 1.1200000000000001 110.523 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.7 m -113.57 116.27 46.05 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.627 -0.715 . . . . 1.26 111.07 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 23.3 Cg_exo -64.95 129.8 24.18 Favored 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 122.623 2.216 . . . . 0.60999999999999999 112.078 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 40' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 N-CA-C 109.688 -0.486 . . . . 0.85999999999999999 109.688 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.548 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--O 1.235 0.324 0 N-CA-C 110.08 -0.341 . . . . 0.54000000000000004 110.08 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.83 134.13 35.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.718 -0.475 . . . . 0.78000000000000003 109.718 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.69 117.85 34.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.284 0.564 . . . . 0.39000000000000001 111.216 -172.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.567 HG11 HG21 ' A' ' 44' ' ' THR . 6.7 m -131.78 165.48 31.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.616 -0.72 . . . . 0.22 110.942 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 37.6 t -110.58 120.75 43.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.419 -0.956 . . . . 0.70999999999999996 108.419 176.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 30.9 m -117.85 151.42 37.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.036 0.446 . . . . 0.60999999999999999 110.844 -170.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.6 t -78.92 -28.39 43.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.631 -0.713 . . . . 0.38 110.448 -172.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.432 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 13.5 m120 -153.57 163.45 39.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.921 -0.581 . . . . 0.78000000000000003 109.977 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.0 t -127.99 130.5 48.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.108 0.48 . . . . 0.41999999999999998 110.375 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.493 ' CB ' HG23 ' A' ' 105' ' ' VAL . 44.2 m-85 -119.48 142.21 48.48 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.749 -0.659 . . . . 0.77000000000000002 110.79 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.455 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 6.6 mm100 61.56 33.27 18.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.071 -0.513 . . . . 0.80000000000000004 111.824 175.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 63.21 6.58 2.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.044 0.538 . . . . 2.1200000000000001 112.181 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.28 -22.11 2.92 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.893 -1.146 . . . . 0.28000000000000003 113.425 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 13.7 mt -50.12 -40.85 47.39 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.475 0.638 . . . . 0.35999999999999999 110.547 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.493 HG23 ' CB ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -130.14 119.09 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.494 0.664 . . . . 0.85999999999999999 110.298 174.644 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.618 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 2.7 t30 -113.51 151.87 30.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.321 -0.992 . . . . 0.91000000000000003 108.321 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 10.5 m -135.55 152.16 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.048 0.758 . . . . 0.29999999999999999 113.048 -175.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 65.75 49.1 61.4 Favored Glycine 0 CA--C 1.506 -0.511 0 CA-C-N 115.154 -0.93 . . . . 0.20000000000000001 111.755 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 72.5 m -97.89 126.36 43.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.894 0.378 . . . . 0.42999999999999999 111.454 -172.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -120.23 126.05 26.99 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.703 -0.681 . . . . 0.29999999999999999 110.009 175.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.552 ' HA ' HG12 ' A' ' 94' ' ' VAL . 73.6 Cg_exo -49.61 109.87 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.12 2.546 . . . . 0.34000000000000002 112.345 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 tt . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.665 -0.698 . . . . 0.58999999999999997 110.789 -175.233 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 39' ' ' TYR . 97.5 t . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 107.616 -1.253 . . . . 0.58999999999999997 107.616 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.483 ' N ' HG12 ' A' ' 38' ' ' VAL . 77.1 m-85 -127.06 139.05 53.28 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.892 0.769 . . . . 0.78000000000000003 111.779 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 42.7 t -116.14 103.77 10.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.323 -0.853 . . . . 0.81999999999999995 110.292 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.6 m -106.01 135.95 46.54 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.253 -0.647 . . . . 0.23999999999999999 109.253 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 59.0 m-80 -59.32 -23.66 62.66 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.696 -0.684 . . . . 2.0800000000000001 110.622 177.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HD3' ' O ' ' A' ' 44' ' ' THR . 12.4 tmtt? -176.15 125.33 0.2 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.739 -1.208 . . . . 2.5800000000000001 107.739 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.588 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 34.1 p -89.64 152.55 21.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.43 -0.908 . . . . 0.37 111.538 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.601 ' HB3' HG22 ' A' ' 72' ' ' VAL . 14.8 tp10 -115.14 138.33 51.02 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.256 -0.883 . . . . 1.1200000000000001 109.15 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.459 ' HA ' HD12 ' A' ' 71' ' ' LEU . 17.6 m-20 -74.59 109.23 7.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.357 -0.383 . . . . 1.77 110.495 -175.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.475 ' HA ' HD21 ' A' ' 50' ' ' LEU . 6.3 m -50.76 -25.31 4.23 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.971 0.794 . . . . 0.92000000000000004 112.454 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.501 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.4 mptp? -64.83 -45.5 85.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.238 0.542 . . . . 2.77 111.012 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -133.45 58.07 1.78 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.548 -0.751 . . . . 2.3300000000000001 110.522 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.475 HD21 ' HA ' ' A' ' 47' ' ' SER . 80.5 mt -57.17 158.36 5.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.311 -0.859 . . . . 1.1599999999999999 112.812 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.66 154.97 39.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.505 -1.225 . . . . 1.8100000000000001 109.243 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -67.54 -32.99 74.15 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.066 -0.346 . . . . 3.23 110.066 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -67.01 -33.74 84.75 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.478 -0.649 . . . . 0.34000000000000002 111.478 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.641 ' HA ' HD22 ' A' ' 57' ' ' LEU . 28.3 m -79.33 -44.29 21.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.35999999999999999 110.056 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.4 m -52.79 -35.37 56.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.485 -0.78 . . . . 0.29999999999999999 109.819 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.528 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.76 -51.59 68.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.306 -0.861 . . . . 0.23000000000000001 112.013 176.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.641 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -61.84 -43.66 98.39 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.518 0.675 . . . . 0.23999999999999999 109.961 -178.135 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.2 mt -60.24 -44.25 95.4 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.933 -1.03 . . . . 0.17999999999999999 110.105 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.29 -38.08 89.15 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.775 -0.648 . . . . 0.26000000000000001 112.281 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 32.7 mt -57.11 -50.44 72.77 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.746 0.784 . . . . 0.34000000000000002 110.124 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.505 HD21 HE21 ' A' ' 101' ' ' GLN . 5.0 mt -84.02 -2.85 57.43 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.581 -1.19 . . . . 0.35999999999999999 111.501 -174.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.5 t30 68.17 35.01 3.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.725 0.774 . . . . 1.8899999999999999 110.488 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 58' ' ' LEU . 55.8 mt -81.77 146.61 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.468 -0.787 . . . . 0.26000000000000001 110.008 176.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -95.98 117.92 31.59 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.265 0.555 . . . . 2.2200000000000002 110.198 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -71.72 -29.98 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.297 -0.865 . . . . 0.28999999999999998 110.332 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.22 -16.64 78.63 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.949 -0.569 . . . . 0.56999999999999995 112.679 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -91.67 -16.41 27.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.179 0.514 . . . . 0.85999999999999999 110.2 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.37 137.86 57.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.64 -0.709 . . . . 0.46000000000000002 111.025 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 2.4 mptp? -94.07 -88.72 0.23 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.168 -0.923 . . . . 2.0099999999999998 111.808 -170.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.13 -96.2 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.888 0.329 . . . . 1.0900000000000001 111.888 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 44' ' ' THR . 1.8 mm? -111.24 170.83 7.85 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.475 0.655 . . . . 0.14999999999999999 111.363 178.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -125.14 169.9 15.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 107.065 -1.457 . . . . 0.25 107.065 166.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -138.69 131.43 5.33 Favored Glycine 0 C--N 1.311 -0.822 0 C-N-CA 119.653 -1.261 . . . . 0.37 112.159 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.31 136.21 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.354 -0.538 . . . . 0.28999999999999998 109.787 178.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.97 49.3 19.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.133 -0.94 . . . . 1.8500000000000001 110.662 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 11.6 t -90.68 144.52 25.66 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.521 -1.218 . . . . 1.1200000000000001 109.588 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 40' ' ' CYS . 13.5 p -106.29 118.63 54.3 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.507 -0.315 . . . . 1.26 111.252 -177.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.15 119.6 6.41 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.457 2.105 . . . . 0.60999999999999999 111.783 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.661 -0.699 . . . . 0.85999999999999999 109.313 -179.29 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.467 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 110.151 -0.314 . . . . 0.54000000000000004 110.151 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB2' HE21 ' A' ' 92' ' ' GLN . 0.0 OUTLIER -82.46 124.59 30.21 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.444 0.64 . . . . 0.78000000000000003 110.366 -176.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.49 126.4 45.42 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.52 0.676 . . . . 0.39000000000000001 111.359 -170.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 111' ' ' PRO . 5.0 m -134.0 165.85 30.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.228 -0.896 . . . . 0.22 110.69 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 46.0 t -112.87 120.95 43.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.541 -0.911 . . . . 0.70999999999999996 108.541 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 13.8 m -124.07 153.55 41.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.864 0.364 . . . . 0.60999999999999999 110.954 -169.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.2 t -83.5 -19.24 36.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.905 -0.589 . . . . 0.38 111.671 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -166.93 169.02 13.47 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 122.554 0.342 . . . . 0.78000000000000003 110.424 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.3 t -145.9 143.53 29.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.869 -0.605 . . . . 0.41999999999999998 110.429 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.578 ' HB2' HG23 ' A' ' 105' ' ' VAL . 35.8 m-85 -135.04 160.21 39.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.074 -0.512 . . . . 0.77000000000000002 109.885 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.505 HE21 HD21 ' A' ' 61' ' ' LEU . 58.1 mm-40 61.14 25.18 15.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.347 -0.388 . . . . 0.80000000000000004 111.842 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 60.17 13.94 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 2.1200000000000001 112.306 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.68 -30.84 1.67 Allowed Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.146 -1.026 . . . . 0.28000000000000003 113.414 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 14.6 mt -49.23 -40.51 34.12 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.969 0.385 . . . . 0.35999999999999999 111.843 -175.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.578 HG23 ' HB2' ' A' ' 100' ' ' TYR . 3.7 m -131.07 136.23 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.546 0.689 . . . . 0.85999999999999999 110.664 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.499 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 32.0 t30 -132.76 141.98 48.79 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.271 -1.381 . . . . 0.91000000000000003 107.271 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 17.1 m -125.07 150.23 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 113.623 0.972 . . . . 0.29999999999999999 113.623 -170.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 63.54 51.7 52.13 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.726 -1.125 . . . . 0.20000000000000001 111.755 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 90.4 m -97.02 131.04 44.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.992 0.425 . . . . 0.42999999999999999 111.66 -173.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 p -123.37 126.56 25.84 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.529 -0.76 . . . . 0.29999999999999999 110.0 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.599 ' HA ' HG12 ' A' ' 94' ' ' VAL . 52.6 Cg_exo -52.31 116.59 2.93 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.8 2.333 . . . . 0.34000000000000002 112.462 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.2 tt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.855 -0.612 . . . . 0.58999999999999997 110.549 -178.65 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 39' ' ' TYR . 84.2 t . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 107.801 -1.185 . . . . 0.58999999999999997 107.801 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.486 ' N ' HG12 ' A' ' 38' ' ' VAL . 87.4 m-85 -127.99 132.25 49.18 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 118.68 0.673 . . . . 0.78000000000000003 111.211 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.825 ' SG ' ' HB2' ' A' ' 77' ' ' SER . 27.1 p -107.09 107.66 18.76 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.555 -0.748 . . . . 0.81999999999999995 110.025 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.6 m -98.66 137.38 37.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.445 -0.798 . . . . 0.23999999999999999 110.626 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -55.03 -27.67 46.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.781 0.801 . . . . 2.0800000000000001 109.356 172.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -169.56 137.4 1.78 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.306 -1.316 . . . . 2.5800000000000001 108.247 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.603 HG21 HG11 ' A' ' 94' ' ' VAL . 14.3 p -92.85 149.28 21.37 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.461 -0.896 . . . . 0.37 110.306 168.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.567 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.7 tp10 -112.35 134.32 53.96 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.528 -0.76 . . . . 1.1200000000000001 109.287 -176.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.497 ' HA ' HD12 ' A' ' 71' ' ' LEU . 4.7 m-20 -67.14 114.1 5.62 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.729 -0.669 . . . . 1.77 111.051 -174.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.768 ' HA ' HD21 ' A' ' 50' ' ' LEU . 68.5 m -60.14 -13.03 10.03 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.392 0.433 . . . . 0.92000000000000004 111.88 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -79.29 -36.22 40.04 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.522 0.677 . . . . 2.77 109.95 177.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -140.4 66.08 1.39 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.039 -0.982 . . . . 2.3300000000000001 111.517 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.7 mm? -64.91 147.43 53.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.096 0.474 . . . . 1.1599999999999999 110.962 171.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.59 171.06 13.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.638 -0.71 . . . . 1.8100000000000001 110.221 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -61.24 -47.96 83.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.62 0.248 . . . . 3.23 111.088 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.64 -35.32 62.0 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.34000000000000002 112.708 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.602 ' HA ' HD22 ' A' ' 57' ' ' LEU . 11.2 m -81.8 -41.61 20.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.243 -0.28 . . . . 0.35999999999999999 110.243 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.2 m -53.81 -34.77 60.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.409 0.623 . . . . 0.29999999999999999 109.928 174.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.469 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.96 -53.76 54.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.063 -0.971 . . . . 0.23000000000000001 111.908 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -61.12 -46.19 91.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.547 0.689 . . . . 0.23999999999999999 109.973 -178.252 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 54' ' ' THR . 46.1 mt -58.64 -41.93 87.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.685 -1.143 . . . . 0.17999999999999999 109.848 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.92 -32.45 84.01 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.748 -0.66 . . . . 0.26000000000000001 112.704 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.1 mt -62.96 -50.55 70.34 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.666 0.746 . . . . 0.34000000000000002 109.811 177.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mt -81.43 -0.75 42.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.517 -1.219 . . . . 0.35999999999999999 111.216 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 t30 68.61 38.18 2.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.324 -0.853 . . . . 1.8899999999999999 110.559 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 58' ' ' LEU . 49.3 mt -87.07 141.59 14.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.584 -0.735 . . . . 0.26000000000000001 109.746 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.65 118.6 31.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.532 0.682 . . . . 2.2200000000000002 110.179 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.437 HG23 HD23 ' A' ' 50' ' ' LEU . 1.8 mp -67.65 -36.99 77.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.818 -1.083 . . . . 0.28999999999999998 110.93 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.58 -14.91 70.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.97 -0.633 . . . . 0.56999999999999995 113.177 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.12 3.62 33.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.238 0.542 . . . . 0.85999999999999999 110.725 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 94.2 mt -71.47 144.27 49.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.052 0.453 . . . . 0.46000000000000002 110.853 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -94.85 -96.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.581 -0.736 . . . . 2.0099999999999998 112.542 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.59 -85.98 0.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 1.0900000000000001 111.897 -172.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.3 mm? -120.13 165.14 15.15 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.529 0.681 . . . . 0.14999999999999999 111.063 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -119.9 167.56 13.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 106.017 -1.846 . . . . 0.25 106.017 167.262 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 105' ' ' VAL . . . -135.01 137.59 9.36 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.671 -1.252 . . . . 0.37 111.583 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.664 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -109.85 129.49 55.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.49 0.645 . . . . 0.28999999999999998 110.765 178.441 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.462 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 0.6 OUTLIER 54.3 52.9 11.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.6 -1.182 . . . . 1.8500000000000001 111.487 176.646 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.6 m -92.0 154.06 19.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.252 -0.885 . . . . 1.1200000000000001 109.983 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.825 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 57.6 m -102.75 129.64 25.43 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.38 -0.373 . . . . 1.26 110.089 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 6.6 Cg_exo -74.09 119.64 5.93 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.601 2.201 . . . . 0.60999999999999999 112.276 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.751 HD21 ' SG ' ' A' ' 40' ' ' CYS . 9.8 mt . . . . . 0 C--N 1.32 -0.71 0 CA-C-N 115.527 -0.76 . . . . 0.85999999999999999 108.952 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 110.201 -0.296 . . . . 0.54000000000000004 110.201 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.55 117.24 29.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.316 0.579 . . . . 0.78000000000000003 109.536 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.85 122.49 33.61 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.817 -0.629 . . . . 0.39000000000000001 111.078 -173.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.603 HG11 HG21 ' A' ' 44' ' ' THR . 12.3 m -135.29 162.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.629 -0.714 . . . . 0.22 111.191 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 49.6 t -108.49 109.68 21.0 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.793 -0.817 . . . . 0.70999999999999996 108.793 176.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 39.5 m -102.01 148.19 25.66 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.242 -0.281 . . . . 0.60999999999999999 110.242 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.0 t -81.46 -27.27 34.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.055 0.455 . . . . 0.38 110.501 -173.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.524 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 14.8 m120 -149.05 165.89 30.35 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.769 -0.65 . . . . 0.78000000000000003 109.374 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.2 t -136.73 139.87 42.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.118 -0.492 . . . . 0.41999999999999998 110.223 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.584 ' HB2' HG23 ' A' ' 105' ' ' VAL . 57.7 m-85 -128.07 147.88 50.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.922 -0.581 . . . . 0.77000000000000002 109.732 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.461 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 12.1 mm-40 63.58 22.91 13.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.80000000000000004 111.208 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 67.49 9.99 7.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.921 -0.581 . . . . 2.1200000000000001 112.079 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.11 -22.12 2.1 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.333 -0.936 . . . . 0.28000000000000003 113.269 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.8 mt -54.0 -35.78 62.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.877 0.338 . . . . 0.35999999999999999 111.574 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.584 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -144.14 119.6 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.253 0.549 . . . . 0.85999999999999999 111.042 174.516 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.4 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 90.6 m-20 -114.62 161.82 17.59 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.728 -0.669 . . . . 0.91000000000000003 109.785 177.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.9 m -130.73 156.89 42.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 111.896 0.332 . . . . 0.29999999999999999 111.896 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 57.37 52.64 50.42 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.554 -0.748 . . . . 0.20000000000000001 111.929 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 68.4 m -96.79 128.42 43.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.763 0.316 . . . . 0.42999999999999999 110.739 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.1 p -123.02 127.36 25.72 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.93 -0.577 . . . . 0.29999999999999999 110.355 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.534 ' HA ' HG12 ' A' ' 94' ' ' VAL . 51.8 Cg_exo -53.58 115.33 2.25 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.129 2.552 . . . . 0.34000000000000002 112.934 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.739 -0.664 . . . . 0.58999999999999997 110.064 178.04 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 39' ' ' TYR . 49.1 t . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 120.791 0.329 . . . . 0.58999999999999997 110.228 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.427 ' N ' HG12 ' A' ' 38' ' ' VAL . 70.2 m-85 -135.77 141.48 44.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.089 0.471 . . . . 0.78000000000000003 109.91 177.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.59 ' HB3' ' OG ' ' A' ' 77' ' ' SER . 16.4 t -107.0 107.86 19.08 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.166 -0.47 . . . . 0.81999999999999995 109.966 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.0 m -108.08 134.18 51.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.925 0.393 . . . . 0.23999999999999999 110.426 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.475 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 4.8 m-20 -60.11 -20.23 57.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 2.0800000000000001 110.293 176.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.92 129.91 0.31 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.1 -1.074 . . . . 2.5800000000000001 108.1 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.533 HG21 HG11 ' A' ' 94' ' ' VAL . 18.4 p -87.42 152.86 21.9 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.174 -1.011 . . . . 0.37 111.09 172.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HB3' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -115.16 142.43 46.67 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.238 -0.892 . . . . 1.1200000000000001 109.29 -174.595 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.474 ' HA ' HD12 ' A' ' 71' ' ' LEU . 10.2 m-20 -78.31 108.4 11.62 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.105 -0.498 . . . . 1.77 110.86 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.747 ' HA ' HD21 ' A' ' 50' ' ' LEU . 46.7 m -58.92 -12.49 4.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.064 0.765 . . . . 0.92000000000000004 113.064 -176.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -81.18 -32.84 33.38 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.967 -0.293 . . . . 2.77 110.343 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -147.29 67.11 1.14 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.328 -0.396 . . . . 2.3300000000000001 110.75 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.747 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.9 mm? -59.42 153.63 18.75 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.462 0.648 . . . . 1.1599999999999999 111.495 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.86 150.67 48.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.916 -1.038 . . . . 1.8100000000000001 109.388 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.732 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -55.58 -36.4 66.84 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.01 0.194 . . . . 3.23 111.12 176.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -63.58 -40.66 98.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.793 -0.718 . . . . 0.34000000000000002 111.778 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.646 ' HA ' HD22 ' A' ' 57' ' ' LEU . 24.5 m -78.53 -42.84 28.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.853 0.359 . . . . 0.35999999999999999 110.229 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.5 m -52.04 -36.59 50.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.571 -0.741 . . . . 0.29999999999999999 109.957 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.503 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.06 -54.41 47.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.264 -0.88 . . . . 0.23000000000000001 111.817 176.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.646 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -59.18 -45.02 92.14 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.385 0.612 . . . . 0.23999999999999999 110.216 -177.292 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 54' ' ' THR . 48.5 mt -58.54 -42.33 87.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.905 -1.043 . . . . 0.17999999999999999 110.132 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.37 -37.05 93.98 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.712 -0.756 . . . . 0.26000000000000001 112.068 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 15.1 mt -63.03 -40.32 97.39 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.651 0.739 . . . . 0.34000000000000002 110.194 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.461 ' CD1' HG21 ' A' ' 105' ' ' VAL . 5.6 mt -90.5 4.19 51.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.86 -1.064 . . . . 0.35999999999999999 111.417 -176.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.9 m120 70.41 26.68 4.12 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.461 -0.79 . . . . 1.8899999999999999 111.264 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 58' ' ' LEU . 52.8 mt -81.48 145.86 8.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.02 -0.536 . . . . 0.26000000000000001 110.485 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.641 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -97.01 117.7 31.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.599 -0.728 . . . . 2.2200000000000002 109.987 -178.379 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.409 HG23 HD23 ' A' ' 50' ' ' LEU . 1.8 mp -75.69 -42.8 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.645 -0.707 . . . . 0.28999999999999998 111.449 -174.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.34 -8.63 71.14 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 121.017 -0.611 . . . . 0.56999999999999995 112.838 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.486 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 29.5 t70 -104.02 -9.31 18.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.974 0.416 . . . . 0.85999999999999999 110.497 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.517 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 94.8 mt -60.92 140.1 57.83 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.03 -0.532 . . . . 0.46000000000000002 110.657 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -88.89 -62.02 1.58 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.325 -0.852 . . . . 2.0099999999999998 113.085 -169.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.77 -95.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.379 0.511 . . . . 1.0900000000000001 112.379 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.1 mm? -117.77 165.78 13.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.544 0.688 . . . . 0.14999999999999999 111.391 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.524 HG13 HD11 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -119.86 173.4 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.776 -1.565 . . . . 0.25 106.776 169.169 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.545 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -141.41 148.66 20.35 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.844 -1.17 . . . . 0.37 111.533 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -110.76 133.52 53.27 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.879 -0.415 . . . . 0.28999999999999998 109.879 174.732 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 53.34 50.47 17.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.992 -1.004 . . . . 1.8500000000000001 111.188 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.545 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 60.6 m -86.93 143.01 27.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.07 -0.513 . . . . 1.1200000000000001 110.705 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.59 ' OG ' ' HB3' ' A' ' 40' ' ' CYS . 7.0 p -97.15 114.61 64.99 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.104 -0.498 . . . . 1.26 109.789 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.26 120.53 8.14 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.44 2.093 . . . . 0.60999999999999999 112.357 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 40' ' ' CYS . 35.0 mt . . . . . 0 C--N 1.322 -0.623 0 N-CA-C 108.964 -0.754 . . . . 0.85999999999999999 108.964 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 110.408 -0.219 . . . . 0.54000000000000004 110.408 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.57 130.09 38.92 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.235 0.54 . . . . 0.78000000000000003 109.769 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.406 HG22 ' CG1' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -105.79 119.11 38.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.319 0.581 . . . . 0.39000000000000001 111.448 -171.456 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 111' ' ' PRO . 5.2 m -130.99 163.86 35.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.577 -0.738 . . . . 0.22 110.573 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.5 t -109.6 120.34 42.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.575 -0.898 . . . . 0.70999999999999996 108.575 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.71 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 17.9 m -121.57 148.51 44.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.053 0.454 . . . . 0.60999999999999999 110.98 -169.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.4 t -78.29 -29.53 47.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.632 -0.713 . . . . 0.38 110.891 -172.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.419 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 17.0 m120 -157.0 158.74 37.11 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.91 -0.404 . . . . 0.78000000000000003 109.91 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 t -132.61 149.2 52.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.388 -0.597 . . . . 0.41999999999999998 109.388 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.608 ' HB2' HG23 ' A' ' 105' ' ' VAL . 81.6 m-85 -131.29 154.0 48.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.287 -0.634 . . . . 0.77000000000000002 109.287 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.503 ' OE1' HD12 ' A' ' 104' ' ' LEU . 13.6 mm-40 63.63 27.11 14.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 0.80000000000000004 110.878 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 65.48 6.53 3.79 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.594 -0.73 . . . . 2.1200000000000001 112.465 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 140.64 -19.64 2.77 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.207 -0.997 . . . . 0.28000000000000003 113.211 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 20.7 mt -47.91 -39.6 19.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.006 0.403 . . . . 0.35999999999999999 110.919 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.608 HG23 ' HB2' ' A' ' 100' ' ' TYR . 4.5 m -130.38 149.93 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.209 -0.663 . . . . 0.85999999999999999 109.209 171.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.494 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 31.5 t30 -144.05 147.82 34.34 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.154 -1.054 . . . . 0.91000000000000003 108.154 -173.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 9.2 m -131.59 153.52 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.415 0.895 . . . . 0.29999999999999999 113.415 -174.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.71 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 62.02 51.72 54.99 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.784 -1.098 . . . . 0.20000000000000001 111.985 176.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 83.9 m -97.82 127.76 43.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.978 0.418 . . . . 0.42999999999999999 111.919 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 p -119.78 127.83 26.19 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.806 -0.634 . . . . 0.29999999999999999 110.226 173.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.573 ' HA ' HG12 ' A' ' 94' ' ' VAL . 54.0 Cg_exo -51.29 113.23 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.049 2.5 . . . . 0.34000000000000002 112.563 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 tt . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.44 -0.8 . . . . 0.58999999999999997 110.414 -176.204 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 39' ' ' TYR . 86.7 t . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 107.397 -1.334 . . . . 0.58999999999999997 107.397 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.445 ' CD2' ' HB2' ' A' ' 96' ' ' CYS . 90.3 m-85 -129.09 134.41 48.07 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.518 -0.873 . . . . 0.78000000000000003 111.952 -177.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 31.9 t -105.46 103.47 13.0 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.857 -1.065 . . . . 0.81999999999999995 109.905 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.0 m -100.62 132.39 46.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.316 0.579 . . . . 0.23999999999999999 110.48 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.489 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 5.8 m-20 -57.6 -24.56 57.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.997 -1.001 . . . . 2.0800000000000001 110.508 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.86 119.33 0.35 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.266 -1.013 . . . . 2.5800000000000001 108.266 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.683 HG21 HG11 ' A' ' 94' ' ' VAL . 15.2 p -80.27 150.81 29.87 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 118.765 -1.174 . . . . 0.37 110.832 174.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.626 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.2 tp10 -119.87 138.32 53.47 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.44 -0.8 . . . . 1.1200000000000001 109.322 -176.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.551 ' HA ' HD12 ' A' ' 71' ' ' LEU . 26.5 m-20 -69.75 114.34 7.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.039 -0.528 . . . . 1.77 110.987 -173.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.733 ' HA ' HD21 ' A' ' 50' ' ' LEU . 49.5 m -61.03 -9.43 4.38 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.115 -0.493 . . . . 0.92000000000000004 111.831 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -90.19 -16.28 29.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.563 -0.29 . . . . 2.77 110.642 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -154.15 57.85 0.72 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.513 -0.312 . . . . 2.3300000000000001 111.542 -176.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.733 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -60.79 149.33 36.14 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.456 0.646 . . . . 1.1599999999999999 112.064 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.53 145.52 52.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.011 -0.995 . . . . 1.8100000000000001 108.401 172.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -20.33 66.23 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.779 -0.368 . . . . 3.23 110.742 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -73.24 -33.56 58.95 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.079 -0.808 . . . . 0.34000000000000002 111.079 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.639 ' HA ' HD22 ' A' ' 57' ' ' LEU . 43.3 m -79.97 -41.56 25.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.725 0.298 . . . . 0.35999999999999999 110.377 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.6 m -53.05 -35.2 59.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.338 0.59 . . . . 0.29999999999999999 109.777 172.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.49 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -55.59 -54.66 41.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.259 -0.882 . . . . 0.23000000000000001 111.611 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.639 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -60.22 -44.02 95.53 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.373 0.606 . . . . 0.23999999999999999 110.214 -178.78 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 54' ' ' THR . 53.3 mt -58.6 -45.06 89.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.988 -1.006 . . . . 0.17999999999999999 109.82 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.27 -36.59 91.26 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.833 -0.622 . . . . 0.26000000000000001 112.744 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 18.6 mt -59.71 -47.81 84.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.712 0.768 . . . . 0.34000000000000002 110.283 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.516 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.1 mt -86.12 -1.34 57.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.72 -1.127 . . . . 0.35999999999999999 111.115 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 66.17 36.54 5.51 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.256 -0.884 . . . . 1.8899999999999999 111.056 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 58' ' ' LEU . 54.8 mt -80.15 143.28 12.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.661 -0.699 . . . . 0.26000000000000001 109.474 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.634 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -94.18 117.87 30.73 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.462 0.649 . . . . 2.2200000000000002 110.002 -177.378 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.39 -34.08 56.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.957 -1.019 . . . . 0.28999999999999998 110.679 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.73 -16.88 72.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.017 -0.611 . . . . 0.56999999999999995 112.741 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.483 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 29.8 t70 -94.5 -15.76 23.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.76 0.314 . . . . 0.85999999999999999 110.659 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 94.1 mt -55.12 129.59 38.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.394 0.616 . . . . 0.46000000000000002 110.984 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 3.3 mptp? -88.07 -86.82 0.16 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.987 -1.006 . . . . 2.0099999999999998 112.262 -170.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -90.74 -94.92 0.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 1.0900000000000001 111.466 -171.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.2 mm? -113.6 167.62 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.088 -0.505 . . . . 0.14999999999999999 110.134 172.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -118.32 166.66 12.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 106.378 -1.712 . . . . 0.25 106.378 167.388 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.39 138.07 9.43 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 119.524 -1.322 . . . . 0.37 112.247 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.587 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -102.66 132.44 48.78 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.011 -0.676 . . . . 0.28999999999999998 109.64 173.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.453 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 1.5 t-20 59.0 57.96 3.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.804 -1.089 . . . . 1.8500000000000001 110.813 175.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 40' ' ' CYS . 29.4 m -94.72 139.23 31.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.531 -0.759 . . . . 1.1200000000000001 111.002 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 32.0 t -94.27 120.82 64.9 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.87 -0.604 . . . . 1.26 109.825 177.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 12.6 Cg_exo -70.86 120.4 7.04 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.816 2.344 . . . . 0.60999999999999999 112.632 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.5 mt . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 115.51 -0.768 . . . . 0.85999999999999999 109.336 179.621 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 110.001 -0.37 . . . . 0.54000000000000004 110.001 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.48 122.94 28.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.097 0.475 . . . . 0.78000000000000003 110.289 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.24 122.72 35.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.321 0.581 . . . . 0.39000000000000001 111.034 -175.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.683 HG11 HG21 ' A' ' 44' ' ' THR . 9.0 m -132.02 161.85 40.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.444 -0.798 . . . . 0.22 110.968 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 37.1 t -108.19 109.63 21.07 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.92 -0.77 . . . . 0.70999999999999996 108.92 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 14.3 m -110.14 153.56 24.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.229 -0.442 . . . . 0.60999999999999999 110.416 -173.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.7 t -80.7 -26.9 37.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.938 -0.574 . . . . 0.38 110.495 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.448 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 63.4 m-20 -155.15 166.21 34.3 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.78000000000000003 109.565 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.431 ' HB ' ' CE1' ' A' ' 39' ' ' TYR . 15.3 t -129.97 143.45 50.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.075 0.464 . . . . 0.41999999999999998 110.026 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.535 ' CB ' HG23 ' A' ' 105' ' ' VAL . 42.0 m-85 -126.12 141.65 51.85 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.79 -0.641 . . . . 0.77000000000000002 110.05 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 101' ' ' GLN . 6.4 mm100 62.06 25.36 15.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.872 0.368 . . . . 0.80000000000000004 110.939 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 62.09 11.56 4.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.424 -0.807 . . . . 2.1200000000000001 112.318 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 149.33 -29.07 1.21 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.891 -1.147 . . . . 0.28000000000000003 113.73 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 15.5 mt -54.92 -35.3 64.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.391 0.596 . . . . 0.35999999999999999 111.394 -175.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.535 HG23 ' CB ' ' A' ' 100' ' ' TYR . 0.4 OUTLIER -132.69 143.89 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.809 -0.632 . . . . 0.85999999999999999 109.774 173.466 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.626 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.0 OUTLIER -139.39 157.75 45.32 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.41 -0.589 . . . . 0.91000000000000003 109.41 -174.314 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.448 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.9 m -136.61 144.61 32.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.879 0.696 . . . . 0.29999999999999999 112.879 -174.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.07 51.63 57.26 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 114.949 -1.023 . . . . 0.20000000000000001 112.05 176.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 73.0 m -97.5 131.12 44.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.611 0.243 . . . . 0.42999999999999999 111.381 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.24 130.65 24.08 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.325 -0.398 . . . . 0.29999999999999999 110.305 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.527 ' HA ' HG12 ' A' ' 94' ' ' VAL . 54.2 Cg_exo -52.6 109.5 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.79 2.327 . . . . 0.34000000000000002 111.78 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.1 tt . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.796 -0.638 . . . . 0.58999999999999997 111.365 -174.089 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 39' ' ' TYR . 98.5 t . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 107.833 -1.173 . . . . 0.58999999999999997 107.833 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.545 ' N ' HG12 ' A' ' 38' ' ' VAL . 62.8 m-85 -131.05 136.1 48.16 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.424 -0.798 . . . . 0.78000000000000003 111.459 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 26.8 t -111.62 109.96 20.12 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.417 -0.81 . . . . 0.81999999999999995 109.67 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.4 m -107.98 133.73 51.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.219 -0.446 . . . . 0.23999999999999999 110.293 -176.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.43 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 53.8 m-80 -55.94 -28.4 56.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.395 -0.821 . . . . 2.0800000000000001 110.057 175.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -164.24 133.46 3.79 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.01 -0.995 . . . . 2.5800000000000001 108.87 176.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.633 HG21 HG11 ' A' ' 94' ' ' VAL . 24.2 p -93.04 142.84 26.85 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.156 -1.018 . . . . 0.37 110.902 168.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.574 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.1 tp10 -112.53 138.0 49.93 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.115 -0.948 . . . . 1.1200000000000001 109.59 -175.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.471 ' HA ' HD12 ' A' ' 71' ' ' LEU . 5.3 m-20 -74.46 107.96 6.93 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.336 -0.393 . . . . 1.77 110.666 -175.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.433 ' HA ' HD21 ' A' ' 50' ' ' LEU . 86.8 p -54.69 -23.02 15.67 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.898 -0.592 . . . . 0.92000000000000004 112.473 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -73.78 -33.31 64.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.046 -0.262 . . . . 2.77 110.951 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -134.45 58.14 1.78 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.813 0.815 . . . . 2.3300000000000001 111.409 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 47' ' ' SER . 89.4 mt -65.05 157.73 27.61 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.782 -1.099 . . . . 1.1599999999999999 111.517 177.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.66 154.68 36.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.947 -1.024 . . . . 1.8100000000000001 108.675 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -65.71 -26.58 67.82 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.587 -0.445 . . . . 3.23 109.971 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -65.07 -38.17 95.05 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.47 -0.652 . . . . 0.34000000000000002 111.47 174.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.635 ' HA ' HD22 ' A' ' 57' ' ' LEU . 27.9 m -76.72 -43.76 36.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.38 . . . . 0.35999999999999999 110.653 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.3 m -53.01 -34.43 56.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.651 -0.704 . . . . 0.29999999999999999 109.937 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.486 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.81 -54.11 50.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.839 -1.073 . . . . 0.23000000000000001 111.794 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -59.33 -44.14 92.64 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.434 0.635 . . . . 0.23999999999999999 110.136 -177.247 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 54' ' ' THR . 36.1 mt -60.14 -42.83 95.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.898 -1.046 . . . . 0.17999999999999999 110.116 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.16 -33.41 84.12 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.742 -0.663 . . . . 0.26000000000000001 112.508 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.9 mt -64.12 -29.51 70.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.748 0.785 . . . . 0.34000000000000002 110.497 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.438 ' CD1' HG21 ' A' ' 105' ' ' VAL . 6.0 mt -102.98 -0.78 30.4 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.68 -1.146 . . . . 0.35999999999999999 110.668 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 68.26 31.64 5.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.993 -1.003 . . . . 1.8899999999999999 111.071 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 58' ' ' LEU . 54.8 mt -80.08 148.68 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.811 -0.632 . . . . 0.26000000000000001 110.551 177.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.615 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -97.21 118.64 34.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.293 0.568 . . . . 2.2200000000000002 110.177 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -73.51 -38.57 52.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 0.28999999999999998 111.2 -174.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.85 -22.5 70.29 Favored Glycine 0 CA--C 1.516 0.151 0 C-N-CA 120.989 -0.624 . . . . 0.56999999999999995 112.683 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.29 -4.94 55.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.189 0.519 . . . . 0.85999999999999999 110.709 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.13 138.59 55.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.293 0.568 . . . . 0.46000000000000002 110.733 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -89.52 -86.07 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.044 -0.98 . . . . 2.0099999999999998 112.289 -171.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.63 -102.35 0.15 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.293 0.479 . . . . 1.0900000000000001 112.293 -173.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.9 mm? -105.82 170.1 8.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.577 0.703 . . . . 0.14999999999999999 111.15 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -122.89 170.53 13.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 106.724 -1.584 . . . . 0.25 106.724 167.746 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.495 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -136.78 142.75 13.93 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 119.838 -1.172 . . . . 0.37 111.567 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -106.42 129.28 54.43 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.14 -0.624 . . . . 0.28999999999999998 110.02 174.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.22 55.39 6.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.0 -1.0 . . . . 1.8500000000000001 111.198 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 58.7 m -88.62 144.0 26.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.628 -0.715 . . . . 1.1200000000000001 111.071 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m -100.52 118.82 60.27 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.733 -0.667 . . . . 1.26 109.969 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.24 124.64 12.38 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.547 2.165 . . . . 0.60999999999999999 111.85 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.2 mt . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 115.938 -0.573 . . . . 0.85999999999999999 109.865 -178.882 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.73 -0.47 . . . . 0.54000000000000004 109.73 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.15 126.06 30.34 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.028 0.442 . . . . 0.78000000000000003 110.359 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.19 123.1 44.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.265 0.555 . . . . 0.39000000000000001 111.299 -171.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.633 HG11 HG21 ' A' ' 44' ' ' THR . 1.5 m -136.44 173.32 13.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.653 -0.703 . . . . 0.22 111.426 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 53.8 t -124.37 118.47 26.79 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.566 -0.743 . . . . 0.70999999999999996 109.964 177.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 1.2 m -103.41 168.49 9.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.598 . . . . 0.60999999999999999 111.921 -175.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 107' ' ' VAL . 9.0 t -87.04 -29.83 21.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.378 -0.828 . . . . 0.38 109.738 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.441 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.2 m120 -151.84 162.76 40.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.68 -0.691 . . . . 0.78000000000000003 109.913 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 t -127.64 129.02 46.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.329 0.585 . . . . 0.41999999999999998 109.87 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.506 ' CB ' HG23 ' A' ' 105' ' ' VAL . 30.0 m-85 -120.51 144.87 47.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.681 -0.69 . . . . 0.77000000000000002 111.414 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.528 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 9.9 mm-40 60.84 34.49 19.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.802 -0.635 . . . . 0.80000000000000004 111.159 176.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 65.4 -0.86 1.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.756 -0.656 . . . . 2.1200000000000001 112.415 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.46 -20.25 2.05 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.512 -0.851 . . . . 0.28000000000000003 112.454 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 28.5 mt -49.77 -40.89 42.84 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.725 0.298 . . . . 0.35999999999999999 111.085 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.506 HG23 ' CB ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -130.15 119.3 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.547 0.689 . . . . 0.85999999999999999 110.489 174.077 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.485 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 2.8 t30 -111.21 144.18 40.78 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.348 -0.982 . . . . 0.91000000000000003 108.348 177.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 97' ' ' THR . 5.9 m -127.13 137.75 56.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 113.113 0.782 . . . . 0.29999999999999999 113.113 -174.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 70.9 51.44 19.16 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.999 -1.001 . . . . 0.20000000000000001 111.975 176.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 1.5 m -97.06 131.83 43.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.346 0.593 . . . . 0.42999999999999999 111.502 -177.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.8 p -116.65 141.42 28.08 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.058 -0.974 . . . . 0.29999999999999999 109.594 174.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HA ' HG12 ' A' ' 94' ' ' VAL . 24.5 Cg_exo -67.42 108.38 1.58 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.717 2.278 . . . . 0.34000000000000002 111.803 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 0.58999999999999997 110.466 -178.865 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 39' ' ' TYR . 92.1 t . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 110.306 -0.257 . . . . 0.58999999999999997 110.306 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.424 ' N ' HG12 ' A' ' 38' ' ' VAL . 29.3 m-85 -127.96 135.69 50.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.135 0.493 . . . . 0.78000000000000003 110.701 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.446 ' HB2' HD11 ' A' ' 79' ' ' LEU . 17.7 t -103.43 107.53 18.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.942 -0.572 . . . . 0.81999999999999995 109.721 177.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -102.46 130.79 49.37 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.804 -0.443 . . . . 0.23999999999999999 109.804 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.512 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 18.3 m120 -57.54 -29.72 64.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.583 -0.735 . . . . 2.0800000000000001 109.749 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 8.3 mmmm -162.86 132.23 4.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.443 -1.253 . . . . 2.5800000000000001 108.013 175.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.5 HG21 HG11 ' A' ' 94' ' ' VAL . 28.1 p -88.86 167.21 13.43 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.36 -0.936 . . . . 0.37 110.101 169.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.481 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.6 tp10 -126.49 139.07 53.51 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.504 -0.771 . . . . 1.1200000000000001 109.424 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.415 ' HA ' HD12 ' A' ' 71' ' ' LEU . 11.1 m-20 -71.26 111.66 6.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.057 -0.52 . . . . 1.77 110.519 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.591 ' HA ' HD21 ' A' ' 50' ' ' LEU . 6.1 m -60.15 -10.45 4.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.803 -0.635 . . . . 0.92000000000000004 112.603 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -90.02 -17.56 27.61 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.669 -0.412 . . . . 2.77 110.338 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -149.53 57.92 1.0 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.328 -0.397 . . . . 2.3300000000000001 111.136 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.0 mm? -60.26 150.7 29.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.267 0.556 . . . . 1.1599999999999999 111.679 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.91 146.35 54.82 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.079 -1.082 . . . . 1.8100000000000001 108.079 170.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -60.4 -28.13 68.0 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.499 -0.481 . . . . 3.23 110.463 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -66.7 -35.95 90.56 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.866 -0.683 . . . . 0.34000000000000002 111.417 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.658 ' HA ' HD22 ' A' ' 57' ' ' LEU . 22.7 m -79.06 -42.94 25.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.35999999999999999 110.411 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.2 m -53.94 -33.69 57.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.325 0.583 . . . . 0.29999999999999999 110.126 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.31 -53.81 53.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.167 -0.924 . . . . 0.23000000000000001 111.285 175.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.658 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -60.69 -44.25 96.76 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.441 0.639 . . . . 0.23999999999999999 110.013 -179.129 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 54' ' ' THR . 53.0 mt -59.35 -43.22 92.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.001 -0.999 . . . . 0.17999999999999999 110.145 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.62 -36.97 92.67 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.906 -0.664 . . . . 0.26000000000000001 112.439 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.2 mt -60.24 -46.78 88.62 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.878 0.847 . . . . 0.34000000000000002 109.903 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 mt -85.71 2.75 44.13 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.364 -1.289 . . . . 0.35999999999999999 111.405 -175.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 65.5 35.35 7.32 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.486 -0.779 . . . . 1.8899999999999999 111.534 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 58' ' ' LEU . 48.2 mt -88.0 147.25 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.551 -0.75 . . . . 0.26000000000000001 110.043 177.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.536 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -100.41 117.67 35.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.319 0.581 . . . . 2.2200000000000002 110.369 -178.427 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.73 -41.99 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.313 -0.858 . . . . 0.28999999999999998 111.449 -174.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.58 -7.15 68.19 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.857 -0.687 . . . . 0.56999999999999995 112.991 -176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.49 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 21.0 t70 -103.81 -16.76 15.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.85999999999999999 110.712 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 95.4 mt -55.5 147.81 16.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.881 -0.6 . . . . 0.46000000000000002 111.626 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -95.32 -85.89 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.159 -0.928 . . . . 2.0099999999999998 112.026 -172.231 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.27 -101.56 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.873 0.324 . . . . 1.0900000000000001 111.873 -174.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.5 mm? -110.52 169.3 8.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.403 0.621 . . . . 0.14999999999999999 111.216 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.49 HG13 HD11 ' A' ' 50' ' ' LEU . 1.5 m -121.07 163.72 18.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 106.058 -1.83 . . . . 0.25 106.058 166.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.57 142.18 13.65 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 119.818 -1.182 . . . . 0.37 111.38 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.618 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -115.4 135.17 54.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.049 -0.661 . . . . 0.28999999999999998 110.4 178.735 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.521 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 1.4 t-20 54.79 47.54 22.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.522 -1.217 . . . . 1.8500000000000001 110.904 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 24.5 m -85.41 150.06 24.99 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.177 -0.92 . . . . 1.1200000000000001 110.554 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.0 m -100.42 117.18 63.44 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.623 -0.717 . . . . 1.26 109.75 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -64.78 130.68 26.85 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.646 2.23 . . . . 0.60999999999999999 112.293 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 40' ' ' CYS . 33.8 mt . . . . . 0 C--N 1.317 -0.808 0 CA-C-N 115.509 -0.769 . . . . 0.85999999999999999 109.371 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.59 0.233 . . . . 0.54000000000000004 110.408 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.98 112.88 18.79 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.772 0.796 . . . . 0.78000000000000003 110.03 -177.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.86 121.11 32.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.215 -0.902 . . . . 0.39000000000000001 110.447 -174.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 111' ' ' PRO . 13.6 m -133.15 162.81 39.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.458 0.646 . . . . 0.22 112.129 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 37.6 t -112.24 114.02 26.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.92 -1.036 . . . . 0.70999999999999996 109.156 175.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.3 m -108.48 146.67 32.81 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.442 -0.344 . . . . 0.60999999999999999 110.318 -174.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.9 t -76.45 -26.77 55.77 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.279 -0.419 . . . . 0.38 110.668 -173.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.609 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.2 m120 -147.03 155.05 41.92 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.131 -0.692 . . . . 0.78000000000000003 109.131 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.2 t -132.58 132.82 42.94 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.122 0.487 . . . . 0.41999999999999998 110.42 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -130.7 156.72 44.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.832 -0.622 . . . . 0.77000000000000002 110.48 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.65 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 20.1 mm-40 60.34 28.96 18.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.79 -0.641 . . . . 0.80000000000000004 111.992 174.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 66.37 -1.02 1.33 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.217 0.607 . . . . 2.1200000000000001 112.535 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 142.64 -14.97 2.45 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.441 -0.885 . . . . 0.28000000000000003 112.161 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 40.8 mt -54.19 -36.89 63.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.994 0.426 . . . . 0.35999999999999999 110.562 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 t -139.3 121.54 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.359 -0.837 . . . . 0.85999999999999999 110.549 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.448 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 95.0 m-20 -124.08 160.4 27.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.641 -0.708 . . . . 0.91000000000000003 109.227 174.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.609 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 5.5 m -134.97 151.51 31.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 111.833 0.309 . . . . 0.29999999999999999 111.833 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.48 54.66 35.31 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.597 -0.729 . . . . 0.20000000000000001 111.439 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 76.4 m -97.2 125.88 42.02 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.72 0.295 . . . . 0.42999999999999999 111.29 -175.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 p -118.28 125.65 27.74 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.169 -0.469 . . . . 0.29999999999999999 110.395 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' A' ' 94' ' ' VAL . 68.3 Cg_exo -51.59 109.96 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.255 2.637 . . . . 0.34000000000000002 112.953 178.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 tt . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.632 -0.713 . . . . 0.58999999999999997 110.271 -179.843 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 108.256 -1.016 . . . . 0.58999999999999997 108.256 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.91 131.21 47.55 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.384 0.611 . . . . 0.78000000000000003 110.823 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.422 ' HB2' HD11 ' A' ' 79' ' ' LEU . 14.4 t -99.43 107.17 19.32 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.382 -0.826 . . . . 0.81999999999999995 109.692 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.4 m -104.34 129.64 52.22 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.012 -0.54 . . . . 0.23999999999999999 109.819 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.497 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 18.4 m120 -55.46 -25.59 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.473 -0.785 . . . . 2.0800000000000001 110.42 176.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 1.8 mmmm -168.85 124.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.243 -1.344 . . . . 2.5800000000000001 108.223 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.594 HG21 HG11 ' A' ' 94' ' ' VAL . 16.8 p -79.61 157.51 27.29 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.493 -0.883 . . . . 0.37 110.713 171.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.57 ' HB3' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.34 146.21 42.62 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.268 -0.878 . . . . 1.1200000000000001 108.957 -176.493 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.06 108.74 14.99 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.227 -0.442 . . . . 1.77 111.115 -173.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.753 ' HA ' HD21 ' A' ' 50' ' ' LEU . 27.5 m -57.68 -12.3 2.81 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.084 0.772 . . . . 0.92000000000000004 113.084 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -90.32 -25.56 20.43 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.882 -0.327 . . . . 2.77 110.644 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -145.92 60.54 1.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.503 -0.317 . . . . 2.3300000000000001 111.299 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.753 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.9 mm? -60.7 147.26 42.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.763 0.792 . . . . 1.1599999999999999 111.784 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -68.02 153.11 44.42 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.235 -1.348 . . . . 1.8100000000000001 109.814 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.576 ' HD3' ' N ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -62.86 -26.6 68.85 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.056 -0.258 . . . . 3.23 111.18 178.538 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.576 ' N ' ' HD3' ' A' ' 52' ' ' LYS . . . -69.51 -37.41 78.41 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.489 -0.863 . . . . 0.34000000000000002 111.332 177.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.624 ' HA ' HD22 ' A' ' 57' ' ' LEU . 26.1 m -80.98 -43.3 19.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.919 -0.4 . . . . 0.35999999999999999 109.919 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.418 ' HA ' HD12 ' A' ' 58' ' ' LEU . 96.9 m -52.88 -34.8 56.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.539 -0.755 . . . . 0.29999999999999999 110.233 173.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.548 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.34 -51.99 66.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.435 -0.802 . . . . 0.23000000000000001 111.34 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -61.55 -44.77 96.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.407 0.623 . . . . 0.23999999999999999 109.893 -179.62 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 54' ' ' THR . 58.5 mt -58.0 -45.12 87.36 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.867 -1.061 . . . . 0.17999999999999999 110.162 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.06 -37.06 92.2 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.793 -0.64 . . . . 0.26000000000000001 112.471 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.6 mt -60.19 -47.38 86.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.502 0.668 . . . . 0.34000000000000002 110.303 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.467 HD21 ' HG2' ' A' ' 101' ' ' GLN . 2.9 mt -84.56 -2.33 57.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.857 -1.065 . . . . 0.35999999999999999 111.343 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 69.76 37.75 1.79 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.939 0.876 . . . . 1.8899999999999999 110.664 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 58' ' ' LEU . 56.1 mt -85.25 145.82 7.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.713 -0.676 . . . . 0.26000000000000001 110.173 175.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.669 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -96.34 117.89 31.76 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.68 -0.691 . . . . 2.2200000000000002 109.937 -178.369 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.439 HG23 HD23 ' A' ' 50' ' ' LEU . 1.8 mp -73.34 -40.18 56.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.509 -0.769 . . . . 0.28999999999999998 111.049 -174.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.83 -9.87 63.42 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.976 -0.63 . . . . 0.56999999999999995 113.055 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -109.15 4.61 23.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 0.85999999999999999 110.903 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 98.3 mt -74.53 142.89 44.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.336 -0.393 . . . . 0.46000000000000002 110.437 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -96.42 -94.64 0.2 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.683 0.623 . . . . 2.0099999999999998 112.683 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.75 -99.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.17 0.433 . . . . 1.0900000000000001 112.17 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.26 164.26 14.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.468 0.652 . . . . 0.14999999999999999 110.928 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -115.4 172.16 4.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 106.162 -1.792 . . . . 0.25 106.162 168.512 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.463 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -140.82 138.8 9.16 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.933 -1.127 . . . . 0.37 111.113 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -111.41 132.22 54.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.532 -0.867 . . . . 0.28999999999999998 110.499 176.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.515 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 2.1 t-20 58.23 46.57 15.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.49 -1.232 . . . . 1.8500000000000001 110.747 175.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 35.4 m -83.72 142.11 30.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.524 -0.762 . . . . 1.1200000000000001 111.096 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -88.27 116.38 66.06 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.568 -0.742 . . . . 1.26 109.375 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.15 122.2 9.25 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.792 2.328 . . . . 0.60999999999999999 112.876 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 40' ' ' CYS . 11.9 mt . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 115.434 -0.803 . . . . 0.85999999999999999 109.21 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.497 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.45 0.167 . . . . 0.54000000000000004 110.802 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.79 120.22 23.76 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.289 0.566 . . . . 0.78000000000000003 110.428 -176.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.37 117.21 29.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.9 -0.591 . . . . 0.39000000000000001 110.892 -175.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.594 HG11 HG21 ' A' ' 44' ' ' THR . 2.9 m -129.29 164.35 32.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.736 -0.666 . . . . 0.22 111.583 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 49.3 t -118.32 110.95 18.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.376 -0.829 . . . . 0.70999999999999996 109.461 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 106' ' ' ASN . 1.3 m -92.34 166.16 12.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.309 0.576 . . . . 0.60999999999999999 111.483 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.9 t -90.95 -24.23 20.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.346 -0.843 . . . . 0.38 109.406 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.414 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 14.3 m120 -156.68 166.86 32.18 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.346 -0.843 . . . . 0.78000000000000003 109.183 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.6 t -138.99 143.19 38.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.991 0.424 . . . . 0.41999999999999998 110.403 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.453 ' HB2' HG23 ' A' ' 105' ' ' VAL . 83.8 m-85 -126.78 149.48 49.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.048 -0.524 . . . . 0.77000000000000002 109.609 176.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.467 ' HG2' HD21 ' A' ' 61' ' ' LEU . 57.8 mm-40 64.67 24.62 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.80000000000000004 111.361 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 64.4 6.04 2.89 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.602 -0.726 . . . . 2.1200000000000001 112.357 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.15 -20.14 1.39 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.905 -1.14 . . . . 0.28000000000000003 113.552 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.1 mt -56.45 -37.3 70.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.619 0.71 . . . . 0.35999999999999999 111.419 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.453 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -142.79 118.87 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.58 0.705 . . . . 0.85999999999999999 110.938 175.489 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.728 ' HB3' ' SG ' ' A' ' 96' ' ' CYS . 7.4 m-20 -115.37 162.33 17.28 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.234 -0.894 . . . . 0.91000000000000003 109.528 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.0 m -133.64 142.46 41.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.549 0.574 . . . . 0.29999999999999999 112.549 -175.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 66.78 53.09 29.35 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.094 -0.957 . . . . 0.20000000000000001 112.254 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 1.3 m -96.65 129.83 43.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.394 0.616 . . . . 0.42999999999999999 111.568 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.0 p -118.45 124.99 28.12 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.774 -1.103 . . . . 0.29999999999999999 109.743 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HA ' HG12 ' A' ' 94' ' ' VAL . 84.9 Cg_exo -47.91 112.28 0.55 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.405 2.737 . . . . 0.34000000000000002 113.012 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.2 tt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.54 -0.755 . . . . 0.58999999999999997 110.519 179.338 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 39' ' ' TYR . 38.8 t . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.58999999999999997 110.236 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.604 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 94.9 m-85 -137.35 135.89 37.44 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.933 0.396 . . . . 0.78000000000000003 110.259 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.802 ' SG ' ' HB2' ' A' ' 77' ' ' SER . 22.1 p -104.04 102.55 12.31 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.869 0.842 . . . . 0.81999999999999995 110.411 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.8 m -100.21 128.98 46.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.104 -0.953 . . . . 0.23999999999999999 109.037 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 49.3 m-80 -57.6 -23.44 50.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.566 0.698 . . . . 2.0800000000000001 110.47 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -161.61 128.96 4.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.31 -1.314 . . . . 2.5800000000000001 107.902 176.339 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.558 HG21 HG11 ' A' ' 94' ' ' VAL . 23.0 p -87.46 155.24 20.1 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.151 -1.02 . . . . 0.37 109.769 167.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.2 tp10 -120.09 133.84 55.41 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.503 -0.771 . . . . 1.1200000000000001 109.545 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 49' ' ' HIS . 15.4 m-20 -69.83 112.62 6.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.507 -0.769 . . . . 1.77 109.788 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.5 p -52.67 -27.9 19.31 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.781 0.676 . . . . 0.92000000000000004 112.183 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -89.45 -10.59 45.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.69 0.281 . . . . 2.77 111.519 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 46' ' ' ASP . 58.9 m-70 -127.79 34.29 4.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.739 0.304 . . . . 2.3300000000000001 111.088 -177.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.453 HD23 ' HG3' ' A' ' 45' ' ' GLU . 96.0 mt -67.46 145.48 54.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.153 0.501 . . . . 1.1599999999999999 111.668 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -86.79 169.55 12.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.382 -0.826 . . . . 1.8100000000000001 109.71 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.71 -41.94 99.4 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.9 -0.32 . . . . 3.23 110.72 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.85 -42.28 85.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.308 -0.472 . . . . 0.34000000000000002 112.969 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.67 ' HA ' HD22 ' A' ' 57' ' ' LEU . 86.9 m -82.6 -42.05 18.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.733 0.267 . . . . 0.35999999999999999 111.121 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.3 m -54.5 -33.39 59.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.211 0.529 . . . . 0.29999999999999999 110.074 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.585 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.57 -54.94 41.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.13 -0.941 . . . . 0.23000000000000001 111.703 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.67 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -56.39 -47.16 79.52 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.494 0.664 . . . . 0.23999999999999999 110.057 -178.164 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 54' ' ' THR . 34.2 mt -57.95 -43.69 86.54 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.738 -1.119 . . . . 0.17999999999999999 110.169 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.19 -36.62 93.25 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.835 -0.698 . . . . 0.26000000000000001 112.395 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 19.8 mt -62.68 -44.71 95.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.875 0.845 . . . . 0.34000000000000002 109.939 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.509 ' CD1' HG21 ' A' ' 105' ' ' VAL . 6.1 mt -87.16 1.48 52.92 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.459 -1.246 . . . . 0.35999999999999999 111.411 -175.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 69.24 27.5 5.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.702 -0.681 . . . . 1.8899999999999999 111.628 174.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 58' ' ' LEU . 56.8 mt -78.69 142.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.953 -0.567 . . . . 0.26000000000000001 110.291 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.479 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -90.07 117.84 29.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.846 -0.615 . . . . 2.2200000000000002 110.058 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.27 -36.94 50.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.89 -0.596 . . . . 0.28999999999999998 109.809 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.2 -10.48 84.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.56999999999999995 112.511 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 28.3 t70 -101.83 -9.65 20.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.036 0.446 . . . . 0.85999999999999999 110.733 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 64' ' ' LYS . 89.1 mt -55.71 134.99 51.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.261 0.553 . . . . 0.46000000000000002 110.538 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.47 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 3.4 mptp? -82.35 -51.15 8.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.093 -0.958 . . . . 2.0099999999999998 112.25 -169.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 1.1 t70 -139.37 -82.45 0.28 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.608 -0.437 . . . . 1.0900000000000001 110.843 -178.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.4 mm? -114.44 173.95 6.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.383 0.611 . . . . 0.14999999999999999 110.722 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 45' ' ' GLU . 1.2 m -121.92 166.1 16.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 106.62 -1.622 . . . . 0.25 106.62 164.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.4 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -137.1 126.16 3.6 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.806 -1.188 . . . . 0.37 112.055 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.654 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -99.58 139.59 35.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.11 -0.636 . . . . 0.28999999999999998 110.018 -178.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.448 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 2.1 t-20 50.17 55.42 9.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.113 0.959 . . . . 1.8500000000000001 109.889 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 20.9 t -105.4 146.77 29.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.043 -1.435 . . . . 1.1200000000000001 110.198 -171.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.802 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 19.8 m -103.6 139.56 20.23 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 120.528 -0.469 . . . . 1.26 110.265 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 6.1 Cg_exo -80.45 119.84 3.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.614 2.209 . . . . 0.60999999999999999 112.472 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.651 HD11 ' SG ' ' A' ' 40' ' ' CYS . 5.6 mp . . . . . 0 C--N 1.319 -0.727 0 N-CA-C 109.224 -0.658 . . . . 0.85999999999999999 109.224 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.851 -0.425 . . . . 0.54000000000000004 109.851 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.35 130.57 41.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.096 0.474 . . . . 0.78000000000000003 110.872 -174.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.2 120.18 37.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.47 0.652 . . . . 0.39000000000000001 112.562 -172.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 44' ' ' THR . 5.5 m -134.65 168.3 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.024 -0.989 . . . . 0.22 110.043 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.8 t -116.97 117.89 30.91 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.122 -0.696 . . . . 0.70999999999999996 109.122 177.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.0 m -111.19 151.26 28.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.925 0.393 . . . . 0.60999999999999999 110.887 -172.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 t -81.09 -28.81 35.08 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.963 -0.562 . . . . 0.38 110.664 -173.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.414 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 14.5 m120 -155.06 156.98 36.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.588 -0.733 . . . . 0.78000000000000003 109.11 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.9 t -136.18 144.62 45.06 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.048 -0.353 . . . . 0.41999999999999998 110.048 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.568 ' HB2' HG23 ' A' ' 105' ' ' VAL . 67.3 m-85 -138.33 161.93 35.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.674 0.273 . . . . 0.77000000000000002 110.915 -177.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.593 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 49.6 mm-40 62.63 33.27 15.84 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.03 -0.532 . . . . 0.80000000000000004 112.255 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 65.43 -0.31 1.21 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.843 0.457 . . . . 2.1200000000000001 112.067 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.55 -13.41 3.71 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.483 -0.865 . . . . 0.28000000000000003 112.883 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.654 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 22.5 mt -55.25 -36.51 66.14 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 117.358 0.579 . . . . 0.35999999999999999 110.862 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.568 HG23 ' HB2' ' A' ' 100' ' ' TYR . 12.2 m -129.97 147.32 33.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.303 0.573 . . . . 0.85999999999999999 110.529 174.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 4.2 t-20 -143.04 143.06 31.73 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.873 -1.158 . . . . 0.91000000000000003 107.873 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 18.0 m -123.79 149.9 27.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 113.062 0.764 . . . . 0.29999999999999999 113.062 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 59.85 54.45 37.45 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 114.913 -1.04 . . . . 0.20000000000000001 111.536 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 70' ' ' ASP . 74.8 m -97.92 123.5 41.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.757 0.313 . . . . 0.42999999999999999 110.54 -173.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.3 p -118.95 126.82 26.87 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.817 -0.629 . . . . 0.29999999999999999 110.91 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.459 ' HA ' HG12 ' A' ' 94' ' ' VAL . 54.2 Cg_exo -51.22 113.26 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.036 2.491 . . . . 0.34000000000000002 112.141 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.8 tt . . . . . 0 N--CA 1.449 -0.515 0 CA-C-N 115.906 -0.588 . . . . 0.58999999999999997 111.512 -175.982 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 39' ' ' TYR . 96.7 t . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 108.744 -0.835 . . . . 0.58999999999999997 108.744 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.413 ' N ' HG12 ' A' ' 38' ' ' VAL . 97.0 m-85 -123.98 141.05 52.38 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.483 0.659 . . . . 0.78000000000000003 111.362 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 49.5 t -113.16 111.24 21.76 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.272 -0.876 . . . . 0.81999999999999995 109.993 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.2 m -107.69 133.11 52.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.095 0.474 . . . . 0.23999999999999999 110.001 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -53.99 -26.48 26.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.173 -0.921 . . . . 2.0800000000000001 110.559 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.458 ' HE2' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -173.32 123.26 0.38 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.896 -1.15 . . . . 2.5800000000000001 107.896 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.525 HG21 HG11 ' A' ' 94' ' ' VAL . 12.5 p -78.66 154.98 29.72 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.466 -0.893 . . . . 0.37 110.727 172.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.557 ' HG3' HD23 ' A' ' 50' ' ' LEU . 7.8 tp10 -120.88 137.94 54.33 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.979 -0.749 . . . . 1.1200000000000001 108.979 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.489 ' HA ' HD12 ' A' ' 71' ' ' LEU . 11.6 m-20 -75.32 107.98 7.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.942 -0.572 . . . . 1.77 109.91 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.474 ' HA ' HD21 ' A' ' 50' ' ' LEU . 9.4 m -47.18 -31.17 3.39 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.849 0.718 . . . . 0.92000000000000004 111.987 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 11.4 mptt -68.17 -40.95 82.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.5 0.667 . . . . 2.77 110.638 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -124.36 51.89 1.55 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.14 -0.936 . . . . 2.3300000000000001 110.934 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.557 HD23 ' HG3' ' A' ' 45' ' ' GLU . 82.0 mt -62.96 159.92 15.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.573 0.701 . . . . 1.1599999999999999 112.215 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.8 146.85 23.33 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.722 -1.126 . . . . 1.8100000000000001 109.059 175.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -59.37 -25.06 63.93 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.239 0.337 . . . . 3.23 110.949 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.62 -41.45 83.95 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.759 -0.734 . . . . 0.34000000000000002 111.844 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.644 ' HA ' HD22 ' A' ' 57' ' ' LEU . 98.3 m -81.15 -42.98 20.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.761 0.315 . . . . 0.35999999999999999 110.559 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.7 m -54.84 -32.51 60.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.912 -0.586 . . . . 0.29999999999999999 110.188 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.58 -54.43 46.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.562 -0.744 . . . . 0.23000000000000001 111.406 175.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.644 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.44 -44.59 89.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.401 0.62 . . . . 0.23999999999999999 110.147 -177.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.6 mt -58.9 -43.92 91.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.066 -0.97 . . . . 0.17999999999999999 110.172 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.92 -35.79 91.04 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.928 -0.653 . . . . 0.26000000000000001 112.537 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 16.9 mt -61.66 -39.81 92.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.751 0.786 . . . . 0.34000000000000002 110.022 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.454 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.8 mt -91.61 2.06 56.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.7 -1.136 . . . . 0.35999999999999999 111.085 -176.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 68.28 30.12 5.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.85 0.833 . . . . 1.8899999999999999 110.691 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 58' ' ' LEU . 54.1 mt -80.93 141.62 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.78 -0.646 . . . . 0.26000000000000001 110.262 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -92.75 118.96 31.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.818 -0.628 . . . . 2.2200000000000002 110.062 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.05 -29.35 28.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.454 -0.794 . . . . 0.28999999999999998 110.856 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.42 -18.02 78.08 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.72 -0.752 . . . . 0.56999999999999995 112.46 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -88.03 -19.18 27.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.071 0.462 . . . . 0.85999999999999999 110.393 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.33 126.36 27.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.488 -0.778 . . . . 0.46000000000000002 110.986 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -91.27 -76.32 0.45 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.053 -0.976 . . . . 2.0099999999999998 112.202 -172.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -90.11 -112.11 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.457 -0.338 . . . . 1.0900000000000001 111.268 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.6 mm? -105.7 170.81 7.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.206 0.527 . . . . 0.14999999999999999 111.182 176.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 45' ' ' GLU . 1.6 m -122.99 167.56 16.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 106.999 -1.482 . . . . 0.25 106.999 167.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.514 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -138.01 144.56 15.87 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.725 -1.226 . . . . 0.37 111.847 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -102.76 127.59 49.85 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.373 -0.531 . . . . 0.28999999999999998 110.279 175.051 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 57.75 54.99 5.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.742 -1.117 . . . . 1.8500000000000001 111.15 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.514 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 47.0 m -87.56 142.27 27.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.356 -0.838 . . . . 1.1200000000000001 110.913 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 14.2 t -98.25 123.41 50.84 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.758 -0.656 . . . . 1.26 109.804 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 12.9 Cg_exo -70.45 120.45 7.14 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.573 2.182 . . . . 0.60999999999999999 112.123 175.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.767 -0.651 . . . . 0.85999999999999999 109.728 -179.56 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.478 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--O 1.235 0.321 0 CA-C-O 120.564 0.221 . . . . 0.54000000000000004 111.051 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.77 130.65 37.98 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.64 -0.504 . . . . 0.78000000000000003 109.64 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.65 123.42 47.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.331 0.586 . . . . 0.39000000000000001 110.952 -173.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 44' ' ' THR . 6.1 m -134.61 166.41 28.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.634 -0.712 . . . . 0.22 111.647 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.5 t -110.73 116.48 31.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.317 -0.856 . . . . 0.70999999999999996 108.965 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 16.1 m -118.63 150.15 40.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.835 0.35 . . . . 0.60999999999999999 110.642 -171.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.405 HG22 ' HA3' ' A' ' 108' ' ' GLY . 8.4 t -78.13 -32.2 50.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.81 -0.632 . . . . 0.38 110.827 -173.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.45 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.6 m120 -155.72 163.48 39.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.862 -0.608 . . . . 0.78000000000000003 109.715 -176.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -139.63 148.68 42.8 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.62 -0.511 . . . . 0.41999999999999998 109.62 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.609 ' HB2' HG23 ' A' ' 105' ' ' VAL . 60.6 m-85 -134.56 154.39 51.49 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.469 -0.567 . . . . 0.77000000000000002 109.469 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.552 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 55.5 mm-40 64.91 29.46 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.335 0.397 . . . . 0.80000000000000004 111.489 176.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.7 m170 63.96 11.5 6.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.951 -0.568 . . . . 2.1200000000000001 111.991 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 132.23 -17.77 4.78 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.136 -1.031 . . . . 0.28000000000000003 113.333 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 14.7 mt -50.55 -40.25 51.49 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.556 0.678 . . . . 0.35999999999999999 110.742 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.609 HG23 ' HB2' ' A' ' 100' ' ' TYR . 4.3 m -127.05 142.63 42.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.656 -0.702 . . . . 0.85999999999999999 109.698 171.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 24.1 t30 -138.61 143.57 39.38 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.15 -1.056 . . . . 0.91000000000000003 108.15 -175.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.45 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.2 m -126.19 152.24 33.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 113.393 0.886 . . . . 0.29999999999999999 113.393 -172.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.06 52.73 51.05 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.703 -1.135 . . . . 0.20000000000000001 112.057 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' CYS . . . . . 0.434 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 93.7 m -96.65 126.72 42.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.951 0.405 . . . . 0.42999999999999999 112.005 -175.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -119.46 126.02 27.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.74 -0.664 . . . . 0.29999999999999999 110.313 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' A' ' 94' ' ' VAL . 70.8 Cg_exo -51.33 110.08 0.38 Allowed 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.997 2.465 . . . . 0.34000000000000002 112.417 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.9 tt . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 0.58999999999999997 110.098 -179.639 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.4 tttm . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 120.907 0.384 . . . . 30.309999999999999 110.389 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 59.88 48.75 8.57 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.819 -0.628 . . . . 28.059999999999999 112.377 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.3 ptp -147.94 -32.16 0.27 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.112 0.482 . . . . 28.52 110.167 174.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.56 18.5 3.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.349 -0.611 . . . . 26.559999999999999 109.349 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.53 163.14 19.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.409 -0.814 . . . . 25.140000000000001 110.035 -175.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.4 pt -134.06 24.36 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.334 0.588 . . . . 24.989999999999998 109.886 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.36 -32.74 4.15 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.617 -0.719 . . . . 22.920000000000002 111.998 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.9 t -70.34 -27.85 64.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.881 0.372 . . . . 22.809999999999999 110.452 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.4 p -106.06 154.94 19.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.315 -0.402 . . . . 22.210000000000001 111.15 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.26 68.85 0.93 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.256 0.551 . . . . 20.949999999999999 110.188 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.29 76.56 68.36 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.636 -0.711 . . . . 19.190000000000001 111.399 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.17 -17.33 15.09 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.306 2.004 . . . . 17.98 112.66 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -89.19 -20.31 24.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.025 0.44 . . . . 18.07 110.305 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -81.51 123.91 29.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.863 -0.608 . . . . 14.66 109.789 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 m -119.86 146.98 23.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.792 0.329 . . . . 13.029999999999999 110.876 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -77.77 100.74 6.39 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.446 -0.575 . . . . 12.26 109.446 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.06 50.65 1.44 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.26 -0.736 . . . . 9.9700000000000006 111.26 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.36 92.99 0.6 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.204 -0.522 . . . . 8.2200000000000006 112.631 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.489 HG22 ' HD2' ' A' ' 30' ' ' PRO . 3.3 m -60.78 134.19 92.2 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.919 -0.4 . . . . 7.2999999999999998 109.919 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.431 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 80.9 Cg_exo -41.1 -50.35 4.29 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.396 2.731 . . . . 6.0999999999999996 114.911 -175.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.489 ' HD2' HG22 ' A' ' 28' ' ' THR . 2.2 Cg_endo -79.77 111.97 2.83 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.036 1.824 . . . . 5.1900000000000004 111.448 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -68.17 141.1 56.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.277 -0.42 . . . . 3.79 111.102 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 p -149.37 174.83 12.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.941 -0.572 . . . . 1.74 110.21 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.2 m -98.81 135.87 39.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.93 0.395 . . . . 1.7 111.004 -175.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.6 t -80.57 -11.84 59.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.196 0.522 . . . . 2.5699999999999998 109.723 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 p -76.86 -8.85 58.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.818 -0.628 . . . . 2.5 110.955 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.29 170.02 15.19 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.618 -0.593 . . . . 1.51 111.618 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.53 ' HB3' ' HA ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -46.63 151.31 2.02 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.692 2.928 . . . . 1.05 113.76 176.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 39' ' ' TYR . 92.9 t -83.52 164.76 2.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.883 -1.053 . . . . 0.58999999999999997 108.375 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.7 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 97.2 m-85 -130.63 139.68 50.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.478 0.656 . . . . 0.78000000000000003 111.601 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 36.9 t -107.9 98.64 8.19 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.166 -0.925 . . . . 0.81999999999999995 109.346 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.461 ' HB2' ' OE1' ' A' ' 92' ' ' GLN . 33.9 m -104.24 141.71 35.8 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.393 -0.595 . . . . 0.23999999999999999 109.393 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -59.63 -30.43 68.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.673 -0.694 . . . . 2.0800000000000001 110.769 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.17 123.46 0.98 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.644 -0.872 . . . . 2.5800000000000001 108.644 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.897 ' H ' HE22 ' A' ' 92' ' ' GLN . 1.5 p -86.65 127.99 34.97 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.814 -0.754 . . . . 0.37 110.433 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.67 ' HB3' HG22 ' A' ' 72' ' ' VAL . 8.8 tp10 -103.45 138.07 40.68 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.973 -1.012 . . . . 1.1200000000000001 109.649 -172.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.46 ' HA ' HD12 ' A' ' 71' ' ' LEU . 6.3 m-20 -65.01 107.44 1.51 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.235 -0.439 . . . . 1.77 111.015 -174.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.593 ' HA ' HD21 ' A' ' 50' ' ' LEU . 92.9 p -65.48 -6.38 10.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.88 -0.6 . . . . 0.92000000000000004 112.032 -174.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.497 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 3.6 mppt? -77.09 -38.63 51.94 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.434 0.635 . . . . 2.77 109.639 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -142.61 67.93 1.31 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.936 -1.029 . . . . 2.3300000000000001 110.988 -176.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.593 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -61.91 160.34 12.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.476 0.655 . . . . 1.1599999999999999 111.469 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -67.65 155.6 38.81 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.341 -0.985 . . . . 1.8100000000000001 108.341 171.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -28.93 70.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.418 0.553 . . . . 3.23 110.233 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -67.62 -38.18 89.98 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.801 -0.714 . . . . 0.34000000000000002 111.495 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.684 ' HA ' HD22 ' A' ' 57' ' ' LEU . 37.0 m -79.0 -41.36 29.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.995 0.426 . . . . 0.35999999999999999 110.119 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.2 m -54.71 -35.16 63.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.52 -0.764 . . . . 0.29999999999999999 109.851 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.19 -53.67 55.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.26 -0.882 . . . . 0.23000000000000001 111.537 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.684 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.42 -45.46 88.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.416 0.626 . . . . 0.23999999999999999 110.238 -178.539 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.5 mt -58.56 -43.31 89.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.954 -1.021 . . . . 0.17999999999999999 110.175 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.18 -36.91 93.1 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.77 -0.728 . . . . 0.26000000000000001 112.196 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.5 mt -60.6 -44.79 95.88 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.506 0.67 . . . . 0.34000000000000002 110.248 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.581 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.2 mt -87.64 1.06 54.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.945 -1.025 . . . . 0.35999999999999999 111.543 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 71.29 26.65 3.31 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.825 -0.625 . . . . 1.8899999999999999 111.392 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 58' ' ' LEU . 60.4 mt -78.44 140.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.938 -0.574 . . . . 0.26000000000000001 110.281 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.54 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 11.5 mptt -91.26 118.0 30.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.709 -0.678 . . . . 2.2200000000000002 109.815 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -73.01 -36.95 52.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.83 -0.623 . . . . 0.28999999999999998 110.195 -175.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.31 -19.23 79.6 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.735 -0.745 . . . . 0.56999999999999995 112.283 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -85.25 -16.77 39.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.048 0.452 . . . . 0.85999999999999999 110.331 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 94.1 mt -64.01 154.07 35.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.883 -0.598 . . . . 0.46000000000000002 111.393 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 12.5 mptt -109.38 -80.37 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.647 -0.706 . . . . 2.0099999999999998 112.503 -171.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -98.69 -90.67 0.29 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 112.537 0.569 . . . . 1.0900000000000001 112.537 -170.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.0 OUTLIER -120.77 166.23 14.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.891 -0.595 . . . . 0.14999999999999999 110.989 178.445 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.67 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.9 OUTLIER -118.03 171.37 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 106.665 -1.605 . . . . 0.25 106.665 167.023 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.77 120.6 1.76 Allowed Glycine 0 C--N 1.31 -0.911 0 C-N-CA 119.668 -1.254 . . . . 0.37 112.132 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.61 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -91.54 140.02 30.14 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 120.089 -0.644 . . . . 0.28999999999999998 110.148 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.502 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 3.0 t-20 50.9 49.86 20.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.921 -1.036 . . . . 1.8500000000000001 110.559 176.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.7 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 7.9 t -92.1 150.44 20.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.733 -1.121 . . . . 1.1200000000000001 110.805 -174.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 17.9 t -109.41 121.12 43.43 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.794 -0.639 . . . . 1.26 110.022 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 12.7 Cg_exo -69.69 124.24 10.92 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.514 2.142 . . . . 0.60999999999999999 112.527 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 40' ' ' CYS . 23.9 mt -103.09 87.63 2.95 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.966 -0.561 . . . . 0.85999999999999999 109.715 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.53 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 27.5 p -100.24 -41.64 7.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.951 0.405 . . . . 1.3700000000000001 110.506 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 m -95.44 103.23 14.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.397 0.618 . . . . 1.6000000000000001 111.042 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 48.8 mm -68.45 139.45 20.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.786 -0.643 . . . . 1.8500000000000001 110.625 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.13 -127.41 7.9 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.369 -1.092 . . . . 3.1800000000000002 110.369 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 m -67.83 114.63 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.331 0.586 . . . . 4.6900000000000004 110.207 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.85 -71.08 0.2 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.566 -0.613 . . . . 4.3499999999999996 111.566 -176.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.44 -44.81 82.87 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 121.063 -0.589 . . . . 3.27 112.648 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -95.03 23.64 5.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.761 0.791 . . . . 5.4699999999999998 109.4 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.4 m -110.64 22.53 15.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.371 -0.831 . . . . 4.7000000000000002 109.678 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.7 t -73.06 114.58 11.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.404 -0.816 . . . . 1.6599999999999999 110.411 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.2 t -101.24 -9.62 21.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.184 0.516 . . . . 1.6499999999999999 109.99 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.585 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -93.25 -158.31 0.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.855 -0.611 . . . . 0.54000000000000004 110.013 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.897 HE22 ' H ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -84.0 136.3 34.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.678 -0.49 . . . . 0.78000000000000003 109.678 -178.561 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.21 121.36 45.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.341 0.591 . . . . 0.39000000000000001 111.217 -174.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.595 HG12 ' HA ' ' A' ' 111' ' ' PRO . 1.9 m -133.07 164.18 35.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.515 -0.766 . . . . 0.22 110.877 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.4 t -108.24 109.08 20.36 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.347 -0.842 . . . . 0.70999999999999996 109.159 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 28.8 m -106.76 153.73 22.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.202 -0.454 . . . . 0.60999999999999999 110.135 -175.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 t -86.64 -28.03 23.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.38 110.655 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.617 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 24.1 m120 -151.74 168.08 26.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.693 -0.484 . . . . 0.78000000000000003 109.693 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.8 t -139.66 144.34 37.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.181 0.301 . . . . 0.41999999999999998 110.783 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.606 ' HB2' HG23 ' A' ' 105' ' ' VAL . 50.8 m-85 -134.07 153.12 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.094 -0.336 . . . . 0.77000000000000002 110.094 175.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.535 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 13.2 mm-40 62.6 30.41 17.01 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.303 0.483 . . . . 0.80000000000000004 112.303 172.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 67.05 -0.89 1.57 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.868 0.467 . . . . 2.1200000000000001 111.827 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 76' ' ' CYS . . . 140.61 -13.73 2.94 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.805 -0.712 . . . . 0.28000000000000003 112.514 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 48.2 mt -52.1 -36.13 50.07 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.991 0.424 . . . . 0.35999999999999999 111.0 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.606 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.3 OUTLIER -137.52 139.04 44.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.504 -0.771 . . . . 0.85999999999999999 109.786 174.389 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.575 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.5 t30 -136.37 157.93 45.63 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.711 -0.848 . . . . 0.91000000000000003 108.711 -174.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.617 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 10.7 m -135.64 150.87 29.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.983 0.734 . . . . 0.29999999999999999 112.983 -175.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.69 50.31 67.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 114.74 -1.118 . . . . 0.20000000000000001 112.086 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 81.0 m -96.87 125.92 41.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.767 0.318 . . . . 0.42999999999999999 110.576 -175.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 18.9 p -119.39 138.95 27.02 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.901 -0.591 . . . . 0.29999999999999999 109.78 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.595 ' HA ' HG12 ' A' ' 94' ' ' VAL . 36.7 Cg_exo -64.92 108.63 1.13 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.889 2.393 . . . . 0.34000000000000002 112.006 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.1 tt -94.58 132.37 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.585 -0.734 . . . . 0.58999999999999997 111.007 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -93.42 100.26 12.6 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.844 -0.798 . . . . 2.3900000000000001 108.844 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 115' ' ' GLY . 1.2 pp -66.75 -21.07 27.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.328 -0.396 . . . . 2.02 111.933 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.42 ' N ' HD12 ' A' ' 114' ' ' ILE . . . 100.06 -22.77 38.7 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.615 -0.802 . . . . 2.6099999999999999 113.666 173.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 116' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.199 -0.905 . . . . 3.6899999999999999 111.037 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.034 -0.358 . . . . 30.309999999999999 110.034 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.78 73.76 0.44 Allowed 'General case' 0 C--O 1.233 0.201 0 O-C-N 123.604 0.565 . . . . 28.059999999999999 110.735 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -84.55 46.73 1.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.239 -0.437 . . . . 28.52 111.696 -175.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.5 35.58 25.4 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.788 -0.642 . . . . 26.559999999999999 112.445 174.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -94.1 147.73 22.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.534 -0.543 . . . . 25.140000000000001 109.534 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.4 mm -120.48 103.44 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.77 0.319 . . . . 24.989999999999998 110.963 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.25 -25.74 12.13 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.332 -0.707 . . . . 22.920000000000002 111.332 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.8 m -125.46 117.39 23.55 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.68 -0.489 . . . . 22.809999999999999 109.68 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.2 m -58.73 -38.0 77.39 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.671 -0.695 . . . . 22.210000000000001 111.602 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -149.29 -58.12 0.21 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.23 0.538 . . . . 20.949999999999999 110.439 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 m -126.68 125.92 24.44 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.856 -0.611 . . . . 19.190000000000001 110.321 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.59 -30.96 77.09 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.165 2.577 . . . . 17.98 112.749 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -122.58 135.75 54.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.823 -0.436 . . . . 18.07 109.823 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -83.36 54.86 2.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.38 0.609 . . . . 14.66 111.103 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.29 117.47 55.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.489 -0.778 . . . . 13.029999999999999 109.396 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -82.7 42.66 0.79 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.972 0.415 . . . . 12.26 110.917 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.01 138.19 26.47 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.898 -0.592 . . . . 9.9700000000000006 111.826 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.89 173.87 13.53 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.749 -0.739 . . . . 8.2200000000000006 111.449 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.582 HG22 ' HD2' ' A' ' 30' ' ' PRO . 6.9 m -148.35 123.13 4.98 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-O 120.937 0.398 . . . . 7.2999999999999998 110.133 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 21.7 Cg_exo -56.51 -54.4 3.91 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.101 2.534 . . . . 6.0999999999999996 112.765 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.582 ' HD2' HG22 ' A' ' 28' ' ' THR . 91.9 Cg_endo -79.53 45.58 1.98 Allowed 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 121.492 1.461 . . . . 5.1900000000000004 112.459 173.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -65.91 125.56 25.76 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.906 -0.776 . . . . 3.79 108.906 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 p -153.34 -165.85 2.27 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.786 -0.365 . . . . 1.74 111.6 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.6 m -77.07 176.88 8.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.134 0.492 . . . . 1.7 111.328 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 m -89.92 -28.26 19.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 2.5699999999999998 110.495 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.8 p -98.64 10.93 39.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 2.5 111.274 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.42 -176.16 37.96 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.324 -0.941 . . . . 1.51 112.516 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HG2' ' HA ' ' A' ' 80' ' ' SER . 8.4 Cg_exo -73.72 -158.76 0.07 OUTLIER 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.718 2.945 . . . . 1.05 112.738 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 39' ' ' TYR . 19.2 t -84.44 166.35 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 110.29 -0.263 . . . . 0.58999999999999997 110.29 -176.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.493 ' N ' HG12 ' A' ' 38' ' ' VAL . 63.8 m-85 -132.91 140.1 47.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.978 0.418 . . . . 0.78000000000000003 110.577 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 52.4 t -117.79 103.21 9.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.017 -0.538 . . . . 0.81999999999999995 110.778 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.8 m -100.17 129.58 46.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.703 -0.851 . . . . 0.23999999999999999 108.703 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.489 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 94.6 m-20 -59.78 -24.24 63.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.55 0.69 . . . . 2.0800000000000001 109.585 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 5.3 mmmm -161.78 134.64 6.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.088 -1.414 . . . . 2.5800000000000001 107.724 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.514 HG21 HG11 ' A' ' 94' ' ' VAL . 22.9 p -88.39 157.73 18.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.441 -0.903 . . . . 0.37 110.49 169.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.509 ' CB ' HG22 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -119.12 142.53 47.83 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.366 -0.834 . . . . 1.1200000000000001 110.179 -176.337 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.523 ' O ' HD13 ' A' ' 50' ' ' LEU . 11.9 t70 -71.88 101.51 2.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.523 -0.762 . . . . 1.77 110.349 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.575 ' HA ' HD21 ' A' ' 50' ' ' LEU . 57.1 p -67.72 -6.67 22.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.631 0.604 . . . . 0.92000000000000004 112.631 -172.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.553 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -77.73 -40.9 39.59 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.777 0.799 . . . . 2.77 109.179 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -147.12 68.86 1.15 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.692 -1.14 . . . . 2.3300000000000001 109.874 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.575 HD21 ' HA ' ' A' ' 47' ' ' SER . 3.1 mm? -53.08 153.18 3.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.562 0.696 . . . . 1.1599999999999999 112.418 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.9 146.54 31.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.711 -1.132 . . . . 1.8100000000000001 108.703 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -59.6 -27.62 66.45 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.705 -0.398 . . . . 3.23 110.857 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.458 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -69.77 -37.07 75.73 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.547 -0.835 . . . . 0.34000000000000002 111.624 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.692 ' HA ' HD22 ' A' ' 57' ' ' LEU . 23.5 m -80.03 -43.95 21.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.831 0.348 . . . . 0.35999999999999999 110.228 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.7 m -51.93 -36.2 48.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 0.29999999999999999 109.813 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.36 -53.7 55.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.511 -0.768 . . . . 0.23000000000000001 111.78 176.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.692 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.49 -46.59 86.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.462 0.649 . . . . 0.23999999999999999 110.313 -178.586 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 54' ' ' THR . 52.9 mt -58.43 -44.8 89.27 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.854 -1.066 . . . . 0.17999999999999999 110.135 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.44 -32.91 79.13 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.968 -0.634 . . . . 0.26000000000000001 112.945 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.8 mt -64.01 -43.47 95.55 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.826 0.822 . . . . 0.34000000000000002 110.123 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.475 HD21 ' HG2' ' A' ' 101' ' ' GLN . 3.4 mt -86.68 -1.33 57.62 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.535 -1.212 . . . . 0.35999999999999999 110.961 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.2 m120 65.61 36.03 6.71 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.215 -0.902 . . . . 1.8899999999999999 111.072 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 58' ' ' LEU . 50.1 mt -82.96 145.09 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.599 -0.728 . . . . 0.26000000000000001 109.502 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.656 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -99.32 117.96 34.93 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.331 0.586 . . . . 2.2200000000000002 109.762 -178.157 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.29 -28.12 34.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.277 -0.874 . . . . 0.28999999999999998 110.877 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.13 -15.44 78.65 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.168 -0.539 . . . . 0.56999999999999995 112.6 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.492 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 17.2 t70 -86.21 -29.39 23.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.925 0.393 . . . . 0.85999999999999999 110.332 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 86.0 mt -52.5 139.39 25.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.099 -0.955 . . . . 0.46000000000000002 111.951 -174.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -96.67 -81.98 0.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.992 -1.004 . . . . 2.0099999999999998 112.197 -171.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -94.77 -92.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.05 0.389 . . . . 1.0900000000000001 112.05 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.3 mm? -117.39 171.32 8.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.319 0.58 . . . . 0.14999999999999999 110.917 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.6 OUTLIER -121.08 172.88 7.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.565 -1.643 . . . . 0.25 106.565 165.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.483 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -139.39 129.16 4.26 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 119.89 -1.147 . . . . 0.37 112.106 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.659 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -99.21 135.96 39.85 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.442 -0.503 . . . . 0.28999999999999998 109.895 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.41 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 24.2 m120 46.56 51.16 12.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.199 -0.91 . . . . 1.8500000000000001 110.531 -175.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -87.41 147.98 25.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.064 -0.971 . . . . 1.1200000000000001 109.575 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.7 m -109.59 108.97 59.94 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 116.048 -0.524 . . . . 1.26 110.356 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.59 120.02 7.15 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.12 1.88 . . . . 0.60999999999999999 111.371 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 37' ' ' PRO . 35.4 mt -90.1 87.03 6.72 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.601 -0.727 . . . . 0.85999999999999999 109.26 -177.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.483 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 10.4 m -80.01 -48.09 13.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.774 -0.648 . . . . 1.3700000000000001 110.654 -175.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.8 m -104.05 113.98 42.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.3 0.571 . . . . 1.6000000000000001 111.026 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.8 mt -122.09 126.78 74.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.922 -0.581 . . . . 1.8500000000000001 110.95 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -180.0 -31.87 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.848 -0.691 . . . . 3.1800000000000002 111.689 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.9 102.01 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.748 -0.464 . . . . 4.6900000000000004 109.748 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.68 -66.0 3.38 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.946 -0.645 . . . . 4.3499999999999996 112.329 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 124.94 12.18 4.08 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.909 -0.662 . . . . 3.27 112.445 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -120.27 -79.45 0.6 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.507 -0.553 . . . . 5.4699999999999998 109.507 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.0 m 50.58 39.65 21.82 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.519 0.676 . . . . 4.7000000000000002 110.94 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.43 -56.69 0.44 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.432 -0.804 . . . . 1.6599999999999999 110.691 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t 64.37 12.29 7.16 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.982 0.513 . . . . 1.6499999999999999 112.07 174.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.698 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -134.33 -158.72 0.9 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.064 -0.346 . . . . 0.54000000000000004 110.064 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.73 115.96 21.88 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.852 0.834 . . . . 0.78000000000000003 109.694 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 117.13 33.24 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.169 -0.923 . . . . 0.39000000000000001 110.832 -169.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.514 HG11 HG21 ' A' ' 44' ' ' THR . 9.5 m -129.93 171.53 17.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.547 -0.751 . . . . 0.22 111.854 -176.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 37.7 t -115.0 108.32 16.55 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.812 -1.085 . . . . 0.70999999999999996 108.93 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 27.6 m -106.03 145.43 31.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.313 -0.403 . . . . 0.60999999999999999 110.076 -176.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -76.04 -28.87 57.85 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.38 110.348 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.445 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 12.1 m120 -151.34 164.18 37.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 0.78000000000000003 109.843 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 t -137.63 133.55 34.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.05 -0.523 . . . . 0.41999999999999998 109.944 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.555 ' HB2' HG23 ' A' ' 105' ' ' VAL . 66.2 m-85 -119.37 157.25 28.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.963 -0.562 . . . . 0.77000000000000002 109.827 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.623 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 12.5 mm-40 60.35 30.51 19.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.441 . . . . 0.80000000000000004 111.586 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 63.68 9.82 4.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 2.1200000000000001 111.875 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.83 -24.29 3.02 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.73 -0.747 . . . . 0.28000000000000003 112.507 175.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 18.6 mt -49.86 -36.13 25.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.825 0.305 . . . . 0.35999999999999999 111.825 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.555 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.3 OUTLIER -141.38 118.82 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.392 0.615 . . . . 0.85999999999999999 110.992 173.148 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.588 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 7.5 m-20 -111.03 162.64 14.66 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.5 -0.773 . . . . 0.91000000000000003 109.488 176.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.445 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.4 m -132.85 154.32 39.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.336 0.495 . . . . 0.29999999999999999 112.336 -176.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 59.8 52.29 53.87 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.278 -0.874 . . . . 0.20000000000000001 111.88 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 73.3 m -96.81 123.6 40.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.878 0.37 . . . . 0.42999999999999999 111.116 -174.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.4 p -119.72 125.94 27.18 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.919 -0.582 . . . . 0.29999999999999999 110.131 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.48 ' HA ' HG12 ' A' ' 94' ' ' VAL . 81.5 Cg_exo -48.38 109.87 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.752 2.301 . . . . 0.34000000000000002 111.665 175.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.3 tt -92.64 144.21 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 0.58999999999999997 111.747 -169.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -107.05 101.39 10.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.549 -0.751 . . . . 2.3900000000000001 110.366 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 115' ' ' GLY . 1.4 pp -94.8 -19.39 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.059 -0.518 . . . . 2.02 111.374 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.416 ' N ' HD12 ' A' ' 114' ' ' ILE . . . 81.21 -8.56 57.61 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 121.149 -0.548 . . . . 2.6099999999999999 113.621 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.539 -0.743 . . . . 3.6899999999999999 109.811 -179.584 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.821 0.343 . . . . 30.309999999999999 110.846 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.29 134.64 36.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.771 0.319 . . . . 28.059999999999999 110.385 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.5 mtp -98.25 125.86 43.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.145 -0.479 . . . . 28.52 110.895 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.33 81.26 2.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.212 0.529 . . . . 26.559999999999999 109.618 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -77.98 134.39 37.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.637 -0.711 . . . . 25.140000000000001 110.514 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.488 ' H ' HD13 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -133.65 20.19 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.986 -0.552 . . . . 24.989999999999998 110.728 -177.489 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.04 52.36 4.61 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.034 -0.603 . . . . 22.920000000000002 112.383 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.5 m -85.8 65.99 9.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.274 0.559 . . . . 22.809999999999999 110.038 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -77.75 64.9 3.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.407 -0.815 . . . . 22.210000000000001 111.195 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.91 48.23 0.94 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.939 -0.573 . . . . 20.949999999999999 110.791 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 20' ' ' VAL . 7.5 p -147.63 71.33 11.62 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 121.772 0.796 . . . . 19.190000000000001 110.677 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.25 -45.27 23.7 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.475 2.117 . . . . 17.98 110.816 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -147.29 123.93 11.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.498 -0.774 . . . . 18.07 109.949 175.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -108.03 -42.33 4.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.007 -0.542 . . . . 14.66 110.162 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.8 m -108.82 155.41 9.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.69 -0.687 . . . . 13.029999999999999 110.746 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -113.46 118.21 33.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.187 -0.461 . . . . 12.26 110.01 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -139.01 -165.24 10.17 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.844 -0.693 . . . . 9.9700000000000006 112.335 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.83 -69.49 0.2 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.539 -0.624 . . . . 8.2200000000000006 111.539 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.643 HG22 ' HD2' ' A' ' 30' ' ' PRO . 61.1 m -152.7 113.11 2.76 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 110.323 -0.251 . . . . 7.2999999999999998 110.323 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 28' ' ' THR . 4.3 Cg_exo -43.5 -51.17 6.26 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.888 3.059 . . . . 6.0999999999999996 114.713 -171.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.643 ' HD2' HG22 ' A' ' 28' ' ' THR . 70.0 Cg_exo -48.58 112.48 0.63 Allowed 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 122.435 2.09 . . . . 5.1900000000000004 112.88 174.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -102.41 -34.07 9.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.172 -0.467 . . . . 3.79 110.392 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.3 t -78.16 178.63 7.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.796 -0.638 . . . . 1.74 109.588 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 73.8 m -101.95 147.45 26.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.99 0.424 . . . . 1.7 110.325 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 p -89.05 -10.84 45.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.091 -0.504 . . . . 2.5699999999999998 110.932 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.2 t -94.62 9.13 39.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 2.5 110.181 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . 149.33 151.26 5.44 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.879 -0.889 . . . . 1.51 110.879 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 16.8 Cg_exo -69.71 -159.6 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.492 2.128 . . . . 1.05 112.495 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.9 t -87.29 156.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.144 -0.317 . . . . 0.58999999999999997 110.144 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.29 136.44 48.16 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.855 -0.424 . . . . 0.78000000000000003 109.855 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 48.0 t -102.99 114.82 29.42 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.806 0.336 . . . . 0.81999999999999995 110.589 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.1 m -115.25 125.18 53.02 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.928 -0.767 . . . . 0.23999999999999999 108.928 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.512 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 24.7 t-20 -50.64 -34.36 25.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.614 -0.721 . . . . 2.0800000000000001 110.231 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -154.58 127.48 8.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.652 -1.158 . . . . 2.5800000000000001 108.725 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.515 HG21 HG11 ' A' ' 94' ' ' VAL . 18.0 p -84.37 156.94 21.62 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.53 -0.868 . . . . 0.37 110.514 168.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.8 tp10 -120.58 139.23 53.25 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.617 -0.72 . . . . 1.1200000000000001 109.451 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.442 ' HA ' HD12 ' A' ' 71' ' ' LEU . 24.1 t70 -65.65 110.81 2.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.029 -0.532 . . . . 1.77 110.376 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 58.5 p -69.41 -2.45 11.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.262 -0.426 . . . . 0.92000000000000004 112.073 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -90.12 -27.99 19.26 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.115 0.483 . . . . 2.77 109.759 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -141.62 64.28 1.41 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.57 . . . . 2.3300000000000001 110.592 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.547 HD11 HG13 ' A' ' 72' ' ' VAL . 2.8 mm? -60.74 150.21 33.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.291 0.567 . . . . 1.1599999999999999 111.559 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.93 144.13 57.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.831 -1.077 . . . . 1.8100000000000001 108.438 169.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -62.8 -21.07 65.62 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.213 -0.195 . . . . 3.23 110.902 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.31 -36.57 63.36 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.583 -0.818 . . . . 0.34000000000000002 111.202 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.643 ' HA ' HD22 ' A' ' 57' ' ' LEU . 37.9 m -82.05 -43.98 17.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.817 0.342 . . . . 0.35999999999999999 110.198 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.1 m -52.5 -35.37 52.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.698 -0.683 . . . . 0.29999999999999999 110.04 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.637 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -55.82 -53.69 53.62 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.377 -0.829 . . . . 0.23000000000000001 111.288 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.643 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -59.6 -44.9 93.23 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.221 0.534 . . . . 0.23999999999999999 109.995 -178.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 54' ' ' THR . 54.1 mt -58.12 -46.08 86.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.094 -0.957 . . . . 0.17999999999999999 109.992 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.24 -29.66 75.15 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.003 -0.617 . . . . 0.26000000000000001 112.574 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.1 mt -65.73 -47.53 75.01 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.639 0.733 . . . . 0.34000000000000002 110.161 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' CD1' HG21 ' A' ' 105' ' ' VAL . 3.7 mt -83.09 -2.41 55.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.764 -1.107 . . . . 0.35999999999999999 110.996 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.2 t30 68.17 38.38 2.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.222 -0.899 . . . . 1.8899999999999999 110.978 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 58' ' ' LEU . 51.3 mt -84.32 137.74 20.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.778 -0.646 . . . . 0.26000000000000001 110.099 175.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -84.11 118.0 23.81 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.645 -0.707 . . . . 2.2200000000000002 110.304 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.91 -31.69 51.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.763 -0.653 . . . . 0.28999999999999998 109.902 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.92 -9.53 86.61 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.774 -0.648 . . . . 0.56999999999999995 112.604 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -95.6 -8.78 33.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.399 0.618 . . . . 0.85999999999999999 110.283 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.6 mt -69.22 144.08 53.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.721 -0.672 . . . . 0.46000000000000002 111.223 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -101.17 -68.73 0.8 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.843 -1.071 . . . . 2.0099999999999998 112.557 -168.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -114.51 -91.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.853 0.359 . . . . 1.0900000000000001 111.825 -172.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.3 mm? -116.25 169.34 9.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.056 0.455 . . . . 0.14999999999999999 110.393 174.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.547 HG13 HD11 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -124.89 166.88 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.596 -1.631 . . . . 0.25 106.596 166.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.464 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -134.1 148.24 19.38 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 119.807 -1.187 . . . . 0.37 111.364 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -112.1 134.4 53.67 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.151 -0.62 . . . . 0.28999999999999998 110.549 177.128 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 55.51 45.14 25.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.824 -1.08 . . . . 1.8500000000000001 111.163 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.464 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 63.3 m -77.61 146.91 35.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.334 0.588 . . . . 1.1200000000000001 111.275 -176.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t -98.03 113.28 63.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.168 -0.924 . . . . 1.26 109.523 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.06 124.39 12.56 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.379 2.053 . . . . 0.60999999999999999 111.954 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.8 mt -103.45 88.46 3.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.932 -0.576 . . . . 0.85999999999999999 109.729 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.4 m -76.8 -32.62 57.78 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.878 -0.601 . . . . 1.3700000000000001 110.727 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 m -112.7 102.95 14.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.664 0.745 . . . . 1.6000000000000001 111.566 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.5 mm -68.09 -47.69 77.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.264 -0.88 . . . . 1.8500000000000001 112.164 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.7 -29.53 69.43 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.522 -0.847 . . . . 3.1800000000000002 112.46 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.46 -46.1 32.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 122.863 -0.198 . . . . 4.6900000000000004 110.918 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.14 59.97 0.27 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.201 -0.999 . . . . 4.3499999999999996 112.859 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.7 -24.67 6.91 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.779 -0.724 . . . . 3.27 112.054 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -83.25 129.81 35.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.38 -0.23 . . . . 5.4699999999999998 110.38 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 p 48.71 91.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.888 0.743 . . . . 4.7000000000000002 111.591 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.519 ' SG ' HG23 ' A' ' 93' ' ' THR . 32.0 p -94.56 17.34 13.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.54 -0.755 . . . . 1.6599999999999999 111.237 -173.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.6 t 68.45 6.62 5.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.796 -0.638 . . . . 1.6499999999999999 110.636 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.786 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -154.44 -162.11 1.34 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.983 -0.553 . . . . 0.54000000000000004 110.362 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.0 124.03 31.23 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.404 0.621 . . . . 0.78000000000000003 110.069 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.519 HG23 ' SG ' ' A' ' 89' ' ' CYS . 0.2 OUTLIER -104.33 115.73 30.89 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.826 -0.625 . . . . 0.39000000000000001 110.991 -173.331 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 111' ' ' PRO . 9.5 m -126.42 165.08 25.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.936 -0.574 . . . . 0.22 111.316 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.6 121.96 45.03 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.079 -1.082 . . . . 0.70999999999999996 108.079 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.709 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 27.1 m -120.57 152.35 38.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 0.60999999999999999 111.664 -167.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.525 HG22 ' HA3' ' A' ' 108' ' ' GLY . 10.9 t -81.2 -30.08 34.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.072 -0.967 . . . . 0.38 110.637 -170.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.487 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 17.8 m120 -154.56 167.82 28.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.39 -0.596 . . . . 0.78000000000000003 109.39 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 t -147.37 135.99 21.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.118 0.485 . . . . 0.41999999999999998 110.622 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.531 ' HB2' HG23 ' A' ' 105' ' ' VAL . 67.1 m-85 -129.55 154.31 47.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.361 -0.607 . . . . 0.77000000000000002 109.361 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.663 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 14.4 mm-40 59.88 38.1 21.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.545 -0.298 . . . . 0.80000000000000004 111.48 176.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.7 p80 58.88 2.18 0.23 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.152 0.981 . . . . 2.1200000000000001 113.201 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.69 -18.19 3.01 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.691 -0.766 . . . . 0.28000000000000003 112.242 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 20.7 mt -49.8 -44.02 48.88 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.871 0.336 . . . . 0.35999999999999999 110.767 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 100' ' ' TYR . 1.4 m -128.9 119.65 50.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.698 0.761 . . . . 0.85999999999999999 110.344 172.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.462 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 32.5 t30 -119.12 146.31 45.23 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.075 -1.083 . . . . 0.91000000000000003 108.075 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.537 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 11.3 m -132.45 156.21 42.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.537 0.94 . . . . 0.29999999999999999 113.537 -173.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 65.45 49.36 61.12 Favored Glycine 0 CA--C 1.503 -0.66 0 CA-C-N 114.952 -1.022 . . . . 0.20000000000000001 111.716 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 98.7 m -98.15 126.59 43.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.964 0.411 . . . . 0.42999999999999999 111.533 -172.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -120.86 126.14 26.78 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.505 -0.771 . . . . 0.29999999999999999 109.852 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 94' ' ' VAL . 71.7 Cg_exo -50.15 112.34 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.049 2.499 . . . . 0.34000000000000002 112.117 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.0 tt -99.57 148.56 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.894 -0.594 . . . . 0.58999999999999997 111.096 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -124.17 109.61 13.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.502 -0.772 . . . . 2.3900000000000001 109.451 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.438 HD12 ' H ' ' A' ' 115' ' ' GLY . 1.2 pp -76.59 -24.7 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.852 -0.339 . . . . 2.02 111.794 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.438 ' H ' HD12 ' A' ' 114' ' ' ILE . . . 88.53 7.78 71.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.586 -0.816 . . . . 2.6099999999999999 113.555 173.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.4 ' H ' HD13 ' A' ' 114' ' ' ILE . 7.6 mp . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.483 -0.77 . . . . 3.6899999999999999 109.956 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 120.934 0.397 . . . . 30.309999999999999 111.114 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.52 86.93 2.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.946 0.403 . . . . 28.059999999999999 110.128 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.9 mmt -77.62 66.36 3.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 28.52 110.902 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.83 132.4 54.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.065 -0.516 . . . . 26.559999999999999 110.258 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.08 94.73 2.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.004 0.431 . . . . 25.140000000000001 110.105 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.2 pt -113.54 158.02 14.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.055 -0.521 . . . . 24.989999999999998 111.113 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.44 56.86 0.55 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.415 -0.674 . . . . 22.920000000000002 111.415 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -87.5 -4.88 58.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.812 0.339 . . . . 22.809999999999999 110.9 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -70.12 142.46 52.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.92 0.39 . . . . 22.210000000000001 109.951 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.93 145.36 27.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.364 -0.38 . . . . 20.949999999999999 111.149 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 t 59.27 85.53 0.18 Allowed Pre-proline 0 CA--C 1.532 0.27 0 O-C-N 123.859 0.724 . . . . 19.190000000000001 111.53 176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.79 -20.38 45.95 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.501 2.134 . . . . 17.98 112.227 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -106.43 84.31 2.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.438 -0.347 . . . . 18.07 110.78 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.91 -19.35 58.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.339 -0.615 . . . . 14.66 109.339 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.57 137.48 18.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.207 -0.906 . . . . 13.029999999999999 109.317 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -82.65 79.27 9.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.205 0.526 . . . . 12.26 110.35 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.95 106.96 2.53 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.598 -0.728 . . . . 9.9700000000000006 112.131 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.92 25.44 2.8 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.936 -0.649 . . . . 8.2200000000000006 111.581 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.542 HG22 ' HD2' ' A' ' 30' ' ' PRO . 7.1 m -77.25 119.44 77.48 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 121.195 0.521 . . . . 7.2999999999999998 110.66 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -56.62 -54.73 3.44 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.605 2.87 . . . . 6.0999999999999996 113.835 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.542 ' HD2' HG22 ' A' ' 28' ' ' THR . 58.5 Cg_endo -70.18 152.43 67.15 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.243 1.295 . . . . 5.1900000000000004 112.104 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.442 ' HB2' HG13 ' A' ' 112' ' ' ILE . 68.3 mttm -88.33 43.35 1.12 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.99 -0.55 . . . . 3.79 110.964 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.1 t -72.87 161.67 30.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.371 0.605 . . . . 1.74 110.457 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 57.1 m -89.47 124.82 34.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.365 -0.834 . . . . 1.7 110.432 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.9 t -66.54 -17.71 64.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.035 0.445 . . . . 2.5699999999999998 110.312 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 t -71.19 -16.32 62.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.951 -0.568 . . . . 2.5 110.602 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.1 -123.79 3.55 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.812 -0.709 . . . . 1.51 112.166 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.54 153.76 33.75 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.142 2.562 . . . . 1.05 113.747 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t -89.06 161.47 2.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.453 -1.249 . . . . 0.58999999999999997 107.85 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -118.3 137.01 53.36 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.872 0.844 . . . . 0.78000000000000003 111.817 -176.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 53.1 t -109.05 115.71 30.57 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.842 -1.072 . . . . 0.81999999999999995 110.152 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.7 m -113.57 126.69 55.57 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.201 -0.666 . . . . 0.23999999999999999 109.201 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -57.63 -23.21 49.92 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.473 -0.785 . . . . 2.0800000000000001 109.769 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -166.24 132.46 2.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.55 -1.204 . . . . 2.5800000000000001 108.028 172.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.494 HG21 HG11 ' A' ' 94' ' ' VAL . 25.1 p -89.6 159.47 17.15 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.456 -0.898 . . . . 0.37 110.494 172.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.449 ' CB ' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -120.58 144.89 47.85 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.208 -0.905 . . . . 1.1200000000000001 109.305 -176.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.469 ' OD2' ' HB2' ' A' ' 48' ' ' LYS . 33.4 t70 -78.52 105.49 9.83 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.973 -0.558 . . . . 1.77 110.313 -174.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.711 ' HA ' HD21 ' A' ' 50' ' ' LEU . 80.1 p -63.21 -7.07 5.17 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.125 0.787 . . . . 0.92000000000000004 113.125 -172.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 2.9 mptp? -81.4 -43.49 18.88 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.335 0.588 . . . . 2.77 110.301 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -135.78 63.94 1.58 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.222 -0.899 . . . . 2.3300000000000001 111.211 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.711 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.8 mm? -60.06 155.97 15.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.265 0.555 . . . . 1.1599999999999999 111.453 176.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.26 152.29 41.4 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.638 -0.875 . . . . 1.8100000000000001 108.638 168.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -63.24 -28.96 70.39 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.415 -0.514 . . . . 3.23 110.638 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -67.54 -38.14 90.29 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.796 -0.716 . . . . 0.34000000000000002 111.879 177.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.686 ' HA ' HD22 ' A' ' 57' ' ' LEU . 41.7 m -78.93 -41.79 28.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.961 0.41 . . . . 0.35999999999999999 109.931 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -52.41 -36.11 53.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.448 -0.796 . . . . 0.29999999999999999 109.805 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.57 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.15 -53.99 52.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.046 -0.979 . . . . 0.23000000000000001 111.626 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.686 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -57.37 -46.31 83.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.492 0.663 . . . . 0.23999999999999999 110.016 -179.048 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.0 mt -58.69 -45.22 89.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.719 -1.128 . . . . 0.17999999999999999 109.827 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.34 -36.39 90.85 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.762 -0.654 . . . . 0.26000000000000001 112.657 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 25.5 mt -59.41 -40.29 86.19 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.613 0.72 . . . . 0.34000000000000002 110.439 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.475 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.3 mt -90.68 -3.65 57.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.923 -1.035 . . . . 0.35999999999999999 110.836 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 72.03 30.69 2.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.353 -0.84 . . . . 1.8899999999999999 111.305 176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 58' ' ' LEU . 60.1 mt -77.59 141.95 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.984 -0.553 . . . . 0.26000000000000001 109.819 176.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.495 ' CG ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -97.46 117.69 32.28 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.355 0.598 . . . . 2.2200000000000002 110.084 -177.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.7 -39.15 59.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.199 -0.909 . . . . 0.28999999999999998 110.791 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.9 -11.42 60.67 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.949 -0.643 . . . . 0.56999999999999995 112.952 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.495 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 36.6 t70 -111.94 3.63 17.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.253 0.549 . . . . 0.85999999999999999 110.793 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.41 ' CB ' ' HB2' ' A' ' 47' ' ' SER . 94.4 mt -70.85 164.72 24.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.304 -0.407 . . . . 0.46000000000000002 110.636 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -106.52 -91.93 0.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.586 0.587 . . . . 2.0099999999999998 112.586 -174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' O ' HD13 ' A' ' 71' ' ' LEU . 5.6 m-20 -91.81 -84.43 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.622 0.601 . . . . 1.0900000000000001 112.622 -171.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.0 OUTLIER -123.55 166.88 14.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.358 0.599 . . . . 0.14999999999999999 111.032 176.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.511 HG23 ' N ' ' A' ' 73' ' ' GLY . 0.8 OUTLIER -117.48 172.92 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.526 -1.657 . . . . 0.25 106.526 166.129 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.533 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -143.26 149.12 21.07 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.145 -1.026 . . . . 0.37 111.532 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.606 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -112.52 132.73 54.95 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.137 0.494 . . . . 0.28999999999999998 109.96 175.117 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 55.59 47.51 20.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.867 -1.06 . . . . 1.8500000000000001 110.91 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.533 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 63.6 m -82.58 138.93 34.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.871 -0.604 . . . . 1.1200000000000001 110.952 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 19.5 m -103.02 127.52 29.68 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.576 -0.738 . . . . 1.26 110.482 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 3.5 Cg_exo -76.04 126.35 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.491 2.127 . . . . 0.60999999999999999 112.365 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.37 88.88 4.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.449 -0.796 . . . . 0.85999999999999999 109.563 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.0 m -75.51 -26.09 57.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.28 -0.418 . . . . 1.3700000000000001 111.138 -177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.8 m -117.73 105.54 18.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.463 0.649 . . . . 1.6000000000000001 112.003 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.5 mt -117.61 127.47 74.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.503 -0.772 . . . . 1.8500000000000001 110.562 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.59 -38.44 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.72 -0.952 . . . . 3.1800000000000002 110.72 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.25 -41.96 43.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.242 -0.651 . . . . 4.6900000000000004 109.242 172.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.65 -142.99 10.26 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.307 -0.86 . . . . 4.3499999999999996 111.291 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.24 25.46 25.66 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.514 -0.85 . . . . 3.27 112.074 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -68.53 -24.95 64.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 5.4699999999999998 111.294 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.9 p -75.73 -13.2 60.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.45 0.643 . . . . 4.7000000000000002 110.204 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 12.5 t -104.69 -74.97 0.63 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.499 -0.773 . . . . 1.6599999999999999 110.681 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.4 t 61.51 29.86 18.54 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.618 0.723 . . . . 1.6499999999999999 110.623 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.697 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -145.62 -158.42 0.89 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.46 -0.941 . . . . 0.54000000000000004 108.46 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.33 116.41 20.39 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.669 0.747 . . . . 0.78000000000000003 109.336 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.19 123.52 44.53 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.558 -0.746 . . . . 0.39000000000000001 110.445 -171.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 111' ' ' PRO . 7.6 m -134.41 163.16 37.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.508 -0.769 . . . . 0.22 111.423 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 47.3 t -107.99 114.88 29.11 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.301 -1.0 . . . . 0.70999999999999996 108.301 176.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 28.0 m -114.88 148.2 38.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.166 -0.47 . . . . 0.60999999999999999 110.142 -173.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -78.97 -32.9 45.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.958 -0.565 . . . . 0.38 110.651 -174.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.401 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 19.9 m120 -153.02 163.4 39.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.78000000000000003 110.313 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -136.03 143.23 44.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.13 -0.486 . . . . 0.41999999999999998 110.119 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.612 ' HB2' HG23 ' A' ' 105' ' ' VAL . 60.0 m-85 -129.67 153.42 48.15 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.332 -0.618 . . . . 0.77000000000000002 109.332 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.637 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 16.6 mm-40 62.9 30.59 16.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 0.80000000000000004 111.075 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 65.53 2.41 2.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.808 -0.633 . . . . 2.1200000000000001 112.378 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.37 -16.62 3.37 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.32 -0.943 . . . . 0.28000000000000003 112.868 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 20.5 mt -50.11 -38.05 36.95 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.026 0.413 . . . . 0.35999999999999999 110.689 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.612 HG23 ' HB2' ' A' ' 100' ' ' TYR . 5.6 m -130.0 149.14 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.755 -0.657 . . . . 0.85999999999999999 109.312 171.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 7.8 t30 -144.31 149.99 37.13 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.778 -0.823 . . . . 0.91000000000000003 108.778 -174.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.401 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 11.0 m -130.88 151.59 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 113.006 0.743 . . . . 0.29999999999999999 113.006 -174.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.19 50.42 67.32 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 114.838 -1.074 . . . . 0.20000000000000001 112.104 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 74.7 m -97.75 126.47 43.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.608 0.242 . . . . 0.42999999999999999 111.304 -175.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 21.4 p -118.88 138.05 25.64 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.464 -0.334 . . . . 0.29999999999999999 110.465 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.553 ' HA ' HG12 ' A' ' 94' ' ' VAL . 24.2 Cg_exo -67.53 110.85 2.17 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.294 2.663 . . . . 0.34000000000000002 112.889 -175.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.442 HG13 ' HB2' ' A' ' 31' ' ' LYS . 5.8 tt -95.85 127.4 47.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.942 -0.572 . . . . 0.58999999999999997 111.123 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -109.49 102.07 10.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.895 -0.593 . . . . 2.3900000000000001 110.806 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.52 2.99 9.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.195 0.521 . . . . 2.02 110.971 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.84 -10.2 7.1 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.158 -0.777 . . . . 2.6099999999999999 111.158 -173.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.621 -0.704 . . . . 3.6899999999999999 110.289 176.023 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 110.011 -0.366 . . . . 30.309999999999999 110.011 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.86 57.21 0.73 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.106 0.479 . . . . 28.059999999999999 110.302 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.4 ttm -95.37 71.57 3.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.37 0.605 . . . . 28.52 110.454 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.16 -8.06 58.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.726 -0.67 . . . . 26.559999999999999 109.569 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -69.94 127.07 31.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.098 -0.956 . . . . 25.140000000000001 110.595 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.558 ' H ' HD13 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -121.81 11.09 5.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.509 0.671 . . . . 24.989999999999998 109.694 177.777 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.46 -158.27 10.13 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.176 -0.92 . . . . 22.920000000000002 111.246 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.2 t -118.41 -57.12 2.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.83 0.348 . . . . 22.809999999999999 110.701 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.4 p -85.48 -42.41 14.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.446 -0.343 . . . . 22.210000000000001 111.848 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.38 135.0 35.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.778 0.323 . . . . 20.949999999999999 111.198 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.99 141.25 22.12 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.219 -0.446 . . . . 19.190000000000001 110.434 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.27 -22.34 46.49 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.859 2.373 . . . . 17.98 112.166 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -146.69 106.64 3.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.755 -0.657 . . . . 18.07 109.511 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -88.81 -70.33 0.65 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.191 -0.67 . . . . 14.66 109.191 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.5 t -129.32 -58.18 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.55 -0.907 . . . . 13.029999999999999 108.55 171.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.7 m120 49.16 66.66 1.04 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.232 -0.895 . . . . 12.26 111.146 173.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.67 -107.3 0.32 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.933 -0.651 . . . . 9.9700000000000006 112.021 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.93 10.97 71.13 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.866 -0.683 . . . . 8.2200000000000006 111.546 -177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.531 HG22 ' HD2' ' A' ' 30' ' ' PRO . 7.1 m -73.92 135.44 77.32 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.202 -0.296 . . . . 7.2999999999999998 110.202 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 53.3 Cg_exo -36.52 -46.49 1.22 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 124.351 3.367 . . . . 6.0999999999999996 115.927 -176.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.531 ' HD2' HG22 ' A' ' 28' ' ' THR . 7.1 Cg_exo -72.06 69.05 3.17 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 121.781 1.654 . . . . 5.1900000000000004 111.483 177.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -81.62 48.84 1.23 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.378 -0.828 . . . . 3.79 110.68 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.2 t -87.07 174.41 8.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.134 -0.485 . . . . 1.74 110.802 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 40.9 m -96.81 151.73 19.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.707 -0.678 . . . . 1.7 110.032 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.7 m -84.58 -2.34 57.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.254 -0.43 . . . . 2.5699999999999998 110.488 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.0 p -73.44 -24.66 60.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.797 -0.638 . . . . 2.5 111.08 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.79 -156.4 26.99 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.634 -0.793 . . . . 1.51 111.978 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -52.42 153.86 12.72 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.168 2.579 . . . . 1.05 113.723 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.43 158.6 3.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.953 -1.129 . . . . 0.58999999999999997 107.953 171.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.476 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 94.6 m-85 -120.89 138.49 54.06 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.827 -0.749 . . . . 0.78000000000000003 111.594 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 42.2 t -111.75 100.29 8.83 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.043 -0.98 . . . . 0.81999999999999995 110.031 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.9 m -101.95 128.19 48.47 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.085 -0.709 . . . . 0.23999999999999999 109.085 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -57.12 -24.6 55.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.817 -0.629 . . . . 2.0800000000000001 110.261 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.8 120.09 0.88 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.308 -0.86 . . . . 2.5800000000000001 108.703 177.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.553 HG21 HG11 ' A' ' 94' ' ' VAL . 18.4 p -78.81 147.35 33.29 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.121 -1.032 . . . . 0.37 110.505 172.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.472 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.2 tp10 -114.07 142.32 46.35 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.479 -0.782 . . . . 1.1200000000000001 109.421 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.436 ' O ' HD13 ' A' ' 50' ' ' LEU . 28.2 m-20 -70.45 103.97 2.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.949 -0.569 . . . . 1.77 111.129 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.681 ' HA ' HD21 ' A' ' 50' ' ' LEU . 7.1 m -58.71 -14.59 8.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.309 0.485 . . . . 0.92000000000000004 112.309 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -77.16 -35.64 55.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.834 0.349 . . . . 2.77 110.218 -178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -146.74 65.35 1.18 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.07 -0.514 . . . . 2.3300000000000001 111.073 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.681 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.7 mm? -57.0 151.3 15.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.481 . . . . 1.1599999999999999 111.242 175.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.77 156.49 39.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.203 -0.666 . . . . 1.8100000000000001 109.203 172.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -59.99 -33.35 71.85 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.806 -0.358 . . . . 3.23 111.014 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.408 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -61.83 -34.2 87.93 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.843 -0.694 . . . . 0.34000000000000002 111.812 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.658 ' HA ' HD22 ' A' ' 57' ' ' LEU . 24.1 m -85.04 -43.08 14.25 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.456 -0.202 . . . . 0.35999999999999999 110.456 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.5 m -52.84 -35.22 57.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.256 0.551 . . . . 0.29999999999999999 109.763 173.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.619 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.5 -55.45 33.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.277 -0.874 . . . . 0.23000000000000001 111.494 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.658 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -58.9 -44.76 91.29 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.34 0.59 . . . . 0.23999999999999999 110.103 -177.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.4 mt -59.99 -43.44 95.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.138 -0.937 . . . . 0.17999999999999999 110.114 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.14 -38.01 94.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.718 -0.754 . . . . 0.26000000000000001 112.162 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.3 mt -62.23 -40.99 97.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.798 0.809 . . . . 0.34000000000000002 110.187 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.425 HD21 ' HG2' ' A' ' 101' ' ' GLN . 10.7 mt -91.27 4.95 51.03 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.566 -1.197 . . . . 0.35999999999999999 111.274 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 64.85 33.62 9.94 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.717 -0.674 . . . . 1.8899999999999999 111.403 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.9 mt -89.91 144.13 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.875 -0.602 . . . . 0.26000000000000001 110.324 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.546 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 11.3 mptt -94.31 118.43 31.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.825 -0.625 . . . . 2.2200000000000002 109.963 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -68.48 -35.67 71.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.499 -0.773 . . . . 0.28999999999999998 110.386 -177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.87 -14.15 82.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.904 -0.665 . . . . 0.56999999999999995 112.39 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 32.0 t70 -88.01 -19.71 26.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.006 0.431 . . . . 0.85999999999999999 110.549 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.433 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 93.0 mt -55.5 141.93 35.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.699 0.762 . . . . 0.46000000000000002 111.771 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -87.86 -66.62 0.89 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.725 -1.125 . . . . 2.0099999999999998 112.457 -170.376 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.489 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 0.3 OUTLIER -123.73 -84.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.786 -0.366 . . . . 1.0900000000000001 111.157 -177.61 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.5 mm? -116.45 167.12 11.33 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.291 0.567 . . . . 0.14999999999999999 111.983 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 45' ' ' GLU . 1.9 m -119.78 165.13 15.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.18 -1.415 . . . . 0.25 107.18 168.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.403 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -137.42 133.85 6.67 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.655 -1.26 . . . . 0.37 112.404 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.23 135.77 36.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.901 -0.407 . . . . 0.28999999999999998 109.901 176.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.419 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 19.7 m120 46.79 52.92 10.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.466 -0.788 . . . . 1.8500000000000001 110.634 -177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 9.3 t -92.85 137.38 32.42 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.118 -0.946 . . . . 1.1200000000000001 109.883 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 13.3 t -100.55 125.71 38.17 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.92 -0.582 . . . . 1.26 110.893 -173.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 3.5 Cg_exo -76.27 122.13 6.45 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.758 2.305 . . . . 0.60999999999999999 112.568 177.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.9 mt -100.4 89.24 3.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.627 -0.715 . . . . 0.85999999999999999 109.845 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.2 m -73.87 -34.55 64.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.419 -0.355 . . . . 1.3700000000000001 110.825 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.38 123.59 70.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.401 0.619 . . . . 1.6000000000000001 111.367 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 48.9 mm -85.51 127.59 39.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.581 -0.736 . . . . 1.8500000000000001 109.904 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 134.05 -65.05 0.59 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.801 -0.714 . . . . 3.1800000000000002 111.858 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 p -95.62 105.55 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.319 0.581 . . . . 4.6900000000000004 110.141 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.43 -51.77 4.25 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.726 -0.749 . . . . 4.3499999999999996 112.168 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 82' ' ' ILE . . . -78.26 76.42 1.81 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 121.246 -0.502 . . . . 3.27 112.476 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -129.55 -88.75 0.51 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.742 -0.836 . . . . 5.4699999999999998 108.742 172.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.2 t -97.54 -18.17 19.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.439 -0.948 . . . . 4.7000000000000002 108.439 171.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.421 ' SG ' HG23 ' A' ' 93' ' ' THR . 0.5 OUTLIER 69.54 6.14 5.55 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.503 -1.226 . . . . 1.6599999999999999 112.654 172.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.0 m 69.21 -43.4 0.52 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.184 0.594 . . . . 1.6499999999999999 111.831 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.753 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -88.58 -159.29 0.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.909 -0.404 . . . . 0.54000000000000004 109.909 178.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.7 115.06 25.96 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.603 0.716 . . . . 0.78000000000000003 110.697 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.421 HG23 ' SG ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -93.64 124.08 37.4 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.422 -0.808 . . . . 0.39000000000000001 111.154 -176.29 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 111' ' ' PRO . 12.0 m -135.47 166.34 27.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.418 -0.81 . . . . 0.22 111.086 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.9 t -112.47 118.63 35.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.795 -0.817 . . . . 0.70999999999999996 108.795 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 13.6 m -120.26 153.37 36.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.903 0.382 . . . . 0.60999999999999999 111.117 -170.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 t -82.39 -29.46 30.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.799 -0.637 . . . . 0.38 111.082 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.43 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 13.3 m120 -156.17 159.16 38.74 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.125 -0.489 . . . . 0.78000000000000003 109.965 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.8 t -135.3 142.44 45.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.127 -0.488 . . . . 0.41999999999999998 110.036 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -130.28 159.74 35.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.646 -0.707 . . . . 0.77000000000000002 109.635 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.667 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 11.5 mm-40 59.32 31.32 21.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.16 -0.473 . . . . 0.80000000000000004 111.61 177.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 67.98 -0.27 2.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.709 -0.678 . . . . 2.1200000000000001 111.814 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 142.76 -19.63 2.37 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.78 -0.724 . . . . 0.28000000000000003 112.162 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 34.5 mt -50.3 -43.4 53.57 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.316 0.579 . . . . 0.35999999999999999 110.593 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 t -121.66 123.62 69.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.915 -1.039 . . . . 0.85999999999999999 109.707 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.441 ' ND2' ' SG ' ' A' ' 96' ' ' CYS . 37.3 t30 -128.17 144.58 51.13 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.142 -1.058 . . . . 0.91000000000000003 108.142 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 14.5 m -131.9 153.54 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 113.631 0.974 . . . . 0.29999999999999999 113.631 -172.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 62.94 50.24 65.4 Favored Glycine 0 CA--C 1.505 -0.563 0 CA-C-N 114.729 -1.123 . . . . 0.20000000000000001 111.725 176.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 70' ' ' ASP . 92.5 m -97.28 130.46 44.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.928 0.394 . . . . 0.42999999999999999 111.436 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.8 p -124.22 125.43 25.72 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.659 -0.7 . . . . 0.29999999999999999 109.962 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.587 ' HA ' HG12 ' A' ' 94' ' ' VAL . 78.5 Cg_exo -49.23 122.12 8.02 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.164 2.576 . . . . 0.34000000000000002 113.002 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.9 tt -117.48 137.07 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.751 -0.658 . . . . 0.58999999999999997 110.84 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -122.91 118.97 29.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.712 -0.477 . . . . 2.3900000000000001 109.712 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.455 HD13 ' HG ' ' A' ' 116' ' ' LEU . 1.2 pp -92.11 -17.48 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.329 -0.396 . . . . 2.02 111.927 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.425 ' N ' HD12 ' A' ' 114' ' ' ILE . . . 73.2 -24.15 0.89 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.039 -0.6 . . . . 2.6099999999999999 113.963 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.479 ' OXT' HD12 ' A' ' 116' ' ' LEU . 3.7 pp . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.489 -0.767 . . . . 3.6899999999999999 110.872 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.058 -0.349 . . . . 30.309999999999999 110.058 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.3 75.68 1.48 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.929 0.395 . . . . 28.059999999999999 110.886 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.7 ptp -143.0 -29.56 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 28.52 111.009 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.65 113.17 23.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.429 -0.35 . . . . 26.559999999999999 110.623 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.3 t70 56.42 70.19 0.67 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.994 -0.548 . . . . 25.140000000000001 110.951 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.9 pt -117.08 33.21 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.053 0.454 . . . . 24.989999999999998 111.258 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.03 43.3 3.1 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.963 -0.637 . . . . 22.920000000000002 111.993 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.9 t -76.91 -55.1 5.76 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.991 -0.374 . . . . 22.809999999999999 109.991 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.5 m -80.78 66.4 6.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.495 0.665 . . . . 22.210000000000001 110.29 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -140.22 173.5 11.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.759 -0.655 . . . . 20.949999999999999 110.241 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.7 t -118.88 93.51 46.63 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.453 -0.34 . . . . 19.190000000000001 110.223 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.38 178.47 1.2 Allowed 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.764 2.31 . . . . 17.98 112.402 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.84 47.35 6.15 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.093 -0.503 . . . . 18.07 110.162 -174.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -76.92 -71.56 0.39 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.02 -0.536 . . . . 14.66 110.649 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.0 m 32.96 58.58 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 124.321 1.013 . . . . 13.029999999999999 112.897 -177.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -61.22 117.06 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 12.26 110.375 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.08 -7.51 69.66 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.726 -0.749 . . . . 9.9700000000000006 112.065 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.2 -78.34 1.59 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.259 -0.496 . . . . 8.2200000000000006 112.016 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.464 HG22 ' HD2' ' A' ' 30' ' ' PRO . 2.9 m -93.15 134.95 26.31 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.61 -0.515 . . . . 7.2999999999999998 109.61 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 93.3 Cg_exo -39.56 -49.33 3.28 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.499 2.8 . . . . 6.0999999999999996 115.269 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.464 ' HD2' HG22 ' A' ' 28' ' ' THR . 3.1 Cg_exo -74.48 101.35 1.42 Allowed 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.967 1.778 . . . . 5.1900000000000004 111.725 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -86.06 31.93 0.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.258 -0.428 . . . . 3.79 111.15 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 m -78.05 -169.58 1.63 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.13 -0.486 . . . . 1.74 111.879 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 84.1 m -77.09 148.03 36.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.303 0.573 . . . . 1.7 112.0 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.1 p -87.27 -14.7 40.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.556 -0.747 . . . . 2.5699999999999998 109.804 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.1 p -81.19 -8.05 59.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.146 -0.934 . . . . 2.5 110.844 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.46 -132.25 8.69 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.234 -0.746 . . . . 1.51 111.234 -177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.8 154.62 9.35 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.215 2.61 . . . . 1.05 113.801 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 39' ' ' TYR . 91.4 t -88.86 168.16 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 107.515 -1.291 . . . . 0.58999999999999997 107.515 172.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.593 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 95.2 m-85 -129.98 135.45 48.31 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.643 0.735 . . . . 0.78000000000000003 112.23 -177.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.1 t -111.15 98.03 7.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.876 -1.056 . . . . 0.81999999999999995 110.031 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.2 m -99.59 134.2 42.82 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.541 -0.541 . . . . 0.23999999999999999 109.541 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.442 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 5.0 m-20 -51.47 -30.6 20.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.485 -0.78 . . . . 2.0800000000000001 110.342 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -170.51 131.81 0.94 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.456 -1.247 . . . . 2.5800000000000001 108.365 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.605 HG21 HG11 ' A' ' 94' ' ' VAL . 17.9 p -87.82 152.43 22.11 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.337 -0.945 . . . . 0.37 111.08 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.586 ' HB3' HG22 ' A' ' 72' ' ' VAL . 10.8 tp10 -119.6 141.25 49.46 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.99 -1.004 . . . . 1.1200000000000001 109.665 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.473 ' HA ' HD12 ' A' ' 71' ' ' LEU . 6.1 m-20 -68.88 110.59 4.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.477 -0.329 . . . . 1.77 110.981 -176.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.618 ' HA ' HD21 ' A' ' 50' ' ' LEU . 89.3 p -65.93 -8.69 23.87 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.099 0.476 . . . . 0.92000000000000004 111.335 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 3.7 mppt? -74.31 -36.39 63.71 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.512 0.673 . . . . 2.77 110.123 175.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -143.83 65.2 1.31 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.09 -0.959 . . . . 2.3300000000000001 111.107 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.618 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.3 mm? -59.68 157.27 12.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.595 0.712 . . . . 1.1599999999999999 111.609 174.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.32 161.09 30.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.637 -1.165 . . . . 1.8100000000000001 109.08 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.675 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -64.08 -32.01 73.41 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.959 -0.696 . . . . 3.23 110.551 177.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -66.0 -37.1 92.86 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.624 -0.798 . . . . 0.34000000000000002 111.293 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.667 ' HA ' HD22 ' A' ' 57' ' ' LEU . 11.7 m -78.89 -42.59 26.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.121 0.486 . . . . 0.35999999999999999 110.275 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.2 m -53.18 -35.25 59.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.335 -0.848 . . . . 0.29999999999999999 109.797 172.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.88 -54.8 42.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.433 -0.803 . . . . 0.23000000000000001 111.616 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.75 -45.72 89.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.467 0.651 . . . . 0.23999999999999999 110.319 -178.282 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.5 mt -61.35 -42.1 98.15 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.964 -1.016 . . . . 0.17999999999999999 109.941 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -34.14 84.25 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.791 -0.641 . . . . 0.26000000000000001 112.583 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 26.0 mt -61.64 -50.2 73.5 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.637 0.732 . . . . 0.34000000000000002 109.814 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.468 HD21 ' HG2' ' A' ' 101' ' ' GLN . 3.2 mt -83.99 8.25 15.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.569 -1.196 . . . . 0.35999999999999999 110.669 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.1 p30 50.97 38.19 19.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.495 1.118 . . . . 1.8899999999999999 111.737 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 58' ' ' LEU . 48.4 mt -79.44 140.89 16.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.795 -1.093 . . . . 0.26000000000000001 110.055 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 11.8 mptt -82.6 117.14 22.35 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.887 -0.597 . . . . 2.2200000000000002 110.001 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.78 -31.32 50.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.342 0.591 . . . . 0.28999999999999998 110.138 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.92 -22.24 72.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.031 -0.604 . . . . 0.56999999999999995 112.638 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.58 -13.19 57.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.242 0.544 . . . . 0.85999999999999999 110.253 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 92.3 mt -64.32 151.55 43.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.498 -0.774 . . . . 0.46000000000000002 111.804 -177.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -101.66 -71.12 0.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.811 -1.086 . . . . 2.0099999999999998 113.017 -169.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -120.49 -83.6 0.66 Allowed 'General case' 0 C--O 1.237 0.41 0 N-CA-C 112.54 0.57 . . . . 1.0900000000000001 112.54 -171.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.2 mm? -119.41 168.41 10.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.296 0.57 . . . . 0.14999999999999999 110.606 175.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.586 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -122.95 168.24 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 106.517 -1.66 . . . . 0.25 106.517 167.294 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.14 129.02 4.24 Favored Glycine 0 C--N 1.312 -0.773 0 C-N-CA 119.62 -1.276 . . . . 0.37 112.041 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.64 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.77 135.88 36.91 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.551 -0.46 . . . . 0.28999999999999998 110.544 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.1 m-20 49.51 49.03 20.58 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.024 -0.989 . . . . 1.8500000000000001 110.731 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 9.0 t -85.98 144.1 27.79 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.159 -0.928 . . . . 1.1200000000000001 110.592 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.6 m -102.12 113.44 65.86 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.855 -0.611 . . . . 1.26 110.855 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.89 130.79 26.98 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.847 2.365 . . . . 0.60999999999999999 112.816 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 mt -108.4 89.27 2.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.675 -0.693 . . . . 0.85999999999999999 109.213 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.2 p -78.58 -39.15 38.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.287 -0.415 . . . . 1.3700000000000001 111.422 -174.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.6 m -100.48 100.42 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.925 0.869 . . . . 1.6000000000000001 112.258 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.7 mt -132.47 115.49 25.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.916 -1.038 . . . . 1.8500000000000001 110.341 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.23 -47.71 0.42 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.317 -0.713 . . . . 3.1800000000000002 111.317 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.1 t -99.31 48.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.203 -1.036 . . . . 4.6900000000000004 108.203 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.2 126.34 4.1 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 114.913 -1.039 . . . . 4.3499999999999996 111.123 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.23 17.99 16.33 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.837 -0.697 . . . . 3.27 112.102 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -90.38 83.39 5.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.121 0.486 . . . . 5.4699999999999998 110.08 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.1 m -148.43 23.41 1.03 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.953 -0.567 . . . . 4.7000000000000002 110.656 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.0 t -142.05 123.11 14.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.97 -0.559 . . . . 1.6599999999999999 110.831 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.3 m -114.56 18.79 16.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.024 0.44 . . . . 1.6499999999999999 110.68 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -134.67 -158.73 0.9 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.874 -0.603 . . . . 0.54000000000000004 109.824 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.74 127.04 31.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.098 0.475 . . . . 0.78000000000000003 110.139 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.91 120.32 39.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.274 0.559 . . . . 0.39000000000000001 110.836 -174.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.605 HG11 HG21 ' A' ' 44' ' ' THR . 10.6 m -131.94 164.75 33.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.624 -0.716 . . . . 0.22 111.271 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 34.2 t -109.81 112.12 23.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.178 -0.919 . . . . 0.70999999999999996 109.156 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 35.4 m -107.88 149.19 28.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.883 0.373 . . . . 0.60999999999999999 110.725 -174.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.405 HG22 ' HA3' ' A' ' 108' ' ' GLY . 13.3 t -80.49 -27.21 37.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.914 -0.584 . . . . 0.38 110.455 -174.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.528 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.6 m120 -153.83 163.85 39.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.449 -0.796 . . . . 0.78000000000000003 109.064 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.5 t -136.22 134.21 37.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.165 0.507 . . . . 0.41999999999999998 110.184 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.51 ' HB2' HG23 ' A' ' 105' ' ' VAL . 89.3 m-85 -117.64 149.5 40.59 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.668 -0.696 . . . . 0.77000000000000002 109.94 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.486 ' OE1' HD12 ' A' ' 104' ' ' LEU . 13.6 mm-40 62.57 26.92 15.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.759 -0.655 . . . . 0.80000000000000004 111.265 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 64.01 9.07 4.35 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.251 -0.886 . . . . 2.1200000000000001 112.177 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.27 -25.47 1.87 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.342 -0.932 . . . . 0.28000000000000003 113.113 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 16.1 mt -49.16 -41.34 36.21 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.904 0.352 . . . . 0.35999999999999999 111.54 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.51 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -139.78 118.87 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.422 0.63 . . . . 0.85999999999999999 111.047 173.52 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.566 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 8.7 m-20 -108.16 162.66 13.86 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.579 -0.737 . . . . 0.91000000000000003 109.475 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 14.3 m -135.28 155.43 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.299 0.481 . . . . 0.29999999999999999 112.299 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 58.62 51.82 56.64 Favored Glycine 0 CA--C 1.505 -0.578 0 CA-C-N 115.396 -0.82 . . . . 0.20000000000000001 111.872 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 84.1 m -97.99 129.02 44.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.703 0.287 . . . . 0.42999999999999999 110.721 -175.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.9 p -125.26 128.19 24.81 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.912 -0.585 . . . . 0.29999999999999999 110.054 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.459 ' HA ' HG12 ' A' ' 94' ' ' VAL . 73.1 Cg_exo -51.3 109.28 0.3 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.785 2.323 . . . . 0.34000000000000002 112.061 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.6 tt -88.52 134.13 29.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.637 -0.711 . . . . 0.58999999999999997 110.735 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -116.09 101.14 8.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.895 -0.593 . . . . 2.3900000000000001 110.042 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.57 HD13 ' HG ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER -73.51 -19.4 18.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.856 -0.611 . . . . 2.02 111.766 -178.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.57 3.46 86.66 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 121.177 -0.535 . . . . 2.6099999999999999 113.419 175.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.57 ' HG ' HD13 ' A' ' 114' ' ' ILE . 4.0 pp . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.309 -0.853 . . . . 3.6899999999999999 110.03 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.713 0.292 . . . . 30.309999999999999 110.478 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.01 30.6 6.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.016 0.436 . . . . 28.059999999999999 110.838 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.1 ttt -77.63 -51.09 11.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.018 -0.537 . . . . 28.52 110.148 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.05 67.61 7.04 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.758 -0.655 . . . . 26.559999999999999 109.904 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.9 -27.97 64.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.647 -0.706 . . . . 25.140000000000001 110.635 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.4 mm -83.34 -4.96 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.869 0.842 . . . . 24.989999999999998 109.45 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.571 ' O ' ' HB ' ' A' ' 20' ' ' VAL . . . -95.72 49.59 1.81 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.54 -0.754 . . . . 22.920000000000002 111.398 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.2 t -75.33 -58.43 3.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.121 0.486 . . . . 22.809999999999999 109.92 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.8 p -97.32 -42.7 7.65 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.083 -0.508 . . . . 22.210000000000001 109.778 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.8 61.29 5.09 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.513 -0.767 . . . . 20.949999999999999 110.366 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 16' ' ' GLY . 7.3 p -112.26 129.84 23.92 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.413 -0.812 . . . . 19.190000000000001 110.015 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.93 113.5 1.75 Allowed 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.591 2.194 . . . . 17.98 112.033 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 20' ' ' VAL . 60.3 mtt180 -108.35 31.86 5.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.173 -0.467 . . . . 18.07 110.468 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.2 138.22 58.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.842 -0.617 . . . . 14.66 111.147 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t 60.78 92.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 115.523 -0.762 . . . . 13.029999999999999 111.283 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -82.62 -43.93 16.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.934 -0.576 . . . . 12.26 110.239 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.36 -106.22 0.5 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.844 -0.616 . . . . 9.9700000000000006 111.794 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.67 -132.64 44.14 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.293 -0.479 . . . . 8.2200000000000006 112.373 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.523 HG22 ' HD2' ' A' ' 30' ' ' PRO . 3.9 m 67.96 116.79 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 121.51 0.671 . . . . 7.2999999999999998 110.878 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.468 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 34.5 Cg_exo -50.89 -50.8 12.7 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.523 2.815 . . . . 6.0999999999999996 112.684 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 71.4 Cg_endo -76.25 106.01 2.18 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.474 1.449 . . . . 5.1900000000000004 111.537 169.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -66.46 132.59 48.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.885 -0.598 . . . . 3.79 110.824 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.5 m -153.17 154.6 35.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.405 . . . . 1.74 110.122 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 59.8 m -76.22 136.7 39.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.272 -0.422 . . . . 1.7 110.646 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.0 m -90.03 -2.1 58.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.237 0.541 . . . . 2.5699999999999998 110.381 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.5 p -74.41 -27.8 60.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.804 -0.634 . . . . 2.5 110.367 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 168.08 173.95 36.51 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-O 119.458 -0.634 . . . . 1.51 111.641 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HB3' ' HA ' ' A' ' 80' ' ' SER . 52.0 Cg_exo -41.78 151.37 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.688 2.925 . . . . 1.05 114.166 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.81 158.75 2.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.63 -1.168 . . . . 0.58999999999999997 108.443 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.618 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 90.5 m-85 -122.28 136.88 54.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.496 0.665 . . . . 0.78000000000000003 111.396 -177.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 34.7 t -109.25 98.32 7.77 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.233 -0.894 . . . . 0.81999999999999995 109.604 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.5 m -99.16 137.59 37.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.111 -0.699 . . . . 0.23999999999999999 109.111 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.446 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 39.8 m-80 -59.03 -24.69 63.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.855 -0.611 . . . . 2.0800000000000001 109.965 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -171.75 131.06 0.68 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.409 -1.269 . . . . 2.5800000000000001 108.085 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.556 HG21 HG11 ' A' ' 94' ' ' VAL . 18.1 p -86.55 157.47 19.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.169 -1.012 . . . . 0.37 110.253 171.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HB3' HG22 ' A' ' 72' ' ' VAL . 7.1 tp10 -121.77 138.2 54.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.836 -0.62 . . . . 1.1200000000000001 109.509 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HA ' HD12 ' A' ' 71' ' ' LEU . 12.9 m-20 -67.6 109.5 3.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.194 -0.457 . . . . 1.77 110.159 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.1 p -57.09 -24.34 53.28 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.498 0.499 . . . . 0.92000000000000004 111.208 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -90.78 -12.13 37.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.903 0.383 . . . . 2.77 111.284 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -126.37 25.2 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.979 0.418 . . . . 2.3300000000000001 110.85 -176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.59 156.39 16.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.629 0.728 . . . . 1.1599999999999999 111.91 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.95 168.48 9.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.894 -1.048 . . . . 1.8100000000000001 109.767 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 11.8 mptt -62.01 -33.58 74.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.8 0.333 . . . . 3.23 110.502 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.75 -36.21 92.4 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.152 -0.547 . . . . 0.34000000000000002 112.72 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.585 ' HA ' HD22 ' A' ' 57' ' ' LEU . 25.6 m -82.73 -43.36 16.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.819 0.31 . . . . 0.35999999999999999 110.434 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.5 m -54.67 -33.21 60.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.896 -0.593 . . . . 0.29999999999999999 110.053 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.23 -54.32 46.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.478 -0.783 . . . . 0.23000000000000001 111.508 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.585 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.42 -47.29 84.42 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.268 0.556 . . . . 0.23999999999999999 109.96 -178.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 54' ' ' THR . 25.1 mt -59.63 -41.99 91.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.98 -1.009 . . . . 0.17999999999999999 110.188 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.53 -36.88 93.25 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.752 -0.658 . . . . 0.26000000000000001 112.23 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 19.8 mt -61.3 -39.34 90.12 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.714 0.768 . . . . 0.34000000000000002 110.092 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.644 HD21 ' HG2' ' A' ' 101' ' ' GLN . 4.5 mt -90.81 0.58 57.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.468 -1.242 . . . . 0.35999999999999999 111.113 -176.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 69.03 34.53 3.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.481 -0.781 . . . . 1.8899999999999999 111.349 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 58' ' ' LEU . 41.6 mt -88.71 147.12 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.001 -0.545 . . . . 0.26000000000000001 110.042 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.614 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -100.62 118.96 37.84 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.383 0.611 . . . . 2.2200000000000002 110.061 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -71.64 -31.48 42.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.15 -0.932 . . . . 0.28999999999999998 110.972 -174.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.16 -15.34 74.49 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.966 -0.635 . . . . 0.56999999999999995 112.752 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.451 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 23.8 t70 -95.32 -14.15 24.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.85999999999999999 110.532 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.0 mt -57.87 140.32 52.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.268 0.556 . . . . 0.46000000000000002 110.909 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -94.94 -77.64 0.46 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.231 -0.895 . . . . 2.0099999999999998 112.532 -170.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.03 -98.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.975 0.361 . . . . 1.0900000000000001 111.975 -173.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.6 mm? -109.04 168.92 9.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.558 0.694 . . . . 0.14999999999999999 111.271 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -117.18 167.9 9.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 106.754 -1.573 . . . . 0.25 106.754 166.518 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -138.34 121.59 2.22 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 119.765 -1.207 . . . . 0.37 111.893 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.711 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -94.06 136.02 34.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.742 -0.783 . . . . 0.28999999999999998 109.705 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 53.14 61.33 3.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.041 0.924 . . . . 1.8500000000000001 109.792 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 7.9 t -103.66 146.1 29.08 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.607 -1.179 . . . . 1.1200000000000001 110.777 -171.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.1 m -102.26 109.97 61.56 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.823 -0.626 . . . . 1.26 110.216 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.9 120.32 7.24 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.777 2.318 . . . . 0.60999999999999999 112.299 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.5 mt -96.01 87.5 4.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 0.85999999999999999 109.555 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.408 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 5.4 p -79.12 -52.27 8.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.9 -0.591 . . . . 1.3700000000000001 109.816 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.7 m -81.06 105.48 11.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.376 -0.829 . . . . 1.6000000000000001 110.286 176.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.431 HG23 ' H ' ' A' ' 86' ' ' GLY . 8.9 mt -116.14 132.43 65.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.848 -0.614 . . . . 1.8500000000000001 111.702 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -129.98 -105.3 1.12 Allowed Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.472 -0.785 . . . . 3.1800000000000002 111.248 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 m -76.47 75.53 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.484 0.659 . . . . 4.6900000000000004 111.486 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.75 49.35 29.98 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.778 -0.646 . . . . 4.3499999999999996 111.89 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.431 ' H ' HG23 ' A' ' 82' ' ' ILE . . . 101.11 -141.92 15.54 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.315 -0.714 . . . . 3.27 111.315 -177.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -160.51 -61.02 0.06 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.009 0.433 . . . . 5.4699999999999998 109.955 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.8 m -124.27 66.35 1.06 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.003 -0.544 . . . . 4.7000000000000002 110.913 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 17.6 t -121.54 122.43 39.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.026 0.441 . . . . 1.6599999999999999 110.815 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -127.89 26.62 5.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.508 0.67 . . . . 1.6499999999999999 109.708 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -141.59 -158.44 0.86 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.353 -0.839 . . . . 0.54000000000000004 110.017 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.05 124.23 28.55 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.354 0.597 . . . . 0.78000000000000003 110.097 -176.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.52 116.0 31.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.744 -0.662 . . . . 0.39000000000000001 110.875 -171.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 44' ' ' THR . 11.2 m -128.29 164.63 29.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.663 -0.699 . . . . 0.22 111.457 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.1 t -108.34 110.98 22.68 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.623 -0.88 . . . . 0.70999999999999996 108.623 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.8 m -112.92 146.41 39.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.934 0.397 . . . . 0.60999999999999999 110.713 -172.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.7 t -81.11 -23.11 38.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 0.38 111.289 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 47.0 m-20 -159.5 168.1 27.01 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.511 -0.551 . . . . 0.78000000000000003 109.511 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.9 t -140.26 142.47 35.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.538 -0.301 . . . . 0.41999999999999998 110.633 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.637 ' HB2' HG23 ' A' ' 105' ' ' VAL . 83.9 m-85 -134.12 158.32 43.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.909 -0.316 . . . . 0.77000000000000002 110.686 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.644 ' HG2' HD21 ' A' ' 61' ' ' LEU . 41.9 mm-40 59.43 40.25 21.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.80000000000000004 111.549 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 p80 58.04 2.07 0.17 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.117 0.967 . . . . 2.1200000000000001 112.393 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.98 -15.9 3.04 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.966 -0.635 . . . . 0.28000000000000003 112.658 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.711 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 24.6 mt -56.1 -37.29 69.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.076 0.438 . . . . 0.35999999999999999 111.594 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.637 HG23 ' HB2' ' A' ' 100' ' ' TYR . 3.6 m -130.39 149.82 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.333 0.587 . . . . 0.85999999999999999 110.314 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.488 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.5 t30 -142.98 153.35 42.91 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.6 -0.889 . . . . 0.91000000000000003 108.6 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.5 m -131.62 150.41 34.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.783 0.66 . . . . 0.29999999999999999 112.783 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.11 52.32 53.52 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.939 -1.028 . . . . 0.20000000000000001 111.824 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 83.1 m -97.31 127.05 42.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.741 0.305 . . . . 0.42999999999999999 111.225 -176.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 p -120.79 126.47 26.67 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.93 -0.577 . . . . 0.29999999999999999 110.574 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.513 ' HA ' HG12 ' A' ' 94' ' ' VAL . 50.5 Cg_exo -53.8 110.68 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.917 2.411 . . . . 0.34000000000000002 112.112 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.4 tt -100.54 134.51 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.273 0.559 . . . . 0.58999999999999997 110.882 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -92.29 99.96 12.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.702 -0.681 . . . . 2.3900000000000001 109.193 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 30' ' ' PRO . 1.2 pp -67.53 -10.76 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.715 0.635 . . . . 2.02 112.715 -177.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.91 -21.32 34.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.44 -0.886 . . . . 2.6099999999999999 112.797 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.9 mp . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.592 -0.718 . . . . 3.6899999999999999 109.743 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 111.547 0.203 . . . . 30.309999999999999 111.547 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.94 -171.53 2.96 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.27 -0.27 . . . . 28.059999999999999 110.27 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.4 ptp -58.01 120.58 8.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.028 0.442 . . . . 28.52 110.293 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.26 14.36 14.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.156 -0.475 . . . . 26.559999999999999 111.123 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 66.12 94.13 0.06 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.416 -0.811 . . . . 25.140000000000001 111.294 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.9 mt 65.37 90.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.533 -0.758 . . . . 24.989999999999998 111.266 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.81 42.22 2.33 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.67 -0.776 . . . . 22.920000000000002 112.961 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.1 m -66.15 108.83 2.39 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.408 -0.219 . . . . 22.809999999999999 110.408 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.2 m 72.56 -54.42 0.69 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.888 -0.596 . . . . 22.210000000000001 111.509 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -115.61 127.03 54.92 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.185 -0.302 . . . . 20.949999999999999 110.185 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.15 120.35 69.84 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 121.133 0.492 . . . . 19.190000000000001 110.191 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.28 -23.21 9.03 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.523 2.148 . . . . 17.98 113.009 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -147.17 77.65 1.46 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.089 0.471 . . . . 18.07 110.564 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.6 120.02 24.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.089 -0.505 . . . . 14.66 110.557 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.6 169.52 20.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.41 . . . . 13.029999999999999 110.72 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -65.05 116.83 6.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.072 -0.513 . . . . 12.26 110.144 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.81 -9.36 27.7 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.706 -0.759 . . . . 9.9700000000000006 111.485 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.61 -111.56 4.15 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.024 -0.607 . . . . 8.2200000000000006 112.381 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.532 HG22 ' HD2' ' A' ' 30' ' ' PRO . 2.2 m -84.47 126.96 67.77 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 110.349 -0.241 . . . . 7.2999999999999998 110.349 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -40.59 -45.92 4.59 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 123.988 3.125 . . . . 6.0999999999999996 115.996 -173.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.532 ' HD2' HG22 ' A' ' 28' ' ' THR . 21.7 Cg_exo -62.47 105.11 0.39 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 121.915 1.743 . . . . 5.1900000000000004 111.898 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -84.04 55.08 3.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.844 -0.616 . . . . 3.79 111.308 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.1 t -70.62 149.99 46.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.653 0.74 . . . . 1.74 111.151 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.25 150.78 35.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.74 -1.118 . . . . 1.7 110.984 -177.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 m -71.05 0.56 7.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.854 -0.612 . . . . 2.5699999999999998 111.986 -174.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -78.51 -6.08 54.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.061 0.458 . . . . 2.5 110.893 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.06 -118.23 6.07 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.196 -0.762 . . . . 1.51 111.196 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.43 150.82 57.18 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.635 2.223 . . . . 1.05 112.979 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 39' ' ' TYR . 97.6 t -94.85 166.47 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 107.761 -1.2 . . . . 0.58999999999999997 107.761 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.452 ' N ' HG12 ' A' ' 38' ' ' VAL . 91.9 m-85 -124.21 135.48 53.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.885 0.85 . . . . 0.78000000000000003 111.605 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.709 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 44.0 t -107.98 111.09 22.99 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.833 -1.076 . . . . 0.81999999999999995 109.964 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 65.4 m -110.37 129.62 55.72 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.32 -0.622 . . . . 0.23999999999999999 109.32 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -62.88 -17.49 61.69 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.538 -0.756 . . . . 2.0800000000000001 109.832 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -169.28 133.83 1.44 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.765 -1.107 . . . . 2.5800000000000001 108.622 172.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.495 HG21 HG11 ' A' ' 94' ' ' VAL . 29.2 p -94.53 151.84 19.02 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.442 -0.903 . . . . 0.37 110.679 168.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.538 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.7 tp10 -119.78 142.73 48.32 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.194 -0.912 . . . . 1.1200000000000001 109.527 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.465 ' O ' HD13 ' A' ' 50' ' ' LEU . 44.8 m-20 -67.28 108.39 2.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.523 -0.308 . . . . 1.77 110.52 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.561 ' HA ' HD21 ' A' ' 50' ' ' LEU . 70.0 p -68.67 -1.16 6.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.955 -0.566 . . . . 0.92000000000000004 112.513 -172.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -79.17 -43.82 23.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.928 0.394 . . . . 2.77 110.145 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -144.77 70.95 1.29 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.569 -0.53 . . . . 2.3300000000000001 109.569 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 47' ' ' SER . 3.1 mm? -55.32 153.49 7.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.338 -0.846 . . . . 1.1599999999999999 112.406 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.95 153.34 21.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.672 -1.149 . . . . 1.8100000000000001 109.406 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -55.96 -41.45 74.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.249 0.477 . . . . 3.23 110.601 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -61.41 -36.85 93.15 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.839 -0.619 . . . . 0.34000000000000002 112.32 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.656 ' HA ' HD22 ' A' ' 57' ' ' LEU . 29.2 m -82.29 -41.43 20.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.836 0.351 . . . . 0.35999999999999999 110.274 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.0 m -53.77 -34.99 60.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.781 -0.645 . . . . 0.29999999999999999 109.861 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.523 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.46 -52.74 63.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.367 -0.833 . . . . 0.23000000000000001 111.92 175.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.656 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -61.17 -44.43 97.31 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.556 0.693 . . . . 0.23999999999999999 110.037 -178.456 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 54' ' ' THR . 46.1 mt -60.05 -44.41 94.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.822 -1.081 . . . . 0.17999999999999999 109.903 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.82 -32.42 79.31 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.631 -0.713 . . . . 0.26000000000000001 113.043 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 33.9 mt -59.83 -41.96 92.49 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.833 0.825 . . . . 0.34000000000000002 110.323 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.479 HD21 ' HG2' ' A' ' 101' ' ' GLN . 3.8 mt -91.18 -5.61 54.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.406 -1.27 . . . . 0.35999999999999999 110.855 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.9 t30 69.62 36.9 2.03 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.047 -0.979 . . . . 1.8899999999999999 110.661 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 58' ' ' LEU . 64.2 mt -77.77 146.19 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.797 -0.638 . . . . 0.26000000000000001 110.029 175.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.665 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -93.99 117.72 30.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.74 -0.664 . . . . 2.2200000000000002 110.279 -178.132 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.91 -40.6 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.609 -0.723 . . . . 0.28999999999999998 111.279 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.93 -7.48 62.22 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.75 -0.738 . . . . 0.56999999999999995 112.845 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.477 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 28.7 t70 -104.5 -12.44 16.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.08 0.467 . . . . 0.85999999999999999 110.529 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.1 mt -62.33 149.84 41.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.845 -0.616 . . . . 0.46000000000000002 110.974 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -95.86 -78.59 0.46 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.458 0.91 . . . . 2.0099999999999998 113.458 -169.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 0.2 OUTLIER -105.95 -85.19 0.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.8 -0.36 . . . . 1.0900000000000001 111.741 -172.244 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 0.9 OUTLIER -120.97 168.17 11.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.169 0.509 . . . . 0.14999999999999999 110.871 177.762 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -122.25 168.5 14.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 106.821 -1.548 . . . . 0.25 106.821 165.192 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.508 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -136.53 144.09 15.67 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.83 -1.176 . . . . 0.37 111.698 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -104.96 128.14 53.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.128 0.49 . . . . 0.28999999999999998 110.116 176.375 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.4 m120 57.77 53.48 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.974 -1.012 . . . . 1.8500000000000001 110.999 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.508 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 58.9 m -87.67 141.57 28.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.399 -0.819 . . . . 1.1200000000000001 111.067 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.2 m -101.21 124.69 40.48 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.679 -0.692 . . . . 1.26 110.399 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.08 129.07 15.65 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.524 2.149 . . . . 0.60999999999999999 112.57 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 mt -109.39 89.89 3.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.285 -0.87 . . . . 0.85999999999999999 109.307 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.0 p -82.32 -39.95 22.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.332 -0.394 . . . . 1.3700000000000001 111.919 -173.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.74 108.39 24.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.668 0.747 . . . . 1.6000000000000001 112.44 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.7 mt -121.62 149.95 24.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.445 -0.798 . . . . 1.8500000000000001 109.166 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 131.49 -14.64 5.3 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.555 -0.831 . . . . 3.1800000000000002 111.734 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.11 29.57 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.445 0.64 . . . . 4.6900000000000004 109.861 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.57 164.89 12.61 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.41 -0.813 . . . . 4.3499999999999996 111.31 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.58 8.16 56.38 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.835 -0.698 . . . . 3.27 111.929 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -74.75 79.3 2.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.398 0.618 . . . . 5.4699999999999998 110.461 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.491 ' O ' ' HB3' ' A' ' 89' ' ' CYS . 50.6 m -159.39 160.5 35.0 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.084 -0.71 . . . . 4.7000000000000002 109.084 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 88' ' ' SER . 8.3 t 73.43 -73.41 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 123.529 0.518 . . . . 1.6599999999999999 111.944 176.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.5 m 61.34 26.22 16.06 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.953 0.406 . . . . 1.6499999999999999 111.575 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.709 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -148.08 -158.29 0.9 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.515 -0.55 . . . . 0.54000000000000004 109.515 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.76 121.54 25.48 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.549 0.69 . . . . 0.78000000000000003 110.033 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.77 121.38 41.57 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.774 -0.648 . . . . 0.39000000000000001 111.356 -171.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 111' ' ' PRO . 9.0 m -133.78 165.87 30.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.598 -0.728 . . . . 0.22 110.847 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 18.0 m -114.06 125.09 53.6 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.75 -0.659 . . . . 0.70999999999999996 109.233 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 22.8 m -121.23 149.97 42.04 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.074 -0.512 . . . . 0.60999999999999999 110.465 -171.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.3 t -80.85 -28.37 36.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.73 -0.668 . . . . 0.38 110.789 -171.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.563 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 21.9 m120 -152.73 159.68 43.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.78000000000000003 109.764 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.4 t -136.12 147.39 47.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.472 -0.331 . . . . 0.41999999999999998 110.114 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.579 ' HB2' HG23 ' A' ' 105' ' ' VAL . 65.7 m-85 -137.17 158.24 44.89 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.83 -0.433 . . . . 0.77000000000000002 109.83 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.479 ' HG2' HD21 ' A' ' 61' ' ' LEU . 57.6 mm-40 62.51 26.6 15.82 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.566 -0.288 . . . . 0.80000000000000004 111.54 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 65.52 0.19 1.36 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.87 -0.604 . . . . 2.1200000000000001 112.534 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.8 -21.99 1.29 Allowed Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.91 -1.138 . . . . 0.28000000000000003 113.621 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.8 mt -51.07 -37.31 44.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.583 0.692 . . . . 0.35999999999999999 111.198 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.579 HG23 ' HB2' ' A' ' 100' ' ' TYR . 5.6 m -131.7 144.43 37.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.813 -0.631 . . . . 0.85999999999999999 109.768 174.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 15.4 t30 -142.86 141.41 31.56 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.974 -1.121 . . . . 0.91000000000000003 107.974 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.563 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.2 m -125.68 152.27 32.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 113.291 0.849 . . . . 0.29999999999999999 113.291 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 64.53 51.71 49.74 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.799 -1.091 . . . . 0.20000000000000001 111.665 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 74.6 m -97.98 128.45 44.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.856 0.36 . . . . 0.42999999999999999 111.494 -174.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.0 p -124.03 126.36 25.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.757 -0.656 . . . . 0.29999999999999999 109.418 173.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.539 ' HA ' HG12 ' A' ' 94' ' ' VAL . 79.6 Cg_exo -50.69 109.15 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.058 2.505 . . . . 0.34000000000000002 112.336 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.41 HD12 ' SG ' ' A' ' 95' ' ' CYS . 4.2 tt -88.02 133.8 29.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.679 -0.691 . . . . 0.58999999999999997 111.144 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -91.79 99.01 11.96 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.044 -1.095 . . . . 2.3900000000000001 108.044 171.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 30' ' ' PRO . 1.4 pp -68.99 -25.17 29.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.737 0.643 . . . . 2.02 112.737 -171.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.428 ' N ' HD12 ' A' ' 114' ' ' ILE . . . 93.3 -10.77 72.86 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.496 -0.859 . . . . 2.6099999999999999 113.814 174.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 116' ' ' LEU . 1.2 pt? . . . . . 0 C--O 1.246 0.875 0 CA-C-N 117.342 0.571 . . . . 3.6899999999999999 110.4 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.523 0.202 . . . . 30.309999999999999 111.358 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.43 88.58 5.55 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.058 0.456 . . . . 28.059999999999999 112.159 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 86.8 mtp -88.11 -31.8 19.02 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.712 -0.847 . . . . 28.52 108.712 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.89 157.28 43.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.952 -1.022 . . . . 26.559999999999999 108.553 172.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -82.2 70.16 9.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.476 0.655 . . . . 25.140000000000001 110.634 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pp -139.53 166.12 21.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.136 -0.938 . . . . 24.989999999999998 109.771 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.96 142.01 3.54 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.431 -0.89 . . . . 22.920000000000002 111.986 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 m -81.52 111.77 18.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.885 0.374 . . . . 22.809999999999999 110.661 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.2 t -87.22 5.96 35.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.073 0.463 . . . . 22.210000000000001 110.188 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.14 -168.81 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.537 -0.756 . . . . 20.949999999999999 110.421 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.436 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 27.9 t -63.57 -51.67 64.86 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 121.065 -0.254 . . . . 19.190000000000001 111.213 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 20' ' ' VAL . 57.1 Cg_endo -71.06 85.43 0.81 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.032 1.821 . . . . 17.98 112.66 175.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -96.07 110.43 22.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.364 -0.38 . . . . 18.07 110.225 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 24' ' ' VAL . 1.9 m-20 68.91 87.0 0.13 Allowed 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.938 0.774 . . . . 14.66 111.558 -177.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 23' ' ' ASP . 3.6 m 64.78 -28.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.967 1.707 . . . . 13.029999999999999 114.688 172.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -151.78 167.85 26.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.622 0.646 . . . . 12.26 111.131 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.82 116.16 0.78 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.392 -0.683 . . . . 9.9700000000000006 111.392 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -160.84 -162.01 12.15 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.85 -0.691 . . . . 8.2200000000000006 111.895 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.689 HG22 ' HD2' ' A' ' 30' ' ' PRO . 1.9 m -125.45 120.69 24.8 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-O 121.269 0.557 . . . . 7.2999999999999998 109.872 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -45.78 -44.88 17.61 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 124.633 3.555 . . . . 6.0999999999999996 115.818 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.689 ' HD2' HG22 ' A' ' 28' ' ' THR . 2.7 Cg_exo -73.71 109.09 2.79 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 121.855 1.703 . . . . 5.1900000000000004 111.702 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -82.19 58.62 4.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.074 -0.512 . . . . 3.79 110.469 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.0 p -75.24 171.66 13.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.896 -0.593 . . . . 1.74 111.239 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.0 m -76.99 152.18 35.33 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.837 -0.62 . . . . 1.7 111.132 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.9 m -90.14 0.24 57.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.006 -0.543 . . . . 2.5699999999999998 110.354 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.7 p -120.06 19.62 12.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 2.5 110.78 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.25 -175.97 27.29 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.445 -0.662 . . . . 1.51 111.445 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.658 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 72.4 Cg_endo -75.04 -160.0 0.1 OUTLIER 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.291 1.994 . . . . 1.05 112.659 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.448 ' HB ' HD11 ' A' ' 82' ' ' ILE . 92.1 t -93.42 161.04 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.547 -0.538 . . . . 0.58999999999999997 109.547 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.423 ' N ' HG12 ' A' ' 38' ' ' VAL . 52.8 m-85 -129.69 134.99 47.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.869 0.366 . . . . 0.78000000000000003 110.54 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 38.6 t -108.06 112.06 24.43 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.302 -0.408 . . . . 0.81999999999999995 109.95 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 72.9 m -103.31 134.15 47.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.143 0.496 . . . . 0.23999999999999999 110.422 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.464 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 88.4 m-20 -59.65 -19.58 50.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.226 -0.897 . . . . 2.0800000000000001 110.361 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -173.13 124.66 0.42 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.71 -1.132 . . . . 2.5800000000000001 107.986 176.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.581 HG21 HG11 ' A' ' 94' ' ' VAL . 8.0 p -78.2 148.0 34.22 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.243 -0.983 . . . . 0.37 110.838 170.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -109.96 138.81 45.81 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.009 -0.996 . . . . 1.1200000000000001 109.017 -176.171 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.67 104.9 4.76 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.741 -0.663 . . . . 1.77 110.337 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.704 ' HA ' HD21 ' A' ' 50' ' ' LEU . 50.1 m -58.93 -16.64 18.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.473 0.546 . . . . 0.92000000000000004 112.473 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -86.57 -20.23 28.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.744 0.307 . . . . 2.77 110.659 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -148.76 57.21 1.04 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.456 -0.338 . . . . 2.3300000000000001 111.601 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -59.59 145.75 43.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.39 0.614 . . . . 1.1599999999999999 111.665 176.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -71.03 156.76 39.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.146 -0.934 . . . . 1.8100000000000001 109.714 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -59.56 -41.65 90.62 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.909 -0.317 . . . . 3.23 110.948 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.03 -38.29 84.59 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.116 -0.564 . . . . 0.34000000000000002 112.34 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.668 ' HA ' HD22 ' A' ' 57' ' ' LEU . 26.2 m -79.92 -43.72 21.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.881 0.372 . . . . 0.35999999999999999 110.559 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -53.89 -34.8 60.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.673 -0.694 . . . . 0.29999999999999999 109.823 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.607 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.14 -52.23 66.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.85 -1.068 . . . . 0.23000000000000001 111.549 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.668 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -60.48 -45.75 92.62 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.424 0.63 . . . . 0.23999999999999999 109.958 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 54' ' ' THR . 50.6 mt -57.96 -45.86 86.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.848 -1.069 . . . . 0.17999999999999999 109.917 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.03 -36.87 91.7 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.621 -0.718 . . . . 0.26000000000000001 112.573 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 25.5 mt -59.61 -47.37 85.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.597 0.713 . . . . 0.34000000000000002 110.238 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.538 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.7 mt -84.48 -4.76 59.11 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.683 -1.144 . . . . 0.35999999999999999 111.556 -176.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.1 t30 70.63 35.54 1.84 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.741 0.781 . . . . 1.8899999999999999 110.524 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 58' ' ' LEU . 60.6 mt -79.6 146.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.162 -0.681 . . . . 0.26000000000000001 109.162 174.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.601 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.33 117.44 32.75 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.536 0.684 . . . . 2.2200000000000002 110.127 -177.442 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.44 -31.4 42.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.054 -0.975 . . . . 0.28999999999999998 110.628 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.06 -14.83 78.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.941 -0.647 . . . . 0.56999999999999995 113.404 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -101.58 -12.57 18.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.07 0.435 . . . . 0.85999999999999999 110.91 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.5 mt -51.75 127.09 19.72 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.661 0.743 . . . . 0.46000000000000002 111.447 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -76.16 -54.38 6.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.424 -1.262 . . . . 2.0099999999999998 113.263 -166.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.17 -84.41 0.37 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.963 -0.295 . . . . 1.0900000000000001 111.614 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.4 mm? -115.11 168.04 10.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.426 0.631 . . . . 0.14999999999999999 110.798 173.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 50' ' ' LEU . 1.6 m -121.67 172.26 9.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.362 -1.718 . . . . 0.25 106.362 168.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -138.96 150.12 21.03 Favored Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.119 -1.038 . . . . 0.37 111.486 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -116.36 133.72 55.7 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.989 0.423 . . . . 0.28999999999999998 109.876 174.55 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 53.09 52.92 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.965 -1.016 . . . . 1.8500000000000001 111.027 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.422 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 35.7 m -86.46 152.4 22.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.479 -0.782 . . . . 1.1200000000000001 110.473 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.5 m -107.37 115.55 59.42 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.773 -0.648 . . . . 1.26 109.932 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.37 121.77 9.11 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.546 2.164 . . . . 0.60999999999999999 111.769 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.658 ' O ' ' HB2' ' A' ' 37' ' ' PRO . 27.1 mt -100.5 87.99 3.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.747 -0.661 . . . . 0.85999999999999999 110.027 -177.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.0 m -71.52 -29.72 65.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.777 0.323 . . . . 1.3700000000000001 110.659 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.8 m -133.8 123.75 45.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.191 0.52 . . . . 1.6000000000000001 110.854 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.448 HD11 ' HB ' ' A' ' 38' ' ' VAL . 6.9 mt -112.94 148.53 15.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.825 -0.625 . . . . 1.8500000000000001 110.859 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.78 50.66 4.44 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.865 -0.607 . . . . 3.1800000000000002 112.267 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 66.4 t 70.21 -61.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.312 0.645 . . . . 4.6900000000000004 111.682 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.83 88.39 0.65 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.08 -0.581 . . . . 4.3499999999999996 112.394 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.97 46.66 2.98 Favored Glycine 0 CA--C 1.517 0.179 0 C-N-CA 121.468 -0.396 . . . . 3.27 113.257 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -127.28 -8.61 5.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.57 0.7 . . . . 5.4699999999999998 109.433 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.1 m -104.34 87.19 2.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.674 -0.694 . . . . 4.7000000000000002 110.341 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.498 ' SG ' HG23 ' A' ' 93' ' ' THR . 31.0 p -137.69 18.07 2.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.239 -0.437 . . . . 1.6599999999999999 110.006 178.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.0 m 73.33 -33.07 0.25 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.126 -0.943 . . . . 1.6499999999999999 111.631 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.605 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -119.27 -158.94 0.75 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.506 -0.315 . . . . 0.54000000000000004 110.841 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.41 122.87 32.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.271 0.557 . . . . 0.78000000000000003 110.745 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.498 HG23 ' SG ' ' A' ' 89' ' ' CYS . 0.2 OUTLIER -95.97 123.16 39.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.229 0.538 . . . . 0.39000000000000001 111.147 -174.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.581 HG11 HG21 ' A' ' 44' ' ' THR . 6.5 m -133.85 167.54 26.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.588 -0.733 . . . . 0.22 111.49 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 41.8 t -111.35 121.74 46.04 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.473 -0.936 . . . . 0.70999999999999996 108.473 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 22.9 m -122.35 148.63 44.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.023 0.439 . . . . 0.60999999999999999 110.969 -171.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.9 t -79.2 -28.15 42.6 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.423 -0.808 . . . . 0.38 110.837 -169.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.499 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 19.6 m120 -156.0 161.64 40.44 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.053 -0.721 . . . . 0.78000000000000003 109.053 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.7 t -142.22 144.67 33.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.799 0.333 . . . . 0.41999999999999998 110.516 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.589 ' HB2' HG23 ' A' ' 105' ' ' VAL . 70.3 m-85 -133.65 160.77 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.756 -0.461 . . . . 0.77000000000000002 109.756 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.539 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 15.9 mm-40 60.97 23.7 13.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 0.80000000000000004 111.566 175.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 63.01 13.39 6.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.582 -0.735 . . . . 2.1200000000000001 112.442 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.88 -24.34 3.01 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.211 -0.995 . . . . 0.28000000000000003 113.133 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 14.9 mt -49.63 -38.01 30.37 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.852 0.326 . . . . 0.35999999999999999 111.018 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.589 HG23 ' HB2' ' A' ' 100' ' ' TYR . 4.2 m -131.87 141.53 45.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.892 -0.595 . . . . 0.85999999999999999 109.559 172.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.438 ' ND2' ' SG ' ' A' ' 96' ' ' CYS . 21.5 t30 -140.63 144.63 35.85 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.201 -1.037 . . . . 0.91000000000000003 108.201 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.499 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.4 m -129.46 151.02 35.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 113.396 0.887 . . . . 0.29999999999999999 113.396 -172.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 64.07 51.85 49.6 Favored Glycine 0 CA--C 1.506 -0.505 0 CA-C-N 114.91 -1.041 . . . . 0.20000000000000001 111.807 177.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 90.9 m -97.12 127.91 43.53 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.014 0.435 . . . . 0.42999999999999999 111.884 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.7 p -122.26 126.47 26.23 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.528 -0.76 . . . . 0.29999999999999999 109.701 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.522 ' HA ' HG12 ' A' ' 94' ' ' VAL . 71.4 Cg_exo -50.46 110.49 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.003 2.469 . . . . 0.34000000000000002 112.586 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 tt -81.66 118.99 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.688 -0.687 . . . . 0.58999999999999997 110.664 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -108.29 114.62 28.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.293 0.568 . . . . 2.3900000000000001 110.04 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.429 ' CD1' ' H ' ' A' ' 116' ' ' LEU . 1.2 pp -92.21 -10.81 9.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.101 -0.5 . . . . 2.02 111.688 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.16 1.65 80.89 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.108 -0.568 . . . . 2.6099999999999999 113.092 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.429 ' H ' ' CD1' ' A' ' 114' ' ' ILE . 12.0 mt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.542 -0.742 . . . . 3.6899999999999999 109.873 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.898 0.38 . . . . 30.309999999999999 110.255 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.78 34.4 5.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.479 0.656 . . . . 28.059999999999999 109.654 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.414 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 26.0 mmt -91.17 -55.82 3.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.282 -0.872 . . . . 28.52 110.291 -177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 67.92 117.84 0.03 OUTLIER 'General case' 0 C--O 1.235 0.291 0 O-C-N 124.048 0.842 . . . . 26.559999999999999 111.608 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.2 t70 73.19 -60.06 0.55 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.358 -0.837 . . . . 25.140000000000001 111.679 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 12' ' ' MET . 33.1 pt -105.23 -179.97 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 110.233 -0.284 . . . . 24.989999999999998 110.233 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.0 44.61 9.71 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.73 -0.748 . . . . 22.920000000000002 112.798 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 t 64.42 68.94 0.53 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.214 0.531 . . . . 22.809999999999999 110.859 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.0 p -102.15 -69.43 0.79 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.117 -0.492 . . . . 22.210000000000001 111.261 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.75 60.88 4.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.088 0.47 . . . . 20.949999999999999 111.245 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.7 t -113.36 97.99 45.0 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.082 -0.508 . . . . 19.190000000000001 110.025 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.17 110.82 2.92 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.379 2.053 . . . . 17.98 112.196 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -86.87 -35.04 19.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.999 -0.546 . . . . 18.07 110.086 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -88.27 97.65 11.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.803 -0.635 . . . . 14.66 109.747 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.5 m -92.43 27.1 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.995 -0.548 . . . . 13.029999999999999 112.073 -173.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.1 t30 59.04 57.79 3.4 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.466 0.65 . . . . 12.26 111.187 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.49 -63.65 0.49 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.908 -0.663 . . . . 9.9700000000000006 112.051 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.41 -168.31 17.55 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.787 -0.72 . . . . 8.2200000000000006 111.808 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.547 HG22 ' HD2' ' A' ' 30' ' ' PRO . 5.1 m -69.16 126.55 92.82 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 110.103 -0.332 . . . . 7.2999999999999998 110.103 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.415 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 81.3 Cg_exo -42.73 -54.34 3.33 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.717 2.945 . . . . 6.0999999999999996 114.953 -173.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.547 ' HD2' HG22 ' A' ' 28' ' ' THR . 37.8 Cg_endo -64.55 117.1 4.19 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.735 1.623 . . . . 5.1900000000000004 112.214 176.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -75.97 142.38 41.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.449 -0.341 . . . . 3.79 110.275 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 p -150.53 176.28 11.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.278 -0.419 . . . . 1.74 110.413 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 71.6 m -83.5 129.96 35.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.429 -0.351 . . . . 1.7 110.667 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.7 p -76.0 -18.35 59.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.151 0.5 . . . . 2.5699999999999998 109.999 176.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.5 t -74.85 -20.02 59.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.421 -0.809 . . . . 2.5 110.47 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . 140.03 -137.83 8.69 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.971 -0.633 . . . . 1.51 112.132 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.01 154.22 13.81 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.023 2.482 . . . . 1.05 113.418 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 39' ' ' TYR . 94.5 t -92.54 163.27 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.143 -1.058 . . . . 0.58999999999999997 108.143 174.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.434 ' N ' HG12 ' A' ' 38' ' ' VAL . 45.7 m-85 -124.2 130.82 53.19 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.875 -0.73 . . . . 0.78000000000000003 111.362 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 36.2 t -105.14 106.12 16.47 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.442 -0.799 . . . . 0.81999999999999995 109.426 176.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -97.8 133.3 42.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.801 -0.636 . . . . 0.23999999999999999 110.44 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.435 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 3.1 m-20 -58.53 -24.85 61.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.772 . . . . 2.0800000000000001 109.716 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.547 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -162.79 135.61 5.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.176 -1.375 . . . . 2.5800000000000001 107.446 177.323 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.603 HG21 HG11 ' A' ' 94' ' ' VAL . 23.7 p -92.63 159.67 15.36 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.356 -0.938 . . . . 0.37 110.062 165.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.554 ' HB3' HG22 ' A' ' 72' ' ' VAL . 8.0 tp10 -126.28 140.32 52.62 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.608 -0.724 . . . . 1.1200000000000001 109.712 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.426 ' HA ' HD12 ' A' ' 71' ' ' LEU . 3.2 m-20 -72.31 109.15 5.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.073 -0.512 . . . . 1.77 110.438 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.603 ' HA ' HD21 ' A' ' 50' ' ' LEU . 88.0 p -64.12 -4.92 3.97 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.48 0.548 . . . . 0.92000000000000004 112.48 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.4 mptp? -73.84 -42.11 61.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.342 0.592 . . . . 2.77 110.243 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -142.51 66.67 1.33 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.19 -0.913 . . . . 2.3300000000000001 110.735 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.603 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -56.97 148.76 20.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.176 0.512 . . . . 1.1599999999999999 111.522 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.26 166.16 19.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.589 -0.732 . . . . 1.8100000000000001 109.78 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 11.3 mptt -58.98 -47.68 84.28 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.539 -0.464 . . . . 3.23 110.698 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.65 -39.27 75.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.066 -0.587 . . . . 0.34000000000000002 112.517 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.674 ' HA ' HD22 ' A' ' 57' ' ' LEU . 13.4 m -77.86 -43.17 31.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.753 0.311 . . . . 0.35999999999999999 110.559 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.9 m -56.05 -33.71 65.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.3 0.572 . . . . 0.29999999999999999 109.795 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.586 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.29 -54.51 46.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.17 -0.923 . . . . 0.23000000000000001 111.304 176.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.674 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -58.12 -46.75 85.05 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.485 0.66 . . . . 0.23999999999999999 110.039 -179.244 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.5 mt -58.69 -44.83 90.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.972 -1.013 . . . . 0.17999999999999999 110.195 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.82 -37.18 92.11 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.955 -0.64 . . . . 0.26000000000000001 112.686 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.5 mt -60.12 -45.58 92.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.041 0.924 . . . . 0.34000000000000002 110.312 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.432 ' CD1' HG21 ' A' ' 105' ' ' VAL . 6.8 mt -86.31 -0.02 54.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.391 -1.277 . . . . 0.35999999999999999 111.371 -176.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 68.79 31.25 4.51 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.544 -0.753 . . . . 1.8899999999999999 111.093 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 58' ' ' LEU . 53.6 mt -79.95 145.08 9.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.827 -0.624 . . . . 0.26000000000000001 109.806 177.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.56 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -98.35 118.2 34.47 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.761 -0.654 . . . . 2.2200000000000002 109.93 -178.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.14 -38.02 54.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.345 -0.843 . . . . 0.28999999999999998 110.963 -174.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.75 -1.98 63.43 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.846 -0.693 . . . . 0.56999999999999995 113.007 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.492 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 33.9 t70 -113.97 2.13 14.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.628 0.728 . . . . 0.85999999999999999 109.968 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.7 mt -74.19 152.47 39.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.593 -0.73 . . . . 0.46000000000000002 111.074 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -95.84 -97.64 0.18 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 2.0099999999999998 112.401 -173.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.79 -93.27 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.13 0.419 . . . . 1.0900000000000001 112.13 -173.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.1 mm? -111.61 170.02 8.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.41 0.624 . . . . 0.14999999999999999 111.279 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.606 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.9 OUTLIER -121.39 165.5 16.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 106.189 -1.782 . . . . 0.25 106.189 165.478 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.47 134.08 6.8 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 119.748 -1.215 . . . . 0.37 112.124 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.659 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -100.89 136.45 40.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.459 . . . . 0.28999999999999998 110.581 178.537 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 51.49 52.2 15.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.855 -1.066 . . . . 1.8500000000000001 111.095 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.1 m -88.51 138.75 31.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.001 -0.545 . . . . 1.1200000000000001 110.89 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 m -86.68 119.6 71.39 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.75 -0.659 . . . . 1.26 110.139 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.27 121.16 7.53 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.467 2.111 . . . . 0.60999999999999999 112.133 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 mt -99.68 88.24 3.77 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 0.85999999999999999 109.196 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.8 m -70.39 -38.09 74.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.825 -0.625 . . . . 1.3700000000000001 110.193 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.24 123.63 70.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.549 0.69 . . . . 1.6000000000000001 110.442 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.9 mm -72.76 -45.8 55.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.234 -0.894 . . . . 1.8500000000000001 111.483 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.12 137.74 30.11 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.66 -0.781 . . . . 3.1800000000000002 111.579 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t 65.82 95.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 121.231 0.539 . . . . 4.6900000000000004 110.596 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.74 6.5 46.45 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.823 -0.703 . . . . 4.3499999999999996 112.156 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.96 -43.18 9.0 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.776 -0.726 . . . . 3.27 111.663 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -76.57 123.71 26.5 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.154 -0.313 . . . . 5.4699999999999998 110.154 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 90' ' ' SER . 33.4 t 59.94 79.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.811 0.694 . . . . 4.7000000000000002 110.608 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.525 ' SG ' HG23 ' A' ' 93' ' ' THR . 28.4 p -79.88 20.19 0.63 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.362 -0.381 . . . . 1.6599999999999999 110.863 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 88' ' ' SER . 30.5 t 72.76 -11.41 0.85 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.82 0.848 . . . . 1.6499999999999999 111.565 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.598 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -147.13 -159.06 0.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.809 0.338 . . . . 0.54000000000000004 111.279 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.56 117.83 30.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.33 0.586 . . . . 0.78000000000000003 110.753 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.525 HG23 ' SG ' ' A' ' 89' ' ' CYS . 0.1 OUTLIER -89.71 121.92 32.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.323 0.583 . . . . 0.39000000000000001 111.566 -174.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.603 HG11 HG21 ' A' ' 44' ' ' THR . 6.7 m -133.26 164.27 35.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.552 -0.749 . . . . 0.22 110.939 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.9 t -113.38 112.29 23.41 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.54 -0.754 . . . . 0.70999999999999996 109.317 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 21.9 m -106.28 145.0 32.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.363 -0.381 . . . . 0.60999999999999999 110.311 -174.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.3 t -77.3 -25.53 51.39 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.069 -0.514 . . . . 0.38 110.797 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.64 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 19.8 m120 -148.67 155.75 41.45 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.786 -0.82 . . . . 0.78000000000000003 108.786 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.4 t -123.12 144.54 49.26 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.915 0.388 . . . . 0.41999999999999998 110.181 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.532 ' CB ' HG23 ' A' ' 105' ' ' VAL . 26.0 m-85 -130.19 143.27 50.68 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.016 -0.538 . . . . 0.77000000000000002 110.731 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.552 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 11.2 mm-40 60.93 32.85 19.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.80000000000000004 111.817 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 66.06 0.33 1.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.197 0.599 . . . . 2.1200000000000001 112.431 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.97 -19.78 1.96 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.372 -0.918 . . . . 0.28000000000000003 112.817 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 20.0 mt -51.89 -39.51 59.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.742 0.271 . . . . 0.35999999999999999 111.258 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.532 HG23 ' CB ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -136.4 145.41 30.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.385 -0.371 . . . . 0.85999999999999999 110.531 175.15 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.606 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 41.4 m-80 -140.28 161.95 36.46 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.298 -0.63 . . . . 0.91000000000000003 109.298 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.64 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 8.3 m -133.71 150.05 31.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.009 0.374 . . . . 0.29999999999999999 112.009 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 58.7 54.89 34.15 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.328 -0.851 . . . . 0.20000000000000001 111.583 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 75.5 m -96.3 124.48 40.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.997 0.427 . . . . 0.42999999999999999 110.669 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 p -121.18 125.49 26.93 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.629 -0.714 . . . . 0.29999999999999999 110.524 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HA ' HG12 ' A' ' 94' ' ' VAL . 78.6 Cg_exo -47.62 114.01 0.93 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.29 2.66 . . . . 0.34000000000000002 112.776 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.2 tt -117.02 138.06 48.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.503 -0.771 . . . . 0.58999999999999997 110.799 -176.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -111.87 120.01 40.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.554 -0.535 . . . . 2.3900000000000001 109.554 173.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.47 ' CD1' ' H ' ' A' ' 116' ' ' LEU . 1.2 pp -72.14 -11.4 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.127 -0.488 . . . . 2.02 112.299 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.02 -8.58 59.41 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.497 -0.859 . . . . 2.6099999999999999 113.231 174.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.47 ' H ' ' CD1' ' A' ' 114' ' ' ILE . 5.2 mp . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.429 -0.796 . . . . 3.6899999999999999 110.161 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.497 0.189 . . . . 30.309999999999999 111.104 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.19 115.91 19.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.819 0.342 . . . . 28.059999999999999 111.248 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.3 ttt -130.25 41.89 3.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.664 0.745 . . . . 28.52 109.317 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.51 -20.5 25.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.389 -0.823 . . . . 26.559999999999999 110.747 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -77.51 121.59 24.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.891 -0.595 . . . . 25.140000000000001 110.525 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.541 ' H ' HD13 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -115.86 140.17 38.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.042 -0.526 . . . . 24.989999999999998 110.476 -179.005 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.09 -6.17 89.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.942 -0.646 . . . . 22.920000000000002 112.985 -175.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -67.88 -30.72 70.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.008 0.433 . . . . 22.809999999999999 110.765 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 p -97.04 2.76 51.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.988 -0.551 . . . . 22.210000000000001 111.256 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.53 96.26 1.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.468 -0.333 . . . . 20.949999999999999 110.681 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 m 38.71 69.83 1.48 Allowed Pre-proline 0 N--CA 1.471 0.618 0 O-C-N 124.364 1.04 . . . . 19.190000000000001 113.134 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.64 -8.23 20.25 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.61 2.207 . . . . 17.98 112.151 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -103.58 136.52 43.15 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.572 -0.529 . . . . 18.07 109.572 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -100.7 -4.63 27.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.022 0.439 . . . . 14.66 110.594 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.24 157.14 38.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.964 -0.562 . . . . 13.029999999999999 110.251 175.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.7 m120 59.51 43.6 15.89 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.246 0.546 . . . . 12.26 110.962 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.12 43.78 0.92 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.632 -0.713 . . . . 9.9700000000000006 111.319 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.38 -127.34 8.91 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.891 -0.671 . . . . 8.2200000000000006 111.444 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.481 HG22 ' HD2' ' A' ' 30' ' ' PRO . 3.5 m -123.65 133.28 24.49 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 110.115 -0.328 . . . . 7.2999999999999998 110.115 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -40.06 -48.67 3.83 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.657 2.905 . . . . 6.0999999999999996 115.47 -175.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.481 ' HD2' HG22 ' A' ' 28' ' ' THR . 5.8 Cg_exo -76.31 104.9 1.98 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.095 1.863 . . . . 5.1900000000000004 111.61 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.421 ' O ' HG22 ' A' ' 114' ' ' ILE . 39.8 ttmt -58.53 142.95 47.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.023 -0.535 . . . . 3.79 110.79 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.2 t -153.22 175.72 12.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.252 -0.431 . . . . 1.74 110.401 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.6 m -76.7 131.0 38.54 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.519 -0.549 . . . . 1.7 109.519 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t -73.68 -12.13 60.63 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.796 0.332 . . . . 2.5699999999999998 110.675 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -91.58 -12.08 35.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.13 -0.486 . . . . 2.5 111.436 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.29 -156.53 26.73 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.471 -0.871 . . . . 1.51 112.73 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.03 155.67 4.19 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.663 2.909 . . . . 1.05 114.375 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.53 HG12 ' N ' ' A' ' 39' ' ' TYR . 47.3 t -85.62 173.76 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.99 -1.115 . . . . 0.58999999999999997 107.99 172.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.557 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 75.4 m-85 -128.71 120.62 26.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.954 0.883 . . . . 0.78000000000000003 112.034 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.622 ' HB2' HD21 ' A' ' 79' ' ' LEU . 33.1 t -91.13 99.13 12.2 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.344 -1.298 . . . . 0.81999999999999995 110.305 177.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.8 m -101.89 129.65 48.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.674 -0.861 . . . . 0.23999999999999999 108.674 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -53.57 -29.52 37.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.356 -0.838 . . . . 2.0800000000000001 110.439 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -170.5 125.13 0.72 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.001 -1.111 . . . . 2.5800000000000001 108.001 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.567 HG21 HG11 ' A' ' 94' ' ' VAL . 20.5 p -85.59 142.15 29.32 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.286 -0.966 . . . . 0.37 111.462 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.58 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.6 tp10 -114.21 142.21 46.55 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.891 -1.05 . . . . 1.1200000000000001 109.591 -174.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.414 ' O ' HD13 ' A' ' 50' ' ' LEU . 10.3 m-20 -62.0 110.79 1.68 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.372 -0.377 . . . . 1.77 110.443 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.587 ' HA ' HD21 ' A' ' 50' ' ' LEU . 77.5 p -65.88 -8.32 21.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.198 0.523 . . . . 0.92000000000000004 111.173 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -91.23 -24.68 19.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.993 -0.549 . . . . 2.77 110.067 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -141.06 59.71 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.029 -0.532 . . . . 2.3300000000000001 111.132 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.7 mm? -64.21 152.61 40.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 1.1599999999999999 111.768 176.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.82 152.86 43.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.551 -0.907 . . . . 1.8100000000000001 108.551 171.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.545 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -57.81 -29.4 64.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.121 -0.632 . . . . 3.23 110.146 176.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -66.17 -40.47 94.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.119 -0.562 . . . . 0.34000000000000002 111.736 176.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.651 ' HA ' HD22 ' A' ' 57' ' ' LEU . 20.0 m -78.06 -42.34 32.58 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.025 -0.27 . . . . 0.35999999999999999 110.647 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.0 m -53.61 -35.62 61.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.962 -0.563 . . . . 0.29999999999999999 109.685 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.527 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.75 -54.32 47.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.211 -0.904 . . . . 0.23000000000000001 111.772 176.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.651 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -59.56 -45.46 91.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.48 0.657 . . . . 0.23999999999999999 109.919 -178.289 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 54' ' ' THR . 48.6 mt -60.01 -44.38 94.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.886 -1.052 . . . . 0.17999999999999999 109.767 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.79 -38.71 92.64 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.707 -0.679 . . . . 0.26000000000000001 112.44 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 24.8 mt -56.89 -49.17 76.35 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.657 0.741 . . . . 0.34000000000000002 110.176 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.7 mt -84.16 -0.78 53.4 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.589 -1.187 . . . . 0.35999999999999999 111.13 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 66.91 35.82 4.65 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.269 -0.878 . . . . 1.8899999999999999 111.252 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 58' ' ' LEU . 52.5 mt -84.08 142.22 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 115.626 -0.716 . . . . 0.26000000000000001 109.702 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.401 ' H ' ' HD3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -95.67 118.2 31.92 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.345 0.593 . . . . 2.2200000000000002 110.12 -178.065 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.58 -30.26 44.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.114 -0.948 . . . . 0.28999999999999998 110.573 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.61 -8.59 84.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.862 -0.685 . . . . 0.56999999999999995 112.968 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -110.04 3.26 20.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.376 0.607 . . . . 0.85999999999999999 110.638 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.2 mt -72.81 156.49 38.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.272 0.558 . . . . 0.46000000000000002 111.05 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -92.76 -82.47 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.543 -0.753 . . . . 2.0099999999999998 112.854 -170.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.42 -88.36 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 1.0900000000000001 111.857 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.1 mm? -114.0 169.23 9.16 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.13 0.49 . . . . 0.14999999999999999 110.892 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.618 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -121.57 168.26 14.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.037 -1.468 . . . . 0.25 107.037 167.491 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.401 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -138.49 127.27 3.72 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.687 -1.244 . . . . 0.37 112.414 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -90.86 136.08 33.31 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.259 -0.576 . . . . 0.28999999999999998 110.179 178.416 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.4 m-20 49.67 49.69 19.59 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.15 -0.932 . . . . 1.8500000000000001 110.848 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 6.0 t -87.62 142.13 28.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.448 -0.796 . . . . 1.1200000000000001 110.523 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.7 m -113.57 116.27 46.05 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.627 -0.715 . . . . 1.26 111.07 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 23.3 Cg_exo -64.95 129.8 24.18 Favored 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 122.623 2.216 . . . . 0.60999999999999999 112.078 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -100.72 90.28 4.18 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.688 -0.486 . . . . 0.85999999999999999 109.688 177.783 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 t -87.01 -3.01 59.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.443 0.639 . . . . 1.3700000000000001 109.889 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.25 19.29 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 122.219 1.009 . . . . 1.6000000000000001 110.892 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 79' ' ' LEU . 47.7 mm -67.54 132.91 32.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.786 -1.097 . . . . 1.8500000000000001 110.543 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.14 -74.48 0.21 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.042 -0.823 . . . . 3.1800000000000002 111.042 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.0 t -84.61 61.34 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.556 0.693 . . . . 4.6900000000000004 109.208 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.47 171.59 30.66 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.391 -0.822 . . . . 4.3499999999999996 111.847 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.62 11.28 21.27 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.69 -0.766 . . . . 3.27 112.237 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -79.85 58.28 2.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.575 0.702 . . . . 5.4699999999999998 110.483 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -108.45 2.11 22.11 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.868 0.842 . . . . 4.7000000000000002 108.893 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.9 t -137.39 141.33 41.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.041 -0.982 . . . . 1.6599999999999999 110.395 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.9 m -112.96 -18.23 12.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.062 0.458 . . . . 1.6499999999999999 110.69 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.548 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -86.1 -157.9 0.37 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.03 -0.532 . . . . 0.54000000000000004 110.08 176.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.83 134.13 35.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.718 -0.475 . . . . 0.78000000000000003 109.718 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.69 117.85 34.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.284 0.564 . . . . 0.39000000000000001 111.216 -172.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.567 HG11 HG21 ' A' ' 44' ' ' THR . 6.7 m -131.78 165.48 31.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.616 -0.72 . . . . 0.22 110.942 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 37.6 t -110.58 120.75 43.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.419 -0.956 . . . . 0.70999999999999996 108.419 176.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 30.9 m -117.85 151.42 37.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.036 0.446 . . . . 0.60999999999999999 110.844 -170.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.6 t -78.92 -28.39 43.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.631 -0.713 . . . . 0.38 110.448 -172.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.432 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 13.5 m120 -153.57 163.45 39.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.921 -0.581 . . . . 0.78000000000000003 109.977 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.0 t -127.99 130.5 48.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.108 0.48 . . . . 0.41999999999999998 110.375 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.493 ' CB ' HG23 ' A' ' 105' ' ' VAL . 44.2 m-85 -119.48 142.21 48.48 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.749 -0.659 . . . . 0.77000000000000002 110.79 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.455 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 6.6 mm100 61.56 33.27 18.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.071 -0.513 . . . . 0.80000000000000004 111.824 175.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 63.21 6.58 2.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.044 0.538 . . . . 2.1200000000000001 112.181 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.28 -22.11 2.92 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.893 -1.146 . . . . 0.28000000000000003 113.425 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 13.7 mt -50.12 -40.85 47.39 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.475 0.638 . . . . 0.35999999999999999 110.547 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.493 HG23 ' CB ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -130.14 119.09 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.494 0.664 . . . . 0.85999999999999999 110.298 174.644 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.618 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 2.7 t30 -113.51 151.87 30.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.321 -0.992 . . . . 0.91000000000000003 108.321 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 10.5 m -135.55 152.16 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.048 0.758 . . . . 0.29999999999999999 113.048 -175.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 65.75 49.1 61.4 Favored Glycine 0 CA--C 1.506 -0.511 0 CA-C-N 115.154 -0.93 . . . . 0.20000000000000001 111.755 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 72.5 m -97.89 126.36 43.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.894 0.378 . . . . 0.42999999999999999 111.454 -172.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -120.23 126.05 26.99 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.703 -0.681 . . . . 0.29999999999999999 110.009 175.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.552 ' HA ' HG12 ' A' ' 94' ' ' VAL . 73.6 Cg_exo -49.61 109.87 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.12 2.546 . . . . 0.34000000000000002 112.345 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 tt -101.81 136.82 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.665 -0.698 . . . . 0.58999999999999997 110.789 -175.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -93.83 98.4 11.05 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.614 0.721 . . . . 2.3900000000000001 109.743 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 31' ' ' LYS . 2.9 pp -82.46 9.42 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.31 -0.859 . . . . 2.02 111.254 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 119.91 -16.48 10.19 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.854 -0.898 . . . . 2.6099999999999999 110.854 -173.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 116' ' ' LEU . 2.9 pp . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.567 -0.73 . . . . 3.6899999999999999 110.827 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.557 0.218 . . . . 30.309999999999999 111.188 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.25 40.93 0.85 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.873 0.323 . . . . 28.059999999999999 111.873 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.1 mpp? 55.71 39.38 30.82 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.188 -0.46 . . . . 28.52 111.936 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.71 -22.63 9.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.13 0.491 . . . . 26.559999999999999 110.557 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.74 -39.31 16.09 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.239 -0.652 . . . . 25.140000000000001 109.239 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.2 pt -125.53 173.58 11.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.292 -0.867 . . . . 24.989999999999998 110.362 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.25 -175.77 22.67 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.375 -0.69 . . . . 22.920000000000002 111.375 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.6 m 57.03 52.71 8.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.238 0.542 . . . . 22.809999999999999 110.88 178.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.7 m -78.06 114.53 17.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.787 -0.642 . . . . 22.210000000000001 110.754 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.92 -24.07 16.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.96 -0.564 . . . . 20.949999999999999 110.832 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.0 m -88.83 115.92 64.86 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.165 0.507 . . . . 19.190000000000001 111.395 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.98 -20.33 11.7 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.545 2.163 . . . . 17.98 112.481 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -88.64 135.54 33.45 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.612 -0.514 . . . . 18.07 109.612 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -74.89 153.43 38.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.014 0.435 . . . . 14.66 110.892 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.6 t -102.93 21.8 2.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.872 0.844 . . . . 13.029999999999999 109.731 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.426 ' HB3' ' HB ' ' A' ' 28' ' ' THR . 21.7 m120 -92.78 -55.16 3.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.605 -0.725 . . . . 12.26 109.984 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.35 60.84 7.29 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.858 -0.687 . . . . 9.9700000000000006 112.379 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.47 52.8 3.26 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.765 -0.731 . . . . 8.2200000000000006 113.124 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.715 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 8.9 t -80.41 145.84 60.39 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.677 -0.49 . . . . 7.2999999999999998 109.677 176.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 28' ' ' THR . 69.2 Cg_endo -99.12 81.68 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.707 2.938 . . . . 6.0999999999999996 113.402 173.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.715 ' HD3' ' O ' ' A' ' 28' ' ' THR . 5.3 Cg_exo -74.18 80.49 2.18 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.76 2.307 . . . . 5.1900000000000004 112.041 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -146.96 174.31 11.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.7 . . . . 3.79 110.621 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.48 ' HA ' ' CD1' ' A' ' 112' ' ' ILE . 45.7 m 70.29 -178.15 0.22 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.75 0.656 . . . . 1.74 111.248 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.7 m -76.96 131.65 38.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.298 -0.41 . . . . 1.7 110.737 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 p -78.71 -8.38 58.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.118 0.485 . . . . 2.5699999999999998 111.043 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -98.13 4.61 49.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.146 -0.479 . . . . 2.5 111.028 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 127.05 -131.57 7.29 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.334 -0.936 . . . . 1.51 113.332 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.48 153.61 17.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.643 2.896 . . . . 1.05 114.299 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 39' ' ' TYR . 97.5 t -96.0 169.13 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.275 -1.329 . . . . 0.58999999999999997 107.616 172.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.483 ' N ' HG12 ' A' ' 38' ' ' VAL . 77.1 m-85 -127.06 139.05 53.28 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.892 0.769 . . . . 0.78000000000000003 111.779 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 42.7 t -116.14 103.77 10.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.323 -0.853 . . . . 0.81999999999999995 110.292 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.6 m -106.01 135.95 46.54 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.253 -0.647 . . . . 0.23999999999999999 109.253 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 59.0 m-80 -59.32 -23.66 62.66 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.696 -0.684 . . . . 2.0800000000000001 110.622 177.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HD3' ' O ' ' A' ' 44' ' ' THR . 12.4 tmtt? -176.15 125.33 0.2 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.739 -1.208 . . . . 2.5800000000000001 107.739 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.588 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 34.1 p -89.64 152.55 21.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.43 -0.908 . . . . 0.37 111.538 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.601 ' HB3' HG22 ' A' ' 72' ' ' VAL . 14.8 tp10 -115.14 138.33 51.02 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.256 -0.883 . . . . 1.1200000000000001 109.15 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.459 ' HA ' HD12 ' A' ' 71' ' ' LEU . 17.6 m-20 -74.59 109.23 7.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.357 -0.383 . . . . 1.77 110.495 -175.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.475 ' HA ' HD21 ' A' ' 50' ' ' LEU . 6.3 m -50.76 -25.31 4.23 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.971 0.794 . . . . 0.92000000000000004 112.454 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.501 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.4 mptp? -64.83 -45.5 85.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.238 0.542 . . . . 2.77 111.012 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -133.45 58.07 1.78 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.548 -0.751 . . . . 2.3300000000000001 110.522 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.475 HD21 ' HA ' ' A' ' 47' ' ' SER . 80.5 mt -57.17 158.36 5.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.311 -0.859 . . . . 1.1599999999999999 112.812 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.66 154.97 39.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.505 -1.225 . . . . 1.8100000000000001 109.243 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -67.54 -32.99 74.15 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.066 -0.346 . . . . 3.23 110.066 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -67.01 -33.74 84.75 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.478 -0.649 . . . . 0.34000000000000002 111.478 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.641 ' HA ' HD22 ' A' ' 57' ' ' LEU . 28.3 m -79.33 -44.29 21.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.35999999999999999 110.056 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.4 m -52.79 -35.37 56.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.485 -0.78 . . . . 0.29999999999999999 109.819 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.528 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.76 -51.59 68.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.306 -0.861 . . . . 0.23000000000000001 112.013 176.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.641 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -61.84 -43.66 98.39 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.518 0.675 . . . . 0.23999999999999999 109.961 -178.135 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.2 mt -60.24 -44.25 95.4 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.933 -1.03 . . . . 0.17999999999999999 110.105 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.29 -38.08 89.15 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.775 -0.648 . . . . 0.26000000000000001 112.281 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 32.7 mt -57.11 -50.44 72.77 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.746 0.784 . . . . 0.34000000000000002 110.124 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.505 HD21 HE21 ' A' ' 101' ' ' GLN . 5.0 mt -84.02 -2.85 57.43 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.581 -1.19 . . . . 0.35999999999999999 111.501 -174.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.5 t30 68.17 35.01 3.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.725 0.774 . . . . 1.8899999999999999 110.488 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 58' ' ' LEU . 55.8 mt -81.77 146.61 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.468 -0.787 . . . . 0.26000000000000001 110.008 176.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -95.98 117.92 31.59 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.265 0.555 . . . . 2.2200000000000002 110.198 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -71.72 -29.98 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.297 -0.865 . . . . 0.28999999999999998 110.332 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.22 -16.64 78.63 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.949 -0.569 . . . . 0.56999999999999995 112.679 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -91.67 -16.41 27.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.179 0.514 . . . . 0.85999999999999999 110.2 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.37 137.86 57.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.64 -0.709 . . . . 0.46000000000000002 111.025 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 2.4 mptp? -94.07 -88.72 0.23 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.168 -0.923 . . . . 2.0099999999999998 111.808 -170.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.13 -96.2 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.888 0.329 . . . . 1.0900000000000001 111.888 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 44' ' ' THR . 1.8 mm? -111.24 170.83 7.85 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.475 0.655 . . . . 0.14999999999999999 111.363 178.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -125.14 169.9 15.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 107.065 -1.457 . . . . 0.25 107.065 166.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -138.69 131.43 5.33 Favored Glycine 0 C--N 1.311 -0.822 0 C-N-CA 119.653 -1.261 . . . . 0.37 112.159 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.31 136.21 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.354 -0.538 . . . . 0.28999999999999998 109.787 178.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.97 49.3 19.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.133 -0.94 . . . . 1.8500000000000001 110.662 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 11.6 t -90.68 144.52 25.66 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.521 -1.218 . . . . 1.1200000000000001 109.588 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 40' ' ' CYS . 13.5 p -106.29 118.63 54.3 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.507 -0.315 . . . . 1.26 111.252 -177.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.15 119.6 6.41 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.457 2.105 . . . . 0.60999999999999999 111.783 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.6 mt -90.16 87.56 6.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.661 -0.699 . . . . 0.85999999999999999 109.313 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.1 p -78.11 -43.52 28.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.934 -0.576 . . . . 1.3700000000000001 111.123 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 m -93.16 96.78 6.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.985 0.898 . . . . 1.6000000000000001 110.784 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 29.5 mm -86.94 -65.18 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.896 -1.047 . . . . 1.8500000000000001 111.268 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.18 -136.5 13.3 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 110.952 -0.859 . . . . 3.1800000000000002 110.952 -172.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.12 -30.65 4.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.265 0.555 . . . . 4.6900000000000004 109.877 174.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.48 -59.57 0.24 Allowed Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.764 -0.653 . . . . 4.3499999999999996 111.988 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.78 -97.27 0.18 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.652 -0.785 . . . . 3.27 112.525 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.423 ' H ' HD13 ' A' ' 116' ' ' LEU . 4.6 t30 56.55 68.04 0.91 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.492 0.663 . . . . 5.4699999999999998 110.473 -178.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.6 t -151.88 15.49 0.65 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.515 -0.766 . . . . 4.7000000000000002 109.638 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.3 t -137.0 121.41 18.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.829 -0.623 . . . . 1.6599999999999999 111.24 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.9 m -107.88 22.33 16.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.899 -0.591 . . . . 1.6499999999999999 110.589 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.467 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -140.33 -158.24 0.84 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.054 -0.521 . . . . 0.54000000000000004 110.151 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB2' HE21 ' A' ' 92' ' ' GLN . 0.0 OUTLIER -82.46 124.59 30.21 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.444 0.64 . . . . 0.78000000000000003 110.366 -176.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.49 126.4 45.42 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.52 0.676 . . . . 0.39000000000000001 111.359 -170.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 111' ' ' PRO . 5.0 m -134.0 165.85 30.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.228 -0.896 . . . . 0.22 110.69 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 46.0 t -112.87 120.95 43.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.541 -0.911 . . . . 0.70999999999999996 108.541 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 13.8 m -124.07 153.55 41.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.864 0.364 . . . . 0.60999999999999999 110.954 -169.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.2 t -83.5 -19.24 36.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.905 -0.589 . . . . 0.38 111.671 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -166.93 169.02 13.47 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 122.554 0.342 . . . . 0.78000000000000003 110.424 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.3 t -145.9 143.53 29.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.869 -0.605 . . . . 0.41999999999999998 110.429 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.578 ' HB2' HG23 ' A' ' 105' ' ' VAL . 35.8 m-85 -135.04 160.21 39.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.074 -0.512 . . . . 0.77000000000000002 109.885 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.505 HE21 HD21 ' A' ' 61' ' ' LEU . 58.1 mm-40 61.14 25.18 15.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.347 -0.388 . . . . 0.80000000000000004 111.842 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 60.17 13.94 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 2.1200000000000001 112.306 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.68 -30.84 1.67 Allowed Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.146 -1.026 . . . . 0.28000000000000003 113.414 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 14.6 mt -49.23 -40.51 34.12 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.969 0.385 . . . . 0.35999999999999999 111.843 -175.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.578 HG23 ' HB2' ' A' ' 100' ' ' TYR . 3.7 m -131.07 136.23 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.546 0.689 . . . . 0.85999999999999999 110.664 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.499 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 32.0 t30 -132.76 141.98 48.79 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.271 -1.381 . . . . 0.91000000000000003 107.271 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 17.1 m -125.07 150.23 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 113.623 0.972 . . . . 0.29999999999999999 113.623 -170.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 63.54 51.7 52.13 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.726 -1.125 . . . . 0.20000000000000001 111.755 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 90.4 m -97.02 131.04 44.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.992 0.425 . . . . 0.42999999999999999 111.66 -173.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 p -123.37 126.56 25.84 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.529 -0.76 . . . . 0.29999999999999999 110.0 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.599 ' HA ' HG12 ' A' ' 94' ' ' VAL . 52.6 Cg_exo -52.31 116.59 2.93 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.8 2.333 . . . . 0.34000000000000002 112.462 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 32' ' ' SER . 7.2 tt -104.98 124.57 59.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.855 -0.612 . . . . 0.58999999999999997 110.549 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -96.23 98.55 10.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.14 -0.482 . . . . 2.3900000000000001 110.061 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.3 pp -95.62 -14.43 7.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.896 -0.593 . . . . 2.02 110.94 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.99 12.12 81.3 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.812 -0.631 . . . . 2.6099999999999999 113.648 173.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.423 HD13 ' H ' ' A' ' 87' ' ' ASN . 15.1 mt . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.531 -0.747 . . . . 3.6899999999999999 109.65 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.084 -0.339 . . . . 30.309999999999999 110.084 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 59.07 32.14 21.94 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.605 0.566 . . . . 28.059999999999999 111.547 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 89.5 mtp -113.93 -7.66 13.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.364 0.602 . . . . 28.52 109.74 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.56 170.26 16.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.247 -0.888 . . . . 26.559999999999999 109.489 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 59.29 34.21 22.87 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.303 0.377 . . . . 25.140000000000001 110.957 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.5 mt -92.97 -30.62 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.143 0.497 . . . . 24.989999999999998 109.861 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.82 24.25 10.07 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.805 -0.712 . . . . 22.920000000000002 112.325 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 t -79.13 -19.78 50.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.216 0.532 . . . . 22.809999999999999 110.435 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.8 m -123.99 -55.5 1.69 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.946 -0.57 . . . . 22.210000000000001 110.612 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -140.93 162.21 36.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.354 -0.384 . . . . 20.949999999999999 110.814 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 22' ' ' ARG . 7.6 p -172.43 131.1 0.66 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.988 -0.551 . . . . 19.190000000000001 110.023 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.39 20.02 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.884 2.389 . . . . 17.98 113.102 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.434 ' H ' HG22 ' A' ' 20' ' ' VAL . 80.7 mtp180 -139.41 86.78 2.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.966 -0.383 . . . . 18.07 109.966 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.91 161.63 20.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.092 -0.503 . . . . 14.66 111.173 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -116.92 126.16 74.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.771 -0.649 . . . . 13.029999999999999 109.625 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -73.74 -28.72 61.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.1 0.476 . . . . 12.26 110.616 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.17 31.65 5.24 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.677 -0.773 . . . . 9.9700000000000006 111.981 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.77 54.07 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.006 -0.616 . . . . 8.2200000000000006 111.648 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.595 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 85.0 m -153.89 133.2 7.23 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.919 0.39 . . . . 7.2999999999999998 111.287 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 28' ' ' THR . 37.4 Cg_endo -101.39 76.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.528 3.485 . . . . 6.0999999999999996 112.445 169.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 28' ' ' THR . 26.0 Cg_exo -61.87 83.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.829 2.353 . . . . 5.1900000000000004 113.06 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -105.97 -14.58 15.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.218 0.533 . . . . 3.79 109.924 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 p -80.87 -168.78 1.91 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.514 -0.766 . . . . 1.74 111.244 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.6 m -75.42 131.05 39.91 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.653 -0.499 . . . . 1.7 109.653 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.6 m -74.01 -17.9 60.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.016 0.436 . . . . 2.5699999999999998 110.692 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -83.96 -16.9 42.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.932 -0.576 . . . . 2.5 111.413 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.91 -138.21 6.78 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.305 -0.95 . . . . 1.51 113.39 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -55.02 154.38 22.27 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.704 2.936 . . . . 1.05 114.375 -176.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 39' ' ' TYR . 84.2 t -98.84 168.67 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.33 -1.305 . . . . 0.58999999999999997 107.801 172.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.486 ' N ' HG12 ' A' ' 38' ' ' VAL . 87.4 m-85 -127.99 132.25 49.18 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 118.68 0.673 . . . . 0.78000000000000003 111.211 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.825 ' SG ' ' HB2' ' A' ' 77' ' ' SER . 27.1 p -107.09 107.66 18.76 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.555 -0.748 . . . . 0.81999999999999995 110.025 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.6 m -98.66 137.38 37.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.445 -0.798 . . . . 0.23999999999999999 110.626 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -55.03 -27.67 46.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.781 0.801 . . . . 2.0800000000000001 109.356 172.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -169.56 137.4 1.78 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.306 -1.316 . . . . 2.5800000000000001 108.247 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.603 HG21 HG11 ' A' ' 94' ' ' VAL . 14.3 p -92.85 149.28 21.37 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.461 -0.896 . . . . 0.37 110.306 168.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.567 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.7 tp10 -112.35 134.32 53.96 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.528 -0.76 . . . . 1.1200000000000001 109.287 -176.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.497 ' HA ' HD12 ' A' ' 71' ' ' LEU . 4.7 m-20 -67.14 114.1 5.62 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.729 -0.669 . . . . 1.77 111.051 -174.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.768 ' HA ' HD21 ' A' ' 50' ' ' LEU . 68.5 m -60.14 -13.03 10.03 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.392 0.433 . . . . 0.92000000000000004 111.88 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -79.29 -36.22 40.04 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.522 0.677 . . . . 2.77 109.95 177.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -140.4 66.08 1.39 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.039 -0.982 . . . . 2.3300000000000001 111.517 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.7 mm? -64.91 147.43 53.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.096 0.474 . . . . 1.1599999999999999 110.962 171.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.59 171.06 13.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.638 -0.71 . . . . 1.8100000000000001 110.221 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -61.24 -47.96 83.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.62 0.248 . . . . 3.23 111.088 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.64 -35.32 62.0 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.34000000000000002 112.708 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.602 ' HA ' HD22 ' A' ' 57' ' ' LEU . 11.2 m -81.8 -41.61 20.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.243 -0.28 . . . . 0.35999999999999999 110.243 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.2 m -53.81 -34.77 60.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.409 0.623 . . . . 0.29999999999999999 109.928 174.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.469 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.96 -53.76 54.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.063 -0.971 . . . . 0.23000000000000001 111.908 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -61.12 -46.19 91.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.547 0.689 . . . . 0.23999999999999999 109.973 -178.252 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 54' ' ' THR . 46.1 mt -58.64 -41.93 87.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.685 -1.143 . . . . 0.17999999999999999 109.848 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.92 -32.45 84.01 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.748 -0.66 . . . . 0.26000000000000001 112.704 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.1 mt -62.96 -50.55 70.34 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.666 0.746 . . . . 0.34000000000000002 109.811 177.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mt -81.43 -0.75 42.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.517 -1.219 . . . . 0.35999999999999999 111.216 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 t30 68.61 38.18 2.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.324 -0.853 . . . . 1.8899999999999999 110.559 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 58' ' ' LEU . 49.3 mt -87.07 141.59 14.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.584 -0.735 . . . . 0.26000000000000001 109.746 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.65 118.6 31.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.532 0.682 . . . . 2.2200000000000002 110.179 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.437 HG23 HD23 ' A' ' 50' ' ' LEU . 1.8 mp -67.65 -36.99 77.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.818 -1.083 . . . . 0.28999999999999998 110.93 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.58 -14.91 70.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.97 -0.633 . . . . 0.56999999999999995 113.177 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.12 3.62 33.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.238 0.542 . . . . 0.85999999999999999 110.725 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 94.2 mt -71.47 144.27 49.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.052 0.453 . . . . 0.46000000000000002 110.853 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -94.85 -96.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.581 -0.736 . . . . 2.0099999999999998 112.542 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.59 -85.98 0.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 1.0900000000000001 111.897 -172.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.3 mm? -120.13 165.14 15.15 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.529 0.681 . . . . 0.14999999999999999 111.063 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -119.9 167.56 13.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 106.017 -1.846 . . . . 0.25 106.017 167.262 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 105' ' ' VAL . . . -135.01 137.59 9.36 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.671 -1.252 . . . . 0.37 111.583 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.664 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -109.85 129.49 55.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.49 0.645 . . . . 0.28999999999999998 110.765 178.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.462 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 0.6 OUTLIER 54.3 52.9 11.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.6 -1.182 . . . . 1.8500000000000001 111.487 176.646 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.6 m -92.0 154.06 19.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.252 -0.885 . . . . 1.1200000000000001 109.983 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.825 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 57.6 m -102.75 129.64 25.43 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.38 -0.373 . . . . 1.26 110.089 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 6.6 Cg_exo -74.09 119.64 5.93 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.601 2.201 . . . . 0.60999999999999999 112.276 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.751 HD21 ' SG ' ' A' ' 40' ' ' CYS . 9.8 mt -94.97 89.58 5.65 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.527 -0.76 . . . . 0.85999999999999999 108.952 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.6 p -80.58 -44.63 18.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.086 -0.506 . . . . 1.3700000000000001 111.775 -173.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 m -92.79 99.27 9.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.83 0.824 . . . . 1.6000000000000001 111.632 -176.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.0 mm -80.89 119.92 31.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.293 -0.867 . . . . 1.8500000000000001 110.539 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 139.33 -48.22 0.87 Allowed Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.26 -1.136 . . . . 3.1800000000000002 110.26 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.4 t -96.15 -46.63 13.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.184 -1.043 . . . . 4.6900000000000004 108.184 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.55 169.61 28.95 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.083 -0.962 . . . . 4.3499999999999996 110.725 172.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.04 -28.67 7.06 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.633 -0.794 . . . . 3.27 111.682 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -62.92 -47.21 84.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.281 0.562 . . . . 5.4699999999999998 110.275 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.9 t -163.6 145.19 9.33 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.374 -0.83 . . . . 4.7000000000000002 109.345 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.4 t -131.1 14.52 5.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.15 0.5 . . . . 1.6599999999999999 110.142 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.5 m 59.09 16.57 4.86 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.577 -0.738 . . . . 1.6499999999999999 110.554 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.33 -168.19 2.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.568 -0.742 . . . . 0.54000000000000004 110.201 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.55 117.24 29.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.316 0.579 . . . . 0.78000000000000003 109.536 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.85 122.49 33.61 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.817 -0.629 . . . . 0.39000000000000001 111.078 -173.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.603 HG11 HG21 ' A' ' 44' ' ' THR . 12.3 m -135.29 162.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.629 -0.714 . . . . 0.22 111.191 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 49.6 t -108.49 109.68 21.0 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.793 -0.817 . . . . 0.70999999999999996 108.793 176.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 39.5 m -102.01 148.19 25.66 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.242 -0.281 . . . . 0.60999999999999999 110.242 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.0 t -81.46 -27.27 34.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.055 0.455 . . . . 0.38 110.501 -173.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.524 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 14.8 m120 -149.05 165.89 30.35 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.769 -0.65 . . . . 0.78000000000000003 109.374 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.2 t -136.73 139.87 42.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.118 -0.492 . . . . 0.41999999999999998 110.223 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.584 ' HB2' HG23 ' A' ' 105' ' ' VAL . 57.7 m-85 -128.07 147.88 50.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.922 -0.581 . . . . 0.77000000000000002 109.732 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.461 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 12.1 mm-40 63.58 22.91 13.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.80000000000000004 111.208 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 67.49 9.99 7.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.921 -0.581 . . . . 2.1200000000000001 112.079 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.11 -22.12 2.1 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.333 -0.936 . . . . 0.28000000000000003 113.269 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.8 mt -54.0 -35.78 62.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.877 0.338 . . . . 0.35999999999999999 111.574 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.584 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -144.14 119.6 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.253 0.549 . . . . 0.85999999999999999 111.042 174.516 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.4 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 90.6 m-20 -114.62 161.82 17.59 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.728 -0.669 . . . . 0.91000000000000003 109.785 177.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.9 m -130.73 156.89 42.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 111.896 0.332 . . . . 0.29999999999999999 111.896 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 57.37 52.64 50.42 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.554 -0.748 . . . . 0.20000000000000001 111.929 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 68.4 m -96.79 128.42 43.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.763 0.316 . . . . 0.42999999999999999 110.739 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.1 p -123.02 127.36 25.72 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.93 -0.577 . . . . 0.29999999999999999 110.355 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.534 ' HA ' HG12 ' A' ' 94' ' ' VAL . 51.8 Cg_exo -53.58 115.33 2.25 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.129 2.552 . . . . 0.34000000000000002 112.934 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 tt -98.27 133.32 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.739 -0.664 . . . . 0.58999999999999997 110.064 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -108.16 113.69 27.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.195 0.521 . . . . 2.3900000000000001 110.865 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.491 HD13 ' HG ' ' A' ' 116' ' ' LEU . 1.1 pp -82.92 -22.82 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.155 -0.475 . . . . 2.02 111.152 176.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.02 6.59 57.14 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.936 -0.574 . . . . 2.6099999999999999 113.762 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.491 ' HG ' HD13 ' A' ' 114' ' ' ILE . 3.4 pp . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.452 -0.785 . . . . 3.6899999999999999 109.94 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.606 ' HE2' ' SD ' ' A' ' 12' ' ' MET . 4.1 ttpm? . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.9 -0.407 . . . . 30.309999999999999 109.9 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.21 103.02 1.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 28.059999999999999 111.194 -177.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.606 ' SD ' ' HE2' ' A' ' 10' ' ' LYS . 24.1 ptm -147.56 -42.19 0.17 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.999 -0.546 . . . . 28.52 110.472 175.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.06 18.98 16.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.811 0.815 . . . . 26.559999999999999 109.015 174.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -145.76 25.89 1.29 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.219 -1.355 . . . . 25.140000000000001 109.553 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.51 121.57 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.539 -0.755 . . . . 24.989999999999998 110.717 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.0 -44.3 1.92 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.877 -0.678 . . . . 22.920000000000002 111.528 -177.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.6 m 56.97 86.76 0.07 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.922 0.489 . . . . 22.809999999999999 110.58 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 m -62.54 92.75 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.749 -0.66 . . . . 22.210000000000001 111.449 -175.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -157.94 57.44 0.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 20.949999999999999 110.091 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.3 t -77.83 114.95 46.15 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.637 -0.711 . . . . 19.190000000000001 110.817 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.16 164.4 35.89 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.465 2.11 . . . . 17.98 112.028 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -144.69 156.05 43.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.559 -0.291 . . . . 18.07 110.575 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 65.84 20.24 11.39 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.713 0.633 . . . . 14.66 111.121 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 p -114.33 110.89 33.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.745 -0.661 . . . . 13.029999999999999 109.865 176.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -115.36 121.35 42.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.906 -0.588 . . . . 12.26 110.386 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.44 96.48 0.56 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.922 -0.656 . . . . 9.9700000000000006 111.891 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.94 37.7 0.6 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.886 -0.673 . . . . 8.2200000000000006 112.459 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.637 HG22 ' HD2' ' A' ' 30' ' ' PRO . 19.7 m -76.54 134.03 70.11 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.388 -0.597 . . . . 7.2999999999999998 109.388 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.431 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 95.8 Cg_exo -41.47 -50.52 4.61 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.829 3.019 . . . . 6.0999999999999996 115.751 -174.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.637 ' HD2' HG22 ' A' ' 28' ' ' THR . 2.8 Cg_endo -79.32 -10.17 14.91 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 121.793 1.662 . . . . 5.1900000000000004 111.357 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.5 mttp 63.98 -78.99 0.03 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.725 -1.125 . . . . 3.79 111.502 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.535 ' OG ' ' HA ' ' A' ' 37' ' ' PRO . 32.7 t -71.14 159.69 34.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.269 0.557 . . . . 1.74 111.282 -175.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 27.9 m -85.63 155.49 21.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.284 -0.871 . . . . 1.7 109.527 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.6 t -80.14 -39.17 29.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.414 -0.357 . . . . 2.5699999999999998 111.659 -174.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -71.72 -31.53 66.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.124 0.487 . . . . 2.5 110.449 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . -154.95 144.45 11.09 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.91 -0.876 . . . . 1.51 110.91 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.535 ' HA ' ' OG ' ' A' ' 32' ' ' SER . 13.3 Cg_exo -71.1 -161.77 0.1 OUTLIER 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.414 2.076 . . . . 1.05 112.554 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 39' ' ' TYR . 49.1 t -88.86 161.0 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.791 0.329 . . . . 0.58999999999999997 110.228 -175.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.427 ' N ' HG12 ' A' ' 38' ' ' VAL . 70.2 m-85 -135.77 141.48 44.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.089 0.471 . . . . 0.78000000000000003 109.91 177.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.59 ' HB3' ' OG ' ' A' ' 77' ' ' SER . 16.4 t -107.0 107.86 19.08 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.166 -0.47 . . . . 0.81999999999999995 109.966 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.0 m -108.08 134.18 51.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.925 0.393 . . . . 0.23999999999999999 110.426 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.475 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 4.8 m-20 -60.11 -20.23 57.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 2.0800000000000001 110.293 176.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.92 129.91 0.31 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.1 -1.074 . . . . 2.5800000000000001 108.1 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.533 HG21 HG11 ' A' ' 94' ' ' VAL . 18.4 p -87.42 152.86 21.9 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.174 -1.011 . . . . 0.37 111.09 172.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HB3' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -115.16 142.43 46.67 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.238 -0.892 . . . . 1.1200000000000001 109.29 -174.595 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.474 ' HA ' HD12 ' A' ' 71' ' ' LEU . 10.2 m-20 -78.31 108.4 11.62 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.105 -0.498 . . . . 1.77 110.86 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.747 ' HA ' HD21 ' A' ' 50' ' ' LEU . 46.7 m -58.92 -12.49 4.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.064 0.765 . . . . 0.92000000000000004 113.064 -176.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -81.18 -32.84 33.38 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.967 -0.293 . . . . 2.77 110.343 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -147.29 67.11 1.14 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.328 -0.396 . . . . 2.3300000000000001 110.75 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.747 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.9 mm? -59.42 153.63 18.75 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.462 0.648 . . . . 1.1599999999999999 111.495 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.86 150.67 48.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.916 -1.038 . . . . 1.8100000000000001 109.388 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.732 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -55.58 -36.4 66.84 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.01 0.194 . . . . 3.23 111.12 176.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -63.58 -40.66 98.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.793 -0.718 . . . . 0.34000000000000002 111.778 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.646 ' HA ' HD22 ' A' ' 57' ' ' LEU . 24.5 m -78.53 -42.84 28.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.853 0.359 . . . . 0.35999999999999999 110.229 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.5 m -52.04 -36.59 50.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.571 -0.741 . . . . 0.29999999999999999 109.957 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.503 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.06 -54.41 47.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.264 -0.88 . . . . 0.23000000000000001 111.817 176.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.646 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -59.18 -45.02 92.14 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.385 0.612 . . . . 0.23999999999999999 110.216 -177.292 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 54' ' ' THR . 48.5 mt -58.54 -42.33 87.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.905 -1.043 . . . . 0.17999999999999999 110.132 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.37 -37.05 93.98 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.712 -0.756 . . . . 0.26000000000000001 112.068 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 15.1 mt -63.03 -40.32 97.39 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.651 0.739 . . . . 0.34000000000000002 110.194 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.461 ' CD1' HG21 ' A' ' 105' ' ' VAL . 5.6 mt -90.5 4.19 51.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.86 -1.064 . . . . 0.35999999999999999 111.417 -176.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.9 m120 70.41 26.68 4.12 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.461 -0.79 . . . . 1.8899999999999999 111.264 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 58' ' ' LEU . 52.8 mt -81.48 145.86 8.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.02 -0.536 . . . . 0.26000000000000001 110.485 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.641 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -97.01 117.7 31.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.599 -0.728 . . . . 2.2200000000000002 109.987 -178.379 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.409 HG23 HD23 ' A' ' 50' ' ' LEU . 1.8 mp -75.69 -42.8 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.645 -0.707 . . . . 0.28999999999999998 111.449 -174.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.34 -8.63 71.14 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 121.017 -0.611 . . . . 0.56999999999999995 112.838 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.486 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 29.5 t70 -104.02 -9.31 18.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.974 0.416 . . . . 0.85999999999999999 110.497 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.517 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 94.8 mt -60.92 140.1 57.83 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.03 -0.532 . . . . 0.46000000000000002 110.657 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -88.89 -62.02 1.58 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.325 -0.852 . . . . 2.0099999999999998 113.085 -169.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.77 -95.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.379 0.511 . . . . 1.0900000000000001 112.379 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.1 mm? -117.77 165.78 13.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.544 0.688 . . . . 0.14999999999999999 111.391 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.524 HG13 HD11 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -119.86 173.4 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.776 -1.565 . . . . 0.25 106.776 169.169 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.545 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -141.41 148.66 20.35 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.844 -1.17 . . . . 0.37 111.533 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -110.76 133.52 53.27 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.879 -0.415 . . . . 0.28999999999999998 109.879 174.732 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 53.34 50.47 17.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.992 -1.004 . . . . 1.8500000000000001 111.188 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.545 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 60.6 m -86.93 143.01 27.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.07 -0.513 . . . . 1.1200000000000001 110.705 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.59 ' OG ' ' HB3' ' A' ' 40' ' ' CYS . 7.0 p -97.15 114.61 64.99 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.104 -0.498 . . . . 1.26 109.789 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.26 120.53 8.14 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.44 2.093 . . . . 0.60999999999999999 112.357 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 40' ' ' CYS . 35.0 mt -99.29 87.31 3.61 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.964 -0.754 . . . . 0.85999999999999999 108.964 177.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.0 m -78.47 -18.51 54.76 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.885 -0.598 . . . . 1.3700000000000001 110.944 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.51 ' O ' ' HA2' ' A' ' 86' ' ' GLY . 4.0 m -129.27 113.36 27.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.914 -0.585 . . . . 1.6000000000000001 111.389 -175.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.7 mm -109.15 128.23 65.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.984 -0.553 . . . . 1.8500000000000001 111.069 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 143.06 -136.69 7.2 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.679 -0.772 . . . . 3.1800000000000002 112.058 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.6 t -71.91 -34.16 50.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.143 0.497 . . . . 4.6900000000000004 110.397 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -105.89 49.52 0.88 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.757 -0.735 . . . . 4.3499999999999996 112.287 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 81' ' ' VAL . . . -76.1 147.72 35.16 Favored Glycine 0 C--N 1.329 0.19 0 C-N-CA 121.069 -0.586 . . . . 3.27 112.249 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -91.38 35.3 0.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.057 0.392 . . . . 5.4699999999999998 112.057 -175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.6 p 61.79 122.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.507 1.299 . . . . 4.7000000000000002 114.507 170.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.3 t -130.99 125.41 33.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.014 -0.994 . . . . 1.6599999999999999 109.523 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.4 p -121.01 10.78 10.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.899 0.38 . . . . 1.6499999999999999 111.204 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -126.19 -159.2 0.9 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.108 -0.496 . . . . 0.54000000000000004 110.408 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.57 130.09 38.92 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.235 0.54 . . . . 0.78000000000000003 109.769 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.406 HG22 ' CG1' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -105.79 119.11 38.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.319 0.581 . . . . 0.39000000000000001 111.448 -171.456 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 111' ' ' PRO . 5.2 m -130.99 163.86 35.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.577 -0.738 . . . . 0.22 110.573 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.5 t -109.6 120.34 42.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.575 -0.898 . . . . 0.70999999999999996 108.575 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.71 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 17.9 m -121.57 148.51 44.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.053 0.454 . . . . 0.60999999999999999 110.98 -169.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.4 t -78.29 -29.53 47.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.632 -0.713 . . . . 0.38 110.891 -172.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.419 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 17.0 m120 -157.0 158.74 37.11 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.91 -0.404 . . . . 0.78000000000000003 109.91 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 t -132.61 149.2 52.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.388 -0.597 . . . . 0.41999999999999998 109.388 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.608 ' HB2' HG23 ' A' ' 105' ' ' VAL . 81.6 m-85 -131.29 154.0 48.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.287 -0.634 . . . . 0.77000000000000002 109.287 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.503 ' OE1' HD12 ' A' ' 104' ' ' LEU . 13.6 mm-40 63.63 27.11 14.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 0.80000000000000004 110.878 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 65.48 6.53 3.79 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.594 -0.73 . . . . 2.1200000000000001 112.465 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 140.64 -19.64 2.77 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.207 -0.997 . . . . 0.28000000000000003 113.211 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.57 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 20.7 mt -47.91 -39.6 19.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.006 0.403 . . . . 0.35999999999999999 110.919 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.608 HG23 ' HB2' ' A' ' 100' ' ' TYR . 4.5 m -130.38 149.93 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.209 -0.663 . . . . 0.85999999999999999 109.209 171.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.494 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 31.5 t30 -144.05 147.82 34.34 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.154 -1.054 . . . . 0.91000000000000003 108.154 -173.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 9.2 m -131.59 153.52 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.415 0.895 . . . . 0.29999999999999999 113.415 -174.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.71 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 62.02 51.72 54.99 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.784 -1.098 . . . . 0.20000000000000001 111.985 176.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 83.9 m -97.82 127.76 43.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.978 0.418 . . . . 0.42999999999999999 111.919 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 p -119.78 127.83 26.19 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.806 -0.634 . . . . 0.29999999999999999 110.226 173.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.573 ' HA ' HG12 ' A' ' 94' ' ' VAL . 54.0 Cg_exo -51.29 113.23 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.049 2.5 . . . . 0.34000000000000002 112.563 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 tt -110.26 144.43 18.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.44 -0.8 . . . . 0.58999999999999997 110.414 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -110.02 99.23 8.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.173 0.511 . . . . 2.3900000000000001 109.693 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.443 HD13 ' H ' ' A' ' 116' ' ' LEU . 1.1 pp -95.55 -18.3 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.625 -0.716 . . . . 2.02 112.524 -174.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.49 8.43 83.21 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.672 -0.775 . . . . 2.6099999999999999 113.44 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.443 ' H ' HD13 ' A' ' 114' ' ' ILE . 6.7 mp . . . . . 0 C--O 1.245 0.858 0 CA-C-O 118.166 -0.921 . . . . 3.6899999999999999 109.416 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.3 pttp . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.467 0.175 . . . . 30.309999999999999 111.323 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.75 -51.65 11.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.337 . . . . 28.059999999999999 110.611 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 67.0 mtt -136.63 102.4 4.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.206 -0.452 . . . . 28.52 110.068 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.17 82.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.969 0.414 . . . . 26.559999999999999 110.594 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -159.35 151.85 21.39 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.564 -0.532 . . . . 25.140000000000001 109.564 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.6 pt -102.77 11.58 7.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.329 0.585 . . . . 24.989999999999998 110.403 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.25 103.72 0.5 Allowed Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.407 -0.815 . . . . 22.920000000000002 111.616 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.1 m -81.09 63.98 5.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.496 0.665 . . . . 22.809999999999999 110.252 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 t -90.73 -21.19 21.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.285 -0.87 . . . . 22.210000000000001 111.089 -177.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.28 -47.06 2.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.412 -0.358 . . . . 20.949999999999999 111.106 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.5 m -72.46 127.06 90.6 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.912 0.387 . . . . 19.190000000000001 111.109 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.7 79.12 2.84 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.795 2.33 . . . . 17.98 111.608 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? 60.54 78.69 0.27 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.722 -0.672 . . . . 18.07 110.578 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -75.31 -21.67 58.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 14.66 110.241 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -81.1 87.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.888 0.851 . . . . 13.029999999999999 109.717 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -95.67 -55.85 2.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.435 -0.802 . . . . 12.26 110.357 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.93 -33.21 83.23 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.73 -0.747 . . . . 9.9700000000000006 112.317 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.36 -67.43 2.83 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.958 -0.639 . . . . 8.2200000000000006 111.586 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.605 HG22 ' HD2' ' A' ' 30' ' ' PRO . 17.4 m -98.94 115.84 65.58 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.701 -0.481 . . . . 7.2999999999999998 109.701 176.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -42.27 -55.01 2.74 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.434 2.756 . . . . 6.0999999999999996 113.797 -173.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' A' ' 28' ' ' THR . 92.9 Cg_endo -82.57 133.41 7.12 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.801 1.667 . . . . 5.1900000000000004 111.51 172.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 13.0 mptt -88.56 -169.45 2.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.291 -0.413 . . . . 3.79 111.023 -177.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 p 68.66 166.17 0.26 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.255 1.022 . . . . 1.74 111.161 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.0 m -84.43 130.9 34.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.056 -0.52 . . . . 1.7 111.17 -175.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.9 m -87.53 -6.44 58.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.413 0.625 . . . . 2.5699999999999998 109.647 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.5 p -81.57 -8.92 59.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.373 -0.831 . . . . 2.5 110.742 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 134.81 -143.96 15.79 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 111.13 -0.788 . . . . 1.51 111.13 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.79 155.26 23.01 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.973 2.448 . . . . 1.05 113.556 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 39' ' ' TYR . 86.7 t -88.46 164.96 2.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.397 -1.334 . . . . 0.58999999999999997 107.397 171.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.445 ' CD2' ' HB2' ' A' ' 96' ' ' CYS . 90.3 m-85 -129.09 134.41 48.07 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.518 -0.873 . . . . 0.78000000000000003 111.952 -177.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 31.9 t -105.46 103.47 13.0 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.857 -1.065 . . . . 0.81999999999999995 109.905 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.0 m -100.62 132.39 46.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.316 0.579 . . . . 0.23999999999999999 110.48 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.489 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 5.8 m-20 -57.6 -24.56 57.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.997 -1.001 . . . . 2.0800000000000001 110.508 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.86 119.33 0.35 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.266 -1.013 . . . . 2.5800000000000001 108.266 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.683 HG21 HG11 ' A' ' 94' ' ' VAL . 15.2 p -80.27 150.81 29.87 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 118.765 -1.174 . . . . 0.37 110.832 174.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.626 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.2 tp10 -119.87 138.32 53.47 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.44 -0.8 . . . . 1.1200000000000001 109.322 -176.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.551 ' HA ' HD12 ' A' ' 71' ' ' LEU . 26.5 m-20 -69.75 114.34 7.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.039 -0.528 . . . . 1.77 110.987 -173.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.733 ' HA ' HD21 ' A' ' 50' ' ' LEU . 49.5 m -61.03 -9.43 4.38 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.115 -0.493 . . . . 0.92000000000000004 111.831 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -90.19 -16.28 29.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.563 -0.29 . . . . 2.77 110.642 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -154.15 57.85 0.72 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.513 -0.312 . . . . 2.3300000000000001 111.542 -176.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.733 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -60.79 149.33 36.14 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.456 0.646 . . . . 1.1599999999999999 112.064 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.53 145.52 52.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.011 -0.995 . . . . 1.8100000000000001 108.401 172.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -20.33 66.23 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.779 -0.368 . . . . 3.23 110.742 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -73.24 -33.56 58.95 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.079 -0.808 . . . . 0.34000000000000002 111.079 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.639 ' HA ' HD22 ' A' ' 57' ' ' LEU . 43.3 m -79.97 -41.56 25.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.725 0.298 . . . . 0.35999999999999999 110.377 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.6 m -53.05 -35.2 59.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.338 0.59 . . . . 0.29999999999999999 109.777 172.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.49 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -55.59 -54.66 41.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.259 -0.882 . . . . 0.23000000000000001 111.611 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.639 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -60.22 -44.02 95.53 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.373 0.606 . . . . 0.23999999999999999 110.214 -178.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 54' ' ' THR . 53.3 mt -58.6 -45.06 89.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.988 -1.006 . . . . 0.17999999999999999 109.82 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.27 -36.59 91.26 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.833 -0.622 . . . . 0.26000000000000001 112.744 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 18.6 mt -59.71 -47.81 84.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.712 0.768 . . . . 0.34000000000000002 110.283 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.516 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.1 mt -86.12 -1.34 57.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.72 -1.127 . . . . 0.35999999999999999 111.115 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 66.17 36.54 5.51 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.256 -0.884 . . . . 1.8899999999999999 111.056 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 58' ' ' LEU . 54.8 mt -80.15 143.28 12.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.661 -0.699 . . . . 0.26000000000000001 109.474 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.634 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -94.18 117.87 30.73 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.462 0.649 . . . . 2.2200000000000002 110.002 -177.378 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.39 -34.08 56.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.957 -1.019 . . . . 0.28999999999999998 110.679 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.73 -16.88 72.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.017 -0.611 . . . . 0.56999999999999995 112.741 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.483 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 29.8 t70 -94.5 -15.76 23.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.76 0.314 . . . . 0.85999999999999999 110.659 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 94.1 mt -55.12 129.59 38.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.394 0.616 . . . . 0.46000000000000002 110.984 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 3.3 mptp? -88.07 -86.82 0.16 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.987 -1.006 . . . . 2.0099999999999998 112.262 -170.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -90.74 -94.92 0.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 1.0900000000000001 111.466 -171.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.2 mm? -113.6 167.62 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.088 -0.505 . . . . 0.14999999999999999 110.134 172.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -118.32 166.66 12.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 106.378 -1.712 . . . . 0.25 106.378 167.388 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.39 138.07 9.43 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 119.524 -1.322 . . . . 0.37 112.247 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.587 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -102.66 132.44 48.78 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.011 -0.676 . . . . 0.28999999999999998 109.64 173.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.453 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 1.5 t-20 59.0 57.96 3.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.804 -1.089 . . . . 1.8500000000000001 110.813 175.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 40' ' ' CYS . 29.4 m -94.72 139.23 31.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.531 -0.759 . . . . 1.1200000000000001 111.002 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 32.0 t -94.27 120.82 64.9 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.87 -0.604 . . . . 1.26 109.825 177.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 12.6 Cg_exo -70.86 120.4 7.04 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.816 2.344 . . . . 0.60999999999999999 112.632 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.5 mt -105.09 89.08 3.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.51 -0.768 . . . . 0.85999999999999999 109.336 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.3 t -80.8 -29.35 36.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.023 0.439 . . . . 1.3700000000000001 110.651 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 m -106.65 102.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.48 0.657 . . . . 1.6000000000000001 111.221 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.7 mm -99.23 143.24 13.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.565 -0.743 . . . . 1.8500000000000001 110.911 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.4 -66.15 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.78 -0.724 . . . . 3.1800000000000002 112.052 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 m -92.43 46.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.366 0.603 . . . . 4.6900000000000004 110.708 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.34 -125.77 7.3 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.635 -0.712 . . . . 4.3499999999999996 112.04 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.22 65.06 4.09 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.943 -0.646 . . . . 3.27 112.254 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -77.08 148.51 36.06 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.105 -0.331 . . . . 5.4699999999999998 110.105 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.2 m 60.83 29.46 19.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.328 0.585 . . . . 4.7000000000000002 110.116 -173.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 11.6 t -140.15 101.88 4.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.577 -0.738 . . . . 1.6599999999999999 110.795 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.8 m -102.64 8.58 39.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.573 0.701 . . . . 1.6499999999999999 110.01 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -116.17 -158.97 0.7 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.24 -0.891 . . . . 0.54000000000000004 110.001 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.48 122.94 28.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.097 0.475 . . . . 0.78000000000000003 110.289 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.24 122.72 35.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.321 0.581 . . . . 0.39000000000000001 111.034 -175.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.683 HG11 HG21 ' A' ' 44' ' ' THR . 9.0 m -132.02 161.85 40.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.444 -0.798 . . . . 0.22 110.968 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 37.1 t -108.19 109.63 21.07 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.92 -0.77 . . . . 0.70999999999999996 108.92 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 14.3 m -110.14 153.56 24.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.229 -0.442 . . . . 0.60999999999999999 110.416 -173.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.7 t -80.7 -26.9 37.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.938 -0.574 . . . . 0.38 110.495 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.448 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 63.4 m-20 -155.15 166.21 34.3 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.78000000000000003 109.565 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.431 ' HB ' ' CE1' ' A' ' 39' ' ' TYR . 15.3 t -129.97 143.45 50.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.075 0.464 . . . . 0.41999999999999998 110.026 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.535 ' CB ' HG23 ' A' ' 105' ' ' VAL . 42.0 m-85 -126.12 141.65 51.85 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.79 -0.641 . . . . 0.77000000000000002 110.05 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 101' ' ' GLN . 6.4 mm100 62.06 25.36 15.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.872 0.368 . . . . 0.80000000000000004 110.939 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 62.09 11.56 4.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.424 -0.807 . . . . 2.1200000000000001 112.318 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 149.33 -29.07 1.21 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.891 -1.147 . . . . 0.28000000000000003 113.73 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 15.5 mt -54.92 -35.3 64.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.391 0.596 . . . . 0.35999999999999999 111.394 -175.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.535 HG23 ' CB ' ' A' ' 100' ' ' TYR . 0.4 OUTLIER -132.69 143.89 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.809 -0.632 . . . . 0.85999999999999999 109.774 173.466 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.626 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.0 OUTLIER -139.39 157.75 45.32 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.41 -0.589 . . . . 0.91000000000000003 109.41 -174.314 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.448 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.9 m -136.61 144.61 32.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.879 0.696 . . . . 0.29999999999999999 112.879 -174.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.07 51.63 57.26 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 114.949 -1.023 . . . . 0.20000000000000001 112.05 176.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 73.0 m -97.5 131.12 44.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.611 0.243 . . . . 0.42999999999999999 111.381 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.24 130.65 24.08 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.325 -0.398 . . . . 0.29999999999999999 110.305 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.527 ' HA ' HG12 ' A' ' 94' ' ' VAL . 54.2 Cg_exo -52.6 109.5 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.79 2.327 . . . . 0.34000000000000002 111.78 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.1 tt -88.08 119.2 35.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.796 -0.638 . . . . 0.58999999999999997 111.365 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -108.89 116.65 32.4 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.286 -0.87 . . . . 2.3900000000000001 109.625 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.508 HD13 ' HG ' ' A' ' 116' ' ' LEU . 1.1 pp -64.59 -21.48 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.045 0.387 . . . . 2.02 112.045 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 66.78 16.84 66.48 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.288 -0.415 . . . . 2.6099999999999999 113.642 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.508 ' HG ' HD13 ' A' ' 114' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.88 -0.581 . . . . 3.6899999999999999 110.574 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.498 -0.556 . . . . 30.309999999999999 109.498 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -18.74 65.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.411 0.523 . . . . 28.059999999999999 112.411 -173.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.6 mtt -73.85 -12.17 60.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.849 0.357 . . . . 28.52 111.057 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.94 97.47 3.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.455 . . . . 26.559999999999999 109.863 177.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.0 t70 70.39 112.78 0.05 Allowed 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.828 0.705 . . . . 25.140000000000001 110.416 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.2 mm -66.0 102.96 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.905 -0.589 . . . . 24.989999999999998 110.394 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.76 -7.26 88.64 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.998 -0.62 . . . . 22.920000000000002 112.102 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.6 t 65.69 37.33 5.86 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.284 0.564 . . . . 22.809999999999999 110.551 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.8 p -77.04 -20.3 56.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.864 -0.607 . . . . 22.210000000000001 111.125 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 72.9 -49.49 0.7 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.724 0.81 . . . . 20.949999999999999 111.857 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.18 149.21 56.84 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.576 -0.284 . . . . 19.190000000000001 110.528 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -84.9 38.13 0.65 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.89 2.393 . . . . 17.98 111.966 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -134.62 109.53 8.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.841 -0.618 . . . . 18.07 110.047 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -96.01 86.29 4.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.085 -0.507 . . . . 14.66 110.086 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.8 m -92.42 133.22 34.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.021 -0.536 . . . . 13.029999999999999 110.196 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -154.43 112.62 3.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.349 -0.387 . . . . 12.26 110.479 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.48 135.8 44.6 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.053 -0.521 . . . . 9.9700000000000006 112.484 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.28 -62.96 4.04 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.723 -0.751 . . . . 8.2200000000000006 111.614 -176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.586 HG22 ' HD2' ' A' ' 30' ' ' PRO . 7.0 m 68.22 120.52 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 121.692 0.758 . . . . 7.2999999999999998 111.374 178.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 27.4 Cg_exo -54.72 -53.27 6.35 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.925 3.084 . . . . 6.0999999999999996 114.077 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 28' ' ' THR . 61.8 Cg_endo -72.61 88.35 0.9 Allowed 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 121.657 1.571 . . . . 5.1900000000000004 112.248 176.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -90.69 84.02 5.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.968 -0.56 . . . . 3.79 110.305 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 p -169.84 177.76 4.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.848 -0.615 . . . . 1.74 110.524 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.5 m -85.15 149.87 25.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.013 0.435 . . . . 1.7 110.928 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.1 t -67.54 -25.87 66.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.915 -0.584 . . . . 2.5699999999999998 110.458 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 m -81.19 -5.81 58.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.414 . . . . 2.5 110.783 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.24 -95.48 0.83 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.977 -0.63 . . . . 1.51 112.587 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.83 151.66 15.01 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.246 2.63 . . . . 1.05 114.063 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 39' ' ' TYR . 98.5 t -94.53 174.63 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.401 -1.272 . . . . 0.58999999999999997 107.833 174.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.545 ' N ' HG12 ' A' ' 38' ' ' VAL . 62.8 m-85 -131.05 136.1 48.16 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.424 -0.798 . . . . 0.78000000000000003 111.459 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 26.8 t -111.62 109.96 20.12 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.417 -0.81 . . . . 0.81999999999999995 109.67 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.4 m -107.98 133.73 51.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.219 -0.446 . . . . 0.23999999999999999 110.293 -176.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.43 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 53.8 m-80 -55.94 -28.4 56.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.395 -0.821 . . . . 2.0800000000000001 110.057 175.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -164.24 133.46 3.79 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.01 -0.995 . . . . 2.5800000000000001 108.87 176.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.633 HG21 HG11 ' A' ' 94' ' ' VAL . 24.2 p -93.04 142.84 26.85 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.156 -1.018 . . . . 0.37 110.902 168.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.574 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.1 tp10 -112.53 138.0 49.93 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.115 -0.948 . . . . 1.1200000000000001 109.59 -175.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.471 ' HA ' HD12 ' A' ' 71' ' ' LEU . 5.3 m-20 -74.46 107.96 6.93 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.336 -0.393 . . . . 1.77 110.666 -175.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.433 ' HA ' HD21 ' A' ' 50' ' ' LEU . 86.8 p -54.69 -23.02 15.67 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.898 -0.592 . . . . 0.92000000000000004 112.473 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -73.78 -33.31 64.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.046 -0.262 . . . . 2.77 110.951 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -134.45 58.14 1.78 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.813 0.815 . . . . 2.3300000000000001 111.409 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 47' ' ' SER . 89.4 mt -65.05 157.73 27.61 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.782 -1.099 . . . . 1.1599999999999999 111.517 177.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.66 154.68 36.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.947 -1.024 . . . . 1.8100000000000001 108.675 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -65.71 -26.58 67.82 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.587 -0.445 . . . . 3.23 109.971 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -65.07 -38.17 95.05 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.47 -0.652 . . . . 0.34000000000000002 111.47 174.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.635 ' HA ' HD22 ' A' ' 57' ' ' LEU . 27.9 m -76.72 -43.76 36.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.38 . . . . 0.35999999999999999 110.653 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.3 m -53.01 -34.43 56.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.651 -0.704 . . . . 0.29999999999999999 109.937 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.486 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.81 -54.11 50.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.839 -1.073 . . . . 0.23000000000000001 111.794 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -59.33 -44.14 92.64 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.434 0.635 . . . . 0.23999999999999999 110.136 -177.247 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 54' ' ' THR . 36.1 mt -60.14 -42.83 95.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.898 -1.046 . . . . 0.17999999999999999 110.116 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.16 -33.41 84.12 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.742 -0.663 . . . . 0.26000000000000001 112.508 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.9 mt -64.12 -29.51 70.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.748 0.785 . . . . 0.34000000000000002 110.497 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.438 ' CD1' HG21 ' A' ' 105' ' ' VAL . 6.0 mt -102.98 -0.78 30.4 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.68 -1.146 . . . . 0.35999999999999999 110.668 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 68.26 31.64 5.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.993 -1.003 . . . . 1.8899999999999999 111.071 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 58' ' ' LEU . 54.8 mt -80.08 148.68 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.811 -0.632 . . . . 0.26000000000000001 110.551 177.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.615 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -97.21 118.64 34.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.293 0.568 . . . . 2.2200000000000002 110.177 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -73.51 -38.57 52.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 0.28999999999999998 111.2 -174.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.85 -22.5 70.29 Favored Glycine 0 CA--C 1.516 0.151 0 C-N-CA 120.989 -0.624 . . . . 0.56999999999999995 112.683 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.29 -4.94 55.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.189 0.519 . . . . 0.85999999999999999 110.709 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.13 138.59 55.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.293 0.568 . . . . 0.46000000000000002 110.733 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -89.52 -86.07 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.044 -0.98 . . . . 2.0099999999999998 112.289 -171.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.63 -102.35 0.15 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.293 0.479 . . . . 1.0900000000000001 112.293 -173.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.9 mm? -105.82 170.1 8.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.577 0.703 . . . . 0.14999999999999999 111.15 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -122.89 170.53 13.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 106.724 -1.584 . . . . 0.25 106.724 167.746 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.495 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -136.78 142.75 13.93 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 119.838 -1.172 . . . . 0.37 111.567 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -106.42 129.28 54.43 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.14 -0.624 . . . . 0.28999999999999998 110.02 174.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.22 55.39 6.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.0 -1.0 . . . . 1.8500000000000001 111.198 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 58.7 m -88.62 144.0 26.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.628 -0.715 . . . . 1.1200000000000001 111.071 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m -100.52 118.82 60.27 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.733 -0.667 . . . . 1.26 109.969 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.24 124.64 12.38 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.547 2.165 . . . . 0.60999999999999999 111.85 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.2 mt -99.42 88.29 3.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.938 -0.573 . . . . 0.85999999999999999 109.865 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.1 m -75.17 -40.04 59.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.876 -0.602 . . . . 1.3700000000000001 110.225 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.6 m -93.98 117.0 36.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.364 -0.835 . . . . 1.6000000000000001 110.676 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 42.4 mm -92.9 142.73 12.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.928 -0.578 . . . . 1.8500000000000001 110.938 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.48 112.0 0.27 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.439 -0.664 . . . . 3.1800000000000002 111.439 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t 56.54 49.69 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.797 0.808 . . . . 4.6900000000000004 109.317 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.19 -61.71 4.43 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.356 -0.838 . . . . 4.3499999999999996 111.793 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.19 101.72 0.16 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.001 -0.619 . . . . 3.27 112.063 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -64.15 -27.68 69.24 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.968 0.413 . . . . 5.4699999999999998 110.803 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.6 p -81.25 6.12 15.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.911 -0.586 . . . . 4.7000000000000002 111.264 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 41.2 t -112.44 129.7 56.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.389 -0.369 . . . . 1.6599999999999999 110.427 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.8 t -134.54 28.29 3.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.032 -0.729 . . . . 1.6499999999999999 109.032 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -149.25 -157.71 0.84 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.941 -1.027 . . . . 0.54000000000000004 109.73 -177.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.15 126.06 30.34 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.028 0.442 . . . . 0.78000000000000003 110.359 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.19 123.1 44.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.265 0.555 . . . . 0.39000000000000001 111.299 -171.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.633 HG11 HG21 ' A' ' 44' ' ' THR . 1.5 m -136.44 173.32 13.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.653 -0.703 . . . . 0.22 111.426 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 53.8 t -124.37 118.47 26.79 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.566 -0.743 . . . . 0.70999999999999996 109.964 177.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 1.2 m -103.41 168.49 9.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.598 . . . . 0.60999999999999999 111.921 -175.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 107' ' ' VAL . 9.0 t -87.04 -29.83 21.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.378 -0.828 . . . . 0.38 109.738 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.441 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.2 m120 -151.84 162.76 40.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.68 -0.691 . . . . 0.78000000000000003 109.913 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 t -127.64 129.02 46.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.329 0.585 . . . . 0.41999999999999998 109.87 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.506 ' CB ' HG23 ' A' ' 105' ' ' VAL . 30.0 m-85 -120.51 144.87 47.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.681 -0.69 . . . . 0.77000000000000002 111.414 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.528 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 9.9 mm-40 60.84 34.49 19.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.802 -0.635 . . . . 0.80000000000000004 111.159 176.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 65.4 -0.86 1.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.756 -0.656 . . . . 2.1200000000000001 112.415 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.46 -20.25 2.05 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.512 -0.851 . . . . 0.28000000000000003 112.454 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.549 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 28.5 mt -49.77 -40.89 42.84 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.725 0.298 . . . . 0.35999999999999999 111.085 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.506 HG23 ' CB ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -130.15 119.3 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.547 0.689 . . . . 0.85999999999999999 110.489 174.077 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.485 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 2.8 t30 -111.21 144.18 40.78 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.348 -0.982 . . . . 0.91000000000000003 108.348 177.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 97' ' ' THR . 5.9 m -127.13 137.75 56.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 113.113 0.782 . . . . 0.29999999999999999 113.113 -174.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 70.9 51.44 19.16 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.999 -1.001 . . . . 0.20000000000000001 111.975 176.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 1.5 m -97.06 131.83 43.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.346 0.593 . . . . 0.42999999999999999 111.502 -177.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.8 p -116.65 141.42 28.08 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.058 -0.974 . . . . 0.29999999999999999 109.594 174.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HA ' HG12 ' A' ' 94' ' ' VAL . 24.5 Cg_exo -67.42 108.38 1.58 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.717 2.278 . . . . 0.34000000000000002 111.803 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.4 tt -85.1 100.34 8.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 0.58999999999999997 110.466 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -95.65 99.87 11.67 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.553 -0.749 . . . . 2.3900000000000001 110.494 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -76.29 -10.75 13.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.61 -0.723 . . . . 2.02 111.81 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.69 17.0 80.0 Favored Glycine 0 C--O 1.228 -0.248 0 C-N-CA 121.217 -0.516 . . . . 2.6099999999999999 112.141 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.457 ' H ' HD13 ' A' ' 114' ' ' ILE . 7.3 tp . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.827 -0.606 . . . . 3.6899999999999999 109.742 -176.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.4 tptp . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.78 0.324 . . . . 30.309999999999999 110.327 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.5 81.05 6.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.907 0.384 . . . . 28.059999999999999 110.397 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.38 125.78 27.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.025 -0.534 . . . . 28.52 110.235 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.21 136.2 41.59 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.786 -0.643 . . . . 26.559999999999999 109.983 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -85.55 66.0 9.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.181 0.515 . . . . 25.140000000000001 110.563 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.0 mt -95.23 103.89 15.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.73 -0.668 . . . . 24.989999999999998 109.472 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.63 23.21 4.26 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.463 -0.875 . . . . 22.920000000000002 112.497 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.1 m -57.05 132.36 52.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.762 0.315 . . . . 22.809999999999999 111.037 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.6 m -78.86 84.06 4.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.191 0.519 . . . . 22.210000000000001 109.91 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.81 62.29 7.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.821 -0.627 . . . . 20.949999999999999 111.193 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.56 126.96 3.67 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.877 -0.601 . . . . 19.190000000000001 110.432 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.91 55.48 4.44 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.816 2.344 . . . . 17.98 112.072 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -80.54 -18.14 49.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.744 -0.662 . . . . 18.07 110.395 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -127.06 86.58 2.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.603 -0.726 . . . . 14.66 109.185 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.85 138.56 31.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.992 -0.549 . . . . 13.029999999999999 110.586 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -121.69 75.09 1.17 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.074 -0.512 . . . . 12.26 110.032 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.13 -59.02 4.93 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.737 -0.744 . . . . 9.9700000000000006 111.661 -177.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.3 151.99 17.93 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.594 -0.602 . . . . 8.2200000000000006 111.594 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.54 HG22 ' HD2' ' A' ' 30' ' ' PRO . 2.5 m -66.42 131.38 94.22 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 119.668 -0.206 . . . . 7.2999999999999998 110.57 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.418 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 82.2 Cg_exo -42.19 -51.89 4.53 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.318 2.679 . . . . 6.0999999999999996 114.475 -176.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.54 ' HD2' HG22 ' A' ' 28' ' ' THR . 6.2 Cg_endo -88.33 16.3 1.9 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.726 2.284 . . . . 5.1900000000000004 111.545 -176.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp 71.33 -59.92 0.53 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.185 -0.916 . . . . 3.79 110.363 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.8 p -77.46 165.28 24.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.196 -0.456 . . . . 1.74 110.394 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 17.1 m -79.19 156.8 28.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.029 -0.532 . . . . 1.7 110.951 -174.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -89.8 -11.72 41.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.299 0.571 . . . . 2.5699999999999998 110.465 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.1 p -104.45 5.0 33.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.797 -0.638 . . . . 2.5 110.79 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . 159.61 175.29 30.41 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.173 -0.771 . . . . 1.51 111.173 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' CB ' ' HA ' ' A' ' 80' ' ' SER . 13.4 Cg_exo -72.35 -165.12 0.2 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.381 2.054 . . . . 1.05 112.296 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 39' ' ' TYR . 92.1 t -86.77 161.45 2.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.306 -0.257 . . . . 0.58999999999999997 110.306 -174.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.424 ' N ' HG12 ' A' ' 38' ' ' VAL . 29.3 m-85 -127.96 135.69 50.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.135 0.493 . . . . 0.78000000000000003 110.701 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.446 ' HB2' HD11 ' A' ' 79' ' ' LEU . 17.7 t -103.43 107.53 18.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.942 -0.572 . . . . 0.81999999999999995 109.721 177.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -102.46 130.79 49.37 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.804 -0.443 . . . . 0.23999999999999999 109.804 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.512 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 18.3 m120 -57.54 -29.72 64.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.583 -0.735 . . . . 2.0800000000000001 109.749 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 8.3 mmmm -162.86 132.23 4.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.443 -1.253 . . . . 2.5800000000000001 108.013 175.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.5 HG21 HG11 ' A' ' 94' ' ' VAL . 28.1 p -88.86 167.21 13.43 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.36 -0.936 . . . . 0.37 110.101 169.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.481 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.6 tp10 -126.49 139.07 53.51 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.504 -0.771 . . . . 1.1200000000000001 109.424 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.415 ' HA ' HD12 ' A' ' 71' ' ' LEU . 11.1 m-20 -71.26 111.66 6.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.057 -0.52 . . . . 1.77 110.519 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.591 ' HA ' HD21 ' A' ' 50' ' ' LEU . 6.1 m -60.15 -10.45 4.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.803 -0.635 . . . . 0.92000000000000004 112.603 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -90.02 -17.56 27.61 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.669 -0.412 . . . . 2.77 110.338 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -149.53 57.92 1.0 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.328 -0.397 . . . . 2.3300000000000001 111.136 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.0 mm? -60.26 150.7 29.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.267 0.556 . . . . 1.1599999999999999 111.679 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.91 146.35 54.82 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.079 -1.082 . . . . 1.8100000000000001 108.079 170.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -60.4 -28.13 68.0 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.499 -0.481 . . . . 3.23 110.463 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -66.7 -35.95 90.56 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.866 -0.683 . . . . 0.34000000000000002 111.417 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.658 ' HA ' HD22 ' A' ' 57' ' ' LEU . 22.7 m -79.06 -42.94 25.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.35999999999999999 110.411 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.2 m -53.94 -33.69 57.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.325 0.583 . . . . 0.29999999999999999 110.126 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.31 -53.81 53.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.167 -0.924 . . . . 0.23000000000000001 111.285 175.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.658 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -60.69 -44.25 96.76 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.441 0.639 . . . . 0.23999999999999999 110.013 -179.129 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 54' ' ' THR . 53.0 mt -59.35 -43.22 92.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.001 -0.999 . . . . 0.17999999999999999 110.145 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.62 -36.97 92.67 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.906 -0.664 . . . . 0.26000000000000001 112.439 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.2 mt -60.24 -46.78 88.62 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.878 0.847 . . . . 0.34000000000000002 109.903 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 mt -85.71 2.75 44.13 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.364 -1.289 . . . . 0.35999999999999999 111.405 -175.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 65.5 35.35 7.32 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.486 -0.779 . . . . 1.8899999999999999 111.534 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 58' ' ' LEU . 48.2 mt -88.0 147.25 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.551 -0.75 . . . . 0.26000000000000001 110.043 177.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.536 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -100.41 117.67 35.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.319 0.581 . . . . 2.2200000000000002 110.369 -178.427 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.73 -41.99 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.313 -0.858 . . . . 0.28999999999999998 111.449 -174.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.58 -7.15 68.19 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.857 -0.687 . . . . 0.56999999999999995 112.991 -176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.49 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 21.0 t70 -103.81 -16.76 15.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.85999999999999999 110.712 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 95.4 mt -55.5 147.81 16.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.881 -0.6 . . . . 0.46000000000000002 111.626 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -95.32 -85.89 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.159 -0.928 . . . . 2.0099999999999998 112.026 -172.231 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.27 -101.56 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.873 0.324 . . . . 1.0900000000000001 111.873 -174.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.5 mm? -110.52 169.3 8.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.403 0.621 . . . . 0.14999999999999999 111.216 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.49 HG13 HD11 ' A' ' 50' ' ' LEU . 1.5 m -121.07 163.72 18.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 106.058 -1.83 . . . . 0.25 106.058 166.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.57 142.18 13.65 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 119.818 -1.182 . . . . 0.37 111.38 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.618 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -115.4 135.17 54.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.049 -0.661 . . . . 0.28999999999999998 110.4 178.735 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.521 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 1.4 t-20 54.79 47.54 22.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.522 -1.217 . . . . 1.8500000000000001 110.904 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 24.5 m -85.41 150.06 24.99 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.177 -0.92 . . . . 1.1200000000000001 110.554 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.0 m -100.42 117.18 63.44 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.623 -0.717 . . . . 1.26 109.75 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -64.78 130.68 26.85 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.646 2.23 . . . . 0.60999999999999999 112.293 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 40' ' ' CYS . 33.8 mt -106.86 87.82 2.6 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.509 -0.769 . . . . 0.85999999999999999 109.371 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 11.9 p -79.8 -24.1 41.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.02 -0.536 . . . . 1.3700000000000001 111.45 -173.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.483 HG23 ' HA3' ' A' ' 85' ' ' GLY . 11.3 m -114.89 106.92 21.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.598 0.713 . . . . 1.6000000000000001 111.3 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.73 141.7 14.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.595 -0.73 . . . . 1.8500000000000001 110.545 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.26 -119.38 5.51 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.773 -0.727 . . . . 3.1800000000000002 111.698 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.0 m -59.57 -38.3 74.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.831 0.348 . . . . 4.6900000000000004 111.399 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.483 ' HA3' HG23 ' A' ' 81' ' ' VAL . . . -80.43 -9.35 86.6 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.767 -0.73 . . . . 4.3499999999999996 112.451 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.27 -15.05 81.91 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.886 -0.674 . . . . 3.27 112.115 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -70.48 -8.76 53.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.939 0.4 . . . . 5.4699999999999998 110.929 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.7 p -68.49 -22.84 64.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 4.7000000000000002 110.553 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 29.1 t -77.1 122.79 25.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 1.6599999999999999 110.082 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.3 t -127.06 24.52 6.37 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.001 -0.74 . . . . 1.6499999999999999 109.001 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -132.85 -158.3 0.88 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.339 -0.846 . . . . 0.54000000000000004 110.408 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.98 112.88 18.79 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.772 0.796 . . . . 0.78000000000000003 110.03 -177.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.86 121.11 32.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.215 -0.902 . . . . 0.39000000000000001 110.447 -174.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 111' ' ' PRO . 13.6 m -133.15 162.81 39.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.458 0.646 . . . . 0.22 112.129 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 37.6 t -112.24 114.02 26.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.92 -1.036 . . . . 0.70999999999999996 109.156 175.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.3 m -108.48 146.67 32.81 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.442 -0.344 . . . . 0.60999999999999999 110.318 -174.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.9 t -76.45 -26.77 55.77 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.279 -0.419 . . . . 0.38 110.668 -173.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.609 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.2 m120 -147.03 155.05 41.92 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.131 -0.692 . . . . 0.78000000000000003 109.131 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.2 t -132.58 132.82 42.94 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.122 0.487 . . . . 0.41999999999999998 110.42 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -130.7 156.72 44.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.832 -0.622 . . . . 0.77000000000000002 110.48 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.65 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 20.1 mm-40 60.34 28.96 18.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.79 -0.641 . . . . 0.80000000000000004 111.992 174.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 66.37 -1.02 1.33 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.217 0.607 . . . . 2.1200000000000001 112.535 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 142.64 -14.97 2.45 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.441 -0.885 . . . . 0.28000000000000003 112.161 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 40.8 mt -54.19 -36.89 63.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.994 0.426 . . . . 0.35999999999999999 110.562 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 t -139.3 121.54 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.359 -0.837 . . . . 0.85999999999999999 110.549 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.448 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 95.0 m-20 -124.08 160.4 27.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.641 -0.708 . . . . 0.91000000000000003 109.227 174.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.609 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 5.5 m -134.97 151.51 31.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 111.833 0.309 . . . . 0.29999999999999999 111.833 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.48 54.66 35.31 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.597 -0.729 . . . . 0.20000000000000001 111.439 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 76.4 m -97.2 125.88 42.02 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.72 0.295 . . . . 0.42999999999999999 111.29 -175.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 p -118.28 125.65 27.74 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.169 -0.469 . . . . 0.29999999999999999 110.395 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' A' ' 94' ' ' VAL . 68.3 Cg_exo -51.59 109.96 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.255 2.637 . . . . 0.34000000000000002 112.953 178.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 tt -103.25 139.84 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.632 -0.713 . . . . 0.58999999999999997 110.271 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -103.2 110.6 22.62 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.923 -0.399 . . . . 2.3900000000000001 109.923 175.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.2 pp -77.12 -13.16 14.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.984 -0.553 . . . . 2.02 112.385 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.65 19.72 79.29 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.894 -0.669 . . . . 2.6099999999999999 113.165 175.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 21.8 mt . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.894 -0.574 . . . . 3.6899999999999999 109.709 176.546 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.2 mttp . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.643 0.259 . . . . 30.309999999999999 110.324 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.2 34.47 5.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.072 0.463 . . . . 28.059999999999999 110.305 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.2 ttt -75.35 -47.28 28.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.005 -0.543 . . . . 28.52 110.103 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.43 21.04 0.99 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.077 -0.51 . . . . 26.559999999999999 110.899 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.06 -34.8 78.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.762 -0.654 . . . . 25.140000000000001 111.328 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 15' ' ' ILE . 3.0 mp -70.53 -29.32 38.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.778 -0.646 . . . . 24.989999999999998 110.603 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.91 -66.87 0.66 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.958 -0.857 . . . . 22.920000000000002 110.958 -175.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -92.88 46.01 1.21 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.046 -0.353 . . . . 22.809999999999999 110.046 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.5 m -64.54 111.85 2.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 22.210000000000001 110.824 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -158.35 163.66 37.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.807 -0.633 . . . . 20.949999999999999 109.647 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.0 m -119.73 76.98 20.91 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 121.095 0.474 . . . . 19.190000000000001 110.979 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.69 107.23 2.42 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.702 2.268 . . . . 17.98 111.758 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -83.12 69.59 9.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.394 0.616 . . . . 18.07 109.537 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -154.37 137.78 15.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.472 -0.786 . . . . 14.66 109.796 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.78 126.38 59.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.44 -0.345 . . . . 13.029999999999999 110.251 -178.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -82.31 -31.52 29.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.219 -0.446 . . . . 12.26 110.069 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 160.36 -138.08 5.35 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.697 -0.763 . . . . 9.9700000000000006 112.526 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.3 42.89 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.459 -0.657 . . . . 8.2200000000000006 111.459 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.586 ' C ' ' HD3' ' A' ' 30' ' ' PRO . 86.6 m -157.18 140.72 11.31 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 110.041 -0.355 . . . . 7.2999999999999998 110.041 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 28' ' ' THR . 43.4 Cg_endo -102.5 73.3 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.845 3.03 . . . . 6.0999999999999996 113.71 171.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HD3' ' C ' ' A' ' 28' ' ' THR . 17.3 Cg_exo -67.38 -18.31 49.71 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.228 1.952 . . . . 5.1900000000000004 112.148 175.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -138.65 130.95 28.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.927 -0.578 . . . . 3.79 110.533 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 p -165.51 178.0 7.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.224 -0.444 . . . . 1.74 110.163 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 59.1 m -106.04 119.62 39.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.087 0.47 . . . . 1.7 111.42 -174.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 t -71.98 -26.15 62.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.245 0.545 . . . . 2.5699999999999998 109.962 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.9 p -72.56 -13.9 61.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.549 -0.75 . . . . 2.5 111.691 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . 165.81 158.32 10.72 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.685 -0.769 . . . . 1.51 112.478 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 80' ' ' SER . 1.1 Cg_endo -47.41 153.77 1.82 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.836 3.024 . . . . 1.05 113.235 175.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.9 t -85.5 157.19 3.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.256 -1.016 . . . . 0.58999999999999997 108.256 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.91 131.21 47.55 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.384 0.611 . . . . 0.78000000000000003 110.823 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.422 ' HB2' HD11 ' A' ' 79' ' ' LEU . 14.4 t -99.43 107.17 19.32 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.382 -0.826 . . . . 0.81999999999999995 109.692 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.4 m -104.34 129.64 52.22 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.012 -0.54 . . . . 0.23999999999999999 109.819 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.497 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 18.4 m120 -55.46 -25.59 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.473 -0.785 . . . . 2.0800000000000001 110.42 176.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 1.8 mmmm -168.85 124.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.243 -1.344 . . . . 2.5800000000000001 108.223 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.594 HG21 HG11 ' A' ' 94' ' ' VAL . 16.8 p -79.61 157.51 27.29 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.493 -0.883 . . . . 0.37 110.713 171.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.57 ' HB3' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.34 146.21 42.62 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.268 -0.878 . . . . 1.1200000000000001 108.957 -176.493 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.06 108.74 14.99 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.227 -0.442 . . . . 1.77 111.115 -173.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.753 ' HA ' HD21 ' A' ' 50' ' ' LEU . 27.5 m -57.68 -12.3 2.81 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.084 0.772 . . . . 0.92000000000000004 113.084 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -90.32 -25.56 20.43 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.882 -0.327 . . . . 2.77 110.644 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -145.92 60.54 1.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.503 -0.317 . . . . 2.3300000000000001 111.299 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.753 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.9 mm? -60.7 147.26 42.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.763 0.792 . . . . 1.1599999999999999 111.784 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -68.02 153.11 44.42 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.235 -1.348 . . . . 1.8100000000000001 109.814 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.576 ' HD3' ' N ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -62.86 -26.6 68.85 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.056 -0.258 . . . . 3.23 111.18 178.538 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.576 ' N ' ' HD3' ' A' ' 52' ' ' LYS . . . -69.51 -37.41 78.41 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.489 -0.863 . . . . 0.34000000000000002 111.332 177.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.624 ' HA ' HD22 ' A' ' 57' ' ' LEU . 26.1 m -80.98 -43.3 19.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.919 -0.4 . . . . 0.35999999999999999 109.919 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.418 ' HA ' HD12 ' A' ' 58' ' ' LEU . 96.9 m -52.88 -34.8 56.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.539 -0.755 . . . . 0.29999999999999999 110.233 173.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.548 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.34 -51.99 66.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.435 -0.802 . . . . 0.23000000000000001 111.34 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -61.55 -44.77 96.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.407 0.623 . . . . 0.23999999999999999 109.893 -179.62 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 54' ' ' THR . 58.5 mt -58.0 -45.12 87.36 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.867 -1.061 . . . . 0.17999999999999999 110.162 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.06 -37.06 92.2 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.793 -0.64 . . . . 0.26000000000000001 112.471 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.6 mt -60.19 -47.38 86.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.502 0.668 . . . . 0.34000000000000002 110.303 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.467 HD21 ' HG2' ' A' ' 101' ' ' GLN . 2.9 mt -84.56 -2.33 57.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.857 -1.065 . . . . 0.35999999999999999 111.343 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 69.76 37.75 1.79 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.939 0.876 . . . . 1.8899999999999999 110.664 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 58' ' ' LEU . 56.1 mt -85.25 145.82 7.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.713 -0.676 . . . . 0.26000000000000001 110.173 175.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.669 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -96.34 117.89 31.76 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.68 -0.691 . . . . 2.2200000000000002 109.937 -178.369 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.439 HG23 HD23 ' A' ' 50' ' ' LEU . 1.8 mp -73.34 -40.18 56.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.509 -0.769 . . . . 0.28999999999999998 111.049 -174.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.83 -9.87 63.42 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.976 -0.63 . . . . 0.56999999999999995 113.055 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -109.15 4.61 23.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 0.85999999999999999 110.903 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 98.3 mt -74.53 142.89 44.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.336 -0.393 . . . . 0.46000000000000002 110.437 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -96.42 -94.64 0.2 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.683 0.623 . . . . 2.0099999999999998 112.683 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.75 -99.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.17 0.433 . . . . 1.0900000000000001 112.17 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.26 164.26 14.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.468 0.652 . . . . 0.14999999999999999 110.928 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -115.4 172.16 4.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 106.162 -1.792 . . . . 0.25 106.162 168.512 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.463 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -140.82 138.8 9.16 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.933 -1.127 . . . . 0.37 111.113 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -111.41 132.22 54.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.532 -0.867 . . . . 0.28999999999999998 110.499 176.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.515 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 2.1 t-20 58.23 46.57 15.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.49 -1.232 . . . . 1.8500000000000001 110.747 175.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 35.4 m -83.72 142.11 30.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.524 -0.762 . . . . 1.1200000000000001 111.096 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -88.27 116.38 66.06 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.568 -0.742 . . . . 1.26 109.375 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.15 122.2 9.25 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.792 2.328 . . . . 0.60999999999999999 112.876 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 40' ' ' CYS . 11.9 mt -107.59 88.52 2.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.434 -0.803 . . . . 0.85999999999999999 109.21 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.524 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 58.0 p -98.37 -50.54 4.28 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.606 -0.27 . . . . 1.3700000000000001 110.745 -177.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 m -95.27 101.39 12.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.523 0.678 . . . . 1.6000000000000001 110.515 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.408 ' CG2' ' HB3' ' A' ' 29' ' ' PRO . 13.2 mt -116.76 139.81 41.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.859 -0.609 . . . . 1.8500000000000001 111.047 -176.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -164.49 -115.71 0.34 Allowed Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 111.179 -0.768 . . . . 3.1800000000000002 111.179 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.5 t -72.89 -30.92 34.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.358 0.599 . . . . 4.6900000000000004 109.416 175.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -106.72 -93.94 2.33 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.279 -0.873 . . . . 4.3499999999999996 111.309 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.82 56.49 2.6 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.757 -0.735 . . . . 3.27 112.156 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.8 m120 64.67 -170.63 0.19 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.898 0.38 . . . . 5.4699999999999998 110.595 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.0 m -121.52 74.51 1.12 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.4 -0.363 . . . . 4.7000000000000002 110.363 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.518 ' SG ' HG23 ' A' ' 93' ' ' THR . 22.2 t -77.91 93.54 4.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.229 0.538 . . . . 1.6599999999999999 110.445 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 m -103.57 23.99 11.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.897 -0.592 . . . . 1.6499999999999999 109.897 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.497 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -134.97 -159.12 0.93 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.668 -0.696 . . . . 0.54000000000000004 110.802 -177.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.79 120.22 23.76 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.289 0.566 . . . . 0.78000000000000003 110.428 -176.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.518 HG23 ' SG ' ' A' ' 89' ' ' CYS . 0.2 OUTLIER -94.37 117.21 29.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.9 -0.591 . . . . 0.39000000000000001 110.892 -175.043 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.594 HG11 HG21 ' A' ' 44' ' ' THR . 2.9 m -129.29 164.35 32.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.736 -0.666 . . . . 0.22 111.583 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 49.3 t -118.32 110.95 18.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.376 -0.829 . . . . 0.70999999999999996 109.461 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 106' ' ' ASN . 1.3 m -92.34 166.16 12.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.309 0.576 . . . . 0.60999999999999999 111.483 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.9 t -90.95 -24.23 20.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.346 -0.843 . . . . 0.38 109.406 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.414 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 14.3 m120 -156.68 166.86 32.18 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.346 -0.843 . . . . 0.78000000000000003 109.183 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.6 t -138.99 143.19 38.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.991 0.424 . . . . 0.41999999999999998 110.403 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.453 ' HB2' HG23 ' A' ' 105' ' ' VAL . 83.8 m-85 -126.78 149.48 49.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.048 -0.524 . . . . 0.77000000000000002 109.609 176.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.467 ' HG2' HD21 ' A' ' 61' ' ' LEU . 57.8 mm-40 64.67 24.62 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.80000000000000004 111.361 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 64.4 6.04 2.89 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.602 -0.726 . . . . 2.1200000000000001 112.357 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.15 -20.14 1.39 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.905 -1.14 . . . . 0.28000000000000003 113.552 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.1 mt -56.45 -37.3 70.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.619 0.71 . . . . 0.35999999999999999 111.419 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.453 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -142.79 118.87 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.58 0.705 . . . . 0.85999999999999999 110.938 175.489 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.728 ' HB3' ' SG ' ' A' ' 96' ' ' CYS . 7.4 m-20 -115.37 162.33 17.28 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.234 -0.894 . . . . 0.91000000000000003 109.528 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.0 m -133.64 142.46 41.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.549 0.574 . . . . 0.29999999999999999 112.549 -175.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 66.78 53.09 29.35 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.094 -0.957 . . . . 0.20000000000000001 112.254 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 1.3 m -96.65 129.83 43.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.394 0.616 . . . . 0.42999999999999999 111.568 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.0 p -118.45 124.99 28.12 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.774 -1.103 . . . . 0.29999999999999999 109.743 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HA ' HG12 ' A' ' 94' ' ' VAL . 84.9 Cg_exo -47.91 112.28 0.55 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.405 2.737 . . . . 0.34000000000000002 113.012 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.2 tt -115.69 134.69 58.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.54 -0.755 . . . . 0.58999999999999997 110.519 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -97.35 99.62 11.06 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.171 -0.677 . . . . 2.3900000000000001 109.171 171.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.471 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 2.7 pp -72.46 -3.02 3.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.479 0.657 . . . . 2.02 110.903 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 143.12 -25.75 2.2 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 109.067 -1.613 . . . . 2.6099999999999999 109.067 -173.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 C--O 1.248 0.976 0 CA-C-N 114.771 -0.715 . . . . 3.6899999999999999 109.595 176.189 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.7 0.286 . . . . 30.309999999999999 110.272 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 57.83 40.98 25.56 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.758 -0.656 . . . . 28.059999999999999 111.878 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 93.8 mmm 61.29 61.62 1.51 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.914 -0.585 . . . . 28.52 110.93 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.94 -29.17 58.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.888 -0.596 . . . . 26.559999999999999 110.414 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.52 147.68 39.05 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.356 -0.609 . . . . 25.140000000000001 109.356 175.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 15' ' ' ILE . 4.1 mp -119.15 63.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.758 0.79 . . . . 24.989999999999998 109.42 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.63 37.79 2.17 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.503 -0.771 . . . . 22.920000000000002 112.745 175.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -96.37 103.56 15.47 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.886 0.375 . . . . 22.809999999999999 110.619 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.5 p -74.67 118.66 17.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.063 -0.517 . . . . 22.210000000000001 110.772 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 71.43 -67.39 0.26 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.587 -0.733 . . . . 20.949999999999999 111.548 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.0 m -130.44 140.63 39.23 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 120.804 0.335 . . . . 19.190000000000001 110.978 -177.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.28 48.39 2.67 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.911 2.408 . . . . 17.98 112.312 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.528 ' HA ' ' OD1' ' A' ' 113' ' ' ASN . 43.4 ttp180 -89.19 96.48 10.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.3 -0.409 . . . . 18.07 110.864 -177.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 59.88 30.2 19.74 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.632 -0.713 . . . . 14.66 112.263 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.1 t -71.17 -41.25 75.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.014 -0.736 . . . . 13.029999999999999 109.014 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -124.43 11.04 8.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.159 -0.928 . . . . 12.26 109.65 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.01 -106.23 0.4 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.465 -0.789 . . . . 9.9700000000000006 112.138 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.5 116.38 2.7 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.769 -0.729 . . . . 8.2200000000000006 112.274 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.695 HG22 ' HD2' ' A' ' 30' ' ' PRO . 2.2 m 70.25 120.44 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 123.352 0.661 . . . . 7.2999999999999998 111.136 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 88.5 Cg_exo -43.42 -45.03 10.45 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.906 3.737 . . . . 6.0999999999999996 116.225 -174.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.695 ' HD2' HG22 ' A' ' 28' ' ' THR . 13.9 Cg_exo -67.63 102.06 0.7 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.696 1.598 . . . . 5.1900000000000004 111.683 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 32.7 mmtp -102.14 4.15 39.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.997 -0.547 . . . . 3.79 110.416 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.1 t -71.48 170.35 13.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.964 -0.562 . . . . 1.74 110.796 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 59.4 m -106.1 150.1 26.11 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.558 -0.746 . . . . 1.7 109.987 -177.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.1 p -85.36 -12.03 53.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.047 0.451 . . . . 2.5699999999999998 110.578 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 t -95.29 21.06 8.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.494 0.664 . . . . 2.5 109.981 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . 135.42 150.1 5.94 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.229 -0.749 . . . . 1.51 111.229 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.603 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 74.0 Cg_endo -71.01 -159.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.519 2.146 . . . . 1.05 112.98 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 39' ' ' TYR . 38.8 t -80.29 162.56 3.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.009 -0.541 . . . . 0.58999999999999997 110.236 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.604 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 94.9 m-85 -137.35 135.89 37.44 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.933 0.396 . . . . 0.78000000000000003 110.259 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.802 ' SG ' ' HB2' ' A' ' 77' ' ' SER . 22.1 p -104.04 102.55 12.31 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.869 0.842 . . . . 0.81999999999999995 110.411 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.8 m -100.21 128.98 46.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.104 -0.953 . . . . 0.23999999999999999 109.037 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 49.3 m-80 -57.6 -23.44 50.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.566 0.698 . . . . 2.0800000000000001 110.47 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -161.61 128.96 4.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.31 -1.314 . . . . 2.5800000000000001 107.902 176.339 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.558 HG21 HG11 ' A' ' 94' ' ' VAL . 23.0 p -87.46 155.24 20.1 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.151 -1.02 . . . . 0.37 109.769 167.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.2 tp10 -120.09 133.84 55.41 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.503 -0.771 . . . . 1.1200000000000001 109.545 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 49' ' ' HIS . 15.4 m-20 -69.83 112.62 6.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.507 -0.769 . . . . 1.77 109.788 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.5 p -52.67 -27.9 19.31 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.781 0.676 . . . . 0.92000000000000004 112.183 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -89.45 -10.59 45.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.69 0.281 . . . . 2.77 111.519 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 46' ' ' ASP . 58.9 m-70 -127.79 34.29 4.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.739 0.304 . . . . 2.3300000000000001 111.088 -177.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.453 HD23 ' HG3' ' A' ' 45' ' ' GLU . 96.0 mt -67.46 145.48 54.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.153 0.501 . . . . 1.1599999999999999 111.668 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -86.79 169.55 12.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.382 -0.826 . . . . 1.8100000000000001 109.71 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.71 -41.94 99.4 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.9 -0.32 . . . . 3.23 110.72 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.85 -42.28 85.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.308 -0.472 . . . . 0.34000000000000002 112.969 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.67 ' HA ' HD22 ' A' ' 57' ' ' LEU . 86.9 m -82.6 -42.05 18.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.733 0.267 . . . . 0.35999999999999999 111.121 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.3 m -54.5 -33.39 59.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.211 0.529 . . . . 0.29999999999999999 110.074 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.585 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.57 -54.94 41.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.13 -0.941 . . . . 0.23000000000000001 111.703 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.67 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -56.39 -47.16 79.52 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.494 0.664 . . . . 0.23999999999999999 110.057 -178.164 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 54' ' ' THR . 34.2 mt -57.95 -43.69 86.54 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.738 -1.119 . . . . 0.17999999999999999 110.169 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.19 -36.62 93.25 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.835 -0.698 . . . . 0.26000000000000001 112.395 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 19.8 mt -62.68 -44.71 95.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.875 0.845 . . . . 0.34000000000000002 109.939 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.509 ' CD1' HG21 ' A' ' 105' ' ' VAL . 6.1 mt -87.16 1.48 52.92 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.459 -1.246 . . . . 0.35999999999999999 111.411 -175.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 69.24 27.5 5.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.702 -0.681 . . . . 1.8899999999999999 111.628 174.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 58' ' ' LEU . 56.8 mt -78.69 142.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.953 -0.567 . . . . 0.26000000000000001 110.291 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.479 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -90.07 117.84 29.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.846 -0.615 . . . . 2.2200000000000002 110.058 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.27 -36.94 50.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.89 -0.596 . . . . 0.28999999999999998 109.809 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.2 -10.48 84.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.56999999999999995 112.511 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 28.3 t70 -101.83 -9.65 20.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.036 0.446 . . . . 0.85999999999999999 110.733 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 64' ' ' LYS . 89.1 mt -55.71 134.99 51.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.261 0.553 . . . . 0.46000000000000002 110.538 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.47 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 3.4 mptp? -82.35 -51.15 8.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.093 -0.958 . . . . 2.0099999999999998 112.25 -169.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 1.1 t70 -139.37 -82.45 0.28 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.608 -0.437 . . . . 1.0900000000000001 110.843 -178.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.4 mm? -114.44 173.95 6.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.383 0.611 . . . . 0.14999999999999999 110.722 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 45' ' ' GLU . 1.2 m -121.92 166.1 16.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 106.62 -1.622 . . . . 0.25 106.62 164.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.4 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -137.1 126.16 3.6 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.806 -1.188 . . . . 0.37 112.055 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.654 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -99.58 139.59 35.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.11 -0.636 . . . . 0.28999999999999998 110.018 -178.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.448 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 2.1 t-20 50.17 55.42 9.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.113 0.959 . . . . 1.8500000000000001 109.889 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 20.9 t -105.4 146.77 29.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.043 -1.435 . . . . 1.1200000000000001 110.198 -171.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.802 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 19.8 m -103.6 139.56 20.23 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 120.528 -0.469 . . . . 1.26 110.265 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 6.1 Cg_exo -80.45 119.84 3.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.614 2.209 . . . . 0.60999999999999999 112.472 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.651 HD11 ' SG ' ' A' ' 40' ' ' CYS . 5.6 mp -97.13 87.02 4.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.224 -0.658 . . . . 0.85999999999999999 109.224 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.411 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 23.8 p -77.81 -34.04 52.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.085 -0.507 . . . . 1.3700000000000001 111.035 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.6 m -103.31 125.75 57.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.205 0.526 . . . . 1.6000000000000001 110.481 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.5 mm -83.34 137.87 20.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.008 -0.542 . . . . 1.8500000000000001 110.17 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.77 -102.26 1.29 Allowed Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.984 -0.846 . . . . 3.1800000000000002 110.984 -176.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 m -62.91 103.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.253 0.549 . . . . 4.6900000000000004 111.008 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.58 19.71 79.01 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.816 -0.707 . . . . 4.3499999999999996 111.714 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.89 -42.22 1.13 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.901 -0.666 . . . . 3.27 112.03 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -91.47 -21.08 21.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.118 0.485 . . . . 5.4699999999999998 110.414 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 p -140.0 113.5 8.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.561 -0.745 . . . . 4.7000000000000002 109.333 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.46 ' SG ' HD11 ' A' ' 79' ' ' LEU . 24.9 t -123.54 19.86 9.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.331 -0.395 . . . . 1.6599999999999999 110.72 -175.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.5 m 65.63 0.69 1.52 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.872 -0.604 . . . . 1.6499999999999999 111.545 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -140.25 172.58 12.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.179 -0.464 . . . . 0.54000000000000004 109.851 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.35 130.57 41.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.096 0.474 . . . . 0.78000000000000003 110.872 -174.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.2 120.18 37.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.47 0.652 . . . . 0.39000000000000001 112.562 -172.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 44' ' ' THR . 5.5 m -134.65 168.3 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.024 -0.989 . . . . 0.22 110.043 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.8 t -116.97 117.89 30.91 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.122 -0.696 . . . . 0.70999999999999996 109.122 177.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.0 m -111.19 151.26 28.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.925 0.393 . . . . 0.60999999999999999 110.887 -172.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 t -81.09 -28.81 35.08 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.963 -0.562 . . . . 0.38 110.664 -173.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.414 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 14.5 m120 -155.06 156.98 36.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.588 -0.733 . . . . 0.78000000000000003 109.11 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.9 t -136.18 144.62 45.06 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.048 -0.353 . . . . 0.41999999999999998 110.048 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.568 ' HB2' HG23 ' A' ' 105' ' ' VAL . 67.3 m-85 -138.33 161.93 35.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.674 0.273 . . . . 0.77000000000000002 110.915 -177.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.593 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 49.6 mm-40 62.63 33.27 15.84 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.03 -0.532 . . . . 0.80000000000000004 112.255 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 65.43 -0.31 1.21 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.843 0.457 . . . . 2.1200000000000001 112.067 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.55 -13.41 3.71 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.483 -0.865 . . . . 0.28000000000000003 112.883 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.654 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 22.5 mt -55.25 -36.51 66.14 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 117.358 0.579 . . . . 0.35999999999999999 110.862 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.568 HG23 ' HB2' ' A' ' 100' ' ' TYR . 12.2 m -129.97 147.32 33.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.303 0.573 . . . . 0.85999999999999999 110.529 174.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 4.2 t-20 -143.04 143.06 31.73 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.873 -1.158 . . . . 0.91000000000000003 107.873 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 18.0 m -123.79 149.9 27.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 113.062 0.764 . . . . 0.29999999999999999 113.062 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 59.85 54.45 37.45 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 114.913 -1.04 . . . . 0.20000000000000001 111.536 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 70' ' ' ASP . 74.8 m -97.92 123.5 41.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.757 0.313 . . . . 0.42999999999999999 110.54 -173.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.3 p -118.95 126.82 26.87 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.817 -0.629 . . . . 0.29999999999999999 110.91 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.459 ' HA ' HG12 ' A' ' 94' ' ' VAL . 54.2 Cg_exo -51.22 113.26 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.036 2.491 . . . . 0.34000000000000002 112.141 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.8 tt -98.05 121.25 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.906 -0.588 . . . . 0.58999999999999997 111.512 -175.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.528 ' OD1' ' HA ' ' A' ' 22' ' ' ARG . 26.3 t-20 -98.22 106.22 18.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.79 -0.641 . . . . 2.3900000000000001 109.88 175.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 115' ' ' GLY . 1.4 pp -90.04 -19.75 7.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.362 -0.381 . . . . 2.02 111.002 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.482 ' N ' HD12 ' A' ' 114' ' ' ILE . . . 89.74 -19.34 41.77 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.781 -0.724 . . . . 2.6099999999999999 114.357 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 116' ' ' LEU . 1.4 pt? . . . . . 0 C--O 1.244 0.771 0 CA-C-N 117.759 0.779 . . . . 3.6899999999999999 110.88 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 110.061 -0.348 . . . . 30.309999999999999 110.061 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 71.19 -63.35 0.42 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.021 0.825 . . . . 28.059999999999999 112.105 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.53 ' HG2' ' H ' ' A' ' 14' ' ' ASP . 49.5 ttm -131.52 118.9 20.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.672 0.272 . . . . 28.52 110.306 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.05 24.05 9.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.752 0.311 . . . . 26.559999999999999 110.924 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.53 ' H ' ' HG2' ' A' ' 12' ' ' MET . 11.8 m-20 67.52 -80.72 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.37 -0.832 . . . . 25.140000000000001 111.569 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.0 pt -98.88 174.1 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.042 -0.527 . . . . 24.989999999999998 111.217 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.31 -166.45 14.19 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.321 -0.711 . . . . 22.920000000000002 111.321 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.5 t -117.02 25.19 10.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.507 0.67 . . . . 22.809999999999999 110.115 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 p -112.73 122.91 49.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.708 -0.678 . . . . 22.210000000000001 110.864 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 68.76 162.67 0.21 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.332 0.653 . . . . 20.949999999999999 111.417 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.97 111.26 65.24 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.857 -0.61 . . . . 19.190000000000001 110.532 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.68 114.18 3.02 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.832 2.355 . . . . 17.98 111.548 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -84.48 80.06 9.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.371 -0.377 . . . . 18.07 110.796 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.0 t70 69.32 -65.24 0.31 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.765 0.826 . . . . 14.66 110.717 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 p -136.93 125.15 33.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.228 -0.656 . . . . 13.029999999999999 109.228 175.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -127.45 45.02 2.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.603 0.716 . . . . 12.26 111.057 -175.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -139.11 174.53 22.11 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.433 -0.803 . . . . 9.9700000000000006 111.921 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.47 -176.86 14.59 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.308 -0.717 . . . . 8.2200000000000006 111.308 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.488 HG22 ' HD2' ' A' ' 30' ' ' PRO . 5.1 m -82.28 125.3 77.06 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 117.019 0.41 . . . . 7.2999999999999998 110.079 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -41.27 -51.07 4.18 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 124.188 3.258 . . . . 6.0999999999999996 116.312 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.488 ' HD2' HG22 ' A' ' 28' ' ' THR . 2.0 Cg_endo -80.66 3.85 7.39 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.072 1.848 . . . . 5.1900000000000004 113.165 -171.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -131.41 115.31 16.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.73 0.3 . . . . 3.79 110.728 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.5 t -175.11 -178.45 1.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 1.74 110.365 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.3 m -122.14 142.64 50.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.062 -0.517 . . . . 1.7 109.808 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -74.39 -6.68 49.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.955 0.407 . . . . 2.5699999999999998 111.055 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.9 t -72.93 -25.53 61.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.115 -0.493 . . . . 2.5 110.604 177.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.03 -174.98 28.49 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.515 -0.85 . . . . 1.51 112.458 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -41.46 149.75 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.282 3.321 . . . . 1.05 114.295 176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 39' ' ' TYR . 96.7 t -78.83 161.04 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.914 -1.039 . . . . 0.58999999999999997 108.744 174.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.413 ' N ' HG12 ' A' ' 38' ' ' VAL . 97.0 m-85 -123.98 141.05 52.38 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.483 0.659 . . . . 0.78000000000000003 111.362 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 49.5 t -113.16 111.24 21.76 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.272 -0.876 . . . . 0.81999999999999995 109.993 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.2 m -107.69 133.11 52.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.095 0.474 . . . . 0.23999999999999999 110.001 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -53.99 -26.48 26.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.173 -0.921 . . . . 2.0800000000000001 110.559 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.458 ' HE2' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -173.32 123.26 0.38 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.896 -1.15 . . . . 2.5800000000000001 107.896 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.525 HG21 HG11 ' A' ' 94' ' ' VAL . 12.5 p -78.66 154.98 29.72 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.466 -0.893 . . . . 0.37 110.727 172.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.557 ' HG3' HD23 ' A' ' 50' ' ' LEU . 7.8 tp10 -120.88 137.94 54.33 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.979 -0.749 . . . . 1.1200000000000001 108.979 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.489 ' HA ' HD12 ' A' ' 71' ' ' LEU . 11.6 m-20 -75.32 107.98 7.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.942 -0.572 . . . . 1.77 109.91 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.474 ' HA ' HD21 ' A' ' 50' ' ' LEU . 9.4 m -47.18 -31.17 3.39 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.849 0.718 . . . . 0.92000000000000004 111.987 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 11.4 mptt -68.17 -40.95 82.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.5 0.667 . . . . 2.77 110.638 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -124.36 51.89 1.55 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.14 -0.936 . . . . 2.3300000000000001 110.934 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.557 HD23 ' HG3' ' A' ' 45' ' ' GLU . 82.0 mt -62.96 159.92 15.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.573 0.701 . . . . 1.1599999999999999 112.215 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.8 146.85 23.33 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.722 -1.126 . . . . 1.8100000000000001 109.059 175.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -59.37 -25.06 63.93 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.239 0.337 . . . . 3.23 110.949 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.62 -41.45 83.95 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.759 -0.734 . . . . 0.34000000000000002 111.844 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.644 ' HA ' HD22 ' A' ' 57' ' ' LEU . 98.3 m -81.15 -42.98 20.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.761 0.315 . . . . 0.35999999999999999 110.559 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.7 m -54.84 -32.51 60.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.912 -0.586 . . . . 0.29999999999999999 110.188 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.58 -54.43 46.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.562 -0.744 . . . . 0.23000000000000001 111.406 175.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.644 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.44 -44.59 89.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.401 0.62 . . . . 0.23999999999999999 110.147 -177.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.6 mt -58.9 -43.92 91.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.066 -0.97 . . . . 0.17999999999999999 110.172 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.92 -35.79 91.04 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.928 -0.653 . . . . 0.26000000000000001 112.537 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 16.9 mt -61.66 -39.81 92.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.751 0.786 . . . . 0.34000000000000002 110.022 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.454 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.8 mt -91.61 2.06 56.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.7 -1.136 . . . . 0.35999999999999999 111.085 -176.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 68.28 30.12 5.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.85 0.833 . . . . 1.8899999999999999 110.691 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 58' ' ' LEU . 54.1 mt -80.93 141.62 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.78 -0.646 . . . . 0.26000000000000001 110.262 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -92.75 118.96 31.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.818 -0.628 . . . . 2.2200000000000002 110.062 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.05 -29.35 28.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.454 -0.794 . . . . 0.28999999999999998 110.856 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.42 -18.02 78.08 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.72 -0.752 . . . . 0.56999999999999995 112.46 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -88.03 -19.18 27.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.071 0.462 . . . . 0.85999999999999999 110.393 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.33 126.36 27.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.488 -0.778 . . . . 0.46000000000000002 110.986 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -91.27 -76.32 0.45 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.053 -0.976 . . . . 2.0099999999999998 112.202 -172.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -90.11 -112.11 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.457 -0.338 . . . . 1.0900000000000001 111.268 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.6 mm? -105.7 170.81 7.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.206 0.527 . . . . 0.14999999999999999 111.182 176.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 45' ' ' GLU . 1.6 m -122.99 167.56 16.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 106.999 -1.482 . . . . 0.25 106.999 167.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.514 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -138.01 144.56 15.87 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.725 -1.226 . . . . 0.37 111.847 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -102.76 127.59 49.85 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.373 -0.531 . . . . 0.28999999999999998 110.279 175.051 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 57.75 54.99 5.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.742 -1.117 . . . . 1.8500000000000001 111.15 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.514 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 47.0 m -87.56 142.27 27.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.356 -0.838 . . . . 1.1200000000000001 110.913 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 14.2 t -98.25 123.41 50.84 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.758 -0.656 . . . . 1.26 109.804 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 12.9 Cg_exo -70.45 120.45 7.14 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.573 2.182 . . . . 0.60999999999999999 112.123 175.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.3 mt -95.52 88.85 5.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.767 -0.651 . . . . 0.85999999999999999 109.728 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.4 p -92.75 -46.32 7.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.853 -0.612 . . . . 1.3700000000000001 111.724 -174.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.7 m -81.7 102.28 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.962 0.887 . . . . 1.6000000000000001 111.303 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.7 mm -91.3 137.74 21.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.255 -0.884 . . . . 1.8500000000000001 110.799 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.18 -43.07 3.18 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.706 -0.759 . . . . 3.1800000000000002 111.718 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.8 t -79.14 79.85 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.887 -0.412 . . . . 4.6900000000000004 109.887 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.99 62.05 4.23 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.692 -0.766 . . . . 4.3499999999999996 111.624 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.7 -116.24 2.24 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.646 -0.787 . . . . 3.27 112.607 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 64.86 -86.7 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.291 0.636 . . . . 5.4699999999999998 111.294 -176.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.0 p -108.23 166.03 11.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.772 0.32 . . . . 4.7000000000000002 110.526 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 p -125.43 162.92 23.75 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.138 -0.69 . . . . 1.6599999999999999 109.138 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.4 m -71.48 1.29 6.64 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.422 0.527 . . . . 1.6499999999999999 112.422 -170.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.478 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -151.98 -157.14 0.77 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.564 0.221 . . . . 0.54000000000000004 111.051 -176.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.77 130.65 37.98 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.64 -0.504 . . . . 0.78000000000000003 109.64 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.65 123.42 47.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.331 0.586 . . . . 0.39000000000000001 110.952 -173.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 44' ' ' THR . 6.1 m -134.61 166.41 28.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.634 -0.712 . . . . 0.22 111.647 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.5 t -110.73 116.48 31.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.317 -0.856 . . . . 0.70999999999999996 108.965 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 16.1 m -118.63 150.15 40.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.835 0.35 . . . . 0.60999999999999999 110.642 -171.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.405 HG22 ' HA3' ' A' ' 108' ' ' GLY . 8.4 t -78.13 -32.2 50.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.81 -0.632 . . . . 0.38 110.827 -173.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.45 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.6 m120 -155.72 163.48 39.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.862 -0.608 . . . . 0.78000000000000003 109.715 -176.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -139.63 148.68 42.8 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.62 -0.511 . . . . 0.41999999999999998 109.62 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.609 ' HB2' HG23 ' A' ' 105' ' ' VAL . 60.6 m-85 -134.56 154.39 51.49 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.469 -0.567 . . . . 0.77000000000000002 109.469 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.552 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 55.5 mm-40 64.91 29.46 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.335 0.397 . . . . 0.80000000000000004 111.489 176.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.7 m170 63.96 11.5 6.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.951 -0.568 . . . . 2.1200000000000001 111.991 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 132.23 -17.77 4.78 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.136 -1.031 . . . . 0.28000000000000003 113.333 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 14.7 mt -50.55 -40.25 51.49 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.556 0.678 . . . . 0.35999999999999999 110.742 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.609 HG23 ' HB2' ' A' ' 100' ' ' TYR . 4.3 m -127.05 142.63 42.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.656 -0.702 . . . . 0.85999999999999999 109.698 171.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 24.1 t30 -138.61 143.57 39.38 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.15 -1.056 . . . . 0.91000000000000003 108.15 -175.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.45 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.2 m -126.19 152.24 33.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 113.393 0.886 . . . . 0.29999999999999999 113.393 -172.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.06 52.73 51.05 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.703 -1.135 . . . . 0.20000000000000001 112.057 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' CYS . . . . . 0.434 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 93.7 m -96.65 126.72 42.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.951 0.405 . . . . 0.42999999999999999 112.005 -175.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -119.46 126.02 27.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.74 -0.664 . . . . 0.29999999999999999 110.313 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' A' ' 94' ' ' VAL . 70.8 Cg_exo -51.33 110.08 0.38 Allowed 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.997 2.465 . . . . 0.34000000000000002 112.417 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.9 tt -89.8 127.57 42.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 0.58999999999999997 110.098 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -84.58 99.12 10.55 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.962 -0.755 . . . . 2.3900000000000001 108.962 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 115' ' ' GLY . 1.4 pp -67.07 -23.86 31.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.025 -0.534 . . . . 2.02 112.41 -175.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.514 ' N ' HD12 ' A' ' 114' ' ' ILE . . . 51.33 29.91 24.01 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.244 -0.889 . . . . 2.6099999999999999 114.009 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.48 -0.771 . . . . 3.6899999999999999 110.248 -178.242 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 39' ' ' TYR . 92.9 t . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 108.375 -0.972 . . . . 0.58999999999999997 108.375 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.7 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 97.2 m-85 -130.63 139.68 50.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.478 0.656 . . . . 0.78000000000000003 111.601 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 36.9 t -107.9 98.64 8.19 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.166 -0.925 . . . . 0.81999999999999995 109.346 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.643 ' HB2' HE21 ' A' ' 92' ' ' GLN . 33.9 m -104.24 141.71 35.8 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.393 -0.595 . . . . 0.23999999999999999 109.393 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -59.63 -30.43 68.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.673 -0.694 . . . . 2.0800000000000001 110.769 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.17 123.46 0.98 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.644 -0.872 . . . . 2.5800000000000001 108.644 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.651 ' N ' HE22 ' A' ' 92' ' ' GLN . 1.5 p -86.65 127.99 34.97 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.814 -0.754 . . . . 0.37 110.433 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.67 ' HB3' HG22 ' A' ' 72' ' ' VAL . 8.8 tp10 -103.45 138.07 40.68 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.973 -1.012 . . . . 1.1200000000000001 109.649 -172.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.46 ' HA ' HD12 ' A' ' 71' ' ' LEU . 6.3 m-20 -65.01 107.44 1.51 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.235 -0.439 . . . . 1.77 111.015 -174.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.593 ' HA ' HD21 ' A' ' 50' ' ' LEU . 92.9 p -65.48 -6.38 10.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.88 -0.6 . . . . 0.92000000000000004 112.032 -174.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.497 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 3.6 mppt? -77.09 -38.63 51.94 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.434 0.635 . . . . 2.77 109.639 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -142.61 67.93 1.31 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.936 -1.029 . . . . 2.3300000000000001 110.988 -176.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.593 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -61.91 160.34 12.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.476 0.655 . . . . 1.1599999999999999 111.469 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -67.65 155.6 38.81 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.341 -0.985 . . . . 1.8100000000000001 108.341 171.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -28.93 70.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.418 0.553 . . . . 3.23 110.233 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -67.62 -38.18 89.98 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.801 -0.714 . . . . 0.34000000000000002 111.495 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.684 ' HA ' HD22 ' A' ' 57' ' ' LEU . 37.0 m -79.0 -41.36 29.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.995 0.426 . . . . 0.35999999999999999 110.119 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.2 m -54.71 -35.16 63.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.52 -0.764 . . . . 0.29999999999999999 109.851 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.19 -53.67 55.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.26 -0.882 . . . . 0.23000000000000001 111.537 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.684 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.42 -45.46 88.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.416 0.626 . . . . 0.23999999999999999 110.238 -178.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.5 mt -58.56 -43.31 89.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.954 -1.021 . . . . 0.17999999999999999 110.175 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.18 -36.91 93.1 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.77 -0.728 . . . . 0.26000000000000001 112.196 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.5 mt -60.6 -44.79 95.88 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.506 0.67 . . . . 0.34000000000000002 110.248 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.581 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.2 mt -87.64 1.06 54.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.945 -1.025 . . . . 0.35999999999999999 111.543 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 71.29 26.65 3.31 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.825 -0.625 . . . . 1.8899999999999999 111.392 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 58' ' ' LEU . 60.4 mt -78.44 140.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.938 -0.574 . . . . 0.26000000000000001 110.281 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.54 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 11.5 mptt -91.26 118.0 30.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.709 -0.678 . . . . 2.2200000000000002 109.815 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -73.01 -36.95 52.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.83 -0.623 . . . . 0.28999999999999998 110.195 -175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.31 -19.23 79.6 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.735 -0.745 . . . . 0.56999999999999995 112.283 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -85.25 -16.77 39.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.048 0.452 . . . . 0.85999999999999999 110.331 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 94.1 mt -64.01 154.07 35.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.883 -0.598 . . . . 0.46000000000000002 111.393 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 12.5 mptt -109.38 -80.37 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.647 -0.706 . . . . 2.0099999999999998 112.503 -171.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -98.69 -90.67 0.29 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 112.537 0.569 . . . . 1.0900000000000001 112.537 -170.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.0 OUTLIER -120.77 166.23 14.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.891 -0.595 . . . . 0.14999999999999999 110.989 178.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.67 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.9 OUTLIER -118.03 171.37 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 106.665 -1.605 . . . . 0.25 106.665 167.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.77 120.6 1.76 Allowed Glycine 0 C--N 1.31 -0.911 0 C-N-CA 119.668 -1.254 . . . . 0.37 112.132 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.61 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -91.54 140.02 30.14 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 120.089 -0.644 . . . . 0.28999999999999998 110.148 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.502 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 3.0 t-20 50.9 49.86 20.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.921 -1.036 . . . . 1.8500000000000001 110.559 176.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.7 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 7.9 t -92.1 150.44 20.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.733 -1.121 . . . . 1.1200000000000001 110.805 -174.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 17.9 t -109.41 121.12 43.43 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.794 -0.639 . . . . 1.26 110.022 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 12.7 Cg_exo -69.69 124.24 10.92 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.514 2.142 . . . . 0.60999999999999999 112.527 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 40' ' ' CYS . 23.9 mt . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 115.966 -0.561 . . . . 0.85999999999999999 109.715 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.585 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 110.013 -0.366 . . . . 0.54000000000000004 110.013 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.651 HE22 ' N ' ' A' ' 44' ' ' THR . 1.2 tt0 -84.0 136.3 34.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.678 -0.49 . . . . 0.78000000000000003 109.678 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.21 121.36 45.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.341 0.591 . . . . 0.39000000000000001 111.217 -174.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.595 HG12 ' HA ' ' A' ' 111' ' ' PRO . 1.9 m -133.07 164.18 35.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.515 -0.766 . . . . 0.22 110.877 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.4 t -108.24 109.08 20.36 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.347 -0.842 . . . . 0.70999999999999996 109.159 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 28.8 m -106.76 153.73 22.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.202 -0.454 . . . . 0.60999999999999999 110.135 -175.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 t -86.64 -28.03 23.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.38 110.655 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.617 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 24.1 m120 -151.74 168.08 26.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.693 -0.484 . . . . 0.78000000000000003 109.693 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.8 t -139.66 144.34 37.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.181 0.301 . . . . 0.41999999999999998 110.783 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.606 ' HB2' HG23 ' A' ' 105' ' ' VAL . 50.8 m-85 -134.07 153.12 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.094 -0.336 . . . . 0.77000000000000002 110.094 175.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.651 ' NE2' HD12 ' A' ' 104' ' ' LEU . 9.6 mm100 62.6 30.41 17.01 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.303 0.483 . . . . 0.80000000000000004 112.303 172.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 67.05 -0.89 1.57 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.868 0.467 . . . . 2.1200000000000001 111.827 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 76' ' ' CYS . . . 140.61 -13.73 2.94 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.805 -0.712 . . . . 0.28000000000000003 112.514 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.651 HD12 ' NE2' ' A' ' 101' ' ' GLN . 48.2 mt -52.1 -36.13 50.07 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.991 0.424 . . . . 0.35999999999999999 111.0 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.606 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.3 OUTLIER -137.52 139.04 44.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.504 -0.771 . . . . 0.85999999999999999 109.786 174.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.575 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.5 t30 -136.37 157.93 45.63 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.711 -0.848 . . . . 0.91000000000000003 108.711 -174.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.617 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 10.7 m -135.64 150.87 29.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.983 0.734 . . . . 0.29999999999999999 112.983 -175.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.69 50.31 67.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 114.74 -1.118 . . . . 0.20000000000000001 112.086 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 81.0 m -96.87 125.92 41.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.767 0.318 . . . . 0.42999999999999999 110.576 -175.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 18.9 p -119.39 138.95 27.02 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.901 -0.591 . . . . 0.29999999999999999 109.78 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.595 ' HA ' HG12 ' A' ' 94' ' ' VAL . 36.7 Cg_exo -64.92 108.63 1.13 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.889 2.393 . . . . 0.34000000000000002 112.006 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.1 tt . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 115.585 -0.734 . . . . 0.58999999999999997 111.007 -175.481 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 39' ' ' TYR . 19.2 t . . . . . 0 N--CA 1.461 0.084 0 N-CA-C 110.29 -0.263 . . . . 0.58999999999999997 110.29 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.493 ' N ' HG12 ' A' ' 38' ' ' VAL . 63.8 m-85 -132.91 140.1 47.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.978 0.418 . . . . 0.78000000000000003 110.577 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 52.4 t -117.79 103.21 9.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.017 -0.538 . . . . 0.81999999999999995 110.778 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.8 m -100.17 129.58 46.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.703 -0.851 . . . . 0.23999999999999999 108.703 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.489 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 94.6 m-20 -59.78 -24.24 63.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.55 0.69 . . . . 2.0800000000000001 109.585 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 5.3 mmmm -161.78 134.64 6.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.088 -1.414 . . . . 2.5800000000000001 107.724 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.514 HG21 HG11 ' A' ' 94' ' ' VAL . 22.9 p -88.39 157.73 18.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.441 -0.903 . . . . 0.37 110.49 169.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.509 ' CB ' HG22 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -119.12 142.53 47.83 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.366 -0.834 . . . . 1.1200000000000001 110.179 -176.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.523 ' O ' HD13 ' A' ' 50' ' ' LEU . 11.9 t70 -71.88 101.51 2.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.523 -0.762 . . . . 1.77 110.349 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.575 ' HA ' HD21 ' A' ' 50' ' ' LEU . 57.1 p -67.72 -6.67 22.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.631 0.604 . . . . 0.92000000000000004 112.631 -172.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.553 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -77.73 -40.9 39.59 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.777 0.799 . . . . 2.77 109.179 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -147.12 68.86 1.15 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.692 -1.14 . . . . 2.3300000000000001 109.874 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.575 HD21 ' HA ' ' A' ' 47' ' ' SER . 3.1 mm? -53.08 153.18 3.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.562 0.696 . . . . 1.1599999999999999 112.418 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.9 146.54 31.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.711 -1.132 . . . . 1.8100000000000001 108.703 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -59.6 -27.62 66.45 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.705 -0.398 . . . . 3.23 110.857 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.458 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -69.77 -37.07 75.73 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.547 -0.835 . . . . 0.34000000000000002 111.624 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.692 ' HA ' HD22 ' A' ' 57' ' ' LEU . 23.5 m -80.03 -43.95 21.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.831 0.348 . . . . 0.35999999999999999 110.228 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.7 m -51.93 -36.2 48.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 0.29999999999999999 109.813 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.36 -53.7 55.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.511 -0.768 . . . . 0.23000000000000001 111.78 176.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.692 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.49 -46.59 86.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.462 0.649 . . . . 0.23999999999999999 110.313 -178.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 54' ' ' THR . 52.9 mt -58.43 -44.8 89.27 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.854 -1.066 . . . . 0.17999999999999999 110.135 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.44 -32.91 79.13 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.968 -0.634 . . . . 0.26000000000000001 112.945 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.8 mt -64.01 -43.47 95.55 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.826 0.822 . . . . 0.34000000000000002 110.123 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.475 HD21 ' HG2' ' A' ' 101' ' ' GLN . 3.4 mt -86.68 -1.33 57.62 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.535 -1.212 . . . . 0.35999999999999999 110.961 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.2 m120 65.61 36.03 6.71 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.215 -0.902 . . . . 1.8899999999999999 111.072 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 58' ' ' LEU . 50.1 mt -82.96 145.09 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.599 -0.728 . . . . 0.26000000000000001 109.502 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.656 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -99.32 117.96 34.93 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.331 0.586 . . . . 2.2200000000000002 109.762 -178.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.29 -28.12 34.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.277 -0.874 . . . . 0.28999999999999998 110.877 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.13 -15.44 78.65 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.168 -0.539 . . . . 0.56999999999999995 112.6 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.492 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 17.2 t70 -86.21 -29.39 23.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.925 0.393 . . . . 0.85999999999999999 110.332 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 86.0 mt -52.5 139.39 25.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.099 -0.955 . . . . 0.46000000000000002 111.951 -174.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -96.67 -81.98 0.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.992 -1.004 . . . . 2.0099999999999998 112.197 -171.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -94.77 -92.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.05 0.389 . . . . 1.0900000000000001 112.05 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.3 mm? -117.39 171.32 8.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.319 0.58 . . . . 0.14999999999999999 110.917 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.6 OUTLIER -121.08 172.88 7.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.565 -1.643 . . . . 0.25 106.565 165.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.483 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -139.39 129.16 4.26 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 119.89 -1.147 . . . . 0.37 112.106 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.659 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -99.21 135.96 39.85 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.442 -0.503 . . . . 0.28999999999999998 109.895 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.41 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 24.2 m120 46.56 51.16 12.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.199 -0.91 . . . . 1.8500000000000001 110.531 -175.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -87.41 147.98 25.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.064 -0.971 . . . . 1.1200000000000001 109.575 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.7 m -109.59 108.97 59.94 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 116.048 -0.524 . . . . 1.26 110.356 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.59 120.02 7.15 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.12 1.88 . . . . 0.60999999999999999 111.371 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.4 mt . . . . . 0 C--N 1.317 -0.809 0 CA-C-N 115.601 -0.727 . . . . 0.85999999999999999 109.26 -177.754 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.698 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--O 1.234 0.262 0 N-CA-C 110.064 -0.346 . . . . 0.54000000000000004 110.064 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.73 115.96 21.88 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.852 0.834 . . . . 0.78000000000000003 109.694 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 117.13 33.24 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.169 -0.923 . . . . 0.39000000000000001 110.832 -169.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.514 HG11 HG21 ' A' ' 44' ' ' THR . 9.5 m -129.93 171.53 17.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.547 -0.751 . . . . 0.22 111.854 -176.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 37.7 t -115.0 108.32 16.55 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.812 -1.085 . . . . 0.70999999999999996 108.93 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 27.6 m -106.03 145.43 31.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.313 -0.403 . . . . 0.60999999999999999 110.076 -176.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -76.04 -28.87 57.85 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.38 110.348 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.445 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 12.1 m120 -151.34 164.18 37.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 0.78000000000000003 109.843 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 t -137.63 133.55 34.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.05 -0.523 . . . . 0.41999999999999998 109.944 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.555 ' HB2' HG23 ' A' ' 105' ' ' VAL . 66.2 m-85 -119.37 157.25 28.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.963 -0.562 . . . . 0.77000000000000002 109.827 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.678 ' NE2' HD12 ' A' ' 104' ' ' LEU . 8.8 mm100 60.35 30.51 19.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.441 . . . . 0.80000000000000004 111.586 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 63.68 9.82 4.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 2.1200000000000001 111.875 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.83 -24.29 3.02 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.73 -0.747 . . . . 0.28000000000000003 112.507 175.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.678 HD12 ' NE2' ' A' ' 101' ' ' GLN . 18.6 mt -49.86 -36.13 25.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.825 0.305 . . . . 0.35999999999999999 111.825 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.555 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.3 OUTLIER -141.38 118.82 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.392 0.615 . . . . 0.85999999999999999 110.992 173.148 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.588 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 7.5 m-20 -111.03 162.64 14.66 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.5 -0.773 . . . . 0.91000000000000003 109.488 176.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.445 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.4 m -132.85 154.32 39.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.336 0.495 . . . . 0.29999999999999999 112.336 -176.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 59.8 52.29 53.87 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.278 -0.874 . . . . 0.20000000000000001 111.88 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 73.3 m -96.81 123.6 40.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.878 0.37 . . . . 0.42999999999999999 111.116 -174.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.4 p -119.72 125.94 27.18 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.919 -0.582 . . . . 0.29999999999999999 110.131 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.48 ' HA ' HG12 ' A' ' 94' ' ' VAL . 81.5 Cg_exo -48.38 109.87 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.752 2.301 . . . . 0.34000000000000002 111.665 175.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.3 tt . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 0.58999999999999997 111.747 -169.477 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.9 t . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 110.144 -0.317 . . . . 0.58999999999999997 110.144 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.29 136.44 48.16 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.855 -0.424 . . . . 0.78000000000000003 109.855 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 48.0 t -102.99 114.82 29.42 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.806 0.336 . . . . 0.81999999999999995 110.589 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.1 m -115.25 125.18 53.02 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.928 -0.767 . . . . 0.23999999999999999 108.928 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.512 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 24.7 t-20 -50.64 -34.36 25.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.614 -0.721 . . . . 2.0800000000000001 110.231 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -154.58 127.48 8.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.652 -1.158 . . . . 2.5800000000000001 108.725 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.515 HG21 HG11 ' A' ' 94' ' ' VAL . 18.0 p -84.37 156.94 21.62 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.53 -0.868 . . . . 0.37 110.514 168.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.8 tp10 -120.58 139.23 53.25 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.617 -0.72 . . . . 1.1200000000000001 109.451 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.442 ' HA ' HD12 ' A' ' 71' ' ' LEU . 24.1 t70 -65.65 110.81 2.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.029 -0.532 . . . . 1.77 110.376 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 58.5 p -69.41 -2.45 11.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.262 -0.426 . . . . 0.92000000000000004 112.073 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -90.12 -27.99 19.26 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.115 0.483 . . . . 2.77 109.759 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -141.62 64.28 1.41 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.57 . . . . 2.3300000000000001 110.592 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.547 HD11 HG13 ' A' ' 72' ' ' VAL . 2.8 mm? -60.74 150.21 33.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.291 0.567 . . . . 1.1599999999999999 111.559 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.93 144.13 57.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.831 -1.077 . . . . 1.8100000000000001 108.438 169.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -62.8 -21.07 65.62 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.213 -0.195 . . . . 3.23 110.902 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.31 -36.57 63.36 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.583 -0.818 . . . . 0.34000000000000002 111.202 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.643 ' HA ' HD22 ' A' ' 57' ' ' LEU . 37.9 m -82.05 -43.98 17.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.817 0.342 . . . . 0.35999999999999999 110.198 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.1 m -52.5 -35.37 52.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.698 -0.683 . . . . 0.29999999999999999 110.04 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.637 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -55.82 -53.69 53.62 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.377 -0.829 . . . . 0.23000000000000001 111.288 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.643 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -59.6 -44.9 93.23 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.221 0.534 . . . . 0.23999999999999999 109.995 -178.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 54' ' ' THR . 54.1 mt -58.12 -46.08 86.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.094 -0.957 . . . . 0.17999999999999999 109.992 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.24 -29.66 75.15 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.003 -0.617 . . . . 0.26000000000000001 112.574 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.1 mt -65.73 -47.53 75.01 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.639 0.733 . . . . 0.34000000000000002 110.161 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' CD1' HG21 ' A' ' 105' ' ' VAL . 3.7 mt -83.09 -2.41 55.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.764 -1.107 . . . . 0.35999999999999999 110.996 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.2 t30 68.17 38.38 2.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.222 -0.899 . . . . 1.8899999999999999 110.978 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 58' ' ' LEU . 51.3 mt -84.32 137.74 20.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.778 -0.646 . . . . 0.26000000000000001 110.099 175.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -84.11 118.0 23.81 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.645 -0.707 . . . . 2.2200000000000002 110.304 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.91 -31.69 51.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.763 -0.653 . . . . 0.28999999999999998 109.902 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.92 -9.53 86.61 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.774 -0.648 . . . . 0.56999999999999995 112.604 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -95.6 -8.78 33.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.399 0.618 . . . . 0.85999999999999999 110.283 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.6 mt -69.22 144.08 53.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.721 -0.672 . . . . 0.46000000000000002 111.223 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -101.17 -68.73 0.8 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.843 -1.071 . . . . 2.0099999999999998 112.557 -168.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -114.51 -91.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.853 0.359 . . . . 1.0900000000000001 111.825 -172.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.3 mm? -116.25 169.34 9.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.056 0.455 . . . . 0.14999999999999999 110.393 174.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.547 HG13 HD11 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -124.89 166.88 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.596 -1.631 . . . . 0.25 106.596 166.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.464 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -134.1 148.24 19.38 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 119.807 -1.187 . . . . 0.37 111.364 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -112.1 134.4 53.67 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.151 -0.62 . . . . 0.28999999999999998 110.549 177.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.51 45.14 25.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.824 -1.08 . . . . 1.8500000000000001 111.163 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.464 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 63.3 m -77.61 146.91 35.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.334 0.588 . . . . 1.1200000000000001 111.275 -176.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t -98.03 113.28 63.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.168 -0.924 . . . . 1.26 109.523 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.06 124.39 12.56 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.379 2.053 . . . . 0.60999999999999999 111.954 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.8 mt . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 115.932 -0.576 . . . . 0.85999999999999999 109.729 -178.789 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.786 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 110.362 -0.236 . . . . 0.54000000000000004 110.362 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.0 124.03 31.23 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.404 0.621 . . . . 0.78000000000000003 110.069 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.33 115.73 30.89 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.826 -0.625 . . . . 0.39000000000000001 110.991 -173.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 111' ' ' PRO . 9.5 m -126.42 165.08 25.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.936 -0.574 . . . . 0.22 111.316 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.6 121.96 45.03 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.079 -1.082 . . . . 0.70999999999999996 108.079 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.709 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 27.1 m -120.57 152.35 38.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 0.60999999999999999 111.664 -167.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.525 HG22 ' HA3' ' A' ' 108' ' ' GLY . 10.9 t -81.2 -30.08 34.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.072 -0.967 . . . . 0.38 110.637 -170.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.487 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 17.8 m120 -154.56 167.82 28.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.39 -0.596 . . . . 0.78000000000000003 109.39 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 t -147.37 135.99 21.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.118 0.485 . . . . 0.41999999999999998 110.622 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.531 ' HB2' HG23 ' A' ' 105' ' ' VAL . 67.1 m-85 -129.55 154.31 47.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.361 -0.607 . . . . 0.77000000000000002 109.361 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.663 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 10.7 mm100 59.88 38.1 21.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.545 -0.298 . . . . 0.80000000000000004 111.48 176.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.7 p80 58.88 2.18 0.23 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.152 0.981 . . . . 2.1200000000000001 113.201 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.69 -18.19 3.01 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.691 -0.766 . . . . 0.28000000000000003 112.242 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 20.7 mt -49.8 -44.02 48.88 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.871 0.336 . . . . 0.35999999999999999 110.767 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 100' ' ' TYR . 1.4 m -128.9 119.65 50.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.698 0.761 . . . . 0.85999999999999999 110.344 172.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.462 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 32.5 t30 -119.12 146.31 45.23 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.075 -1.083 . . . . 0.91000000000000003 108.075 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.537 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 11.3 m -132.45 156.21 42.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.537 0.94 . . . . 0.29999999999999999 113.537 -173.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 65.45 49.36 61.12 Favored Glycine 0 CA--C 1.503 -0.66 0 CA-C-N 114.952 -1.022 . . . . 0.20000000000000001 111.716 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 98.7 m -98.15 126.59 43.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.964 0.411 . . . . 0.42999999999999999 111.533 -172.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -120.86 126.14 26.78 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.505 -0.771 . . . . 0.29999999999999999 109.852 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 94' ' ' VAL . 71.7 Cg_exo -50.15 112.34 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.049 2.499 . . . . 0.34000000000000002 112.117 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.0 tt . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.894 -0.594 . . . . 0.58999999999999997 111.096 -173.343 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 107.85 -1.167 . . . . 0.58999999999999997 107.85 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -118.3 137.01 53.36 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.872 0.844 . . . . 0.78000000000000003 111.817 -176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 53.1 t -109.05 115.71 30.57 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.842 -1.072 . . . . 0.81999999999999995 110.152 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.7 m -113.57 126.69 55.57 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.201 -0.666 . . . . 0.23999999999999999 109.201 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -57.63 -23.21 49.92 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.473 -0.785 . . . . 2.0800000000000001 109.769 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -166.24 132.46 2.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.55 -1.204 . . . . 2.5800000000000001 108.028 172.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.494 HG21 HG11 ' A' ' 94' ' ' VAL . 25.1 p -89.6 159.47 17.15 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.456 -0.898 . . . . 0.37 110.494 172.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.449 ' CB ' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -120.58 144.89 47.85 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.208 -0.905 . . . . 1.1200000000000001 109.305 -176.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.469 ' OD2' ' HB2' ' A' ' 48' ' ' LYS . 33.4 t70 -78.52 105.49 9.83 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.973 -0.558 . . . . 1.77 110.313 -174.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.711 ' HA ' HD21 ' A' ' 50' ' ' LEU . 80.1 p -63.21 -7.07 5.17 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.125 0.787 . . . . 0.92000000000000004 113.125 -172.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 2.9 mptp? -81.4 -43.49 18.88 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.335 0.588 . . . . 2.77 110.301 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -135.78 63.94 1.58 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.222 -0.899 . . . . 2.3300000000000001 111.211 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.711 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.8 mm? -60.06 155.97 15.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.265 0.555 . . . . 1.1599999999999999 111.453 176.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.26 152.29 41.4 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.638 -0.875 . . . . 1.8100000000000001 108.638 168.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -63.24 -28.96 70.39 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.415 -0.514 . . . . 3.23 110.638 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -67.54 -38.14 90.29 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.796 -0.716 . . . . 0.34000000000000002 111.879 177.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.686 ' HA ' HD22 ' A' ' 57' ' ' LEU . 41.7 m -78.93 -41.79 28.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.961 0.41 . . . . 0.35999999999999999 109.931 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -52.41 -36.11 53.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.448 -0.796 . . . . 0.29999999999999999 109.805 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.57 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.15 -53.99 52.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.046 -0.979 . . . . 0.23000000000000001 111.626 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.686 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -57.37 -46.31 83.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.492 0.663 . . . . 0.23999999999999999 110.016 -179.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.0 mt -58.69 -45.22 89.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.719 -1.128 . . . . 0.17999999999999999 109.827 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.34 -36.39 90.85 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.762 -0.654 . . . . 0.26000000000000001 112.657 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 25.5 mt -59.41 -40.29 86.19 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.613 0.72 . . . . 0.34000000000000002 110.439 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.475 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.3 mt -90.68 -3.65 57.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.923 -1.035 . . . . 0.35999999999999999 110.836 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 72.03 30.69 2.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.353 -0.84 . . . . 1.8899999999999999 111.305 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 58' ' ' LEU . 60.1 mt -77.59 141.95 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.984 -0.553 . . . . 0.26000000000000001 109.819 176.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.495 ' CG ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -97.46 117.69 32.28 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.355 0.598 . . . . 2.2200000000000002 110.084 -177.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.7 -39.15 59.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.199 -0.909 . . . . 0.28999999999999998 110.791 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.9 -11.42 60.67 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.949 -0.643 . . . . 0.56999999999999995 112.952 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.495 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 36.6 t70 -111.94 3.63 17.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.253 0.549 . . . . 0.85999999999999999 110.793 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.41 ' CB ' ' HB2' ' A' ' 47' ' ' SER . 94.4 mt -70.85 164.72 24.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.304 -0.407 . . . . 0.46000000000000002 110.636 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -106.52 -91.93 0.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.586 0.587 . . . . 2.0099999999999998 112.586 -174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.451 ' O ' HD13 ' A' ' 71' ' ' LEU . 5.6 m-20 -91.81 -84.43 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.622 0.601 . . . . 1.0900000000000001 112.622 -171.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.0 OUTLIER -123.55 166.88 14.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.358 0.599 . . . . 0.14999999999999999 111.032 176.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.511 HG23 ' N ' ' A' ' 73' ' ' GLY . 0.8 OUTLIER -117.48 172.92 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.526 -1.657 . . . . 0.25 106.526 166.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.533 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -143.26 149.12 21.07 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.145 -1.026 . . . . 0.37 111.532 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.606 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -112.52 132.73 54.95 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.137 0.494 . . . . 0.28999999999999998 109.96 175.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.4 m120 55.59 47.51 20.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.867 -1.06 . . . . 1.8500000000000001 110.91 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.533 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 63.6 m -82.58 138.93 34.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.871 -0.604 . . . . 1.1200000000000001 110.952 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 19.5 m -103.02 127.52 29.68 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.576 -0.738 . . . . 1.26 110.482 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 3.5 Cg_exo -76.04 126.35 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.491 2.127 . . . . 0.60999999999999999 112.365 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.449 -0.796 . . . . 0.85999999999999999 109.563 -179.521 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.697 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 108.46 -0.941 . . . . 0.54000000000000004 108.46 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.33 116.41 20.39 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.669 0.747 . . . . 0.78000000000000003 109.336 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.19 123.52 44.53 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.558 -0.746 . . . . 0.39000000000000001 110.445 -171.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 111' ' ' PRO . 7.6 m -134.41 163.16 37.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.508 -0.769 . . . . 0.22 111.423 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 47.3 t -107.99 114.88 29.11 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.301 -1.0 . . . . 0.70999999999999996 108.301 176.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 28.0 m -114.88 148.2 38.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.166 -0.47 . . . . 0.60999999999999999 110.142 -173.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -78.97 -32.9 45.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.958 -0.565 . . . . 0.38 110.651 -174.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.401 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 19.9 m120 -153.02 163.4 39.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.78000000000000003 110.313 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -136.03 143.23 44.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.13 -0.486 . . . . 0.41999999999999998 110.119 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.612 ' HB2' HG23 ' A' ' 105' ' ' VAL . 60.0 m-85 -129.67 153.42 48.15 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.332 -0.618 . . . . 0.77000000000000002 109.332 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.638 ' NE2' HD12 ' A' ' 104' ' ' LEU . 10.1 mm100 62.9 30.59 16.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 0.80000000000000004 111.075 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 65.53 2.41 2.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.808 -0.633 . . . . 2.1200000000000001 112.378 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.37 -16.62 3.37 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.32 -0.943 . . . . 0.28000000000000003 112.868 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.638 HD12 ' NE2' ' A' ' 101' ' ' GLN . 20.5 mt -50.11 -38.05 36.95 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.026 0.413 . . . . 0.35999999999999999 110.689 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.612 HG23 ' HB2' ' A' ' 100' ' ' TYR . 5.6 m -130.0 149.14 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.755 -0.657 . . . . 0.85999999999999999 109.312 171.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 7.8 t30 -144.31 149.99 37.13 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.778 -0.823 . . . . 0.91000000000000003 108.778 -174.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.401 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 11.0 m -130.88 151.59 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 113.006 0.743 . . . . 0.29999999999999999 113.006 -174.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.19 50.42 67.32 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 114.838 -1.074 . . . . 0.20000000000000001 112.104 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 74.7 m -97.75 126.47 43.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.608 0.242 . . . . 0.42999999999999999 111.304 -175.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 21.4 p -118.88 138.05 25.64 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.464 -0.334 . . . . 0.29999999999999999 110.465 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.553 ' HA ' HG12 ' A' ' 94' ' ' VAL . 24.2 Cg_exo -67.53 110.85 2.17 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.294 2.663 . . . . 0.34000000000000002 112.889 -175.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.8 tt . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.942 -0.572 . . . . 0.58999999999999997 111.123 -178.78 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 107.953 -1.129 . . . . 0.58999999999999997 107.953 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.476 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 94.6 m-85 -120.89 138.49 54.06 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.827 -0.749 . . . . 0.78000000000000003 111.594 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 42.2 t -111.75 100.29 8.83 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.043 -0.98 . . . . 0.81999999999999995 110.031 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.9 m -101.95 128.19 48.47 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.085 -0.709 . . . . 0.23999999999999999 109.085 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -57.12 -24.6 55.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.817 -0.629 . . . . 2.0800000000000001 110.261 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.8 120.09 0.88 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.308 -0.86 . . . . 2.5800000000000001 108.703 177.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.553 HG21 HG11 ' A' ' 94' ' ' VAL . 18.4 p -78.81 147.35 33.29 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.121 -1.032 . . . . 0.37 110.505 172.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.472 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.2 tp10 -114.07 142.32 46.35 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.479 -0.782 . . . . 1.1200000000000001 109.421 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.436 ' O ' HD13 ' A' ' 50' ' ' LEU . 28.2 m-20 -70.45 103.97 2.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.949 -0.569 . . . . 1.77 111.129 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.681 ' HA ' HD21 ' A' ' 50' ' ' LEU . 7.1 m -58.71 -14.59 8.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.309 0.485 . . . . 0.92000000000000004 112.309 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -77.16 -35.64 55.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.834 0.349 . . . . 2.77 110.218 -178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -146.74 65.35 1.18 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.07 -0.514 . . . . 2.3300000000000001 111.073 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.681 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.7 mm? -57.0 151.3 15.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.481 . . . . 1.1599999999999999 111.242 175.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.77 156.49 39.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.203 -0.666 . . . . 1.8100000000000001 109.203 172.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -59.99 -33.35 71.85 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.806 -0.358 . . . . 3.23 111.014 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.408 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -61.83 -34.2 87.93 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.843 -0.694 . . . . 0.34000000000000002 111.812 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.658 ' HA ' HD22 ' A' ' 57' ' ' LEU . 24.1 m -85.04 -43.08 14.25 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.456 -0.202 . . . . 0.35999999999999999 110.456 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.5 m -52.84 -35.22 57.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.256 0.551 . . . . 0.29999999999999999 109.763 173.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.619 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.5 -55.45 33.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.277 -0.874 . . . . 0.23000000000000001 111.494 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.658 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -58.9 -44.76 91.29 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.34 0.59 . . . . 0.23999999999999999 110.103 -177.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.4 mt -59.99 -43.44 95.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.138 -0.937 . . . . 0.17999999999999999 110.114 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.14 -38.01 94.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.718 -0.754 . . . . 0.26000000000000001 112.162 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.3 mt -62.23 -40.99 97.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.798 0.809 . . . . 0.34000000000000002 110.187 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.425 HD21 ' HG2' ' A' ' 101' ' ' GLN . 10.7 mt -91.27 4.95 51.03 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.566 -1.197 . . . . 0.35999999999999999 111.274 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 64.85 33.62 9.94 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.717 -0.674 . . . . 1.8899999999999999 111.403 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.9 mt -89.91 144.13 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.875 -0.602 . . . . 0.26000000000000001 110.324 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.546 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 11.3 mptt -94.31 118.43 31.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.825 -0.625 . . . . 2.2200000000000002 109.963 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -68.48 -35.67 71.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.499 -0.773 . . . . 0.28999999999999998 110.386 -177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.87 -14.15 82.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.904 -0.665 . . . . 0.56999999999999995 112.39 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 32.0 t70 -88.01 -19.71 26.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.006 0.431 . . . . 0.85999999999999999 110.549 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.433 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 93.0 mt -55.5 141.93 35.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.699 0.762 . . . . 0.46000000000000002 111.771 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -87.86 -66.62 0.89 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.725 -1.125 . . . . 2.0099999999999998 112.457 -170.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.489 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 0.3 OUTLIER -123.73 -84.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.786 -0.366 . . . . 1.0900000000000001 111.157 -177.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.5 mm? -116.45 167.12 11.33 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.291 0.567 . . . . 0.14999999999999999 111.983 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 45' ' ' GLU . 1.9 m -119.78 165.13 15.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.18 -1.415 . . . . 0.25 107.18 168.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.403 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -137.42 133.85 6.67 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.655 -1.26 . . . . 0.37 112.404 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.23 135.77 36.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.901 -0.407 . . . . 0.28999999999999998 109.901 176.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.419 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 19.7 m120 46.79 52.92 10.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.466 -0.788 . . . . 1.8500000000000001 110.634 -177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 9.3 t -92.85 137.38 32.42 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.118 -0.946 . . . . 1.1200000000000001 109.883 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 13.3 t -100.55 125.71 38.17 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.92 -0.582 . . . . 1.26 110.893 -173.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 3.5 Cg_exo -76.27 122.13 6.45 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.758 2.305 . . . . 0.60999999999999999 112.568 177.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.627 -0.715 . . . . 0.85999999999999999 109.845 -179.838 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.753 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.909 -0.404 . . . . 0.54000000000000004 109.909 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.7 115.06 25.96 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.603 0.716 . . . . 0.78000000000000003 110.697 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.64 124.08 37.4 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.422 -0.808 . . . . 0.39000000000000001 111.154 -176.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 111' ' ' PRO . 12.0 m -135.47 166.34 27.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.418 -0.81 . . . . 0.22 111.086 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.9 t -112.47 118.63 35.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.795 -0.817 . . . . 0.70999999999999996 108.795 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 13.6 m -120.26 153.37 36.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.903 0.382 . . . . 0.60999999999999999 111.117 -170.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 t -82.39 -29.46 30.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.799 -0.637 . . . . 0.38 111.082 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.43 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 13.3 m120 -156.17 159.16 38.74 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.125 -0.489 . . . . 0.78000000000000003 109.965 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.8 t -135.3 142.44 45.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.127 -0.488 . . . . 0.41999999999999998 110.036 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -130.28 159.74 35.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.646 -0.707 . . . . 0.77000000000000002 109.635 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.667 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 9.7 mm100 59.32 31.32 21.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.16 -0.473 . . . . 0.80000000000000004 111.61 177.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 67.98 -0.27 2.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.709 -0.678 . . . . 2.1200000000000001 111.814 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 142.76 -19.63 2.37 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.78 -0.724 . . . . 0.28000000000000003 112.162 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 34.5 mt -50.3 -43.4 53.57 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.316 0.579 . . . . 0.35999999999999999 110.593 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 t -121.66 123.62 69.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.915 -1.039 . . . . 0.85999999999999999 109.707 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.441 ' ND2' ' SG ' ' A' ' 96' ' ' CYS . 37.3 t30 -128.17 144.58 51.13 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.142 -1.058 . . . . 0.91000000000000003 108.142 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 14.5 m -131.9 153.54 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 113.631 0.974 . . . . 0.29999999999999999 113.631 -172.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 62.94 50.24 65.4 Favored Glycine 0 CA--C 1.505 -0.563 0 CA-C-N 114.729 -1.123 . . . . 0.20000000000000001 111.725 176.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 70' ' ' ASP . 92.5 m -97.28 130.46 44.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.928 0.394 . . . . 0.42999999999999999 111.436 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.8 p -124.22 125.43 25.72 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.659 -0.7 . . . . 0.29999999999999999 109.962 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.587 ' HA ' HG12 ' A' ' 94' ' ' VAL . 78.5 Cg_exo -49.23 122.12 8.02 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.164 2.576 . . . . 0.34000000000000002 113.002 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.9 tt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.751 -0.658 . . . . 0.58999999999999997 110.84 -179.736 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 39' ' ' TYR . 91.4 t . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 107.515 -1.291 . . . . 0.58999999999999997 107.515 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.593 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 95.2 m-85 -129.98 135.45 48.31 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.643 0.735 . . . . 0.78000000000000003 112.23 -177.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.1 t -111.15 98.03 7.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.876 -1.056 . . . . 0.81999999999999995 110.031 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.2 m -99.59 134.2 42.82 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.541 -0.541 . . . . 0.23999999999999999 109.541 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.442 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 5.0 m-20 -51.47 -30.6 20.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.485 -0.78 . . . . 2.0800000000000001 110.342 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -170.51 131.81 0.94 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.456 -1.247 . . . . 2.5800000000000001 108.365 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.605 HG21 HG11 ' A' ' 94' ' ' VAL . 17.9 p -87.82 152.43 22.11 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.337 -0.945 . . . . 0.37 111.08 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.586 ' HB3' HG22 ' A' ' 72' ' ' VAL . 10.8 tp10 -119.6 141.25 49.46 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.99 -1.004 . . . . 1.1200000000000001 109.665 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.473 ' HA ' HD12 ' A' ' 71' ' ' LEU . 6.1 m-20 -68.88 110.59 4.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.477 -0.329 . . . . 1.77 110.981 -176.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.618 ' HA ' HD21 ' A' ' 50' ' ' LEU . 89.3 p -65.93 -8.69 23.87 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.099 0.476 . . . . 0.92000000000000004 111.335 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 3.7 mppt? -74.31 -36.39 63.71 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.512 0.673 . . . . 2.77 110.123 175.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -143.83 65.2 1.31 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.09 -0.959 . . . . 2.3300000000000001 111.107 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.618 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.3 mm? -59.68 157.27 12.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.595 0.712 . . . . 1.1599999999999999 111.609 174.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.32 161.09 30.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.637 -1.165 . . . . 1.8100000000000001 109.08 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.675 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -64.08 -32.01 73.41 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.959 -0.696 . . . . 3.23 110.551 177.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -66.0 -37.1 92.86 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.624 -0.798 . . . . 0.34000000000000002 111.293 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.667 ' HA ' HD22 ' A' ' 57' ' ' LEU . 11.7 m -78.89 -42.59 26.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.121 0.486 . . . . 0.35999999999999999 110.275 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.2 m -53.18 -35.25 59.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.335 -0.848 . . . . 0.29999999999999999 109.797 172.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.88 -54.8 42.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.433 -0.803 . . . . 0.23000000000000001 111.616 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.75 -45.72 89.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.467 0.651 . . . . 0.23999999999999999 110.319 -178.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.5 mt -61.35 -42.1 98.15 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.964 -1.016 . . . . 0.17999999999999999 109.941 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -34.14 84.25 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.791 -0.641 . . . . 0.26000000000000001 112.583 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 26.0 mt -61.64 -50.2 73.5 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.637 0.732 . . . . 0.34000000000000002 109.814 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.468 HD21 ' HG2' ' A' ' 101' ' ' GLN . 3.2 mt -83.99 8.25 15.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.569 -1.196 . . . . 0.35999999999999999 110.669 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.1 p30 50.97 38.19 19.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.495 1.118 . . . . 1.8899999999999999 111.737 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 58' ' ' LEU . 48.4 mt -79.44 140.89 16.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.795 -1.093 . . . . 0.26000000000000001 110.055 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 11.8 mptt -82.6 117.14 22.35 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.887 -0.597 . . . . 2.2200000000000002 110.001 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.78 -31.32 50.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.342 0.591 . . . . 0.28999999999999998 110.138 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.92 -22.24 72.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.031 -0.604 . . . . 0.56999999999999995 112.638 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.58 -13.19 57.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.242 0.544 . . . . 0.85999999999999999 110.253 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 92.3 mt -64.32 151.55 43.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.498 -0.774 . . . . 0.46000000000000002 111.804 -177.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -101.66 -71.12 0.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.811 -1.086 . . . . 2.0099999999999998 113.017 -169.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -120.49 -83.6 0.66 Allowed 'General case' 0 C--O 1.237 0.41 0 N-CA-C 112.54 0.57 . . . . 1.0900000000000001 112.54 -171.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.2 mm? -119.41 168.41 10.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.296 0.57 . . . . 0.14999999999999999 110.606 175.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.586 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -122.95 168.24 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 106.517 -1.66 . . . . 0.25 106.517 167.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.14 129.02 4.24 Favored Glycine 0 C--N 1.312 -0.773 0 C-N-CA 119.62 -1.276 . . . . 0.37 112.041 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.64 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.77 135.88 36.91 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.551 -0.46 . . . . 0.28999999999999998 110.544 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m120 49.51 49.03 20.58 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.024 -0.989 . . . . 1.8500000000000001 110.731 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 9.0 t -85.98 144.1 27.79 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.159 -0.928 . . . . 1.1200000000000001 110.592 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.6 m -102.12 113.44 65.86 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.855 -0.611 . . . . 1.26 110.855 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.89 130.79 26.98 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.847 2.365 . . . . 0.60999999999999999 112.816 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 mt . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.675 -0.693 . . . . 0.85999999999999999 109.213 177.657 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.824 -0.436 . . . . 0.54000000000000004 109.824 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.74 127.04 31.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.098 0.475 . . . . 0.78000000000000003 110.139 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.91 120.32 39.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.274 0.559 . . . . 0.39000000000000001 110.836 -174.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.605 HG11 HG21 ' A' ' 44' ' ' THR . 10.6 m -131.94 164.75 33.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.624 -0.716 . . . . 0.22 111.271 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 34.2 t -109.81 112.12 23.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.178 -0.919 . . . . 0.70999999999999996 109.156 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 35.4 m -107.88 149.19 28.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.883 0.373 . . . . 0.60999999999999999 110.725 -174.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.405 HG22 ' HA3' ' A' ' 108' ' ' GLY . 13.3 t -80.49 -27.21 37.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.914 -0.584 . . . . 0.38 110.455 -174.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.528 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.6 m120 -153.83 163.85 39.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.449 -0.796 . . . . 0.78000000000000003 109.064 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.5 t -136.22 134.21 37.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.165 0.507 . . . . 0.41999999999999998 110.184 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.51 ' HB2' HG23 ' A' ' 105' ' ' VAL . 89.3 m-85 -117.64 149.5 40.59 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.668 -0.696 . . . . 0.77000000000000002 109.94 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.625 ' NE2' HD12 ' A' ' 104' ' ' LEU . 9.7 mm100 62.57 26.92 15.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.759 -0.655 . . . . 0.80000000000000004 111.265 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 64.01 9.07 4.35 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.251 -0.886 . . . . 2.1200000000000001 112.177 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.27 -25.47 1.87 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.342 -0.932 . . . . 0.28000000000000003 113.113 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 16.1 mt -49.16 -41.34 36.21 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.904 0.352 . . . . 0.35999999999999999 111.54 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.51 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -139.78 118.87 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.422 0.63 . . . . 0.85999999999999999 111.047 173.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.566 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 8.7 m-20 -108.16 162.66 13.86 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.579 -0.737 . . . . 0.91000000000000003 109.475 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 14.3 m -135.28 155.43 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.299 0.481 . . . . 0.29999999999999999 112.299 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 58.62 51.82 56.64 Favored Glycine 0 CA--C 1.505 -0.578 0 CA-C-N 115.396 -0.82 . . . . 0.20000000000000001 111.872 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 84.1 m -97.99 129.02 44.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.703 0.287 . . . . 0.42999999999999999 110.721 -175.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.9 p -125.26 128.19 24.81 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.912 -0.585 . . . . 0.29999999999999999 110.054 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.459 ' HA ' HG12 ' A' ' 94' ' ' VAL . 73.1 Cg_exo -51.3 109.28 0.3 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.785 2.323 . . . . 0.34000000000000002 112.061 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.6 tt . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.637 -0.711 . . . . 0.58999999999999997 110.735 -176.195 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.2 t . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 108.443 -0.947 . . . . 0.58999999999999997 108.443 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.618 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 90.5 m-85 -122.28 136.88 54.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.496 0.665 . . . . 0.78000000000000003 111.396 -177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 34.7 t -109.25 98.32 7.77 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.233 -0.894 . . . . 0.81999999999999995 109.604 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.5 m -99.16 137.59 37.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.111 -0.699 . . . . 0.23999999999999999 109.111 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.446 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 39.8 m-80 -59.03 -24.69 63.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.855 -0.611 . . . . 2.0800000000000001 109.965 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -171.75 131.06 0.68 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.409 -1.269 . . . . 2.5800000000000001 108.085 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.556 HG21 HG11 ' A' ' 94' ' ' VAL . 18.1 p -86.55 157.47 19.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.169 -1.012 . . . . 0.37 110.253 171.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HB3' HG22 ' A' ' 72' ' ' VAL . 7.1 tp10 -121.77 138.2 54.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.836 -0.62 . . . . 1.1200000000000001 109.509 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HA ' HD12 ' A' ' 71' ' ' LEU . 12.9 m-20 -67.6 109.5 3.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.194 -0.457 . . . . 1.77 110.159 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.1 p -57.09 -24.34 53.28 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.498 0.499 . . . . 0.92000000000000004 111.208 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -90.78 -12.13 37.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.903 0.383 . . . . 2.77 111.284 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -126.37 25.2 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.979 0.418 . . . . 2.3300000000000001 110.85 -176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.59 156.39 16.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.629 0.728 . . . . 1.1599999999999999 111.91 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.95 168.48 9.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.894 -1.048 . . . . 1.8100000000000001 109.767 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 11.8 mptt -62.01 -33.58 74.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.8 0.333 . . . . 3.23 110.502 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.75 -36.21 92.4 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.152 -0.547 . . . . 0.34000000000000002 112.72 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.585 ' HA ' HD22 ' A' ' 57' ' ' LEU . 25.6 m -82.73 -43.36 16.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.819 0.31 . . . . 0.35999999999999999 110.434 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.5 m -54.67 -33.21 60.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.896 -0.593 . . . . 0.29999999999999999 110.053 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.23 -54.32 46.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.478 -0.783 . . . . 0.23000000000000001 111.508 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.585 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.42 -47.29 84.42 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.268 0.556 . . . . 0.23999999999999999 109.96 -178.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 54' ' ' THR . 25.1 mt -59.63 -41.99 91.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.98 -1.009 . . . . 0.17999999999999999 110.188 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.53 -36.88 93.25 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.752 -0.658 . . . . 0.26000000000000001 112.23 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 19.8 mt -61.3 -39.34 90.12 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.714 0.768 . . . . 0.34000000000000002 110.092 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.644 HD21 ' HG2' ' A' ' 101' ' ' GLN . 4.5 mt -90.81 0.58 57.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.468 -1.242 . . . . 0.35999999999999999 111.113 -176.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 69.03 34.53 3.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.481 -0.781 . . . . 1.8899999999999999 111.349 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 58' ' ' LEU . 41.6 mt -88.71 147.12 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.001 -0.545 . . . . 0.26000000000000001 110.042 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.614 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -100.62 118.96 37.84 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.383 0.611 . . . . 2.2200000000000002 110.061 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -71.64 -31.48 42.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.15 -0.932 . . . . 0.28999999999999998 110.972 -174.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.16 -15.34 74.49 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.966 -0.635 . . . . 0.56999999999999995 112.752 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.451 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 23.8 t70 -95.32 -14.15 24.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.85999999999999999 110.532 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.0 mt -57.87 140.32 52.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.268 0.556 . . . . 0.46000000000000002 110.909 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -94.94 -77.64 0.46 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.231 -0.895 . . . . 2.0099999999999998 112.532 -170.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.03 -98.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.975 0.361 . . . . 1.0900000000000001 111.975 -173.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.6 mm? -109.04 168.92 9.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.558 0.694 . . . . 0.14999999999999999 111.271 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -117.18 167.9 9.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 106.754 -1.573 . . . . 0.25 106.754 166.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -138.34 121.59 2.22 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 119.765 -1.207 . . . . 0.37 111.893 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.711 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -94.06 136.02 34.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.742 -0.783 . . . . 0.28999999999999998 109.705 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 53.14 61.33 3.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.041 0.924 . . . . 1.8500000000000001 109.792 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 7.9 t -103.66 146.1 29.08 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.607 -1.179 . . . . 1.1200000000000001 110.777 -171.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.1 m -102.26 109.97 61.56 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.823 -0.626 . . . . 1.26 110.216 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.9 120.32 7.24 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.777 2.318 . . . . 0.60999999999999999 112.299 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 0.85999999999999999 109.555 -179.716 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 110.017 -0.364 . . . . 0.54000000000000004 110.017 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.05 124.23 28.55 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.354 0.597 . . . . 0.78000000000000003 110.097 -176.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.52 116.0 31.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.744 -0.662 . . . . 0.39000000000000001 110.875 -171.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 44' ' ' THR . 11.2 m -128.29 164.63 29.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.663 -0.699 . . . . 0.22 111.457 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.1 t -108.34 110.98 22.68 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.623 -0.88 . . . . 0.70999999999999996 108.623 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.8 m -112.92 146.41 39.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.934 0.397 . . . . 0.60999999999999999 110.713 -172.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.7 t -81.11 -23.11 38.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 0.38 111.289 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -159.5 168.1 27.01 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.511 -0.551 . . . . 0.78000000000000003 109.511 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.9 t -140.26 142.47 35.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.538 -0.301 . . . . 0.41999999999999998 110.633 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.637 ' HB2' HG23 ' A' ' 105' ' ' VAL . 83.9 m-85 -134.12 158.32 43.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.909 -0.316 . . . . 0.77000000000000002 110.686 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.644 ' HG2' HD21 ' A' ' 61' ' ' LEU . 6.5 mm100 59.43 40.25 21.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.80000000000000004 111.549 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 p80 58.04 2.07 0.17 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.117 0.967 . . . . 2.1200000000000001 112.393 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.98 -15.9 3.04 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.966 -0.635 . . . . 0.28000000000000003 112.658 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.711 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 24.6 mt -56.1 -37.29 69.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.076 0.438 . . . . 0.35999999999999999 111.594 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.637 HG23 ' HB2' ' A' ' 100' ' ' TYR . 3.6 m -130.39 149.82 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.333 0.587 . . . . 0.85999999999999999 110.314 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.488 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.5 t30 -142.98 153.35 42.91 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.6 -0.889 . . . . 0.91000000000000003 108.6 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.5 m -131.62 150.41 34.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.783 0.66 . . . . 0.29999999999999999 112.783 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.11 52.32 53.52 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.939 -1.028 . . . . 0.20000000000000001 111.824 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 83.1 m -97.31 127.05 42.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.741 0.305 . . . . 0.42999999999999999 111.225 -176.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 p -120.79 126.47 26.67 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.93 -0.577 . . . . 0.29999999999999999 110.574 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.513 ' HA ' HG12 ' A' ' 94' ' ' VAL . 50.5 Cg_exo -53.8 110.68 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.917 2.411 . . . . 0.34000000000000002 112.112 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.4 tt . . . . . 0 C--N 1.324 -0.539 0 CA-C-O 121.273 0.559 . . . . 0.58999999999999997 110.882 -177.191 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 39' ' ' TYR . 97.6 t . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 107.761 -1.2 . . . . 0.58999999999999997 107.761 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.452 ' N ' HG12 ' A' ' 38' ' ' VAL . 91.9 m-85 -124.21 135.48 53.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.885 0.85 . . . . 0.78000000000000003 111.605 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.709 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 44.0 t -107.98 111.09 22.99 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.833 -1.076 . . . . 0.81999999999999995 109.964 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 65.4 m -110.37 129.62 55.72 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.32 -0.622 . . . . 0.23999999999999999 109.32 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -62.88 -17.49 61.69 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.538 -0.756 . . . . 2.0800000000000001 109.832 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -169.28 133.83 1.44 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.765 -1.107 . . . . 2.5800000000000001 108.622 172.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.495 HG21 HG11 ' A' ' 94' ' ' VAL . 29.2 p -94.53 151.84 19.02 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.442 -0.903 . . . . 0.37 110.679 168.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.538 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.7 tp10 -119.78 142.73 48.32 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.194 -0.912 . . . . 1.1200000000000001 109.527 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.465 ' O ' HD13 ' A' ' 50' ' ' LEU . 44.8 m-20 -67.28 108.39 2.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.523 -0.308 . . . . 1.77 110.52 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.561 ' HA ' HD21 ' A' ' 50' ' ' LEU . 70.0 p -68.67 -1.16 6.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.955 -0.566 . . . . 0.92000000000000004 112.513 -172.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -79.17 -43.82 23.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.928 0.394 . . . . 2.77 110.145 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -144.77 70.95 1.29 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.569 -0.53 . . . . 2.3300000000000001 109.569 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 47' ' ' SER . 3.1 mm? -55.32 153.49 7.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.338 -0.846 . . . . 1.1599999999999999 112.406 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.95 153.34 21.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.672 -1.149 . . . . 1.8100000000000001 109.406 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -55.96 -41.45 74.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.249 0.477 . . . . 3.23 110.601 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -61.41 -36.85 93.15 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.839 -0.619 . . . . 0.34000000000000002 112.32 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.656 ' HA ' HD22 ' A' ' 57' ' ' LEU . 29.2 m -82.29 -41.43 20.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.836 0.351 . . . . 0.35999999999999999 110.274 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.0 m -53.77 -34.99 60.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.781 -0.645 . . . . 0.29999999999999999 109.861 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.523 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.46 -52.74 63.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.367 -0.833 . . . . 0.23000000000000001 111.92 175.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.656 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -61.17 -44.43 97.31 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.556 0.693 . . . . 0.23999999999999999 110.037 -178.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 54' ' ' THR . 46.1 mt -60.05 -44.41 94.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.822 -1.081 . . . . 0.17999999999999999 109.903 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.82 -32.42 79.31 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.631 -0.713 . . . . 0.26000000000000001 113.043 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 33.9 mt -59.83 -41.96 92.49 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.833 0.825 . . . . 0.34000000000000002 110.323 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.479 HD21 ' HG2' ' A' ' 101' ' ' GLN . 3.8 mt -91.18 -5.61 54.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.406 -1.27 . . . . 0.35999999999999999 110.855 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.9 t30 69.62 36.9 2.03 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.047 -0.979 . . . . 1.8899999999999999 110.661 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 58' ' ' LEU . 64.2 mt -77.77 146.19 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.797 -0.638 . . . . 0.26000000000000001 110.029 175.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.665 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -93.99 117.72 30.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.74 -0.664 . . . . 2.2200000000000002 110.279 -178.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.91 -40.6 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.609 -0.723 . . . . 0.28999999999999998 111.279 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.93 -7.48 62.22 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.75 -0.738 . . . . 0.56999999999999995 112.845 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.477 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 28.7 t70 -104.5 -12.44 16.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.08 0.467 . . . . 0.85999999999999999 110.529 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.1 mt -62.33 149.84 41.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.845 -0.616 . . . . 0.46000000000000002 110.974 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -95.86 -78.59 0.46 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.458 0.91 . . . . 2.0099999999999998 113.458 -169.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 0.2 OUTLIER -105.95 -85.19 0.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.8 -0.36 . . . . 1.0900000000000001 111.741 -172.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 0.9 OUTLIER -120.97 168.17 11.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.169 0.509 . . . . 0.14999999999999999 110.871 177.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -122.25 168.5 14.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 106.821 -1.548 . . . . 0.25 106.821 165.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.508 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -136.53 144.09 15.67 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.83 -1.176 . . . . 0.37 111.698 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -104.96 128.14 53.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.128 0.49 . . . . 0.28999999999999998 110.116 176.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.4 m120 57.77 53.48 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.974 -1.012 . . . . 1.8500000000000001 110.999 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.508 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 58.9 m -87.67 141.57 28.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.399 -0.819 . . . . 1.1200000000000001 111.067 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.2 m -101.21 124.69 40.48 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.679 -0.692 . . . . 1.26 110.399 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.08 129.07 15.65 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.524 2.149 . . . . 0.60999999999999999 112.57 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 mt . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 115.285 -0.87 . . . . 0.85999999999999999 109.307 178.844 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.709 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--O 1.235 0.29 0 N-CA-C 109.515 -0.55 . . . . 0.54000000000000004 109.515 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.76 121.54 25.48 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.549 0.69 . . . . 0.78000000000000003 110.033 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.77 121.38 41.57 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.774 -0.648 . . . . 0.39000000000000001 111.356 -171.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 111' ' ' PRO . 9.0 m -133.78 165.87 30.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.598 -0.728 . . . . 0.22 110.847 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 18.0 m -114.06 125.09 53.6 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.75 -0.659 . . . . 0.70999999999999996 109.233 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 22.8 m -121.23 149.97 42.04 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.074 -0.512 . . . . 0.60999999999999999 110.465 -171.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.3 t -80.85 -28.37 36.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.73 -0.668 . . . . 0.38 110.789 -171.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.563 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 21.9 m120 -152.73 159.68 43.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.78000000000000003 109.764 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.4 t -136.12 147.39 47.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.472 -0.331 . . . . 0.41999999999999998 110.114 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.579 ' HB2' HG23 ' A' ' 105' ' ' VAL . 65.7 m-85 -137.17 158.24 44.89 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.83 -0.433 . . . . 0.77000000000000002 109.83 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.479 ' HG2' HD21 ' A' ' 61' ' ' LEU . 7.8 mm100 62.51 26.6 15.82 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.566 -0.288 . . . . 0.80000000000000004 111.54 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 65.52 0.19 1.36 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.87 -0.604 . . . . 2.1200000000000001 112.534 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.8 -21.99 1.29 Allowed Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.91 -1.138 . . . . 0.28000000000000003 113.621 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.8 mt -51.07 -37.31 44.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.583 0.692 . . . . 0.35999999999999999 111.198 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.579 HG23 ' HB2' ' A' ' 100' ' ' TYR . 5.6 m -131.7 144.43 37.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.813 -0.631 . . . . 0.85999999999999999 109.768 174.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 15.4 t30 -142.86 141.41 31.56 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.974 -1.121 . . . . 0.91000000000000003 107.974 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.563 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.2 m -125.68 152.27 32.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 113.291 0.849 . . . . 0.29999999999999999 113.291 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 64.53 51.71 49.74 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.799 -1.091 . . . . 0.20000000000000001 111.665 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 74.6 m -97.98 128.45 44.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.856 0.36 . . . . 0.42999999999999999 111.494 -174.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.0 p -124.03 126.36 25.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.757 -0.656 . . . . 0.29999999999999999 109.418 173.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.539 ' HA ' HG12 ' A' ' 94' ' ' VAL . 79.6 Cg_exo -50.69 109.15 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.058 2.505 . . . . 0.34000000000000002 112.336 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.41 HD12 ' SG ' ' A' ' 95' ' ' CYS . 4.2 tt . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 115.679 -0.691 . . . . 0.58999999999999997 111.144 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 39' ' ' TYR . 92.1 t . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.547 -0.538 . . . . 0.58999999999999997 109.547 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.423 ' N ' HG12 ' A' ' 38' ' ' VAL . 52.8 m-85 -129.69 134.99 47.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.869 0.366 . . . . 0.78000000000000003 110.54 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 38.6 t -108.06 112.06 24.43 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.302 -0.408 . . . . 0.81999999999999995 109.95 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 72.9 m -103.31 134.15 47.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.143 0.496 . . . . 0.23999999999999999 110.422 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.464 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 88.4 m-20 -59.65 -19.58 50.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.226 -0.897 . . . . 2.0800000000000001 110.361 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -173.13 124.66 0.42 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.71 -1.132 . . . . 2.5800000000000001 107.986 176.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.581 HG21 HG11 ' A' ' 94' ' ' VAL . 8.0 p -78.2 148.0 34.22 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.243 -0.983 . . . . 0.37 110.838 170.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -109.96 138.81 45.81 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.009 -0.996 . . . . 1.1200000000000001 109.017 -176.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.67 104.9 4.76 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.741 -0.663 . . . . 1.77 110.337 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.704 ' HA ' HD21 ' A' ' 50' ' ' LEU . 50.1 m -58.93 -16.64 18.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.473 0.546 . . . . 0.92000000000000004 112.473 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -86.57 -20.23 28.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.744 0.307 . . . . 2.77 110.659 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -148.76 57.21 1.04 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.456 -0.338 . . . . 2.3300000000000001 111.601 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -59.59 145.75 43.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.39 0.614 . . . . 1.1599999999999999 111.665 176.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -71.03 156.76 39.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.146 -0.934 . . . . 1.8100000000000001 109.714 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -59.56 -41.65 90.62 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.909 -0.317 . . . . 3.23 110.948 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.03 -38.29 84.59 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.116 -0.564 . . . . 0.34000000000000002 112.34 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.668 ' HA ' HD22 ' A' ' 57' ' ' LEU . 26.2 m -79.92 -43.72 21.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.881 0.372 . . . . 0.35999999999999999 110.559 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -53.89 -34.8 60.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.673 -0.694 . . . . 0.29999999999999999 109.823 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.607 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.14 -52.23 66.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.85 -1.068 . . . . 0.23000000000000001 111.549 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.668 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -60.48 -45.75 92.62 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.424 0.63 . . . . 0.23999999999999999 109.958 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 54' ' ' THR . 50.6 mt -57.96 -45.86 86.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.848 -1.069 . . . . 0.17999999999999999 109.917 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.03 -36.87 91.7 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.621 -0.718 . . . . 0.26000000000000001 112.573 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 25.5 mt -59.61 -47.37 85.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.597 0.713 . . . . 0.34000000000000002 110.238 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.538 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.7 mt -84.48 -4.76 59.11 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.683 -1.144 . . . . 0.35999999999999999 111.556 -176.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 70.63 35.54 1.84 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.741 0.781 . . . . 1.8899999999999999 110.524 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 58' ' ' LEU . 60.6 mt -79.6 146.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.162 -0.681 . . . . 0.26000000000000001 109.162 174.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.601 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.33 117.44 32.75 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.536 0.684 . . . . 2.2200000000000002 110.127 -177.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.44 -31.4 42.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.054 -0.975 . . . . 0.28999999999999998 110.628 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.06 -14.83 78.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.941 -0.647 . . . . 0.56999999999999995 113.404 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -101.58 -12.57 18.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.07 0.435 . . . . 0.85999999999999999 110.91 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.5 mt -51.75 127.09 19.72 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.661 0.743 . . . . 0.46000000000000002 111.447 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -76.16 -54.38 6.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.424 -1.262 . . . . 2.0099999999999998 113.263 -166.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.17 -84.41 0.37 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.963 -0.295 . . . . 1.0900000000000001 111.614 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.4 mm? -115.11 168.04 10.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.426 0.631 . . . . 0.14999999999999999 110.798 173.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 50' ' ' LEU . 1.6 m -121.67 172.26 9.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.362 -1.718 . . . . 0.25 106.362 168.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -138.96 150.12 21.03 Favored Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.119 -1.038 . . . . 0.37 111.486 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -116.36 133.72 55.7 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.989 0.423 . . . . 0.28999999999999998 109.876 174.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.5 m120 53.09 52.92 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.965 -1.016 . . . . 1.8500000000000001 111.027 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.422 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 35.7 m -86.46 152.4 22.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.479 -0.782 . . . . 1.1200000000000001 110.473 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.5 m -107.37 115.55 59.42 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.773 -0.648 . . . . 1.26 109.932 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.37 121.77 9.11 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.546 2.164 . . . . 0.60999999999999999 111.769 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.518 HD11 ' HB2' ' A' ' 40' ' ' CYS . 27.1 mt . . . . . 0 C--N 1.32 -0.695 0 CA-C-N 115.747 -0.661 . . . . 0.85999999999999999 110.027 -177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.605 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.532 0.206 . . . . 0.54000000000000004 110.841 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.41 122.87 32.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.271 0.557 . . . . 0.78000000000000003 110.745 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.97 123.16 39.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.229 0.538 . . . . 0.39000000000000001 111.147 -174.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.581 HG11 HG21 ' A' ' 44' ' ' THR . 6.5 m -133.85 167.54 26.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.588 -0.733 . . . . 0.22 111.49 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 41.8 t -111.35 121.74 46.04 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.473 -0.936 . . . . 0.70999999999999996 108.473 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 22.9 m -122.35 148.63 44.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.023 0.439 . . . . 0.60999999999999999 110.969 -171.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.9 t -79.2 -28.15 42.6 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.423 -0.808 . . . . 0.38 110.837 -169.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.499 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 19.6 m120 -156.0 161.64 40.44 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.053 -0.721 . . . . 0.78000000000000003 109.053 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.7 t -142.22 144.67 33.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.799 0.333 . . . . 0.41999999999999998 110.516 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.589 ' HB2' HG23 ' A' ' 105' ' ' VAL . 70.3 m-85 -133.65 160.77 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.756 -0.461 . . . . 0.77000000000000002 109.756 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.636 ' NE2' HD12 ' A' ' 104' ' ' LEU . 11.4 mm100 60.97 23.7 13.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 0.80000000000000004 111.566 175.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 63.01 13.39 6.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.582 -0.735 . . . . 2.1200000000000001 112.442 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.88 -24.34 3.01 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.211 -0.995 . . . . 0.28000000000000003 113.133 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.636 HD12 ' NE2' ' A' ' 101' ' ' GLN . 14.9 mt -49.63 -38.01 30.37 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.852 0.326 . . . . 0.35999999999999999 111.018 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.589 HG23 ' HB2' ' A' ' 100' ' ' TYR . 4.2 m -131.87 141.53 45.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.892 -0.595 . . . . 0.85999999999999999 109.559 172.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.438 ' ND2' ' SG ' ' A' ' 96' ' ' CYS . 21.5 t30 -140.63 144.63 35.85 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.201 -1.037 . . . . 0.91000000000000003 108.201 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.499 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.4 m -129.46 151.02 35.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 113.396 0.887 . . . . 0.29999999999999999 113.396 -172.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 64.07 51.85 49.6 Favored Glycine 0 CA--C 1.506 -0.505 0 CA-C-N 114.91 -1.041 . . . . 0.20000000000000001 111.807 177.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 90.9 m -97.12 127.91 43.53 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.014 0.435 . . . . 0.42999999999999999 111.884 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.7 p -122.26 126.47 26.23 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.528 -0.76 . . . . 0.29999999999999999 109.701 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.522 ' HA ' HG12 ' A' ' 94' ' ' VAL . 71.4 Cg_exo -50.46 110.49 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.003 2.469 . . . . 0.34000000000000002 112.586 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 115.688 -0.687 . . . . 0.58999999999999997 110.664 -179.439 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 39' ' ' TYR . 94.5 t . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 108.143 -1.058 . . . . 0.58999999999999997 108.143 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.434 ' N ' HG12 ' A' ' 38' ' ' VAL . 45.7 m-85 -124.2 130.82 53.19 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.875 -0.73 . . . . 0.78000000000000003 111.362 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 36.2 t -105.14 106.12 16.47 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.442 -0.799 . . . . 0.81999999999999995 109.426 176.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -97.8 133.3 42.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.801 -0.636 . . . . 0.23999999999999999 110.44 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.435 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 3.1 m-20 -58.53 -24.85 61.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.772 . . . . 2.0800000000000001 109.716 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.547 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -162.79 135.61 5.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.176 -1.375 . . . . 2.5800000000000001 107.446 177.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.603 HG21 HG11 ' A' ' 94' ' ' VAL . 23.7 p -92.63 159.67 15.36 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.356 -0.938 . . . . 0.37 110.062 165.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.554 ' HB3' HG22 ' A' ' 72' ' ' VAL . 8.0 tp10 -126.28 140.32 52.62 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.608 -0.724 . . . . 1.1200000000000001 109.712 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.426 ' HA ' HD12 ' A' ' 71' ' ' LEU . 3.2 m-20 -72.31 109.15 5.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.073 -0.512 . . . . 1.77 110.438 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.603 ' HA ' HD21 ' A' ' 50' ' ' LEU . 88.0 p -64.12 -4.92 3.97 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.48 0.548 . . . . 0.92000000000000004 112.48 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.4 mptp? -73.84 -42.11 61.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.342 0.592 . . . . 2.77 110.243 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -142.51 66.67 1.33 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.19 -0.913 . . . . 2.3300000000000001 110.735 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.603 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -56.97 148.76 20.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.176 0.512 . . . . 1.1599999999999999 111.522 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.26 166.16 19.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.589 -0.732 . . . . 1.8100000000000001 109.78 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 11.3 mptt -58.98 -47.68 84.28 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.539 -0.464 . . . . 3.23 110.698 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.65 -39.27 75.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.066 -0.587 . . . . 0.34000000000000002 112.517 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.674 ' HA ' HD22 ' A' ' 57' ' ' LEU . 13.4 m -77.86 -43.17 31.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.753 0.311 . . . . 0.35999999999999999 110.559 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.9 m -56.05 -33.71 65.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.3 0.572 . . . . 0.29999999999999999 109.795 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.586 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.29 -54.51 46.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.17 -0.923 . . . . 0.23000000000000001 111.304 176.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.674 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -58.12 -46.75 85.05 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.485 0.66 . . . . 0.23999999999999999 110.039 -179.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.5 mt -58.69 -44.83 90.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.972 -1.013 . . . . 0.17999999999999999 110.195 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.82 -37.18 92.11 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.955 -0.64 . . . . 0.26000000000000001 112.686 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.5 mt -60.12 -45.58 92.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.041 0.924 . . . . 0.34000000000000002 110.312 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.432 ' CD1' HG21 ' A' ' 105' ' ' VAL . 6.8 mt -86.31 -0.02 54.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.391 -1.277 . . . . 0.35999999999999999 111.371 -176.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 68.79 31.25 4.51 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.544 -0.753 . . . . 1.8899999999999999 111.093 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 58' ' ' LEU . 53.6 mt -79.95 145.08 9.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.827 -0.624 . . . . 0.26000000000000001 109.806 177.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.56 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -98.35 118.2 34.47 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.761 -0.654 . . . . 2.2200000000000002 109.93 -178.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.14 -38.02 54.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.345 -0.843 . . . . 0.28999999999999998 110.963 -174.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.75 -1.98 63.43 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.846 -0.693 . . . . 0.56999999999999995 113.007 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.492 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 33.9 t70 -113.97 2.13 14.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.628 0.728 . . . . 0.85999999999999999 109.968 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.7 mt -74.19 152.47 39.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.593 -0.73 . . . . 0.46000000000000002 111.074 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -95.84 -97.64 0.18 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 2.0099999999999998 112.401 -173.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.79 -93.27 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.13 0.419 . . . . 1.0900000000000001 112.13 -173.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.1 mm? -111.61 170.02 8.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.41 0.624 . . . . 0.14999999999999999 111.279 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.606 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.9 OUTLIER -121.39 165.5 16.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 106.189 -1.782 . . . . 0.25 106.189 165.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.47 134.08 6.8 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 119.748 -1.215 . . . . 0.37 112.124 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.659 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -100.89 136.45 40.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.459 . . . . 0.28999999999999998 110.581 178.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.6 m120 51.49 52.2 15.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.855 -1.066 . . . . 1.8500000000000001 111.095 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.1 m -88.51 138.75 31.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.001 -0.545 . . . . 1.1200000000000001 110.89 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 m -86.68 119.6 71.39 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.75 -0.659 . . . . 1.26 110.139 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.27 121.16 7.53 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.467 2.111 . . . . 0.60999999999999999 112.133 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 mt . . . . . 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 0.85999999999999999 109.196 179.91 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.598 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.809 0.338 . . . . 0.54000000000000004 111.279 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.56 117.83 30.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.33 0.586 . . . . 0.78000000000000003 110.753 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.71 121.92 32.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.323 0.583 . . . . 0.39000000000000001 111.566 -174.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.603 HG11 HG21 ' A' ' 44' ' ' THR . 6.7 m -133.26 164.27 35.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.552 -0.749 . . . . 0.22 110.939 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.9 t -113.38 112.29 23.41 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.54 -0.754 . . . . 0.70999999999999996 109.317 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 21.9 m -106.28 145.0 32.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.363 -0.381 . . . . 0.60999999999999999 110.311 -174.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.3 t -77.3 -25.53 51.39 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.069 -0.514 . . . . 0.38 110.797 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.64 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 19.8 m120 -148.67 155.75 41.45 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.786 -0.82 . . . . 0.78000000000000003 108.786 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.4 t -123.12 144.54 49.26 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.915 0.388 . . . . 0.41999999999999998 110.181 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.532 ' CB ' HG23 ' A' ' 105' ' ' VAL . 26.0 m-85 -130.19 143.27 50.68 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.016 -0.538 . . . . 0.77000000000000002 110.731 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.664 ' NE2' HD12 ' A' ' 104' ' ' LEU . 7.9 mm100 60.93 32.85 19.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.80000000000000004 111.817 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 66.06 0.33 1.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.197 0.599 . . . . 2.1200000000000001 112.431 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.97 -19.78 1.96 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.372 -0.918 . . . . 0.28000000000000003 112.817 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.664 HD12 ' NE2' ' A' ' 101' ' ' GLN . 20.0 mt -51.89 -39.51 59.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.742 0.271 . . . . 0.35999999999999999 111.258 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.532 HG23 ' CB ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -136.4 145.41 30.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.385 -0.371 . . . . 0.85999999999999999 110.531 175.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.606 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 41.4 m-80 -140.28 161.95 36.46 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.298 -0.63 . . . . 0.91000000000000003 109.298 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.64 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 8.3 m -133.71 150.05 31.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.009 0.374 . . . . 0.29999999999999999 112.009 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 58.7 54.89 34.15 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.328 -0.851 . . . . 0.20000000000000001 111.583 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 75.5 m -96.3 124.48 40.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.997 0.427 . . . . 0.42999999999999999 110.669 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 p -121.18 125.49 26.93 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.629 -0.714 . . . . 0.29999999999999999 110.524 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HA ' HG12 ' A' ' 94' ' ' VAL . 78.6 Cg_exo -47.62 114.01 0.93 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.29 2.66 . . . . 0.34000000000000002 112.776 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.2 tt . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.503 -0.771 . . . . 0.58999999999999997 110.799 -176.951 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.53 HG12 ' N ' ' A' ' 39' ' ' TYR . 47.3 t . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 107.99 -1.115 . . . . 0.58999999999999997 107.99 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.557 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 75.4 m-85 -128.71 120.62 26.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.954 0.883 . . . . 0.78000000000000003 112.034 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.622 ' HB2' HD21 ' A' ' 79' ' ' LEU . 33.1 t -91.13 99.13 12.2 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.344 -1.298 . . . . 0.81999999999999995 110.305 177.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.8 m -101.89 129.65 48.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.674 -0.861 . . . . 0.23999999999999999 108.674 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -53.57 -29.52 37.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.356 -0.838 . . . . 2.0800000000000001 110.439 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -170.5 125.13 0.72 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.001 -1.111 . . . . 2.5800000000000001 108.001 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.567 HG21 HG11 ' A' ' 94' ' ' VAL . 20.5 p -85.59 142.15 29.32 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.286 -0.966 . . . . 0.37 111.462 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.58 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.6 tp10 -114.21 142.21 46.55 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.891 -1.05 . . . . 1.1200000000000001 109.591 -174.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.414 ' O ' HD13 ' A' ' 50' ' ' LEU . 10.3 m-20 -62.0 110.79 1.68 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.372 -0.377 . . . . 1.77 110.443 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.587 ' HA ' HD21 ' A' ' 50' ' ' LEU . 77.5 p -65.88 -8.32 21.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.198 0.523 . . . . 0.92000000000000004 111.173 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -91.23 -24.68 19.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.993 -0.549 . . . . 2.77 110.067 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -141.06 59.71 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.029 -0.532 . . . . 2.3300000000000001 111.132 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.7 mm? -64.21 152.61 40.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 1.1599999999999999 111.768 176.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.82 152.86 43.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.551 -0.907 . . . . 1.8100000000000001 108.551 171.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.545 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -57.81 -29.4 64.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.121 -0.632 . . . . 3.23 110.146 176.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -66.17 -40.47 94.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.119 -0.562 . . . . 0.34000000000000002 111.736 176.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.651 ' HA ' HD22 ' A' ' 57' ' ' LEU . 20.0 m -78.06 -42.34 32.58 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.025 -0.27 . . . . 0.35999999999999999 110.647 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.0 m -53.61 -35.62 61.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.962 -0.563 . . . . 0.29999999999999999 109.685 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.527 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.75 -54.32 47.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.211 -0.904 . . . . 0.23000000000000001 111.772 176.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.651 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -59.56 -45.46 91.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.48 0.657 . . . . 0.23999999999999999 109.919 -178.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 54' ' ' THR . 48.6 mt -60.01 -44.38 94.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.886 -1.052 . . . . 0.17999999999999999 109.767 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.79 -38.71 92.64 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.707 -0.679 . . . . 0.26000000000000001 112.44 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 24.8 mt -56.89 -49.17 76.35 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.657 0.741 . . . . 0.34000000000000002 110.176 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.7 mt -84.16 -0.78 53.4 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.589 -1.187 . . . . 0.35999999999999999 111.13 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 66.91 35.82 4.65 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.269 -0.878 . . . . 1.8899999999999999 111.252 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 58' ' ' LEU . 52.5 mt -84.08 142.22 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 115.626 -0.716 . . . . 0.26000000000000001 109.702 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.401 ' H ' ' HD3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -95.67 118.2 31.92 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.345 0.593 . . . . 2.2200000000000002 110.12 -178.065 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.58 -30.26 44.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.114 -0.948 . . . . 0.28999999999999998 110.573 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.61 -8.59 84.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.862 -0.685 . . . . 0.56999999999999995 112.968 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -110.04 3.26 20.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.376 0.607 . . . . 0.85999999999999999 110.638 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.2 mt -72.81 156.49 38.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.272 0.558 . . . . 0.46000000000000002 111.05 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -92.76 -82.47 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.543 -0.753 . . . . 2.0099999999999998 112.854 -170.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.42 -88.36 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 1.0900000000000001 111.857 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.1 mm? -114.0 169.23 9.16 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.13 0.49 . . . . 0.14999999999999999 110.892 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.618 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -121.57 168.26 14.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.037 -1.468 . . . . 0.25 107.037 167.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.401 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -138.49 127.27 3.72 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.687 -1.244 . . . . 0.37 112.414 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -90.86 136.08 33.31 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.259 -0.576 . . . . 0.28999999999999998 110.179 178.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.8 m120 49.67 49.69 19.59 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.15 -0.932 . . . . 1.8500000000000001 110.848 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 6.0 t -87.62 142.13 28.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.448 -0.796 . . . . 1.1200000000000001 110.523 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.7 m -113.57 116.27 46.05 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.627 -0.715 . . . . 1.26 111.07 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 23.3 Cg_exo -64.95 129.8 24.18 Favored 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 122.623 2.216 . . . . 0.60999999999999999 112.078 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 40' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 N-CA-C 109.688 -0.486 . . . . 0.85999999999999999 109.688 177.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.548 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--O 1.235 0.324 0 N-CA-C 110.08 -0.341 . . . . 0.54000000000000004 110.08 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.83 134.13 35.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.718 -0.475 . . . . 0.78000000000000003 109.718 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.69 117.85 34.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.284 0.564 . . . . 0.39000000000000001 111.216 -172.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.567 HG11 HG21 ' A' ' 44' ' ' THR . 6.7 m -131.78 165.48 31.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.616 -0.72 . . . . 0.22 110.942 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 37.6 t -110.58 120.75 43.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.419 -0.956 . . . . 0.70999999999999996 108.419 176.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 30.9 m -117.85 151.42 37.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.036 0.446 . . . . 0.60999999999999999 110.844 -170.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.6 t -78.92 -28.39 43.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.631 -0.713 . . . . 0.38 110.448 -172.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.432 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 13.5 m120 -153.57 163.45 39.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.921 -0.581 . . . . 0.78000000000000003 109.977 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.0 t -127.99 130.5 48.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.108 0.48 . . . . 0.41999999999999998 110.375 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.493 ' CB ' HG23 ' A' ' 105' ' ' VAL . 44.2 m-85 -119.48 142.21 48.48 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.749 -0.659 . . . . 0.77000000000000002 110.79 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.455 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 6.6 mm100 61.56 33.27 18.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.071 -0.513 . . . . 0.80000000000000004 111.824 175.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 63.21 6.58 2.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.044 0.538 . . . . 2.1200000000000001 112.181 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.28 -22.11 2.92 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.893 -1.146 . . . . 0.28000000000000003 113.425 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 13.7 mt -50.12 -40.85 47.39 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.475 0.638 . . . . 0.35999999999999999 110.547 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.493 HG23 ' CB ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -130.14 119.09 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.494 0.664 . . . . 0.85999999999999999 110.298 174.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.618 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 2.7 t30 -113.51 151.87 30.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.321 -0.992 . . . . 0.91000000000000003 108.321 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 10.5 m -135.55 152.16 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.048 0.758 . . . . 0.29999999999999999 113.048 -175.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 65.75 49.1 61.4 Favored Glycine 0 CA--C 1.506 -0.511 0 CA-C-N 115.154 -0.93 . . . . 0.20000000000000001 111.755 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 72.5 m -97.89 126.36 43.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.894 0.378 . . . . 0.42999999999999999 111.454 -172.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -120.23 126.05 26.99 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.703 -0.681 . . . . 0.29999999999999999 110.009 175.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.552 ' HA ' HG12 ' A' ' 94' ' ' VAL . 73.6 Cg_exo -49.61 109.87 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.12 2.546 . . . . 0.34000000000000002 112.345 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 tt . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.665 -0.698 . . . . 0.58999999999999997 110.789 -175.233 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 39' ' ' TYR . 97.5 t . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 107.616 -1.253 . . . . 0.58999999999999997 107.616 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.483 ' N ' HG12 ' A' ' 38' ' ' VAL . 77.1 m-85 -127.06 139.05 53.28 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.892 0.769 . . . . 0.78000000000000003 111.779 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 42.7 t -116.14 103.77 10.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.323 -0.853 . . . . 0.81999999999999995 110.292 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.6 m -106.01 135.95 46.54 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.253 -0.647 . . . . 0.23999999999999999 109.253 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.467 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 59.0 m-80 -59.32 -23.66 62.66 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.696 -0.684 . . . . 2.0800000000000001 110.622 177.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HD3' ' O ' ' A' ' 44' ' ' THR . 12.4 tmtt? -176.15 125.33 0.2 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.739 -1.208 . . . . 2.5800000000000001 107.739 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.588 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 34.1 p -89.64 152.55 21.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.43 -0.908 . . . . 0.37 111.538 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.601 ' HB3' HG22 ' A' ' 72' ' ' VAL . 14.8 tp10 -115.14 138.33 51.02 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.256 -0.883 . . . . 1.1200000000000001 109.15 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.459 ' HA ' HD12 ' A' ' 71' ' ' LEU . 17.6 m-20 -74.59 109.23 7.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.357 -0.383 . . . . 1.77 110.495 -175.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.475 ' HA ' HD21 ' A' ' 50' ' ' LEU . 6.3 m -50.76 -25.31 4.23 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.971 0.794 . . . . 0.92000000000000004 112.454 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.501 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.4 mptp? -64.83 -45.5 85.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.238 0.542 . . . . 2.77 111.012 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -133.45 58.07 1.78 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.548 -0.751 . . . . 2.3300000000000001 110.522 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.475 HD21 ' HA ' ' A' ' 47' ' ' SER . 80.5 mt -57.17 158.36 5.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.311 -0.859 . . . . 1.1599999999999999 112.812 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.66 154.97 39.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.505 -1.225 . . . . 1.8100000000000001 109.243 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -67.54 -32.99 74.15 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.066 -0.346 . . . . 3.23 110.066 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -67.01 -33.74 84.75 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.478 -0.649 . . . . 0.34000000000000002 111.478 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.641 ' HA ' HD22 ' A' ' 57' ' ' LEU . 28.3 m -79.33 -44.29 21.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.35999999999999999 110.056 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.4 m -52.79 -35.37 56.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.485 -0.78 . . . . 0.29999999999999999 109.819 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.528 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.76 -51.59 68.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.306 -0.861 . . . . 0.23000000000000001 112.013 176.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.641 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -61.84 -43.66 98.39 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.518 0.675 . . . . 0.23999999999999999 109.961 -178.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.2 mt -60.24 -44.25 95.4 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.933 -1.03 . . . . 0.17999999999999999 110.105 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.29 -38.08 89.15 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.775 -0.648 . . . . 0.26000000000000001 112.281 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 32.7 mt -57.11 -50.44 72.77 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.746 0.784 . . . . 0.34000000000000002 110.124 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.488 HD21 ' HG2' ' A' ' 101' ' ' GLN . 5.0 mt -84.02 -2.85 57.43 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.581 -1.19 . . . . 0.35999999999999999 111.501 -174.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 68.17 35.01 3.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.725 0.774 . . . . 1.8899999999999999 110.488 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 58' ' ' LEU . 55.8 mt -81.77 146.61 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.468 -0.787 . . . . 0.26000000000000001 110.008 176.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -95.98 117.92 31.59 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.265 0.555 . . . . 2.2200000000000002 110.198 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -71.72 -29.98 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.297 -0.865 . . . . 0.28999999999999998 110.332 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.22 -16.64 78.63 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.949 -0.569 . . . . 0.56999999999999995 112.679 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -91.67 -16.41 27.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.179 0.514 . . . . 0.85999999999999999 110.2 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.37 137.86 57.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.64 -0.709 . . . . 0.46000000000000002 111.025 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 2.4 mptp? -94.07 -88.72 0.23 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.168 -0.923 . . . . 2.0099999999999998 111.808 -170.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.13 -96.2 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.888 0.329 . . . . 1.0900000000000001 111.888 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 44' ' ' THR . 1.8 mm? -111.24 170.83 7.85 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.475 0.655 . . . . 0.14999999999999999 111.363 178.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -125.14 169.9 15.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 107.065 -1.457 . . . . 0.25 107.065 166.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -138.69 131.43 5.33 Favored Glycine 0 C--N 1.311 -0.822 0 C-N-CA 119.653 -1.261 . . . . 0.37 112.159 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.31 136.21 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.354 -0.538 . . . . 0.28999999999999998 109.787 178.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.97 49.3 19.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.133 -0.94 . . . . 1.8500000000000001 110.662 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 11.6 t -90.68 144.52 25.66 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.521 -1.218 . . . . 1.1200000000000001 109.588 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 40' ' ' CYS . 13.5 p -106.29 118.63 54.3 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.507 -0.315 . . . . 1.26 111.252 -177.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.15 119.6 6.41 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.457 2.105 . . . . 0.60999999999999999 111.783 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.661 -0.699 . . . . 0.85999999999999999 109.313 -179.29 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.467 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 110.151 -0.314 . . . . 0.54000000000000004 110.151 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB2' HE21 ' A' ' 92' ' ' GLN . 0.0 OUTLIER -82.46 124.59 30.21 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.444 0.64 . . . . 0.78000000000000003 110.366 -176.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.49 126.4 45.42 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.52 0.676 . . . . 0.39000000000000001 111.359 -170.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 111' ' ' PRO . 5.0 m -134.0 165.85 30.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.228 -0.896 . . . . 0.22 110.69 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 46.0 t -112.87 120.95 43.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.541 -0.911 . . . . 0.70999999999999996 108.541 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 13.8 m -124.07 153.55 41.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.864 0.364 . . . . 0.60999999999999999 110.954 -169.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.2 t -83.5 -19.24 36.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.905 -0.589 . . . . 0.38 111.671 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -166.93 169.02 13.47 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 122.554 0.342 . . . . 0.78000000000000003 110.424 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.3 t -145.9 143.53 29.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.869 -0.605 . . . . 0.41999999999999998 110.429 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.578 ' HB2' HG23 ' A' ' 105' ' ' VAL . 35.8 m-85 -135.04 160.21 39.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.074 -0.512 . . . . 0.77000000000000002 109.885 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.488 ' HG2' HD21 ' A' ' 61' ' ' LEU . 8.5 mm100 61.14 25.18 15.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.347 -0.388 . . . . 0.80000000000000004 111.842 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 60.17 13.94 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 2.1200000000000001 112.306 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.68 -30.84 1.67 Allowed Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.146 -1.026 . . . . 0.28000000000000003 113.414 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 14.6 mt -49.23 -40.51 34.12 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.969 0.385 . . . . 0.35999999999999999 111.843 -175.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.578 HG23 ' HB2' ' A' ' 100' ' ' TYR . 3.7 m -131.07 136.23 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.546 0.689 . . . . 0.85999999999999999 110.664 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.499 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 32.0 t30 -132.76 141.98 48.79 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.271 -1.381 . . . . 0.91000000000000003 107.271 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 17.1 m -125.07 150.23 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 113.623 0.972 . . . . 0.29999999999999999 113.623 -170.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 63.54 51.7 52.13 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.726 -1.125 . . . . 0.20000000000000001 111.755 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 90.4 m -97.02 131.04 44.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.992 0.425 . . . . 0.42999999999999999 111.66 -173.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 p -123.37 126.56 25.84 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.529 -0.76 . . . . 0.29999999999999999 110.0 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.599 ' HA ' HG12 ' A' ' 94' ' ' VAL . 52.6 Cg_exo -52.31 116.59 2.93 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.8 2.333 . . . . 0.34000000000000002 112.462 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.2 tt . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.855 -0.612 . . . . 0.58999999999999997 110.549 -178.65 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 39' ' ' TYR . 84.2 t . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 107.801 -1.185 . . . . 0.58999999999999997 107.801 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.486 ' N ' HG12 ' A' ' 38' ' ' VAL . 87.4 m-85 -127.99 132.25 49.18 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 118.68 0.673 . . . . 0.78000000000000003 111.211 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.825 ' SG ' ' HB2' ' A' ' 77' ' ' SER . 27.1 p -107.09 107.66 18.76 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.555 -0.748 . . . . 0.81999999999999995 110.025 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.6 m -98.66 137.38 37.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.445 -0.798 . . . . 0.23999999999999999 110.626 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -55.03 -27.67 46.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.781 0.801 . . . . 2.0800000000000001 109.356 172.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -169.56 137.4 1.78 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.306 -1.316 . . . . 2.5800000000000001 108.247 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.603 HG21 HG11 ' A' ' 94' ' ' VAL . 14.3 p -92.85 149.28 21.37 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.461 -0.896 . . . . 0.37 110.306 168.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.567 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.7 tp10 -112.35 134.32 53.96 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.528 -0.76 . . . . 1.1200000000000001 109.287 -176.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.497 ' HA ' HD12 ' A' ' 71' ' ' LEU . 4.7 m-20 -67.14 114.1 5.62 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.729 -0.669 . . . . 1.77 111.051 -174.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.768 ' HA ' HD21 ' A' ' 50' ' ' LEU . 68.5 m -60.14 -13.03 10.03 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.392 0.433 . . . . 0.92000000000000004 111.88 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -79.29 -36.22 40.04 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.522 0.677 . . . . 2.77 109.95 177.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -140.4 66.08 1.39 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.039 -0.982 . . . . 2.3300000000000001 111.517 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.7 mm? -64.91 147.43 53.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.096 0.474 . . . . 1.1599999999999999 110.962 171.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.59 171.06 13.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.638 -0.71 . . . . 1.8100000000000001 110.221 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -61.24 -47.96 83.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.62 0.248 . . . . 3.23 111.088 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.64 -35.32 62.0 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.34000000000000002 112.708 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.602 ' HA ' HD22 ' A' ' 57' ' ' LEU . 11.2 m -81.8 -41.61 20.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.243 -0.28 . . . . 0.35999999999999999 110.243 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.2 m -53.81 -34.77 60.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.409 0.623 . . . . 0.29999999999999999 109.928 174.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.469 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.96 -53.76 54.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.063 -0.971 . . . . 0.23000000000000001 111.908 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -61.12 -46.19 91.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.547 0.689 . . . . 0.23999999999999999 109.973 -178.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 54' ' ' THR . 46.1 mt -58.64 -41.93 87.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.685 -1.143 . . . . 0.17999999999999999 109.848 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.92 -32.45 84.01 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.748 -0.66 . . . . 0.26000000000000001 112.704 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.1 mt -62.96 -50.55 70.34 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.666 0.746 . . . . 0.34000000000000002 109.811 177.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mt -81.43 -0.75 42.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.517 -1.219 . . . . 0.35999999999999999 111.216 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 t30 68.61 38.18 2.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.324 -0.853 . . . . 1.8899999999999999 110.559 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 58' ' ' LEU . 49.3 mt -87.07 141.59 14.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.584 -0.735 . . . . 0.26000000000000001 109.746 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.65 118.6 31.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.532 0.682 . . . . 2.2200000000000002 110.179 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.437 HG23 HD23 ' A' ' 50' ' ' LEU . 1.8 mp -67.65 -36.99 77.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.818 -1.083 . . . . 0.28999999999999998 110.93 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.58 -14.91 70.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.97 -0.633 . . . . 0.56999999999999995 113.177 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.12 3.62 33.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.238 0.542 . . . . 0.85999999999999999 110.725 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 94.2 mt -71.47 144.27 49.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.052 0.453 . . . . 0.46000000000000002 110.853 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -94.85 -96.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.581 -0.736 . . . . 2.0099999999999998 112.542 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.59 -85.98 0.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 1.0900000000000001 111.897 -172.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.3 mm? -120.13 165.14 15.15 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.529 0.681 . . . . 0.14999999999999999 111.063 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -119.9 167.56 13.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 106.017 -1.846 . . . . 0.25 106.017 167.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 105' ' ' VAL . . . -135.01 137.59 9.36 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.671 -1.252 . . . . 0.37 111.583 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.664 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -109.85 129.49 55.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.49 0.645 . . . . 0.28999999999999998 110.765 178.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.5 ' ND2' HD22 ' A' ' 104' ' ' LEU . 0.4 OUTLIER 54.3 52.9 11.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.6 -1.182 . . . . 1.8500000000000001 111.487 176.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.6 m -92.0 154.06 19.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.252 -0.885 . . . . 1.1200000000000001 109.983 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.825 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 57.6 m -102.75 129.64 25.43 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.38 -0.373 . . . . 1.26 110.089 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 6.6 Cg_exo -74.09 119.64 5.93 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.601 2.201 . . . . 0.60999999999999999 112.276 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.751 HD21 ' SG ' ' A' ' 40' ' ' CYS . 9.8 mt . . . . . 0 C--N 1.32 -0.71 0 CA-C-N 115.527 -0.76 . . . . 0.85999999999999999 108.952 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 110.201 -0.296 . . . . 0.54000000000000004 110.201 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.55 117.24 29.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.316 0.579 . . . . 0.78000000000000003 109.536 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.85 122.49 33.61 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.817 -0.629 . . . . 0.39000000000000001 111.078 -173.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.603 HG11 HG21 ' A' ' 44' ' ' THR . 12.3 m -135.29 162.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.629 -0.714 . . . . 0.22 111.191 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 49.6 t -108.49 109.68 21.0 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.793 -0.817 . . . . 0.70999999999999996 108.793 176.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 39.5 m -102.01 148.19 25.66 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.242 -0.281 . . . . 0.60999999999999999 110.242 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.0 t -81.46 -27.27 34.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.055 0.455 . . . . 0.38 110.501 -173.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.524 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 14.8 m120 -149.05 165.89 30.35 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.769 -0.65 . . . . 0.78000000000000003 109.374 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.2 t -136.73 139.87 42.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.118 -0.492 . . . . 0.41999999999999998 110.223 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.584 ' HB2' HG23 ' A' ' 105' ' ' VAL . 57.7 m-85 -128.07 147.88 50.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.922 -0.581 . . . . 0.77000000000000002 109.732 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.461 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER 63.58 22.91 13.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.80000000000000004 111.208 178.143 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 67.49 9.99 7.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.921 -0.581 . . . . 2.1200000000000001 112.079 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.11 -22.12 2.1 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.333 -0.936 . . . . 0.28000000000000003 113.269 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.8 mt -54.0 -35.78 62.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.877 0.338 . . . . 0.35999999999999999 111.574 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.584 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -144.14 119.6 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.253 0.549 . . . . 0.85999999999999999 111.042 174.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.4 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 90.6 m-20 -114.62 161.82 17.59 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.728 -0.669 . . . . 0.91000000000000003 109.785 177.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.9 m -130.73 156.89 42.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 111.896 0.332 . . . . 0.29999999999999999 111.896 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 57.37 52.64 50.42 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.554 -0.748 . . . . 0.20000000000000001 111.929 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 68.4 m -96.79 128.42 43.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.763 0.316 . . . . 0.42999999999999999 110.739 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.1 p -123.02 127.36 25.72 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.93 -0.577 . . . . 0.29999999999999999 110.355 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.534 ' HA ' HG12 ' A' ' 94' ' ' VAL . 51.8 Cg_exo -53.58 115.33 2.25 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.129 2.552 . . . . 0.34000000000000002 112.934 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 tt . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.739 -0.664 . . . . 0.58999999999999997 110.064 178.04 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 39' ' ' TYR . 49.1 t . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 120.791 0.329 . . . . 0.58999999999999997 110.228 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.427 ' N ' HG12 ' A' ' 38' ' ' VAL . 70.2 m-85 -135.77 141.48 44.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.089 0.471 . . . . 0.78000000000000003 109.91 177.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.59 ' HB3' ' OG ' ' A' ' 77' ' ' SER . 16.4 t -107.0 107.86 19.08 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.166 -0.47 . . . . 0.81999999999999995 109.966 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.0 m -108.08 134.18 51.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.925 0.393 . . . . 0.23999999999999999 110.426 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.475 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 4.8 m-20 -60.11 -20.23 57.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 2.0800000000000001 110.293 176.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.92 129.91 0.31 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.1 -1.074 . . . . 2.5800000000000001 108.1 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.533 HG21 HG11 ' A' ' 94' ' ' VAL . 18.4 p -87.42 152.86 21.9 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.174 -1.011 . . . . 0.37 111.09 172.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HB3' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -115.16 142.43 46.67 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.238 -0.892 . . . . 1.1200000000000001 109.29 -174.595 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.474 ' HA ' HD12 ' A' ' 71' ' ' LEU . 10.2 m-20 -78.31 108.4 11.62 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.105 -0.498 . . . . 1.77 110.86 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.747 ' HA ' HD21 ' A' ' 50' ' ' LEU . 46.7 m -58.92 -12.49 4.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.064 0.765 . . . . 0.92000000000000004 113.064 -176.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -81.18 -32.84 33.38 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.967 -0.293 . . . . 2.77 110.343 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -147.29 67.11 1.14 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.328 -0.396 . . . . 2.3300000000000001 110.75 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.747 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.9 mm? -59.42 153.63 18.75 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.462 0.648 . . . . 1.1599999999999999 111.495 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.86 150.67 48.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.916 -1.038 . . . . 1.8100000000000001 109.388 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.732 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -55.58 -36.4 66.84 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.01 0.194 . . . . 3.23 111.12 176.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -63.58 -40.66 98.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.793 -0.718 . . . . 0.34000000000000002 111.778 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.646 ' HA ' HD22 ' A' ' 57' ' ' LEU . 24.5 m -78.53 -42.84 28.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.853 0.359 . . . . 0.35999999999999999 110.229 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.5 m -52.04 -36.59 50.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.571 -0.741 . . . . 0.29999999999999999 109.957 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.503 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.06 -54.41 47.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.264 -0.88 . . . . 0.23000000000000001 111.817 176.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.646 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -59.18 -45.02 92.14 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.385 0.612 . . . . 0.23999999999999999 110.216 -177.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 54' ' ' THR . 48.5 mt -58.54 -42.33 87.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.905 -1.043 . . . . 0.17999999999999999 110.132 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.37 -37.05 93.98 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.712 -0.756 . . . . 0.26000000000000001 112.068 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 15.1 mt -63.03 -40.32 97.39 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.651 0.739 . . . . 0.34000000000000002 110.194 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.461 ' CD1' HG21 ' A' ' 105' ' ' VAL . 5.6 mt -90.5 4.19 51.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.86 -1.064 . . . . 0.35999999999999999 111.417 -176.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.9 m120 70.41 26.68 4.12 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.461 -0.79 . . . . 1.8899999999999999 111.264 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 58' ' ' LEU . 52.8 mt -81.48 145.86 8.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.02 -0.536 . . . . 0.26000000000000001 110.485 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.641 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -97.01 117.7 31.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.599 -0.728 . . . . 2.2200000000000002 109.987 -178.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.409 HG23 HD23 ' A' ' 50' ' ' LEU . 1.8 mp -75.69 -42.8 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.645 -0.707 . . . . 0.28999999999999998 111.449 -174.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.34 -8.63 71.14 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 121.017 -0.611 . . . . 0.56999999999999995 112.838 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.486 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 29.5 t70 -104.02 -9.31 18.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.974 0.416 . . . . 0.85999999999999999 110.497 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.517 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 94.8 mt -60.92 140.1 57.83 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.03 -0.532 . . . . 0.46000000000000002 110.657 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -88.89 -62.02 1.58 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.325 -0.852 . . . . 2.0099999999999998 113.085 -169.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.77 -95.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.379 0.511 . . . . 1.0900000000000001 112.379 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.1 mm? -117.77 165.78 13.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.544 0.688 . . . . 0.14999999999999999 111.391 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.524 HG13 HD11 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -119.86 173.4 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.776 -1.565 . . . . 0.25 106.776 169.169 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.545 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -141.41 148.66 20.35 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.844 -1.17 . . . . 0.37 111.533 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -110.76 133.52 53.27 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.879 -0.415 . . . . 0.28999999999999998 109.879 174.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.8 m120 53.34 50.47 17.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.992 -1.004 . . . . 1.8500000000000001 111.188 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.545 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 60.6 m -86.93 143.01 27.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.07 -0.513 . . . . 1.1200000000000001 110.705 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.59 ' OG ' ' HB3' ' A' ' 40' ' ' CYS . 7.0 p -97.15 114.61 64.99 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.104 -0.498 . . . . 1.26 109.789 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.26 120.53 8.14 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.44 2.093 . . . . 0.60999999999999999 112.357 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 40' ' ' CYS . 35.0 mt . . . . . 0 C--N 1.322 -0.623 0 N-CA-C 108.964 -0.754 . . . . 0.85999999999999999 108.964 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 110.408 -0.219 . . . . 0.54000000000000004 110.408 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.57 130.09 38.92 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.235 0.54 . . . . 0.78000000000000003 109.769 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.406 HG22 ' CG1' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -105.79 119.11 38.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.319 0.581 . . . . 0.39000000000000001 111.448 -171.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 111' ' ' PRO . 5.2 m -130.99 163.86 35.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.577 -0.738 . . . . 0.22 110.573 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.5 t -109.6 120.34 42.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.575 -0.898 . . . . 0.70999999999999996 108.575 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.71 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 17.9 m -121.57 148.51 44.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.053 0.454 . . . . 0.60999999999999999 110.98 -169.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.4 t -78.29 -29.53 47.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.632 -0.713 . . . . 0.38 110.891 -172.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.419 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 17.0 m120 -157.0 158.74 37.11 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.91 -0.404 . . . . 0.78000000000000003 109.91 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 t -132.61 149.2 52.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.388 -0.597 . . . . 0.41999999999999998 109.388 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.608 ' HB2' HG23 ' A' ' 105' ' ' VAL . 81.6 m-85 -131.29 154.0 48.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.287 -0.634 . . . . 0.77000000000000002 109.287 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.656 ' NE2' HD12 ' A' ' 104' ' ' LEU . 8.7 mm100 63.63 27.11 14.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 0.80000000000000004 110.878 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 65.48 6.53 3.79 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.594 -0.73 . . . . 2.1200000000000001 112.465 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 140.64 -19.64 2.77 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.207 -0.997 . . . . 0.28000000000000003 113.211 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.656 HD12 ' NE2' ' A' ' 101' ' ' GLN . 20.7 mt -47.91 -39.6 19.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.006 0.403 . . . . 0.35999999999999999 110.919 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.608 HG23 ' HB2' ' A' ' 100' ' ' TYR . 4.5 m -130.38 149.93 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.209 -0.663 . . . . 0.85999999999999999 109.209 171.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.494 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 31.5 t30 -144.05 147.82 34.34 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.154 -1.054 . . . . 0.91000000000000003 108.154 -173.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 9.2 m -131.59 153.52 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.415 0.895 . . . . 0.29999999999999999 113.415 -174.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.71 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 62.02 51.72 54.99 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.784 -1.098 . . . . 0.20000000000000001 111.985 176.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 83.9 m -97.82 127.76 43.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.978 0.418 . . . . 0.42999999999999999 111.919 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 p -119.78 127.83 26.19 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.806 -0.634 . . . . 0.29999999999999999 110.226 173.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.573 ' HA ' HG12 ' A' ' 94' ' ' VAL . 54.0 Cg_exo -51.29 113.23 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.049 2.5 . . . . 0.34000000000000002 112.563 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 tt . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.44 -0.8 . . . . 0.58999999999999997 110.414 -176.204 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 39' ' ' TYR . 86.7 t . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 107.397 -1.334 . . . . 0.58999999999999997 107.397 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.445 ' CD2' ' HB2' ' A' ' 96' ' ' CYS . 90.3 m-85 -129.09 134.41 48.07 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.518 -0.873 . . . . 0.78000000000000003 111.952 -177.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 31.9 t -105.46 103.47 13.0 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.857 -1.065 . . . . 0.81999999999999995 109.905 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.0 m -100.62 132.39 46.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.316 0.579 . . . . 0.23999999999999999 110.48 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.489 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 5.8 m-20 -57.6 -24.56 57.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.997 -1.001 . . . . 2.0800000000000001 110.508 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.86 119.33 0.35 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.266 -1.013 . . . . 2.5800000000000001 108.266 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.683 HG21 HG11 ' A' ' 94' ' ' VAL . 15.2 p -80.27 150.81 29.87 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 118.765 -1.174 . . . . 0.37 110.832 174.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.626 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.2 tp10 -119.87 138.32 53.47 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.44 -0.8 . . . . 1.1200000000000001 109.322 -176.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.551 ' HA ' HD12 ' A' ' 71' ' ' LEU . 26.5 m-20 -69.75 114.34 7.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.039 -0.528 . . . . 1.77 110.987 -173.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.733 ' HA ' HD21 ' A' ' 50' ' ' LEU . 49.5 m -61.03 -9.43 4.38 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.115 -0.493 . . . . 0.92000000000000004 111.831 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -90.19 -16.28 29.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.563 -0.29 . . . . 2.77 110.642 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -154.15 57.85 0.72 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.513 -0.312 . . . . 2.3300000000000001 111.542 -176.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.733 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -60.79 149.33 36.14 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.456 0.646 . . . . 1.1599999999999999 112.064 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.53 145.52 52.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.011 -0.995 . . . . 1.8100000000000001 108.401 172.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -20.33 66.23 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.779 -0.368 . . . . 3.23 110.742 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -73.24 -33.56 58.95 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.079 -0.808 . . . . 0.34000000000000002 111.079 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.639 ' HA ' HD22 ' A' ' 57' ' ' LEU . 43.3 m -79.97 -41.56 25.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.725 0.298 . . . . 0.35999999999999999 110.377 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.6 m -53.05 -35.2 59.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.338 0.59 . . . . 0.29999999999999999 109.777 172.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.49 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -55.59 -54.66 41.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.259 -0.882 . . . . 0.23000000000000001 111.611 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.639 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -60.22 -44.02 95.53 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.373 0.606 . . . . 0.23999999999999999 110.214 -178.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 54' ' ' THR . 53.3 mt -58.6 -45.06 89.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.988 -1.006 . . . . 0.17999999999999999 109.82 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.27 -36.59 91.26 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.833 -0.622 . . . . 0.26000000000000001 112.744 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 18.6 mt -59.71 -47.81 84.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.712 0.768 . . . . 0.34000000000000002 110.283 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.516 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.1 mt -86.12 -1.34 57.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.72 -1.127 . . . . 0.35999999999999999 111.115 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 66.17 36.54 5.51 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.256 -0.884 . . . . 1.8899999999999999 111.056 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 58' ' ' LEU . 54.8 mt -80.15 143.28 12.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.661 -0.699 . . . . 0.26000000000000001 109.474 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.634 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -94.18 117.87 30.73 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.462 0.649 . . . . 2.2200000000000002 110.002 -177.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.39 -34.08 56.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.957 -1.019 . . . . 0.28999999999999998 110.679 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.73 -16.88 72.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.017 -0.611 . . . . 0.56999999999999995 112.741 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.483 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 29.8 t70 -94.5 -15.76 23.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.76 0.314 . . . . 0.85999999999999999 110.659 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 94.1 mt -55.12 129.59 38.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.394 0.616 . . . . 0.46000000000000002 110.984 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 3.3 mptp? -88.07 -86.82 0.16 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.987 -1.006 . . . . 2.0099999999999998 112.262 -170.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -90.74 -94.92 0.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 1.0900000000000001 111.466 -171.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.2 mm? -113.6 167.62 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.088 -0.505 . . . . 0.14999999999999999 110.134 172.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -118.32 166.66 12.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 106.378 -1.712 . . . . 0.25 106.378 167.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.39 138.07 9.43 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 119.524 -1.322 . . . . 0.37 112.247 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.587 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -102.66 132.44 48.78 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.011 -0.676 . . . . 0.28999999999999998 109.64 173.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.453 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 1.5 t-20 59.0 57.96 3.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.804 -1.089 . . . . 1.8500000000000001 110.813 175.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 40' ' ' CYS . 29.4 m -94.72 139.23 31.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.531 -0.759 . . . . 1.1200000000000001 111.002 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 32.0 t -94.27 120.82 64.9 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.87 -0.604 . . . . 1.26 109.825 177.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 12.6 Cg_exo -70.86 120.4 7.04 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.816 2.344 . . . . 0.60999999999999999 112.632 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.5 mt . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 115.51 -0.768 . . . . 0.85999999999999999 109.336 179.621 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 110.001 -0.37 . . . . 0.54000000000000004 110.001 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.48 122.94 28.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.097 0.475 . . . . 0.78000000000000003 110.289 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.24 122.72 35.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.321 0.581 . . . . 0.39000000000000001 111.034 -175.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.683 HG11 HG21 ' A' ' 44' ' ' THR . 9.0 m -132.02 161.85 40.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.444 -0.798 . . . . 0.22 110.968 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 37.1 t -108.19 109.63 21.07 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.92 -0.77 . . . . 0.70999999999999996 108.92 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 14.3 m -110.14 153.56 24.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.229 -0.442 . . . . 0.60999999999999999 110.416 -173.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.7 t -80.7 -26.9 37.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.938 -0.574 . . . . 0.38 110.495 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.448 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 3.6 m120 -155.15 166.21 34.3 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.78000000000000003 109.565 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.431 ' HB ' ' CE1' ' A' ' 39' ' ' TYR . 15.3 t -129.97 143.45 50.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.075 0.464 . . . . 0.41999999999999998 110.026 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.535 ' CB ' HG23 ' A' ' 105' ' ' VAL . 42.0 m-85 -126.12 141.65 51.85 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.79 -0.641 . . . . 0.77000000000000002 110.05 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 101' ' ' GLN . 6.4 mm100 62.06 25.36 15.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.872 0.368 . . . . 0.80000000000000004 110.939 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 62.09 11.56 4.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.424 -0.807 . . . . 2.1200000000000001 112.318 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 149.33 -29.07 1.21 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.891 -1.147 . . . . 0.28000000000000003 113.73 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 15.5 mt -54.92 -35.3 64.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.391 0.596 . . . . 0.35999999999999999 111.394 -175.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.535 HG23 ' CB ' ' A' ' 100' ' ' TYR . 0.4 OUTLIER -132.69 143.89 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.809 -0.632 . . . . 0.85999999999999999 109.774 173.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.626 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.0 OUTLIER -139.39 157.75 45.32 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.41 -0.589 . . . . 0.91000000000000003 109.41 -174.314 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.448 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.9 m -136.61 144.61 32.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.879 0.696 . . . . 0.29999999999999999 112.879 -174.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.07 51.63 57.26 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 114.949 -1.023 . . . . 0.20000000000000001 112.05 176.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 73.0 m -97.5 131.12 44.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.611 0.243 . . . . 0.42999999999999999 111.381 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.24 130.65 24.08 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.325 -0.398 . . . . 0.29999999999999999 110.305 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.527 ' HA ' HG12 ' A' ' 94' ' ' VAL . 54.2 Cg_exo -52.6 109.5 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.79 2.327 . . . . 0.34000000000000002 111.78 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.1 tt . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.796 -0.638 . . . . 0.58999999999999997 111.365 -174.089 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 39' ' ' TYR . 98.5 t . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 107.833 -1.173 . . . . 0.58999999999999997 107.833 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.545 ' N ' HG12 ' A' ' 38' ' ' VAL . 62.8 m-85 -131.05 136.1 48.16 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.424 -0.798 . . . . 0.78000000000000003 111.459 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 26.8 t -111.62 109.96 20.12 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.417 -0.81 . . . . 0.81999999999999995 109.67 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.4 m -107.98 133.73 51.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.219 -0.446 . . . . 0.23999999999999999 110.293 -176.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.43 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 53.8 m-80 -55.94 -28.4 56.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.395 -0.821 . . . . 2.0800000000000001 110.057 175.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -164.24 133.46 3.79 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.01 -0.995 . . . . 2.5800000000000001 108.87 176.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.633 HG21 HG11 ' A' ' 94' ' ' VAL . 24.2 p -93.04 142.84 26.85 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.156 -1.018 . . . . 0.37 110.902 168.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.574 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.1 tp10 -112.53 138.0 49.93 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.115 -0.948 . . . . 1.1200000000000001 109.59 -175.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.471 ' HA ' HD12 ' A' ' 71' ' ' LEU . 5.3 m-20 -74.46 107.96 6.93 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.336 -0.393 . . . . 1.77 110.666 -175.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.433 ' HA ' HD21 ' A' ' 50' ' ' LEU . 86.8 p -54.69 -23.02 15.67 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.898 -0.592 . . . . 0.92000000000000004 112.473 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -73.78 -33.31 64.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.046 -0.262 . . . . 2.77 110.951 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -134.45 58.14 1.78 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.813 0.815 . . . . 2.3300000000000001 111.409 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 47' ' ' SER . 89.4 mt -65.05 157.73 27.61 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.782 -1.099 . . . . 1.1599999999999999 111.517 177.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.66 154.68 36.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.947 -1.024 . . . . 1.8100000000000001 108.675 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -65.71 -26.58 67.82 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.587 -0.445 . . . . 3.23 109.971 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -65.07 -38.17 95.05 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.47 -0.652 . . . . 0.34000000000000002 111.47 174.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.635 ' HA ' HD22 ' A' ' 57' ' ' LEU . 27.9 m -76.72 -43.76 36.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.38 . . . . 0.35999999999999999 110.653 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.3 m -53.01 -34.43 56.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.651 -0.704 . . . . 0.29999999999999999 109.937 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.486 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.81 -54.11 50.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.839 -1.073 . . . . 0.23000000000000001 111.794 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -59.33 -44.14 92.64 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.434 0.635 . . . . 0.23999999999999999 110.136 -177.247 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 54' ' ' THR . 36.1 mt -60.14 -42.83 95.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.898 -1.046 . . . . 0.17999999999999999 110.116 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.16 -33.41 84.12 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.742 -0.663 . . . . 0.26000000000000001 112.508 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.9 mt -64.12 -29.51 70.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.748 0.785 . . . . 0.34000000000000002 110.497 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.438 ' CD1' HG21 ' A' ' 105' ' ' VAL . 6.0 mt -102.98 -0.78 30.4 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.68 -1.146 . . . . 0.35999999999999999 110.668 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 68.26 31.64 5.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.993 -1.003 . . . . 1.8899999999999999 111.071 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 58' ' ' LEU . 54.8 mt -80.08 148.68 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.811 -0.632 . . . . 0.26000000000000001 110.551 177.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.615 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -97.21 118.64 34.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.293 0.568 . . . . 2.2200000000000002 110.177 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -73.51 -38.57 52.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 0.28999999999999998 111.2 -174.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.85 -22.5 70.29 Favored Glycine 0 CA--C 1.516 0.151 0 C-N-CA 120.989 -0.624 . . . . 0.56999999999999995 112.683 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.29 -4.94 55.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.189 0.519 . . . . 0.85999999999999999 110.709 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.13 138.59 55.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.293 0.568 . . . . 0.46000000000000002 110.733 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -89.52 -86.07 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.044 -0.98 . . . . 2.0099999999999998 112.289 -171.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.63 -102.35 0.15 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.293 0.479 . . . . 1.0900000000000001 112.293 -173.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.9 mm? -105.82 170.1 8.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.577 0.703 . . . . 0.14999999999999999 111.15 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -122.89 170.53 13.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 106.724 -1.584 . . . . 0.25 106.724 167.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.495 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -136.78 142.75 13.93 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 119.838 -1.172 . . . . 0.37 111.567 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -106.42 129.28 54.43 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.14 -0.624 . . . . 0.28999999999999998 110.02 174.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.22 55.39 6.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.0 -1.0 . . . . 1.8500000000000001 111.198 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 58.7 m -88.62 144.0 26.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.628 -0.715 . . . . 1.1200000000000001 111.071 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m -100.52 118.82 60.27 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.733 -0.667 . . . . 1.26 109.969 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.24 124.64 12.38 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.547 2.165 . . . . 0.60999999999999999 111.85 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.2 mt . . . . . 0 C--N 1.32 -0.69 0 CA-C-N 115.938 -0.573 . . . . 0.85999999999999999 109.865 -178.882 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.73 -0.47 . . . . 0.54000000000000004 109.73 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.15 126.06 30.34 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.028 0.442 . . . . 0.78000000000000003 110.359 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.19 123.1 44.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.265 0.555 . . . . 0.39000000000000001 111.299 -171.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.633 HG11 HG21 ' A' ' 44' ' ' THR . 1.5 m -136.44 173.32 13.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.653 -0.703 . . . . 0.22 111.426 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 53.8 t -124.37 118.47 26.79 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.566 -0.743 . . . . 0.70999999999999996 109.964 177.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 1.2 m -103.41 168.49 9.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.598 . . . . 0.60999999999999999 111.921 -175.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 107' ' ' VAL . 9.0 t -87.04 -29.83 21.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.378 -0.828 . . . . 0.38 109.738 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.441 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.2 m120 -151.84 162.76 40.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.68 -0.691 . . . . 0.78000000000000003 109.913 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 t -127.64 129.02 46.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.329 0.585 . . . . 0.41999999999999998 109.87 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.506 ' CB ' HG23 ' A' ' 105' ' ' VAL . 30.0 m-85 -120.51 144.87 47.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.681 -0.69 . . . . 0.77000000000000002 111.414 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.643 ' NE2' HD12 ' A' ' 104' ' ' LEU . 7.1 mm100 60.84 34.49 19.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.802 -0.635 . . . . 0.80000000000000004 111.159 176.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 65.4 -0.86 1.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.756 -0.656 . . . . 2.1200000000000001 112.415 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.46 -20.25 2.05 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.512 -0.851 . . . . 0.28000000000000003 112.454 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.643 HD12 ' NE2' ' A' ' 101' ' ' GLN . 28.5 mt -49.77 -40.89 42.84 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.725 0.298 . . . . 0.35999999999999999 111.085 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.506 HG23 ' CB ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -130.15 119.3 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.547 0.689 . . . . 0.85999999999999999 110.489 174.077 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.485 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 2.8 t30 -111.21 144.18 40.78 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.348 -0.982 . . . . 0.91000000000000003 108.348 177.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 97' ' ' THR . 5.9 m -127.13 137.75 56.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 113.113 0.782 . . . . 0.29999999999999999 113.113 -174.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 70.9 51.44 19.16 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.999 -1.001 . . . . 0.20000000000000001 111.975 176.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 1.5 m -97.06 131.83 43.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.346 0.593 . . . . 0.42999999999999999 111.502 -177.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.8 p -116.65 141.42 28.08 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.058 -0.974 . . . . 0.29999999999999999 109.594 174.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HA ' HG12 ' A' ' 94' ' ' VAL . 24.5 Cg_exo -67.42 108.38 1.58 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.717 2.278 . . . . 0.34000000000000002 111.803 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.4 tt . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 0.58999999999999997 110.466 -178.865 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 39' ' ' TYR . 92.1 t . . . . . 0 CA--C 1.528 0.115 0 N-CA-C 110.306 -0.257 . . . . 0.58999999999999997 110.306 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.424 ' N ' HG12 ' A' ' 38' ' ' VAL . 29.3 m-85 -127.96 135.69 50.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.135 0.493 . . . . 0.78000000000000003 110.701 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.446 ' HB2' HD11 ' A' ' 79' ' ' LEU . 17.7 t -103.43 107.53 18.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.942 -0.572 . . . . 0.81999999999999995 109.721 177.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -102.46 130.79 49.37 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.804 -0.443 . . . . 0.23999999999999999 109.804 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.512 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 18.3 m120 -57.54 -29.72 64.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.583 -0.735 . . . . 2.0800000000000001 109.749 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 8.3 mmmm -162.86 132.23 4.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.443 -1.253 . . . . 2.5800000000000001 108.013 175.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.5 HG21 HG11 ' A' ' 94' ' ' VAL . 28.1 p -88.86 167.21 13.43 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.36 -0.936 . . . . 0.37 110.101 169.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.481 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.6 tp10 -126.49 139.07 53.51 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.504 -0.771 . . . . 1.1200000000000001 109.424 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.415 ' HA ' HD12 ' A' ' 71' ' ' LEU . 11.1 m-20 -71.26 111.66 6.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.057 -0.52 . . . . 1.77 110.519 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.591 ' HA ' HD21 ' A' ' 50' ' ' LEU . 6.1 m -60.15 -10.45 4.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.803 -0.635 . . . . 0.92000000000000004 112.603 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -90.02 -17.56 27.61 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.669 -0.412 . . . . 2.77 110.338 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -149.53 57.92 1.0 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.328 -0.397 . . . . 2.3300000000000001 111.136 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.0 mm? -60.26 150.7 29.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.267 0.556 . . . . 1.1599999999999999 111.679 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.91 146.35 54.82 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.079 -1.082 . . . . 1.8100000000000001 108.079 170.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -60.4 -28.13 68.0 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.499 -0.481 . . . . 3.23 110.463 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -66.7 -35.95 90.56 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.866 -0.683 . . . . 0.34000000000000002 111.417 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.658 ' HA ' HD22 ' A' ' 57' ' ' LEU . 22.7 m -79.06 -42.94 25.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.35999999999999999 110.411 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.2 m -53.94 -33.69 57.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.325 0.583 . . . . 0.29999999999999999 110.126 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.31 -53.81 53.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.167 -0.924 . . . . 0.23000000000000001 111.285 175.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.658 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -60.69 -44.25 96.76 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.441 0.639 . . . . 0.23999999999999999 110.013 -179.129 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 54' ' ' THR . 53.0 mt -59.35 -43.22 92.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.001 -0.999 . . . . 0.17999999999999999 110.145 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.62 -36.97 92.67 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.906 -0.664 . . . . 0.26000000000000001 112.439 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.2 mt -60.24 -46.78 88.62 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.878 0.847 . . . . 0.34000000000000002 109.903 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 mt -85.71 2.75 44.13 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.364 -1.289 . . . . 0.35999999999999999 111.405 -175.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 65.5 35.35 7.32 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.486 -0.779 . . . . 1.8899999999999999 111.534 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 58' ' ' LEU . 48.2 mt -88.0 147.25 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.551 -0.75 . . . . 0.26000000000000001 110.043 177.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.536 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -100.41 117.67 35.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.319 0.581 . . . . 2.2200000000000002 110.369 -178.427 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.73 -41.99 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.313 -0.858 . . . . 0.28999999999999998 111.449 -174.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.58 -7.15 68.19 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.857 -0.687 . . . . 0.56999999999999995 112.991 -176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.49 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 21.0 t70 -103.81 -16.76 15.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.85999999999999999 110.712 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 95.4 mt -55.5 147.81 16.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.881 -0.6 . . . . 0.46000000000000002 111.626 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -95.32 -85.89 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.159 -0.928 . . . . 2.0099999999999998 112.026 -172.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.27 -101.56 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.873 0.324 . . . . 1.0900000000000001 111.873 -174.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.5 mm? -110.52 169.3 8.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.403 0.621 . . . . 0.14999999999999999 111.216 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.49 HG13 HD11 ' A' ' 50' ' ' LEU . 1.5 m -121.07 163.72 18.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 106.058 -1.83 . . . . 0.25 106.058 166.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.57 142.18 13.65 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 119.818 -1.182 . . . . 0.37 111.38 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.618 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -115.4 135.17 54.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.049 -0.661 . . . . 0.28999999999999998 110.4 178.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.521 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 1.4 t-20 54.79 47.54 22.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.522 -1.217 . . . . 1.8500000000000001 110.904 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 24.5 m -85.41 150.06 24.99 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.177 -0.92 . . . . 1.1200000000000001 110.554 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.0 m -100.42 117.18 63.44 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.623 -0.717 . . . . 1.26 109.75 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -64.78 130.68 26.85 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.646 2.23 . . . . 0.60999999999999999 112.293 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 40' ' ' CYS . 33.8 mt . . . . . 0 C--N 1.317 -0.808 0 CA-C-N 115.509 -0.769 . . . . 0.85999999999999999 109.371 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.59 0.233 . . . . 0.54000000000000004 110.408 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.98 112.88 18.79 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.772 0.796 . . . . 0.78000000000000003 110.03 -177.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.86 121.11 32.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.215 -0.902 . . . . 0.39000000000000001 110.447 -174.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 111' ' ' PRO . 13.6 m -133.15 162.81 39.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.458 0.646 . . . . 0.22 112.129 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 37.6 t -112.24 114.02 26.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.92 -1.036 . . . . 0.70999999999999996 109.156 175.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.3 m -108.48 146.67 32.81 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.442 -0.344 . . . . 0.60999999999999999 110.318 -174.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.9 t -76.45 -26.77 55.77 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.279 -0.419 . . . . 0.38 110.668 -173.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.609 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.2 m120 -147.03 155.05 41.92 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.131 -0.692 . . . . 0.78000000000000003 109.131 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.2 t -132.58 132.82 42.94 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.122 0.487 . . . . 0.41999999999999998 110.42 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -130.7 156.72 44.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.832 -0.622 . . . . 0.77000000000000002 110.48 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.65 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 12.8 mm100 60.34 28.96 18.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.79 -0.641 . . . . 0.80000000000000004 111.992 174.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 66.37 -1.02 1.33 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.217 0.607 . . . . 2.1200000000000001 112.535 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 142.64 -14.97 2.45 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.441 -0.885 . . . . 0.28000000000000003 112.161 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 40.8 mt -54.19 -36.89 63.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.994 0.426 . . . . 0.35999999999999999 110.562 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 t -139.3 121.54 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.359 -0.837 . . . . 0.85999999999999999 110.549 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.448 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 95.0 m-20 -124.08 160.4 27.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.641 -0.708 . . . . 0.91000000000000003 109.227 174.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.609 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 5.5 m -134.97 151.51 31.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 111.833 0.309 . . . . 0.29999999999999999 111.833 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.48 54.66 35.31 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.597 -0.729 . . . . 0.20000000000000001 111.439 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 76.4 m -97.2 125.88 42.02 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.72 0.295 . . . . 0.42999999999999999 111.29 -175.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 p -118.28 125.65 27.74 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.169 -0.469 . . . . 0.29999999999999999 110.395 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' A' ' 94' ' ' VAL . 68.3 Cg_exo -51.59 109.96 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.255 2.637 . . . . 0.34000000000000002 112.953 178.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 tt . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.632 -0.713 . . . . 0.58999999999999997 110.271 -179.843 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 108.256 -1.016 . . . . 0.58999999999999997 108.256 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.91 131.21 47.55 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.384 0.611 . . . . 0.78000000000000003 110.823 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.422 ' HB2' HD11 ' A' ' 79' ' ' LEU . 14.4 t -99.43 107.17 19.32 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.382 -0.826 . . . . 0.81999999999999995 109.692 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.4 m -104.34 129.64 52.22 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.012 -0.54 . . . . 0.23999999999999999 109.819 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.497 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 18.4 m120 -55.46 -25.59 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.473 -0.785 . . . . 2.0800000000000001 110.42 176.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 1.8 mmmm -168.85 124.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.243 -1.344 . . . . 2.5800000000000001 108.223 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.594 HG21 HG11 ' A' ' 94' ' ' VAL . 16.8 p -79.61 157.51 27.29 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.493 -0.883 . . . . 0.37 110.713 171.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.57 ' HB3' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.34 146.21 42.62 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.268 -0.878 . . . . 1.1200000000000001 108.957 -176.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.06 108.74 14.99 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.227 -0.442 . . . . 1.77 111.115 -173.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.753 ' HA ' HD21 ' A' ' 50' ' ' LEU . 27.5 m -57.68 -12.3 2.81 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.084 0.772 . . . . 0.92000000000000004 113.084 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -90.32 -25.56 20.43 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.882 -0.327 . . . . 2.77 110.644 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -145.92 60.54 1.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.503 -0.317 . . . . 2.3300000000000001 111.299 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.753 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.9 mm? -60.7 147.26 42.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.763 0.792 . . . . 1.1599999999999999 111.784 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -68.02 153.11 44.42 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.235 -1.348 . . . . 1.8100000000000001 109.814 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.576 ' HD3' ' N ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -62.86 -26.6 68.85 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.056 -0.258 . . . . 3.23 111.18 178.538 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.576 ' N ' ' HD3' ' A' ' 52' ' ' LYS . . . -69.51 -37.41 78.41 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.489 -0.863 . . . . 0.34000000000000002 111.332 177.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.624 ' HA ' HD22 ' A' ' 57' ' ' LEU . 26.1 m -80.98 -43.3 19.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.919 -0.4 . . . . 0.35999999999999999 109.919 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.418 ' HA ' HD12 ' A' ' 58' ' ' LEU . 96.9 m -52.88 -34.8 56.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.539 -0.755 . . . . 0.29999999999999999 110.233 173.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.548 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.34 -51.99 66.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.435 -0.802 . . . . 0.23000000000000001 111.34 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -61.55 -44.77 96.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.407 0.623 . . . . 0.23999999999999999 109.893 -179.62 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 54' ' ' THR . 58.5 mt -58.0 -45.12 87.36 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.867 -1.061 . . . . 0.17999999999999999 110.162 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.06 -37.06 92.2 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.793 -0.64 . . . . 0.26000000000000001 112.471 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.6 mt -60.19 -47.38 86.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.502 0.668 . . . . 0.34000000000000002 110.303 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.467 HD21 ' HG2' ' A' ' 101' ' ' GLN . 2.9 mt -84.56 -2.33 57.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.857 -1.065 . . . . 0.35999999999999999 111.343 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 69.76 37.75 1.79 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.939 0.876 . . . . 1.8899999999999999 110.664 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 58' ' ' LEU . 56.1 mt -85.25 145.82 7.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.713 -0.676 . . . . 0.26000000000000001 110.173 175.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.669 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -96.34 117.89 31.76 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.68 -0.691 . . . . 2.2200000000000002 109.937 -178.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.439 HG23 HD23 ' A' ' 50' ' ' LEU . 1.8 mp -73.34 -40.18 56.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.509 -0.769 . . . . 0.28999999999999998 111.049 -174.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.83 -9.87 63.42 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.976 -0.63 . . . . 0.56999999999999995 113.055 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -109.15 4.61 23.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 0.85999999999999999 110.903 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 98.3 mt -74.53 142.89 44.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.336 -0.393 . . . . 0.46000000000000002 110.437 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -96.42 -94.64 0.2 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.683 0.623 . . . . 2.0099999999999998 112.683 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.75 -99.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.17 0.433 . . . . 1.0900000000000001 112.17 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.26 164.26 14.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.468 0.652 . . . . 0.14999999999999999 110.928 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -115.4 172.16 4.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 106.162 -1.792 . . . . 0.25 106.162 168.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.463 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -140.82 138.8 9.16 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.933 -1.127 . . . . 0.37 111.113 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -111.41 132.22 54.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.532 -0.867 . . . . 0.28999999999999998 110.499 176.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.515 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 2.1 t-20 58.23 46.57 15.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.49 -1.232 . . . . 1.8500000000000001 110.747 175.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 35.4 m -83.72 142.11 30.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.524 -0.762 . . . . 1.1200000000000001 111.096 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -88.27 116.38 66.06 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.568 -0.742 . . . . 1.26 109.375 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.15 122.2 9.25 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.792 2.328 . . . . 0.60999999999999999 112.876 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 40' ' ' CYS . 11.9 mt . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 115.434 -0.803 . . . . 0.85999999999999999 109.21 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.497 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.45 0.167 . . . . 0.54000000000000004 110.802 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.79 120.22 23.76 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.289 0.566 . . . . 0.78000000000000003 110.428 -176.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.37 117.21 29.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.9 -0.591 . . . . 0.39000000000000001 110.892 -175.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.594 HG11 HG21 ' A' ' 44' ' ' THR . 2.9 m -129.29 164.35 32.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.736 -0.666 . . . . 0.22 111.583 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 49.3 t -118.32 110.95 18.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.376 -0.829 . . . . 0.70999999999999996 109.461 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 106' ' ' ASN . 1.3 m -92.34 166.16 12.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.309 0.576 . . . . 0.60999999999999999 111.483 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.9 t -90.95 -24.23 20.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.346 -0.843 . . . . 0.38 109.406 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.414 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 14.3 m120 -156.68 166.86 32.18 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.346 -0.843 . . . . 0.78000000000000003 109.183 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.6 t -138.99 143.19 38.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.991 0.424 . . . . 0.41999999999999998 110.403 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.453 ' HB2' HG23 ' A' ' 105' ' ' VAL . 83.8 m-85 -126.78 149.48 49.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.048 -0.524 . . . . 0.77000000000000002 109.609 176.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.467 ' HG2' HD21 ' A' ' 61' ' ' LEU . 8.1 mm100 64.67 24.62 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.80000000000000004 111.361 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 64.4 6.04 2.89 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.602 -0.726 . . . . 2.1200000000000001 112.357 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.15 -20.14 1.39 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.905 -1.14 . . . . 0.28000000000000003 113.552 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.1 mt -56.45 -37.3 70.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.619 0.71 . . . . 0.35999999999999999 111.419 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.453 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -142.79 118.87 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.58 0.705 . . . . 0.85999999999999999 110.938 175.489 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.728 ' HB3' ' SG ' ' A' ' 96' ' ' CYS . 7.4 m-20 -115.37 162.33 17.28 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.234 -0.894 . . . . 0.91000000000000003 109.528 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.0 m -133.64 142.46 41.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.549 0.574 . . . . 0.29999999999999999 112.549 -175.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 66.78 53.09 29.35 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.094 -0.957 . . . . 0.20000000000000001 112.254 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 1.3 m -96.65 129.83 43.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.394 0.616 . . . . 0.42999999999999999 111.568 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.0 p -118.45 124.99 28.12 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.774 -1.103 . . . . 0.29999999999999999 109.743 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HA ' HG12 ' A' ' 94' ' ' VAL . 84.9 Cg_exo -47.91 112.28 0.55 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.405 2.737 . . . . 0.34000000000000002 113.012 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.2 tt . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.54 -0.755 . . . . 0.58999999999999997 110.519 179.338 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 39' ' ' TYR . 38.8 t . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.858 0.361 . . . . 0.58999999999999997 110.236 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.604 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 94.9 m-85 -137.35 135.89 37.44 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.933 0.396 . . . . 0.78000000000000003 110.259 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.802 ' SG ' ' HB2' ' A' ' 77' ' ' SER . 22.1 p -104.04 102.55 12.31 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.869 0.842 . . . . 0.81999999999999995 110.411 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.8 m -100.21 128.98 46.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.104 -0.953 . . . . 0.23999999999999999 109.037 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 49.3 m-80 -57.6 -23.44 50.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.566 0.698 . . . . 2.0800000000000001 110.47 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -161.61 128.96 4.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.31 -1.314 . . . . 2.5800000000000001 107.902 176.339 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.558 HG21 HG11 ' A' ' 94' ' ' VAL . 23.0 p -87.46 155.24 20.1 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.151 -1.02 . . . . 0.37 109.769 167.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.2 tp10 -120.09 133.84 55.41 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.503 -0.771 . . . . 1.1200000000000001 109.545 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 49' ' ' HIS . 15.4 m-20 -69.83 112.62 6.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.507 -0.769 . . . . 1.77 109.788 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.5 p -52.67 -27.9 19.31 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.781 0.676 . . . . 0.92000000000000004 112.183 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -89.45 -10.59 45.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.69 0.281 . . . . 2.77 111.519 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 46' ' ' ASP . 58.9 m-70 -127.79 34.29 4.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.739 0.304 . . . . 2.3300000000000001 111.088 -177.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.453 HD23 ' HG3' ' A' ' 45' ' ' GLU . 96.0 mt -67.46 145.48 54.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.153 0.501 . . . . 1.1599999999999999 111.668 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -86.79 169.55 12.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.382 -0.826 . . . . 1.8100000000000001 109.71 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.71 -41.94 99.4 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.9 -0.32 . . . . 3.23 110.72 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.85 -42.28 85.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.308 -0.472 . . . . 0.34000000000000002 112.969 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.67 ' HA ' HD22 ' A' ' 57' ' ' LEU . 86.9 m -82.6 -42.05 18.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.733 0.267 . . . . 0.35999999999999999 111.121 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.3 m -54.5 -33.39 59.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.211 0.529 . . . . 0.29999999999999999 110.074 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.585 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.57 -54.94 41.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.13 -0.941 . . . . 0.23000000000000001 111.703 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.67 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -56.39 -47.16 79.52 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.494 0.664 . . . . 0.23999999999999999 110.057 -178.164 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 54' ' ' THR . 34.2 mt -57.95 -43.69 86.54 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.738 -1.119 . . . . 0.17999999999999999 110.169 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.19 -36.62 93.25 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.835 -0.698 . . . . 0.26000000000000001 112.395 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 19.8 mt -62.68 -44.71 95.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.875 0.845 . . . . 0.34000000000000002 109.939 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.509 ' CD1' HG21 ' A' ' 105' ' ' VAL . 6.1 mt -87.16 1.48 52.92 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.459 -1.246 . . . . 0.35999999999999999 111.411 -175.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 69.24 27.5 5.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.702 -0.681 . . . . 1.8899999999999999 111.628 174.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 58' ' ' LEU . 56.8 mt -78.69 142.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.953 -0.567 . . . . 0.26000000000000001 110.291 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.479 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -90.07 117.84 29.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.846 -0.615 . . . . 2.2200000000000002 110.058 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.27 -36.94 50.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.89 -0.596 . . . . 0.28999999999999998 109.809 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.2 -10.48 84.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.56999999999999995 112.511 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 28.3 t70 -101.83 -9.65 20.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.036 0.446 . . . . 0.85999999999999999 110.733 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 64' ' ' LYS . 89.1 mt -55.71 134.99 51.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.261 0.553 . . . . 0.46000000000000002 110.538 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.47 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 3.4 mptp? -82.35 -51.15 8.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.093 -0.958 . . . . 2.0099999999999998 112.25 -169.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 1.1 t70 -139.37 -82.45 0.28 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.608 -0.437 . . . . 1.0900000000000001 110.843 -178.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.4 mm? -114.44 173.95 6.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.383 0.611 . . . . 0.14999999999999999 110.722 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 45' ' ' GLU . 1.2 m -121.92 166.1 16.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 106.62 -1.622 . . . . 0.25 106.62 164.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.4 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -137.1 126.16 3.6 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.806 -1.188 . . . . 0.37 112.055 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.654 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -99.58 139.59 35.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.11 -0.636 . . . . 0.28999999999999998 110.018 -178.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.448 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 2.1 t-20 50.17 55.42 9.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.113 0.959 . . . . 1.8500000000000001 109.889 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 20.9 t -105.4 146.77 29.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.043 -1.435 . . . . 1.1200000000000001 110.198 -171.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.802 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 19.8 m -103.6 139.56 20.23 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 120.528 -0.469 . . . . 1.26 110.265 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 6.1 Cg_exo -80.45 119.84 3.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.614 2.209 . . . . 0.60999999999999999 112.472 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.651 HD11 ' SG ' ' A' ' 40' ' ' CYS . 5.6 mp . . . . . 0 C--N 1.319 -0.727 0 N-CA-C 109.224 -0.658 . . . . 0.85999999999999999 109.224 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.17 0 N-CA-C 109.851 -0.425 . . . . 0.54000000000000004 109.851 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.35 130.57 41.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.096 0.474 . . . . 0.78000000000000003 110.872 -174.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.2 120.18 37.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.47 0.652 . . . . 0.39000000000000001 112.562 -172.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 44' ' ' THR . 5.5 m -134.65 168.3 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.024 -0.989 . . . . 0.22 110.043 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.8 t -116.97 117.89 30.91 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.122 -0.696 . . . . 0.70999999999999996 109.122 177.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.0 m -111.19 151.26 28.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.925 0.393 . . . . 0.60999999999999999 110.887 -172.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 t -81.09 -28.81 35.08 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.963 -0.562 . . . . 0.38 110.664 -173.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.414 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 14.5 m120 -155.06 156.98 36.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.588 -0.733 . . . . 0.78000000000000003 109.11 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.9 t -136.18 144.62 45.06 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.048 -0.353 . . . . 0.41999999999999998 110.048 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.568 ' HB2' HG23 ' A' ' 105' ' ' VAL . 67.3 m-85 -138.33 161.93 35.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.674 0.273 . . . . 0.77000000000000002 110.915 -177.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.593 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 7.5 mm100 62.63 33.27 15.84 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.03 -0.532 . . . . 0.80000000000000004 112.255 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 65.43 -0.31 1.21 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.843 0.457 . . . . 2.1200000000000001 112.067 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.55 -13.41 3.71 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.483 -0.865 . . . . 0.28000000000000003 112.883 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.654 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 22.5 mt -55.25 -36.51 66.14 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 117.358 0.579 . . . . 0.35999999999999999 110.862 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.568 HG23 ' HB2' ' A' ' 100' ' ' TYR . 12.2 m -129.97 147.32 33.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.303 0.573 . . . . 0.85999999999999999 110.529 174.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 4.2 t-20 -143.04 143.06 31.73 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.873 -1.158 . . . . 0.91000000000000003 107.873 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 18.0 m -123.79 149.9 27.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 113.062 0.764 . . . . 0.29999999999999999 113.062 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 59.85 54.45 37.45 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 114.913 -1.04 . . . . 0.20000000000000001 111.536 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 70' ' ' ASP . 74.8 m -97.92 123.5 41.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.757 0.313 . . . . 0.42999999999999999 110.54 -173.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.3 p -118.95 126.82 26.87 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.817 -0.629 . . . . 0.29999999999999999 110.91 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.459 ' HA ' HG12 ' A' ' 94' ' ' VAL . 54.2 Cg_exo -51.22 113.26 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.036 2.491 . . . . 0.34000000000000002 112.141 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.8 tt . . . . . 0 N--CA 1.449 -0.515 0 CA-C-N 115.906 -0.588 . . . . 0.58999999999999997 111.512 -175.982 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 39' ' ' TYR . 96.7 t . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 108.744 -0.835 . . . . 0.58999999999999997 108.744 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.413 ' N ' HG12 ' A' ' 38' ' ' VAL . 97.0 m-85 -123.98 141.05 52.38 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.483 0.659 . . . . 0.78000000000000003 111.362 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 49.5 t -113.16 111.24 21.76 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.272 -0.876 . . . . 0.81999999999999995 109.993 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.2 m -107.69 133.11 52.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.095 0.474 . . . . 0.23999999999999999 110.001 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -53.99 -26.48 26.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.173 -0.921 . . . . 2.0800000000000001 110.559 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.458 ' HE2' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -173.32 123.26 0.38 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.896 -1.15 . . . . 2.5800000000000001 107.896 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.525 HG21 HG11 ' A' ' 94' ' ' VAL . 12.5 p -78.66 154.98 29.72 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.466 -0.893 . . . . 0.37 110.727 172.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.557 ' HG3' HD23 ' A' ' 50' ' ' LEU . 7.8 tp10 -120.88 137.94 54.33 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.979 -0.749 . . . . 1.1200000000000001 108.979 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.489 ' HA ' HD12 ' A' ' 71' ' ' LEU . 11.6 m-20 -75.32 107.98 7.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.942 -0.572 . . . . 1.77 109.91 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.474 ' HA ' HD21 ' A' ' 50' ' ' LEU . 9.4 m -47.18 -31.17 3.39 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.849 0.718 . . . . 0.92000000000000004 111.987 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 11.4 mptt -68.17 -40.95 82.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.5 0.667 . . . . 2.77 110.638 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -124.36 51.89 1.55 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.14 -0.936 . . . . 2.3300000000000001 110.934 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.557 HD23 ' HG3' ' A' ' 45' ' ' GLU . 82.0 mt -62.96 159.92 15.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.573 0.701 . . . . 1.1599999999999999 112.215 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.8 146.85 23.33 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.722 -1.126 . . . . 1.8100000000000001 109.059 175.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -59.37 -25.06 63.93 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.239 0.337 . . . . 3.23 110.949 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.62 -41.45 83.95 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.759 -0.734 . . . . 0.34000000000000002 111.844 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.644 ' HA ' HD22 ' A' ' 57' ' ' LEU . 98.3 m -81.15 -42.98 20.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.761 0.315 . . . . 0.35999999999999999 110.559 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.7 m -54.84 -32.51 60.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.912 -0.586 . . . . 0.29999999999999999 110.188 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.58 -54.43 46.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.562 -0.744 . . . . 0.23000000000000001 111.406 175.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.644 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.44 -44.59 89.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.401 0.62 . . . . 0.23999999999999999 110.147 -177.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.6 mt -58.9 -43.92 91.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.066 -0.97 . . . . 0.17999999999999999 110.172 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.92 -35.79 91.04 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.928 -0.653 . . . . 0.26000000000000001 112.537 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 16.9 mt -61.66 -39.81 92.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.751 0.786 . . . . 0.34000000000000002 110.022 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.454 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.8 mt -91.61 2.06 56.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.7 -1.136 . . . . 0.35999999999999999 111.085 -176.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 68.28 30.12 5.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.85 0.833 . . . . 1.8899999999999999 110.691 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 58' ' ' LEU . 54.1 mt -80.93 141.62 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.78 -0.646 . . . . 0.26000000000000001 110.262 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -92.75 118.96 31.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.818 -0.628 . . . . 2.2200000000000002 110.062 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.05 -29.35 28.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.454 -0.794 . . . . 0.28999999999999998 110.856 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.42 -18.02 78.08 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.72 -0.752 . . . . 0.56999999999999995 112.46 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -88.03 -19.18 27.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.071 0.462 . . . . 0.85999999999999999 110.393 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.33 126.36 27.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.488 -0.778 . . . . 0.46000000000000002 110.986 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -91.27 -76.32 0.45 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.053 -0.976 . . . . 2.0099999999999998 112.202 -172.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -90.11 -112.11 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.457 -0.338 . . . . 1.0900000000000001 111.268 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.6 mm? -105.7 170.81 7.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.206 0.527 . . . . 0.14999999999999999 111.182 176.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 45' ' ' GLU . 1.6 m -122.99 167.56 16.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 106.999 -1.482 . . . . 0.25 106.999 167.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.514 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -138.01 144.56 15.87 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.725 -1.226 . . . . 0.37 111.847 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -102.76 127.59 49.85 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.373 -0.531 . . . . 0.28999999999999998 110.279 175.051 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.53 ' N ' HD22 ' A' ' 75' ' ' ASN . 0.8 OUTLIER 57.75 54.99 5.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.742 -1.117 . . . . 1.8500000000000001 111.15 177.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.514 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 47.0 m -87.56 142.27 27.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.356 -0.838 . . . . 1.1200000000000001 110.913 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 14.2 t -98.25 123.41 50.84 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.758 -0.656 . . . . 1.26 109.804 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 12.9 Cg_exo -70.45 120.45 7.14 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.573 2.182 . . . . 0.60999999999999999 112.123 175.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.3 mt . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.767 -0.651 . . . . 0.85999999999999999 109.728 -179.56 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.478 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . . . . . . 0 C--O 1.235 0.321 0 CA-C-O 120.564 0.221 . . . . 0.54000000000000004 111.051 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.77 130.65 37.98 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.64 -0.504 . . . . 0.78000000000000003 109.64 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.65 123.42 47.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.331 0.586 . . . . 0.39000000000000001 110.952 -173.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 44' ' ' THR . 6.1 m -134.61 166.41 28.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.634 -0.712 . . . . 0.22 111.647 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.5 t -110.73 116.48 31.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.317 -0.856 . . . . 0.70999999999999996 108.965 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 16.1 m -118.63 150.15 40.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.835 0.35 . . . . 0.60999999999999999 110.642 -171.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.405 HG22 ' HA3' ' A' ' 108' ' ' GLY . 8.4 t -78.13 -32.2 50.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.81 -0.632 . . . . 0.38 110.827 -173.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.45 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.6 m120 -155.72 163.48 39.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.862 -0.608 . . . . 0.78000000000000003 109.715 -176.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -139.63 148.68 42.8 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.62 -0.511 . . . . 0.41999999999999998 109.62 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.609 ' HB2' HG23 ' A' ' 105' ' ' VAL . 60.6 m-85 -134.56 154.39 51.49 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.469 -0.567 . . . . 0.77000000000000002 109.469 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.552 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 8.4 mm100 64.91 29.46 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.335 0.397 . . . . 0.80000000000000004 111.489 176.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.7 m170 63.96 11.5 6.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.951 -0.568 . . . . 2.1200000000000001 111.991 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 132.23 -17.77 4.78 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.136 -1.031 . . . . 0.28000000000000003 113.333 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 14.7 mt -50.55 -40.25 51.49 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.556 0.678 . . . . 0.35999999999999999 110.742 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.609 HG23 ' HB2' ' A' ' 100' ' ' TYR . 4.3 m -127.05 142.63 42.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.656 -0.702 . . . . 0.85999999999999999 109.698 171.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 24.1 t30 -138.61 143.57 39.38 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.15 -1.056 . . . . 0.91000000000000003 108.15 -175.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.45 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.2 m -126.19 152.24 33.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 113.393 0.886 . . . . 0.29999999999999999 113.393 -172.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.06 52.73 51.05 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.703 -1.135 . . . . 0.20000000000000001 112.057 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' CYS . . . . . 0.434 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 93.7 m -96.65 126.72 42.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.951 0.405 . . . . 0.42999999999999999 112.005 -175.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -119.46 126.02 27.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.74 -0.664 . . . . 0.29999999999999999 110.313 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' A' ' 94' ' ' VAL . 70.8 Cg_exo -51.33 110.08 0.38 Allowed 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.997 2.465 . . . . 0.34000000000000002 112.417 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.9 tt . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 0.58999999999999997 110.098 -179.639 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.4 tttm . . . . . 0 N--CA 1.477 0.923 0 CA-C-O 120.907 0.384 . . . . 30.309999999999999 110.389 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 59.88 48.75 8.57 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.819 -0.628 . . . . 28.059999999999999 112.377 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 22.3 ptp -147.94 -32.16 0.27 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.112 0.482 . . . . 28.52 110.167 174.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.56 18.5 3.61 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.349 -0.611 . . . . 26.559999999999999 109.349 173.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.53 163.14 19.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.409 -0.814 . . . . 25.140000000000001 110.035 -175.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 24.4 pt -134.06 24.36 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.334 0.588 . . . . 24.989999999999998 109.886 174.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -104.36 -32.74 4.15 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.617 -0.719 . . . . 22.920000000000002 111.998 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.9 t -70.34 -27.85 64.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.881 0.372 . . . . 22.809999999999999 110.452 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.4 p -106.06 154.94 19.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.315 -0.402 . . . . 22.210000000000001 111.15 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.26 68.85 0.93 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.256 0.551 . . . . 20.949999999999999 110.188 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.29 76.56 68.36 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.636 -0.711 . . . . 19.190000000000001 111.399 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.17 -17.33 15.09 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.306 2.004 . . . . 17.98 112.66 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 -89.19 -20.31 24.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.025 0.44 . . . . 18.07 110.305 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -81.51 123.91 29.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.863 -0.608 . . . . 14.66 109.789 176.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.3 m -119.86 146.98 23.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.792 0.329 . . . . 13.029999999999999 110.876 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -77.77 100.74 6.39 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.446 -0.575 . . . . 12.26 109.446 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.06 50.65 1.44 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.26 -0.736 . . . . 9.9700000000000006 111.26 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.36 92.99 0.6 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 121.204 -0.522 . . . . 8.2200000000000006 112.631 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.489 HG22 ' HD2' ' A' ' 30' ' ' PRO . 3.3 m -60.78 134.19 92.2 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.919 -0.4 . . . . 7.2999999999999998 109.919 176.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.431 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 80.9 Cg_exo -41.1 -50.35 4.29 Favored 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.396 2.731 . . . . 6.0999999999999996 114.911 -175.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.489 ' HD2' HG22 ' A' ' 28' ' ' THR . 2.2 Cg_endo -79.77 111.97 2.83 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.036 1.824 . . . . 5.1900000000000004 111.448 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -68.17 141.1 56.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.277 -0.42 . . . . 3.79 111.102 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.9 p -149.37 174.83 12.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.941 -0.572 . . . . 1.74 110.21 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.2 m -98.81 135.87 39.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.93 0.395 . . . . 1.7 111.004 -175.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.6 t -80.57 -11.84 59.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.196 0.522 . . . . 2.5699999999999998 109.723 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.7 p -76.86 -8.85 58.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.818 -0.628 . . . . 2.5 110.955 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 147.29 170.02 15.19 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.618 -0.593 . . . . 1.51 111.618 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.53 ' HB3' ' HA ' ' A' ' 80' ' ' SER . 0.9 OUTLIER -46.63 151.31 2.02 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.692 2.928 . . . . 1.05 113.76 176.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 39' ' ' TYR . 92.9 t -83.52 164.76 2.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.883 -1.053 . . . . 0.58999999999999997 108.375 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.7 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 97.2 m-85 -130.63 139.68 50.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.478 0.656 . . . . 0.78000000000000003 111.601 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 36.9 t -107.9 98.64 8.19 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.166 -0.925 . . . . 0.81999999999999995 109.346 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.643 ' HB2' HE21 ' A' ' 92' ' ' GLN . 33.9 m -104.24 141.71 35.8 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.393 -0.595 . . . . 0.23999999999999999 109.393 -174.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -59.63 -30.43 68.71 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.673 -0.694 . . . . 2.0800000000000001 110.769 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.17 123.46 0.98 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.644 -0.872 . . . . 2.5800000000000001 108.644 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.651 ' N ' HE22 ' A' ' 92' ' ' GLN . 1.5 p -86.65 127.99 34.97 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.814 -0.754 . . . . 0.37 110.433 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.67 ' HB3' HG22 ' A' ' 72' ' ' VAL . 8.8 tp10 -103.45 138.07 40.68 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.973 -1.012 . . . . 1.1200000000000001 109.649 -172.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.46 ' HA ' HD12 ' A' ' 71' ' ' LEU . 6.3 m-20 -65.01 107.44 1.51 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.235 -0.439 . . . . 1.77 111.015 -174.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.593 ' HA ' HD21 ' A' ' 50' ' ' LEU . 92.9 p -65.48 -6.38 10.44 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.88 -0.6 . . . . 0.92000000000000004 112.032 -174.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.497 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 3.6 mppt? -77.09 -38.63 51.94 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.434 0.635 . . . . 2.77 109.639 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -142.61 67.93 1.31 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.936 -1.029 . . . . 2.3300000000000001 110.988 -176.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.593 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -61.91 160.34 12.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.476 0.655 . . . . 1.1599999999999999 111.469 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -67.65 155.6 38.81 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.341 -0.985 . . . . 1.8100000000000001 108.341 171.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -28.93 70.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 118.418 0.553 . . . . 3.23 110.233 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -67.62 -38.18 89.98 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.801 -0.714 . . . . 0.34000000000000002 111.495 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.684 ' HA ' HD22 ' A' ' 57' ' ' LEU . 37.0 m -79.0 -41.36 29.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.995 0.426 . . . . 0.35999999999999999 110.119 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.2 m -54.71 -35.16 63.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.52 -0.764 . . . . 0.29999999999999999 109.851 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.565 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.19 -53.67 55.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.26 -0.882 . . . . 0.23000000000000001 111.537 175.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.684 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.42 -45.46 88.38 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.416 0.626 . . . . 0.23999999999999999 110.238 -178.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.5 mt -58.56 -43.31 89.3 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.954 -1.021 . . . . 0.17999999999999999 110.175 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.18 -36.91 93.1 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.77 -0.728 . . . . 0.26000000000000001 112.196 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.5 mt -60.6 -44.79 95.88 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 121.506 0.67 . . . . 0.34000000000000002 110.248 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.581 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.2 mt -87.64 1.06 54.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.945 -1.025 . . . . 0.35999999999999999 111.543 -176.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 71.29 26.65 3.31 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.825 -0.625 . . . . 1.8899999999999999 111.392 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 58' ' ' LEU . 60.4 mt -78.44 140.57 16.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.938 -0.574 . . . . 0.26000000000000001 110.281 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.54 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 11.5 mptt -91.26 118.0 30.12 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.709 -0.678 . . . . 2.2200000000000002 109.815 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -73.01 -36.95 52.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.83 -0.623 . . . . 0.28999999999999998 110.195 -175.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.31 -19.23 79.6 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.735 -0.745 . . . . 0.56999999999999995 112.283 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -85.25 -16.77 39.06 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.048 0.452 . . . . 0.85999999999999999 110.331 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 94.1 mt -64.01 154.07 35.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.883 -0.598 . . . . 0.46000000000000002 111.393 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.409 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 12.5 mptt -109.38 -80.37 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.647 -0.706 . . . . 2.0099999999999998 112.503 -171.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -98.69 -90.67 0.29 Allowed 'General case' 0 C--O 1.236 0.388 0 N-CA-C 112.537 0.569 . . . . 1.0900000000000001 112.537 -170.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.0 OUTLIER -120.77 166.23 14.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.891 -0.595 . . . . 0.14999999999999999 110.989 178.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.67 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.9 OUTLIER -118.03 171.37 6.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 106.665 -1.605 . . . . 0.25 106.665 167.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.77 120.6 1.76 Allowed Glycine 0 C--N 1.31 -0.911 0 C-N-CA 119.668 -1.254 . . . . 0.37 112.132 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.61 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -91.54 140.02 30.14 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 120.089 -0.644 . . . . 0.28999999999999998 110.148 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.502 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 3.0 t-20 50.9 49.86 20.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.921 -1.036 . . . . 1.8500000000000001 110.559 176.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.7 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 7.9 t -92.1 150.44 20.95 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.733 -1.121 . . . . 1.1200000000000001 110.805 -174.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 17.9 t -109.41 121.12 43.43 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.794 -0.639 . . . . 1.26 110.022 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 12.7 Cg_exo -69.69 124.24 10.92 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.514 2.142 . . . . 0.60999999999999999 112.527 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.436 HD11 ' HB2' ' A' ' 40' ' ' CYS . 23.9 mt -103.09 87.63 2.95 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.966 -0.561 . . . . 0.85999999999999999 109.715 178.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.53 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 27.5 p -100.24 -41.64 7.0 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.951 0.405 . . . . 1.3700000000000001 110.506 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.8 m -95.44 103.23 14.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.397 0.618 . . . . 1.6000000000000001 111.042 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 48.8 mm -68.45 139.45 20.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.786 -0.643 . . . . 1.8500000000000001 110.625 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.13 -127.41 7.9 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.369 -1.092 . . . . 3.1800000000000002 110.369 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 m -67.83 114.63 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.331 0.586 . . . . 4.6900000000000004 110.207 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.85 -71.08 0.2 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.566 -0.613 . . . . 4.3499999999999996 111.566 -176.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.44 -44.81 82.87 Favored Glycine 0 C--O 1.227 -0.327 0 C-N-CA 121.063 -0.589 . . . . 3.27 112.648 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -95.03 23.64 5.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.761 0.791 . . . . 5.4699999999999998 109.4 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.4 m -110.64 22.53 15.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.371 -0.831 . . . . 4.7000000000000002 109.678 176.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.7 t -73.06 114.58 11.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.404 -0.816 . . . . 1.6599999999999999 110.411 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 29.2 t -101.24 -9.62 21.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.184 0.516 . . . . 1.6499999999999999 109.99 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.585 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -93.25 -158.31 0.6 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.855 -0.611 . . . . 0.54000000000000004 110.013 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.651 HE22 ' N ' ' A' ' 44' ' ' THR . 1.2 tt0 -84.0 136.3 34.11 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 109.678 -0.49 . . . . 0.78000000000000003 109.678 -178.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.21 121.36 45.1 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.341 0.591 . . . . 0.39000000000000001 111.217 -174.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.595 HG12 ' HA ' ' A' ' 111' ' ' PRO . 1.9 m -133.07 164.18 35.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.515 -0.766 . . . . 0.22 110.877 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 42.4 t -108.24 109.08 20.36 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.347 -0.842 . . . . 0.70999999999999996 109.159 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 28.8 m -106.76 153.73 22.02 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.202 -0.454 . . . . 0.60999999999999999 110.135 -175.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.6 t -86.64 -28.03 23.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.38 110.655 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.617 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 24.1 m120 -151.74 168.08 26.17 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.693 -0.484 . . . . 0.78000000000000003 109.693 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.8 t -139.66 144.34 37.57 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.181 0.301 . . . . 0.41999999999999998 110.783 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.606 ' HB2' HG23 ' A' ' 105' ' ' VAL . 50.8 m-85 -134.07 153.12 52.01 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 110.094 -0.336 . . . . 0.77000000000000002 110.094 175.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.651 ' NE2' HD12 ' A' ' 104' ' ' LEU . 9.6 mm100 62.6 30.41 17.01 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.303 0.483 . . . . 0.80000000000000004 112.303 172.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 67.05 -0.89 1.57 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.868 0.467 . . . . 2.1200000000000001 111.827 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 76' ' ' CYS . . . 140.61 -13.73 2.94 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.805 -0.712 . . . . 0.28000000000000003 112.514 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.651 HD12 ' NE2' ' A' ' 101' ' ' GLN . 48.2 mt -52.1 -36.13 50.07 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.991 0.424 . . . . 0.35999999999999999 111.0 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.606 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.3 OUTLIER -137.52 139.04 44.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.504 -0.771 . . . . 0.85999999999999999 109.786 174.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.575 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.5 t30 -136.37 157.93 45.63 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.711 -0.848 . . . . 0.91000000000000003 108.711 -174.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.617 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 10.7 m -135.64 150.87 29.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 112.983 0.734 . . . . 0.29999999999999999 112.983 -175.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.69 50.31 67.48 Favored Glycine 0 N--CA 1.447 -0.571 0 CA-C-N 114.74 -1.118 . . . . 0.20000000000000001 112.086 175.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 81.0 m -96.87 125.92 41.65 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.767 0.318 . . . . 0.42999999999999999 110.576 -175.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 18.9 p -119.39 138.95 27.02 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.901 -0.591 . . . . 0.29999999999999999 109.78 175.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.595 ' HA ' HG12 ' A' ' 94' ' ' VAL . 36.7 Cg_exo -64.92 108.63 1.13 Allowed 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.889 2.393 . . . . 0.34000000000000002 112.006 -176.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.1 tt -94.58 132.37 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.585 -0.734 . . . . 0.58999999999999997 111.007 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -93.42 100.26 12.6 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.844 -0.798 . . . . 2.3900000000000001 108.844 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 115' ' ' GLY . 1.2 pp -66.75 -21.07 27.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.328 -0.396 . . . . 2.02 111.933 -177.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.42 ' N ' HD12 ' A' ' 114' ' ' ILE . . . 100.06 -22.77 38.7 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.615 -0.802 . . . . 2.6099999999999999 113.666 173.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 116' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.199 -0.905 . . . . 3.6899999999999999 111.037 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 110.034 -0.358 . . . . 30.309999999999999 110.034 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 56.78 73.76 0.44 Allowed 'General case' 0 C--O 1.233 0.201 0 O-C-N 123.604 0.565 . . . . 28.059999999999999 110.735 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -84.55 46.73 1.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.239 -0.437 . . . . 28.52 111.696 -175.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 55.5 35.58 25.4 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.788 -0.642 . . . . 26.559999999999999 112.445 174.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -94.1 147.73 22.86 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.534 -0.543 . . . . 25.140000000000001 109.534 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 44.4 mm -120.48 103.44 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.77 0.319 . . . . 24.989999999999998 110.963 -176.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.25 -25.74 12.13 Favored Glycine 0 N--CA 1.449 -0.498 0 N-CA-C 111.332 -0.707 . . . . 22.920000000000002 111.332 175.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.8 m -125.46 117.39 23.55 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.68 -0.489 . . . . 22.809999999999999 109.68 178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.2 m -58.73 -38.0 77.39 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.671 -0.695 . . . . 22.210000000000001 111.602 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -149.29 -58.12 0.21 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.23 0.538 . . . . 20.949999999999999 110.439 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 m -126.68 125.92 24.44 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.856 -0.611 . . . . 19.190000000000001 110.321 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.59 -30.96 77.09 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.165 2.577 . . . . 17.98 112.749 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.5 mtm180 -122.58 135.75 54.7 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.823 -0.436 . . . . 18.07 109.823 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -83.36 54.86 2.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.38 0.609 . . . . 14.66 111.103 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.29 117.47 55.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.489 -0.778 . . . . 13.029999999999999 109.396 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -82.7 42.66 0.79 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.972 0.415 . . . . 12.26 110.917 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.01 138.19 26.47 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.898 -0.592 . . . . 9.9700000000000006 111.826 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.89 173.87 13.53 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.749 -0.739 . . . . 8.2200000000000006 111.449 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.582 HG22 ' HD2' ' A' ' 30' ' ' PRO . 6.9 m -148.35 123.13 4.98 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-O 120.937 0.398 . . . . 7.2999999999999998 110.133 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 21.7 Cg_exo -56.51 -54.4 3.91 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.101 2.534 . . . . 6.0999999999999996 112.765 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.582 ' HD2' HG22 ' A' ' 28' ' ' THR . 91.9 Cg_endo -79.53 45.58 1.98 Allowed 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 121.492 1.461 . . . . 5.1900000000000004 112.459 173.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -65.91 125.56 25.76 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.906 -0.776 . . . . 3.79 108.906 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.4 p -153.34 -165.85 2.27 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.786 -0.365 . . . . 1.74 111.6 -174.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.6 m -77.07 176.88 8.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.134 0.492 . . . . 1.7 111.328 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.1 m -89.92 -28.26 19.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.968 -0.56 . . . . 2.5699999999999998 110.495 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.8 p -98.64 10.93 39.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 2.5 111.274 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 161.42 -176.16 37.96 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.324 -0.941 . . . . 1.51 112.516 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HG2' ' HA ' ' A' ' 80' ' ' SER . 8.4 Cg_exo -73.72 -158.76 0.07 OUTLIER 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 123.718 2.945 . . . . 1.05 112.738 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 39' ' ' TYR . 19.2 t -84.44 166.35 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 110.29 -0.263 . . . . 0.58999999999999997 110.29 -176.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.493 ' N ' HG12 ' A' ' 38' ' ' VAL . 63.8 m-85 -132.91 140.1 47.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.978 0.418 . . . . 0.78000000000000003 110.577 177.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 52.4 t -117.79 103.21 9.76 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.017 -0.538 . . . . 0.81999999999999995 110.778 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 56.8 m -100.17 129.58 46.21 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.703 -0.851 . . . . 0.23999999999999999 108.703 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.489 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 94.6 m-20 -59.78 -24.24 63.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.55 0.69 . . . . 2.0800000000000001 109.585 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 5.3 mmmm -161.78 134.64 6.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.088 -1.414 . . . . 2.5800000000000001 107.724 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.514 HG21 HG11 ' A' ' 94' ' ' VAL . 22.9 p -88.39 157.73 18.61 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.441 -0.903 . . . . 0.37 110.49 169.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.509 ' CB ' HG22 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -119.12 142.53 47.83 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.366 -0.834 . . . . 1.1200000000000001 110.179 -176.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.523 ' O ' HD13 ' A' ' 50' ' ' LEU . 11.9 t70 -71.88 101.51 2.67 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.523 -0.762 . . . . 1.77 110.349 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.575 ' HA ' HD21 ' A' ' 50' ' ' LEU . 57.1 p -67.72 -6.67 22.0 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.631 0.604 . . . . 0.92000000000000004 112.631 -172.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.553 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -77.73 -40.9 39.59 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.777 0.799 . . . . 2.77 109.179 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -147.12 68.86 1.15 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.692 -1.14 . . . . 2.3300000000000001 109.874 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.575 HD21 ' HA ' ' A' ' 47' ' ' SER . 3.1 mm? -53.08 153.18 3.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.562 0.696 . . . . 1.1599999999999999 112.418 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -57.9 146.54 31.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.711 -1.132 . . . . 1.8100000000000001 108.703 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -59.6 -27.62 66.45 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.705 -0.398 . . . . 3.23 110.857 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.458 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -69.77 -37.07 75.73 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.547 -0.835 . . . . 0.34000000000000002 111.624 176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.692 ' HA ' HD22 ' A' ' 57' ' ' LEU . 23.5 m -80.03 -43.95 21.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.831 0.348 . . . . 0.35999999999999999 110.228 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.7 m -51.93 -36.2 48.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.875 -0.602 . . . . 0.29999999999999999 109.813 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.36 -53.7 55.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.511 -0.768 . . . . 0.23000000000000001 111.78 176.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.692 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.49 -46.59 86.36 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.462 0.649 . . . . 0.23999999999999999 110.313 -178.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 54' ' ' THR . 52.9 mt -58.43 -44.8 89.27 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.854 -1.066 . . . . 0.17999999999999999 110.135 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.44 -32.91 79.13 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.968 -0.634 . . . . 0.26000000000000001 112.945 175.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.8 mt -64.01 -43.47 95.55 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.826 0.822 . . . . 0.34000000000000002 110.123 177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.475 HD21 ' HG2' ' A' ' 101' ' ' GLN . 3.4 mt -86.68 -1.33 57.62 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.535 -1.212 . . . . 0.35999999999999999 110.961 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.2 m120 65.61 36.03 6.71 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.215 -0.902 . . . . 1.8899999999999999 111.072 177.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 58' ' ' LEU . 50.1 mt -82.96 145.09 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 115.599 -0.728 . . . . 0.26000000000000001 109.502 175.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.656 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -99.32 117.96 34.93 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.331 0.586 . . . . 2.2200000000000002 109.762 -178.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.29 -28.12 34.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.277 -0.874 . . . . 0.28999999999999998 110.877 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.13 -15.44 78.65 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 121.168 -0.539 . . . . 0.56999999999999995 112.6 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.492 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 17.2 t70 -86.21 -29.39 23.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.925 0.393 . . . . 0.85999999999999999 110.332 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 86.0 mt -52.5 139.39 25.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.099 -0.955 . . . . 0.46000000000000002 111.951 -174.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -96.67 -81.98 0.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.992 -1.004 . . . . 2.0099999999999998 112.197 -171.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -94.77 -92.06 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.05 0.389 . . . . 1.0900000000000001 112.05 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.3 mm? -117.39 171.32 8.06 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.319 0.58 . . . . 0.14999999999999999 110.917 177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.6 OUTLIER -121.08 172.88 7.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.565 -1.643 . . . . 0.25 106.565 165.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.483 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -139.39 129.16 4.26 Favored Glycine 0 C--N 1.31 -0.893 0 C-N-CA 119.89 -1.147 . . . . 0.37 112.106 -178.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.659 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -99.21 135.96 39.85 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.442 -0.503 . . . . 0.28999999999999998 109.895 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.41 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 24.2 m120 46.56 51.16 12.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.199 -0.91 . . . . 1.8500000000000001 110.531 -175.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 8.9 t -87.41 147.98 25.2 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.064 -0.971 . . . . 1.1200000000000001 109.575 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.7 m -109.59 108.97 59.94 Favored Pre-proline 0 C--N 1.312 -1.031 0 CA-C-N 116.048 -0.524 . . . . 1.26 110.356 -176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.59 120.02 7.15 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.12 1.88 . . . . 0.60999999999999999 111.371 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 37' ' ' PRO . 35.4 mt -90.1 87.03 6.72 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.601 -0.727 . . . . 0.85999999999999999 109.26 -177.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.483 ' HA ' ' HG2' ' A' ' 37' ' ' PRO . 10.4 m -80.01 -48.09 13.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.774 -0.648 . . . . 1.3700000000000001 110.654 -175.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.8 m -104.05 113.98 42.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.3 0.571 . . . . 1.6000000000000001 111.026 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.8 mt -122.09 126.78 74.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.922 -0.581 . . . . 1.8500000000000001 110.95 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -180.0 -31.87 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.848 -0.691 . . . . 3.1800000000000002 111.689 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.9 102.01 3.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.748 -0.464 . . . . 4.6900000000000004 109.748 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.68 -66.0 3.38 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.946 -0.645 . . . . 4.3499999999999996 112.329 -178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 124.94 12.18 4.08 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.909 -0.662 . . . . 3.27 112.445 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -120.27 -79.45 0.6 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.507 -0.553 . . . . 5.4699999999999998 109.507 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.0 m 50.58 39.65 21.82 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.519 0.676 . . . . 4.7000000000000002 110.94 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.43 -56.69 0.44 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.432 -0.804 . . . . 1.6599999999999999 110.691 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t 64.37 12.29 7.16 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.982 0.513 . . . . 1.6499999999999999 112.07 174.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.698 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -134.33 -158.72 0.9 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.064 -0.346 . . . . 0.54000000000000004 110.064 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.73 115.96 21.88 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.852 0.834 . . . . 0.78000000000000003 109.694 -175.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.51 117.13 33.24 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.169 -0.923 . . . . 0.39000000000000001 110.832 -169.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.514 HG11 HG21 ' A' ' 44' ' ' THR . 9.5 m -129.93 171.53 17.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.547 -0.751 . . . . 0.22 111.854 -176.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 37.7 t -115.0 108.32 16.55 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.812 -1.085 . . . . 0.70999999999999996 108.93 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 27.6 m -106.03 145.43 31.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.313 -0.403 . . . . 0.60999999999999999 110.076 -176.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -76.04 -28.87 57.85 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.38 110.348 -174.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.445 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 12.1 m120 -151.34 164.18 37.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 0.78000000000000003 109.843 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 t -137.63 133.55 34.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.05 -0.523 . . . . 0.41999999999999998 109.944 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.555 ' HB2' HG23 ' A' ' 105' ' ' VAL . 66.2 m-85 -119.37 157.25 28.55 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.963 -0.562 . . . . 0.77000000000000002 109.827 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.678 ' NE2' HD12 ' A' ' 104' ' ' LEU . 8.8 mm100 60.35 30.51 19.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.229 -0.441 . . . . 0.80000000000000004 111.586 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 63.68 9.82 4.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 2.1200000000000001 111.875 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.83 -24.29 3.02 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.73 -0.747 . . . . 0.28000000000000003 112.507 175.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.678 HD12 ' NE2' ' A' ' 101' ' ' GLN . 18.6 mt -49.86 -36.13 25.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.825 0.305 . . . . 0.35999999999999999 111.825 -177.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.555 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.3 OUTLIER -141.38 118.82 8.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.392 0.615 . . . . 0.85999999999999999 110.992 173.148 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.588 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 7.5 m-20 -111.03 162.64 14.66 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.5 -0.773 . . . . 0.91000000000000003 109.488 176.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.445 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.4 m -132.85 154.32 39.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 112.336 0.495 . . . . 0.29999999999999999 112.336 -176.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 59.8 52.29 53.87 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.278 -0.874 . . . . 0.20000000000000001 111.88 177.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 73.3 m -96.81 123.6 40.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.878 0.37 . . . . 0.42999999999999999 111.116 -174.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.4 p -119.72 125.94 27.18 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.919 -0.582 . . . . 0.29999999999999999 110.131 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.48 ' HA ' HG12 ' A' ' 94' ' ' VAL . 81.5 Cg_exo -48.38 109.87 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.752 2.301 . . . . 0.34000000000000002 111.665 175.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.3 tt -92.64 144.21 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.661 -0.7 . . . . 0.58999999999999997 111.747 -169.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -107.05 101.39 10.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.549 -0.751 . . . . 2.3900000000000001 110.366 178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 115' ' ' GLY . 1.4 pp -94.8 -19.39 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.059 -0.518 . . . . 2.02 111.374 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.416 ' N ' HD12 ' A' ' 114' ' ' ILE . . . 81.21 -8.56 57.61 Favored Glycine 0 C--N 1.33 0.205 0 C-N-CA 121.149 -0.548 . . . . 2.6099999999999999 113.621 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.539 -0.743 . . . . 3.6899999999999999 109.811 -179.584 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.821 0.343 . . . . 30.309999999999999 110.846 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.29 134.64 36.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.771 0.319 . . . . 28.059999999999999 110.385 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 82.5 mtp -98.25 125.86 43.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.145 -0.479 . . . . 28.52 110.895 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.33 81.26 2.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.212 0.529 . . . . 26.559999999999999 109.618 174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -77.98 134.39 37.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.637 -0.711 . . . . 25.140000000000001 110.514 -176.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.488 ' H ' HD13 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -133.65 20.19 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.986 -0.552 . . . . 24.989999999999998 110.728 -177.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.04 52.36 4.61 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.034 -0.603 . . . . 22.920000000000002 112.383 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.5 m -85.8 65.99 9.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.274 0.559 . . . . 22.809999999999999 110.038 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.9 p -77.75 64.9 3.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.407 -0.815 . . . . 22.210000000000001 111.195 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.91 48.23 0.94 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.939 -0.573 . . . . 20.949999999999999 110.791 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 20' ' ' VAL . 7.5 p -147.63 71.33 11.62 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 121.772 0.796 . . . . 19.190000000000001 110.677 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.25 -45.27 23.7 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.475 2.117 . . . . 17.98 110.816 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -147.29 123.93 11.13 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.498 -0.774 . . . . 18.07 109.949 175.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -108.03 -42.33 4.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.007 -0.542 . . . . 14.66 110.162 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.8 m -108.82 155.41 9.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.69 -0.687 . . . . 13.029999999999999 110.746 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -113.46 118.21 33.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.187 -0.461 . . . . 12.26 110.01 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -139.01 -165.24 10.17 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.844 -0.693 . . . . 9.9700000000000006 112.335 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 164.83 -69.49 0.2 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.539 -0.624 . . . . 8.2200000000000006 111.539 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.643 HG22 ' HD2' ' A' ' 30' ' ' PRO . 61.1 m -152.7 113.11 2.76 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 110.323 -0.251 . . . . 7.2999999999999998 110.323 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 28' ' ' THR . 4.3 Cg_exo -43.5 -51.17 6.26 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.888 3.059 . . . . 6.0999999999999996 114.713 -171.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.643 ' HD2' HG22 ' A' ' 28' ' ' THR . 70.0 Cg_exo -48.58 112.48 0.63 Allowed 'Trans proline' 0 C--N 1.362 1.247 0 C-N-CA 122.435 2.09 . . . . 5.1900000000000004 112.88 174.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -102.41 -34.07 9.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.172 -0.467 . . . . 3.79 110.392 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.3 t -78.16 178.63 7.43 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.796 -0.638 . . . . 1.74 109.588 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 73.8 m -101.95 147.45 26.53 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.99 0.424 . . . . 1.7 110.325 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 p -89.05 -10.84 45.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.091 -0.504 . . . . 2.5699999999999998 110.932 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.2 t -94.62 9.13 39.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.012 -0.54 . . . . 2.5 110.181 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . 149.33 151.26 5.44 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.879 -0.889 . . . . 1.51 110.879 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 16.8 Cg_exo -69.71 -159.6 0.06 OUTLIER 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.492 2.128 . . . . 1.05 112.495 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 83.9 t -87.29 156.61 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 110.144 -0.317 . . . . 0.58999999999999997 110.144 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.29 136.44 48.16 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.855 -0.424 . . . . 0.78000000000000003 109.855 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 48.0 t -102.99 114.82 29.42 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.806 0.336 . . . . 0.81999999999999995 110.589 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.1 m -115.25 125.18 53.02 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.928 -0.767 . . . . 0.23999999999999999 108.928 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.512 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 24.7 t-20 -50.64 -34.36 25.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.614 -0.721 . . . . 2.0800000000000001 110.231 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 mmmm -154.58 127.48 8.2 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.652 -1.158 . . . . 2.5800000000000001 108.725 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.515 HG21 HG11 ' A' ' 94' ' ' VAL . 18.0 p -84.37 156.94 21.62 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 119.53 -0.868 . . . . 0.37 110.514 168.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.494 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.8 tp10 -120.58 139.23 53.25 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.617 -0.72 . . . . 1.1200000000000001 109.451 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.442 ' HA ' HD12 ' A' ' 71' ' ' LEU . 24.1 t70 -65.65 110.81 2.9 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.029 -0.532 . . . . 1.77 110.376 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 68' ' ' LEU . 58.5 p -69.41 -2.45 11.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.262 -0.426 . . . . 0.92000000000000004 112.073 -173.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -90.12 -27.99 19.26 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.115 0.483 . . . . 2.77 109.759 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -141.62 64.28 1.41 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.945 -0.57 . . . . 2.3300000000000001 110.592 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.547 HD11 HG13 ' A' ' 72' ' ' VAL . 2.8 mm? -60.74 150.21 33.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.291 0.567 . . . . 1.1599999999999999 111.559 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.93 144.13 57.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.831 -1.077 . . . . 1.8100000000000001 108.438 169.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -62.8 -21.07 65.62 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 121.213 -0.195 . . . . 3.23 110.902 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.31 -36.57 63.36 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.583 -0.818 . . . . 0.34000000000000002 111.202 174.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.643 ' HA ' HD22 ' A' ' 57' ' ' LEU . 37.9 m -82.05 -43.98 17.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.817 0.342 . . . . 0.35999999999999999 110.198 178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.1 m -52.5 -35.37 52.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.698 -0.683 . . . . 0.29999999999999999 110.04 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.637 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -55.82 -53.69 53.62 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.377 -0.829 . . . . 0.23000000000000001 111.288 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.643 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -59.6 -44.9 93.23 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.221 0.534 . . . . 0.23999999999999999 109.995 -178.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 54' ' ' THR . 54.1 mt -58.12 -46.08 86.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.094 -0.957 . . . . 0.17999999999999999 109.992 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.24 -29.66 75.15 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.003 -0.617 . . . . 0.26000000000000001 112.574 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.1 mt -65.73 -47.53 75.01 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.639 0.733 . . . . 0.34000000000000002 110.161 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' CD1' HG21 ' A' ' 105' ' ' VAL . 3.7 mt -83.09 -2.41 55.32 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.764 -1.107 . . . . 0.35999999999999999 110.996 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 65.2 t30 68.17 38.38 2.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.222 -0.899 . . . . 1.8899999999999999 110.978 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 58' ' ' LEU . 51.3 mt -84.32 137.74 20.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.778 -0.646 . . . . 0.26000000000000001 110.099 175.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -84.11 118.0 23.81 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.645 -0.707 . . . . 2.2200000000000002 110.304 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.91 -31.69 51.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.763 -0.653 . . . . 0.28999999999999998 109.902 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.92 -9.53 86.61 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.774 -0.648 . . . . 0.56999999999999995 112.604 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -95.6 -8.78 33.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.399 0.618 . . . . 0.85999999999999999 110.283 176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.578 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.6 mt -69.22 144.08 53.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.721 -0.672 . . . . 0.46000000000000002 111.223 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -101.17 -68.73 0.8 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.843 -1.071 . . . . 2.0099999999999998 112.557 -168.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -114.51 -91.74 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.853 0.359 . . . . 1.0900000000000001 111.825 -172.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.3 mm? -116.25 169.34 9.36 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.056 0.455 . . . . 0.14999999999999999 110.393 174.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.547 HG13 HD11 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -124.89 166.88 19.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 106.596 -1.631 . . . . 0.25 106.596 166.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.464 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -134.1 148.24 19.38 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 119.807 -1.187 . . . . 0.37 111.364 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -112.1 134.4 53.67 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.151 -0.62 . . . . 0.28999999999999998 110.549 177.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.7 m120 55.51 45.14 25.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.824 -1.08 . . . . 1.8500000000000001 111.163 179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.464 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 63.3 m -77.61 146.91 35.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.334 0.588 . . . . 1.1200000000000001 111.275 -176.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.9 t -98.03 113.28 63.63 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 115.168 -0.924 . . . . 1.26 109.523 175.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.06 124.39 12.56 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.379 2.053 . . . . 0.60999999999999999 111.954 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.8 mt -103.45 88.46 3.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.932 -0.576 . . . . 0.85999999999999999 109.729 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.4 m -76.8 -32.62 57.78 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.878 -0.601 . . . . 1.3700000000000001 110.727 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.4 m -112.7 102.95 14.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.664 0.745 . . . . 1.6000000000000001 111.566 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.5 mm -68.09 -47.69 77.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.264 -0.88 . . . . 1.8500000000000001 112.164 -176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -70.7 -29.53 69.43 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.522 -0.847 . . . . 3.1800000000000002 112.46 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.46 -46.1 32.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 122.863 -0.198 . . . . 4.6900000000000004 110.918 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -163.14 59.97 0.27 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.201 -0.999 . . . . 4.3499999999999996 112.859 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -105.7 -24.67 6.91 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.779 -0.724 . . . . 3.27 112.054 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 t30 -83.25 129.81 35.03 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.38 -0.23 . . . . 5.4699999999999998 110.38 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 p 48.71 91.31 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 O-C-N 123.888 0.743 . . . . 4.7000000000000002 111.591 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.519 ' SG ' HG23 ' A' ' 93' ' ' THR . 32.0 p -94.56 17.34 13.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.54 -0.755 . . . . 1.6599999999999999 111.237 -173.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.6 t 68.45 6.62 5.49 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.796 -0.638 . . . . 1.6499999999999999 110.636 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.786 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -154.44 -162.11 1.34 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.983 -0.553 . . . . 0.54000000000000004 110.362 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.0 124.03 31.23 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.404 0.621 . . . . 0.78000000000000003 110.069 -177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.519 HG23 ' SG ' ' A' ' 89' ' ' CYS . 0.2 OUTLIER -104.33 115.73 30.89 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.826 -0.625 . . . . 0.39000000000000001 110.991 -173.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 111' ' ' PRO . 9.5 m -126.42 165.08 25.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.936 -0.574 . . . . 0.22 111.316 -177.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.7 t -114.6 121.96 45.03 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.079 -1.082 . . . . 0.70999999999999996 108.079 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.709 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 27.1 m -120.57 152.35 38.22 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.28 0.562 . . . . 0.60999999999999999 111.664 -167.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.525 HG22 ' HA3' ' A' ' 108' ' ' GLY . 10.9 t -81.2 -30.08 34.4 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.072 -0.967 . . . . 0.38 110.637 -170.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.487 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 17.8 m120 -154.56 167.82 28.82 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.39 -0.596 . . . . 0.78000000000000003 109.39 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 t -147.37 135.99 21.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.118 0.485 . . . . 0.41999999999999998 110.622 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.531 ' HB2' HG23 ' A' ' 105' ' ' VAL . 67.1 m-85 -129.55 154.31 47.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.361 -0.607 . . . . 0.77000000000000002 109.361 178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.663 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 10.7 mm100 59.88 38.1 21.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.545 -0.298 . . . . 0.80000000000000004 111.48 176.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.7 p80 58.88 2.18 0.23 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.152 0.981 . . . . 2.1200000000000001 113.201 176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.69 -18.19 3.01 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.691 -0.766 . . . . 0.28000000000000003 112.242 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 20.7 mt -49.8 -44.02 48.88 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.871 0.336 . . . . 0.35999999999999999 110.767 178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 100' ' ' TYR . 1.4 m -128.9 119.65 50.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.698 0.761 . . . . 0.85999999999999999 110.344 172.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.462 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 32.5 t30 -119.12 146.31 45.23 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.075 -1.083 . . . . 0.91000000000000003 108.075 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.537 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 11.3 m -132.45 156.21 42.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 113.537 0.94 . . . . 0.29999999999999999 113.537 -173.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 65.45 49.36 61.12 Favored Glycine 0 CA--C 1.503 -0.66 0 CA-C-N 114.952 -1.022 . . . . 0.20000000000000001 111.716 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 98.7 m -98.15 126.59 43.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.964 0.411 . . . . 0.42999999999999999 111.533 -172.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -120.86 126.14 26.78 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.505 -0.771 . . . . 0.29999999999999999 109.852 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.54 ' HA ' HG12 ' A' ' 94' ' ' VAL . 71.7 Cg_exo -50.15 112.34 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.049 2.499 . . . . 0.34000000000000002 112.117 178.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 13.0 tt -99.57 148.56 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.894 -0.594 . . . . 0.58999999999999997 111.096 -173.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -124.17 109.61 13.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.502 -0.772 . . . . 2.3900000000000001 109.451 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.438 HD12 ' H ' ' A' ' 115' ' ' GLY . 1.2 pp -76.59 -24.7 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 120.852 -0.339 . . . . 2.02 111.794 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.438 ' H ' HD12 ' A' ' 114' ' ' ILE . . . 88.53 7.78 71.6 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.586 -0.816 . . . . 2.6099999999999999 113.555 173.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.4 ' H ' HD13 ' A' ' 114' ' ' ILE . 7.6 mp . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.483 -0.77 . . . . 3.6899999999999999 109.956 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 120.934 0.397 . . . . 30.309999999999999 111.114 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.52 86.93 2.42 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.946 0.403 . . . . 28.059999999999999 110.128 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.9 mmt -77.62 66.36 3.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.108 -0.496 . . . . 28.52 110.902 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -111.83 132.4 54.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.065 -0.516 . . . . 26.559999999999999 110.258 178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -75.08 94.73 2.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.004 0.431 . . . . 25.140000000000001 110.105 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.2 pt -113.54 158.02 14.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.055 -0.521 . . . . 24.989999999999998 111.113 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -118.44 56.86 0.55 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 111.415 -0.674 . . . . 22.920000000000002 111.415 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -87.5 -4.88 58.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.812 0.339 . . . . 22.809999999999999 110.9 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -70.12 142.46 52.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.92 0.39 . . . . 22.210000000000001 109.951 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.93 145.36 27.92 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.364 -0.38 . . . . 20.949999999999999 111.149 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 t 59.27 85.53 0.18 Allowed Pre-proline 0 CA--C 1.532 0.27 0 O-C-N 123.859 0.724 . . . . 19.190000000000001 111.53 176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.79 -20.38 45.95 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.501 2.134 . . . . 17.98 112.227 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -106.43 84.31 2.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.438 -0.347 . . . . 18.07 110.78 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.91 -19.35 58.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.339 -0.615 . . . . 14.66 109.339 174.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.57 137.48 18.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.207 -0.906 . . . . 13.029999999999999 109.317 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -82.65 79.27 9.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.205 0.526 . . . . 12.26 110.35 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.95 106.96 2.53 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.598 -0.728 . . . . 9.9700000000000006 112.131 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.92 25.44 2.8 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.936 -0.649 . . . . 8.2200000000000006 111.581 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.542 HG22 ' HD2' ' A' ' 30' ' ' PRO . 7.1 m -77.25 119.44 77.48 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 121.195 0.521 . . . . 7.2999999999999998 110.66 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -56.62 -54.73 3.44 Favored 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 123.605 2.87 . . . . 6.0999999999999996 113.835 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.542 ' HD2' HG22 ' A' ' 28' ' ' THR . 58.5 Cg_endo -70.18 152.43 67.15 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.243 1.295 . . . . 5.1900000000000004 112.104 178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.442 ' HB2' HG13 ' A' ' 112' ' ' ILE . 68.3 mttm -88.33 43.35 1.12 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.99 -0.55 . . . . 3.79 110.964 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 43.1 t -72.87 161.67 30.43 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.371 0.605 . . . . 1.74 110.457 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 57.1 m -89.47 124.82 34.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.365 -0.834 . . . . 1.7 110.432 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.9 t -66.54 -17.71 64.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.035 0.445 . . . . 2.5699999999999998 110.312 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.2 t -71.19 -16.32 62.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.951 -0.568 . . . . 2.5 110.602 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 133.1 -123.79 3.55 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.812 -0.709 . . . . 1.51 112.166 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -56.54 153.76 33.75 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 123.142 2.562 . . . . 1.05 113.747 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 71.4 t -89.06 161.47 2.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.453 -1.249 . . . . 0.58999999999999997 107.85 172.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -118.3 137.01 53.36 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.872 0.844 . . . . 0.78000000000000003 111.817 -176.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 53.1 t -109.05 115.71 30.57 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.842 -1.072 . . . . 0.81999999999999995 110.152 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.7 m -113.57 126.69 55.57 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.201 -0.666 . . . . 0.23999999999999999 109.201 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -57.63 -23.21 49.92 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.473 -0.785 . . . . 2.0800000000000001 109.769 178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -166.24 132.46 2.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 114.55 -1.204 . . . . 2.5800000000000001 108.028 172.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.494 HG21 HG11 ' A' ' 94' ' ' VAL . 25.1 p -89.6 159.47 17.15 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.456 -0.898 . . . . 0.37 110.494 172.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.449 ' CB ' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -120.58 144.89 47.85 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.208 -0.905 . . . . 1.1200000000000001 109.305 -176.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.469 ' OD2' ' HB2' ' A' ' 48' ' ' LYS . 33.4 t70 -78.52 105.49 9.83 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.973 -0.558 . . . . 1.77 110.313 -174.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.711 ' HA ' HD21 ' A' ' 50' ' ' LEU . 80.1 p -63.21 -7.07 5.17 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.125 0.787 . . . . 0.92000000000000004 113.125 -172.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 2.9 mptp? -81.4 -43.49 18.88 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.335 0.588 . . . . 2.77 110.301 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -135.78 63.94 1.58 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.222 -0.899 . . . . 2.3300000000000001 111.211 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.711 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.8 mm? -60.06 155.97 15.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.265 0.555 . . . . 1.1599999999999999 111.453 176.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -64.26 152.29 41.4 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.638 -0.875 . . . . 1.8100000000000001 108.638 168.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -63.24 -28.96 70.39 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.415 -0.514 . . . . 3.23 110.638 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -67.54 -38.14 90.29 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.796 -0.716 . . . . 0.34000000000000002 111.879 177.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.686 ' HA ' HD22 ' A' ' 57' ' ' LEU . 41.7 m -78.93 -41.79 28.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.961 0.41 . . . . 0.35999999999999999 109.931 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.4 m -52.41 -36.11 53.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.448 -0.796 . . . . 0.29999999999999999 109.805 172.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.57 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.15 -53.99 52.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.046 -0.979 . . . . 0.23000000000000001 111.626 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.686 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -57.37 -46.31 83.51 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.492 0.663 . . . . 0.23999999999999999 110.016 -179.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.0 mt -58.69 -45.22 89.97 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.719 -1.128 . . . . 0.17999999999999999 109.827 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.34 -36.39 90.85 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.762 -0.654 . . . . 0.26000000000000001 112.657 175.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 25.5 mt -59.41 -40.29 86.19 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.613 0.72 . . . . 0.34000000000000002 110.439 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.475 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.3 mt -90.68 -3.65 57.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 114.923 -1.035 . . . . 0.35999999999999999 110.836 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 72.03 30.69 2.14 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.353 -0.84 . . . . 1.8899999999999999 111.305 176.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 58' ' ' LEU . 60.1 mt -77.59 141.95 14.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.984 -0.553 . . . . 0.26000000000000001 109.819 176.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.495 ' CG ' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -97.46 117.69 32.28 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.355 0.598 . . . . 2.2200000000000002 110.084 -177.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.7 -39.15 59.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.199 -0.909 . . . . 0.28999999999999998 110.791 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -67.9 -11.42 60.67 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.949 -0.643 . . . . 0.56999999999999995 112.952 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.495 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 36.6 t70 -111.94 3.63 17.65 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.253 0.549 . . . . 0.85999999999999999 110.793 -177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.41 ' CB ' ' HB2' ' A' ' 47' ' ' SER . 94.4 mt -70.85 164.72 24.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.304 -0.407 . . . . 0.46000000000000002 110.636 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -106.52 -91.93 0.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.586 0.587 . . . . 2.0099999999999998 112.586 -174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' O ' HD13 ' A' ' 71' ' ' LEU . 5.6 m-20 -91.81 -84.43 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.622 0.601 . . . . 1.0900000000000001 112.622 -171.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.0 OUTLIER -123.55 166.88 14.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.358 0.599 . . . . 0.14999999999999999 111.032 176.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.511 HG23 ' N ' ' A' ' 73' ' ' GLY . 0.8 OUTLIER -117.48 172.92 4.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.526 -1.657 . . . . 0.25 106.526 166.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.533 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -143.26 149.12 21.07 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 120.145 -1.026 . . . . 0.37 111.532 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.606 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -112.52 132.73 54.95 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.137 0.494 . . . . 0.28999999999999998 109.96 175.117 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.4 m120 55.59 47.51 20.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.867 -1.06 . . . . 1.8500000000000001 110.91 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.533 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 63.6 m -82.58 138.93 34.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.871 -0.604 . . . . 1.1200000000000001 110.952 -178.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 19.5 m -103.02 127.52 29.68 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.576 -0.738 . . . . 1.26 110.482 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 3.5 Cg_exo -76.04 126.35 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.491 2.127 . . . . 0.60999999999999999 112.365 177.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.37 88.88 4.01 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.449 -0.796 . . . . 0.85999999999999999 109.563 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.0 m -75.51 -26.09 57.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.28 -0.418 . . . . 1.3700000000000001 111.138 -177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.8 m -117.73 105.54 18.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.463 0.649 . . . . 1.6000000000000001 112.003 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.5 mt -117.61 127.47 74.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.503 -0.772 . . . . 1.8500000000000001 110.562 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.59 -38.44 0.04 OUTLIER Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 110.72 -0.952 . . . . 3.1800000000000002 110.72 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.25 -41.96 43.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.242 -0.651 . . . . 4.6900000000000004 109.242 172.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.65 -142.99 10.26 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.307 -0.86 . . . . 4.3499999999999996 111.291 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -96.24 25.46 25.66 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.514 -0.85 . . . . 3.27 112.074 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -68.53 -24.95 64.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 5.4699999999999998 111.294 -178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.9 p -75.73 -13.2 60.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.45 0.643 . . . . 4.7000000000000002 110.204 175.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 12.5 t -104.69 -74.97 0.63 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.499 -0.773 . . . . 1.6599999999999999 110.681 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.4 t 61.51 29.86 18.54 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.618 0.723 . . . . 1.6499999999999999 110.623 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.697 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -145.62 -158.42 0.89 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.46 -0.941 . . . . 0.54000000000000004 108.46 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.33 116.41 20.39 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 121.669 0.747 . . . . 0.78000000000000003 109.336 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.19 123.52 44.53 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.558 -0.746 . . . . 0.39000000000000001 110.445 -171.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 111' ' ' PRO . 7.6 m -134.41 163.16 37.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.508 -0.769 . . . . 0.22 111.423 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 47.3 t -107.99 114.88 29.11 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.301 -1.0 . . . . 0.70999999999999996 108.301 176.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 28.0 m -114.88 148.2 38.91 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.166 -0.47 . . . . 0.60999999999999999 110.142 -173.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.7 t -78.97 -32.9 45.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.958 -0.565 . . . . 0.38 110.651 -174.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.401 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 19.9 m120 -153.02 163.4 39.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.78000000000000003 110.313 -178.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -136.03 143.23 44.62 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.13 -0.486 . . . . 0.41999999999999998 110.119 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.612 ' HB2' HG23 ' A' ' 105' ' ' VAL . 60.0 m-85 -129.67 153.42 48.15 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.332 -0.618 . . . . 0.77000000000000002 109.332 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.638 ' NE2' HD12 ' A' ' 104' ' ' LEU . 10.1 mm100 62.9 30.59 16.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.848 0.356 . . . . 0.80000000000000004 111.075 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 65.53 2.41 2.02 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.808 -0.633 . . . . 2.1200000000000001 112.378 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 138.37 -16.62 3.37 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.32 -0.943 . . . . 0.28000000000000003 112.868 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.638 HD12 ' NE2' ' A' ' 101' ' ' GLN . 20.5 mt -50.11 -38.05 36.95 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 117.026 0.413 . . . . 0.35999999999999999 110.689 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.612 HG23 ' HB2' ' A' ' 100' ' ' TYR . 5.6 m -130.0 149.14 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.755 -0.657 . . . . 0.85999999999999999 109.312 171.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 7.8 t30 -144.31 149.99 37.13 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.778 -0.823 . . . . 0.91000000000000003 108.778 -174.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.401 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 11.0 m -130.88 151.59 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 113.006 0.743 . . . . 0.29999999999999999 113.006 -174.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.61 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.19 50.42 67.32 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 114.838 -1.074 . . . . 0.20000000000000001 112.104 176.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 74.7 m -97.75 126.47 43.11 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.608 0.242 . . . . 0.42999999999999999 111.304 -175.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 21.4 p -118.88 138.05 25.64 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.464 -0.334 . . . . 0.29999999999999999 110.465 174.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.553 ' HA ' HG12 ' A' ' 94' ' ' VAL . 24.2 Cg_exo -67.53 110.85 2.17 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.294 2.663 . . . . 0.34000000000000002 112.889 -175.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.442 HG13 ' HB2' ' A' ' 31' ' ' LYS . 5.8 tt -95.85 127.4 47.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.942 -0.572 . . . . 0.58999999999999997 111.123 -178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -109.49 102.07 10.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.895 -0.593 . . . . 2.3900000000000001 110.806 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.7 pp -96.52 2.99 9.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.195 0.521 . . . . 2.02 110.971 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 126.84 -10.2 7.1 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.158 -0.777 . . . . 2.6099999999999999 111.158 -173.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.621 -0.704 . . . . 3.6899999999999999 110.289 176.023 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 110.011 -0.366 . . . . 30.309999999999999 110.011 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -153.86 57.21 0.73 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.106 0.479 . . . . 28.059999999999999 110.302 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.4 ttm -95.37 71.57 3.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.37 0.605 . . . . 28.52 110.454 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.16 -8.06 58.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.726 -0.67 . . . . 26.559999999999999 109.569 175.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -69.94 127.07 31.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.098 -0.956 . . . . 25.140000000000001 110.595 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.558 ' H ' HD13 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -121.81 11.09 5.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.509 0.671 . . . . 24.989999999999998 109.694 177.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.46 -158.27 10.13 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.176 -0.92 . . . . 22.920000000000002 111.246 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.2 t -118.41 -57.12 2.09 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.83 0.348 . . . . 22.809999999999999 110.701 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.4 p -85.48 -42.41 14.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.446 -0.343 . . . . 22.210000000000001 111.848 -176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.38 135.0 35.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.778 0.323 . . . . 20.949999999999999 111.198 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -103.99 141.25 22.12 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.219 -0.446 . . . . 19.190000000000001 110.434 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.27 -22.34 46.49 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.859 2.373 . . . . 17.98 112.166 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -146.69 106.64 3.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.755 -0.657 . . . . 18.07 109.511 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -88.81 -70.33 0.65 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.191 -0.67 . . . . 14.66 109.191 176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 95.5 t -129.32 -58.18 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.55 -0.907 . . . . 13.029999999999999 108.55 171.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.7 m120 49.16 66.66 1.04 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.232 -0.895 . . . . 12.26 111.146 173.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 152.67 -107.3 0.32 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.933 -0.651 . . . . 9.9700000000000006 112.021 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.93 10.97 71.13 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.866 -0.683 . . . . 8.2200000000000006 111.546 -177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.531 HG22 ' HD2' ' A' ' 30' ' ' PRO . 7.1 m -73.92 135.44 77.32 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.202 -0.296 . . . . 7.2999999999999998 110.202 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.45 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 53.3 Cg_exo -36.52 -46.49 1.22 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 124.351 3.367 . . . . 6.0999999999999996 115.927 -176.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.531 ' HD2' HG22 ' A' ' 28' ' ' THR . 7.1 Cg_exo -72.06 69.05 3.17 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 121.781 1.654 . . . . 5.1900000000000004 111.483 177.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -81.62 48.84 1.23 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.378 -0.828 . . . . 3.79 110.68 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.2 t -87.07 174.41 8.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.134 -0.485 . . . . 1.74 110.802 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 40.9 m -96.81 151.73 19.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.707 -0.678 . . . . 1.7 110.032 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.7 m -84.58 -2.34 57.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.254 -0.43 . . . . 2.5699999999999998 110.488 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.0 p -73.44 -24.66 60.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.797 -0.638 . . . . 2.5 111.08 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 146.79 -156.4 26.99 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.634 -0.793 . . . . 1.51 111.978 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -52.42 153.86 12.72 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.168 2.579 . . . . 1.05 113.723 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.43 158.6 3.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 107.953 -1.129 . . . . 0.58999999999999997 107.953 171.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.476 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 94.6 m-85 -120.89 138.49 54.06 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 119.827 -0.749 . . . . 0.78000000000000003 111.594 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.753 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 42.2 t -111.75 100.29 8.83 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.043 -0.98 . . . . 0.81999999999999995 110.031 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 50.9 m -101.95 128.19 48.47 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.085 -0.709 . . . . 0.23999999999999999 109.085 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -57.12 -24.6 55.29 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.817 -0.629 . . . . 2.0800000000000001 110.261 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.8 120.09 0.88 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.308 -0.86 . . . . 2.5800000000000001 108.703 177.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.553 HG21 HG11 ' A' ' 94' ' ' VAL . 18.4 p -78.81 147.35 33.29 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 119.121 -1.032 . . . . 0.37 110.505 172.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.472 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.2 tp10 -114.07 142.32 46.35 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.479 -0.782 . . . . 1.1200000000000001 109.421 -175.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.436 ' O ' HD13 ' A' ' 50' ' ' LEU . 28.2 m-20 -70.45 103.97 2.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.949 -0.569 . . . . 1.77 111.129 -174.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.681 ' HA ' HD21 ' A' ' 50' ' ' LEU . 7.1 m -58.71 -14.59 8.91 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.309 0.485 . . . . 0.92000000000000004 112.309 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -77.16 -35.64 55.81 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.834 0.349 . . . . 2.77 110.218 -178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -146.74 65.35 1.18 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.07 -0.514 . . . . 2.3300000000000001 111.073 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.681 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.7 mm? -57.0 151.3 15.17 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.109 0.481 . . . . 1.1599999999999999 111.242 175.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -70.77 156.49 39.46 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.203 -0.666 . . . . 1.8100000000000001 109.203 172.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -59.99 -33.35 71.85 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.806 -0.358 . . . . 3.23 111.014 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.408 ' O ' HD22 ' A' ' 57' ' ' LEU . . . -61.83 -34.2 87.93 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.843 -0.694 . . . . 0.34000000000000002 111.812 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.658 ' HA ' HD22 ' A' ' 57' ' ' LEU . 24.1 m -85.04 -43.08 14.25 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.456 -0.202 . . . . 0.35999999999999999 110.456 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.5 m -52.84 -35.22 57.01 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.256 0.551 . . . . 0.29999999999999999 109.763 173.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.619 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.5 -55.45 33.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.277 -0.874 . . . . 0.23000000000000001 111.494 176.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.658 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -58.9 -44.76 91.29 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-O 121.34 0.59 . . . . 0.23999999999999999 110.103 -177.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.4 mt -59.99 -43.44 95.17 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.138 -0.937 . . . . 0.17999999999999999 110.114 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.14 -38.01 94.88 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.718 -0.754 . . . . 0.26000000000000001 112.162 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.3 mt -62.23 -40.99 97.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.798 0.809 . . . . 0.34000000000000002 110.187 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.425 HD21 ' HG2' ' A' ' 101' ' ' GLN . 10.7 mt -91.27 4.95 51.03 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.566 -1.197 . . . . 0.35999999999999999 111.274 -176.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 64.85 33.62 9.94 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.717 -0.674 . . . . 1.8899999999999999 111.403 174.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.9 mt -89.91 144.13 9.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.875 -0.602 . . . . 0.26000000000000001 110.324 178.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.546 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 11.3 mptt -94.31 118.43 31.59 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.825 -0.625 . . . . 2.2200000000000002 109.963 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -68.48 -35.67 71.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.499 -0.773 . . . . 0.28999999999999998 110.386 -177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.87 -14.15 82.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.904 -0.665 . . . . 0.56999999999999995 112.39 178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 32.0 t70 -88.01 -19.71 26.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.006 0.431 . . . . 0.85999999999999999 110.549 178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.433 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 93.0 mt -55.5 141.93 35.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.699 0.762 . . . . 0.46000000000000002 111.771 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -87.86 -66.62 0.89 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.725 -1.125 . . . . 2.0099999999999998 112.457 -170.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.489 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 0.3 OUTLIER -123.73 -84.77 0.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.786 -0.366 . . . . 1.0900000000000001 111.157 -177.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.5 mm? -116.45 167.12 11.33 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.291 0.567 . . . . 0.14999999999999999 111.983 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.472 HG22 ' HB3' ' A' ' 45' ' ' GLU . 1.9 m -119.78 165.13 15.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.18 -1.415 . . . . 0.25 107.18 168.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.403 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -137.42 133.85 6.67 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.655 -1.26 . . . . 0.37 112.404 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.663 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.23 135.77 36.41 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.901 -0.407 . . . . 0.28999999999999998 109.901 176.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.419 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 19.7 m120 46.79 52.92 10.88 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.466 -0.788 . . . . 1.8500000000000001 110.634 -177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 9.3 t -92.85 137.38 32.42 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.118 -0.946 . . . . 1.1200000000000001 109.883 -176.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 13.3 t -100.55 125.71 38.17 Favored Pre-proline 0 C--N 1.315 -0.906 0 CA-C-N 115.92 -0.582 . . . . 1.26 110.893 -173.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 3.5 Cg_exo -76.27 122.13 6.45 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.758 2.305 . . . . 0.60999999999999999 112.568 177.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.9 mt -100.4 89.24 3.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.627 -0.715 . . . . 0.85999999999999999 109.845 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.2 m -73.87 -34.55 64.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.419 -0.355 . . . . 1.3700000000000001 110.825 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 27.7 m -114.38 123.59 70.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.401 0.619 . . . . 1.6000000000000001 111.367 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 48.9 mm -85.51 127.59 39.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.581 -0.736 . . . . 1.8500000000000001 109.904 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 134.05 -65.05 0.59 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.801 -0.714 . . . . 3.1800000000000002 111.858 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 p -95.62 105.55 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.319 0.581 . . . . 4.6900000000000004 110.141 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 80.43 -51.77 4.25 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.726 -0.749 . . . . 4.3499999999999996 112.168 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 82' ' ' ILE . . . -78.26 76.42 1.81 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 121.246 -0.502 . . . . 3.27 112.476 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -129.55 -88.75 0.51 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.742 -0.836 . . . . 5.4699999999999998 108.742 172.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.2 t -97.54 -18.17 19.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.439 -0.948 . . . . 4.7000000000000002 108.439 171.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.421 ' SG ' HG23 ' A' ' 93' ' ' THR . 0.5 OUTLIER 69.54 6.14 5.55 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.503 -1.226 . . . . 1.6599999999999999 112.654 172.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.0 m 69.21 -43.4 0.52 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.184 0.594 . . . . 1.6499999999999999 111.831 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.753 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -88.58 -159.29 0.54 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.909 -0.404 . . . . 0.54000000000000004 109.909 178.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.7 115.06 25.96 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.603 0.716 . . . . 0.78000000000000003 110.697 -175.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.421 HG23 ' SG ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -93.64 124.08 37.4 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.422 -0.808 . . . . 0.39000000000000001 111.154 -176.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 111' ' ' PRO . 12.0 m -135.47 166.34 27.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.418 -0.81 . . . . 0.22 111.086 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 53.9 t -112.47 118.63 35.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.795 -0.817 . . . . 0.70999999999999996 108.795 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.662 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 13.6 m -120.26 153.37 36.45 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.903 0.382 . . . . 0.60999999999999999 111.117 -170.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.7 t -82.39 -29.46 30.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.799 -0.637 . . . . 0.38 111.082 -173.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.43 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 13.3 m120 -156.17 159.16 38.74 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.125 -0.489 . . . . 0.78000000000000003 109.965 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.8 t -135.3 142.44 45.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.127 -0.488 . . . . 0.41999999999999998 110.036 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -130.28 159.74 35.99 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.646 -0.707 . . . . 0.77000000000000002 109.635 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.667 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 9.7 mm100 59.32 31.32 21.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.16 -0.473 . . . . 0.80000000000000004 111.61 177.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 67.98 -0.27 2.12 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.709 -0.678 . . . . 2.1200000000000001 111.814 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 142.76 -19.63 2.37 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.78 -0.724 . . . . 0.28000000000000003 112.162 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.667 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 34.5 mt -50.3 -43.4 53.57 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.316 0.579 . . . . 0.35999999999999999 110.593 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.7 t -121.66 123.62 69.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.915 -1.039 . . . . 0.85999999999999999 109.707 177.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.441 ' ND2' ' SG ' ' A' ' 96' ' ' CYS . 37.3 t30 -128.17 144.58 51.13 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.142 -1.058 . . . . 0.91000000000000003 108.142 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 14.5 m -131.9 153.54 38.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 113.631 0.974 . . . . 0.29999999999999999 113.631 -172.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.662 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 62.94 50.24 65.4 Favored Glycine 0 CA--C 1.505 -0.563 0 CA-C-N 114.729 -1.123 . . . . 0.20000000000000001 111.725 176.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 70' ' ' ASP . 92.5 m -97.28 130.46 44.47 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.928 0.394 . . . . 0.42999999999999999 111.436 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.8 p -124.22 125.43 25.72 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.659 -0.7 . . . . 0.29999999999999999 109.962 175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.587 ' HA ' HG12 ' A' ' 94' ' ' VAL . 78.5 Cg_exo -49.23 122.12 8.02 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.164 2.576 . . . . 0.34000000000000002 113.002 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.9 tt -117.48 137.07 52.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.751 -0.658 . . . . 0.58999999999999997 110.84 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -122.91 118.97 29.1 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.712 -0.477 . . . . 2.3900000000000001 109.712 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.455 HD13 ' HG ' ' A' ' 116' ' ' LEU . 1.2 pp -92.11 -17.48 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.329 -0.396 . . . . 2.02 111.927 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.425 ' N ' HD12 ' A' ' 114' ' ' ILE . . . 73.2 -24.15 0.89 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.039 -0.6 . . . . 2.6099999999999999 113.963 177.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.479 ' OXT' HD12 ' A' ' 116' ' ' LEU . 3.7 pp . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.489 -0.767 . . . . 3.6899999999999999 110.872 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.058 -0.349 . . . . 30.309999999999999 110.058 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.3 75.68 1.48 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.929 0.395 . . . . 28.059999999999999 110.886 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 21.7 ptp -143.0 -29.56 0.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 28.52 111.009 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.65 113.17 23.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.429 -0.35 . . . . 26.559999999999999 110.623 -179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.3 t70 56.42 70.19 0.67 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.994 -0.548 . . . . 25.140000000000001 110.951 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.9 pt -117.08 33.21 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.053 0.454 . . . . 24.989999999999998 111.258 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.03 43.3 3.1 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.963 -0.637 . . . . 22.920000000000002 111.993 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.9 t -76.91 -55.1 5.76 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.991 -0.374 . . . . 22.809999999999999 109.991 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.5 m -80.78 66.4 6.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.495 0.665 . . . . 22.210000000000001 110.29 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -140.22 173.5 11.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.759 -0.655 . . . . 20.949999999999999 110.241 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.7 t -118.88 93.51 46.63 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.453 -0.34 . . . . 19.190000000000001 110.223 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -63.38 178.47 1.2 Allowed 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.764 2.31 . . . . 17.98 112.402 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.84 47.35 6.15 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.093 -0.503 . . . . 18.07 110.162 -174.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -76.92 -71.56 0.39 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.02 -0.536 . . . . 14.66 110.649 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.0 m 32.96 58.58 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 124.321 1.013 . . . . 13.029999999999999 112.897 -177.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -61.22 117.06 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 12.26 110.375 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.08 -7.51 69.66 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.726 -0.749 . . . . 9.9700000000000006 112.065 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.2 -78.34 1.59 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 121.259 -0.496 . . . . 8.2200000000000006 112.016 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.464 HG22 ' HD2' ' A' ' 30' ' ' PRO . 2.9 m -93.15 134.95 26.31 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 109.61 -0.515 . . . . 7.2999999999999998 109.61 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 93.3 Cg_exo -39.56 -49.33 3.28 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.499 2.8 . . . . 6.0999999999999996 115.269 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.464 ' HD2' HG22 ' A' ' 28' ' ' THR . 3.1 Cg_exo -74.48 101.35 1.42 Allowed 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.967 1.778 . . . . 5.1900000000000004 111.725 -178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -86.06 31.93 0.62 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.258 -0.428 . . . . 3.79 111.15 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.2 m -78.05 -169.58 1.63 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.13 -0.486 . . . . 1.74 111.879 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 84.1 m -77.09 148.03 36.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.303 0.573 . . . . 1.7 112.0 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.1 p -87.27 -14.7 40.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.556 -0.747 . . . . 2.5699999999999998 109.804 174.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.1 p -81.19 -8.05 59.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.146 -0.934 . . . . 2.5 110.844 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 122.46 -132.25 8.69 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.234 -0.746 . . . . 1.51 111.234 -177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.8 154.62 9.35 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.215 2.61 . . . . 1.05 113.801 177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 39' ' ' TYR . 91.4 t -88.86 168.16 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 107.515 -1.291 . . . . 0.58999999999999997 107.515 172.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.593 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 95.2 m-85 -129.98 135.45 48.31 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.643 0.735 . . . . 0.78000000000000003 112.23 -177.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 43.1 t -111.15 98.03 7.22 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.876 -1.056 . . . . 0.81999999999999995 110.031 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.2 m -99.59 134.2 42.82 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 109.541 -0.541 . . . . 0.23999999999999999 109.541 -174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.442 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 5.0 m-20 -51.47 -30.6 20.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.485 -0.78 . . . . 2.0800000000000001 110.342 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -170.51 131.81 0.94 Allowed 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.456 -1.247 . . . . 2.5800000000000001 108.365 178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.605 HG21 HG11 ' A' ' 94' ' ' VAL . 17.9 p -87.82 152.43 22.11 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.337 -0.945 . . . . 0.37 111.08 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.586 ' HB3' HG22 ' A' ' 72' ' ' VAL . 10.8 tp10 -119.6 141.25 49.46 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.99 -1.004 . . . . 1.1200000000000001 109.665 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.473 ' HA ' HD12 ' A' ' 71' ' ' LEU . 6.1 m-20 -68.88 110.59 4.46 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.477 -0.329 . . . . 1.77 110.981 -176.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.618 ' HA ' HD21 ' A' ' 50' ' ' LEU . 89.3 p -65.93 -8.69 23.87 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.099 0.476 . . . . 0.92000000000000004 111.335 -177.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 3.7 mppt? -74.31 -36.39 63.71 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.512 0.673 . . . . 2.77 110.123 175.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -143.83 65.2 1.31 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.09 -0.959 . . . . 2.3300000000000001 111.107 -176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.618 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.3 mm? -59.68 157.27 12.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.595 0.712 . . . . 1.1599999999999999 111.609 174.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -74.32 161.09 30.22 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.637 -1.165 . . . . 1.8100000000000001 109.08 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.675 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -64.08 -32.01 73.41 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.959 -0.696 . . . . 3.23 110.551 177.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -66.0 -37.1 92.86 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.624 -0.798 . . . . 0.34000000000000002 111.293 176.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.667 ' HA ' HD22 ' A' ' 57' ' ' LEU . 11.7 m -78.89 -42.59 26.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.121 0.486 . . . . 0.35999999999999999 110.275 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.2 m -53.18 -35.25 59.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.335 -0.848 . . . . 0.29999999999999999 109.797 172.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.88 -54.8 42.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.433 -0.803 . . . . 0.23000000000000001 111.616 175.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.75 -45.72 89.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.467 0.651 . . . . 0.23999999999999999 110.319 -178.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.5 mt -61.35 -42.1 98.15 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.964 -1.016 . . . . 0.17999999999999999 109.941 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.46 -34.14 84.25 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.791 -0.641 . . . . 0.26000000000000001 112.583 174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 26.0 mt -61.64 -50.2 73.5 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.637 0.732 . . . . 0.34000000000000002 109.814 176.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.468 HD21 ' HG2' ' A' ' 101' ' ' GLN . 3.2 mt -83.99 8.25 15.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.569 -1.196 . . . . 0.35999999999999999 110.669 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.1 p30 50.97 38.19 19.64 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.495 1.118 . . . . 1.8899999999999999 111.737 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 58' ' ' LEU . 48.4 mt -79.44 140.89 16.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.795 -1.093 . . . . 0.26000000000000001 110.055 176.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.461 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 11.8 mptt -82.6 117.14 22.35 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.887 -0.597 . . . . 2.2200000000000002 110.001 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -68.78 -31.32 50.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.342 0.591 . . . . 0.28999999999999998 110.138 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.92 -22.24 72.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.031 -0.604 . . . . 0.56999999999999995 112.638 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.58 -13.19 57.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.242 0.544 . . . . 0.85999999999999999 110.253 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 92.3 mt -64.32 151.55 43.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.498 -0.774 . . . . 0.46000000000000002 111.804 -177.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -101.66 -71.12 0.72 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.811 -1.086 . . . . 2.0099999999999998 113.017 -169.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -120.49 -83.6 0.66 Allowed 'General case' 0 C--O 1.237 0.41 0 N-CA-C 112.54 0.57 . . . . 1.0900000000000001 112.54 -171.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.507 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.2 mm? -119.41 168.41 10.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.296 0.57 . . . . 0.14999999999999999 110.606 175.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.586 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -122.95 168.24 15.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 106.517 -1.66 . . . . 0.25 106.517 167.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.14 129.02 4.24 Favored Glycine 0 C--N 1.312 -0.773 0 C-N-CA 119.62 -1.276 . . . . 0.37 112.041 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.64 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.77 135.88 36.91 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 120.551 -0.46 . . . . 0.28999999999999998 110.544 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m120 49.51 49.03 20.58 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.024 -0.989 . . . . 1.8500000000000001 110.731 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 9.0 t -85.98 144.1 27.79 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.159 -0.928 . . . . 1.1200000000000001 110.592 -174.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.6 m -102.12 113.44 65.86 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.855 -0.611 . . . . 1.26 110.855 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.89 130.79 26.98 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.847 2.365 . . . . 0.60999999999999999 112.816 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 mt -108.4 89.27 2.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.675 -0.693 . . . . 0.85999999999999999 109.213 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.2 p -78.58 -39.15 38.36 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.287 -0.415 . . . . 1.3700000000000001 111.422 -174.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.6 m -100.48 100.42 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.925 0.869 . . . . 1.6000000000000001 112.258 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.7 mt -132.47 115.49 25.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.916 -1.038 . . . . 1.8500000000000001 110.341 177.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.23 -47.71 0.42 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.317 -0.713 . . . . 3.1800000000000002 111.317 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.1 t -99.31 48.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.203 -1.036 . . . . 4.6900000000000004 108.203 173.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.2 126.34 4.1 Favored Glycine 0 N--CA 1.441 -1.007 0 CA-C-N 114.913 -1.039 . . . . 4.3499999999999996 111.123 -173.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -115.23 17.99 16.33 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.837 -0.697 . . . . 3.27 112.102 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -90.38 83.39 5.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.121 0.486 . . . . 5.4699999999999998 110.08 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 71.1 m -148.43 23.41 1.03 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.953 -0.567 . . . . 4.7000000000000002 110.656 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 6.0 t -142.05 123.11 14.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.97 -0.559 . . . . 1.6599999999999999 110.831 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.3 m -114.56 18.79 16.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.024 0.44 . . . . 1.6499999999999999 110.68 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -134.67 -158.73 0.9 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.874 -0.603 . . . . 0.54000000000000004 109.824 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.74 127.04 31.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.098 0.475 . . . . 0.78000000000000003 110.139 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.91 120.32 39.6 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.274 0.559 . . . . 0.39000000000000001 110.836 -174.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.605 HG11 HG21 ' A' ' 44' ' ' THR . 10.6 m -131.94 164.75 33.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.624 -0.716 . . . . 0.22 111.271 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 34.2 t -109.81 112.12 23.97 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.178 -0.919 . . . . 0.70999999999999996 109.156 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 35.4 m -107.88 149.19 28.6 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.883 0.373 . . . . 0.60999999999999999 110.725 -174.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.405 HG22 ' HA3' ' A' ' 108' ' ' GLY . 13.3 t -80.49 -27.21 37.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.914 -0.584 . . . . 0.38 110.455 -174.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.528 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.6 m120 -153.83 163.85 39.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.449 -0.796 . . . . 0.78000000000000003 109.064 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.5 t -136.22 134.21 37.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.165 0.507 . . . . 0.41999999999999998 110.184 176.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.51 ' HB2' HG23 ' A' ' 105' ' ' VAL . 89.3 m-85 -117.64 149.5 40.59 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.668 -0.696 . . . . 0.77000000000000002 109.94 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.625 ' NE2' HD12 ' A' ' 104' ' ' LEU . 9.7 mm100 62.57 26.92 15.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.759 -0.655 . . . . 0.80000000000000004 111.265 176.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 64.01 9.07 4.35 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.251 -0.886 . . . . 2.1200000000000001 112.177 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.27 -25.47 1.87 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.342 -0.932 . . . . 0.28000000000000003 113.113 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 16.1 mt -49.16 -41.34 36.21 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.904 0.352 . . . . 0.35999999999999999 111.54 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.51 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -139.78 118.87 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.422 0.63 . . . . 0.85999999999999999 111.047 173.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.566 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 8.7 m-20 -108.16 162.66 13.86 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.579 -0.737 . . . . 0.91000000000000003 109.475 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 14.3 m -135.28 155.43 37.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 112.299 0.481 . . . . 0.29999999999999999 112.299 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 58.62 51.82 56.64 Favored Glycine 0 CA--C 1.505 -0.578 0 CA-C-N 115.396 -0.82 . . . . 0.20000000000000001 111.872 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 84.1 m -97.99 129.02 44.89 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.703 0.287 . . . . 0.42999999999999999 110.721 -175.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 16.9 p -125.26 128.19 24.81 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.912 -0.585 . . . . 0.29999999999999999 110.054 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.459 ' HA ' HG12 ' A' ' 94' ' ' VAL . 73.1 Cg_exo -51.3 109.28 0.3 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.785 2.323 . . . . 0.34000000000000002 112.061 177.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.6 tt -88.52 134.13 29.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.637 -0.711 . . . . 0.58999999999999997 110.735 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -116.09 101.14 8.46 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.895 -0.593 . . . . 2.3900000000000001 110.042 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.57 HD13 ' HG ' ' A' ' 116' ' ' LEU . 0.9 OUTLIER -73.51 -19.4 18.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.856 -0.611 . . . . 2.02 111.766 -178.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.57 3.46 86.66 Favored Glycine 0 CA--C 1.516 0.154 0 C-N-CA 121.177 -0.535 . . . . 2.6099999999999999 113.419 175.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.57 ' HG ' HD13 ' A' ' 114' ' ' ILE . 4.0 pp . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.309 -0.853 . . . . 3.6899999999999999 110.03 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.713 0.292 . . . . 30.309999999999999 110.478 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.01 30.6 6.56 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.016 0.436 . . . . 28.059999999999999 110.838 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.1 ttt -77.63 -51.09 11.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.018 -0.537 . . . . 28.52 110.148 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.05 67.61 7.04 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.758 -0.655 . . . . 26.559999999999999 109.904 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.9 -27.97 64.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.647 -0.706 . . . . 25.140000000000001 110.635 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.4 mm -83.34 -4.96 8.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.869 0.842 . . . . 24.989999999999998 109.45 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.571 ' O ' ' HB ' ' A' ' 20' ' ' VAL . . . -95.72 49.59 1.81 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.54 -0.754 . . . . 22.920000000000002 111.398 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.2 t -75.33 -58.43 3.28 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.121 0.486 . . . . 22.809999999999999 109.92 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.8 p -97.32 -42.7 7.65 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.083 -0.508 . . . . 22.210000000000001 109.778 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.8 61.29 5.09 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.513 -0.767 . . . . 20.949999999999999 110.366 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.571 ' HB ' ' O ' ' A' ' 16' ' ' GLY . 7.3 p -112.26 129.84 23.92 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.413 -0.812 . . . . 19.190000000000001 110.015 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.93 113.5 1.75 Allowed 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.591 2.194 . . . . 17.98 112.033 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 20' ' ' VAL . 60.3 mtt180 -108.35 31.86 5.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.173 -0.467 . . . . 18.07 110.468 -177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -62.2 138.22 58.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.842 -0.617 . . . . 14.66 111.147 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.0 t 60.78 92.9 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 115.523 -0.762 . . . . 13.029999999999999 111.283 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -82.62 -43.93 16.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.934 -0.576 . . . . 12.26 110.239 178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.36 -106.22 0.5 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.844 -0.616 . . . . 9.9700000000000006 111.794 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.67 -132.64 44.14 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.293 -0.479 . . . . 8.2200000000000006 112.373 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.523 HG22 ' HD2' ' A' ' 30' ' ' PRO . 3.9 m 67.96 116.79 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.245 0 CA-C-O 121.51 0.671 . . . . 7.2999999999999998 110.878 -179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.468 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 34.5 Cg_exo -50.89 -50.8 12.7 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.523 2.815 . . . . 6.0999999999999996 112.684 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 71.4 Cg_endo -76.25 106.01 2.18 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.474 1.449 . . . . 5.1900000000000004 111.537 169.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -66.46 132.59 48.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.885 -0.598 . . . . 3.79 110.824 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.5 m -153.17 154.6 35.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.308 -0.405 . . . . 1.74 110.122 177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 59.8 m -76.22 136.7 39.7 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.272 -0.422 . . . . 1.7 110.646 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.0 m -90.03 -2.1 58.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.237 0.541 . . . . 2.5699999999999998 110.381 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.5 p -74.41 -27.8 60.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.804 -0.634 . . . . 2.5 110.367 176.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 168.08 173.95 36.51 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-O 119.458 -0.634 . . . . 1.51 111.641 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HB3' ' HA ' ' A' ' 80' ' ' SER . 52.0 Cg_exo -41.78 151.37 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.688 2.925 . . . . 1.05 114.166 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.2 t -89.81 158.75 2.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 114.63 -1.168 . . . . 0.58999999999999997 108.443 176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.618 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 90.5 m-85 -122.28 136.88 54.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.496 0.665 . . . . 0.78000000000000003 111.396 -177.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 34.7 t -109.25 98.32 7.77 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.233 -0.894 . . . . 0.81999999999999995 109.604 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.5 m -99.16 137.59 37.47 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.111 -0.699 . . . . 0.23999999999999999 109.111 -175.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.446 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 39.8 m-80 -59.03 -24.69 63.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.855 -0.611 . . . . 2.0800000000000001 109.965 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 mmmt -171.75 131.06 0.68 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.409 -1.269 . . . . 2.5800000000000001 108.085 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.556 HG21 HG11 ' A' ' 94' ' ' VAL . 18.1 p -86.55 157.47 19.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 119.169 -1.012 . . . . 0.37 110.253 171.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HB3' HG22 ' A' ' 72' ' ' VAL . 7.1 tp10 -121.77 138.2 54.46 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.836 -0.62 . . . . 1.1200000000000001 109.509 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HA ' HD12 ' A' ' 71' ' ' LEU . 12.9 m-20 -67.6 109.5 3.3 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.194 -0.457 . . . . 1.77 110.159 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 88.1 p -57.09 -24.34 53.28 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 123.498 0.499 . . . . 0.92000000000000004 111.208 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -90.78 -12.13 37.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.903 0.383 . . . . 2.77 111.284 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -126.37 25.2 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.979 0.418 . . . . 2.3300000000000001 110.85 -176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.9 mt -60.59 156.39 16.63 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.629 0.728 . . . . 1.1599999999999999 111.91 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -99.95 168.48 9.84 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.894 -1.048 . . . . 1.8100000000000001 109.767 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 11.8 mptt -62.01 -33.58 74.62 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.8 0.333 . . . . 3.23 110.502 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.75 -36.21 92.4 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.152 -0.547 . . . . 0.34000000000000002 112.72 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.585 ' HA ' HD22 ' A' ' 57' ' ' LEU . 25.6 m -82.73 -43.36 16.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.819 0.31 . . . . 0.35999999999999999 110.434 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 88.5 m -54.67 -33.21 60.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.896 -0.593 . . . . 0.29999999999999999 110.053 174.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.23 -54.32 46.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.478 -0.783 . . . . 0.23000000000000001 111.508 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.585 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.42 -47.29 84.42 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.268 0.556 . . . . 0.23999999999999999 109.96 -178.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 54' ' ' THR . 25.1 mt -59.63 -41.99 91.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.98 -1.009 . . . . 0.17999999999999999 110.188 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.53 -36.88 93.25 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.752 -0.658 . . . . 0.26000000000000001 112.23 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 19.8 mt -61.3 -39.34 90.12 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.714 0.768 . . . . 0.34000000000000002 110.092 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.644 HD21 ' HG2' ' A' ' 101' ' ' GLN . 4.5 mt -90.81 0.58 57.42 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.468 -1.242 . . . . 0.35999999999999999 111.113 -176.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 69.03 34.53 3.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.481 -0.781 . . . . 1.8899999999999999 111.349 175.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 58' ' ' LEU . 41.6 mt -88.71 147.12 5.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.001 -0.545 . . . . 0.26000000000000001 110.042 176.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.614 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -100.62 118.96 37.84 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.383 0.611 . . . . 2.2200000000000002 110.061 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -71.64 -31.48 42.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.15 -0.932 . . . . 0.28999999999999998 110.972 -174.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.16 -15.34 74.49 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.966 -0.635 . . . . 0.56999999999999995 112.752 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.451 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 23.8 t70 -95.32 -14.15 24.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.85999999999999999 110.532 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.0 mt -57.87 140.32 52.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.268 0.556 . . . . 0.46000000000000002 110.909 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -94.94 -77.64 0.46 Allowed 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.231 -0.895 . . . . 2.0099999999999998 112.532 -170.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -104.03 -98.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.975 0.361 . . . . 1.0900000000000001 111.975 -173.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.6 mm? -109.04 168.92 9.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.558 0.694 . . . . 0.14999999999999999 111.271 178.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -117.18 167.9 9.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 106.754 -1.573 . . . . 0.25 106.754 166.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -138.34 121.59 2.22 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 119.765 -1.207 . . . . 0.37 111.893 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.711 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -94.06 136.02 34.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 119.742 -0.783 . . . . 0.28999999999999998 109.705 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 53.14 61.33 3.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.041 0.924 . . . . 1.8500000000000001 109.792 176.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 7.9 t -103.66 146.1 29.08 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.607 -1.179 . . . . 1.1200000000000001 110.777 -171.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.1 m -102.26 109.97 61.56 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 115.823 -0.626 . . . . 1.26 110.216 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.9 120.32 7.24 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.777 2.318 . . . . 0.60999999999999999 112.299 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.5 mt -96.01 87.5 4.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 0.85999999999999999 109.555 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.408 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 5.4 p -79.12 -52.27 8.41 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.9 -0.591 . . . . 1.3700000000000001 109.816 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.7 m -81.06 105.48 11.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.376 -0.829 . . . . 1.6000000000000001 110.286 176.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.431 HG23 ' H ' ' A' ' 86' ' ' GLY . 8.9 mt -116.14 132.43 65.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.848 -0.614 . . . . 1.8500000000000001 111.702 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -129.98 -105.3 1.12 Allowed Glycine 0 N--CA 1.439 -1.13 0 CA-C-N 115.472 -0.785 . . . . 3.1800000000000002 111.248 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.1 m -76.47 75.53 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.484 0.659 . . . . 4.6900000000000004 111.486 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.75 49.35 29.98 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.778 -0.646 . . . . 4.3499999999999996 111.89 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.431 ' H ' HG23 ' A' ' 82' ' ' ILE . . . 101.11 -141.92 15.54 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.315 -0.714 . . . . 3.27 111.315 -177.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -160.51 -61.02 0.06 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.009 0.433 . . . . 5.4699999999999998 109.955 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.8 m -124.27 66.35 1.06 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.003 -0.544 . . . . 4.7000000000000002 110.913 178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 17.6 t -121.54 122.43 39.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.026 0.441 . . . . 1.6599999999999999 110.815 176.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -127.89 26.62 5.82 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.508 0.67 . . . . 1.6499999999999999 109.708 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.446 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -141.59 -158.44 0.86 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.353 -0.839 . . . . 0.54000000000000004 110.017 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.05 124.23 28.55 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.354 0.597 . . . . 0.78000000000000003 110.097 -176.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.52 116.0 31.77 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.744 -0.662 . . . . 0.39000000000000001 110.875 -171.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.556 HG11 HG21 ' A' ' 44' ' ' THR . 11.2 m -128.29 164.63 29.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.663 -0.699 . . . . 0.22 111.457 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.1 t -108.34 110.98 22.68 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.623 -0.88 . . . . 0.70999999999999996 108.623 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.8 m -112.92 146.41 39.03 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.934 0.397 . . . . 0.60999999999999999 110.713 -172.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.7 t -81.11 -23.11 38.61 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.91 -0.586 . . . . 0.38 111.289 -171.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -159.5 168.1 27.01 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.511 -0.551 . . . . 0.78000000000000003 109.511 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 5.9 t -140.26 142.47 35.75 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.538 -0.301 . . . . 0.41999999999999998 110.633 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.637 ' HB2' HG23 ' A' ' 105' ' ' VAL . 83.9 m-85 -134.12 158.32 43.92 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.909 -0.316 . . . . 0.77000000000000002 110.686 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.644 ' HG2' HD21 ' A' ' 61' ' ' LEU . 6.5 mm100 59.43 40.25 21.01 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-N 116.138 -0.483 . . . . 0.80000000000000004 111.549 178.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 p80 58.04 2.07 0.17 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.117 0.967 . . . . 2.1200000000000001 112.393 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.98 -15.9 3.04 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.966 -0.635 . . . . 0.28000000000000003 112.658 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.711 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 24.6 mt -56.1 -37.29 69.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.076 0.438 . . . . 0.35999999999999999 111.594 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.637 HG23 ' HB2' ' A' ' 100' ' ' TYR . 3.6 m -130.39 149.82 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.333 0.587 . . . . 0.85999999999999999 110.314 173.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.488 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.5 t30 -142.98 153.35 42.91 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.6 -0.889 . . . . 0.91000000000000003 108.6 -174.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.5 m -131.62 150.41 34.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 112.783 0.66 . . . . 0.29999999999999999 112.783 -175.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.628 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.11 52.32 53.52 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 114.939 -1.028 . . . . 0.20000000000000001 111.824 176.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 83.1 m -97.31 127.05 42.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.741 0.305 . . . . 0.42999999999999999 111.225 -176.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 p -120.79 126.47 26.67 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.93 -0.577 . . . . 0.29999999999999999 110.574 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.513 ' HA ' HG12 ' A' ' 94' ' ' VAL . 50.5 Cg_exo -53.8 110.68 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.917 2.411 . . . . 0.34000000000000002 112.112 177.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 9.4 tt -100.54 134.51 40.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.273 0.559 . . . . 0.58999999999999997 110.882 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -92.29 99.96 12.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.702 -0.681 . . . . 2.3900000000000001 109.193 176.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 30' ' ' PRO . 1.2 pp -67.53 -10.76 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.715 0.635 . . . . 2.02 112.715 -177.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 105.91 -21.32 34.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.44 -0.886 . . . . 2.6099999999999999 112.797 174.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 116' ' ' LEU . 5.9 mp . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.592 -0.718 . . . . 3.6899999999999999 109.743 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 111.547 0.203 . . . . 30.309999999999999 111.547 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.94 -171.53 2.96 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.27 -0.27 . . . . 28.059999999999999 110.27 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 18.4 ptp -58.01 120.58 8.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.028 0.442 . . . . 28.52 110.293 176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.26 14.36 14.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.156 -0.475 . . . . 26.559999999999999 111.123 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 66.12 94.13 0.06 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.416 -0.811 . . . . 25.140000000000001 111.294 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 58.9 mt 65.37 90.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.533 -0.758 . . . . 24.989999999999998 111.266 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.81 42.22 2.33 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.67 -0.776 . . . . 22.920000000000002 112.961 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.1 m -66.15 108.83 2.39 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.408 -0.219 . . . . 22.809999999999999 110.408 177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 91.2 m 72.56 -54.42 0.69 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.888 -0.596 . . . . 22.210000000000001 111.509 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -115.61 127.03 54.92 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.185 -0.302 . . . . 20.949999999999999 110.185 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.15 120.35 69.84 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 121.133 0.492 . . . . 19.190000000000001 110.191 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.28 -23.21 9.03 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.523 2.148 . . . . 17.98 113.009 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -147.17 77.65 1.46 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.089 0.471 . . . . 18.07 110.564 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -81.6 120.02 24.54 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.089 -0.505 . . . . 14.66 110.557 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.6 169.52 20.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.297 -0.41 . . . . 13.029999999999999 110.72 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -65.05 116.83 6.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.072 -0.513 . . . . 12.26 110.144 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.81 -9.36 27.7 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.706 -0.759 . . . . 9.9700000000000006 111.485 -176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.61 -111.56 4.15 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.024 -0.607 . . . . 8.2200000000000006 112.381 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.532 HG22 ' HD2' ' A' ' 30' ' ' PRO . 2.2 m -84.47 126.96 67.77 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 110.349 -0.241 . . . . 7.2999999999999998 110.349 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -40.59 -45.92 4.59 Favored 'Trans proline' 0 CA--C 1.546 1.117 0 C-N-CA 123.988 3.125 . . . . 6.0999999999999996 115.996 -173.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.532 ' HD2' HG22 ' A' ' 28' ' ' THR . 21.7 Cg_exo -62.47 105.11 0.39 Allowed 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 121.915 1.743 . . . . 5.1900000000000004 111.898 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -84.04 55.08 3.15 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.844 -0.616 . . . . 3.79 111.308 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.1 t -70.62 149.99 46.49 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.653 0.74 . . . . 1.74 111.151 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.25 150.78 35.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.74 -1.118 . . . . 1.7 110.984 -177.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.4 m -71.05 0.56 7.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.854 -0.612 . . . . 2.5699999999999998 111.986 -174.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.1 p -78.51 -6.08 54.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.061 0.458 . . . . 2.5 110.893 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 102.06 -118.23 6.07 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.196 -0.762 . . . . 1.51 111.196 -178.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.43 150.82 57.18 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.635 2.223 . . . . 1.05 112.979 175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 39' ' ' TYR . 97.6 t -94.85 166.47 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 107.761 -1.2 . . . . 0.58999999999999997 107.761 174.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.452 ' N ' HG12 ' A' ' 38' ' ' VAL . 91.9 m-85 -124.21 135.48 53.48 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.885 0.85 . . . . 0.78000000000000003 111.605 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.709 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 44.0 t -107.98 111.09 22.99 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 114.833 -1.076 . . . . 0.81999999999999995 109.964 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 65.4 m -110.37 129.62 55.72 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.32 -0.622 . . . . 0.23999999999999999 109.32 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -62.88 -17.49 61.69 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.538 -0.756 . . . . 2.0800000000000001 109.832 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -169.28 133.83 1.44 Allowed 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 114.765 -1.107 . . . . 2.5800000000000001 108.622 172.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.495 HG21 HG11 ' A' ' 94' ' ' VAL . 29.2 p -94.53 151.84 19.02 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 119.442 -0.903 . . . . 0.37 110.679 168.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.538 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.7 tp10 -119.78 142.73 48.32 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.194 -0.912 . . . . 1.1200000000000001 109.527 -176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.465 ' O ' HD13 ' A' ' 50' ' ' LEU . 44.8 m-20 -67.28 108.39 2.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.523 -0.308 . . . . 1.77 110.52 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.561 ' HA ' HD21 ' A' ' 50' ' ' LEU . 70.0 p -68.67 -1.16 6.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.955 -0.566 . . . . 0.92000000000000004 112.513 -172.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -79.17 -43.82 23.17 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.928 0.394 . . . . 2.77 110.145 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -144.77 70.95 1.29 Allowed 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.569 -0.53 . . . . 2.3300000000000001 109.569 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 47' ' ' SER . 3.1 mm? -55.32 153.49 7.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.338 -0.846 . . . . 1.1599999999999999 112.406 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.95 153.34 21.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.672 -1.149 . . . . 1.8100000000000001 109.406 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -55.96 -41.45 74.74 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.249 0.477 . . . . 3.23 110.601 177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -61.41 -36.85 93.15 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.839 -0.619 . . . . 0.34000000000000002 112.32 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.656 ' HA ' HD22 ' A' ' 57' ' ' LEU . 29.2 m -82.29 -41.43 20.14 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.836 0.351 . . . . 0.35999999999999999 110.274 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.0 m -53.77 -34.99 60.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.781 -0.645 . . . . 0.29999999999999999 109.861 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.523 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.46 -52.74 63.55 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.367 -0.833 . . . . 0.23000000000000001 111.92 175.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.656 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -61.17 -44.43 97.31 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.556 0.693 . . . . 0.23999999999999999 110.037 -178.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 54' ' ' THR . 46.1 mt -60.05 -44.41 94.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.822 -1.081 . . . . 0.17999999999999999 109.903 178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.82 -32.42 79.31 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.631 -0.713 . . . . 0.26000000000000001 113.043 175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 33.9 mt -59.83 -41.96 92.49 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.833 0.825 . . . . 0.34000000000000002 110.323 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.479 HD21 ' HG2' ' A' ' 101' ' ' GLN . 3.8 mt -91.18 -5.61 54.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.406 -1.27 . . . . 0.35999999999999999 110.855 -178.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.9 t30 69.62 36.9 2.03 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.047 -0.979 . . . . 1.8899999999999999 110.661 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 58' ' ' LEU . 64.2 mt -77.77 146.19 8.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.797 -0.638 . . . . 0.26000000000000001 110.029 175.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.665 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -93.99 117.72 30.49 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.74 -0.664 . . . . 2.2200000000000002 110.279 -178.132 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -76.91 -40.6 31.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.609 -0.723 . . . . 0.28999999999999998 111.279 -175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -70.93 -7.48 62.22 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.75 -0.738 . . . . 0.56999999999999995 112.845 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.477 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 28.7 t70 -104.5 -12.44 16.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.08 0.467 . . . . 0.85999999999999999 110.529 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.1 mt -62.33 149.84 41.11 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.845 -0.616 . . . . 0.46000000000000002 110.974 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -95.86 -78.59 0.46 Allowed 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.458 0.91 . . . . 2.0099999999999998 113.458 -169.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 0.2 OUTLIER -105.95 -85.19 0.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.8 -0.36 . . . . 1.0900000000000001 111.741 -172.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.495 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 0.9 OUTLIER -120.97 168.17 11.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.169 0.509 . . . . 0.14999999999999999 110.871 177.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.538 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -122.25 168.5 14.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 106.821 -1.548 . . . . 0.25 106.821 165.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.508 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -136.53 144.09 15.67 Favored Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 119.83 -1.176 . . . . 0.37 111.698 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -104.96 128.14 53.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.128 0.49 . . . . 0.28999999999999998 110.116 176.375 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.4 m120 57.77 53.48 7.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.974 -1.012 . . . . 1.8500000000000001 110.999 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.508 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 58.9 m -87.67 141.57 28.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.399 -0.819 . . . . 1.1200000000000001 111.067 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.2 m -101.21 124.69 40.48 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.679 -0.692 . . . . 1.26 110.399 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -71.08 129.07 15.65 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.524 2.149 . . . . 0.60999999999999999 112.57 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 mt -109.39 89.89 3.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.285 -0.87 . . . . 0.85999999999999999 109.307 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.0 p -82.32 -39.95 22.14 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.332 -0.394 . . . . 1.3700000000000001 111.919 -173.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.4 m -117.74 108.39 24.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.668 0.747 . . . . 1.6000000000000001 112.44 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.7 mt -121.62 149.95 24.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.445 -0.798 . . . . 1.8500000000000001 109.166 173.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 131.49 -14.64 5.3 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.555 -0.831 . . . . 3.1800000000000002 111.734 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.11 29.57 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.445 0.64 . . . . 4.6900000000000004 109.861 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.57 164.89 12.61 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.41 -0.813 . . . . 4.3499999999999996 111.31 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -101.58 8.16 56.38 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.835 -0.698 . . . . 3.27 111.929 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -74.75 79.3 2.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.398 0.618 . . . . 5.4699999999999998 110.461 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.491 ' O ' ' HB3' ' A' ' 89' ' ' CYS . 50.6 m -159.39 160.5 35.0 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.084 -0.71 . . . . 4.7000000000000002 109.084 178.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 88' ' ' SER . 8.3 t 73.43 -73.41 0.1 Allowed 'General case' 0 CA--C 1.535 0.382 0 O-C-N 123.529 0.518 . . . . 1.6599999999999999 111.944 176.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.5 m 61.34 26.22 16.06 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.953 0.406 . . . . 1.6499999999999999 111.575 -178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.709 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -148.08 -158.29 0.9 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.515 -0.55 . . . . 0.54000000000000004 109.515 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.76 121.54 25.48 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.549 0.69 . . . . 0.78000000000000003 110.033 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.77 121.38 41.57 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.774 -0.648 . . . . 0.39000000000000001 111.356 -171.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 111' ' ' PRO . 9.0 m -133.78 165.87 30.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 115.598 -0.728 . . . . 0.22 110.847 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 18.0 m -114.06 125.09 53.6 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.75 -0.659 . . . . 0.70999999999999996 109.233 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 22.8 m -121.23 149.97 42.04 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.074 -0.512 . . . . 0.60999999999999999 110.465 -171.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.3 t -80.85 -28.37 36.09 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.73 -0.668 . . . . 0.38 110.789 -171.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.563 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 21.9 m120 -152.73 159.68 43.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.78000000000000003 109.764 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.4 t -136.12 147.39 47.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.472 -0.331 . . . . 0.41999999999999998 110.114 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.579 ' HB2' HG23 ' A' ' 105' ' ' VAL . 65.7 m-85 -137.17 158.24 44.89 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.83 -0.433 . . . . 0.77000000000000002 109.83 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.479 ' HG2' HD21 ' A' ' 61' ' ' LEU . 7.8 mm100 62.51 26.6 15.82 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.566 -0.288 . . . . 0.80000000000000004 111.54 177.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 65.52 0.19 1.36 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.87 -0.604 . . . . 2.1200000000000001 112.534 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.8 -21.99 1.29 Allowed Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 119.91 -1.138 . . . . 0.28000000000000003 113.621 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.8 mt -51.07 -37.31 44.89 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 117.583 0.692 . . . . 0.35999999999999999 111.198 -177.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.579 HG23 ' HB2' ' A' ' 100' ' ' TYR . 5.6 m -131.7 144.43 37.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.813 -0.631 . . . . 0.85999999999999999 109.768 174.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 15.4 t30 -142.86 141.41 31.56 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.974 -1.121 . . . . 0.91000000000000003 107.974 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.563 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.2 m -125.68 152.27 32.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 113.291 0.849 . . . . 0.29999999999999999 113.291 -172.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 64.53 51.71 49.74 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.799 -1.091 . . . . 0.20000000000000001 111.665 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.495 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 74.6 m -97.98 128.45 44.55 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.856 0.36 . . . . 0.42999999999999999 111.494 -174.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.0 p -124.03 126.36 25.63 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.757 -0.656 . . . . 0.29999999999999999 109.418 173.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.539 ' HA ' HG12 ' A' ' 94' ' ' VAL . 79.6 Cg_exo -50.69 109.15 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.058 2.505 . . . . 0.34000000000000002 112.336 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.41 HD12 ' SG ' ' A' ' 95' ' ' CYS . 4.2 tt -88.02 133.8 29.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.679 -0.691 . . . . 0.58999999999999997 111.144 -177.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -91.79 99.01 11.96 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.044 -1.095 . . . . 2.3900000000000001 108.044 171.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 30' ' ' PRO . 1.4 pp -68.99 -25.17 29.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.737 0.643 . . . . 2.02 112.737 -171.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.428 ' N ' HD12 ' A' ' 114' ' ' ILE . . . 93.3 -10.77 72.86 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.496 -0.859 . . . . 2.6099999999999999 113.814 174.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 116' ' ' LEU . 1.2 pt? . . . . . 0 C--O 1.246 0.875 0 CA-C-N 117.342 0.571 . . . . 3.6899999999999999 110.4 177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.523 0.202 . . . . 30.309999999999999 111.358 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -94.43 88.58 5.55 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.058 0.456 . . . . 28.059999999999999 112.159 -174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 86.8 mtp -88.11 -31.8 19.02 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.712 -0.847 . . . . 28.52 108.712 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -130.89 157.28 43.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.952 -1.022 . . . . 26.559999999999999 108.553 172.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -82.2 70.16 9.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.476 0.655 . . . . 25.140000000000001 110.634 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pp -139.53 166.12 21.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.136 -0.938 . . . . 24.989999999999998 109.771 176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.96 142.01 3.54 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.431 -0.89 . . . . 22.920000000000002 111.986 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.3 m -81.52 111.77 18.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.885 0.374 . . . . 22.809999999999999 110.661 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.2 t -87.22 5.96 35.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.073 0.463 . . . . 22.210000000000001 110.188 178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.14 -168.81 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.537 -0.756 . . . . 20.949999999999999 110.421 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.436 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 27.9 t -63.57 -51.67 64.86 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 121.065 -0.254 . . . . 19.190000000000001 111.213 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 20' ' ' VAL . 57.1 Cg_endo -71.06 85.43 0.81 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.032 1.821 . . . . 17.98 112.66 175.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.1 mtp180 -96.07 110.43 22.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.364 -0.38 . . . . 18.07 110.225 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 24' ' ' VAL . 1.9 m-20 68.91 87.0 0.13 Allowed 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.938 0.774 . . . . 14.66 111.558 -177.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 23' ' ' ASP . 3.6 m 64.78 -28.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.967 1.707 . . . . 13.029999999999999 114.688 172.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -151.78 167.85 26.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 118.622 0.646 . . . . 12.26 111.131 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.82 116.16 0.78 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.392 -0.683 . . . . 9.9700000000000006 111.392 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -160.84 -162.01 12.15 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.85 -0.691 . . . . 8.2200000000000006 111.895 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.689 HG22 ' HD2' ' A' ' 30' ' ' PRO . 1.9 m -125.45 120.69 24.8 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-O 121.269 0.557 . . . . 7.2999999999999998 109.872 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -45.78 -44.88 17.61 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 124.633 3.555 . . . . 6.0999999999999996 115.818 -174.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.689 ' HD2' HG22 ' A' ' 28' ' ' THR . 2.7 Cg_exo -73.71 109.09 2.79 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 121.855 1.703 . . . . 5.1900000000000004 111.702 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -82.19 58.62 4.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.074 -0.512 . . . . 3.79 110.469 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.0 p -75.24 171.66 13.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.896 -0.593 . . . . 1.74 111.239 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 58.0 m -76.99 152.18 35.33 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.837 -0.62 . . . . 1.7 111.132 -175.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.9 m -90.14 0.24 57.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.006 -0.543 . . . . 2.5699999999999998 110.354 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.7 p -120.06 19.62 12.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 2.5 110.78 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.25 -175.97 27.29 Favored Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 111.445 -0.662 . . . . 1.51 111.445 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.658 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 72.4 Cg_endo -75.04 -160.0 0.1 OUTLIER 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 122.291 1.994 . . . . 1.05 112.659 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.448 ' HB ' HD11 ' A' ' 82' ' ' ILE . 92.1 t -93.42 161.04 2.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.547 -0.538 . . . . 0.58999999999999997 109.547 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.423 ' N ' HG12 ' A' ' 38' ' ' VAL . 52.8 m-85 -129.69 134.99 47.96 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.869 0.366 . . . . 0.78000000000000003 110.54 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 38.6 t -108.06 112.06 24.43 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.302 -0.408 . . . . 0.81999999999999995 109.95 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 72.9 m -103.31 134.15 47.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.143 0.496 . . . . 0.23999999999999999 110.422 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.464 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 88.4 m-20 -59.65 -19.58 50.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.226 -0.897 . . . . 2.0800000000000001 110.361 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -173.13 124.66 0.42 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.71 -1.132 . . . . 2.5800000000000001 107.986 176.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.581 HG21 HG11 ' A' ' 94' ' ' VAL . 8.0 p -78.2 148.0 34.22 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.243 -0.983 . . . . 0.37 110.838 170.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' OE2' ' HA ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -109.96 138.81 45.81 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.009 -0.996 . . . . 1.1200000000000001 109.017 -176.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -73.67 104.9 4.76 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.741 -0.663 . . . . 1.77 110.337 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.704 ' HA ' HD21 ' A' ' 50' ' ' LEU . 50.1 m -58.93 -16.64 18.69 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.473 0.546 . . . . 0.92000000000000004 112.473 -177.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -86.57 -20.23 28.25 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.744 0.307 . . . . 2.77 110.659 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -148.76 57.21 1.04 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.456 -0.338 . . . . 2.3300000000000001 111.601 -177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -59.59 145.75 43.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.39 0.614 . . . . 1.1599999999999999 111.665 176.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -71.03 156.76 39.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.146 -0.934 . . . . 1.8100000000000001 109.714 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -59.56 -41.65 90.62 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.909 -0.317 . . . . 3.23 110.948 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -57.03 -38.29 84.59 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.116 -0.564 . . . . 0.34000000000000002 112.34 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.668 ' HA ' HD22 ' A' ' 57' ' ' LEU . 26.2 m -79.92 -43.72 21.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.881 0.372 . . . . 0.35999999999999999 110.559 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 94.6 m -53.89 -34.8 60.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.673 -0.694 . . . . 0.29999999999999999 109.823 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.607 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.14 -52.23 66.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.85 -1.068 . . . . 0.23000000000000001 111.549 177.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.668 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -60.48 -45.75 92.62 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.424 0.63 . . . . 0.23999999999999999 109.958 -179.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 54' ' ' THR . 50.6 mt -57.96 -45.86 86.03 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.848 -1.069 . . . . 0.17999999999999999 109.917 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.03 -36.87 91.7 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.621 -0.718 . . . . 0.26000000000000001 112.573 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 25.5 mt -59.61 -47.37 85.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.597 0.713 . . . . 0.34000000000000002 110.238 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.538 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.7 mt -84.48 -4.76 59.11 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.683 -1.144 . . . . 0.35999999999999999 111.556 -176.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 70.63 35.54 1.84 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.741 0.781 . . . . 1.8899999999999999 110.524 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 58' ' ' LEU . 60.6 mt -79.6 146.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.162 -0.681 . . . . 0.26000000000000001 109.162 174.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.601 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -98.33 117.44 32.75 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.536 0.684 . . . . 2.2200000000000002 110.127 -177.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.44 -31.4 42.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.054 -0.975 . . . . 0.28999999999999998 110.628 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.06 -14.83 78.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.941 -0.647 . . . . 0.56999999999999995 113.404 -176.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -101.58 -12.57 18.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.07 0.435 . . . . 0.85999999999999999 110.91 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.5 mt -51.75 127.09 19.72 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.661 0.743 . . . . 0.46000000000000002 111.447 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -76.16 -54.38 6.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.424 -1.262 . . . . 2.0099999999999998 113.263 -166.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.17 -84.41 0.37 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.963 -0.295 . . . . 1.0900000000000001 111.614 -176.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.4 mm? -115.11 168.04 10.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.426 0.631 . . . . 0.14999999999999999 110.798 173.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.521 HG13 HD11 ' A' ' 50' ' ' LEU . 1.6 m -121.67 172.26 9.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.362 -1.718 . . . . 0.25 106.362 168.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.478 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -138.96 150.12 21.03 Favored Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 120.119 -1.038 . . . . 0.37 111.486 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -116.36 133.72 55.7 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.989 0.423 . . . . 0.28999999999999998 109.876 174.55 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 12.5 m120 53.09 52.92 12.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.965 -1.016 . . . . 1.8500000000000001 111.027 179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.422 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 35.7 m -86.46 152.4 22.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.479 -0.782 . . . . 1.1200000000000001 110.473 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.5 m -107.37 115.55 59.42 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.773 -0.648 . . . . 1.26 109.932 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.37 121.77 9.11 Favored 'Trans proline' 0 N--CA 1.464 -0.233 0 C-N-CA 122.546 2.164 . . . . 0.60999999999999999 111.769 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.658 ' O ' ' HB2' ' A' ' 37' ' ' PRO . 27.1 mt -100.5 87.99 3.53 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.747 -0.661 . . . . 0.85999999999999999 110.027 -177.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.0 m -71.52 -29.72 65.11 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.777 0.323 . . . . 1.3700000000000001 110.659 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.8 m -133.8 123.75 45.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.191 0.52 . . . . 1.6000000000000001 110.854 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.448 HD11 ' HB ' ' A' ' 38' ' ' VAL . 6.9 mt -112.94 148.53 15.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.825 -0.625 . . . . 1.8500000000000001 110.859 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -83.78 50.66 4.44 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.865 -0.607 . . . . 3.1800000000000002 112.267 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 66.4 t 70.21 -61.68 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 123.312 0.645 . . . . 4.6900000000000004 111.682 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -73.83 88.39 0.65 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.08 -0.581 . . . . 4.3499999999999996 112.394 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.97 46.66 2.98 Favored Glycine 0 CA--C 1.517 0.179 0 C-N-CA 121.468 -0.396 . . . . 3.27 113.257 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -127.28 -8.61 5.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.57 0.7 . . . . 5.4699999999999998 109.433 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.1 m -104.34 87.19 2.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.674 -0.694 . . . . 4.7000000000000002 110.341 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.498 ' SG ' HG23 ' A' ' 93' ' ' THR . 31.0 p -137.69 18.07 2.88 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.239 -0.437 . . . . 1.6599999999999999 110.006 178.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.0 m 73.33 -33.07 0.25 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.126 -0.943 . . . . 1.6499999999999999 111.631 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.605 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -119.27 -158.94 0.75 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.506 -0.315 . . . . 0.54000000000000004 110.841 -178.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.41 122.87 32.39 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.271 0.557 . . . . 0.78000000000000003 110.745 -177.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.498 HG23 ' SG ' ' A' ' 89' ' ' CYS . 0.2 OUTLIER -95.97 123.16 39.45 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.229 0.538 . . . . 0.39000000000000001 111.147 -174.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.581 HG11 HG21 ' A' ' 44' ' ' THR . 6.5 m -133.85 167.54 26.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.588 -0.733 . . . . 0.22 111.49 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 41.8 t -111.35 121.74 46.04 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.473 -0.936 . . . . 0.70999999999999996 108.473 174.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 22.9 m -122.35 148.63 44.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.023 0.439 . . . . 0.60999999999999999 110.969 -171.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.9 t -79.2 -28.15 42.6 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.423 -0.808 . . . . 0.38 110.837 -169.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.499 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 19.6 m120 -156.0 161.64 40.44 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.053 -0.721 . . . . 0.78000000000000003 109.053 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.7 t -142.22 144.67 33.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.799 0.333 . . . . 0.41999999999999998 110.516 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.589 ' HB2' HG23 ' A' ' 105' ' ' VAL . 70.3 m-85 -133.65 160.77 36.53 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.756 -0.461 . . . . 0.77000000000000002 109.756 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.636 ' NE2' HD12 ' A' ' 104' ' ' LEU . 11.4 mm100 60.97 23.7 13.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 0.80000000000000004 111.566 175.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 63.01 13.39 6.67 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.582 -0.735 . . . . 2.1200000000000001 112.442 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.88 -24.34 3.01 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.211 -0.995 . . . . 0.28000000000000003 113.133 175.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.636 HD12 ' NE2' ' A' ' 101' ' ' GLN . 14.9 mt -49.63 -38.01 30.37 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.852 0.326 . . . . 0.35999999999999999 111.018 -177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.589 HG23 ' HB2' ' A' ' 100' ' ' TYR . 4.2 m -131.87 141.53 45.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.892 -0.595 . . . . 0.85999999999999999 109.559 172.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.438 ' ND2' ' SG ' ' A' ' 96' ' ' CYS . 21.5 t30 -140.63 144.63 35.85 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 108.201 -1.037 . . . . 0.91000000000000003 108.201 -176.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.499 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.4 m -129.46 151.02 35.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 113.396 0.887 . . . . 0.29999999999999999 113.396 -172.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.644 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 64.07 51.85 49.6 Favored Glycine 0 CA--C 1.506 -0.505 0 CA-C-N 114.91 -1.041 . . . . 0.20000000000000001 111.807 177.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 90.9 m -97.12 127.91 43.53 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.014 0.435 . . . . 0.42999999999999999 111.884 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.7 p -122.26 126.47 26.23 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.528 -0.76 . . . . 0.29999999999999999 109.701 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.522 ' HA ' HG12 ' A' ' 94' ' ' VAL . 71.4 Cg_exo -50.46 110.49 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.003 2.469 . . . . 0.34000000000000002 112.586 177.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 tt -81.66 118.99 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.688 -0.687 . . . . 0.58999999999999997 110.664 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -108.29 114.62 28.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.293 0.568 . . . . 2.3900000000000001 110.04 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.429 ' CD1' ' H ' ' A' ' 116' ' ' LEU . 1.2 pp -92.21 -10.81 9.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.101 -0.5 . . . . 2.02 111.688 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 78.16 1.65 80.89 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.108 -0.568 . . . . 2.6099999999999999 113.092 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.429 ' H ' ' CD1' ' A' ' 114' ' ' ILE . 12.0 mt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.542 -0.742 . . . . 3.6899999999999999 109.873 -176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.898 0.38 . . . . 30.309999999999999 110.255 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -119.78 34.4 5.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.479 0.656 . . . . 28.059999999999999 109.654 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.414 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 26.0 mmt -91.17 -55.82 3.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.282 -0.872 . . . . 28.52 110.291 -177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 67.92 117.84 0.03 OUTLIER 'General case' 0 C--O 1.235 0.291 0 O-C-N 124.048 0.842 . . . . 26.559999999999999 111.608 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.2 t70 73.19 -60.06 0.55 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.358 -0.837 . . . . 25.140000000000001 111.679 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.414 ' O ' ' HB3' ' A' ' 12' ' ' MET . 33.1 pt -105.23 -179.97 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 110.233 -0.284 . . . . 24.989999999999998 110.233 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.0 44.61 9.71 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.73 -0.748 . . . . 22.920000000000002 112.798 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 t 64.42 68.94 0.53 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.214 0.531 . . . . 22.809999999999999 110.859 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.0 p -102.15 -69.43 0.79 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.117 -0.492 . . . . 22.210000000000001 111.261 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.75 60.88 4.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.088 0.47 . . . . 20.949999999999999 111.245 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.7 t -113.36 97.99 45.0 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.082 -0.508 . . . . 19.190000000000001 110.025 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.17 110.82 2.92 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.379 2.053 . . . . 17.98 112.196 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 -86.87 -35.04 19.24 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.999 -0.546 . . . . 18.07 110.086 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -88.27 97.65 11.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.803 -0.635 . . . . 14.66 109.747 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.5 m -92.43 27.1 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.995 -0.548 . . . . 13.029999999999999 112.073 -173.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.1 t30 59.04 57.79 3.4 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.466 0.65 . . . . 12.26 111.187 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.49 -63.65 0.49 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.908 -0.663 . . . . 9.9700000000000006 112.051 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 125.41 -168.31 17.55 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.787 -0.72 . . . . 8.2200000000000006 111.808 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.547 HG22 ' HD2' ' A' ' 30' ' ' PRO . 5.1 m -69.16 126.55 92.82 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 110.103 -0.332 . . . . 7.2999999999999998 110.103 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.415 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 81.3 Cg_exo -42.73 -54.34 3.33 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 123.717 2.945 . . . . 6.0999999999999996 114.953 -173.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.547 ' HD2' HG22 ' A' ' 28' ' ' THR . 37.8 Cg_endo -64.55 117.1 4.19 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 121.735 1.623 . . . . 5.1900000000000004 112.214 176.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -75.97 142.38 41.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.449 -0.341 . . . . 3.79 110.275 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.4 p -150.53 176.28 11.11 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.278 -0.419 . . . . 1.74 110.413 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 71.6 m -83.5 129.96 35.0 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.429 -0.351 . . . . 1.7 110.667 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.7 p -76.0 -18.35 59.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.151 0.5 . . . . 2.5699999999999998 109.999 176.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.5 t -74.85 -20.02 59.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.421 -0.809 . . . . 2.5 110.47 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . 140.03 -137.83 8.69 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.971 -0.633 . . . . 1.51 112.132 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.01 154.22 13.81 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 123.023 2.482 . . . . 1.05 113.418 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.434 HG12 ' N ' ' A' ' 39' ' ' TYR . 94.5 t -92.54 163.27 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 108.143 -1.058 . . . . 0.58999999999999997 108.143 174.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.434 ' N ' HG12 ' A' ' 38' ' ' VAL . 45.7 m-85 -124.2 130.82 53.19 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 119.875 -0.73 . . . . 0.78000000000000003 111.362 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 36.2 t -105.14 106.12 16.47 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.442 -0.799 . . . . 0.81999999999999995 109.426 176.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.7 m -97.8 133.3 42.49 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.801 -0.636 . . . . 0.23999999999999999 110.44 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.435 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 3.1 m-20 -58.53 -24.85 61.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.503 -0.772 . . . . 2.0800000000000001 109.716 176.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.547 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -162.79 135.61 5.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.176 -1.375 . . . . 2.5800000000000001 107.446 177.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.603 HG21 HG11 ' A' ' 94' ' ' VAL . 23.7 p -92.63 159.67 15.36 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 119.356 -0.938 . . . . 0.37 110.062 165.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.554 ' HB3' HG22 ' A' ' 72' ' ' VAL . 8.0 tp10 -126.28 140.32 52.62 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.608 -0.724 . . . . 1.1200000000000001 109.712 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.426 ' HA ' HD12 ' A' ' 71' ' ' LEU . 3.2 m-20 -72.31 109.15 5.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.073 -0.512 . . . . 1.77 110.438 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.603 ' HA ' HD21 ' A' ' 50' ' ' LEU . 88.0 p -64.12 -4.92 3.97 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.48 0.548 . . . . 0.92000000000000004 112.48 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.4 mptp? -73.84 -42.11 61.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.342 0.592 . . . . 2.77 110.243 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -142.51 66.67 1.33 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.19 -0.913 . . . . 2.3300000000000001 110.735 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.603 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -56.97 148.76 20.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.176 0.512 . . . . 1.1599999999999999 111.522 175.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -69.26 166.16 19.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.589 -0.732 . . . . 1.8100000000000001 109.78 174.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 11.3 mptt -58.98 -47.68 84.28 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.539 -0.464 . . . . 3.23 110.698 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -55.65 -39.27 75.05 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.066 -0.587 . . . . 0.34000000000000002 112.517 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.674 ' HA ' HD22 ' A' ' 57' ' ' LEU . 13.4 m -77.86 -43.17 31.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.753 0.311 . . . . 0.35999999999999999 110.559 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 93.9 m -56.05 -33.71 65.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.3 0.572 . . . . 0.29999999999999999 109.795 174.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.586 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -58.29 -54.51 46.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.17 -0.923 . . . . 0.23000000000000001 111.304 176.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.674 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -58.12 -46.75 85.05 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.485 0.66 . . . . 0.23999999999999999 110.039 -179.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 54' ' ' THR . 47.5 mt -58.69 -44.83 90.37 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.972 -1.013 . . . . 0.17999999999999999 110.195 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -59.82 -37.18 92.11 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.955 -0.64 . . . . 0.26000000000000001 112.686 175.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.5 mt -60.12 -45.58 92.53 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.041 0.924 . . . . 0.34000000000000002 110.312 178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.432 ' CD1' HG21 ' A' ' 105' ' ' VAL . 6.8 mt -86.31 -0.02 54.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.391 -1.277 . . . . 0.35999999999999999 111.371 -176.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 68.79 31.25 4.51 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.544 -0.753 . . . . 1.8899999999999999 111.093 176.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.525 HD12 ' HA ' ' A' ' 58' ' ' LEU . 53.6 mt -79.95 145.08 9.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.827 -0.624 . . . . 0.26000000000000001 109.806 177.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.56 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -98.35 118.2 34.47 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.761 -0.654 . . . . 2.2200000000000002 109.93 -178.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.14 -38.02 54.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.345 -0.843 . . . . 0.28999999999999998 110.963 -174.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.75 -1.98 63.43 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.846 -0.693 . . . . 0.56999999999999995 113.007 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.492 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 33.9 t70 -113.97 2.13 14.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.628 0.728 . . . . 0.85999999999999999 109.968 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.7 mt -74.19 152.47 39.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.593 -0.73 . . . . 0.46000000000000002 111.074 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -95.84 -97.64 0.18 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.561 -0.745 . . . . 2.0099999999999998 112.401 -173.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.79 -93.27 0.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.13 0.419 . . . . 1.0900000000000001 112.13 -173.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.517 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.1 mm? -111.61 170.02 8.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.41 0.624 . . . . 0.14999999999999999 111.279 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.606 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.9 OUTLIER -121.39 165.5 16.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 106.189 -1.782 . . . . 0.25 106.189 165.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.47 134.08 6.8 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 119.748 -1.215 . . . . 0.37 112.124 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.659 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -100.89 136.45 40.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.065 0.459 . . . . 0.28999999999999998 110.581 178.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.6 m120 51.49 52.2 15.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.855 -1.066 . . . . 1.8500000000000001 111.095 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.1 m -88.51 138.75 31.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.001 -0.545 . . . . 1.1200000000000001 110.89 -177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 m -86.68 119.6 71.39 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.75 -0.659 . . . . 1.26 110.139 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -71.27 121.16 7.53 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.467 2.111 . . . . 0.60999999999999999 112.133 178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.9 mt -99.68 88.24 3.77 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.366 -0.834 . . . . 0.85999999999999999 109.196 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.8 m -70.39 -38.09 74.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.825 -0.625 . . . . 1.3700000000000001 110.193 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.24 123.63 70.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.549 0.69 . . . . 1.6000000000000001 110.442 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.9 mm -72.76 -45.8 55.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.234 -0.894 . . . . 1.8500000000000001 111.483 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.12 137.74 30.11 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 120.66 -0.781 . . . . 3.1800000000000002 111.579 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t 65.82 95.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 121.231 0.539 . . . . 4.6900000000000004 110.596 -176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.74 6.5 46.45 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.823 -0.703 . . . . 4.3499999999999996 112.156 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.96 -43.18 9.0 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.776 -0.726 . . . . 3.27 111.663 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -76.57 123.71 26.5 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.154 -0.313 . . . . 5.4699999999999998 110.154 177.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 90' ' ' SER . 33.4 t 59.94 79.03 0.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.811 0.694 . . . . 4.7000000000000002 110.608 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.525 ' SG ' HG23 ' A' ' 93' ' ' THR . 28.4 p -79.88 20.19 0.63 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.362 -0.381 . . . . 1.6599999999999999 110.863 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 88' ' ' SER . 30.5 t 72.76 -11.41 0.85 Allowed 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 123.82 0.848 . . . . 1.6499999999999999 111.565 178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.598 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -147.13 -159.06 0.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.809 0.338 . . . . 0.54000000000000004 111.279 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.56 117.83 30.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.33 0.586 . . . . 0.78000000000000003 110.753 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.525 HG23 ' SG ' ' A' ' 89' ' ' CYS . 0.1 OUTLIER -89.71 121.92 32.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.323 0.583 . . . . 0.39000000000000001 111.566 -174.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.603 HG11 HG21 ' A' ' 44' ' ' THR . 6.7 m -133.26 164.27 35.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.552 -0.749 . . . . 0.22 110.939 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.9 t -113.38 112.29 23.41 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.54 -0.754 . . . . 0.70999999999999996 109.317 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 21.9 m -106.28 145.0 32.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.363 -0.381 . . . . 0.60999999999999999 110.311 -174.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.3 t -77.3 -25.53 51.39 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.069 -0.514 . . . . 0.38 110.797 -172.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.64 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 19.8 m120 -148.67 155.75 41.45 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.786 -0.82 . . . . 0.78000000000000003 108.786 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.4 t -123.12 144.54 49.26 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 120.915 0.388 . . . . 0.41999999999999998 110.181 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.532 ' CB ' HG23 ' A' ' 105' ' ' VAL . 26.0 m-85 -130.19 143.27 50.68 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.016 -0.538 . . . . 0.77000000000000002 110.731 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.664 ' NE2' HD12 ' A' ' 104' ' ' LEU . 7.9 mm100 60.93 32.85 19.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.272 -0.422 . . . . 0.80000000000000004 111.817 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 66.06 0.33 1.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.197 0.599 . . . . 2.1200000000000001 112.431 177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.97 -19.78 1.96 Allowed Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.372 -0.918 . . . . 0.28000000000000003 112.817 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.664 HD12 ' NE2' ' A' ' 101' ' ' GLN . 20.0 mt -51.89 -39.51 59.15 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.742 0.271 . . . . 0.35999999999999999 111.258 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.532 HG23 ' CB ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -136.4 145.41 30.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.385 -0.371 . . . . 0.85999999999999999 110.531 175.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.606 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 41.4 m-80 -140.28 161.95 36.46 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.298 -0.63 . . . . 0.91000000000000003 109.298 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.64 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 8.3 m -133.71 150.05 31.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 112.009 0.374 . . . . 0.29999999999999999 112.009 -176.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 58.7 54.89 34.15 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.328 -0.851 . . . . 0.20000000000000001 111.583 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 75.5 m -96.3 124.48 40.32 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.997 0.427 . . . . 0.42999999999999999 110.669 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.5 p -121.18 125.49 26.93 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.629 -0.714 . . . . 0.29999999999999999 110.524 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HA ' HG12 ' A' ' 94' ' ' VAL . 78.6 Cg_exo -47.62 114.01 0.93 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 123.29 2.66 . . . . 0.34000000000000002 112.776 177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.2 tt -117.02 138.06 48.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.503 -0.771 . . . . 0.58999999999999997 110.799 -176.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -111.87 120.01 40.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.554 -0.535 . . . . 2.3900000000000001 109.554 173.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.47 ' CD1' ' H ' ' A' ' 116' ' ' LEU . 1.2 pp -72.14 -11.4 14.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.127 -0.488 . . . . 2.02 112.299 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 100.02 -8.58 59.41 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.497 -0.859 . . . . 2.6099999999999999 113.231 174.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.47 ' H ' ' CD1' ' A' ' 114' ' ' ILE . 5.2 mp . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.429 -0.796 . . . . 3.6899999999999999 110.161 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.497 0.189 . . . . 30.309999999999999 111.104 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.19 115.91 19.81 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.819 0.342 . . . . 28.059999999999999 111.248 -176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 24.3 ttt -130.25 41.89 3.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.664 0.745 . . . . 28.52 109.317 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.51 -20.5 25.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.389 -0.823 . . . . 26.559999999999999 110.747 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -77.51 121.59 24.07 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.891 -0.595 . . . . 25.140000000000001 110.525 -177.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.541 ' H ' HD13 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -115.86 140.17 38.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.042 -0.526 . . . . 24.989999999999998 110.476 -179.005 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.09 -6.17 89.08 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.942 -0.646 . . . . 22.920000000000002 112.985 -175.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -67.88 -30.72 70.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.008 0.433 . . . . 22.809999999999999 110.765 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.8 p -97.04 2.76 51.78 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.988 -0.551 . . . . 22.210000000000001 111.256 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.53 96.26 1.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.468 -0.333 . . . . 20.949999999999999 110.681 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 m 38.71 69.83 1.48 Allowed Pre-proline 0 N--CA 1.471 0.618 0 O-C-N 124.364 1.04 . . . . 19.190000000000001 113.134 -178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.64 -8.23 20.25 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.61 2.207 . . . . 17.98 112.151 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -103.58 136.52 43.15 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.572 -0.529 . . . . 18.07 109.572 177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -100.7 -4.63 27.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.022 0.439 . . . . 14.66 110.594 -178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.24 157.14 38.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.964 -0.562 . . . . 13.029999999999999 110.251 175.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.7 m120 59.51 43.6 15.89 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.246 0.546 . . . . 12.26 110.962 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.12 43.78 0.92 Allowed Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.632 -0.713 . . . . 9.9700000000000006 111.319 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.38 -127.34 8.91 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.891 -0.671 . . . . 8.2200000000000006 111.444 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.481 HG22 ' HD2' ' A' ' 30' ' ' PRO . 3.5 m -123.65 133.28 24.49 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 110.115 -0.328 . . . . 7.2999999999999998 110.115 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -40.06 -48.67 3.83 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.657 2.905 . . . . 6.0999999999999996 115.47 -175.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.481 ' HD2' HG22 ' A' ' 28' ' ' THR . 5.8 Cg_exo -76.31 104.9 1.98 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.095 1.863 . . . . 5.1900000000000004 111.61 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.421 ' O ' HG22 ' A' ' 114' ' ' ILE . 39.8 ttmt -58.53 142.95 47.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.023 -0.535 . . . . 3.79 110.79 -179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.2 t -153.22 175.72 12.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.252 -0.431 . . . . 1.74 110.401 -175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.6 m -76.7 131.0 38.54 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.519 -0.549 . . . . 1.7 109.519 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t -73.68 -12.13 60.63 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.796 0.332 . . . . 2.5699999999999998 110.675 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -91.58 -12.08 35.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.13 -0.486 . . . . 2.5 111.436 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 151.29 -156.53 26.73 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.471 -0.871 . . . . 1.51 112.73 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.03 155.67 4.19 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.663 2.909 . . . . 1.05 114.375 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.53 HG12 ' N ' ' A' ' 39' ' ' TYR . 47.3 t -85.62 173.76 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.99 -1.115 . . . . 0.58999999999999997 107.99 172.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.557 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 75.4 m-85 -128.71 120.62 26.81 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.954 0.883 . . . . 0.78000000000000003 112.034 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.622 ' HB2' HD21 ' A' ' 79' ' ' LEU . 33.1 t -91.13 99.13 12.2 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.344 -1.298 . . . . 0.81999999999999995 110.305 177.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 62.8 m -101.89 129.65 48.19 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.674 -0.861 . . . . 0.23999999999999999 108.674 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -53.57 -29.52 37.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.356 -0.838 . . . . 2.0800000000000001 110.439 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.9 tmmm? -170.5 125.13 0.72 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.001 -1.111 . . . . 2.5800000000000001 108.001 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.567 HG21 HG11 ' A' ' 94' ' ' VAL . 20.5 p -85.59 142.15 29.32 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 119.286 -0.966 . . . . 0.37 111.462 175.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.58 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.6 tp10 -114.21 142.21 46.55 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.891 -1.05 . . . . 1.1200000000000001 109.591 -174.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.414 ' O ' HD13 ' A' ' 50' ' ' LEU . 10.3 m-20 -62.0 110.79 1.68 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.372 -0.377 . . . . 1.77 110.443 -178.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.587 ' HA ' HD21 ' A' ' 50' ' ' LEU . 77.5 p -65.88 -8.32 21.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.198 0.523 . . . . 0.92000000000000004 111.173 -177.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -91.23 -24.68 19.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.993 -0.549 . . . . 2.77 110.067 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -141.06 59.71 1.52 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.029 -0.532 . . . . 2.3300000000000001 111.132 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.7 mm? -64.21 152.61 40.39 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 1.1599999999999999 111.768 176.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.82 152.86 43.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.551 -0.907 . . . . 1.8100000000000001 108.551 171.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.545 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -57.81 -29.4 64.88 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.121 -0.632 . . . . 3.23 110.146 176.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -66.17 -40.47 94.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 121.119 -0.562 . . . . 0.34000000000000002 111.736 176.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.651 ' HA ' HD22 ' A' ' 57' ' ' LEU . 20.0 m -78.06 -42.34 32.58 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 121.025 -0.27 . . . . 0.35999999999999999 110.647 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 95.0 m -53.61 -35.62 61.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.962 -0.563 . . . . 0.29999999999999999 109.685 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.527 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.75 -54.32 47.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.211 -0.904 . . . . 0.23000000000000001 111.772 176.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.651 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -59.56 -45.46 91.76 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.48 0.657 . . . . 0.23999999999999999 109.919 -178.289 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 54' ' ' THR . 48.6 mt -60.01 -44.38 94.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.886 -1.052 . . . . 0.17999999999999999 109.767 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.79 -38.71 92.64 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.707 -0.679 . . . . 0.26000000000000001 112.44 175.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 24.8 mt -56.89 -49.17 76.35 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.657 0.741 . . . . 0.34000000000000002 110.176 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.7 mt -84.16 -0.78 53.4 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.589 -1.187 . . . . 0.35999999999999999 111.13 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 66.91 35.82 4.65 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.269 -0.878 . . . . 1.8899999999999999 111.252 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 58' ' ' LEU . 52.5 mt -84.08 142.22 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 115.626 -0.716 . . . . 0.26000000000000001 109.702 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.401 ' H ' ' HD3' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -95.67 118.2 31.92 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.345 0.593 . . . . 2.2200000000000002 110.12 -178.065 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.58 -30.26 44.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.114 -0.948 . . . . 0.28999999999999998 110.573 -176.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.61 -8.59 84.34 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.862 -0.685 . . . . 0.56999999999999995 112.968 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -110.04 3.26 20.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.376 0.607 . . . . 0.85999999999999999 110.638 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 96.2 mt -72.81 156.49 38.85 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.272 0.558 . . . . 0.46000000000000002 111.05 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -92.76 -82.47 0.33 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.543 -0.753 . . . . 2.0099999999999998 112.854 -170.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.42 -88.36 0.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 1.0900000000000001 111.857 -174.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.1 mm? -114.0 169.23 9.16 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.13 0.49 . . . . 0.14999999999999999 110.892 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.618 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -121.57 168.26 14.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 107.037 -1.468 . . . . 0.25 107.037 167.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.401 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -138.49 127.27 3.72 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 119.687 -1.244 . . . . 0.37 112.414 -178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.544 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -90.86 136.08 33.31 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.259 -0.576 . . . . 0.28999999999999998 110.179 178.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 10.8 m120 49.67 49.69 19.59 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.15 -0.932 . . . . 1.8500000000000001 110.848 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 6.0 t -87.62 142.13 28.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.448 -0.796 . . . . 1.1200000000000001 110.523 -176.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.7 m -113.57 116.27 46.05 Favored Pre-proline 0 C--N 1.315 -0.894 0 CA-C-N 115.627 -0.715 . . . . 1.26 111.07 -175.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 23.3 Cg_exo -64.95 129.8 24.18 Favored 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 122.623 2.216 . . . . 0.60999999999999999 112.078 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -100.72 90.28 4.18 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.688 -0.486 . . . . 0.85999999999999999 109.688 177.783 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.9 t -87.01 -3.01 59.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.443 0.639 . . . . 1.3700000000000001 109.889 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.25 19.29 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 122.219 1.009 . . . . 1.6000000000000001 110.892 -176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 79' ' ' LEU . 47.7 mm -67.54 132.91 32.25 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.786 -1.097 . . . . 1.8500000000000001 110.543 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 159.14 -74.48 0.21 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.042 -0.823 . . . . 3.1800000000000002 111.042 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.0 t -84.61 61.34 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.556 0.693 . . . . 4.6900000000000004 109.208 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.47 171.59 30.66 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.391 -0.822 . . . . 4.3499999999999996 111.847 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.62 11.28 21.27 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.69 -0.766 . . . . 3.27 112.237 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -79.85 58.28 2.81 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.575 0.702 . . . . 5.4699999999999998 110.483 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -108.45 2.11 22.11 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.868 0.842 . . . . 4.7000000000000002 108.893 177.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.9 t -137.39 141.33 41.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.041 -0.982 . . . . 1.6599999999999999 110.395 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 50.9 m -112.96 -18.23 12.28 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.062 0.458 . . . . 1.6499999999999999 110.69 177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.548 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -86.1 -157.9 0.37 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.03 -0.532 . . . . 0.54000000000000004 110.08 176.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.83 134.13 35.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.718 -0.475 . . . . 0.78000000000000003 109.718 -177.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.69 117.85 34.59 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.284 0.564 . . . . 0.39000000000000001 111.216 -172.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.567 HG11 HG21 ' A' ' 44' ' ' THR . 6.7 m -131.78 165.48 31.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.616 -0.72 . . . . 0.22 110.942 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 37.6 t -110.58 120.75 43.44 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.419 -0.956 . . . . 0.70999999999999996 108.419 176.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 30.9 m -117.85 151.42 37.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.036 0.446 . . . . 0.60999999999999999 110.844 -170.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.6 t -78.92 -28.39 43.87 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.631 -0.713 . . . . 0.38 110.448 -172.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.432 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 13.5 m120 -153.57 163.45 39.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.921 -0.581 . . . . 0.78000000000000003 109.977 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.0 t -127.99 130.5 48.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.108 0.48 . . . . 0.41999999999999998 110.375 175.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.493 ' CB ' HG23 ' A' ' 105' ' ' VAL . 44.2 m-85 -119.48 142.21 48.48 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.749 -0.659 . . . . 0.77000000000000002 110.79 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.455 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 6.6 mm100 61.56 33.27 18.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.071 -0.513 . . . . 0.80000000000000004 111.824 175.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 63.21 6.58 2.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.044 0.538 . . . . 2.1200000000000001 112.181 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 139.28 -22.11 2.92 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 119.893 -1.146 . . . . 0.28000000000000003 113.425 176.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 13.7 mt -50.12 -40.85 47.39 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 117.475 0.638 . . . . 0.35999999999999999 110.547 -178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.493 HG23 ' CB ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -130.14 119.09 45.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.494 0.664 . . . . 0.85999999999999999 110.298 174.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.618 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 2.7 t30 -113.51 151.87 30.95 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.321 -0.992 . . . . 0.91000000000000003 108.321 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 10.5 m -135.55 152.16 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 113.048 0.758 . . . . 0.29999999999999999 113.048 -175.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.679 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 65.75 49.1 61.4 Favored Glycine 0 CA--C 1.506 -0.511 0 CA-C-N 115.154 -0.93 . . . . 0.20000000000000001 111.755 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 72.5 m -97.89 126.36 43.24 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.894 0.378 . . . . 0.42999999999999999 111.454 -172.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 20.0 p -120.23 126.05 26.99 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.703 -0.681 . . . . 0.29999999999999999 110.009 175.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.552 ' HA ' HG12 ' A' ' 94' ' ' VAL . 73.6 Cg_exo -49.61 109.87 0.32 Allowed 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 123.12 2.546 . . . . 0.34000000000000002 112.345 177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.4 tt -101.81 136.82 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.665 -0.698 . . . . 0.58999999999999997 110.789 -175.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -93.83 98.4 11.05 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.614 0.721 . . . . 2.3900000000000001 109.743 173.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 31' ' ' LYS . 2.9 pp -82.46 9.42 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.31 -0.859 . . . . 2.02 111.254 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 119.91 -16.48 10.19 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.854 -0.898 . . . . 2.6099999999999999 110.854 -173.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.606 HD12 ' O ' ' A' ' 116' ' ' LEU . 2.9 pp . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.567 -0.73 . . . . 3.6899999999999999 110.827 175.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 120.557 0.218 . . . . 30.309999999999999 111.188 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.25 40.93 0.85 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.873 0.323 . . . . 28.059999999999999 111.873 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.1 mpp? 55.71 39.38 30.82 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.188 -0.46 . . . . 28.52 111.936 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.71 -22.63 9.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.13 0.491 . . . . 26.559999999999999 110.557 175.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.74 -39.31 16.09 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.239 -0.652 . . . . 25.140000000000001 109.239 177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 37.2 pt -125.53 173.58 11.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.292 -0.867 . . . . 24.989999999999998 110.362 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -150.25 -175.77 22.67 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.375 -0.69 . . . . 22.920000000000002 111.375 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.6 m 57.03 52.71 8.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.238 0.542 . . . . 22.809999999999999 110.88 178.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.7 m -78.06 114.53 17.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.787 -0.642 . . . . 22.210000000000001 110.754 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -96.92 -24.07 16.02 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.96 -0.564 . . . . 20.949999999999999 110.832 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.0 m -88.83 115.92 64.86 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.165 0.507 . . . . 19.190000000000001 111.395 -178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.98 -20.33 11.7 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.545 2.163 . . . . 17.98 112.481 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -88.64 135.54 33.45 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.612 -0.514 . . . . 18.07 109.612 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -74.89 153.43 38.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.014 0.435 . . . . 14.66 110.892 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.6 t -102.93 21.8 2.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.872 0.844 . . . . 13.029999999999999 109.731 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.426 ' HB3' ' HB ' ' A' ' 28' ' ' THR . 54.0 m-80 -92.78 -55.16 3.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.605 -0.725 . . . . 12.26 109.984 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.35 60.84 7.29 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.858 -0.687 . . . . 9.9700000000000006 112.379 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.47 52.8 3.26 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.765 -0.731 . . . . 8.2200000000000006 113.124 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.715 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 8.9 t -80.41 145.84 60.39 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.677 -0.49 . . . . 7.2999999999999998 109.677 176.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 28' ' ' THR . 69.2 Cg_endo -99.12 81.68 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.707 2.938 . . . . 6.0999999999999996 113.402 173.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.715 ' HD3' ' O ' ' A' ' 28' ' ' THR . 5.3 Cg_exo -74.18 80.49 2.18 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.76 2.307 . . . . 5.1900000000000004 112.041 178.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -146.96 174.31 11.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.7 . . . . 3.79 110.621 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.48 ' HA ' ' CD1' ' A' ' 112' ' ' ILE . 45.7 m 70.29 -178.15 0.22 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.75 0.656 . . . . 1.74 111.248 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.7 m -76.96 131.65 38.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.298 -0.41 . . . . 1.7 110.737 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 p -78.71 -8.38 58.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.118 0.485 . . . . 2.5699999999999998 111.043 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.7 m -98.13 4.61 49.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.146 -0.479 . . . . 2.5 111.028 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 127.05 -131.57 7.29 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.334 -0.936 . . . . 1.51 113.332 176.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.48 153.61 17.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.643 2.896 . . . . 1.05 114.299 -177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 39' ' ' TYR . 97.5 t -96.0 169.13 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.275 -1.329 . . . . 0.58999999999999997 107.616 172.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.483 ' N ' HG12 ' A' ' 38' ' ' VAL . 77.1 m-85 -127.06 139.05 53.28 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 118.892 0.769 . . . . 0.78000000000000003 111.779 -177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 42.7 t -116.14 103.77 10.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.323 -0.853 . . . . 0.81999999999999995 110.292 -179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.6 m -106.01 135.95 46.54 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.253 -0.647 . . . . 0.23999999999999999 109.253 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.467 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 59.0 m-80 -59.32 -23.66 62.66 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.696 -0.684 . . . . 2.0800000000000001 110.622 177.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HD3' ' O ' ' A' ' 44' ' ' THR . 12.4 tmtt? -176.15 125.33 0.2 Allowed 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.739 -1.208 . . . . 2.5800000000000001 107.739 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.588 ' O ' ' HD3' ' A' ' 43' ' ' LYS . 34.1 p -89.64 152.55 21.32 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.43 -0.908 . . . . 0.37 111.538 175.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.601 ' HB3' HG22 ' A' ' 72' ' ' VAL . 14.8 tp10 -115.14 138.33 51.02 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.256 -0.883 . . . . 1.1200000000000001 109.15 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.459 ' HA ' HD12 ' A' ' 71' ' ' LEU . 17.6 m-20 -74.59 109.23 7.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.357 -0.383 . . . . 1.77 110.495 -175.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.475 ' HA ' HD21 ' A' ' 50' ' ' LEU . 6.3 m -50.76 -25.31 4.23 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.971 0.794 . . . . 0.92000000000000004 112.454 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.501 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 3.4 mptp? -64.83 -45.5 85.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.238 0.542 . . . . 2.77 111.012 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -133.45 58.07 1.78 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.548 -0.751 . . . . 2.3300000000000001 110.522 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.475 HD21 ' HA ' ' A' ' 47' ' ' SER . 80.5 mt -57.17 158.36 5.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.311 -0.859 . . . . 1.1599999999999999 112.812 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -73.66 154.97 39.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.505 -1.225 . . . . 1.8100000000000001 109.243 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -67.54 -32.99 74.15 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.066 -0.346 . . . . 3.23 110.066 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -67.01 -33.74 84.75 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.478 -0.649 . . . . 0.34000000000000002 111.478 178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.641 ' HA ' HD22 ' A' ' 57' ' ' LEU . 28.3 m -79.33 -44.29 21.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.35999999999999999 110.056 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 98.4 m -52.79 -35.37 56.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.485 -0.78 . . . . 0.29999999999999999 109.819 173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.528 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.76 -51.59 68.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.306 -0.861 . . . . 0.23000000000000001 112.013 176.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.641 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -61.84 -43.66 98.39 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.518 0.675 . . . . 0.23999999999999999 109.961 -178.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.2 mt -60.24 -44.25 95.4 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.933 -1.03 . . . . 0.17999999999999999 110.105 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.29 -38.08 89.15 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.775 -0.648 . . . . 0.26000000000000001 112.281 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 32.7 mt -57.11 -50.44 72.77 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.746 0.784 . . . . 0.34000000000000002 110.124 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.488 HD21 ' HG2' ' A' ' 101' ' ' GLN . 5.0 mt -84.02 -2.85 57.43 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.581 -1.19 . . . . 0.35999999999999999 111.501 -174.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 68.17 35.01 3.73 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.725 0.774 . . . . 1.8899999999999999 110.488 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 58' ' ' LEU . 55.8 mt -81.77 146.61 7.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.468 -0.787 . . . . 0.26000000000000001 110.008 176.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -95.98 117.92 31.59 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.265 0.555 . . . . 2.2200000000000002 110.198 -179.824 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.426 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -71.72 -29.98 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.297 -0.865 . . . . 0.28999999999999998 110.332 -176.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.22 -16.64 78.63 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.949 -0.569 . . . . 0.56999999999999995 112.679 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -91.67 -16.41 27.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.179 0.514 . . . . 0.85999999999999999 110.2 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 88.2 mt -59.37 137.86 57.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.64 -0.709 . . . . 0.46000000000000002 111.025 -178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 2.4 mptp? -94.07 -88.72 0.23 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.168 -0.923 . . . . 2.0099999999999998 111.808 -170.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.13 -96.2 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.888 0.329 . . . . 1.0900000000000001 111.888 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 44' ' ' THR . 1.8 mm? -111.24 170.83 7.85 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.475 0.655 . . . . 0.14999999999999999 111.363 178.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -125.14 169.9 15.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 107.065 -1.457 . . . . 0.25 107.065 166.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.418 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -138.69 131.43 5.33 Favored Glycine 0 C--N 1.311 -0.822 0 C-N-CA 119.653 -1.261 . . . . 0.37 112.159 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.603 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -95.31 136.21 35.96 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.354 -0.538 . . . . 0.28999999999999998 109.787 178.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.97 49.3 19.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.133 -0.94 . . . . 1.8500000000000001 110.662 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 11.6 t -90.68 144.52 25.66 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.521 -1.218 . . . . 1.1200000000000001 109.588 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 40' ' ' CYS . 13.5 p -106.29 118.63 54.3 Favored Pre-proline 0 C--N 1.311 -1.077 0 CA-C-N 116.507 -0.315 . . . . 1.26 111.252 -177.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.15 119.6 6.41 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.457 2.105 . . . . 0.60999999999999999 111.783 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.6 mt -90.16 87.56 6.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.661 -0.699 . . . . 0.85999999999999999 109.313 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.1 p -78.11 -43.52 28.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.934 -0.576 . . . . 1.3700000000000001 111.123 -176.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 5.0 m -93.16 96.78 6.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.985 0.898 . . . . 1.6000000000000001 110.784 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 29.5 mm -86.94 -65.18 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.896 -1.047 . . . . 1.8500000000000001 111.268 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.18 -136.5 13.3 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 110.952 -0.859 . . . . 3.1800000000000002 110.952 -172.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.6 p -95.12 -30.65 4.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.265 0.555 . . . . 4.6900000000000004 109.877 174.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -120.48 -59.57 0.24 Allowed Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.764 -0.653 . . . . 4.3499999999999996 111.988 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.78 -97.27 0.18 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.652 -0.785 . . . . 3.27 112.525 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.423 ' H ' HD13 ' A' ' 116' ' ' LEU . 4.6 t30 56.55 68.04 0.91 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.492 0.663 . . . . 5.4699999999999998 110.473 -178.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 27.6 t -151.88 15.49 0.65 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.515 -0.766 . . . . 4.7000000000000002 109.638 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 3.3 t -137.0 121.41 18.19 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.829 -0.623 . . . . 1.6599999999999999 111.24 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.9 m -107.88 22.33 16.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.899 -0.591 . . . . 1.6499999999999999 110.589 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.467 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -140.33 -158.24 0.84 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.054 -0.521 . . . . 0.54000000000000004 110.151 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.425 ' HB2' HE21 ' A' ' 92' ' ' GLN . 0.0 OUTLIER -82.46 124.59 30.21 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.444 0.64 . . . . 0.78000000000000003 110.366 -176.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.49 126.4 45.42 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.52 0.676 . . . . 0.39000000000000001 111.359 -170.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.599 HG12 ' HA ' ' A' ' 111' ' ' PRO . 5.0 m -134.0 165.85 30.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.228 -0.896 . . . . 0.22 110.69 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 46.0 t -112.87 120.95 43.23 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.541 -0.911 . . . . 0.70999999999999996 108.541 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 13.8 m -124.07 153.55 41.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.864 0.364 . . . . 0.60999999999999999 110.954 -169.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.2 t -83.5 -19.24 36.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.905 -0.589 . . . . 0.38 111.671 -172.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -166.93 169.02 13.47 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 122.554 0.342 . . . . 0.78000000000000003 110.424 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.3 t -145.9 143.53 29.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.869 -0.605 . . . . 0.41999999999999998 110.429 178.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.578 ' HB2' HG23 ' A' ' 105' ' ' VAL . 35.8 m-85 -135.04 160.21 39.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.074 -0.512 . . . . 0.77000000000000002 109.885 -178.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.488 ' HG2' HD21 ' A' ' 61' ' ' LEU . 8.5 mm100 61.14 25.18 15.22 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.347 -0.388 . . . . 0.80000000000000004 111.842 177.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 60.17 13.94 4.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.75 -0.659 . . . . 2.1200000000000001 112.306 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 145.68 -30.84 1.67 Allowed Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.146 -1.026 . . . . 0.28000000000000003 113.414 174.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 14.6 mt -49.23 -40.51 34.12 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.969 0.385 . . . . 0.35999999999999999 111.843 -175.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.578 HG23 ' HB2' ' A' ' 100' ' ' TYR . 3.7 m -131.07 136.23 58.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.546 0.689 . . . . 0.85999999999999999 110.664 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.499 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 32.0 t30 -132.76 141.98 48.79 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.271 -1.381 . . . . 0.91000000000000003 107.271 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 17.1 m -125.07 150.23 30.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 113.623 0.972 . . . . 0.29999999999999999 113.623 -170.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.659 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 63.54 51.7 52.13 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.726 -1.125 . . . . 0.20000000000000001 111.755 176.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 90.4 m -97.02 131.04 44.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.992 0.425 . . . . 0.42999999999999999 111.66 -173.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 p -123.37 126.56 25.84 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.529 -0.76 . . . . 0.29999999999999999 110.0 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.599 ' HA ' HG12 ' A' ' 94' ' ' VAL . 52.6 Cg_exo -52.31 116.59 2.93 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.8 2.333 . . . . 0.34000000000000002 112.462 179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.48 ' CD1' ' HA ' ' A' ' 32' ' ' SER . 7.2 tt -104.98 124.57 59.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.855 -0.612 . . . . 0.58999999999999997 110.549 -178.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.1 m-80 -96.23 98.55 10.4 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.14 -0.482 . . . . 2.3900000000000001 110.061 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.3 pp -95.62 -14.43 7.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.896 -0.593 . . . . 2.02 110.94 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.99 12.12 81.3 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.812 -0.631 . . . . 2.6099999999999999 113.648 173.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.423 HD13 ' H ' ' A' ' 87' ' ' ASN . 15.1 mt . . . . . 0 C--O 1.246 0.893 0 CA-C-O 118.531 -0.747 . . . . 3.6899999999999999 109.65 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 110.084 -0.339 . . . . 30.309999999999999 110.084 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 59.07 32.14 21.94 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.605 0.566 . . . . 28.059999999999999 111.547 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 89.5 mtp -113.93 -7.66 13.15 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.364 0.602 . . . . 28.52 109.74 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.56 170.26 16.24 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.247 -0.888 . . . . 26.559999999999999 109.489 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 59.29 34.21 22.87 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 123.303 0.377 . . . . 25.140000000000001 110.957 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 51.5 mt -92.97 -30.62 4.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.143 0.497 . . . . 24.989999999999998 109.861 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.82 24.25 10.07 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.805 -0.712 . . . . 22.920000000000002 112.325 177.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 t -79.13 -19.78 50.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.216 0.532 . . . . 22.809999999999999 110.435 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.8 m -123.99 -55.5 1.69 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.946 -0.57 . . . . 22.210000000000001 110.612 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -140.93 162.21 36.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.354 -0.384 . . . . 20.949999999999999 110.814 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 22' ' ' ARG . 7.6 p -172.43 131.1 0.66 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.988 -0.551 . . . . 19.190000000000001 110.023 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.39 20.02 0.43 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.884 2.389 . . . . 17.98 113.102 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.434 ' H ' HG22 ' A' ' 20' ' ' VAL . 80.7 mtp180 -139.41 86.78 2.14 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.966 -0.383 . . . . 18.07 109.966 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -83.91 161.63 20.77 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.092 -0.503 . . . . 14.66 111.173 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.2 t -116.92 126.16 74.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.771 -0.649 . . . . 13.029999999999999 109.625 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -73.74 -28.72 61.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.1 0.476 . . . . 12.26 110.616 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.17 31.65 5.24 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.677 -0.773 . . . . 9.9700000000000006 111.981 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 140.77 54.07 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.006 -0.616 . . . . 8.2200000000000006 111.648 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.595 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 85.0 m -153.89 133.2 7.23 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 120.919 0.39 . . . . 7.2999999999999998 111.287 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 28' ' ' THR . 37.4 Cg_endo -101.39 76.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.528 3.485 . . . . 6.0999999999999996 112.445 169.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.595 ' HD3' ' O ' ' A' ' 28' ' ' THR . 26.0 Cg_exo -61.87 83.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.829 2.353 . . . . 5.1900000000000004 113.06 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -105.97 -14.58 15.15 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.218 0.533 . . . . 3.79 109.924 176.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 p -80.87 -168.78 1.91 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.514 -0.766 . . . . 1.74 111.244 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 25.6 m -75.42 131.05 39.91 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.653 -0.499 . . . . 1.7 109.653 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.6 m -74.01 -17.9 60.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.016 0.436 . . . . 2.5699999999999998 110.692 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.3 m -83.96 -16.9 42.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.932 -0.576 . . . . 2.5 111.413 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 148.91 -138.21 6.78 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.305 -0.95 . . . . 1.51 113.39 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -55.02 154.38 22.27 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.704 2.936 . . . . 1.05 114.375 -176.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 39' ' ' TYR . 84.2 t -98.84 168.67 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.33 -1.305 . . . . 0.58999999999999997 107.801 172.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.486 ' N ' HG12 ' A' ' 38' ' ' VAL . 87.4 m-85 -127.99 132.25 49.18 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 118.68 0.673 . . . . 0.78000000000000003 111.211 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.825 ' SG ' ' HB2' ' A' ' 77' ' ' SER . 27.1 p -107.09 107.66 18.76 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.555 -0.748 . . . . 0.81999999999999995 110.025 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 85.6 m -98.66 137.38 37.36 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.445 -0.798 . . . . 0.23999999999999999 110.626 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -55.03 -27.67 46.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.781 0.801 . . . . 2.0800000000000001 109.356 172.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -169.56 137.4 1.78 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.306 -1.316 . . . . 2.5800000000000001 108.247 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.603 HG21 HG11 ' A' ' 94' ' ' VAL . 14.3 p -92.85 149.28 21.37 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.461 -0.896 . . . . 0.37 110.306 168.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.567 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.7 tp10 -112.35 134.32 53.96 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.528 -0.76 . . . . 1.1200000000000001 109.287 -176.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.497 ' HA ' HD12 ' A' ' 71' ' ' LEU . 4.7 m-20 -67.14 114.1 5.62 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.729 -0.669 . . . . 1.77 111.051 -174.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.768 ' HA ' HD21 ' A' ' 50' ' ' LEU . 68.5 m -60.14 -13.03 10.03 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.392 0.433 . . . . 0.92000000000000004 111.88 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HD3' ' N ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -79.29 -36.22 40.04 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.522 0.677 . . . . 2.77 109.95 177.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -140.4 66.08 1.39 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.039 -0.982 . . . . 2.3300000000000001 111.517 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.7 mm? -64.91 147.43 53.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.096 0.474 . . . . 1.1599999999999999 110.962 171.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.59 171.06 13.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.638 -0.71 . . . . 1.8100000000000001 110.221 176.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -61.24 -47.96 83.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.62 0.248 . . . . 3.23 111.088 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.64 -35.32 62.0 Favored Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.34000000000000002 112.708 -177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.602 ' HA ' HD22 ' A' ' 57' ' ' LEU . 11.2 m -81.8 -41.61 20.88 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.243 -0.28 . . . . 0.35999999999999999 110.243 178.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 99.2 m -53.81 -34.77 60.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.409 0.623 . . . . 0.29999999999999999 109.928 174.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.469 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.96 -53.76 54.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.063 -0.971 . . . . 0.23000000000000001 111.908 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.602 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -61.12 -46.19 91.58 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.547 0.689 . . . . 0.23999999999999999 109.973 -178.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 54' ' ' THR . 46.1 mt -58.64 -41.93 87.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.685 -1.143 . . . . 0.17999999999999999 109.848 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.92 -32.45 84.01 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.748 -0.66 . . . . 0.26000000000000001 112.704 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 22.1 mt -62.96 -50.55 70.34 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.666 0.746 . . . . 0.34000000000000002 109.811 177.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 mt -81.43 -0.75 42.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.517 -1.219 . . . . 0.35999999999999999 111.216 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.4 t30 68.61 38.18 2.35 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.324 -0.853 . . . . 1.8899999999999999 110.559 176.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 58' ' ' LEU . 49.3 mt -87.07 141.59 14.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.584 -0.735 . . . . 0.26000000000000001 109.746 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.65 118.6 31.6 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.532 0.682 . . . . 2.2200000000000002 110.179 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.437 HG23 HD23 ' A' ' 50' ' ' LEU . 1.8 mp -67.65 -36.99 77.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.818 -1.083 . . . . 0.28999999999999998 110.93 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.58 -14.91 70.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.97 -0.633 . . . . 0.56999999999999995 113.177 -177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -104.12 3.62 33.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.238 0.542 . . . . 0.85999999999999999 110.725 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 94.2 mt -71.47 144.27 49.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.052 0.453 . . . . 0.46000000000000002 110.853 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -94.85 -96.56 0.16 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.581 -0.736 . . . . 2.0099999999999998 112.542 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.59 -85.98 0.17 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.898 0.38 . . . . 1.0900000000000001 111.897 -172.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.3 mm? -120.13 165.14 15.15 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.529 0.681 . . . . 0.14999999999999999 111.063 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -119.9 167.56 13.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 106.017 -1.846 . . . . 0.25 106.017 167.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 105' ' ' VAL . . . -135.01 137.59 9.36 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.671 -1.252 . . . . 0.37 111.583 -178.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.664 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -109.85 129.49 55.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 117.49 0.645 . . . . 0.28999999999999998 110.765 178.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.5 ' ND2' HD22 ' A' ' 104' ' ' LEU . 0.4 OUTLIER 54.3 52.9 11.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.6 -1.182 . . . . 1.8500000000000001 111.487 176.646 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 6.6 m -92.0 154.06 19.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.252 -0.885 . . . . 1.1200000000000001 109.983 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.825 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 57.6 m -102.75 129.64 25.43 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 116.38 -0.373 . . . . 1.26 110.089 176.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 6.6 Cg_exo -74.09 119.64 5.93 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.601 2.201 . . . . 0.60999999999999999 112.276 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.751 HD21 ' SG ' ' A' ' 40' ' ' CYS . 9.8 mt -94.97 89.58 5.65 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.527 -0.76 . . . . 0.85999999999999999 108.952 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.6 p -80.58 -44.63 18.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.086 -0.506 . . . . 1.3700000000000001 111.775 -173.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 m -92.79 99.27 9.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.83 0.824 . . . . 1.6000000000000001 111.632 -176.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.0 mm -80.89 119.92 31.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.293 -0.867 . . . . 1.8500000000000001 110.539 -179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 139.33 -48.22 0.87 Allowed Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.26 -1.136 . . . . 3.1800000000000002 110.26 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.4 t -96.15 -46.63 13.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.184 -1.043 . . . . 4.6900000000000004 108.184 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -94.55 169.61 28.95 Favored Glycine 0 N--CA 1.442 -0.935 0 CA-C-N 115.083 -0.962 . . . . 4.3499999999999996 110.725 172.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.04 -28.67 7.06 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.633 -0.794 . . . . 3.27 111.682 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -62.92 -47.21 84.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.281 0.562 . . . . 5.4699999999999998 110.275 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.9 t -163.6 145.19 9.33 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.374 -0.83 . . . . 4.7000000000000002 109.345 178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 45.4 t -131.1 14.52 5.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.15 0.5 . . . . 1.6599999999999999 110.142 177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.5 m 59.09 16.57 4.86 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.577 -0.738 . . . . 1.6499999999999999 110.554 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -137.33 -168.19 2.26 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.568 -0.742 . . . . 0.54000000000000004 110.201 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.55 117.24 29.53 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.316 0.579 . . . . 0.78000000000000003 109.536 178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.85 122.49 33.61 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.817 -0.629 . . . . 0.39000000000000001 111.078 -173.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.603 HG11 HG21 ' A' ' 44' ' ' THR . 12.3 m -135.29 162.85 37.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.629 -0.714 . . . . 0.22 111.191 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 49.6 t -108.49 109.68 21.0 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.793 -0.817 . . . . 0.70999999999999996 108.793 176.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 39.5 m -102.01 148.19 25.66 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.242 -0.281 . . . . 0.60999999999999999 110.242 -176.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.0 t -81.46 -27.27 34.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.055 0.455 . . . . 0.38 110.501 -173.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.524 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 14.8 m120 -149.05 165.89 30.35 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.769 -0.65 . . . . 0.78000000000000003 109.374 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.2 t -136.73 139.87 42.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.118 -0.492 . . . . 0.41999999999999998 110.223 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.584 ' HB2' HG23 ' A' ' 105' ' ' VAL . 57.7 m-85 -128.07 147.88 50.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.922 -0.581 . . . . 0.77000000000000002 109.732 177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.461 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER 63.58 22.91 13.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.80000000000000004 111.208 178.143 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 67.49 9.99 7.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.921 -0.581 . . . . 2.1200000000000001 112.079 177.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.11 -22.12 2.1 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.333 -0.936 . . . . 0.28000000000000003 113.269 175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.664 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.8 mt -54.0 -35.78 62.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.877 0.338 . . . . 0.35999999999999999 111.574 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.584 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -144.14 119.6 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.253 0.549 . . . . 0.85999999999999999 111.042 174.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.4 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 90.6 m-20 -114.62 161.82 17.59 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.728 -0.669 . . . . 0.91000000000000003 109.785 177.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.9 m -130.73 156.89 42.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 111.896 0.332 . . . . 0.29999999999999999 111.896 -178.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 57.37 52.64 50.42 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.554 -0.748 . . . . 0.20000000000000001 111.929 178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.522 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 68.4 m -96.79 128.42 43.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.763 0.316 . . . . 0.42999999999999999 110.739 -176.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.1 p -123.02 127.36 25.72 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.93 -0.577 . . . . 0.29999999999999999 110.355 176.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.534 ' HA ' HG12 ' A' ' 94' ' ' VAL . 51.8 Cg_exo -53.58 115.33 2.25 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.129 2.552 . . . . 0.34000000000000002 112.934 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.4 tt -98.27 133.32 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.739 -0.664 . . . . 0.58999999999999997 110.064 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -108.16 113.69 27.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.195 0.521 . . . . 2.3900000000000001 110.865 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.491 HD13 ' HG ' ' A' ' 116' ' ' LEU . 1.1 pp -82.92 -22.82 8.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.155 -0.475 . . . . 2.02 111.152 176.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 70.02 6.59 57.14 Favored Glycine 0 C--N 1.331 0.289 0 CA-C-N 115.936 -0.574 . . . . 2.6099999999999999 113.762 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.491 ' HG ' HD13 ' A' ' 114' ' ' ILE . 3.4 pp . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.452 -0.785 . . . . 3.6899999999999999 109.94 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.606 ' HE2' ' SD ' ' A' ' 12' ' ' MET . 4.1 ttpm? . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.9 -0.407 . . . . 30.309999999999999 109.9 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.21 103.02 1.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 28.059999999999999 111.194 -177.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.606 ' SD ' ' HE2' ' A' ' 10' ' ' LYS . 24.1 ptm -147.56 -42.19 0.17 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.999 -0.546 . . . . 28.52 110.472 175.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.06 18.98 16.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.811 0.815 . . . . 26.559999999999999 109.015 174.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -145.76 25.89 1.29 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.219 -1.355 . . . . 25.140000000000001 109.553 -174.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.51 121.57 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.539 -0.755 . . . . 24.989999999999998 110.717 -175.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.0 -44.3 1.92 Allowed Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.877 -0.678 . . . . 22.920000000000002 111.528 -177.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.6 m 56.97 86.76 0.07 Allowed 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.922 0.489 . . . . 22.809999999999999 110.58 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 m -62.54 92.75 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.749 -0.66 . . . . 22.210000000000001 111.449 -175.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -157.94 57.44 0.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.882 -0.599 . . . . 20.949999999999999 110.091 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.3 t -77.83 114.95 46.15 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.637 -0.711 . . . . 19.190000000000001 110.817 -177.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.16 164.4 35.89 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.465 2.11 . . . . 17.98 112.028 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -144.69 156.05 43.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.559 -0.291 . . . . 18.07 110.575 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 65.84 20.24 11.39 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.713 0.633 . . . . 14.66 111.121 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 p -114.33 110.89 33.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.745 -0.661 . . . . 13.029999999999999 109.865 176.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -115.36 121.35 42.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.906 -0.588 . . . . 12.26 110.386 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.44 96.48 0.56 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.922 -0.656 . . . . 9.9700000000000006 111.891 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 122.94 37.7 0.6 Allowed Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.886 -0.673 . . . . 8.2200000000000006 112.459 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.637 HG22 ' HD2' ' A' ' 30' ' ' PRO . 19.7 m -76.54 134.03 70.11 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 109.388 -0.597 . . . . 7.2999999999999998 109.388 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.431 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 95.8 Cg_exo -41.47 -50.52 4.61 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.829 3.019 . . . . 6.0999999999999996 115.751 -174.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.637 ' HD2' HG22 ' A' ' 28' ' ' THR . 2.8 Cg_endo -79.32 -10.17 14.91 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 121.793 1.662 . . . . 5.1900000000000004 111.357 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.5 mttp 63.98 -78.99 0.03 OUTLIER 'General case' 0 C--O 1.233 0.192 0 CA-C-N 114.725 -1.125 . . . . 3.79 111.502 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.535 ' OG ' ' HA ' ' A' ' 37' ' ' PRO . 32.7 t -71.14 159.69 34.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.269 0.557 . . . . 1.74 111.282 -175.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 27.9 m -85.63 155.49 21.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.284 -0.871 . . . . 1.7 109.527 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.6 t -80.14 -39.17 29.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.414 -0.357 . . . . 2.5699999999999998 111.659 -174.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -71.72 -31.53 66.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.124 0.487 . . . . 2.5 110.449 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . -154.95 144.45 11.09 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.91 -0.876 . . . . 1.51 110.91 179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.535 ' HA ' ' OG ' ' A' ' 32' ' ' SER . 13.3 Cg_exo -71.1 -161.77 0.1 OUTLIER 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.414 2.076 . . . . 1.05 112.554 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 39' ' ' TYR . 49.1 t -88.86 161.0 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.791 0.329 . . . . 0.58999999999999997 110.228 -175.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.427 ' N ' HG12 ' A' ' 38' ' ' VAL . 70.2 m-85 -135.77 141.48 44.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.089 0.471 . . . . 0.78000000000000003 109.91 177.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.59 ' HB3' ' OG ' ' A' ' 77' ' ' SER . 16.4 t -107.0 107.86 19.08 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.166 -0.47 . . . . 0.81999999999999995 109.966 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.0 m -108.08 134.18 51.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.925 0.393 . . . . 0.23999999999999999 110.426 -176.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.475 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 4.8 m-20 -60.11 -20.23 57.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.598 -0.728 . . . . 2.0800000000000001 110.293 176.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.92 129.91 0.31 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.1 -1.074 . . . . 2.5800000000000001 108.1 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.533 HG21 HG11 ' A' ' 94' ' ' VAL . 18.4 p -87.42 152.86 21.9 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 119.174 -1.011 . . . . 0.37 111.09 172.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.464 ' HB3' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -115.16 142.43 46.67 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.238 -0.892 . . . . 1.1200000000000001 109.29 -174.595 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.474 ' HA ' HD12 ' A' ' 71' ' ' LEU . 10.2 m-20 -78.31 108.4 11.62 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.105 -0.498 . . . . 1.77 110.86 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.747 ' HA ' HD21 ' A' ' 50' ' ' LEU . 46.7 m -58.92 -12.49 4.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.064 0.765 . . . . 0.92000000000000004 113.064 -176.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -81.18 -32.84 33.38 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.967 -0.293 . . . . 2.77 110.343 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -147.29 67.11 1.14 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.328 -0.396 . . . . 2.3300000000000001 110.75 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.747 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.9 mm? -59.42 153.63 18.75 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.462 0.648 . . . . 1.1599999999999999 111.495 175.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -66.86 150.67 48.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.916 -1.038 . . . . 1.8100000000000001 109.388 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.732 ' HD2' ' H ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -55.58 -36.4 66.84 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 123.01 0.194 . . . . 3.23 111.12 176.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -63.58 -40.66 98.91 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.793 -0.718 . . . . 0.34000000000000002 111.778 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.646 ' HA ' HD22 ' A' ' 57' ' ' LEU . 24.5 m -78.53 -42.84 28.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.853 0.359 . . . . 0.35999999999999999 110.229 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.5 m -52.04 -36.59 50.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.571 -0.741 . . . . 0.29999999999999999 109.957 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.503 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.06 -54.41 47.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.264 -0.88 . . . . 0.23000000000000001 111.817 176.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.646 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -59.18 -45.02 92.14 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.385 0.612 . . . . 0.23999999999999999 110.216 -177.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 54' ' ' THR . 48.5 mt -58.54 -42.33 87.6 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.905 -1.043 . . . . 0.17999999999999999 110.132 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.37 -37.05 93.98 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.712 -0.756 . . . . 0.26000000000000001 112.068 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 15.1 mt -63.03 -40.32 97.39 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.651 0.739 . . . . 0.34000000000000002 110.194 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.461 ' CD1' HG21 ' A' ' 105' ' ' VAL . 5.6 mt -90.5 4.19 51.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.86 -1.064 . . . . 0.35999999999999999 111.417 -176.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.9 m120 70.41 26.68 4.12 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.461 -0.79 . . . . 1.8899999999999999 111.264 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 58' ' ' LEU . 52.8 mt -81.48 145.86 8.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 116.02 -0.536 . . . . 0.26000000000000001 110.485 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.641 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.2 OUTLIER -97.01 117.7 31.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.599 -0.728 . . . . 2.2200000000000002 109.987 -178.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.409 HG23 HD23 ' A' ' 50' ' ' LEU . 1.8 mp -75.69 -42.8 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.645 -0.707 . . . . 0.28999999999999998 111.449 -174.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.34 -8.63 71.14 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 121.017 -0.611 . . . . 0.56999999999999995 112.838 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.486 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 29.5 t70 -104.02 -9.31 18.91 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.974 0.416 . . . . 0.85999999999999999 110.497 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.517 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 94.8 mt -60.92 140.1 57.83 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.03 -0.532 . . . . 0.46000000000000002 110.657 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -88.89 -62.02 1.58 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.325 -0.852 . . . . 2.0099999999999998 113.085 -169.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -117.77 -95.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.379 0.511 . . . . 1.0900000000000001 112.379 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.1 mm? -117.77 165.78 13.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.544 0.688 . . . . 0.14999999999999999 111.391 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.524 HG13 HD11 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -119.86 173.4 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 106.776 -1.565 . . . . 0.25 106.776 169.169 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.545 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -141.41 148.66 20.35 Favored Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 119.844 -1.17 . . . . 0.37 111.533 178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.57 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -110.76 133.52 53.27 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.879 -0.415 . . . . 0.28999999999999998 109.879 174.732 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.8 m120 53.34 50.47 17.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.992 -1.004 . . . . 1.8500000000000001 111.188 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.545 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 60.6 m -86.93 143.01 27.58 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.07 -0.513 . . . . 1.1200000000000001 110.705 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.59 ' OG ' ' HB3' ' A' ' 40' ' ' CYS . 7.0 p -97.15 114.61 64.99 Favored Pre-proline 0 C--N 1.316 -0.865 0 CA-C-N 116.104 -0.498 . . . . 1.26 109.789 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.26 120.53 8.14 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.44 2.093 . . . . 0.60999999999999999 112.357 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 40' ' ' CYS . 35.0 mt -99.29 87.31 3.61 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.964 -0.754 . . . . 0.85999999999999999 108.964 177.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.0 m -78.47 -18.51 54.76 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.885 -0.598 . . . . 1.3700000000000001 110.944 -174.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.51 ' O ' ' HA2' ' A' ' 86' ' ' GLY . 4.0 m -129.27 113.36 27.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.914 -0.585 . . . . 1.6000000000000001 111.389 -175.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.7 mm -109.15 128.23 65.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.984 -0.553 . . . . 1.8500000000000001 111.069 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 143.06 -136.69 7.2 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.679 -0.772 . . . . 3.1800000000000002 112.058 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 45.6 t -71.91 -34.16 50.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.143 0.497 . . . . 4.6900000000000004 110.397 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -105.89 49.52 0.88 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.757 -0.735 . . . . 4.3499999999999996 112.287 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 81' ' ' VAL . . . -76.1 147.72 35.16 Favored Glycine 0 C--N 1.329 0.19 0 C-N-CA 121.069 -0.586 . . . . 3.27 112.249 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -91.38 35.3 0.93 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.057 0.392 . . . . 5.4699999999999998 112.057 -175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.6 p 61.79 122.93 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.507 1.299 . . . . 4.7000000000000002 114.507 170.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 4.3 t -130.99 125.41 33.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.014 -0.994 . . . . 1.6599999999999999 109.523 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.4 p -121.01 10.78 10.86 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.899 0.38 . . . . 1.6499999999999999 111.204 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -126.19 -159.2 0.9 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.108 -0.496 . . . . 0.54000000000000004 110.408 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.57 130.09 38.92 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.235 0.54 . . . . 0.78000000000000003 109.769 -178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.406 HG22 ' CG1' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -105.79 119.11 38.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.319 0.581 . . . . 0.39000000000000001 111.448 -171.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 111' ' ' PRO . 5.2 m -130.99 163.86 35.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.577 -0.738 . . . . 0.22 110.573 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.5 t -109.6 120.34 42.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.575 -0.898 . . . . 0.70999999999999996 108.575 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.71 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 17.9 m -121.57 148.51 44.42 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.053 0.454 . . . . 0.60999999999999999 110.98 -169.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.4 t -78.29 -29.53 47.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.632 -0.713 . . . . 0.38 110.891 -172.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.419 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 17.0 m120 -157.0 158.74 37.11 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.91 -0.404 . . . . 0.78000000000000003 109.91 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.8 t -132.61 149.2 52.34 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.388 -0.597 . . . . 0.41999999999999998 109.388 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.608 ' HB2' HG23 ' A' ' 105' ' ' VAL . 81.6 m-85 -131.29 154.0 48.97 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.287 -0.634 . . . . 0.77000000000000002 109.287 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.656 ' NE2' HD12 ' A' ' 104' ' ' LEU . 8.7 mm100 63.63 27.11 14.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.81 0.338 . . . . 0.80000000000000004 110.878 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 65.48 6.53 3.79 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.594 -0.73 . . . . 2.1200000000000001 112.465 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 140.64 -19.64 2.77 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.207 -0.997 . . . . 0.28000000000000003 113.211 174.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.656 HD12 ' NE2' ' A' ' 101' ' ' GLN . 20.7 mt -47.91 -39.6 19.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 117.006 0.403 . . . . 0.35999999999999999 110.919 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.608 HG23 ' HB2' ' A' ' 100' ' ' TYR . 4.5 m -130.38 149.93 34.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 109.209 -0.663 . . . . 0.85999999999999999 109.209 171.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.494 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 31.5 t30 -144.05 147.82 34.34 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.154 -1.054 . . . . 0.91000000000000003 108.154 -173.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.447 ' O ' ' HB3' ' A' ' 96' ' ' CYS . 9.2 m -131.59 153.52 38.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 113.415 0.895 . . . . 0.29999999999999999 113.415 -174.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.71 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 62.02 51.72 54.99 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 114.784 -1.098 . . . . 0.20000000000000001 111.985 176.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 83.9 m -97.82 127.76 43.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.978 0.418 . . . . 0.42999999999999999 111.919 -175.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.3 p -119.78 127.83 26.19 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.806 -0.634 . . . . 0.29999999999999999 110.226 173.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.573 ' HA ' HG12 ' A' ' 94' ' ' VAL . 54.0 Cg_exo -51.29 113.23 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.049 2.5 . . . . 0.34000000000000002 112.563 177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 8.5 tt -110.26 144.43 18.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.44 -0.8 . . . . 0.58999999999999997 110.414 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -110.02 99.23 8.36 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.173 0.511 . . . . 2.3900000000000001 109.693 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.443 HD13 ' H ' ' A' ' 116' ' ' LEU . 1.1 pp -95.55 -18.3 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.625 -0.716 . . . . 2.02 112.524 -174.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.49 8.43 83.21 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.672 -0.775 . . . . 2.6099999999999999 113.44 177.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.443 ' H ' HD13 ' A' ' 114' ' ' ILE . 6.7 mp . . . . . 0 C--O 1.245 0.858 0 CA-C-O 118.166 -0.921 . . . . 3.6899999999999999 109.416 176.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.3 pttp . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.467 0.175 . . . . 30.309999999999999 111.323 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.75 -51.65 11.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.337 . . . . 28.059999999999999 110.611 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 67.0 mtt -136.63 102.4 4.91 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.206 -0.452 . . . . 28.52 110.068 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.27 -43.17 82.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.969 0.414 . . . . 26.559999999999999 110.594 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -159.35 151.85 21.39 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.564 -0.532 . . . . 25.140000000000001 109.564 175.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.6 pt -102.77 11.58 7.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.329 0.585 . . . . 24.989999999999998 110.403 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.25 103.72 0.5 Allowed Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.407 -0.815 . . . . 22.920000000000002 111.616 -177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.1 m -81.09 63.98 5.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.496 0.665 . . . . 22.809999999999999 110.252 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 t -90.73 -21.19 21.71 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.285 -0.87 . . . . 22.210000000000001 111.089 -177.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.28 -47.06 2.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.412 -0.358 . . . . 20.949999999999999 111.106 -178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.5 m -72.46 127.06 90.6 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.912 0.387 . . . . 19.190000000000001 111.109 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.7 79.12 2.84 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.795 2.33 . . . . 17.98 111.608 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? 60.54 78.69 0.27 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.722 -0.672 . . . . 18.07 110.578 -175.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -75.31 -21.67 58.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.064 -0.516 . . . . 14.66 110.241 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.1 p -81.1 87.02 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.888 0.851 . . . . 13.029999999999999 109.717 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -95.67 -55.85 2.88 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.435 -0.802 . . . . 12.26 110.357 -175.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.93 -33.21 83.23 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.73 -0.747 . . . . 9.9700000000000006 112.317 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.36 -67.43 2.83 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.958 -0.639 . . . . 8.2200000000000006 111.586 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.605 HG22 ' HD2' ' A' ' 30' ' ' PRO . 17.4 m -98.94 115.84 65.58 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 109.701 -0.481 . . . . 7.2999999999999998 109.701 176.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -42.27 -55.01 2.74 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.434 2.756 . . . . 6.0999999999999996 113.797 -173.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' A' ' 28' ' ' THR . 92.9 Cg_endo -82.57 133.41 7.12 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.801 1.667 . . . . 5.1900000000000004 111.51 172.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.46 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 13.0 mptt -88.56 -169.45 2.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.291 -0.413 . . . . 3.79 111.023 -177.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.8 p 68.66 166.17 0.26 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.255 1.022 . . . . 1.74 111.161 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 62.0 m -84.43 130.9 34.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.056 -0.52 . . . . 1.7 111.17 -175.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.9 m -87.53 -6.44 58.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.413 0.625 . . . . 2.5699999999999998 109.647 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.5 p -81.57 -8.92 59.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.373 -0.831 . . . . 2.5 110.742 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 134.81 -143.96 15.79 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 111.13 -0.788 . . . . 1.51 111.13 -177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.79 155.26 23.01 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.973 2.448 . . . . 1.05 113.556 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 39' ' ' TYR . 86.7 t -88.46 164.96 2.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 107.397 -1.334 . . . . 0.58999999999999997 107.397 171.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.445 ' CD2' ' HB2' ' A' ' 96' ' ' CYS . 90.3 m-85 -129.09 134.41 48.07 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.518 -0.873 . . . . 0.78000000000000003 111.952 -177.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 76' ' ' CYS . 31.9 t -105.46 103.47 13.0 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.857 -1.065 . . . . 0.81999999999999995 109.905 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.0 m -100.62 132.39 46.04 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.316 0.579 . . . . 0.23999999999999999 110.48 -174.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.489 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 5.8 m-20 -57.6 -24.56 57.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.997 -1.001 . . . . 2.0800000000000001 110.508 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.86 119.33 0.35 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.266 -1.013 . . . . 2.5800000000000001 108.266 179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.683 HG21 HG11 ' A' ' 94' ' ' VAL . 15.2 p -80.27 150.81 29.87 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 118.765 -1.174 . . . . 0.37 110.832 174.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.626 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.2 tp10 -119.87 138.32 53.47 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.44 -0.8 . . . . 1.1200000000000001 109.322 -176.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.551 ' HA ' HD12 ' A' ' 71' ' ' LEU . 26.5 m-20 -69.75 114.34 7.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.039 -0.528 . . . . 1.77 110.987 -173.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.733 ' HA ' HD21 ' A' ' 50' ' ' LEU . 49.5 m -61.03 -9.43 4.38 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.115 -0.493 . . . . 0.92000000000000004 111.831 178.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -90.19 -16.28 29.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.563 -0.29 . . . . 2.77 110.642 177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 39.1 m-70 -154.15 57.85 0.72 Allowed 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.513 -0.312 . . . . 2.3300000000000001 111.542 -176.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.733 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.4 mm? -60.79 149.33 36.14 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.456 0.646 . . . . 1.1599999999999999 112.064 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.53 145.52 52.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.011 -0.995 . . . . 1.8100000000000001 108.401 172.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.65 -20.33 66.23 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.779 -0.368 . . . . 3.23 110.742 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -73.24 -33.56 58.95 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.079 -0.808 . . . . 0.34000000000000002 111.079 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.639 ' HA ' HD22 ' A' ' 57' ' ' LEU . 43.3 m -79.97 -41.56 25.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.725 0.298 . . . . 0.35999999999999999 110.377 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 92.6 m -53.05 -35.2 59.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.338 0.59 . . . . 0.29999999999999999 109.777 172.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.49 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -55.59 -54.66 41.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.259 -0.882 . . . . 0.23000000000000001 111.611 175.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.639 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -60.22 -44.02 95.53 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.373 0.606 . . . . 0.23999999999999999 110.214 -178.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 54' ' ' THR . 53.3 mt -58.6 -45.06 89.95 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.988 -1.006 . . . . 0.17999999999999999 109.82 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.27 -36.59 91.26 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.833 -0.622 . . . . 0.26000000000000001 112.744 176.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 18.6 mt -59.71 -47.81 84.15 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.712 0.768 . . . . 0.34000000000000002 110.283 178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.516 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.1 mt -86.12 -1.34 57.32 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.72 -1.127 . . . . 0.35999999999999999 111.115 -177.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 66.17 36.54 5.51 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 115.256 -0.884 . . . . 1.8899999999999999 111.056 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 58' ' ' LEU . 54.8 mt -80.15 143.28 12.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.661 -0.699 . . . . 0.26000000000000001 109.474 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.634 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -94.18 117.87 30.73 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.462 0.649 . . . . 2.2200000000000002 110.002 -177.378 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.39 -34.08 56.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.957 -1.019 . . . . 0.28999999999999998 110.679 -175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.73 -16.88 72.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.017 -0.611 . . . . 0.56999999999999995 112.741 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.483 ' HB3' ' HG2' ' A' ' 64' ' ' LYS . 29.8 t70 -94.5 -15.76 23.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.76 0.314 . . . . 0.85999999999999999 110.659 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 94.1 mt -55.12 129.59 38.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.394 0.616 . . . . 0.46000000000000002 110.984 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 3.3 mptp? -88.07 -86.82 0.16 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.987 -1.006 . . . . 2.0099999999999998 112.262 -170.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -90.74 -94.92 0.12 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.827 -0.624 . . . . 1.0900000000000001 111.466 -171.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.551 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.2 mm? -113.6 167.62 10.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.088 -0.505 . . . . 0.14999999999999999 110.134 172.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -118.32 166.66 12.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 106.378 -1.712 . . . . 0.25 106.378 167.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.39 138.07 9.43 Favored Glycine 0 N--CA 1.439 -1.112 0 C-N-CA 119.524 -1.322 . . . . 0.37 112.247 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.587 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -102.66 132.44 48.78 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 120.011 -0.676 . . . . 0.28999999999999998 109.64 173.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.453 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 1.5 t-20 59.0 57.96 3.35 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.804 -1.089 . . . . 1.8500000000000001 110.813 175.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 40' ' ' CYS . 29.4 m -94.72 139.23 31.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.531 -0.759 . . . . 1.1200000000000001 111.002 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 32.0 t -94.27 120.82 64.9 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.87 -0.604 . . . . 1.26 109.825 177.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 12.6 Cg_exo -70.86 120.4 7.04 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.816 2.344 . . . . 0.60999999999999999 112.632 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.5 mt -105.09 89.08 3.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.51 -0.768 . . . . 0.85999999999999999 109.336 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.3 t -80.8 -29.35 36.05 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.023 0.439 . . . . 1.3700000000000001 110.651 -176.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.2 m -106.65 102.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.48 0.657 . . . . 1.6000000000000001 111.221 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.7 mm -99.23 143.24 13.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.565 -0.743 . . . . 1.8500000000000001 110.911 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.4 -66.15 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.78 -0.724 . . . . 3.1800000000000002 112.052 175.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 19.1 m -92.43 46.4 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.366 0.603 . . . . 4.6900000000000004 110.708 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 78.34 -125.77 7.3 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.635 -0.712 . . . . 4.3499999999999996 112.04 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -85.22 65.06 4.09 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.943 -0.646 . . . . 3.27 112.254 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -77.08 148.51 36.06 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.105 -0.331 . . . . 5.4699999999999998 110.105 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.2 m 60.83 29.46 19.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.328 0.585 . . . . 4.7000000000000002 110.116 -173.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 11.6 t -140.15 101.88 4.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.577 -0.738 . . . . 1.6599999999999999 110.795 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.8 m -102.64 8.58 39.64 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.573 0.701 . . . . 1.6499999999999999 110.01 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -116.17 -158.97 0.7 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.24 -0.891 . . . . 0.54000000000000004 110.001 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.48 122.94 28.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.097 0.475 . . . . 0.78000000000000003 110.289 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.24 122.72 35.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.321 0.581 . . . . 0.39000000000000001 111.034 -175.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.683 HG11 HG21 ' A' ' 44' ' ' THR . 9.0 m -132.02 161.85 40.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.444 -0.798 . . . . 0.22 110.968 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 37.1 t -108.19 109.63 21.07 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.92 -0.77 . . . . 0.70999999999999996 108.92 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 14.3 m -110.14 153.56 24.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.229 -0.442 . . . . 0.60999999999999999 110.416 -173.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.7 t -80.7 -26.9 37.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.938 -0.574 . . . . 0.38 110.495 -175.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.448 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 3.6 m120 -155.15 166.21 34.3 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.965 -0.561 . . . . 0.78000000000000003 109.565 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.431 ' HB ' ' CE1' ' A' ' 39' ' ' TYR . 15.3 t -129.97 143.45 50.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.075 0.464 . . . . 0.41999999999999998 110.026 174.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.535 ' CB ' HG23 ' A' ' 105' ' ' VAL . 42.0 m-85 -126.12 141.65 51.85 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.79 -0.641 . . . . 0.77000000000000002 110.05 -178.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 101' ' ' GLN . 6.4 mm100 62.06 25.36 15.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.872 0.368 . . . . 0.80000000000000004 110.939 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 62.09 11.56 4.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.424 -0.807 . . . . 2.1200000000000001 112.318 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 149.33 -29.07 1.21 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.891 -1.147 . . . . 0.28000000000000003 113.73 174.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.587 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 15.5 mt -54.92 -35.3 64.03 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 117.391 0.596 . . . . 0.35999999999999999 111.394 -175.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.535 HG23 ' CB ' ' A' ' 100' ' ' TYR . 0.4 OUTLIER -132.69 143.89 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.809 -0.632 . . . . 0.85999999999999999 109.774 173.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.626 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 1.0 OUTLIER -139.39 157.75 45.32 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.41 -0.589 . . . . 0.91000000000000003 109.41 -174.314 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.448 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 13.9 m -136.61 144.61 32.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.879 0.696 . . . . 0.29999999999999999 112.879 -174.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 61.07 51.63 57.26 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 114.949 -1.023 . . . . 0.20000000000000001 112.05 176.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 73.0 m -97.5 131.12 44.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.611 0.243 . . . . 0.42999999999999999 111.381 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.24 130.65 24.08 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.325 -0.398 . . . . 0.29999999999999999 110.305 173.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.527 ' HA ' HG12 ' A' ' 94' ' ' VAL . 54.2 Cg_exo -52.6 109.5 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.79 2.327 . . . . 0.34000000000000002 111.78 177.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.1 tt -88.08 119.2 35.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.796 -0.638 . . . . 0.58999999999999997 111.365 -174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -108.89 116.65 32.4 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.286 -0.87 . . . . 2.3900000000000001 109.625 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.508 HD13 ' HG ' ' A' ' 116' ' ' LEU . 1.1 pp -64.59 -21.48 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.045 0.387 . . . . 2.02 112.045 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 66.78 16.84 66.48 Favored Glycine 0 C--N 1.331 0.266 0 CA-C-N 116.288 -0.415 . . . . 2.6099999999999999 113.642 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.508 ' HG ' HD13 ' A' ' 114' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.88 -0.581 . . . . 3.6899999999999999 110.574 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.498 -0.556 . . . . 30.309999999999999 109.498 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -18.74 65.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.411 0.523 . . . . 28.059999999999999 112.411 -173.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.6 mtt -73.85 -12.17 60.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.849 0.357 . . . . 28.52 111.057 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.94 97.47 3.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.455 . . . . 26.559999999999999 109.863 177.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 35.0 t70 70.39 112.78 0.05 Allowed 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.828 0.705 . . . . 25.140000000000001 110.416 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 50.2 mm -66.0 102.96 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.905 -0.589 . . . . 24.989999999999998 110.394 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.76 -7.26 88.64 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.998 -0.62 . . . . 22.920000000000002 112.102 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.6 t 65.69 37.33 5.86 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.284 0.564 . . . . 22.809999999999999 110.551 177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.8 p -77.04 -20.3 56.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.864 -0.607 . . . . 22.210000000000001 111.125 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 72.9 -49.49 0.7 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.724 0.81 . . . . 20.949999999999999 111.857 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.18 149.21 56.84 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.576 -0.284 . . . . 19.190000000000001 110.528 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -84.9 38.13 0.65 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.89 2.393 . . . . 17.98 111.966 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 52.3 mtm-85 -134.62 109.53 8.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.841 -0.618 . . . . 18.07 110.047 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -96.01 86.29 4.26 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.085 -0.507 . . . . 14.66 110.086 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 28.8 m -92.42 133.22 34.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.021 -0.536 . . . . 13.029999999999999 110.196 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -154.43 112.62 3.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.349 -0.387 . . . . 12.26 110.479 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -54.48 135.8 44.6 Favored Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 116.053 -0.521 . . . . 9.9700000000000006 112.484 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.28 -62.96 4.04 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.723 -0.751 . . . . 8.2200000000000006 111.614 -176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.586 HG22 ' HD2' ' A' ' 30' ' ' PRO . 7.0 m 68.22 120.52 0.03 OUTLIER Pre-proline 0 CA--C 1.537 0.453 0 CA-C-O 121.692 0.758 . . . . 7.2999999999999998 111.374 178.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 27.4 Cg_exo -54.72 -53.27 6.35 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.925 3.084 . . . . 6.0999999999999996 114.077 -179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 28' ' ' THR . 61.8 Cg_endo -72.61 88.35 0.9 Allowed 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 121.657 1.571 . . . . 5.1900000000000004 112.248 176.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -90.69 84.02 5.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.968 -0.56 . . . . 3.79 110.305 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.5 p -169.84 177.76 4.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.848 -0.615 . . . . 1.74 110.524 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 99.5 m -85.15 149.87 25.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.013 0.435 . . . . 1.7 110.928 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.1 t -67.54 -25.87 66.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.915 -0.584 . . . . 2.5699999999999998 110.458 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 m -81.19 -5.81 58.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.414 . . . . 2.5 110.783 176.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.24 -95.48 0.83 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.977 -0.63 . . . . 1.51 112.587 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.83 151.66 15.01 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.246 2.63 . . . . 1.05 114.063 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 39' ' ' TYR . 98.5 t -94.53 174.63 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.401 -1.272 . . . . 0.58999999999999997 107.833 174.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.545 ' N ' HG12 ' A' ' 38' ' ' VAL . 62.8 m-85 -131.05 136.1 48.16 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.424 -0.798 . . . . 0.78000000000000003 111.459 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 26.8 t -111.62 109.96 20.12 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.417 -0.81 . . . . 0.81999999999999995 109.67 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.4 m -107.98 133.73 51.88 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.219 -0.446 . . . . 0.23999999999999999 110.293 -176.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.43 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 53.8 m-80 -55.94 -28.4 56.75 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.395 -0.821 . . . . 2.0800000000000001 110.057 175.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.3 tptp -164.24 133.46 3.79 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.01 -0.995 . . . . 2.5800000000000001 108.87 176.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.633 HG21 HG11 ' A' ' 94' ' ' VAL . 24.2 p -93.04 142.84 26.85 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.156 -1.018 . . . . 0.37 110.902 168.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.574 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.1 tp10 -112.53 138.0 49.93 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.115 -0.948 . . . . 1.1200000000000001 109.59 -175.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.471 ' HA ' HD12 ' A' ' 71' ' ' LEU . 5.3 m-20 -74.46 107.96 6.93 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.336 -0.393 . . . . 1.77 110.666 -175.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.433 ' HA ' HD21 ' A' ' 50' ' ' LEU . 86.8 p -54.69 -23.02 15.67 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.898 -0.592 . . . . 0.92000000000000004 112.473 -175.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -73.78 -33.31 64.19 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.046 -0.262 . . . . 2.77 110.951 -177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -134.45 58.14 1.78 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.813 0.815 . . . . 2.3300000000000001 111.409 178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 47' ' ' SER . 89.4 mt -65.05 157.73 27.61 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.782 -1.099 . . . . 1.1599999999999999 111.517 177.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -75.66 154.68 36.39 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.947 -1.024 . . . . 1.8100000000000001 108.675 174.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -65.71 -26.58 67.82 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.587 -0.445 . . . . 3.23 109.971 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -65.07 -38.17 95.05 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.47 -0.652 . . . . 0.34000000000000002 111.47 174.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.635 ' HA ' HD22 ' A' ' 57' ' ' LEU . 27.9 m -76.72 -43.76 36.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.899 0.38 . . . . 0.35999999999999999 110.653 176.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 91.3 m -53.01 -34.43 56.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.651 -0.704 . . . . 0.29999999999999999 109.937 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.486 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.81 -54.11 50.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.839 -1.073 . . . . 0.23000000000000001 111.794 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -59.33 -44.14 92.64 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.434 0.635 . . . . 0.23999999999999999 110.136 -177.247 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 54' ' ' THR . 36.1 mt -60.14 -42.83 95.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.898 -1.046 . . . . 0.17999999999999999 110.116 178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.16 -33.41 84.12 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.742 -0.663 . . . . 0.26000000000000001 112.508 175.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.9 mt -64.12 -29.51 70.63 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.748 0.785 . . . . 0.34000000000000002 110.497 178.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.438 ' CD1' HG21 ' A' ' 105' ' ' VAL . 6.0 mt -102.98 -0.78 30.4 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.68 -1.146 . . . . 0.35999999999999999 110.668 -177.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 68.26 31.64 5.09 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 114.993 -1.003 . . . . 1.8899999999999999 111.071 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 58' ' ' LEU . 54.8 mt -80.08 148.68 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.811 -0.632 . . . . 0.26000000000000001 110.551 177.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.615 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -97.21 118.64 34.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.293 0.568 . . . . 2.2200000000000002 110.177 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 65' ' ' ILE . 1.8 mp -73.51 -38.57 52.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 0.28999999999999998 111.2 -174.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -65.85 -22.5 70.29 Favored Glycine 0 CA--C 1.516 0.151 0 C-N-CA 120.989 -0.624 . . . . 0.56999999999999995 112.683 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -91.29 -4.94 55.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.189 0.519 . . . . 0.85999999999999999 110.709 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.13 138.59 55.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.293 0.568 . . . . 0.46000000000000002 110.733 179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -89.52 -86.07 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.044 -0.98 . . . . 2.0099999999999998 112.289 -171.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.63 -102.35 0.15 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.293 0.479 . . . . 1.0900000000000001 112.293 -173.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.9 mm? -105.82 170.1 8.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.577 0.703 . . . . 0.14999999999999999 111.15 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' A' ' 45' ' ' GLU . 0.7 OUTLIER -122.89 170.53 13.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 106.724 -1.584 . . . . 0.25 106.724 167.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.495 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -136.78 142.75 13.93 Favored Glycine 0 N--CA 1.437 -1.242 0 C-N-CA 119.838 -1.172 . . . . 0.37 111.567 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.549 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -106.42 129.28 54.43 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.14 -0.624 . . . . 0.28999999999999998 110.02 174.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.22 55.39 6.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.0 -1.0 . . . . 1.8500000000000001 111.198 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.495 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 58.7 m -88.62 144.0 26.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.628 -0.715 . . . . 1.1200000000000001 111.071 -178.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.3 m -100.52 118.82 60.27 Favored Pre-proline 0 C--N 1.318 -0.796 0 CA-C-N 115.733 -0.667 . . . . 1.26 109.969 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.24 124.64 12.38 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.547 2.165 . . . . 0.60999999999999999 111.85 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.2 mt -99.42 88.29 3.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.938 -0.573 . . . . 0.85999999999999999 109.865 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.1 m -75.17 -40.04 59.83 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.876 -0.602 . . . . 1.3700000000000001 110.225 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.6 m -93.98 117.0 36.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.364 -0.835 . . . . 1.6000000000000001 110.676 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 42.4 mm -92.9 142.73 12.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.928 -0.578 . . . . 1.8500000000000001 110.938 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 171.48 112.0 0.27 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.439 -0.664 . . . . 3.1800000000000002 111.439 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t 56.54 49.69 0.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 121.797 0.808 . . . . 4.6900000000000004 109.317 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.19 -61.71 4.43 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.356 -0.838 . . . . 4.3499999999999996 111.793 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.19 101.72 0.16 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 121.001 -0.619 . . . . 3.27 112.063 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -64.15 -27.68 69.24 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.968 0.413 . . . . 5.4699999999999998 110.803 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.6 p -81.25 6.12 15.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.911 -0.586 . . . . 4.7000000000000002 111.264 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 41.2 t -112.44 129.7 56.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.389 -0.369 . . . . 1.6599999999999999 110.427 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.8 t -134.54 28.29 3.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.032 -0.729 . . . . 1.6499999999999999 109.032 177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -149.25 -157.71 0.84 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.941 -1.027 . . . . 0.54000000000000004 109.73 -177.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.15 126.06 30.34 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.028 0.442 . . . . 0.78000000000000003 110.359 -177.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.19 123.1 44.79 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.265 0.555 . . . . 0.39000000000000001 111.299 -171.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.633 HG11 HG21 ' A' ' 44' ' ' THR . 1.5 m -136.44 173.32 13.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.653 -0.703 . . . . 0.22 111.426 -178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 53.8 t -124.37 118.47 26.79 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.566 -0.743 . . . . 0.70999999999999996 109.964 177.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 1.2 m -103.41 168.49 9.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.355 0.598 . . . . 0.60999999999999999 111.921 -175.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.486 HG22 ' O ' ' A' ' 107' ' ' VAL . 9.0 t -87.04 -29.83 21.64 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.378 -0.828 . . . . 0.38 109.738 175.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.441 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.2 m120 -151.84 162.76 40.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.68 -0.691 . . . . 0.78000000000000003 109.913 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 t -127.64 129.02 46.5 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.329 0.585 . . . . 0.41999999999999998 109.87 175.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.506 ' CB ' HG23 ' A' ' 105' ' ' VAL . 30.0 m-85 -120.51 144.87 47.8 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.681 -0.69 . . . . 0.77000000000000002 111.414 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.643 ' NE2' HD12 ' A' ' 104' ' ' LEU . 7.1 mm100 60.84 34.49 19.66 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.802 -0.635 . . . . 0.80000000000000004 111.159 176.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 65.4 -0.86 1.07 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.756 -0.656 . . . . 2.1200000000000001 112.415 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 144.46 -20.25 2.05 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.512 -0.851 . . . . 0.28000000000000003 112.454 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.643 HD12 ' NE2' ' A' ' 101' ' ' GLN . 28.5 mt -49.77 -40.89 42.84 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.725 0.298 . . . . 0.35999999999999999 111.085 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.506 HG23 ' CB ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -130.15 119.3 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.547 0.689 . . . . 0.85999999999999999 110.489 174.077 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.485 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 2.8 t30 -111.21 144.18 40.78 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.348 -0.982 . . . . 0.91000000000000003 108.348 177.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.486 ' O ' HG22 ' A' ' 97' ' ' THR . 5.9 m -127.13 137.75 56.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 113.113 0.782 . . . . 0.29999999999999999 113.113 -174.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 70.9 51.44 19.16 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.999 -1.001 . . . . 0.20000000000000001 111.975 176.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 1.5 m -97.06 131.83 43.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.346 0.593 . . . . 0.42999999999999999 111.502 -177.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 23.8 p -116.65 141.42 28.08 Favored Pre-proline 0 C--N 1.316 -0.849 0 CA-C-N 115.058 -0.974 . . . . 0.29999999999999999 109.594 174.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.428 ' HA ' HG12 ' A' ' 94' ' ' VAL . 24.5 Cg_exo -67.42 108.38 1.58 Allowed 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.717 2.278 . . . . 0.34000000000000002 111.803 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 3.4 tt -85.1 100.34 8.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.371 -0.831 . . . . 0.58999999999999997 110.466 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -95.65 99.87 11.67 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.553 -0.749 . . . . 2.3900000000000001 110.494 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -76.29 -10.75 13.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.61 -0.723 . . . . 2.02 111.81 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.69 17.0 80.0 Favored Glycine 0 C--O 1.228 -0.248 0 C-N-CA 121.217 -0.516 . . . . 2.6099999999999999 112.141 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.457 ' H ' HD13 ' A' ' 114' ' ' ILE . 7.3 tp . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.827 -0.606 . . . . 3.6899999999999999 109.742 -176.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.4 tptp . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.78 0.324 . . . . 30.309999999999999 110.327 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -89.5 81.05 6.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.907 0.384 . . . . 28.059999999999999 110.397 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.38 125.78 27.9 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.025 -0.534 . . . . 28.52 110.235 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.21 136.2 41.59 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.786 -0.643 . . . . 26.559999999999999 109.983 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -85.55 66.0 9.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.181 0.515 . . . . 25.140000000000001 110.563 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 63.0 mt -95.23 103.89 15.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.73 -0.668 . . . . 24.989999999999998 109.472 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.63 23.21 4.26 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.463 -0.875 . . . . 22.920000000000002 112.497 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.1 m -57.05 132.36 52.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.762 0.315 . . . . 22.809999999999999 111.037 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.6 m -78.86 84.06 4.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.191 0.519 . . . . 22.210000000000001 109.91 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.81 62.29 7.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.821 -0.627 . . . . 20.949999999999999 111.193 -175.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.5 p -155.56 126.96 3.67 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.877 -0.601 . . . . 19.190000000000001 110.432 177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.91 55.48 4.44 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.816 2.344 . . . . 17.98 112.072 177.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -80.54 -18.14 49.35 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.744 -0.662 . . . . 18.07 110.395 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -127.06 86.58 2.52 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.603 -0.726 . . . . 14.66 109.185 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.85 138.56 31.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.992 -0.549 . . . . 13.029999999999999 110.586 -175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -121.69 75.09 1.17 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.074 -0.512 . . . . 12.26 110.032 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 82.13 -59.02 4.93 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.737 -0.744 . . . . 9.9700000000000006 111.661 -177.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.3 151.99 17.93 Favored Glycine 0 N--CA 1.445 -0.742 0 N-CA-C 111.594 -0.602 . . . . 8.2200000000000006 111.594 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.54 HG22 ' HD2' ' A' ' 30' ' ' PRO . 2.5 m -66.42 131.38 94.22 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-O 119.668 -0.206 . . . . 7.2999999999999998 110.57 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.418 ' HB2' ' HD3' ' A' ' 30' ' ' PRO . 82.2 Cg_exo -42.19 -51.89 4.53 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.318 2.679 . . . . 6.0999999999999996 114.475 -176.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.54 ' HD2' HG22 ' A' ' 28' ' ' THR . 6.2 Cg_endo -88.33 16.3 1.9 Allowed 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 122.726 2.284 . . . . 5.1900000000000004 111.545 -176.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp 71.33 -59.92 0.53 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.185 -0.916 . . . . 3.79 110.363 -175.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.8 p -77.46 165.28 24.58 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.196 -0.456 . . . . 1.74 110.394 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 17.1 m -79.19 156.8 28.04 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.029 -0.532 . . . . 1.7 110.951 -174.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -89.8 -11.72 41.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.299 0.571 . . . . 2.5699999999999998 110.465 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.1 p -104.45 5.0 33.84 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.797 -0.638 . . . . 2.5 110.79 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . 159.61 175.29 30.41 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.173 -0.771 . . . . 1.51 111.173 -178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' CB ' ' HA ' ' A' ' 80' ' ' SER . 13.4 Cg_exo -72.35 -165.12 0.2 Allowed 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.381 2.054 . . . . 1.05 112.296 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 39' ' ' TYR . 92.1 t -86.77 161.45 2.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 110.306 -0.257 . . . . 0.58999999999999997 110.306 -174.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.424 ' N ' HG12 ' A' ' 38' ' ' VAL . 29.3 m-85 -127.96 135.69 50.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.135 0.493 . . . . 0.78000000000000003 110.701 178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.446 ' HB2' HD11 ' A' ' 79' ' ' LEU . 17.7 t -103.43 107.53 18.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.942 -0.572 . . . . 0.81999999999999995 109.721 177.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 64.3 m -102.46 130.79 49.37 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 109.804 -0.443 . . . . 0.23999999999999999 109.804 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.512 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 18.3 m120 -57.54 -29.72 64.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.583 -0.735 . . . . 2.0800000000000001 109.749 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 8.3 mmmm -162.86 132.23 4.23 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.443 -1.253 . . . . 2.5800000000000001 108.013 175.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.5 HG21 HG11 ' A' ' 94' ' ' VAL . 28.1 p -88.86 167.21 13.43 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.36 -0.936 . . . . 0.37 110.101 169.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.481 ' HB3' HG22 ' A' ' 72' ' ' VAL . 9.6 tp10 -126.49 139.07 53.51 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.504 -0.771 . . . . 1.1200000000000001 109.424 -178.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.415 ' HA ' HD12 ' A' ' 71' ' ' LEU . 11.1 m-20 -71.26 111.66 6.78 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.057 -0.52 . . . . 1.77 110.519 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.591 ' HA ' HD21 ' A' ' 50' ' ' LEU . 6.1 m -60.15 -10.45 4.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.803 -0.635 . . . . 0.92000000000000004 112.603 -177.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -90.02 -17.56 27.61 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 120.669 -0.412 . . . . 2.77 110.338 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -149.53 57.92 1.0 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.328 -0.397 . . . . 2.3300000000000001 111.136 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.0 mm? -60.26 150.7 29.46 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.267 0.556 . . . . 1.1599999999999999 111.679 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.91 146.35 54.82 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.079 -1.082 . . . . 1.8100000000000001 108.079 170.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -60.4 -28.13 68.0 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.499 -0.481 . . . . 3.23 110.463 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . -66.7 -35.95 90.56 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.866 -0.683 . . . . 0.34000000000000002 111.417 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.658 ' HA ' HD22 ' A' ' 57' ' ' LEU . 22.7 m -79.06 -42.94 25.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.35999999999999999 110.411 177.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.2 m -53.94 -33.69 57.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.325 0.583 . . . . 0.29999999999999999 110.126 173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.567 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.31 -53.81 53.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.167 -0.924 . . . . 0.23000000000000001 111.285 175.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.658 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -60.69 -44.25 96.76 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.441 0.639 . . . . 0.23999999999999999 110.013 -179.129 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 54' ' ' THR . 53.0 mt -59.35 -43.22 92.82 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.001 -0.999 . . . . 0.17999999999999999 110.145 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.62 -36.97 92.67 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.906 -0.664 . . . . 0.26000000000000001 112.439 175.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 27.2 mt -60.24 -46.78 88.62 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.878 0.847 . . . . 0.34000000000000002 109.903 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 8.9 mt -85.71 2.75 44.13 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.364 -1.289 . . . . 0.35999999999999999 111.405 -175.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 65.5 35.35 7.32 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.486 -0.779 . . . . 1.8899999999999999 111.534 175.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' A' ' 58' ' ' LEU . 48.2 mt -88.0 147.25 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 115.551 -0.75 . . . . 0.26000000000000001 110.043 177.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.536 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -100.41 117.67 35.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.319 0.581 . . . . 2.2200000000000002 110.369 -178.427 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.73 -41.99 70.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.313 -0.858 . . . . 0.28999999999999998 111.449 -174.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.58 -7.15 68.19 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.857 -0.687 . . . . 0.56999999999999995 112.991 -176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.49 ' HB3' ' CG ' ' A' ' 64' ' ' LYS . 21.0 t70 -103.81 -16.76 15.31 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.85999999999999999 110.712 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.552 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 95.4 mt -55.5 147.81 16.89 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.881 -0.6 . . . . 0.46000000000000002 111.626 -177.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -95.32 -85.89 0.31 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.159 -0.928 . . . . 2.0099999999999998 112.026 -172.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -93.27 -101.56 0.13 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.873 0.324 . . . . 1.0900000000000001 111.873 -174.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 109' ' ' CYS . 1.5 mm? -110.52 169.3 8.84 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.403 0.621 . . . . 0.14999999999999999 111.216 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.49 HG13 HD11 ' A' ' 50' ' ' LEU . 1.5 m -121.07 163.72 18.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 106.058 -1.83 . . . . 0.25 106.058 166.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -133.57 142.18 13.65 Favored Glycine 0 N--CA 1.437 -1.235 0 C-N-CA 119.818 -1.182 . . . . 0.37 111.38 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.618 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -115.4 135.17 54.4 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.049 -0.661 . . . . 0.28999999999999998 110.4 178.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.521 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 1.4 t-20 54.79 47.54 22.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.522 -1.217 . . . . 1.8500000000000001 110.904 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 24.5 m -85.41 150.06 24.99 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.177 -0.92 . . . . 1.1200000000000001 110.554 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.0 m -100.42 117.18 63.44 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.623 -0.717 . . . . 1.26 109.75 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -64.78 130.68 26.85 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.646 2.23 . . . . 0.60999999999999999 112.293 179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 40' ' ' CYS . 33.8 mt -106.86 87.82 2.6 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.509 -0.769 . . . . 0.85999999999999999 109.371 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.409 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 11.9 p -79.8 -24.1 41.65 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.02 -0.536 . . . . 1.3700000000000001 111.45 -173.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.483 HG23 ' HA3' ' A' ' 85' ' ' GLY . 11.3 m -114.89 106.92 21.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.598 0.713 . . . . 1.6000000000000001 111.3 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 48.1 mm -79.73 141.7 14.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.595 -0.73 . . . . 1.8500000000000001 110.545 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 109.26 -119.38 5.51 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.773 -0.727 . . . . 3.1800000000000002 111.698 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.0 m -59.57 -38.3 74.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.831 0.348 . . . . 4.6900000000000004 111.399 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.483 ' HA3' HG23 ' A' ' 81' ' ' VAL . . . -80.43 -9.35 86.6 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.767 -0.73 . . . . 4.3499999999999996 112.451 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -77.27 -15.05 81.91 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.886 -0.674 . . . . 3.27 112.115 -178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -70.48 -8.76 53.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.939 0.4 . . . . 5.4699999999999998 110.929 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.7 p -68.49 -22.84 64.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 4.7000000000000002 110.553 177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 29.1 t -77.1 122.79 25.47 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 1.6599999999999999 110.082 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.3 t -127.06 24.52 6.37 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.001 -0.74 . . . . 1.6499999999999999 109.001 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -132.85 -158.3 0.88 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.339 -0.846 . . . . 0.54000000000000004 110.408 -177.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.98 112.88 18.79 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.772 0.796 . . . . 0.78000000000000003 110.03 -177.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.86 121.11 32.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.215 -0.902 . . . . 0.39000000000000001 110.447 -174.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 111' ' ' PRO . 13.6 m -133.15 162.81 39.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.458 0.646 . . . . 0.22 112.129 -179.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 37.6 t -112.24 114.02 26.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.92 -1.036 . . . . 0.70999999999999996 109.156 175.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.3 m -108.48 146.67 32.81 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.442 -0.344 . . . . 0.60999999999999999 110.318 -174.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.9 t -76.45 -26.77 55.77 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.279 -0.419 . . . . 0.38 110.668 -173.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.609 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.2 m120 -147.03 155.05 41.92 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.131 -0.692 . . . . 0.78000000000000003 109.131 177.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.2 t -132.58 132.82 42.94 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.122 0.487 . . . . 0.41999999999999998 110.42 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -130.7 156.72 44.46 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.832 -0.622 . . . . 0.77000000000000002 110.48 -178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.65 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 12.8 mm100 60.34 28.96 18.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.79 -0.641 . . . . 0.80000000000000004 111.992 174.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.1 m-70 66.37 -1.02 1.33 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.217 0.607 . . . . 2.1200000000000001 112.535 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 142.64 -14.97 2.45 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.441 -0.885 . . . . 0.28000000000000003 112.161 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.65 ' HG ' ' O ' ' A' ' 101' ' ' GLN . 40.8 mt -54.19 -36.89 63.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.994 0.426 . . . . 0.35999999999999999 110.562 178.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.9 t -139.3 121.54 16.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.359 -0.837 . . . . 0.85999999999999999 110.549 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.448 ' O ' ' HB ' ' A' ' 72' ' ' VAL . 95.0 m-20 -124.08 160.4 27.81 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.641 -0.708 . . . . 0.91000000000000003 109.227 174.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.609 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 5.5 m -134.97 151.51 31.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 111.833 0.309 . . . . 0.29999999999999999 111.833 -176.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.48 54.66 35.31 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.597 -0.729 . . . . 0.20000000000000001 111.439 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 76.4 m -97.2 125.88 42.02 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.72 0.295 . . . . 0.42999999999999999 111.29 -175.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.8 p -118.28 125.65 27.74 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.169 -0.469 . . . . 0.29999999999999999 110.395 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' A' ' 94' ' ' VAL . 68.3 Cg_exo -51.59 109.96 0.38 Allowed 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.255 2.637 . . . . 0.34000000000000002 112.953 178.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.5 tt -103.25 139.84 23.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.632 -0.713 . . . . 0.58999999999999997 110.271 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 -103.2 110.6 22.62 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.923 -0.399 . . . . 2.3900000000000001 109.923 175.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.2 pp -77.12 -13.16 14.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.984 -0.553 . . . . 2.02 112.385 -175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.65 19.72 79.29 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.894 -0.669 . . . . 2.6099999999999999 113.165 175.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 21.8 mt . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.894 -0.574 . . . . 3.6899999999999999 109.709 176.546 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.2 mttp . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.643 0.259 . . . . 30.309999999999999 110.324 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.2 34.47 5.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.072 0.463 . . . . 28.059999999999999 110.305 178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 28.2 ttt -75.35 -47.28 28.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.005 -0.543 . . . . 28.52 110.103 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.43 21.04 0.99 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.077 -0.51 . . . . 26.559999999999999 110.899 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.06 -34.8 78.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.762 -0.654 . . . . 25.140000000000001 111.328 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 15' ' ' ILE . 3.0 mp -70.53 -29.32 38.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.778 -0.646 . . . . 24.989999999999998 110.603 -178.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.91 -66.87 0.66 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.958 -0.857 . . . . 22.920000000000002 110.958 -175.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -92.88 46.01 1.21 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.046 -0.353 . . . . 22.809999999999999 110.046 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.5 m -64.54 111.85 2.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 22.210000000000001 110.824 -178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -158.35 163.66 37.09 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.807 -0.633 . . . . 20.949999999999999 109.647 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.0 m -119.73 76.98 20.91 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 121.095 0.474 . . . . 19.190000000000001 110.979 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.69 107.23 2.42 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.702 2.268 . . . . 17.98 111.758 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -83.12 69.59 9.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.394 0.616 . . . . 18.07 109.537 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -154.37 137.78 15.85 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.472 -0.786 . . . . 14.66 109.796 -178.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.78 126.38 59.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.44 -0.345 . . . . 13.029999999999999 110.251 -178.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -82.31 -31.52 29.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.219 -0.446 . . . . 12.26 110.069 178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 160.36 -138.08 5.35 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.697 -0.763 . . . . 9.9700000000000006 112.526 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.3 42.89 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.459 -0.657 . . . . 8.2200000000000006 111.459 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.586 ' C ' ' HD3' ' A' ' 30' ' ' PRO . 86.6 m -157.18 140.72 11.31 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 110.041 -0.355 . . . . 7.2999999999999998 110.041 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 28' ' ' THR . 43.4 Cg_endo -102.5 73.3 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.845 3.03 . . . . 6.0999999999999996 113.71 171.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.586 ' HD3' ' C ' ' A' ' 28' ' ' THR . 17.3 Cg_exo -67.38 -18.31 49.71 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.228 1.952 . . . . 5.1900000000000004 112.148 175.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -138.65 130.95 28.56 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.927 -0.578 . . . . 3.79 110.533 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.3 p -165.51 178.0 7.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.224 -0.444 . . . . 1.74 110.163 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 59.1 m -106.04 119.62 39.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.087 0.47 . . . . 1.7 111.42 -174.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 t -71.98 -26.15 62.13 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.245 0.545 . . . . 2.5699999999999998 109.962 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.9 p -72.56 -13.9 61.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.549 -0.75 . . . . 2.5 111.691 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . 165.81 158.32 10.72 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.685 -0.769 . . . . 1.51 112.478 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.524 ' HB3' ' HA ' ' A' ' 80' ' ' SER . 1.1 Cg_endo -47.41 153.77 1.82 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.836 3.024 . . . . 1.05 113.235 175.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.9 t -85.5 157.19 3.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.256 -1.016 . . . . 0.58999999999999997 108.256 174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -128.91 131.21 47.55 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.384 0.611 . . . . 0.78000000000000003 110.823 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.422 ' HB2' HD11 ' A' ' 79' ' ' LEU . 14.4 t -99.43 107.17 19.32 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.382 -0.826 . . . . 0.81999999999999995 109.692 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.4 m -104.34 129.64 52.22 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.012 -0.54 . . . . 0.23999999999999999 109.819 -176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.497 ' HA ' ' HB1' ' A' ' 91' ' ' ALA . 18.4 m120 -55.46 -25.59 37.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.473 -0.785 . . . . 2.0800000000000001 110.42 176.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 42' ' ' ASN . 1.8 mmmm -168.85 124.72 0.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.243 -1.344 . . . . 2.5800000000000001 108.223 176.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.594 HG21 HG11 ' A' ' 94' ' ' VAL . 16.8 p -79.61 157.51 27.29 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.493 -0.883 . . . . 0.37 110.713 171.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.57 ' HB3' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -116.34 146.21 42.62 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.268 -0.878 . . . . 1.1200000000000001 108.957 -176.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -81.06 108.74 14.99 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.227 -0.442 . . . . 1.77 111.115 -173.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.753 ' HA ' HD21 ' A' ' 50' ' ' LEU . 27.5 m -57.68 -12.3 2.81 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 113.084 0.772 . . . . 0.92000000000000004 113.084 -177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -90.32 -25.56 20.43 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.882 -0.327 . . . . 2.77 110.644 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -145.92 60.54 1.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.503 -0.317 . . . . 2.3300000000000001 111.299 -178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.753 HD21 ' HA ' ' A' ' 47' ' ' SER . 2.9 mm? -60.7 147.26 42.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.763 0.792 . . . . 1.1599999999999999 111.784 178.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -68.02 153.11 44.42 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.235 -1.348 . . . . 1.8100000000000001 109.814 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.576 ' HD3' ' N ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -62.86 -26.6 68.85 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.056 -0.258 . . . . 3.23 111.18 178.538 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.576 ' N ' ' HD3' ' A' ' 52' ' ' LYS . . . -69.51 -37.41 78.41 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.489 -0.863 . . . . 0.34000000000000002 111.332 177.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.624 ' HA ' HD22 ' A' ' 57' ' ' LEU . 26.1 m -80.98 -43.3 19.88 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.919 -0.4 . . . . 0.35999999999999999 109.919 178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.418 ' HA ' HD12 ' A' ' 58' ' ' LEU . 96.9 m -52.88 -34.8 56.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.539 -0.755 . . . . 0.29999999999999999 110.233 173.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.548 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.34 -51.99 66.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.435 -0.802 . . . . 0.23000000000000001 111.34 176.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.624 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -61.55 -44.77 96.44 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.407 0.623 . . . . 0.23999999999999999 109.893 -179.62 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 54' ' ' THR . 58.5 mt -58.0 -45.12 87.36 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.867 -1.061 . . . . 0.17999999999999999 110.162 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.06 -37.06 92.2 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.793 -0.64 . . . . 0.26000000000000001 112.471 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 17.6 mt -60.19 -47.38 86.19 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.502 0.668 . . . . 0.34000000000000002 110.303 178.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.467 HD21 ' HG2' ' A' ' 101' ' ' GLN . 2.9 mt -84.56 -2.33 57.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.857 -1.065 . . . . 0.35999999999999999 111.343 -176.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 69.76 37.75 1.79 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.939 0.876 . . . . 1.8899999999999999 110.664 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.495 HD12 ' HA ' ' A' ' 58' ' ' LEU . 56.1 mt -85.25 145.82 7.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.713 -0.676 . . . . 0.26000000000000001 110.173 175.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.669 ' HD3' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -96.34 117.89 31.76 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.68 -0.691 . . . . 2.2200000000000002 109.937 -178.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.439 HG23 HD23 ' A' ' 50' ' ' LEU . 1.8 mp -73.34 -40.18 56.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.509 -0.769 . . . . 0.28999999999999998 111.049 -174.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -69.83 -9.87 63.42 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.976 -0.63 . . . . 0.56999999999999995 113.055 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -109.15 4.61 23.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.493 . . . . 0.85999999999999999 110.903 -179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 47' ' ' SER . 98.3 mt -74.53 142.89 44.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.336 -0.393 . . . . 0.46000000000000002 110.437 178.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -96.42 -94.64 0.2 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.683 0.623 . . . . 2.0099999999999998 112.683 -171.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -79.75 -99.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.17 0.433 . . . . 1.0900000000000001 112.17 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -115.26 164.26 14.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.468 0.652 . . . . 0.14999999999999999 110.928 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 106' ' ' ASN . 0.7 OUTLIER -115.4 172.16 4.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 106.162 -1.792 . . . . 0.25 106.162 168.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.463 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -140.82 138.8 9.16 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.933 -1.127 . . . . 0.37 111.113 -178.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -111.41 132.22 54.61 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 119.532 -0.867 . . . . 0.28999999999999998 110.499 176.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.515 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 2.1 t-20 58.23 46.57 15.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.49 -1.232 . . . . 1.8500000000000001 110.747 175.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 35.4 m -83.72 142.11 30.95 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.524 -0.762 . . . . 1.1200000000000001 111.096 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.0 t -88.27 116.38 66.06 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.568 -0.742 . . . . 1.26 109.375 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -68.15 122.2 9.25 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.792 2.328 . . . . 0.60999999999999999 112.876 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 40' ' ' CYS . 11.9 mt -107.59 88.52 2.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.434 -0.803 . . . . 0.85999999999999999 109.21 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.524 ' HA ' ' HB3' ' A' ' 37' ' ' PRO . 58.0 p -98.37 -50.54 4.28 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.606 -0.27 . . . . 1.3700000000000001 110.745 -177.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 m -95.27 101.39 12.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.523 0.678 . . . . 1.6000000000000001 110.515 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.408 ' CG2' ' HB3' ' A' ' 29' ' ' PRO . 13.2 mt -116.76 139.81 41.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.859 -0.609 . . . . 1.8500000000000001 111.047 -176.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -164.49 -115.71 0.34 Allowed Glycine 0 N--CA 1.441 -1.025 0 N-CA-C 111.179 -0.768 . . . . 3.1800000000000002 111.179 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.5 t -72.89 -30.92 34.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.358 0.599 . . . . 4.6900000000000004 109.416 175.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -106.72 -93.94 2.33 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.279 -0.873 . . . . 4.3499999999999996 111.309 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.82 56.49 2.6 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.757 -0.735 . . . . 3.27 112.156 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.8 m120 64.67 -170.63 0.19 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.898 0.38 . . . . 5.4699999999999998 110.595 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 51.0 m -121.52 74.51 1.12 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.4 -0.363 . . . . 4.7000000000000002 110.363 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.518 ' SG ' HG23 ' A' ' 93' ' ' THR . 22.2 t -77.91 93.54 4.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.229 0.538 . . . . 1.6599999999999999 110.445 178.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 m -103.57 23.99 11.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.897 -0.592 . . . . 1.6499999999999999 109.897 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.497 ' HB1' ' HA ' ' A' ' 42' ' ' ASN . . . -134.97 -159.12 0.93 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.668 -0.696 . . . . 0.54000000000000004 110.802 -177.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.79 120.22 23.76 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 121.289 0.566 . . . . 0.78000000000000003 110.428 -176.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.518 HG23 ' SG ' ' A' ' 89' ' ' CYS . 0.2 OUTLIER -94.37 117.21 29.78 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.9 -0.591 . . . . 0.39000000000000001 110.892 -175.043 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.594 HG11 HG21 ' A' ' 44' ' ' THR . 2.9 m -129.29 164.35 32.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.736 -0.666 . . . . 0.22 111.583 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 109' ' ' CYS . 49.3 t -118.32 110.95 18.12 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.376 -0.829 . . . . 0.70999999999999996 109.461 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 106' ' ' ASN . 1.3 m -92.34 166.16 12.72 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.309 0.576 . . . . 0.60999999999999999 111.483 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.9 t -90.95 -24.23 20.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.346 -0.843 . . . . 0.38 109.406 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.414 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 14.3 m120 -156.68 166.86 32.18 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.346 -0.843 . . . . 0.78000000000000003 109.183 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.6 t -138.99 143.19 38.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.991 0.424 . . . . 0.41999999999999998 110.403 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.453 ' HB2' HG23 ' A' ' 105' ' ' VAL . 83.8 m-85 -126.78 149.48 49.63 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.048 -0.524 . . . . 0.77000000000000002 109.609 176.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.467 ' HG2' HD21 ' A' ' 61' ' ' LEU . 8.1 mm100 64.67 24.62 12.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 0.80000000000000004 111.361 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 64.4 6.04 2.89 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.602 -0.726 . . . . 2.1200000000000001 112.357 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 148.15 -20.14 1.39 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.905 -1.14 . . . . 0.28000000000000003 113.552 176.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 17.1 mt -56.45 -37.3 70.07 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 117.619 0.71 . . . . 0.35999999999999999 111.419 -177.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.453 HG23 ' HB2' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -142.79 118.87 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.58 0.705 . . . . 0.85999999999999999 110.938 175.489 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.728 ' HB3' ' SG ' ' A' ' 96' ' ' CYS . 7.4 m-20 -115.37 162.33 17.28 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.234 -0.894 . . . . 0.91000000000000003 109.528 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.0 m -133.64 142.46 41.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 112.549 0.574 . . . . 0.29999999999999999 112.549 -175.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 66.78 53.09 29.35 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.094 -0.957 . . . . 0.20000000000000001 112.254 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 95' ' ' CYS . 1.3 m -96.65 129.83 43.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.394 0.616 . . . . 0.42999999999999999 111.568 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.0 p -118.45 124.99 28.12 Favored Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 114.774 -1.103 . . . . 0.29999999999999999 109.743 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HA ' HG12 ' A' ' 94' ' ' VAL . 84.9 Cg_exo -47.91 112.28 0.55 Allowed 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.405 2.737 . . . . 0.34000000000000002 113.012 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 5.2 tt -115.69 134.69 58.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.54 -0.755 . . . . 0.58999999999999997 110.519 179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -97.35 99.62 11.06 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.171 -0.677 . . . . 2.3900000000000001 109.171 171.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.471 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 2.7 pp -72.46 -3.02 3.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.479 0.657 . . . . 2.02 110.903 -178.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 143.12 -25.75 2.2 Favored Glycine 0 N--CA 1.44 -1.061 0 N-CA-C 109.067 -1.613 . . . . 2.6099999999999999 109.067 -173.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 C--O 1.248 0.976 0 CA-C-N 114.771 -0.715 . . . . 3.6899999999999999 109.595 176.189 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.7 0.286 . . . . 30.309999999999999 110.272 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 57.83 40.98 25.56 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.758 -0.656 . . . . 28.059999999999999 111.878 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 93.8 mmm 61.29 61.62 1.51 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.914 -0.585 . . . . 28.52 110.93 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.94 -29.17 58.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.888 -0.596 . . . . 26.559999999999999 110.414 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.52 147.68 39.05 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.356 -0.609 . . . . 25.140000000000001 109.356 175.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 15' ' ' ILE . 4.1 mp -119.15 63.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.758 0.79 . . . . 24.989999999999998 109.42 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.63 37.79 2.17 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.503 -0.771 . . . . 22.920000000000002 112.745 175.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.0 m -96.37 103.56 15.47 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.886 0.375 . . . . 22.809999999999999 110.619 178.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.5 p -74.67 118.66 17.89 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.063 -0.517 . . . . 22.210000000000001 110.772 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 71.43 -67.39 0.26 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.587 -0.733 . . . . 20.949999999999999 111.548 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.0 m -130.44 140.63 39.23 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-O 120.804 0.335 . . . . 19.190000000000001 110.978 -177.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.28 48.39 2.67 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.911 2.408 . . . . 17.98 112.312 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.528 ' HA ' ' OD1' ' A' ' 113' ' ' ASN . 43.4 ttp180 -89.19 96.48 10.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.3 -0.409 . . . . 18.07 110.864 -177.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 59.88 30.2 19.74 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.632 -0.713 . . . . 14.66 112.263 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.1 t -71.17 -41.25 75.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 109.014 -0.736 . . . . 13.029999999999999 109.014 175.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -124.43 11.04 8.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.159 -0.928 . . . . 12.26 109.65 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.01 -106.23 0.4 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.465 -0.789 . . . . 9.9700000000000006 112.138 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 118.5 116.38 2.7 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.769 -0.729 . . . . 8.2200000000000006 112.274 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.695 HG22 ' HD2' ' A' ' 30' ' ' PRO . 2.2 m 70.25 120.44 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 123.352 0.661 . . . . 7.2999999999999998 111.136 179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 31' ' ' LYS . 88.5 Cg_exo -43.42 -45.03 10.45 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.906 3.737 . . . . 6.0999999999999996 116.225 -174.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.695 ' HD2' HG22 ' A' ' 28' ' ' THR . 13.9 Cg_exo -67.63 102.06 0.7 Allowed 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 121.696 1.598 . . . . 5.1900000000000004 111.683 -178.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 113' ' ' ASN . 32.7 mmtp -102.14 4.15 39.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.997 -0.547 . . . . 3.79 110.416 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 28.1 t -71.48 170.35 13.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.964 -0.562 . . . . 1.74 110.796 -176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 59.4 m -106.1 150.1 26.11 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.558 -0.746 . . . . 1.7 109.987 -177.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.1 p -85.36 -12.03 53.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.047 0.451 . . . . 2.5699999999999998 110.578 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 t -95.29 21.06 8.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.494 0.664 . . . . 2.5 109.981 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 33' ' ' CYS . . . 135.42 150.1 5.94 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.229 -0.749 . . . . 1.51 111.229 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.603 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 74.0 Cg_endo -71.01 -159.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.519 2.146 . . . . 1.05 112.98 -178.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 39' ' ' TYR . 38.8 t -80.29 162.56 3.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.009 -0.541 . . . . 0.58999999999999997 110.236 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.604 ' HB3' ' SG ' ' A' ' 76' ' ' CYS . 94.9 m-85 -137.35 135.89 37.44 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.933 0.396 . . . . 0.78000000000000003 110.259 177.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.802 ' SG ' ' HB2' ' A' ' 77' ' ' SER . 22.1 p -104.04 102.55 12.31 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 121.869 0.842 . . . . 0.81999999999999995 110.411 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.8 m -100.21 128.98 46.17 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.104 -0.953 . . . . 0.23999999999999999 109.037 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 49.3 m-80 -57.6 -23.44 50.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.566 0.698 . . . . 2.0800000000000001 110.47 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HA ' ' HE3' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -161.61 128.96 4.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.31 -1.314 . . . . 2.5800000000000001 107.902 176.339 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.558 HG21 HG11 ' A' ' 94' ' ' VAL . 23.0 p -87.46 155.24 20.1 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.151 -1.02 . . . . 0.37 109.769 167.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.617 ' HB3' HG22 ' A' ' 72' ' ' VAL . 6.2 tp10 -120.09 133.84 55.41 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.503 -0.771 . . . . 1.1200000000000001 109.545 -179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 49' ' ' HIS . 15.4 m-20 -69.83 112.62 6.39 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.507 -0.769 . . . . 1.77 109.788 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.5 p -52.67 -27.9 19.31 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 123.781 0.676 . . . . 0.92000000000000004 112.183 -177.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -89.45 -10.59 45.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.69 0.281 . . . . 2.77 111.519 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 46' ' ' ASP . 58.9 m-70 -127.79 34.29 4.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.739 0.304 . . . . 2.3300000000000001 111.088 -177.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.453 HD23 ' HG3' ' A' ' 45' ' ' GLU . 96.0 mt -67.46 145.48 54.94 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.153 0.501 . . . . 1.1599999999999999 111.668 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -86.79 169.55 12.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.382 -0.826 . . . . 1.8100000000000001 109.71 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.71 -41.94 99.4 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.9 -0.32 . . . . 3.23 110.72 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.85 -42.28 85.63 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.308 -0.472 . . . . 0.34000000000000002 112.969 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.67 ' HA ' HD22 ' A' ' 57' ' ' LEU . 86.9 m -82.6 -42.05 18.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.733 0.267 . . . . 0.35999999999999999 111.121 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.3 m -54.5 -33.39 59.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.211 0.529 . . . . 0.29999999999999999 110.074 173.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.585 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -57.57 -54.94 41.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.13 -0.941 . . . . 0.23000000000000001 111.703 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.67 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -56.39 -47.16 79.52 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.494 0.664 . . . . 0.23999999999999999 110.057 -178.164 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 54' ' ' THR . 34.2 mt -57.95 -43.69 86.54 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.738 -1.119 . . . . 0.17999999999999999 110.169 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.19 -36.62 93.25 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.835 -0.698 . . . . 0.26000000000000001 112.395 176.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 19.8 mt -62.68 -44.71 95.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.875 0.845 . . . . 0.34000000000000002 109.939 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.509 ' CD1' HG21 ' A' ' 105' ' ' VAL . 6.1 mt -87.16 1.48 52.92 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.459 -1.246 . . . . 0.35999999999999999 111.411 -175.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 69.24 27.5 5.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.702 -0.681 . . . . 1.8899999999999999 111.628 174.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 58' ' ' LEU . 56.8 mt -78.69 142.48 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.953 -0.567 . . . . 0.26000000000000001 110.291 178.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.479 ' N ' ' HD2' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -90.07 117.84 29.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.846 -0.615 . . . . 2.2200000000000002 110.058 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.27 -36.94 50.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.89 -0.596 . . . . 0.28999999999999998 109.809 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.2 -10.48 84.29 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.682 -0.69 . . . . 0.56999999999999995 112.511 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 64' ' ' LYS . 28.3 t70 -101.83 -9.65 20.58 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.036 0.446 . . . . 0.85999999999999999 110.733 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 64' ' ' LYS . 89.1 mt -55.71 134.99 51.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.261 0.553 . . . . 0.46000000000000002 110.538 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.47 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 3.4 mptp? -82.35 -51.15 8.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.093 -0.958 . . . . 2.0099999999999998 112.25 -169.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' HB3' ' O ' ' A' ' 109' ' ' CYS . 1.1 t70 -139.37 -82.45 0.28 Allowed 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.608 -0.437 . . . . 1.0900000000000001 110.843 -178.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.4 mm? -114.44 173.95 6.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.383 0.611 . . . . 0.14999999999999999 110.722 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.617 HG22 ' HB3' ' A' ' 45' ' ' GLU . 1.2 m -121.92 166.1 16.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 106.62 -1.622 . . . . 0.25 106.62 164.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.4 ' N ' HG23 ' A' ' 72' ' ' VAL . . . -137.1 126.16 3.6 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 119.806 -1.188 . . . . 0.37 112.055 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.654 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -99.58 139.59 35.02 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.11 -0.636 . . . . 0.28999999999999998 110.018 -178.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.448 ' H ' ' HA ' ' A' ' 104' ' ' LEU . 2.1 t-20 50.17 55.42 9.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.113 0.959 . . . . 1.8500000000000001 109.889 178.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 39' ' ' TYR . 20.9 t -105.4 146.77 29.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.043 -1.435 . . . . 1.1200000000000001 110.198 -171.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.802 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . 19.8 m -103.6 139.56 20.23 Favored Pre-proline 0 C--N 1.322 -0.603 0 C-N-CA 120.528 -0.469 . . . . 1.26 110.265 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 6.1 Cg_exo -80.45 119.84 3.86 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.614 2.209 . . . . 0.60999999999999999 112.472 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.651 HD11 ' SG ' ' A' ' 40' ' ' CYS . 5.6 mp -97.13 87.02 4.09 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.224 -0.658 . . . . 0.85999999999999999 109.224 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.411 ' HA ' ' HG3' ' A' ' 37' ' ' PRO . 23.8 p -77.81 -34.04 52.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.085 -0.507 . . . . 1.3700000000000001 111.035 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.6 m -103.31 125.75 57.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.205 0.526 . . . . 1.6000000000000001 110.481 178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.5 mm -83.34 137.87 20.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.008 -0.542 . . . . 1.8500000000000001 110.17 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.77 -102.26 1.29 Allowed Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.984 -0.846 . . . . 3.1800000000000002 110.984 -176.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 m -62.91 103.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.253 0.549 . . . . 4.6900000000000004 111.008 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.58 19.71 79.01 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.816 -0.707 . . . . 4.3499999999999996 111.714 -176.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -110.89 -42.22 1.13 Allowed Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.901 -0.666 . . . . 3.27 112.03 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -91.47 -21.08 21.11 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.118 0.485 . . . . 5.4699999999999998 110.414 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.5 p -140.0 113.5 8.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.561 -0.745 . . . . 4.7000000000000002 109.333 175.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.46 ' SG ' HD11 ' A' ' 79' ' ' LEU . 24.9 t -123.54 19.86 9.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.331 -0.395 . . . . 1.6599999999999999 110.72 -175.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 14.5 m 65.63 0.69 1.52 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.872 -0.604 . . . . 1.6499999999999999 111.545 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -140.25 172.58 12.54 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.179 -0.464 . . . . 0.54000000000000004 109.851 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.35 130.57 41.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.096 0.474 . . . . 0.78000000000000003 110.872 -174.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.2 120.18 37.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.47 0.652 . . . . 0.39000000000000001 112.562 -172.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 44' ' ' THR . 5.5 m -134.65 168.3 23.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.024 -0.989 . . . . 0.22 110.043 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.8 t -116.97 117.89 30.91 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.122 -0.696 . . . . 0.70999999999999996 109.122 177.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 25.0 m -111.19 151.26 28.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.925 0.393 . . . . 0.60999999999999999 110.887 -172.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.5 t -81.09 -28.81 35.08 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.963 -0.562 . . . . 0.38 110.664 -173.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.414 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 14.5 m120 -155.06 156.98 36.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.588 -0.733 . . . . 0.78000000000000003 109.11 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.9 t -136.18 144.62 45.06 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.048 -0.353 . . . . 0.41999999999999998 110.048 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.568 ' HB2' HG23 ' A' ' 105' ' ' VAL . 67.3 m-85 -138.33 161.93 35.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.674 0.273 . . . . 0.77000000000000002 110.915 -177.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.593 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 7.5 mm100 62.63 33.27 15.84 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.03 -0.532 . . . . 0.80000000000000004 112.255 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 65.43 -0.31 1.21 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.843 0.457 . . . . 2.1200000000000001 112.067 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 137.55 -13.41 3.71 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.483 -0.865 . . . . 0.28000000000000003 112.883 177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.654 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 22.5 mt -55.25 -36.51 66.14 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 117.358 0.579 . . . . 0.35999999999999999 110.862 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.568 HG23 ' HB2' ' A' ' 100' ' ' TYR . 12.2 m -129.97 147.32 33.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.303 0.573 . . . . 0.85999999999999999 110.529 174.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 4.2 t-20 -143.04 143.06 31.73 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.873 -1.158 . . . . 0.91000000000000003 107.873 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 18.0 m -123.79 149.9 27.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 113.062 0.764 . . . . 0.29999999999999999 113.062 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 59.85 54.45 37.45 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 114.913 -1.04 . . . . 0.20000000000000001 111.536 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.512 ' O ' ' HB3' ' A' ' 70' ' ' ASP . 74.8 m -97.92 123.5 41.93 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.757 0.313 . . . . 0.42999999999999999 110.54 -173.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.3 p -118.95 126.82 26.87 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.817 -0.629 . . . . 0.29999999999999999 110.91 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.459 ' HA ' HG12 ' A' ' 94' ' ' VAL . 54.2 Cg_exo -51.22 113.26 1.04 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.036 2.491 . . . . 0.34000000000000002 112.141 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.8 tt -98.05 121.25 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.906 -0.588 . . . . 0.58999999999999997 111.512 -175.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.528 ' OD1' ' HA ' ' A' ' 22' ' ' ARG . 26.3 t-20 -98.22 106.22 18.48 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.79 -0.641 . . . . 2.3900000000000001 109.88 175.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 115' ' ' GLY . 1.4 pp -90.04 -19.75 7.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.362 -0.381 . . . . 2.02 111.002 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.482 ' N ' HD12 ' A' ' 114' ' ' ILE . . . 89.74 -19.34 41.77 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.781 -0.724 . . . . 2.6099999999999999 114.357 173.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.513 HD23 ' H ' ' A' ' 116' ' ' LEU . 1.4 pt? . . . . . 0 C--O 1.244 0.771 0 CA-C-N 117.759 0.779 . . . . 3.6899999999999999 110.88 -176.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 110.061 -0.348 . . . . 30.309999999999999 110.061 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 71.19 -63.35 0.42 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.021 0.825 . . . . 28.059999999999999 112.105 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.53 ' HG2' ' H ' ' A' ' 14' ' ' ASP . 49.5 ttm -131.52 118.9 20.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.672 0.272 . . . . 28.52 110.306 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.05 24.05 9.09 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.752 0.311 . . . . 26.559999999999999 110.924 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.53 ' H ' ' HG2' ' A' ' 12' ' ' MET . 11.8 m-20 67.52 -80.72 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.37 -0.832 . . . . 25.140000000000001 111.569 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.0 pt -98.88 174.1 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.042 -0.527 . . . . 24.989999999999998 111.217 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -152.31 -166.45 14.19 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.321 -0.711 . . . . 22.920000000000002 111.321 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.5 t -117.02 25.19 10.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.507 0.67 . . . . 22.809999999999999 110.115 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 p -112.73 122.91 49.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.708 -0.678 . . . . 22.210000000000001 110.864 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 68.76 162.67 0.21 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.332 0.653 . . . . 20.949999999999999 111.417 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.97 111.26 65.24 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.857 -0.61 . . . . 19.190000000000001 110.532 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.68 114.18 3.02 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.832 2.355 . . . . 17.98 111.548 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -84.48 80.06 9.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.371 -0.377 . . . . 18.07 110.796 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.0 t70 69.32 -65.24 0.31 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.765 0.826 . . . . 14.66 110.717 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 p -136.93 125.15 33.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.228 -0.656 . . . . 13.029999999999999 109.228 175.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.586 ' H ' HD22 ' A' ' 25' ' ' ASN . 0.1 OUTLIER -127.45 45.02 2.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.603 0.716 . . . . 12.26 111.057 -175.713 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -139.11 174.53 22.11 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.433 -0.803 . . . . 9.9700000000000006 111.921 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.47 -176.86 14.59 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.308 -0.717 . . . . 8.2200000000000006 111.308 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.488 HG22 ' HD2' ' A' ' 30' ' ' PRO . 5.1 m -82.28 125.3 77.06 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 117.019 0.41 . . . . 7.2999999999999998 110.079 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -41.27 -51.07 4.18 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 124.188 3.258 . . . . 6.0999999999999996 116.312 -173.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.488 ' HD2' HG22 ' A' ' 28' ' ' THR . 2.0 Cg_endo -80.66 3.85 7.39 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.072 1.848 . . . . 5.1900000000000004 113.165 -171.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -131.41 115.31 16.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.73 0.3 . . . . 3.79 110.728 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.5 t -175.11 -178.45 1.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 1.74 110.365 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 60.3 m -122.14 142.64 50.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.062 -0.517 . . . . 1.7 109.808 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.5 m -74.39 -6.68 49.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.955 0.407 . . . . 2.5699999999999998 111.055 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.9 t -72.93 -25.53 61.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.115 -0.493 . . . . 2.5 110.604 177.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.03 -174.98 28.49 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.515 -0.85 . . . . 1.51 112.458 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -41.46 149.75 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.282 3.321 . . . . 1.05 114.295 176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.413 HG12 ' N ' ' A' ' 39' ' ' TYR . 96.7 t -78.83 161.04 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.914 -1.039 . . . . 0.58999999999999997 108.744 174.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.413 ' N ' HG12 ' A' ' 38' ' ' VAL . 97.0 m-85 -123.98 141.05 52.38 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.483 0.659 . . . . 0.78000000000000003 111.362 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' ' 91' ' ' ALA . 49.5 t -113.16 111.24 21.76 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.272 -0.876 . . . . 0.81999999999999995 109.993 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 67.2 m -107.69 133.11 52.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.095 0.474 . . . . 0.23999999999999999 110.001 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -53.99 -26.48 26.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.173 -0.921 . . . . 2.0800000000000001 110.559 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.458 ' HE2' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -173.32 123.26 0.38 Allowed 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.896 -1.15 . . . . 2.5800000000000001 107.896 179.293 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.525 HG21 HG11 ' A' ' 94' ' ' VAL . 12.5 p -78.66 154.98 29.72 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 119.466 -0.893 . . . . 0.37 110.727 172.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.557 ' HG3' HD23 ' A' ' 50' ' ' LEU . 7.8 tp10 -120.88 137.94 54.33 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.979 -0.749 . . . . 1.1200000000000001 108.979 -179.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.489 ' HA ' HD12 ' A' ' 71' ' ' LEU . 11.6 m-20 -75.32 107.98 7.8 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.942 -0.572 . . . . 1.77 109.91 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.474 ' HA ' HD21 ' A' ' 50' ' ' LEU . 9.4 m -47.18 -31.17 3.39 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.849 0.718 . . . . 0.92000000000000004 111.987 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 11.4 mptt -68.17 -40.95 82.15 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.5 0.667 . . . . 2.77 110.638 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -124.36 51.89 1.55 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.14 -0.936 . . . . 2.3300000000000001 110.934 -174.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.557 HD23 ' HG3' ' A' ' 45' ' ' GLU . 82.0 mt -62.96 159.92 15.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.573 0.701 . . . . 1.1599999999999999 112.215 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -92.8 146.85 23.33 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.722 -1.126 . . . . 1.8100000000000001 109.059 175.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -59.37 -25.06 63.93 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.239 0.337 . . . . 3.23 110.949 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.62 -41.45 83.95 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.759 -0.734 . . . . 0.34000000000000002 111.844 176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.644 ' HA ' HD22 ' A' ' 57' ' ' LEU . 98.3 m -81.15 -42.98 20.06 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.761 0.315 . . . . 0.35999999999999999 110.559 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 97.7 m -54.84 -32.51 60.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.912 -0.586 . . . . 0.29999999999999999 110.188 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 60' ' ' LEU . . . -56.58 -54.43 46.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.562 -0.744 . . . . 0.23000000000000001 111.406 175.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.644 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -58.44 -44.59 89.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 121.401 0.62 . . . . 0.23999999999999999 110.147 -177.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 54' ' ' THR . 42.6 mt -58.9 -43.92 91.12 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.066 -0.97 . . . . 0.17999999999999999 110.172 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.92 -35.79 91.04 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.928 -0.653 . . . . 0.26000000000000001 112.537 175.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 56' ' ' ALA . 16.9 mt -61.66 -39.81 92.68 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.751 0.786 . . . . 0.34000000000000002 110.022 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.454 ' CD1' HG21 ' A' ' 105' ' ' VAL . 4.8 mt -91.61 2.06 56.72 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 114.7 -1.136 . . . . 0.35999999999999999 111.085 -176.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 68.28 30.12 5.71 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.85 0.833 . . . . 1.8899999999999999 110.691 173.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 58' ' ' LEU . 54.1 mt -80.93 141.62 14.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.78 -0.646 . . . . 0.26000000000000001 110.262 177.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.459 ' HD2' ' H ' ' A' ' 64' ' ' LYS . 0.0 OUTLIER -92.75 118.96 31.64 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.818 -0.628 . . . . 2.2200000000000002 110.062 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.05 -29.35 28.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.454 -0.794 . . . . 0.28999999999999998 110.856 -175.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.42 -18.02 78.08 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.72 -0.752 . . . . 0.56999999999999995 112.46 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -88.03 -19.18 27.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.071 0.462 . . . . 0.85999999999999999 110.393 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 91.6 mt -59.33 126.36 27.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.488 -0.778 . . . . 0.46000000000000002 110.986 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -91.27 -76.32 0.45 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.053 -0.976 . . . . 2.0099999999999998 112.202 -172.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -90.11 -112.11 0.08 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.457 -0.338 . . . . 1.0900000000000001 111.268 -173.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 46' ' ' ASP . 1.6 mm? -105.7 170.81 7.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.206 0.527 . . . . 0.14999999999999999 111.182 176.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG22 ' HB3' ' A' ' 45' ' ' GLU . 1.6 m -122.99 167.56 16.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 106.999 -1.482 . . . . 0.25 106.999 167.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.514 ' HA3' ' SG ' ' A' ' 76' ' ' CYS . . . -138.01 144.56 15.87 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.725 -1.226 . . . . 0.37 111.847 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -102.76 127.59 49.85 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.373 -0.531 . . . . 0.28999999999999998 110.279 175.051 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.53 ' N ' HD22 ' A' ' 75' ' ' ASN . 0.8 OUTLIER 57.75 54.99 5.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.742 -1.117 . . . . 1.8500000000000001 111.15 177.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.514 ' SG ' ' HA3' ' A' ' 73' ' ' GLY . 47.0 m -87.56 142.27 27.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.356 -0.838 . . . . 1.1200000000000001 110.913 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 14.2 t -98.25 123.41 50.84 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.758 -0.656 . . . . 1.26 109.804 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 77' ' ' SER . 12.9 Cg_exo -70.45 120.45 7.14 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.573 2.182 . . . . 0.60999999999999999 112.123 175.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.3 mt -95.52 88.85 5.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.767 -0.651 . . . . 0.85999999999999999 109.728 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.4 p -92.75 -46.32 7.61 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.853 -0.612 . . . . 1.3700000000000001 111.724 -174.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 14.7 m -81.7 102.28 7.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.962 0.887 . . . . 1.6000000000000001 111.303 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 46.7 mm -91.3 137.74 21.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.255 -0.884 . . . . 1.8500000000000001 110.799 -179.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.18 -43.07 3.18 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.706 -0.759 . . . . 3.1800000000000002 111.718 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 38.8 t -79.14 79.85 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.887 -0.412 . . . . 4.6900000000000004 109.887 176.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.99 62.05 4.23 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.692 -0.766 . . . . 4.3499999999999996 111.624 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.7 -116.24 2.24 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.646 -0.787 . . . . 3.27 112.607 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 64.86 -86.7 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.291 0.636 . . . . 5.4699999999999998 111.294 -176.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.0 p -108.23 166.03 11.05 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.772 0.32 . . . . 4.7000000000000002 110.526 -178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 p -125.43 162.92 23.75 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.138 -0.69 . . . . 1.6599999999999999 109.138 179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.4 m -71.48 1.29 6.64 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.422 0.527 . . . . 1.6499999999999999 112.422 -170.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.478 ' HB3' ' SG ' ' A' ' 40' ' ' CYS . . . -151.98 -157.14 0.77 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.564 0.221 . . . . 0.54000000000000004 111.051 -176.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.77 130.65 37.98 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.64 -0.504 . . . . 0.78000000000000003 109.64 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.65 123.42 47.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.331 0.586 . . . . 0.39000000000000001 110.952 -173.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 44' ' ' THR . 6.1 m -134.61 166.41 28.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.634 -0.712 . . . . 0.22 111.647 -177.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 38.5 t -110.73 116.48 31.38 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.317 -0.856 . . . . 0.70999999999999996 108.965 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 108' ' ' GLY . 16.1 m -118.63 150.15 40.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.835 0.35 . . . . 0.60999999999999999 110.642 -171.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.405 HG22 ' HA3' ' A' ' 108' ' ' GLY . 8.4 t -78.13 -32.2 50.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.81 -0.632 . . . . 0.38 110.827 -173.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.45 ' HB2' ' CG2' ' A' ' 107' ' ' VAL . 18.6 m120 -155.72 163.48 39.82 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.862 -0.608 . . . . 0.78000000000000003 109.715 -176.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -139.63 148.68 42.8 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.62 -0.511 . . . . 0.41999999999999998 109.62 177.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.609 ' HB2' HG23 ' A' ' 105' ' ' VAL . 60.6 m-85 -134.56 154.39 51.49 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.469 -0.567 . . . . 0.77000000000000002 109.469 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.552 ' O ' ' HG ' ' A' ' 104' ' ' LEU . 8.4 mm100 64.91 29.46 12.4 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.335 0.397 . . . . 0.80000000000000004 111.489 176.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.7 m170 63.96 11.5 6.12 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.951 -0.568 . . . . 2.1200000000000001 111.991 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 132.23 -17.77 4.78 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 120.136 -1.031 . . . . 0.28000000000000003 113.333 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.621 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 14.7 mt -50.55 -40.25 51.49 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.556 0.678 . . . . 0.35999999999999999 110.742 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.609 HG23 ' HB2' ' A' ' 100' ' ' TYR . 4.3 m -127.05 142.63 42.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.656 -0.702 . . . . 0.85999999999999999 109.698 171.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 24.1 t30 -138.61 143.57 39.38 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.15 -1.056 . . . . 0.91000000000000003 108.15 -175.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.45 ' CG2' ' HB2' ' A' ' 98' ' ' ASN . 12.2 m -126.19 152.24 33.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 113.393 0.886 . . . . 0.29999999999999999 113.393 -172.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 96' ' ' CYS . . . 60.06 52.73 51.05 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 114.703 -1.135 . . . . 0.20000000000000001 112.057 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' CYS . . . . . 0.434 ' HB2' ' HB2' ' A' ' 71' ' ' LEU . 93.7 m -96.65 126.72 42.02 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.951 0.405 . . . . 0.42999999999999999 112.005 -175.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.3 p -119.46 126.02 27.2 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.74 -0.664 . . . . 0.29999999999999999 110.313 174.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.521 ' HA ' HG12 ' A' ' 94' ' ' VAL . 70.8 Cg_exo -51.33 110.08 0.38 Allowed 'Trans proline' 0 C--O 1.234 0.324 0 C-N-CA 122.997 2.465 . . . . 0.34000000000000002 112.417 177.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 4.9 tt -89.8 127.57 42.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.706 -0.679 . . . . 0.58999999999999997 110.098 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -84.58 99.12 10.55 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.962 -0.755 . . . . 2.3900000000000001 108.962 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 115' ' ' GLY . 1.4 pp -67.07 -23.86 31.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.025 -0.534 . . . . 2.02 112.41 -175.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.514 ' N ' HD12 ' A' ' 114' ' ' ILE . . . 51.33 29.91 24.01 Favored Glycine 0 C--N 1.335 0.473 0 CA-C-N 115.244 -0.889 . . . . 2.6099999999999999 114.009 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.48 -0.771 . . . . 3.6899999999999999 110.248 -178.242 . . . . . . . . 0 0 . 1 stop_ save_